data_1awz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1awz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 CA--C 1.501 -0.936 0 N-CA-C 110.621 -0.141 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -90.38 -1.64 57.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.45 -45.35 59.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.55 -52.72 63.72 Favored 'General case' 0 N--CA 1.412 -2.344 0 C-N-CA 125.538 1.535 . . . . 0.0 112.366 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.449 1.8 t -87.97 9.8 21.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.99 -42.2 33.45 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 120.207 -1.558 . . . . 0.0 107.463 157.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -59.77 -36.91 77.64 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.982 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 mt -83.77 -15.91 46.71 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 119.567 1.076 . . . . 0.0 113.863 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.7 m -65.8 -48.61 71.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 119.911 1.232 . . . . 0.0 108.908 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -72.91 -37.25 67.31 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -104.34 -53.64 2.68 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.251 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 14.8 t80 -76.61 115.33 16.27 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 119.232 0.924 . . . . 0.0 110.123 -168.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -134.76 98.73 4.12 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.11 -38.01 16.72 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -165.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -159.77 134.52 5.52 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -71.54 178.05 6.09 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 123.051 2.501 . . . . 0.0 114.66 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.31 -59.63 2.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -179.36 22.73 Favored Glycine 0 CA--C 1.478 -2.228 0 N-CA-C 104.403 -3.479 . . . . 0.0 104.403 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.507 HH21 ' HG3' ' A' ' 77' ' ' GLN . 11.1 mpt_? -106.84 73.46 0.94 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -156.92 173.46 16.97 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.41 -20.77 62.9 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 125.373 1.469 . . . . 0.0 113.963 -169.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -80.46 -29.61 37.47 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.32 -41.58 66.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . 0.27 0.7 OUTLIER -80.34 -25.39 39.27 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.729 -1.188 . . . . 0.0 113.097 -170.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.01 -36.48 69.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 118.99 -0.528 . . . . 0.0 110.175 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.4 t -65.65 -42.96 90.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.37 -28.09 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 117.83 0.286 . . . . 0.0 111.199 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 mmt -74.25 -29.99 61.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.035 -0.415 . . . . 0.0 110.325 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.424 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.3 tpp180 -66.43 -45.75 78.82 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.774 0.83 . . . . 0.0 111.869 172.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -80.22 -39.68 28.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -170.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.47 -39.65 74.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.46 68.82 1.34 Allowed Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 mt -113.94 21.83 14.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 163.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -94.6 -5.78 45.01 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 109.085 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -132.6 102.66 13.75 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.86 163.31 89.39 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.484 -1.776 . . . . 0.0 107.484 -18.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.62 125.75 24.87 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 124.492 1.117 . . . . 0.0 110.693 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -76.19 138.46 40.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.83 -40.71 60.89 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 123.432 0.457 . . . . 0.0 111.256 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.91 128.0 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -148.79 131.72 16.17 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 m -96.97 124.38 40.92 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.645 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.98 120.08 30.88 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.77 149.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.636 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -143.37 138.46 29.43 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.98 -140.28 6.78 Favored Glycine 0 CA--C 1.484 -1.871 0 N-CA-C 106.651 -2.579 . . . . 0.0 106.651 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.38 146.55 25.07 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 1.2 tmtp? -83.89 -25.4 30.23 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -70.75 -34.23 71.63 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.006 1.323 . . . . 0.0 108.708 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -69.93 -41.44 74.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 117.614 -1.184 . . . . 0.0 110.459 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.74 -50.73 76.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 123.837 0.855 . . . . 0.0 111.909 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -63.87 -37.67 88.24 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.343 0.657 . . . . 0.0 111.188 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.35 4.81 8.15 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.0 mm -77.3 -26.85 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.7 t -82.74 -15.02 53.42 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.152 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.47 154.41 38.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -83.34 -7.49 59.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.757 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -80.41 -41.84 23.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.921 0.488 . . . . 0.0 109.769 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -123.29 31.46 5.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.67 136.95 3.37 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -90.01 154.02 47.27 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.572 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 37.2 Cg_endo -74.79 138.43 23.58 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 122.335 2.024 . . . . 0.0 106.974 169.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -130.67 104.77 7.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.47 ' CD ' ' H ' ' A' ' 67' ' ' GLU 0.398 0.0 OUTLIER 46.31 -109.59 0.23 Allowed 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 127.806 2.442 . . . . 0.0 115.661 -177.862 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 50.2 mt-10 -107.33 77.47 1.15 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.766 1.226 . . . . 0.0 108.763 -165.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.372 1.2 p-10 76.59 12.12 2.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 129.102 2.961 . . . . 0.0 114.345 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.3 mp -95.82 154.17 17.36 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HE ' ' HA ' ' A' ' 64' ' ' PRO . 13.8 mmp_? -136.57 112.64 9.7 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -95.73 132.21 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.2 p -82.45 157.05 23.79 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.652 0.739 . . . . 0.0 112.424 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -108.94 -15.93 14.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.533 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -112.91 90.57 3.38 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.8 m -50.92 133.23 27.05 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 127.402 2.281 . . . . 0.0 112.419 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.4 161.3 15.43 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' HH21 ' A' ' 21' ' ' ARG . 0.3 OUTLIER -82.16 126.77 32.44 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 175.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 108.5 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.2 m -94.82 108.31 20.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.1 m -91.83 102.9 15.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.2 m -93.3 117.65 30.33 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.54 144.73 37.43 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -78.98 126.67 30.99 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.72 52.58 2.04 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.69 -70.54 1.18 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.71 -32.44 4.44 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.9 t -87.48 135.34 34.47 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -78.38 -22.65 9.35 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.161 1.908 . . . . 0.0 109.074 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -95.32 167.4 12.89 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -72.32 142.63 37.69 Favored 'Trans proline' 0 N--CA 1.438 -1.788 0 C-N-CA 122.028 1.819 . . . . 0.0 107.526 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.424 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.0 Cg_endo -88.15 164.56 42.96 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 CA-C-N 122.63 1.975 . . . . 0.0 108.775 15.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.7 m -130.01 122.66 28.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -94.87 117.35 30.0 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -107.28 122.6 46.88 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -96.79 121.4 38.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.67 130.33 35.02 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.9 m -118.05 95.4 4.89 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.94 34.27 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.105 -173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.94 -176.18 19.61 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.328 -3.109 . . . . 0.0 105.328 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -148.43 109.71 4.37 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.568 -3.123 . . . . 0.0 102.568 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -162.12 175.11 12.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.971 0.891 . . . . 0.0 109.018 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -77.56 142.24 39.11 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 125.244 1.418 . . . . 0.0 110.675 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.38 150.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.12 91.73 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 166.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.64 132.62 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.52 125.02 36.97 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.3 t -108.67 131.24 55.09 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -126.19 136.84 53.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 13.1 p30 65.05 18.98 11.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 127.514 2.326 . . . . 0.0 117.083 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.9 54.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 0.4 OUTLIER -134.47 132.2 20.76 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 -178.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.95 108.21 2.6 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 N-CA-C 105.78 -2.431 . . . . 0.0 105.78 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 m -94.27 -11.72 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -172.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.455 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 61.9 t60 -153.85 179.53 8.79 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -169.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.455 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -164.21 130.58 3.06 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.85 135.02 36.92 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.251 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -100.86 41.84 1.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.3 t -96.38 -32.39 12.39 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.89 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.837 172.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.422 -1.854 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -171.434 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.319 0.5 OUTLIER . . . . . 0 CA--C 1.489 -1.393 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 m -92.19 -13.82 29.98 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -43.68 67.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.268 41.4 t80 -56.82 -51.96 66.95 Favored 'General case' 0 N--CA 1.399 -3.012 0 C-N-CA 126.623 1.969 . . . . 0.0 113.422 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.42 ' HA ' ' HG ' ' A' ' 10' ' ' LEU 0.252 1.5 p -82.06 -3.24 54.22 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -85.63 -31.21 22.7 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 120.136 1.335 . . . . 0.0 108.229 167.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.18 -36.98 85.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.407 1.083 . . . . 0.0 109.405 167.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.295 8.9 mt -69.25 -31.15 69.5 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 170.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.6 m -65.26 -44.28 88.61 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 119.509 1.049 . . . . 0.0 108.936 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.465 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 66.5 mt-30 -70.0 -55.16 10.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 123.556 0.535 . . . . 0.0 111.92 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 91.1 m-70 -96.49 -49.44 5.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.913 -162.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -71.15 115.09 9.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 120.065 1.302 . . . . 0.0 112.635 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -138.56 98.05 3.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 100.789 -3.782 . . . . 0.0 100.789 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.82 -40.69 10.09 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.515 2.326 . . . . 0.0 117.055 -168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -157.63 144.11 13.04 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -76.51 178.39 7.61 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.507 2.138 . . . . 0.0 112.916 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.64 -74.99 0.17 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.74 -176.44 14.74 Favored Glycine 0 CA--C 1.477 -2.336 1 N-CA-C 102.557 -4.217 . . . . 0.0 102.557 163.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -118.16 72.56 0.87 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -145.01 177.8 8.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.72 -22.33 63.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.704 1.202 . . . . 0.0 113.595 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.8 -29.45 40.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -41.87 69.48 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.43 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.282 0.8 OUTLIER -79.69 -26.92 40.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.227 -170.585 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.66 -35.47 70.36 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.286 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -67.73 -38.91 84.17 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 26' ' ' CYS . 4.1 tt -79.69 -30.85 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 118.535 0.607 . . . . 0.0 110.629 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -74.4 -30.09 61.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 122.392 -0.192 . . . . 0.0 111.0 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -68.43 -44.85 74.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.467 0.707 . . . . 0.0 111.873 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -71.2 -48.99 48.21 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.913 0.885 . . . . 0.0 112.277 -173.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -36.82 75.35 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.201 0.6 . . . . 0.0 110.408 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.58 68.79 1.36 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -114.91 22.48 13.41 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -91.25 -10.21 42.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 124.267 1.027 . . . . 0.0 109.132 -172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -129.99 104.54 16.82 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.65 160.01 95.66 Favored 'Cis proline' 0 N--CA 1.444 -1.404 0 N-CA-C 107.073 -1.934 . . . . 0.0 107.073 -20.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.92 125.26 23.37 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.059 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.01 143.17 45.67 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.03 -39.14 61.23 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.161 0.584 . . . . 0.0 111.541 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 tt -149.11 128.83 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -147.26 125.73 12.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 m -101.51 114.36 28.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.586 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -85.67 125.96 33.57 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.41 146.37 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.726 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -136.91 127.45 26.86 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 125.311 1.444 . . . . 0.0 107.949 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.65 -148.49 17.67 Favored Glycine 0 CA--C 1.483 -1.91 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -84.02 140.5 31.82 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 122.2 1.0 . . . . 0.0 108.33 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -85.27 -15.78 42.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.308 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -79.32 -31.42 43.18 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 125.317 1.447 . . . . 0.0 107.857 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.7 m -73.37 -36.47 66.11 Favored 'General case' 0 N--CA 1.424 -1.744 0 C-N-CA 124.177 0.991 . . . . 0.0 109.992 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.9 -52.25 63.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.996 0 C-N-CA 123.379 0.672 . . . . 0.0 110.992 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.05 -39.7 79.11 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.821 0.849 . . . . 0.0 112.849 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.69 10.35 3.34 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.9 mt -78.63 -30.53 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.0 t -68.08 -41.27 82.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.36 154.98 28.64 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.26 99.22 8.5 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -159.77 -49.08 0.05 Allowed 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.34 47.24 1.39 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.94 129.53 1.54 Allowed Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.76 160.63 32.66 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -72.64 138.26 28.98 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 122.914 2.409 . . . . 0.0 107.971 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -141.32 129.63 22.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 65.66 -108.72 0.16 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.052 1.341 . . . . 0.0 111.447 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -140.67 95.15 2.81 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.345 1.6 p-10 64.15 23.38 13.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 128.92 2.888 . . . . 0.0 114.327 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.9 mt -106.46 168.48 9.13 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -141.13 124.75 16.82 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.53 142.52 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.3 p -84.31 175.16 9.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.826 0.822 . . . . 0.0 110.418 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -131.45 -1.18 3.94 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -109.54 74.02 0.87 Allowed 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.4 p -51.19 123.89 10.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.137 1.775 . . . . 0.0 113.544 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -108.6 160.99 15.49 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.68 136.45 35.49 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.47 110.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -172.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.0 m -93.64 110.63 22.23 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.1 m -88.95 104.63 17.14 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.4 m -94.19 115.47 27.75 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.423 ' HZ2' ' HE2' ' A' ' 84' ' ' HIS . 6.9 mtmp? -110.13 147.66 33.25 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 tp -79.99 112.91 17.74 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.423 ' HE2' ' HZ2' ' A' ' 82' ' ' LYS . 88.2 m-70 -132.81 96.54 3.82 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.85 -40.92 0.06 OUTLIER Glycine 0 CA--C 1.479 -2.197 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.6 42.48 6.46 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.8 m -114.61 107.19 51.25 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -83.76 -20.53 4.53 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 CA-C-N 122.213 1.826 . . . . 0.0 108.398 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -110.17 161.32 24.93 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -73.96 144.45 34.32 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.665 2.244 . . . . 0.0 108.31 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -81.89 163.63 76.49 Favored 'Cis proline' 0 N--CA 1.437 -1.848 0 CA-C-N 122.641 1.979 . . . . 0.0 108.731 -1.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.1 m -108.53 159.41 16.72 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.739 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.18 98.7 7.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.77 128.3 44.32 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -101.34 121.03 41.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.46 132.67 35.2 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 48.4 m -116.12 105.52 12.69 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.1 125.53 29.48 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.3 177.99 18.75 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 105.691 -2.963 . . . . 0.0 105.691 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -158.95 111.13 2.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -161.21 171.12 18.98 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.24 133.77 42.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.852 172.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.65 149.51 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.424 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.98 122.38 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.35 138.94 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.21 132.16 36.28 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.5 t -104.42 133.81 48.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 124.744 1.278 . . . . 0.0 109.903 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -132.57 141.37 48.68 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 164.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.326 11.2 p30 66.34 17.79 10.76 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.301 2.24 . . . . 0.0 116.503 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.12 50.77 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.267 3.5 tp -143.43 149.84 49.21 Favored Pre-proline 0 CA--C 1.484 -1.591 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.19 147.21 78.5 Favored 'Trans proline' 0 N--CA 1.436 -1.898 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 164.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.28 -19.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 42.1 t60 -155.86 178.79 9.87 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 -165.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.447 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -159.32 146.43 16.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -173.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -95.44 141.23 29.23 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -115.56 20.71 14.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.301 1.04 . . . . 0.0 110.029 -170.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.3 m -95.13 -20.75 19.01 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 118.94 0.791 . . . . 0.0 109.938 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -33.0 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.42 1.088 . . . . 0.0 111.036 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -169.234 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.9 m -88.76 -26.52 21.7 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.13 -49.88 68.2 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.76 -57.3 11.37 Favored 'General case' 0 N--CA 1.4 -2.949 0 C-N-CA 127.209 2.204 . . . . 0.0 114.327 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -82.64 -2.34 53.67 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -86.12 -31.33 21.92 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -64.07 -41.18 97.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.373 166.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . 0.335 0.7 OUTLIER -61.16 -39.81 91.51 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 172.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -69.65 -46.22 66.64 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 120.072 1.305 . . . . 0.0 110.463 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.92 -5.18 59.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -127.29 -62.94 1.07 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.591 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -67.43 118.3 10.57 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.957 1.253 . . . . 0.0 112.02 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -147.27 99.29 3.13 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.94 -29.58 0.85 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -163.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -153.06 157.1 33.05 Favored Pre-proline 0 N--CA 1.434 -1.234 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.5 Cg_endo -74.41 157.5 45.2 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 123.188 2.592 . . . . 0.0 108.859 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.97 -63.22 1.31 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.62 177.0 18.64 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 103.072 -4.011 . . . . 0.0 103.072 161.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' HE ' ' HB3' ' A' ' 98' ' ' ALA . 77.8 mtp180 -109.53 68.28 0.67 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.06 173.9 14.87 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -170.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.82 -14.94 61.18 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.66 1.184 . . . . 0.0 113.093 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -32.29 53.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.112 0.565 . . . . 0.0 109.621 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.95 -41.47 61.97 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.45 -26.68 46.25 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 118.451 -1.299 . . . . 0.0 114.042 -170.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 -34.14 59.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.161 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -69.81 -32.56 71.06 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.286 14.6 tt -79.97 -35.12 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.198 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -22.31 59.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.223 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.82 -29.75 29.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 119.433 1.015 . . . . 0.0 112.959 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.6 -41.95 20.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 118.758 0.708 . . . . 0.0 110.91 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -72.42 -38.59 68.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.329 1.052 . . . . 0.0 109.54 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.73 68.01 1.41 Allowed Glycine 0 CA--C 1.48 -2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.83 17.66 16.9 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 t -90.54 -10.33 43.9 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 p -126.55 102.21 26.39 Favored Pre-proline 0 N--CA 1.428 -1.547 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.84 161.72 93.66 Favored 'Cis proline' 0 N--CA 1.445 -1.372 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -21.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 m -61.08 120.42 10.24 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.239 1.015 . . . . 0.0 109.673 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -79.82 145.82 32.59 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -68.78 -42.93 76.72 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.239 1.015 . . . . 0.0 113.103 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -156.4 134.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -147.91 137.01 22.15 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.4 m -99.62 122.97 43.43 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.13 122.25 35.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.4 144.45 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.508 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 20.8 m-70 -134.04 131.65 39.1 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 124.067 0.947 . . . . 0.0 108.454 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.34 -151.42 21.7 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 104.317 -3.513 . . . . 0.0 104.317 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' HB2' ' HG ' ' A' ' 52' ' ' SER . 3.2 m120 -89.83 152.88 21.06 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.62 -8.74 51.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -36.73 49.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.412 ' HG ' ' HB2' ' A' ' 49' ' ' ASN . 72.7 p -78.62 -28.47 45.64 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.798 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -66.14 -44.31 91.75 Favored 'Isoleucine or valine' 0 C--N 1.368 1.399 0 CA-C-N 120.324 1.42 . . . . 0.0 110.381 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.73 -33.67 76.15 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.49 1.116 . . . . 0.0 111.437 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 8.4 5.08 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.77 -19.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.1 m -75.76 -12.77 60.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.76 156.52 32.33 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -85.94 -13.4 47.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.224 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.83 -34.0 22.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 123.06 0.544 . . . . 0.0 109.875 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -124.23 45.02 2.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.75 141.26 3.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -89.84 154.29 47.73 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.83 138.37 28.65 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.771 2.314 . . . . 0.0 106.246 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -137.94 123.08 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 60.5 -109.81 0.42 Allowed 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 125.883 1.673 . . . . 0.0 112.451 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -134.77 95.18 3.29 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.348 1.2 p-10 69.83 16.55 7.77 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 129.253 3.021 . . . . 0.0 114.531 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.2 167.32 10.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -140.56 117.41 11.05 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.54 145.82 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -91.13 152.21 20.68 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.436 0.636 . . . . 0.0 111.653 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.76 -17.55 14.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 t -108.93 85.28 2.07 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 p -50.2 135.47 21.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 127.516 2.326 . . . . 0.0 113.093 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.31 161.67 16.37 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 4.2 mt-30 -82.11 136.03 35.23 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.94 100.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m -91.56 111.47 23.0 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.0 m -94.54 102.35 14.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.9 m -96.53 122.23 39.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -118.78 144.08 46.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.29 104.44 7.8 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.791 1.236 . . . . 0.0 108.852 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -87.15 155.13 20.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.28 -76.13 0.51 Allowed Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.42 38.78 2.95 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 106.758 -2.537 . . . . 0.0 106.758 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 t -94.11 117.73 67.15 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.23 -12.29 5.87 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 CA-C-N 121.897 1.713 . . . . 0.0 108.041 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -103.89 161.78 21.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -75.01 145.7 31.73 Favored 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.028 1.818 . . . . 0.0 107.424 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -83.44 165.26 67.93 Favored 'Cis proline' 0 N--CA 1.439 -1.713 0 CA-C-N 122.997 2.106 . . . . 0.0 109.623 7.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.6 m -120.66 141.26 50.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.29 100.52 10.42 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.35 108.49 21.02 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -92.68 124.05 36.41 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.63 130.08 34.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.535 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.8 m -117.7 93.34 4.12 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.425 ' HB3' ' HE ' ' A' ' 21' ' ' ARG . . . -82.19 134.79 35.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 -170.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.71 -173.25 12.94 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -159.77 108.62 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.34 178.22 5.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.974 0.893 . . . . 0.0 109.371 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -69.6 140.81 53.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.576 1.95 . . . . 0.0 111.853 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.73 152.66 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.7 t -108.3 90.47 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.36 131.36 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.08 35.65 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.8 t -106.17 133.89 50.16 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.486 1.116 . . . . 0.0 110.689 -167.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.05 125.47 33.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 13.0 p30 66.87 15.78 10.22 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 127.632 2.373 . . . . 0.0 116.748 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.58 40.86 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.9 tp -135.22 123.28 15.49 Favored Pre-proline 0 N--CA 1.435 -1.222 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.13 107.77 2.1 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 106.038 -2.331 . . . . 0.0 106.038 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.96 -18.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 123.38 0.425 . . . . 0.0 110.927 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 46.3 t60 -146.27 177.03 9.32 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.39 129.62 6.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.38 150.62 36.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.2 59.53 0.68 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -171.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.0 t -65.45 -67.06 0.47 Allowed 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.789 1.236 . . . . 0.0 111.164 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 pt -100.78 1.34 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -167.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.7 t30 . . . . . 0 CA--C 1.493 -1.213 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.531 1.133 . . . . 0.0 109.932 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.402 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -64.14 -54.23 37.01 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.297 1.439 . . . . 0.0 107.893 170.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.63 -41.75 95.96 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.04 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.447 0.3 OUTLIER -85.95 -3.72 58.99 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -77.47 -36.85 52.42 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 119.54 1.064 . . . . 0.0 108.911 163.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.434 ' CD2' HD21 ' A' ' 10' ' ' LEU . 7.3 t80 -59.48 -37.23 77.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.099 0.96 . . . . 0.0 110.214 168.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD21 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -82.77 -18.69 39.78 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 119.236 0.926 . . . . 0.0 113.03 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 m -69.08 -51.83 34.72 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.453 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 12.9 pt20 -85.61 -12.35 51.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.453 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 94.7 m-70 -117.76 -51.57 2.47 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 119.08 0.855 . . . . 0.0 111.278 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -79.1 119.28 21.99 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.824 1.193 . . . . 0.0 109.58 -167.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -136.27 96.76 3.44 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 100.678 -3.823 . . . . 0.0 100.678 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.02 -45.52 2.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 128.449 2.7 . . . . 0.0 117.424 -168.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 141.94 14.17 Favored Pre-proline 0 N--CA 1.433 -1.324 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 164.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -74.18 -179.07 4.36 Favored 'Trans proline' 0 N--CA 1.437 -1.827 0 C-N-CA 122.628 2.219 . . . . 0.0 114.125 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.1 -76.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.1 -174.96 13.9 Favored Glycine 0 CA--C 1.476 -2.348 1 N-CA-C 101.399 -4.68 . . . . 0.0 101.399 160.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -112.63 74.47 0.86 Allowed 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -137.81 178.13 7.35 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -72.09 -26.03 61.99 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 124.084 0.953 . . . . 0.0 111.641 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -81.52 -23.19 37.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 123.341 0.656 . . . . 0.0 109.65 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -73.64 -45.68 51.35 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.259 2.0 t -78.69 -23.99 45.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.768 -173.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.91 -40.4 79.13 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -68.29 -41.51 80.84 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 26' ' ' CYS . 16.3 tt -78.18 -32.06 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 117.85 0.296 . . . . 0.0 110.827 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 47.1 mtp -78.56 -27.46 45.81 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.2 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -67.34 -41.1 85.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -75.84 -46.65 29.27 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.4 HH21 HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -68.5 -32.67 72.8 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 123.289 0.636 . . . . 0.0 111.366 176.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.76 62.63 1.59 Allowed Glycine 0 CA--C 1.478 -2.258 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.4 mt -112.88 20.36 16.49 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 163.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -96.3 -8.01 33.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 p -125.05 99.84 34.02 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 167.22 81.11 Favored 'Cis proline' 0 N--CA 1.446 -1.322 0 N-CA-C 107.384 -1.814 . . . . 0.0 107.384 -22.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.47 121.91 11.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.344 1.058 . . . . 0.0 111.316 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.63 136.85 38.28 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.13 -39.46 63.29 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 123.781 0.676 . . . . 0.0 112.222 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -153.76 125.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -144.01 134.17 24.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.184 0.516 . . . . 0.0 109.886 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.3 m -101.41 114.95 29.41 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.959 0.903 . . . . 0.0 110.339 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -90.58 119.84 31.16 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.72 150.94 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -141.88 139.52 32.63 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.6 -135.23 3.83 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.31 140.86 32.87 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -85.69 -19.6 30.65 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.31 96.46 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.546 1.938 . . . . 0.0 108.084 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -71.45 -37.55 71.38 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.97 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.3 mm -55.63 -55.75 15.77 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 119.631 1.105 . . . . 0.0 110.958 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -58.27 -42.97 87.69 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.525 1.13 . . . . 0.0 111.416 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 15.58 1.75 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mm -78.52 -23.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.14 -15.96 48.64 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.873 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.42 150.06 43.7 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -77.39 -19.61 55.91 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 124.51 1.124 . . . . 0.0 111.311 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -77.54 -40.16 43.54 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 123.159 0.584 . . . . 0.0 109.977 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -119.47 34.02 5.39 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.17 129.15 1.08 Allowed Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 106.661 -2.576 . . . . 0.0 106.661 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -99.27 159.24 30.62 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -71.85 131.17 17.9 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 122.911 2.407 . . . . 0.0 106.822 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -125.54 126.05 44.2 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 65.51 -102.49 0.08 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.26 1.424 . . . . 0.0 110.99 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.78 105.68 3.45 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 3.5 p30 75.58 1.9 3.68 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.503 3.121 . . . . 0.0 114.717 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.32 171.63 8.07 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -144.71 119.04 9.56 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -170.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 tt -98.1 138.71 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -77.34 165.39 24.52 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.615 0.721 . . . . 0.0 112.785 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.24 -27.74 11.36 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -106.1 81.12 1.59 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 p -41.1 120.11 1.3 Allowed 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.987 2.515 . . . . 0.0 113.816 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.37 158.24 16.48 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 6.1 mt-30 -79.92 149.49 30.86 Favored 'General case' 0 CA--C 1.472 -2.031 0 CA-C-N 113.912 -1.495 . . . . 0.0 107.384 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.504 ' HB ' HH12 ' A' ' 101' ' ' ARG . 0.9 OUTLIER -150.3 148.51 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -126.53 105.49 8.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 165.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -88.51 98.48 11.66 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.84 119.49 29.38 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -108.76 142.37 39.39 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 85' ' ' GLY . 2.2 tm? -78.37 125.68 29.71 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.52 1.528 . . . . 0.0 107.459 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.39 47.06 2.57 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.407 ' H ' HD12 ' A' ' 83' ' ' LEU . . . -85.71 -69.44 1.35 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.68 -31.06 5.69 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 p -85.55 145.4 41.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -79.57 -23.5 7.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.024 1.816 . . . . 0.0 108.773 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -99.61 165.84 13.95 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 117.979 -1.01 . . . . 0.0 108.994 -168.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -71.91 144.83 44.06 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.604 2.202 . . . . 0.0 108.141 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -86.22 165.17 52.32 Favored 'Cis proline' 0 N--CA 1.438 -1.756 0 CA-C-N 122.432 1.904 . . . . 0.0 107.914 9.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 63.9 m -132.57 126.49 32.91 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -89.8 136.75 32.85 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -124.67 122.6 37.96 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.88 115.15 27.82 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 126.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 m -117.58 103.55 10.17 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.56 130.49 35.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 120.819 0.342 . . . . 0.0 110.38 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.01 172.86 16.61 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -154.3 99.82 2.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.504 HH12 ' HB ' ' A' ' 78' ' ' VAL 0.256 0.0 OUTLIER -161.65 -179.78 7.54 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.623 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.13 133.14 47.64 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.124 0.969 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.9 142.77 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.5 t -104.66 110.09 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 165.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -106.65 152.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.03 49.19 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.2 t -109.72 131.28 55.21 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 124.745 1.278 . . . . 0.0 111.229 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -124.27 136.54 54.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 164.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.304 14.2 p30 64.15 21.56 12.6 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.9 16.87 57.41 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.29 0.9 OUTLIER -135.33 134.29 21.18 Favored Pre-proline 0 CA--C 1.487 -1.478 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.02 109.67 2.93 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 106.173 -2.28 . . . . 0.0 106.173 168.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -94.46 -12.16 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 118.11 0.413 . . . . 0.0 110.438 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -150.66 155.74 39.96 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -165.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.85 125.34 52.67 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -80.94 128.68 33.95 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -106.59 51.04 0.75 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 t -87.19 -47.23 9.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -32.12 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 . . . . . 0 N--CA 1.427 -1.605 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.304 -163.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 t -91.2 -30.63 16.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.29 -41.15 66.97 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.29 -60.65 2.96 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 127.311 2.244 . . . . 0.0 113.665 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.458 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 30.9 p -69.65 -20.96 63.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -78.71 -37.02 42.53 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 119.352 0.978 . . . . 0.0 110.155 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.83 -41.71 87.53 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.601 1.56 . . . . 0.0 109.625 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.397 0.3 OUTLIER -91.23 -4.46 55.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.849 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.3 m -75.9 -43.32 45.82 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 166.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.21 -40.54 86.45 Favored 'General case' 0 CA--C 1.488 -1.421 0 O-C-N 123.605 0.565 . . . . 0.0 111.201 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -106.75 -56.98 2.12 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.661 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 9.5 t80 -74.51 114.26 12.7 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.989 1.268 . . . . 0.0 110.438 -168.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.81 94.5 3.4 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.3 -33.54 0.65 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -163.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -151.34 155.99 34.77 Favored Pre-proline 0 N--CA 1.432 -1.326 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.458 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -73.3 156.87 50.51 Favored 'Trans proline' 0 N--CA 1.433 -2.073 0 C-N-CA 123.215 2.61 . . . . 0.0 110.049 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.46 -60.7 2.22 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 164.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.09 -177.01 14.66 Favored Glycine 0 CA--C 1.479 -2.19 1 N-CA-C 103.019 -4.032 . . . . 0.0 103.019 163.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -125.46 67.65 1.15 Allowed 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.64 179.12 6.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.43 -24.17 63.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -84.89 -21.28 29.78 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.75 -43.72 58.24 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.443 ' HA ' HG21 ' A' ' 29' ' ' ILE . 4.3 t -81.3 -21.66 39.13 Favored 'General case' 0 N--CA 1.412 -2.359 0 C-N-CA 117.936 -1.506 . . . . 0.0 112.543 -171.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.75 -34.34 66.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 121.879 -0.513 . . . . 0.0 110.417 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 t -70.58 -35.15 72.89 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 26' ' ' CYS . 20.1 tt -86.28 -25.26 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-N 118.214 0.461 . . . . 0.0 110.943 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 mmt -77.31 -28.82 53.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 121.7 -0.625 . . . . 0.0 109.789 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.26 -38.51 71.89 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.054 0.942 . . . . 0.0 112.204 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -70.4 -51.63 28.22 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 124.531 1.132 . . . . 0.0 110.893 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -30.52 62.28 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.882 0.873 . . . . 0.0 109.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.65 60.49 2.97 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.57 16.17 22.39 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 t -100.04 0.47 40.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -129.79 104.08 17.25 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.96 156.48 99.41 Favored 'Cis proline' 0 N--CA 1.442 -1.508 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -20.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 m -66.81 116.38 7.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.132 0.973 . . . . 0.0 111.107 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -82.27 146.2 29.59 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -75.06 -29.75 60.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.901 1.28 . . . . 0.0 113.064 -170.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 128.25 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -141.9 137.15 31.13 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.7 m -103.78 129.95 51.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -103.97 115.24 30.09 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mm -80.3 149.81 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 C-N-CA 126.132 1.773 . . . . 0.0 107.029 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.458 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.4 m-70 -136.35 131.49 34.35 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.54 -145.84 9.9 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -105.08 148.24 27.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -84.37 -18.07 37.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -82.34 -21.82 35.81 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -72.81 -39.83 66.32 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 118.462 -0.78 . . . . 0.0 108.996 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.73 -50.98 75.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.579 1.151 . . . . 0.0 111.01 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.46 -39.36 90.58 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.783 0.833 . . . . 0.0 112.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.07 6.45 5.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.82 -30.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 m -82.73 -7.08 59.67 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -80.05 159.03 26.31 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -87.49 -4.59 58.99 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.548 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -80.69 -45.68 16.76 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -122.59 39.91 3.81 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.59 166.84 32.48 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.95 159.29 35.93 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -76.96 137.71 17.77 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.218 1.945 . . . . 0.0 107.671 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -124.83 139.09 54.16 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 66.29 -103.21 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.423 1.089 . . . . 0.0 110.227 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -163.36 113.75 1.37 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.374 0.8 OUTLIER 74.13 7.29 4.75 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 129.528 3.131 . . . . 0.0 114.376 177.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.51 164.7 11.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.31 105.49 3.35 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -166.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -85.64 138.58 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -79.88 166.17 21.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.412 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -112.92 -16.2 12.74 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -109.93 87.85 2.61 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.8 t -46.79 124.21 5.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.958 2.503 . . . . 0.0 112.238 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -104.66 155.98 18.39 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 4.6 mt-30 -80.28 152.08 29.23 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.36 151.19 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -168.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -132.47 102.61 5.79 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 165.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.1 m -86.38 102.08 13.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.02 128.17 37.76 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -113.96 147.42 38.59 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.27 128.93 37.16 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -142.1 46.85 1.63 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.54 -65.57 0.9 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.28 -23.78 11.06 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -85.7 143.33 38.05 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -79.65 -22.98 7.42 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 122.049 1.833 . . . . 0.0 108.725 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -106.28 157.3 35.25 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.637 -168.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.44 150.34 36.2 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.441 2.094 . . . . 0.0 108.401 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -83.32 167.33 64.01 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 CA-C-N 122.423 1.901 . . . . 0.0 108.742 1.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.3 m -147.75 141.61 25.79 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -87.23 146.79 25.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.65 118.57 23.14 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -79.27 108.53 12.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.82 126.75 34.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -116.68 108.66 16.18 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.79 122.22 24.46 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.95 179.46 16.22 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -162.28 101.61 1.09 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.727 -3.434 . . . . 0.0 101.727 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 170.28 22.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.814 -171.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -75.01 130.71 39.82 Favored 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 124.225 1.01 . . . . 0.0 109.556 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.7 130.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.89 80.45 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.3 m -95.88 142.59 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.96 39.15 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.5 m -100.04 141.81 32.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 124.298 0.999 . . . . 0.0 111.237 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.73 130.41 19.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 12.1 p30 62.59 18.25 10.34 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 128.153 2.581 . . . . 0.0 115.372 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.62 -10.67 61.04 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -102.76 144.04 27.81 Favored Pre-proline 0 CA--C 1.478 -1.797 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.83 114.66 4.09 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 N-CA-C 105.269 -2.627 . . . . 0.0 105.269 161.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 m -99.77 -15.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 69.1 t60 -149.03 175.41 11.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -169.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.62 129.12 2.59 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.26 135.81 39.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.926 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.18 37.44 1.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 t -95.75 -16.6 21.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pt -95.53 -21.39 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.246 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 . . . . . 0 N--CA 1.426 -1.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.72 -170.174 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -91.44 -1.8 57.45 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.826 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -74.32 -43.76 55.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -58.76 -52.67 64.72 Favored 'General case' 0 N--CA 1.41 -2.449 0 C-N-CA 124.939 1.295 . . . . 0.0 111.633 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.51 2.5 t -89.94 12.77 16.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -82.19 -40.23 22.02 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.204 -1.56 . . . . 0.0 108.1 156.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.92 -41.64 83.13 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.366 1.066 . . . . 0.0 109.525 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 19.4 mt -83.84 -13.84 52.69 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -65.55 -53.21 45.24 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 120.411 1.46 . . . . 0.0 107.811 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.524 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 4.9 pt20 -81.64 -17.14 49.13 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.524 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 84.4 m-70 -110.97 -55.03 2.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 118.965 0.802 . . . . 0.0 111.151 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 43.7 t80 -76.34 122.27 24.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.683 1.128 . . . . 0.0 109.208 -168.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -136.21 97.58 3.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.59 -38.45 4.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -166.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 140.57 9.92 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 165.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 81.1 Cg_exo -73.18 175.83 9.98 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 122.794 2.33 . . . . 0.0 113.794 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -73.21 -73.05 0.22 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.3 -176.66 14.61 Favored Glycine 0 CA--C 1.478 -2.249 1 N-CA-C 102.428 -4.269 . . . . 0.0 102.428 163.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -115.16 72.81 0.81 Allowed 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -147.83 -179.34 6.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.1 -21.66 62.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.714 1.206 . . . . 0.0 112.867 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -88.79 -15.47 34.54 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.1 -39.04 34.71 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 m -68.79 -34.32 75.34 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -66.85 -44.93 79.73 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 123.551 0.741 . . . . 0.0 109.587 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -64.75 -35.68 81.86 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.384 0.673 . . . . 0.0 112.54 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.29 13.3 tt -83.72 -28.97 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.973 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 -23.55 43.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 117.657 -1.617 . . . . 0.0 111.724 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -79.4 -32.9 43.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 118.995 0.816 . . . . 0.0 111.042 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -47.97 15.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.327 0.651 . . . . 0.0 110.064 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -76.81 -32.04 57.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.68 66.7 1.53 Allowed Glycine 0 CA--C 1.476 -2.347 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.9 31.13 6.75 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 162.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.64 2.65 44.69 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 p -124.64 94.77 43.95 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.48 167.1 81.05 Favored 'Cis proline' 0 N--CA 1.443 -1.498 0 N-CA-C 106.981 -1.969 . . . . 0.0 106.981 -24.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.2 m -63.3 116.05 5.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 124.352 1.061 . . . . 0.0 111.115 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.26 134.62 42.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -71.15 -35.4 71.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 124.373 1.045 . . . . 0.0 112.295 -168.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.43 136.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -147.58 122.11 9.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.7 m -90.89 106.33 18.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -85.88 121.37 28.42 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.0 148.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.432 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -141.15 132.87 27.27 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.36 -137.32 4.59 Favored Glycine 0 CA--C 1.483 -1.935 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -113.43 144.62 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -85.45 -17.5 36.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.906 -169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -82.26 -26.65 32.99 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.8 p -77.67 -30.11 51.83 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.658 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.93 -46.34 96.67 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 CA-C-N 119.403 1.001 . . . . 0.0 110.627 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 3.3 ttmp? -60.42 -38.82 85.26 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.487 1.115 . . . . 0.0 111.828 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 9.85 5.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.705 1.202 . . . . 0.0 113.889 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.48 -17.92 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.6 t -66.37 -69.94 0.27 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.452 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -141.19 118.95 11.71 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.419 ' H ' ' H ' ' A' ' 60' ' ' LYS . 54.8 t30 -159.88 -3.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 164.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' H ' ' H ' ' A' ' 59' ' ' ASN 0.386 62.5 pttt 57.81 26.96 13.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.859 2.064 . . . . 0.0 111.748 -156.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -105.57 -14.74 15.19 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 167.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.77 139.98 10.87 Favored Glycine 0 CA--C 1.488 -1.636 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 160.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.39 153.88 43.23 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -69.68 143.27 50.68 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.824 2.349 . . . . 0.0 108.513 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -145.56 130.84 18.55 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 66.39 -103.59 0.08 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.884 1.273 . . . . 0.0 109.549 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -156.66 102.64 2.05 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER 90.93 -12.7 0.26 Allowed 'General case' 0 C--N 1.354 0.798 0 C-N-CA 128.323 2.649 . . . . 0.0 112.526 173.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.36 158.61 16.44 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -143.67 114.97 7.98 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -92.12 141.15 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -80.8 166.35 21.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.708 0.766 . . . . 0.0 110.823 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -120.6 -14.77 8.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.4 t -109.82 86.49 2.31 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.6 p -51.75 131.6 30.51 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 127.028 2.131 . . . . 0.0 112.293 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.16 156.69 19.56 Favored 'General case' 0 CA--C 1.476 -1.896 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 -171.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.61 142.03 40.84 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.9 143.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -166.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.6 m -131.01 108.39 9.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.61 -3.107 . . . . 0.0 102.61 168.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -82.69 101.38 10.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 71.8 m -88.91 111.42 22.07 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -109.5 137.69 46.97 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -76.3 112.33 12.68 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 125.172 1.389 . . . . 0.0 108.366 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -90.81 147.76 22.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 -74.24 0.21 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 28.68 4.31 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.6 p -92.09 127.19 50.35 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -80.44 -29.76 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 N-CA-C 107.735 -1.679 . . . . 0.0 107.735 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -99.35 148.07 34.17 Favored Pre-proline 0 N--CA 1.427 -1.591 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.476 -168.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -74.91 144.37 30.51 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.643 2.229 . . . . 0.0 107.0 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -81.74 160.98 79.84 Favored 'Cis proline' 0 CA--C 1.486 -1.884 0 CA-C-N 123.705 2.359 . . . . 0.0 109.982 10.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.9 m -146.94 146.97 30.3 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -167.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -102.52 154.19 19.35 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -137.66 125.12 22.0 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -104.68 130.69 52.68 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.24 138.96 31.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 122.826 0.451 . . . . 0.0 110.737 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.2 m -133.25 95.07 3.45 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.75 153.31 17.83 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.664 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.46 -163.63 12.14 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -149.59 97.9 2.69 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.5 ttt-85 -140.65 158.89 43.31 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -165.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.55 137.32 57.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.667 1.187 . . . . 0.0 109.679 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.46 136.87 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -104.02 91.37 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.86 138.77 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.65 123.63 32.04 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.5 t -103.25 125.93 50.16 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.589 1.181 . . . . 0.0 109.493 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -109.58 126.88 54.07 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 163.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.307 0.4 OUTLIER 31.95 68.55 0.13 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 128.622 2.769 . . . . 0.0 118.359 175.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.42 4.74 90.04 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.23 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.27 0.8 OUTLIER -138.2 135.32 18.34 Favored Pre-proline 0 CA--C 1.486 -1.486 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -63.53 132.95 37.59 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.817 2.345 . . . . 0.0 106.387 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.61 -18.57 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 20.7 t60 -151.92 179.8 8.14 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 -170.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 5.6 tp -151.83 132.47 13.97 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.56 123.57 27.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.89 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -103.56 24.02 11.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.788 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.6 p -81.71 -31.58 32.06 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 121.48 -0.763 . . . . 0.0 113.056 -167.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -32.58 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.427 -1.615 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.0 -165.811 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -88.78 0.25 56.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.761 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -68.14 -52.23 37.02 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -60.87 -50.72 72.27 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 117.333 -1.318 . . . . 0.0 113.164 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.527 2.3 t -90.82 11.36 22.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -81.69 -38.4 25.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 120.087 -1.633 . . . . 0.0 108.381 155.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.02 0.928 . . . . 0.0 109.686 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.66 -12.55 53.69 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.5 m -65.55 -52.22 54.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 120.68 1.582 . . . . 0.0 108.074 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.9 pt20 -79.31 -28.54 42.18 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 87.0 m-70 -100.1 -53.98 3.0 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 119.044 0.838 . . . . 0.0 110.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -73.66 134.62 43.65 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 120.296 1.407 . . . . 0.0 111.481 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.62 99.92 2.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.84 -50.93 1.73 Allowed 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 128.061 2.544 . . . . 0.0 117.843 -166.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -142.69 146.59 38.82 Favored Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.7 Cg_endo -81.38 171.75 13.34 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 123.086 2.524 . . . . 0.0 108.662 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.08 -77.97 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.59 -178.88 15.59 Favored Glycine 0 CA--C 1.475 -2.427 1 N-CA-C 101.464 -4.654 . . . . 0.0 101.464 159.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.15 74.67 0.89 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -136.06 173.1 12.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -74.06 -21.27 60.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.886 0.874 . . . . 0.0 113.23 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -14.18 29.92 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.31 -41.71 63.22 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . 0.257 0.6 OUTLIER -77.06 -25.42 52.39 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 113.054 -174.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.81 -39.51 73.03 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 m -70.19 -33.06 71.26 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -85.28 -29.74 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 118.644 0.656 . . . . 0.0 110.369 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mmt -71.78 -34.76 69.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -67.04 -45.94 75.92 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.265 1.026 . . . . 0.0 113.389 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -83.37 -32.52 26.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -74.52 -38.16 62.88 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.59 68.96 1.4 Allowed Glycine 0 CA--C 1.475 -2.451 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.96 29.17 5.24 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 163.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -81.91 -13.48 57.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 111.721 -2.491 . . . . 0.0 109.963 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -119.83 106.99 40.82 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.974 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 162.89 90.92 Favored 'Cis proline' 0 N--CA 1.444 -1.399 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 -22.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.2 m -61.3 121.97 13.93 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.139 0.976 . . . . 0.0 110.631 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -72.79 134.65 45.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -72.44 -39.11 68.07 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 123.631 0.582 . . . . 0.0 111.555 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.95 129.08 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 172.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -144.9 120.56 10.47 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 m -96.1 116.64 29.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.5 127.27 34.85 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mm -102.35 147.4 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.464 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.432 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -138.06 133.45 33.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.18 -125.36 1.41 Allowed Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.5 147.28 46.55 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -86.26 -3.04 58.9 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -43.05 65.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.657 1.583 . . . . 0.0 107.089 172.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -80.52 -25.27 38.8 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.681 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.78 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 CA-C-N 119.079 0.854 . . . . 0.0 110.195 168.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -55.77 -39.35 71.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 126.02 1.728 . . . . 0.0 112.405 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.74 11.48 2.58 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.67 -31.9 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.7 m -79.0 -23.1 44.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.63 156.1 17.86 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -86.57 87.6 7.48 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.951 0.882 . . . . 0.0 109.306 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -141.06 -46.51 0.39 Allowed 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.73 58.52 1.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.43 151.88 9.54 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -107.42 157.83 34.68 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 140.0 32.18 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.766 2.31 . . . . 0.0 106.248 160.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -139.82 118.1 12.04 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -103.91 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 108.989 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -151.87 102.76 2.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 1.9 p-10 66.24 18.1 10.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 129.516 3.126 . . . . 0.0 114.582 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.0 mt -107.35 158.73 16.93 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 100.407 -3.923 . . . . 0.0 100.407 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -146.11 119.29 8.88 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.104 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.53 145.51 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 92.5 p -93.71 149.45 21.22 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -102.46 -8.31 21.2 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.7 t -106.69 85.75 2.21 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.0 m -57.35 126.43 27.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 125.566 1.546 . . . . 0.0 110.501 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.71 159.69 15.41 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.8 135.88 45.32 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.73 147.92 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -165.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.3 m -134.95 107.22 7.22 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 103.474 -2.788 . . . . 0.0 103.474 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.4 m -86.43 105.62 16.88 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.1 m -99.42 116.77 32.33 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -116.97 130.31 56.61 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.3 tp -74.02 118.03 16.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 124.916 1.286 . . . . 0.0 108.716 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.35 115.5 27.59 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 158.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.76 94.03 1.78 Allowed Glycine 0 CA--C 1.482 -2.011 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -167.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.89 49.86 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 166.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 t -163.51 110.74 0.98 Allowed Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -80.08 -16.31 11.2 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 110.411 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.03 168.08 9.54 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.44 145.54 30.09 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.06 1.84 . . . . 0.0 108.13 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -81.76 163.81 76.62 Favored 'Cis proline' 0 N--CA 1.436 -1.872 0 CA-C-N 122.228 1.831 . . . . 0.0 107.923 -4.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -106.09 174.47 5.87 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -133.58 115.35 14.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -104.17 149.47 25.23 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -100.97 147.35 26.27 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 160.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.11 126.41 52.78 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -107.63 108.46 19.74 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.88 141.8 34.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.2 -175.46 30.17 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -157.69 99.68 1.73 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.905 -2.998 . . . . 0.0 102.905 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -161.61 173.78 14.27 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.81 0.814 . . . . 0.0 109.846 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -78.3 151.38 33.0 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.406 1.482 . . . . 0.0 111.148 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.96 159.18 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.12 96.26 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 165.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.79 132.35 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.51 122.58 32.14 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.42 142.29 30.22 Favored 'General case' 0 CA--C 1.488 -1.43 0 O-C-N 124.603 1.189 . . . . 0.0 110.153 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.09 129.42 18.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 167.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.337 11.2 p30 67.54 15.24 9.77 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 128.1 2.56 . . . . 0.0 115.287 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.22 62.08 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 0.9 OUTLIER -113.92 138.41 22.78 Favored Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -70.34 111.55 2.95 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 N-CA-C 107.048 -1.943 . . . . 0.0 107.048 166.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.46 -14.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 119.173 0.897 . . . . 0.0 110.077 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 38.6 t60 -155.06 178.52 10.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 8.9 tp -158.9 133.57 8.07 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.66 131.12 34.24 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -106.06 41.06 1.47 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -97.01 -26.26 15.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -171.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -33.99 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.706 0 C-N-CA 123.935 0.894 . . . . 0.0 109.215 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -168.804 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.4 m -90.21 -33.13 16.3 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -69.29 -35.46 76.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.199 1.0 . . . . 0.0 111.1 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE2' HD11 ' A' ' 10' ' ' LEU . 52.7 t80 -74.29 -46.09 43.43 Favored 'General case' 0 N--CA 1.398 -3.053 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 33.7 p -73.72 -17.87 61.06 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -84.42 -35.89 22.76 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 119.514 1.052 . . . . 0.0 109.42 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -56.69 -45.79 81.58 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.531 1.532 . . . . 0.0 108.519 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.471 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -65.82 -29.91 70.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 126.854 2.062 . . . . 0.0 115.109 178.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.7 m -66.93 -52.58 41.3 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.0 pt20 -85.22 -5.05 59.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.49 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 88.8 m-70 -123.64 -55.59 1.72 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.762 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 13.6 t80 -71.29 123.86 23.24 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 120.583 1.538 . . . . 0.0 111.919 -169.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.88 97.11 3.12 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.19 -41.51 8.3 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -167.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -158.43 140.09 9.87 Favored Pre-proline 0 N--CA 1.434 -1.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 163.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -74.44 -178.86 4.28 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.651 2.234 . . . . 0.0 114.168 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -71.92 -64.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.21 -176.39 16.35 Favored Glycine 0 CA--C 1.476 -2.382 1 N-CA-C 102.343 -4.303 . . . . 0.0 102.343 164.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -109.38 75.53 0.95 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -145.5 176.42 9.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.17 -22.75 62.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 124.327 1.051 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -89.27 -17.21 29.45 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.08 -40.86 52.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.2 m -70.3 -33.28 71.35 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -68.06 -43.58 78.29 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.939 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.8 p -76.06 -23.88 55.09 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.274 12.5 tt -85.87 -28.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 119.081 0.855 . . . . 0.0 110.06 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.4 mmm -79.1 -24.05 43.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.621 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.485 HH12 ' HA ' ' A' ' 91' ' ' PRO . 14.7 tpt180 -74.53 -49.33 22.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 122.605 0.362 . . . . 0.0 111.694 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -86.44 -32.6 20.77 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.273 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -76.79 -33.84 58.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.89 71.23 1.29 Allowed Glycine 0 CA--C 1.478 -2.238 0 C-N-CA 124.987 1.279 . . . . 0.0 112.028 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.331 2.5 mm? -108.08 0.02 21.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 167.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -80.31 -3.78 50.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.005 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -129.42 108.16 17.51 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.66 153.77 98.76 Favored 'Cis proline' 0 N--CA 1.443 -1.447 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 -22.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.2 m -62.77 123.27 18.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 125.483 1.513 . . . . 0.0 112.197 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -74.12 139.62 44.69 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.8 -41.52 44.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.644 0.778 . . . . 0.0 111.899 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 tt -154.6 134.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -154.52 167.23 30.78 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.0 m -128.89 127.27 41.48 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.91 127.53 39.72 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.273 4.9 mm -94.35 146.03 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 2.2 m-70 -139.8 127.77 22.19 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.06 -151.58 18.84 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.23 144.37 25.92 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.24 -22.0 45.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -70.54 -33.98 71.74 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 124.441 1.096 . . . . 0.0 110.532 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 p -76.68 -31.39 57.24 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 116.906 -1.521 . . . . 0.0 111.265 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -48.71 84.36 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-N 119.739 1.154 . . . . 0.0 110.996 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.29 -36.6 84.58 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.34 0.656 . . . . 0.0 111.657 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.78 4.91 10.56 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mm -75.94 -24.92 16.82 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.9 m -73.72 -24.59 59.94 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 122.124 -0.36 . . . . 0.0 111.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -79.68 164.8 23.46 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -93.2 0.0 56.99 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.429 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.57 -33.11 28.17 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 122.899 0.48 . . . . 0.0 110.848 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -134.73 7.31 3.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.08 -162.91 10.61 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 104.831 -3.307 . . . . 0.0 104.831 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.59 158.25 27.32 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -74.02 135.36 20.97 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.761 2.307 . . . . 0.0 107.162 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -123.07 104.61 9.32 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 69.85 -97.13 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.846 1.659 . . . . 0.0 110.528 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.45 106.51 3.13 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.358 4.5 p30 75.76 2.81 3.77 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 129.725 3.21 . . . . 0.0 114.594 169.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 mt -104.43 158.91 16.15 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -142.97 116.15 8.94 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 tt -89.32 142.14 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -81.01 161.41 24.25 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.779 0.8 . . . . 0.0 112.454 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -110.2 -17.95 13.41 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.6 t -110.06 87.87 2.62 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -52.03 129.67 27.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.671 1.989 . . . . 0.0 111.608 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -106.02 157.37 17.56 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 5.0 tp60 -75.33 131.99 40.66 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 175.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.94 126.43 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 -165.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.7 m -119.21 110.18 16.72 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -83.13 105.17 13.89 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.81 114.63 23.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.81 136.46 53.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.44 127.67 32.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.42 1.088 . . . . 0.0 109.069 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.411 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 93.5 m-70 -119.47 171.69 8.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.61 -94.24 1.02 Allowed Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 105.939 -2.865 . . . . 0.0 105.939 -173.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.6 -6.97 1.26 Allowed Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 p -79.0 132.92 62.27 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -91.28 -9.22 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.922 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -109.76 155.58 41.24 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.95 146.19 29.12 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.369 2.046 . . . . 0.0 107.397 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.485 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.7 Cg_endo -85.99 163.4 56.19 Favored 'Cis proline' 0 N--CA 1.436 -1.899 0 CA-C-N 122.888 2.067 . . . . 0.0 108.521 12.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.8 m -150.99 126.24 9.97 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -85.81 129.23 34.89 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.93 133.24 56.17 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.411 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 81.8 mtp180 -111.72 137.51 49.52 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.74 140.55 31.17 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.157 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.7 m -123.34 110.3 15.0 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.62 155.85 23.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.549 0.69 . . . . 0.0 109.9 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.96 176.1 37.58 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 106.914 -2.474 . . . . 0.0 106.914 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -150.11 91.63 1.79 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 101.932 -3.358 . . . . 0.0 101.932 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -146.73 169.21 19.52 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -168.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.03 145.44 48.29 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.427 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.99 138.39 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.04 87.78 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.82 132.88 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.82 125.29 40.28 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.9 m -109.03 153.79 23.12 Favored 'General case' 0 CA--C 1.485 -1.533 0 O-C-N 124.414 1.071 . . . . 0.0 110.985 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.33 129.73 23.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 171.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 9.4 p30 68.16 12.44 8.77 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 13.15 60.1 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.64 144.89 52.69 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -68.84 150.94 74.15 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 121.858 1.705 . . . . 0.0 110.694 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.57 -14.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 51.1 t60 -158.07 174.91 14.5 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -169.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.1 128.68 6.28 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.35 137.2 38.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.67 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -105.41 42.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -91.92 -33.77 14.76 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 -29.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.896 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.298 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -169.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.3 t30 . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -89.52 -7.43 54.96 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.924 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -72.75 -42.92 63.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -59.23 -48.23 82.4 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.409 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.465 2.9 t -89.86 10.75 22.53 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -78.16 -42.07 32.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.193 -1.567 . . . . 0.0 107.34 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.14 -35.18 76.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.037 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.15 -15.42 41.09 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 119.444 1.02 . . . . 0.0 113.399 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -65.8 -49.0 69.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 119.827 1.194 . . . . 0.0 108.703 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.59 -42.66 67.48 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -99.45 -51.42 3.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.695 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -77.07 116.39 17.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 119.278 0.945 . . . . 0.0 110.7 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.12 100.35 4.69 Favored 'General case' 0 N--CA 1.421 -1.921 1 N-CA-C 98.538 -4.615 . . . . 0.0 98.538 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.35 -33.5 9.09 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -165.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -154.79 144.46 15.4 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 168.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 10.7 Cg_endo -74.41 154.72 45.71 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 122.979 2.453 . . . . 0.0 109.638 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.88 -60.84 2.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.05 178.28 16.95 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 103.304 -3.919 . . . . 0.0 103.304 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -123.74 57.91 1.17 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.34 177.75 8.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -172.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.71 -18.96 62.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.591 1.156 . . . . 0.0 113.736 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -82.5 -28.03 31.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -41.31 63.32 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.421 ' HA ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -81.2 -25.21 36.91 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.561 -171.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.87 -45.37 82.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -64.94 -41.13 95.78 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 26' ' ' CYS . 10.3 tt -79.51 -29.58 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.141 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -26.22 58.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.468 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -77.53 -34.18 54.01 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 117.962 0.346 . . . . 0.0 110.866 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -73.75 -52.63 12.56 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.332 0.653 . . . . 0.0 111.639 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.4 HH21 HG13 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -68.01 -36.38 79.88 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 123.269 0.628 . . . . 0.0 111.561 178.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.05 71.65 1.31 Allowed Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.321 3.4 mm? -97.99 -8.87 27.09 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 164.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -81.0 1.64 30.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.623 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 p -119.22 98.82 50.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.741 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.3 163.16 90.53 Favored 'Cis proline' 0 N--CA 1.443 -1.493 0 N-CA-C 106.595 -2.117 . . . . 0.0 106.595 -27.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.3 m -64.85 121.82 15.5 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -166.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -70.51 140.68 51.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 126.622 1.969 . . . . 0.0 107.661 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -70.87 -46.97 61.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 123.725 0.81 . . . . 0.0 113.14 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 tt -149.64 129.61 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -154.84 137.44 15.15 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.2 m -101.5 137.02 40.38 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.953 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -100.43 119.96 39.27 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 167.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.92 150.31 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.484 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -142.59 139.74 31.45 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.286 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.8 -136.34 5.12 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.439 ' HB3' ' H ' ' A' ' 52' ' ' SER . 1.2 m120 -95.3 140.06 30.72 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.34 -21.01 29.09 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HB3' HD21 ' A' ' 49' ' ' ASN . 65.5 ttt180 -70.2 -36.38 74.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.368 1.867 . . . . 0.0 108.874 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.439 ' H ' ' HB3' ' A' ' 49' ' ' ASN . 39.5 m -72.5 -38.41 68.12 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.776 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.7 -48.47 85.83 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 CA-C-N 118.904 0.775 . . . . 0.0 111.402 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.06 -42.1 98.83 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.147 0.579 . . . . 0.0 111.473 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.24 7.59 5.0 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.0 mm -74.74 -32.33 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.2 t -71.88 -34.28 69.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.149 0.281 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.09 160.21 33.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.451 0.643 . . . . 0.0 110.032 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -75.96 -28.91 58.09 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.823 0.849 . . . . 0.0 109.389 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -77.12 124.65 28.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 44.2 t30 73.64 36.14 0.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 128.058 2.543 . . . . 0.0 112.679 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 148.88 5.58 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -98.36 152.09 37.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.45 131.35 18.73 Favored 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 122.858 2.372 . . . . 0.0 106.272 162.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -121.56 103.05 8.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HG3' ' H ' ' A' ' 67' ' ' GLU 0.338 14.5 ptp180 49.47 -107.33 0.24 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 128.077 2.551 . . . . 0.0 115.264 177.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 34.2 tt0 -103.74 77.53 1.48 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.516 1.126 . . . . 0.0 108.058 -167.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.317 1.6 p-10 62.25 26.65 15.98 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.45 3.1 . . . . 0.0 114.713 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.71 164.41 12.26 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -142.94 122.45 13.2 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.3 138.14 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -82.81 153.98 24.94 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 121.818 0.818 . . . . 0.0 112.655 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 -27.23 14.95 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.955 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 p -105.77 84.02 2.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.6 p -51.17 130.84 27.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.9 1.68 . . . . 0.0 111.152 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.59 163.92 12.66 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -165.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.7 mt-30 -75.68 141.94 42.62 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.38 145.37 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -169.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.0 m -134.8 103.92 5.81 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.2 m -87.34 106.37 17.89 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.0 m -99.74 128.25 45.85 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -118.8 138.41 52.72 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.69 116.73 14.63 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 125.703 1.601 . . . . 0.0 110.022 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.57 110.14 18.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.26 93.17 1.81 Allowed Glycine 0 CA--C 1.484 -1.858 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.08 -11.49 49.13 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 104.888 -3.285 . . . . 0.0 104.888 161.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -165.19 132.93 2.41 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -78.15 -25.38 7.3 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.319 2.012 . . . . 0.0 109.328 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -89.58 160.27 42.12 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.26 147.13 32.59 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.282 1.988 . . . . 0.0 108.132 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -82.98 165.69 69.64 Favored 'Cis proline' 0 N--CA 1.439 -1.7 0 CA-C-N 122.879 2.064 . . . . 0.0 108.932 5.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.3 m -145.15 125.96 14.34 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -169.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.75 131.75 36.0 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.74 120.63 42.17 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -88.32 117.93 27.57 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 137.69 35.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.883 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -120.32 106.66 12.09 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 170.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.38 149.95 30.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.108 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.04 -175.14 34.62 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -150.86 97.87 2.53 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.241 -3.615 . . . . 0.0 101.241 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -144.25 150.81 38.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -159.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -83.24 144.98 29.39 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.752 1.221 . . . . 0.0 109.165 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.98 153.37 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.46 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 162.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.4 m -91.29 134.97 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.36 133.4 36.65 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.33 134.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.168 0.918 . . . . 0.0 111.317 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -127.44 136.59 52.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.328 5.0 p30 73.54 4.41 4.77 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.891 2.077 . . . . 0.0 116.582 168.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.78 19.69 28.56 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.254 0.7 OUTLIER -136.86 133.09 18.61 Favored Pre-proline 0 CA--C 1.49 -1.357 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.98 113.47 3.8 Favored 'Trans proline' 0 N--CA 1.435 -1.944 0 N-CA-C 106.482 -2.161 . . . . 0.0 106.482 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -96.53 -7.38 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 49.7 t60 -159.0 177.5 11.07 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 -168.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -167.0 133.59 2.32 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 102.822 -3.029 . . . . 0.0 102.822 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -78.26 138.03 38.41 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.071 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -101.3 41.76 1.17 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -98.48 -32.22 11.58 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -36.91 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.771 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 N--CA 1.422 -1.864 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 t -91.53 -27.52 18.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -68.4 -50.56 52.03 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.367 1.067 . . . . 0.0 111.836 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.269 76.9 t80 -53.07 -53.76 45.51 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.697 169.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -69.16 -15.95 63.52 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -83.77 -36.36 23.65 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.912 1.233 . . . . 0.0 110.267 173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.732 1.213 . . . . 0.0 109.915 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.481 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -79.53 -26.94 41.36 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.83 2.052 . . . . 0.0 112.239 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -68.4 -52.48 32.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 40.3 mt-30 -68.53 -42.27 78.7 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 85.8 m-70 -105.38 -41.67 5.45 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.343 -165.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 14.6 t80 -76.02 120.16 20.96 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 120.805 1.639 . . . . 0.0 111.731 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -140.8 99.72 3.68 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 100.82 -3.77 . . . . 0.0 100.82 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -40.92 11.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.423 2.289 . . . . 0.0 117.115 -167.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.42 144.89 14.55 Favored Pre-proline 0 N--CA 1.433 -1.297 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 83.0 Cg_exo -76.65 176.84 9.58 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.654 1.569 . . . . 0.0 113.787 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -73.93 -60.2 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 165.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -151.07 -175.01 22.54 Favored Glycine 0 CA--C 1.477 -2.287 0 N-CA-C 103.322 -3.911 . . . . 0.0 103.322 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.03 74.4 0.86 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.08 170.89 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.75 -22.21 61.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -169.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -79.75 -26.57 40.68 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.124 0.42 . . . . 0.0 110.214 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.89 -43.71 62.15 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.27 0.5 OUTLIER -80.57 -25.36 38.6 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 119.02 -1.072 . . . . 0.0 113.061 -169.794 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.19 -36.79 69.31 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.307 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -69.86 -35.19 74.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 26' ' ' CYS . 15.2 tt -83.15 -29.22 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.332 0 CA-C-N 118.338 0.517 . . . . 0.0 110.096 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.4 mmt -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.328 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.502 HH22 ' H ' ' A' ' 92' ' ' CYS . 17.4 tpp180 -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.013 0.925 . . . . 0.0 111.844 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -74.04 -49.05 25.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 123.865 0.866 . . . . 0.0 110.796 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -70.82 -37.89 73.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.199 1.0 . . . . 0.0 109.99 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.98 70.16 1.26 Allowed Glycine 0 CA--C 1.481 -2.061 0 C-N-CA 124.275 0.941 . . . . 0.0 111.266 168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.361 2.5 mm? -104.52 -2.41 25.27 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 163.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.1 t -78.32 -8.57 58.56 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.086 -159.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -131.92 107.37 13.94 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 117.925 -1.036 . . . . 0.0 108.724 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.88 156.66 95.74 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.162 -1.899 . . . . 0.0 107.162 -19.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.1 m -57.8 122.91 14.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.616 1.567 . . . . 0.0 110.454 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 135.87 45.63 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -72.73 -38.89 67.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.632 0.773 . . . . 0.0 112.385 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -146.89 132.51 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -149.57 128.69 12.75 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.381 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 m -101.66 116.18 32.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.656 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.62 122.33 30.38 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.94 148.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.412 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -138.35 128.6 25.89 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.996 1.318 . . . . 0.0 108.42 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.01 -130.83 2.1 Favored Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 51' ' ' ARG . 6.1 t30 -119.64 144.35 47.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.27 -2.75 58.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.031 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB3' HD21 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -81.02 -30.08 34.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -75.11 -31.31 61.11 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.127 0.971 . . . . 0.0 110.342 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.12 -58.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 124.089 0.956 . . . . 0.0 110.245 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.14 -38.19 73.14 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.33 59.49 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 126.102 1.761 . . . . 0.0 113.83 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.55 -39.98 65.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 C-N-CA 125.484 1.513 . . . . 0.0 111.11 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.27 -21.06 29.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.58 53.12 0.7 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.943 0.401 . . . . 0.0 111.288 -171.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 79.44 -35.97 0.16 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.775 2.43 . . . . 0.0 115.023 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.59 154.98 38.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 26.96 55.7 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 129.377 3.071 . . . . 0.0 116.038 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.57 146.5 4.93 Favored Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -128.98 164.75 36.79 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.05 137.47 19.5 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.063 1.842 . . . . 0.0 107.816 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -106.74 161.03 15.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.214 -2.514 . . . . 0.0 104.214 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -70.81 150.99 45.28 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.285 0.634 . . . . 0.0 111.693 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 69.14 55.43 0.41 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.355 2.662 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.273 3.0 p-10 51.65 45.49 28.03 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.473 2.709 . . . . 0.0 114.095 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 mt -124.89 178.69 5.36 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -151.17 112.41 4.35 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.55 150.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.4 p -99.74 161.46 13.6 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.18 18.41 5.98 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 p -117.23 100.16 7.51 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.762 -3.792 . . . . 0.0 100.762 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 120.12 11.99 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.192 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -102.76 158.4 16.28 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.06 140.86 36.32 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.34 144.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -132.8 102.3 5.6 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 170.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -84.19 103.26 13.24 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 35.1 m -94.61 116.8 29.2 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -105.11 140.61 38.03 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.91 136.57 33.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -134.04 174.6 10.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.73 -101.39 0.72 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 106.092 -2.803 . . . . 0.0 106.092 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.15 -26.97 0.17 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.1 m -81.82 130.69 59.88 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -81.11 -25.37 4.06 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 121.968 1.779 . . . . 0.0 108.138 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -89.76 165.29 25.57 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.79 144.6 35.24 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 N-CA-C 107.584 -1.737 . . . . 0.0 107.584 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.484 ' HA ' HH12 ' A' ' 31' ' ' ARG . 48.7 Cg_endo -86.8 162.47 51.43 Favored 'Cis proline' 0 N--CA 1.435 -1.928 0 CA-C-N 122.457 1.913 . . . . 0.0 109.257 19.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.502 ' H ' HH22 ' A' ' 31' ' ' ARG . 46.2 m -119.07 158.09 26.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -172.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -135.79 93.09 2.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.05 123.62 34.08 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.932 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -102.05 125.57 48.77 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.86 135.87 33.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.181 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.0 m -123.51 113.51 18.83 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.93 145.52 29.35 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.241 0.543 . . . . 0.0 110.024 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.7 168.46 30.5 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 105.13 -3.188 . . . . 0.0 105.13 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.02 103.04 3.7 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.84 174.88 14.32 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.051 -171.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.55 135.48 50.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 124.536 1.134 . . . . 0.0 110.233 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.91 138.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.18 110.76 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.71 151.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.83 140.3 31.6 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 166.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.5 t -119.61 146.42 45.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 124.899 1.374 . . . . 0.0 111.41 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.42 122.14 11.88 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.35 6.2 p30 72.32 3.13 4.58 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 127.917 2.487 . . . . 0.0 115.838 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.2 38.18 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 108.426 -1.869 . . . . 0.0 108.426 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.47 117.12 23.04 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.19 120.97 5.54 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 CA-C-N 122.594 1.962 . . . . 0.0 107.9 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.97 -12.71 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 124.171 0.92 . . . . 0.0 111.712 -169.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.408 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.9 t60 -152.26 170.0 21.1 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -166.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.408 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 6.7 tp -140.44 136.14 32.73 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -84.12 134.16 34.6 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -110.59 40.23 2.03 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -99.25 -29.42 12.83 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -33.21 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.97 171.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.418 -2.033 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -170.835 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -90.5 -30.56 17.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -62.38 -51.2 68.53 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.463 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.416 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 45.5 t80 -53.9 -62.54 1.59 Allowed 'General case' 0 N--CA 1.404 -2.757 0 C-N-CA 127.103 2.161 . . . . 0.0 114.483 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.468 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 24.2 p -69.56 -16.39 63.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -81.81 -37.91 26.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 120.074 1.306 . . . . 0.0 110.02 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.85 -41.3 82.1 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.105 1.362 . . . . 0.0 109.902 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.402 0.0 OUTLIER -92.95 -6.37 48.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 118.084 0.402 . . . . 0.0 111.245 -173.25 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.7 m -73.47 -48.97 29.29 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.52 -1.363 . . . . 0.0 107.341 166.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -65.94 -41.9 90.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 126.291 1.836 . . . . 0.0 111.958 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.15 -50.28 3.2 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.562 -171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 53.9 t80 -77.88 120.98 23.52 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.585 1.538 . . . . 0.0 110.338 -168.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -139.25 94.25 2.78 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -35.5 -53.53 0.67 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 128.583 2.753 . . . . 0.0 118.338 -166.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -147.96 147.36 26.48 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 168.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -75.46 175.34 11.41 Favored 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 122.214 1.942 . . . . 0.0 113.322 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -76.05 -69.41 0.5 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.21 -176.89 14.6 Favored Glycine 0 CA--C 1.478 -2.252 1 N-CA-C 102.873 -4.091 . . . . 0.0 102.873 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -121.56 69.35 0.92 Allowed 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.63 174.65 11.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.42 -19.93 62.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.81 1.244 . . . . 0.0 113.3 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -81.31 -27.33 35.08 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.92 -34.62 51.26 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -34.03 54.93 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 123.327 0.651 . . . . 0.0 109.3 -170.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.02 -38.71 66.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.56 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -69.67 -30.82 68.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.267 14.2 tt -85.99 -27.38 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-N 118.504 0.593 . . . . 0.0 110.762 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.66 -29.41 64.58 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 118.628 -1.229 . . . . 0.0 110.066 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.63 HH22 ' H ' ' A' ' 92' ' ' CYS . 40.9 ttm-85 -81.43 -42.16 20.79 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -86.79 -28.0 23.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.44 -171.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -75.86 -36.08 59.68 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.63 72.0 1.23 Allowed Glycine 0 CA--C 1.473 -2.55 0 C-N-CA 125.164 1.364 . . . . 0.0 110.072 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.04 28.72 5.02 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 165.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -5.76 59.31 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.241 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.4 m -114.57 104.71 54.27 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.22 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 162.78 91.64 Favored 'Cis proline' 0 N--CA 1.44 -1.63 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 -24.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -70.3 114.35 8.35 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 123.677 0.791 . . . . 0.0 109.659 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -82.39 152.21 26.29 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.5 -74.38 0.1 Allowed 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.244 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -120.6 125.96 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -165.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -144.79 142.35 29.92 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.7 m -107.51 125.48 51.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.992 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.81 121.17 36.13 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.267 5.7 mm -93.63 147.64 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.81 133.07 35.53 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.97 -141.59 6.83 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 105.526 -3.029 . . . . 0.0 105.526 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -96.05 149.85 21.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.81 -18.74 27.06 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -71.31 -37.08 71.8 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -72.07 -38.33 69.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 117.375 -1.298 . . . . 0.0 111.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tp -65.54 -47.5 86.27 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 CA-C-N 119.242 0.928 . . . . 0.0 109.967 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.96 -39.37 91.9 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.661 1.584 . . . . 0.0 111.476 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.46 9.1 2.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.88 -44.04 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 165.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.3 m -99.64 42.93 1.08 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.87 24.1 3.94 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 40.38 61.98 1.45 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.5 3.12 . . . . 0.0 113.856 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -133.06 -35.39 1.05 Allowed 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -127.92 31.45 5.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.12 149.13 12.45 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.93 147.26 64.81 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.31 132.71 15.31 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.757 2.305 . . . . 0.0 107.919 -163.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -108.68 85.07 2.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 72.12 -101.53 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.935 1.694 . . . . 0.0 111.975 172.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -116.26 81.68 1.65 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -165.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 1.5 p-10 63.83 22.54 13.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 129.196 2.998 . . . . 0.0 114.534 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.1 164.54 11.73 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.756 -3.794 . . . . 0.0 100.756 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.31 113.95 4.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 117.3 -1.76 . . . . 0.0 109.171 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 tt -85.66 139.69 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -80.66 171.38 15.1 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 0.0 111.367 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.65 -9.3 10.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -127.19 96.49 4.61 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -48.15 127.76 13.0 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 127.614 2.365 . . . . 0.0 112.939 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.31 154.14 19.33 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.28 148.17 33.98 Favored 'General case' 0 CA--C 1.469 -2.152 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.88 144.37 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -168.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.3 m -135.99 101.91 4.87 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.2 m -86.25 111.99 20.95 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 69.0 m -88.72 116.15 26.77 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -111.75 142.6 43.9 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -75.86 121.64 22.93 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -130.95 64.77 1.57 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.5 -48.88 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 105.314 -3.115 . . . . 0.0 105.314 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.29 11.94 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -106.25 124.19 36.59 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -79.98 -27.31 3.88 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 121.56 1.593 . . . . 0.0 108.078 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -105.42 147.82 35.27 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 117.386 -1.293 . . . . 0.0 107.846 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.87 144.09 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.381 2.054 . . . . 0.0 107.09 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -82.32 161.1 77.5 Favored 'Cis proline' 0 CA--C 1.487 -1.853 0 CA-C-N 123.683 2.351 . . . . 0.0 110.697 10.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.63 ' H ' HH22 ' A' ' 31' ' ' ARG . 56.3 m -147.3 125.29 12.04 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.973 -166.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -84.55 129.34 34.86 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.23 120.05 36.52 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -97.69 127.76 43.88 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.52 127.25 33.57 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -113.25 100.09 8.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 172.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.87 130.51 35.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.93 -177.28 14.83 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -163.53 106.25 0.98 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.0 170.44 22.31 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.176 -172.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.23 131.75 44.69 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 124.195 0.998 . . . . 0.0 109.597 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.82 133.49 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.22 84.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.67 138.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.26 136.74 40.61 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.6 149.78 22.42 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 124.059 0.849 . . . . 0.0 111.458 -168.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -148.23 123.51 10.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.1 p30 64.41 18.69 11.47 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.571 2.349 . . . . 0.0 115.071 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.14 22.15 55.42 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 19.2 tp -132.24 130.21 21.9 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.37 109.23 2.28 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 123.49 2.282 . . . . 0.0 107.482 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.07 -12.42 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 O-C-N 123.731 0.644 . . . . 0.0 111.376 -171.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 59.1 t60 -143.55 176.55 9.12 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.64 131.26 2.99 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.81 125.19 28.27 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.48 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -94.04 12.65 25.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.209 1.004 . . . . 0.0 108.951 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -92.37 -6.42 50.16 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.58 0.752 . . . . 0.0 109.827 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.27 -25.05 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 N--CA 1.423 -1.788 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.68 -170.717 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 . . . . . 0 CA--C 1.502 -0.898 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t -93.36 -13.28 28.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -25.78 63.35 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.122 1.369 . . . . 0.0 110.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.13 -41.64 66.95 Favored 'General case' 0 N--CA 1.407 -2.606 0 C-N-CA 125.914 1.685 . . . . 0.0 108.94 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.0 -7.63 59.6 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -76.28 -47.23 24.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -57.36 -41.65 80.53 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 126.977 2.111 . . . . 0.0 110.632 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.399 0.1 OUTLIER -99.39 -5.29 29.79 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.457 -173.539 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.1 t -79.55 -38.86 33.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.727 1.603 . . . . 0.0 107.064 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.6 pt20 -82.98 -28.07 29.99 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.458 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 79.9 m-70 -103.65 -50.31 3.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 49.3 t80 -76.59 118.07 18.87 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 120.038 1.29 . . . . 0.0 110.837 -168.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -136.08 97.59 3.65 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.34 -42.09 4.37 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -166.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -160.08 134.9 5.53 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -73.76 -179.8 4.91 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 122.757 2.304 . . . . 0.0 114.012 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -74.86 -71.54 0.35 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.99 -177.48 14.9 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 103.343 -3.903 . . . . 0.0 103.343 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -121.64 72.51 1.02 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.98 177.99 7.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.61 -14.44 61.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -77.54 -33.96 53.99 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.63 -39.23 62.23 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.0 t -68.52 -43.08 77.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.0 111.81 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.1 -35.46 66.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.033 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -73.21 -30.17 63.33 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.87 -28.75 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-N 118.501 0.592 . . . . 0.0 109.528 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.8 mmt -70.33 -33.29 71.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.229 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -44.47 64.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.401 0.681 . . . . 0.0 111.406 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.44 -39.56 58.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -35.59 63.75 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.18 75.54 1.05 Allowed Glycine 0 CA--C 1.479 -2.217 0 C-N-CA 124.789 1.185 . . . . 0.0 111.274 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.354 2.6 mm? -104.86 -3.69 23.14 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -78.88 -5.1 52.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.792 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 m -119.66 103.27 46.47 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.583 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.59 164.06 88.95 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 CA-C-N 122.96 2.093 . . . . 0.0 107.054 -23.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.8 m -57.14 125.1 21.19 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.563 -171.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -76.86 141.6 40.55 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -77.18 -39.86 47.42 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.354 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.73 128.9 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -148.87 125.67 11.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -98.58 119.97 38.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.064 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.6 114.09 23.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.05 149.45 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.64 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -139.05 136.16 34.97 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 124.581 1.153 . . . . 0.0 108.063 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.09 -143.77 8.65 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.91 147.01 24.41 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -86.23 -12.81 48.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.32 -36.29 71.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.436 1.494 . . . . 0.0 109.338 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 p -81.19 -25.69 36.55 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.307 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -56.93 -50.99 73.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.297 0 CA-C-N 120.232 1.378 . . . . 0.0 110.356 166.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -62.61 -40.67 97.7 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 123.464 0.706 . . . . 0.0 112.212 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.03 29.9 0.62 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 122.958 0.503 . . . . 0.0 112.082 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.4 mm -87.64 -30.13 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 160.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.0 t -83.15 -57.16 3.39 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.399 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.89 107.44 19.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -168.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 56.25 -87.51 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.575 2.75 . . . . 0.0 116.792 163.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.27 145.13 55.47 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.222 1.409 . . . . 0.0 107.839 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.331 6.8 p-10 43.83 39.4 2.57 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 130.873 3.669 . . . . 0.0 117.473 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.58 134.8 2.27 Favored Glycine 0 CA--C 1.489 -1.542 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 168.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -122.62 162.88 36.02 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -164.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 149.13 34.24 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.653 2.236 . . . . 0.0 108.491 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -148.28 116.82 6.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -168.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 66.68 -111.44 0.17 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.211 1.404 . . . . 0.0 110.792 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -136.16 95.21 3.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.359 2.2 p-10 64.98 23.13 12.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 129.161 2.985 . . . . 0.0 114.587 172.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -106.76 163.32 13.02 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 167.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -142.41 124.73 15.56 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.09 144.75 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 97.7 p -83.33 158.0 22.36 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 121.748 0.785 . . . . 0.0 110.686 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -117.18 -5.06 11.37 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -116.5 88.94 3.0 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -55.69 128.8 36.48 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.058 1.743 . . . . 0.0 110.954 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -108.32 158.71 17.25 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 5.6 mt-30 -76.89 146.31 37.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.48 146.85 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -131.8 101.95 5.67 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 164.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -79.24 103.75 9.38 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 32.2 m -90.11 112.09 23.44 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -121.5 140.21 52.48 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 tp -79.3 120.32 23.59 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -135.28 56.28 1.85 Allowed 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.54 -86.56 1.81 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 106.272 -2.731 . . . . 0.0 106.272 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.66 -16.67 3.31 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 m -85.41 134.02 41.18 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -79.67 -27.56 3.97 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.848 1.698 . . . . 0.0 108.209 170.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -97.7 163.36 19.74 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.263 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.54 144.13 35.47 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 122.268 1.979 . . . . 0.0 107.431 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -83.07 163.15 72.95 Favored 'Cis proline' 0 CA--C 1.489 -1.775 0 CA-C-N 123.164 2.166 . . . . 0.0 109.936 9.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.57 122.59 36.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -88.93 113.06 24.05 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.18 126.11 51.82 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -89.89 126.28 35.66 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 131.16 35.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.0 m -119.66 90.83 3.41 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.547 -2.761 . . . . 0.0 103.547 172.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.53 130.01 36.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.51 -165.67 10.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -157.51 101.09 1.83 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.442 -3.911 . . . . 0.0 100.442 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -138.19 149.32 45.71 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -165.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -77.3 134.21 38.59 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.596 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.23 153.37 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.08 115.94 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 102.01 -3.329 . . . . 0.0 102.01 161.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.43 161.44 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.03 144.7 32.38 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 163.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.6 t -123.33 138.83 54.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.527 1.142 . . . . 0.0 110.068 -170.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -127.43 132.99 49.99 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.308 5.6 p30 73.74 6.32 4.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.93 20.33 21.58 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.76 144.94 18.24 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -71.12 154.63 62.18 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 122.417 1.899 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.25 -17.38 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -149.81 166.93 27.99 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -164.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -127.64 130.66 49.33 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.9 120.1 24.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 21.57 17.19 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -173.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -90.57 -16.1 29.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.697 -174.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.09 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.424 -1.77 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.609 -175.702 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.0 p -91.64 -17.05 26.11 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -76.44 -32.84 58.68 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 123.353 0.661 . . . . 0.0 110.457 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -68.01 -37.94 82.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.65 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -74.68 -19.19 60.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -72.3 -45.57 59.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.98 0.809 . . . . 0.0 108.86 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -56.69 -40.49 75.68 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.176 1.79 . . . . 0.0 111.27 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.415 0.2 OUTLIER -96.88 -2.52 43.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 118.44 0.564 . . . . 0.0 111.732 -173.328 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.6 m -76.63 -42.97 40.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -68.75 -46.49 68.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.873 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -102.68 -41.33 6.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 118.448 -0.786 . . . . 0.0 111.173 -167.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 39.4 t80 -80.84 117.09 21.18 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.558 1.527 . . . . 0.0 111.124 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.07 96.29 3.48 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 100.958 -3.719 . . . . 0.0 100.958 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.27 6.12 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 127.937 2.495 . . . . 0.0 117.573 -165.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -151.69 138.82 12.23 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -74.71 179.55 5.87 Favored 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 122.824 2.35 . . . . 0.0 113.834 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.3 -70.19 0.38 Allowed 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.74 -175.35 13.96 Favored Glycine 0 CA--C 1.477 -2.332 1 N-CA-C 101.995 -4.442 . . . . 0.0 101.995 163.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -116.1 72.57 0.81 Allowed 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.32 -179.7 6.15 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.488 -170.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.55 -39.34 87.58 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 127.457 2.303 . . . . 0.0 111.836 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -83.72 -16.02 46.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 110.775 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -77.73 -40.48 41.0 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 m -69.51 -34.68 74.64 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 123.485 0.491 . . . . 0.0 111.98 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.05 -37.71 72.52 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.409 0.443 . . . . 0.0 110.04 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -70.74 -31.08 67.78 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.275 14.5 tt -86.25 -27.84 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.067 0.394 . . . . 0.0 111.713 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.76 -19.56 48.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.552 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -75.79 -42.09 51.04 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 118.781 0.719 . . . . 0.0 109.425 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -75.73 -48.42 21.96 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.865 0.866 . . . . 0.0 111.505 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.87 -27.96 44.12 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.97 65.61 1.59 Allowed Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.91 22.48 14.85 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 165.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -89.37 -12.27 40.89 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -129.83 105.95 16.88 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.4 160.17 96.25 Favored 'Cis proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 -19.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.7 m -61.1 121.67 13.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.443 1.097 . . . . 0.0 110.258 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -73.65 133.52 43.45 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -72.83 -42.31 63.93 Favored 'General case' 0 CA--C 1.491 -1.316 0 O-C-N 123.766 0.666 . . . . 0.0 112.456 -169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 tt -154.49 126.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -154.77 129.31 9.17 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -94.86 125.14 39.32 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.32 120.67 33.87 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 167.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -98.08 148.59 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -135.51 133.4 38.42 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.352 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.93 -140.59 6.39 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 104.451 -3.459 . . . . 0.0 104.451 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -105.11 148.38 26.9 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 168.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -87.43 0.48 55.44 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.186 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.36 -34.98 58.91 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 167.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -77.22 -33.26 56.22 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.458 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mm -59.26 -50.03 81.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 124.335 1.054 . . . . 0.0 110.386 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -61.33 -33.83 74.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.171 0.988 . . . . 0.0 113.275 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 7.38 8.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 mm -84.83 -21.29 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.3 t -80.16 -19.46 47.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 122.064 -0.398 . . . . 0.0 110.736 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.64 142.9 51.59 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 165.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.42 -7.43 59.58 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.742 0.817 . . . . 0.0 112.699 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -81.26 -41.77 21.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.11 15.58 16.04 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -167.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.25 112.45 0.4 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 172.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -96.01 152.15 38.75 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.44 118.46 5.61 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 122.635 2.224 . . . . 0.0 106.373 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.647 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 15.8 p-80 -91.13 119.97 31.69 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 61.84 -96.67 0.06 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.784 1.634 . . . . 0.0 112.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -122.28 82.02 1.91 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -171.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 0.7 OUTLIER 65.88 11.75 7.88 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 129.192 2.997 . . . . 0.0 117.826 160.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.9 OUTLIER -102.84 148.33 25.77 Favored 'General case' 0 CA--C 1.476 -1.887 1 N-CA-C 99.0 -4.445 . . . . 0.0 99.0 174.372 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -124.44 118.48 26.76 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -158.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.6 tt -95.61 137.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.5 p -80.34 164.25 23.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.626 0.727 . . . . 0.0 111.914 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.06 -11.78 8.83 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -103.69 83.33 2.12 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.8 m -47.52 124.81 7.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 127.126 2.17 . . . . 0.0 112.048 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.68 158.08 16.5 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -78.96 143.36 35.84 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.13 141.23 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -167.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.8 m -129.62 105.77 8.28 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -81.66 100.11 9.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 99.9 m -86.84 112.33 21.63 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -111.35 143.09 42.7 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.16 109.72 17.42 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -94.5 158.68 15.44 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.2 -91.13 1.48 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.71 39.65 0.46 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.3 p -92.9 120.63 67.0 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.43 -8.64 4.49 Favored 'Trans proline' 0 N--CA 1.438 -1.781 0 CA-C-N 121.618 1.614 . . . . 0.0 108.036 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -110.6 161.84 23.07 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.04 146.14 36.52 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.454 2.102 . . . . 0.0 107.684 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.79 164.25 67.63 Favored 'Cis proline' 0 N--CA 1.435 -1.925 0 CA-C-N 122.073 1.776 . . . . 0.0 107.934 3.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.54 159.78 21.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -117.02 129.12 55.81 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -124.24 124.3 42.14 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -100.65 127.85 46.9 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.48 130.98 35.92 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.027 0.442 . . . . 0.0 109.964 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -119.1 89.55 3.15 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.49 136.85 33.25 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.104 0.478 . . . . 0.0 109.907 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.19 179.26 18.82 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -143.56 101.21 3.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -160.82 175.05 12.99 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -70.56 145.88 50.5 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 124.811 1.244 . . . . 0.0 111.539 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.37 147.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.586 HG13 ' HE1' ' A' ' 65' ' ' HIS . 56.0 t -110.25 94.19 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 165.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 m -96.5 133.17 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.96 132.01 43.18 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.05 134.96 52.24 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 124.548 1.155 . . . . 0.0 111.289 -166.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.74 135.23 45.62 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 10.2 p30 68.87 12.6 8.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.395 2.278 . . . . 0.0 116.411 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.93 19.51 46.92 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.2 19.86 Favored Pre-proline 0 CA--C 1.491 -1.32 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.06 113.21 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.59 -6.98 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.7 t60 -155.04 174.83 14.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -168.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.429 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -165.98 131.58 2.45 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.94 141.58 35.9 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.529 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -103.84 44.28 1.03 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -95.2 -34.41 12.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -33.84 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 C-N-CA 125.143 1.377 . . . . 0.0 109.498 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 . . . . . 0 N--CA 1.421 -1.906 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -169.1 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 120.673 0.273 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -91.59 -7.06 51.23 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 124.356 1.062 . . . . 0.0 109.13 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -43.15 62.59 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -59.67 -50.84 72.28 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-O 117.523 -1.227 . . . . 0.0 112.309 173.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.433 3.4 t -87.16 9.04 21.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -76.68 -44.67 32.8 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 119.958 -1.713 . . . . 0.0 107.916 156.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.2 -31.86 70.55 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.597 1.159 . . . . 0.0 111.462 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.31 -23.77 23.35 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.691 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -71.03 -35.65 72.08 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 120.102 1.319 . . . . 0.0 109.82 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -69.29 -63.62 1.03 Allowed 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.924 168.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -88.8 -49.11 7.03 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -162.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -76.44 118.19 18.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.991 1.723 . . . . 0.0 110.14 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -137.31 98.29 3.68 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.67 -34.71 0.4 Allowed 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 119.942 3.312 . . . . 0.0 119.942 -165.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -150.13 156.62 37.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 16.8 Cg_endo -72.18 149.76 52.37 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 123.246 2.631 . . . . 0.0 108.964 170.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -84.06 -50.91 7.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 166.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.38 -179.01 16.04 Favored Glycine 0 CA--C 1.48 -2.115 0 N-CA-C 103.621 -3.792 . . . . 0.0 103.621 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -126.6 53.03 1.69 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -141.07 -179.26 5.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.67 -38.59 72.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 128.437 2.695 . . . . 0.0 112.734 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -79.23 -23.93 43.41 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 124.129 0.971 . . . . 0.0 111.025 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -76.65 -38.94 53.75 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.3 m -69.81 -35.94 75.23 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 123.613 0.571 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.88 -35.7 64.72 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 t -70.51 -32.59 70.13 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 122.78 0.432 . . . . 0.0 111.998 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.295 10.5 tt -82.69 -30.83 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.077 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.15 -18.72 52.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.216 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -74.42 -37.15 63.41 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 119.062 0.846 . . . . 0.0 111.296 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -51.67 14.97 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.806 0.443 . . . . 0.0 110.107 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.91 -36.74 67.33 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.736 0.814 . . . . 0.0 110.646 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.98 67.02 1.57 Allowed Glycine 0 CA--C 1.479 -2.173 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.1 mt -114.46 22.88 13.27 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 164.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -99.06 2.56 46.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -146.54 103.85 3.98 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 159.05 94.83 Favored 'Cis proline' 0 N--CA 1.447 -1.246 0 CA-C-N 122.127 1.795 . . . . 0.0 107.636 -16.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.3 m -61.83 124.88 21.98 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 123.974 0.796 . . . . 0.0 110.148 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -77.95 132.28 37.8 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 171.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.17 -42.32 69.24 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.048 0.842 . . . . 0.0 112.455 -165.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.68 126.47 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -145.61 126.33 14.31 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.408 ' HG1' HE22 ' A' ' 117' ' ' GLN . 18.3 m -95.24 118.64 32.37 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.739 -174.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.54 115.47 28.07 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.2 mm -92.13 146.13 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.522 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.3 m-70 -134.58 138.44 44.58 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.0 -153.46 24.71 Favored Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.34 138.56 34.48 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.62 -9.08 57.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -37.33 73.51 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.6 m -76.34 -30.81 57.78 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.288 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -57.28 11.83 Favored 'Isoleucine or valine' 0 C--N 1.363 1.161 0 CA-C-N 119.558 1.072 . . . . 0.0 110.377 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 54' ' ' LYS . 3.5 ttmp? -68.12 -38.43 82.22 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.09 1.314 . . . . 0.0 110.958 -172.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.66 -0.15 22.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.869 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.286 0.6 OUTLIER -79.57 -24.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.296 0 C-N-CA 116.532 -2.067 . . . . 0.0 110.113 170.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 92.8 m -98.8 34.88 1.97 Allowed 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.39 0.995 . . . . 0.0 111.074 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -118.35 21.72 12.51 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.273 13.5 p-10 26.23 46.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.551 1 C-N-CA 132.021 4.128 . . . . 0.0 116.122 -167.122 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.49 -19.37 14.42 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -127.22 28.97 5.65 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.77 161.67 31.36 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -122.56 148.41 52.92 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-O 116.092 -1.909 . . . . 0.0 106.021 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -69.92 154.82 66.69 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.767 2.311 . . . . 0.0 111.806 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -125.57 57.8 1.33 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.27 15.7 tpp180 81.56 -100.31 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.152 2.181 . . . . 0.0 113.044 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.34 78.03 1.34 Allowed 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 124.049 0.94 . . . . 0.0 109.318 -166.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.336 1.3 p-10 74.33 8.68 4.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 129.291 3.037 . . . . 0.0 113.749 169.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.17 158.78 16.07 Favored 'General case' 0 CA--C 1.466 -2.252 1 N-CA-C 98.794 -4.521 . . . . 0.0 98.794 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.469 HH22 HG21 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -152.09 138.19 18.26 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -174.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.19 136.64 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.0 p -84.38 163.2 19.69 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.39 0.614 . . . . 0.0 110.696 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -126.7 -0.97 6.74 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.0 t -101.33 92.49 4.97 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 162.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.1 m -58.33 126.58 28.13 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.28 1.432 . . . . 0.0 110.373 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -107.85 161.0 15.31 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 4.4 mt-30 -79.88 151.4 30.2 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.98 146.36 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -168.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.0 m -135.19 103.51 5.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 165.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.8 m -84.31 101.62 12.08 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.7 m -85.72 113.75 22.15 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -122.66 135.77 54.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.271 19.3 mt -65.4 118.28 9.15 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.106 0.479 . . . . 0.0 110.621 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -88.54 126.81 35.44 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 169.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.18 -84.86 0.38 Allowed Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 106.519 -2.633 . . . . 0.0 106.519 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.98 37.86 1.09 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.7 t -86.9 123.91 69.73 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.92 3.63 3.0 Favored 'Trans proline' 0 N--CA 1.437 -1.837 0 CA-C-N 122.192 1.818 . . . . 0.0 108.492 -171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.35 160.71 38.53 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.19 146.17 31.67 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.73 1.62 . . . . 0.0 108.215 -171.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -82.74 161.71 75.41 Favored 'Cis proline' 0 N--CA 1.437 -1.834 0 CA-C-N 122.656 1.984 . . . . 0.0 109.482 7.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 m -119.95 111.81 18.4 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -85.76 122.4 29.79 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -121.11 111.21 17.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -85.75 129.75 34.74 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.11 127.35 32.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.7 m -114.6 92.59 4.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.14 29.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.024 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.7 -172.83 18.92 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -156.4 106.34 2.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.49 25.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.803 0.811 . . . . 0.0 109.97 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 129.38 34.49 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.053 1.341 . . . . 0.0 109.429 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.4 m -89.41 143.1 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.163 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.32 97.46 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 HH22 ' A' ' 70' ' ' ARG . 25.6 m -105.58 138.38 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.67 134.55 39.78 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.3 m -106.53 153.35 22.44 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.612 1.195 . . . . 0.0 110.135 -171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -151.07 128.55 11.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.86 -2.645 . . . . 0.0 103.86 167.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.329 12.9 p30 66.02 17.55 10.81 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.216 2.607 . . . . 0.0 115.672 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.55 0.87 62.45 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.54 139.82 21.18 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.03 114.83 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 N-CA-C 105.224 -2.644 . . . . 0.0 105.224 164.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 m -100.32 -10.77 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 80.9 t60 -158.53 175.65 13.4 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -165.67 125.23 1.72 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.53 130.77 34.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.408 HE22 ' HG1' ' A' ' 44' ' ' THR . 1.0 OUTLIER -99.96 43.16 1.07 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.4 p -95.04 -18.01 21.4 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pt -97.03 -19.04 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 106.014 -1.846 . . . . 0.0 106.014 178.363 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.487 -1.465 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 t -93.08 -24.99 18.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 171.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -68.59 -37.94 80.24 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.167 1.387 . . . . 0.0 109.383 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 42.9 t80 -50.32 -60.65 2.77 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 127.642 2.377 . . . . 0.0 114.191 166.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -16.58 64.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -70.84 -51.34 27.13 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.531 1.059 . . . . 0.0 109.063 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.09 -34.34 70.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 126.95 2.1 . . . . 0.0 111.555 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.43 0.0 OUTLIER -98.53 -8.91 25.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 118.698 0.681 . . . . 0.0 110.441 -171.774 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -76.52 -45.07 32.39 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 168.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -45.65 86.57 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.987 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -106.15 -49.02 3.45 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-O 118.547 -0.739 . . . . 0.0 111.782 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 60.5 t80 -76.48 121.9 23.78 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 120.136 1.335 . . . . 0.0 110.05 -167.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.72 97.17 3.2 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 102.063 -3.31 . . . . 0.0 102.063 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.29 -43.5 1.15 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 128.594 2.758 . . . . 0.0 118.291 -168.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.09 148.77 17.98 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 165.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -74.14 168.95 23.56 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 121.63 1.553 . . . . 0.0 112.443 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.96 -67.02 0.57 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.59 -178.46 15.44 Favored Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 102.159 -4.376 . . . . 0.0 102.159 163.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -113.3 72.91 0.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.14 175.76 11.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.08 -24.87 63.3 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.707 1.203 . . . . 0.0 113.176 -171.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -86.85 -18.31 31.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -41.53 62.26 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.29 0.5 OUTLIER -76.95 -26.51 54.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.167 -1.413 . . . . 0.0 113.605 -173.978 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.56 -39.33 81.08 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.293 170.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -66.88 -38.04 85.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 26' ' ' CYS . 20.2 tt -80.95 -27.09 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 117.851 0.296 . . . . 0.0 110.504 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -24.58 55.73 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.186 -1.006 . . . . 0.0 112.03 174.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -75.63 -34.54 60.56 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 118.608 0.64 . . . . 0.0 111.82 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -76.99 -46.17 24.82 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 118.27 0.486 . . . . 0.0 111.769 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.28 -34.44 65.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 72.59 1.19 Allowed Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.6 mt -113.25 20.14 16.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -89.01 -7.11 56.59 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.7 m -125.65 100.86 30.87 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.553 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.52 167.48 80.19 Favored 'Cis proline' 0 N--CA 1.445 -1.359 0 N-CA-C 107.066 -1.936 . . . . 0.0 107.066 -22.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -60.02 126.65 28.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 124.031 0.932 . . . . 0.0 111.034 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.29 139.43 46.11 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.95 -51.94 16.45 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 123.581 0.551 . . . . 0.0 110.091 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 tt -147.83 135.58 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -152.26 130.1 11.69 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.2 m -97.21 120.52 37.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.186 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -90.62 126.46 35.97 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.262 5.9 mm -89.95 148.94 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 3.2 m-70 -138.49 139.25 38.71 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.61 -114.32 0.6 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 106.479 -2.648 . . . . 0.0 106.479 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -134.08 134.73 42.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.04 3.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.674 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -84.79 -28.29 26.26 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.1 m -84.62 -25.29 28.67 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -71.19 -41.94 75.28 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -61.77 -52.36 64.56 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.949 0.899 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.6 3.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.747 1.219 . . . . 0.0 113.399 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 tp -76.93 -33.92 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.2 m -94.23 9.67 37.09 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -166.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -104.44 23.11 13.74 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.79 0.805 . . . . 0.0 110.737 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.4 m120 42.63 38.04 1.18 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 130.81 3.644 . . . . 0.0 114.002 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.49 -35.24 7.95 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -120.98 26.15 9.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 149.97 17.99 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 119.178 -1.486 . . . . 0.0 110.729 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -100.46 125.36 39.51 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-O 116.529 -1.7 . . . . 0.0 107.934 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.8 141.62 34.08 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.648 2.899 . . . . 0.0 108.167 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -123.76 80.39 1.8 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 65.76 -99.49 0.06 Allowed 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 126.479 1.911 . . . . 0.0 114.516 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.42 72.39 1.41 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -164.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.309 2.6 p-10 57.31 30.6 18.76 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 129.495 3.118 . . . . 0.0 114.832 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.0 161.36 20.34 Favored 'General case' 0 CA--C 1.47 -2.101 1 N-CA-C 98.677 -4.564 . . . . 0.0 98.677 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.594 HH12 HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -156.82 148.55 22.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -171.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.31 126.07 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -69.07 160.4 31.08 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -117.54 -18.75 9.67 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.143 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 t -103.44 84.02 2.25 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.2 p -52.18 136.47 30.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.179 2.192 . . . . 0.0 112.701 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.82 163.58 14.87 Favored 'General case' 0 CA--C 1.473 -2.011 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -168.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 5.6 mt-30 -78.33 148.26 33.85 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -145.66 146.32 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -167.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.6 m -138.5 104.84 5.25 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 m -90.17 99.8 12.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.8 m -92.49 123.57 35.89 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -115.16 146.36 41.45 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.468 1.107 . . . . 0.0 108.584 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -94.2 156.52 16.5 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.82 -79.6 0.34 Allowed Glycine 0 CA--C 1.486 -1.776 0 N-CA-C 106.036 -2.826 . . . . 0.0 106.036 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.06 27.39 6.6 Favored Glycine 0 CA--C 1.488 -1.644 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -89.38 127.28 55.55 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 171.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -80.14 -20.63 8.49 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 CA-C-N 122.686 1.995 . . . . 0.0 108.849 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -101.21 163.62 17.59 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.94 144.58 34.62 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 N-CA-C 107.516 -1.763 . . . . 0.0 107.516 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -84.08 163.19 67.82 Favored 'Cis proline' 0 CA--C 1.489 -1.746 0 CA-C-N 123.174 2.169 . . . . 0.0 110.423 13.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 m -126.24 117.31 22.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.77 83.97 1.85 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.648 1.213 . . . . 0.0 108.067 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -70.0 130.66 42.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -97.18 120.52 37.68 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.53 135.73 33.71 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -115.31 98.97 7.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.85 141.72 35.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.96 -163.01 13.91 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -162.38 108.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -146.26 151.12 37.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -167.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -75.21 135.16 41.04 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -96.31 136.79 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.725 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.46 ' H ' HD13 ' A' ' 119' ' ' ILE . 89.3 t -91.81 105.74 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 164.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.594 HG22 HH12 ' A' ' 70' ' ' ARG . 16.2 m -117.06 155.68 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.29 133.3 53.22 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.3 m -102.67 153.95 19.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 124.717 1.261 . . . . 0.0 111.295 -170.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -147.85 123.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 167.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.0 p30 69.63 15.76 8.11 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.307 2.243 . . . . 0.0 115.069 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.83 55.64 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.417 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 7.6 tp -128.56 133.48 25.23 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -77.33 118.56 4.68 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 CA-C-N 124.181 2.529 . . . . 0.0 106.381 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.79 -11.34 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 O-C-N 123.635 0.584 . . . . 0.0 109.802 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -145.26 152.05 39.34 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.74 127.35 55.31 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 117.53 30.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -100.75 37.93 1.63 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -166.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.2 p -87.39 -20.83 26.13 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 121.747 -0.596 . . . . 0.0 109.411 -174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -86.15 -23.5 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.105 0 C-N-CA 123.87 0.868 . . . . 0.0 109.579 173.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 . . . . . 0 N--CA 1.419 -2.008 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -164.477 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -87.92 -17.09 32.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.533 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -73.28 -41.79 63.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CG ' ' HG ' ' A' ' 111' ' ' LEU . 2.4 t80 -64.53 -48.02 76.67 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.836 173.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -79.78 -10.41 59.78 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 120.304 1.411 . . . . 0.0 114.506 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -82.82 -30.56 28.66 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 119.093 0.86 . . . . 0.0 108.81 171.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.44 ' CD2' HD13 ' A' ' 10' ' ' LEU . 3.3 t80 -60.25 -34.94 74.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.492 0.717 . . . . 0.0 109.986 165.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 9' ' ' PHE . 10.8 mp -81.03 -23.3 38.7 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.9 p -75.11 -30.65 60.91 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 120.495 1.498 . . . . 0.0 110.881 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -72.74 -55.16 7.17 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -95.66 -54.04 3.5 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.708 -162.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 23.4 t80 -78.45 112.2 15.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.926 1.239 . . . . 0.0 109.977 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.43 94.07 3.58 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 101.445 -3.539 . . . . 0.0 101.445 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.9 -38.02 0.89 Allowed 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 120.141 3.386 . . . . 0.0 120.141 -162.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.7 154.38 47.92 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.9 Cg_endo -75.0 163.16 35.89 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 123.613 2.875 . . . . 0.0 109.883 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -75.16 -71.39 0.36 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 166.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.91 178.42 16.44 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.459 -3.856 . . . . 0.0 103.459 164.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -114.68 70.61 0.74 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.68 174.98 14.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.72 -16.75 62.81 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.814 1.246 . . . . 0.0 113.535 -170.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -81.75 -28.83 33.12 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -76.99 -34.3 57.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -33.57 42.07 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -169.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.58 -46.27 80.09 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 124.631 1.172 . . . . 0.0 109.34 170.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.1 t -64.33 -36.75 85.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.9 tt -83.08 -28.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 CA-C-N 118.023 0.374 . . . . 0.0 111.21 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.0 mmt -73.28 -23.88 60.35 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.117 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -82.6 -29.32 30.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 118.903 0.774 . . . . 0.0 112.58 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -80.74 -37.35 30.68 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.402 0.546 . . . . 0.0 111.122 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -22.67 55.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.671 0.388 . . . . 0.0 110.306 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.3 5.66 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.62 16.55 19.66 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -91.1 -11.71 37.79 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 m -126.42 102.9 26.0 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.74 161.48 94.12 Favored 'Cis proline' 0 N--CA 1.443 -1.494 0 N-CA-C 106.865 -2.013 . . . . 0.0 106.865 -20.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 m -62.12 120.62 11.23 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.96 0.904 . . . . 0.0 110.339 -175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -72.0 138.9 48.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.32 -40.98 57.87 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 123.557 0.536 . . . . 0.0 111.338 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.15 128.25 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -148.39 127.14 12.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 170.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.463 ' HG1' HG21 ' A' ' 80' ' ' THR . 28.1 m -97.48 123.84 41.49 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.085 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -94.6 113.23 25.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.8 mm -87.37 145.34 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.53 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.498 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 8.9 m-70 -133.8 133.62 41.88 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.61 -147.12 12.43 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.313 -2.315 . . . . 0.0 107.313 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.423 HD21 ' HD3' ' A' ' 51' ' ' ARG . 4.5 m120 -94.92 149.04 21.67 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.07 -17.85 34.01 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HD3' HD21 ' A' ' 49' ' ' ASN . 9.0 mpt_? -68.85 -40.84 79.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.439 1.896 . . . . 0.0 106.565 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.1 m -70.21 -41.95 72.97 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 116.645 -1.645 . . . . 0.0 111.665 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.1 mm -53.97 -58.18 4.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 124.368 1.067 . . . . 0.0 111.478 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.03 -42.55 90.48 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.062 1.345 . . . . 0.0 111.489 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.65 4.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mm -77.59 -31.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.2 m -94.58 7.68 44.84 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.624 0.249 . . . . 0.0 111.502 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -91.09 173.26 8.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 158.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -85.55 1.8 47.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.344 0.658 . . . . 0.0 111.555 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -77.52 -60.01 2.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.243 0.617 . . . . 0.0 111.32 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -89.34 -49.51 6.67 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.55 147.81 18.65 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -168.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.71 156.66 35.27 Favored Pre-proline 0 N--CA 1.434 -1.262 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -73.92 125.44 9.9 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 122.663 2.242 . . . . 0.0 107.629 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -117.71 123.35 45.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 66.46 -107.2 0.11 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.912 1.285 . . . . 0.0 112.124 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.75 95.61 2.88 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.333 2.2 p-10 60.31 35.55 20.71 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 128.666 2.786 . . . . 0.0 113.602 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -117.67 165.69 13.3 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 101.31 -3.589 . . . . 0.0 101.31 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.8 mtt85 -145.14 127.59 15.96 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -95.58 134.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -81.84 160.21 23.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.351 0.596 . . . . 0.0 111.054 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.97 -1.87 9.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -106.37 77.26 1.2 Allowed 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -59.69 138.06 57.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 125.898 1.679 . . . . 0.0 111.912 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -113.43 158.85 20.13 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -166.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 8.7 mt-30 -79.89 138.9 37.26 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.22 105.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -171.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.0 m -97.98 106.31 18.58 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.463 HG21 ' HG1' ' A' ' 44' ' ' THR . 25.4 m -87.39 112.19 21.88 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -89.38 116.29 27.47 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -121.47 142.33 50.15 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -80.36 110.54 15.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -93.13 155.02 17.74 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.91 -89.79 1.52 Allowed Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.33 38.41 0.59 Allowed Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -80.15 126.08 80.14 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -84.88 -19.96 3.79 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 122.165 1.809 . . . . 0.0 108.314 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -110.47 160.66 27.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 117.618 -1.182 . . . . 0.0 107.962 -168.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -73.25 142.04 33.17 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 C-N-CA 122.695 2.263 . . . . 0.0 106.767 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -82.04 159.47 79.43 Favored 'Cis proline' 0 N--CA 1.435 -1.944 0 CA-C-N 123.027 2.117 . . . . 0.0 108.949 4.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.6 m -109.52 170.27 8.17 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -125.48 109.92 13.29 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -105.84 113.98 27.86 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -89.04 125.61 35.08 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.72 125.69 29.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 m -106.53 87.22 2.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.75 129.21 34.4 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.08 -167.13 14.4 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -157.32 114.26 3.01 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -155.14 156.18 35.29 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -168.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.57 139.58 42.19 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.61 172.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.22 147.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.08 94.7 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 165.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 m -91.6 136.11 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.5 m -107.03 142.62 36.38 Favored 'General case' 0 CA--C 1.485 -1.556 0 O-C-N 124.42 1.075 . . . . 0.0 110.577 -172.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -150.77 130.49 13.17 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.322 14.8 p30 64.37 20.44 12.17 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 115.553 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.77 -3.07 70.54 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HG ' ' CG ' ' A' ' 6' ' ' TYR 0.261 0.3 OUTLIER -102.73 142.42 24.53 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 176.789 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.72 109.85 2.93 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 N-CA-C 105.386 -2.582 . . . . 0.0 105.386 160.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 114' ' ' HIS . 2.8 m -85.98 -22.58 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.623 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.473 ' CD2' HG21 ' A' ' 113' ' ' VAL . 54.6 m-70 -156.37 -163.4 1.45 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 132.88 1.06 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.54 127.29 32.76 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -97.55 16.94 18.9 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 m -91.84 -20.85 21.03 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 118.765 0.711 . . . . 0.0 110.376 -165.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -26.71 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 C-N-CA 123.672 0.789 . . . . 0.0 109.03 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.14 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -90.05 -27.02 19.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -71.65 -41.66 68.5 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.177 0.591 . . . . 0.0 109.437 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -55.0 -56.81 15.59 Favored 'General case' 0 N--CA 1.398 -3.032 0 C-N-CA 126.158 1.783 . . . . 0.0 113.957 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -78.72 -6.16 55.08 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -86.28 -35.63 19.82 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 120.582 1.537 . . . . 0.0 108.496 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -41.34 87.69 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.547 1.139 . . . . 0.0 109.416 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.392 0.0 OUTLIER -97.34 0.02 47.22 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 118.267 0.485 . . . . 0.0 111.168 -174.027 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -71.22 -53.91 12.75 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 161.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.12 -40.58 94.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 124.053 0.846 . . . . 0.0 112.94 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -121.25 4.86 10.29 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.245 -162.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 30.7 t80 -110.29 130.0 55.63 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 120.173 1.351 . . . . 0.0 109.438 167.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.82 104.6 3.33 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 164.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.88 -43.38 4.05 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 118.321 2.712 . . . . 0.0 118.321 -164.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -142.24 156.49 64.4 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -71.04 147.28 54.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.584 2.856 . . . . 0.0 108.838 172.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -80.02 -53.51 6.66 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.04 -178.38 15.57 Favored Glycine 0 CA--C 1.48 -2.125 0 N-CA-C 103.331 -3.908 . . . . 0.0 103.331 164.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.11 48.01 2.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.95 179.33 6.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.896 -168.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.68 -41.52 77.47 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.707 2.403 . . . . 0.0 112.926 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -81.63 -18.93 42.96 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.865 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -74.29 -44.59 52.09 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -68.66 -36.93 79.2 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 124.238 0.961 . . . . 0.0 112.869 -175.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.57 -41.87 75.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 123.371 0.42 . . . . 0.0 110.275 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.9 m -73.06 -23.17 60.53 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.827 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.429 HD13 HH21 ' A' ' 33' ' ' ARG 0.288 9.9 tt -85.74 -36.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 119.77 1.168 . . . . 0.0 110.965 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.1 mmm -72.05 -30.77 65.49 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.19 -39.32 55.04 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.53 -48.56 26.27 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.407 -170.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.429 HH21 HD13 ' A' ' 29' ' ' ILE . 11.1 ptp180 -79.66 -23.77 42.29 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.152 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.37 61.95 1.52 Allowed Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 161.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.69 15.3 5.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 t -84.33 8.83 14.79 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.705 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.6 m -113.18 106.27 54.88 Favored Pre-proline 0 N--CA 1.428 -1.575 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.368 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.7 162.24 93.09 Favored 'Cis proline' 0 N--CA 1.443 -1.474 0 CA-C-N 123.401 2.25 . . . . 0.0 107.262 -22.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.28 117.48 7.9 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.58 1.152 . . . . 0.0 111.819 -168.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -73.93 137.15 43.42 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -75.09 -35.19 61.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.371 1.044 . . . . 0.0 112.629 -168.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.21 130.63 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -154.1 119.4 5.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -102.88 120.59 40.89 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.647 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.39 116.29 26.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.04 149.03 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.51 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m-70 -131.6 132.92 44.45 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.641 -172.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.85 -116.56 0.72 Allowed Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -133.5 140.69 47.38 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -88.36 -0.75 57.51 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -79.62 -31.06 41.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -78.16 -28.51 48.34 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.674 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.16 -41.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 CA-C-N 119.142 0.883 . . . . 0.0 110.609 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -58.96 -43.31 91.3 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.744 1.217 . . . . 0.0 111.122 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.94 13.6 1.35 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.11 -22.88 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.6 m -84.55 -11.03 56.85 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.62 166.61 15.24 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.26 -17.06 47.28 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -81.33 -30.49 33.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -130.4 37.86 3.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.73 128.25 1.04 Allowed Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -104.89 156.05 36.61 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.04 122.17 6.57 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 122.496 2.131 . . . . 0.0 107.036 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -106.23 127.82 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 63.46 -105.2 0.15 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.415 1.486 . . . . 0.0 112.058 170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -139.75 97.77 3.33 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.341 1.9 p-10 64.37 26.72 13.62 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 129.033 2.933 . . . . 0.0 114.343 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.18 167.83 9.73 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.51 115.55 8.82 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.1 tt -96.61 139.89 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.8 p -81.32 164.86 21.88 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.591 0.71 . . . . 0.0 111.833 -173.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -115.13 -12.68 11.88 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -116.86 90.65 3.38 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -49.9 132.92 22.71 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.543 2.337 . . . . 0.0 113.656 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.11 157.64 19.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -81.05 149.14 29.36 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.71 141.62 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -166.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.9 m -134.3 104.93 6.37 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.4 m -85.67 104.05 15.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 70.2 m -83.32 114.74 21.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -111.34 142.29 43.77 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -93.43 136.67 33.47 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 95.0 m-70 -140.83 172.6 12.46 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.39 -91.22 0.6 Allowed Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.62 -11.33 1.12 Allowed Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -78.46 134.86 61.53 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -80.35 -30.35 2.07 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.682 1.588 . . . . 0.0 108.093 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -97.14 154.88 37.99 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.44 -168.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.57 150.19 27.73 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 122.292 1.995 . . . . 0.0 107.429 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -81.7 165.04 74.67 Favored 'Cis proline' 0 CA--C 1.49 -1.707 0 CA-C-N 123.028 2.117 . . . . 0.0 109.462 7.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.7 m -149.84 141.49 23.55 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -167.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.73 141.33 30.63 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.35 110.01 9.17 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.4 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 3.8 mpt_? -91.16 132.71 35.9 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.76 130.49 35.38 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.618 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -113.9 95.63 5.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.78 141.7 34.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.41 -173.8 23.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -160.62 107.97 1.55 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.33 164.04 39.3 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.247 -173.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.81 123.78 28.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.718 1.207 . . . . 0.0 108.745 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -96.02 139.61 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.664 -163.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.6 t -96.36 112.06 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.276 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -105.06 148.13 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 170.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.24 36.61 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.95 151.15 24.96 Favored 'General case' 0 CA--C 1.494 -1.209 0 O-C-N 124.237 0.96 . . . . 0.0 110.636 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -148.76 128.74 13.51 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.346 8.2 p30 70.77 7.85 6.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.592 2.357 . . . . 0.0 115.557 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.37 2.79 57.73 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.263 5.5 tp -113.99 154.72 45.99 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -72.0 159.35 50.45 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.054 1.836 . . . . 0.0 108.263 163.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -138.27 -20.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.493 175.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.435 ' CD2' HG21 ' A' ' 113' ' ' VAL . 41.1 m-70 -149.86 177.71 9.57 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -126.74 136.07 51.94 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.52 118.73 28.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.08 40.26 1.36 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.0 m -96.76 -28.32 14.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 pt -91.47 -20.78 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.449 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.31 -6.63 49.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -33.46 44.39 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.68 -50.25 67.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.055 1.342 . . . . 0.0 109.0 173.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.484 1.7 t -88.06 10.85 17.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -80.49 -40.78 25.51 Favored 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 119.974 -1.704 . . . . 0.0 107.836 157.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.95 -40.25 80.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.117 1.367 . . . . 0.0 109.588 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 18.0 mt -83.28 -15.65 49.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.3 m -65.86 -47.71 74.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-N 120.465 1.484 . . . . 0.0 109.224 169.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.511 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 12.4 tt0 -77.83 -40.3 40.77 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 124.212 1.005 . . . . 0.0 111.187 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.511 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 80.1 m-70 -96.17 -54.92 3.13 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 118.482 0.583 . . . . 0.0 110.377 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 50.5 t80 -77.66 118.77 20.37 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.982 0.896 . . . . 0.0 110.382 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.07 98.11 3.79 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.45 -41.24 6.12 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 -165.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -156.26 139.27 10.8 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 164.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -85.54 170.96 8.85 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.876 1.717 . . . . 0.0 108.663 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -73.25 -79.77 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -177.03 20.05 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 103.494 -3.842 . . . . 0.0 103.494 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -127.38 70.87 1.32 Allowed 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -147.46 -178.76 6.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -66.21 -26.2 67.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.824 1.249 . . . . 0.0 113.777 -171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -81.25 -27.08 35.33 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 122.599 0.36 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -72.11 -42.72 65.77 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.259 0.1 OUTLIER -81.25 -24.99 36.97 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 119.081 -1.048 . . . . 0.0 113.371 -170.064 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.06 -36.6 66.91 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.467 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -69.62 -34.19 73.73 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 26' ' ' CYS . 19.3 tt -85.19 -24.75 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 CA-C-N 118.308 0.504 . . . . 0.0 110.579 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -31.09 63.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.588 172.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -73.75 -36.63 65.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -81.54 -41.91 20.95 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -77.63 -21.15 52.7 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.233 0.469 . . . . 0.0 111.904 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.67 50.69 1.94 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.344 4.0 mm? -108.09 -14.65 14.68 Favored 'General case' 0 CA--C 1.48 -1.749 0 C-N-CA 124.216 1.006 . . . . 0.0 108.636 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 t -74.6 -15.34 60.84 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.897 1.679 . . . . 0.0 112.735 -163.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -121.84 108.3 35.0 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.78 156.22 99.69 Favored 'Cis proline' 0 N--CA 1.441 -1.594 0 N-CA-C 106.722 -2.068 . . . . 0.0 106.722 -25.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.1 m -59.9 127.91 34.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 125.518 1.527 . . . . 0.0 112.026 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -80.3 140.27 36.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -77.06 -37.62 54.25 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.774 -168.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.56 129.7 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -152.38 130.0 11.53 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 170.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -97.64 128.72 44.55 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.893 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -94.83 118.04 31.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -87.14 148.07 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 3.4 m-70 -142.86 130.09 20.93 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.719 -176.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 -129.98 1.84 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 106.579 -2.609 . . . . 0.0 106.579 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -115.36 145.08 42.86 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.01 -18.83 29.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.02 0.438 . . . . 0.0 109.907 -170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -80.26 -24.64 39.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -71.07 -40.65 71.49 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 117.312 -1.328 . . . . 0.0 110.076 172.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.19 -53.87 34.31 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 C-N-CA 124.844 1.258 . . . . 0.0 111.165 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.56 -43.26 89.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.189 1.396 . . . . 0.0 111.517 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.24 8.41 9.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mm -75.37 -27.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.5 t -72.85 -29.03 62.88 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 117.564 0.165 . . . . 0.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.34 153.72 42.13 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.03 8.76 33.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.666 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.04 -50.86 7.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -110.76 -3.88 15.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.684 -166.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.31 -159.12 7.99 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 103.894 -3.682 . . . . 0.0 103.894 168.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -162.26 152.95 14.54 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -73.5 137.89 26.09 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.995 2.463 . . . . 0.0 107.503 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -129.61 122.78 29.77 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? 67.94 -100.26 0.05 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 125.181 1.393 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -162.57 108.8 1.22 Allowed 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.412 0.5 OUTLIER 86.71 -6.66 0.71 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 129.857 3.263 . . . . 0.0 114.145 173.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.8 156.82 17.27 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -141.75 115.72 9.28 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.26 141.95 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -84.47 162.71 19.81 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.63 0.729 . . . . 0.0 112.181 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.89 -27.28 9.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 m -103.03 79.78 1.79 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -47.4 133.81 12.29 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 128.336 2.654 . . . . 0.0 113.502 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -112.3 158.73 19.41 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -167.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 4.9 tp60 -79.92 125.19 29.42 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.11 103.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.9 m -90.6 107.77 19.38 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -87.41 105.59 17.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.1 m -97.4 114.49 26.32 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -114.76 136.85 52.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.86 118.66 10.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.832 1.653 . . . . 0.0 107.824 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -136.39 97.5 3.6 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.32 -42.61 0.07 OUTLIER Glycine 0 CA--C 1.48 -2.136 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.72 6.18 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 m -112.13 109.92 54.17 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -85.2 -20.46 3.38 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 121.769 1.668 . . . . 0.0 108.51 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -112.1 159.46 33.62 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -169.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -75.11 145.36 30.98 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.563 2.176 . . . . 0.0 107.929 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -81.91 162.68 77.74 Favored 'Cis proline' 0 N--CA 1.436 -1.91 0 CA-C-N 122.437 1.906 . . . . 0.0 107.969 -1.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.0 m -108.45 166.03 11.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -171.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -122.27 116.75 24.64 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.76 133.02 54.98 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -99.47 117.06 33.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 165.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.39 131.68 34.66 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 m -123.31 107.83 12.09 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.45 135.01 36.55 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.898 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.72 -174.89 13.57 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 106.09 -2.804 . . . . 0.0 106.09 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.48 106.18 1.9 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -156.88 168.92 26.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -78.1 132.67 37.79 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.569 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.46 138.89 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.391 -170.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.9 t -101.22 96.13 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.24 136.65 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.58 143.54 30.07 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.8 t -136.42 137.02 40.03 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.178 0.513 . . . . 0.0 110.624 -170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -128.23 131.73 48.8 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.306 14.1 p30 64.47 21.19 12.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 117.106 2.262 . . . . 0.0 117.106 171.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.56 53.73 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tp -144.63 118.49 5.69 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -172.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -71.51 118.29 5.58 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 CA-C-N 121.817 1.685 . . . . 0.0 111.416 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -26.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 118.816 0.735 . . . . 0.0 112.664 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -149.3 -166.2 2.49 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.1 133.56 4.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.65 141.02 34.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.509 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -105.16 42.09 1.27 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.0 m -95.87 -29.07 14.4 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -32.67 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 124.981 1.312 . . . . 0.0 109.475 170.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -171.762 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.428 -1.55 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t -93.59 -28.12 16.21 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 167.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -34.46 63.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.084 0.954 . . . . 0.0 108.803 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -46.46 -60.32 2.42 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 127.053 2.141 . . . . 0.0 111.796 162.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -72.73 -12.56 61.06 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -76.62 -41.91 44.22 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.799 1.181 . . . . 0.0 109.824 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -63.03 -36.27 83.0 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.995 1.718 . . . . 0.0 109.342 171.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -73.67 -26.7 60.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.034 1.333 . . . . 0.0 114.493 177.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 79.8 m -69.81 -51.31 34.81 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.572 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.4 pt20 -84.82 -10.25 57.36 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.572 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 83.7 m-70 -138.03 2.67 2.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 36.2 t80 -107.07 132.34 53.09 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 120.52 1.509 . . . . 0.0 108.834 171.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.33 104.36 3.09 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 167.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -37.92 16.77 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -162.14 138.13 5.8 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 86.0 Cg_exo -74.01 173.58 13.83 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.274 1.983 . . . . 0.0 114.465 -172.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.78 -73.87 0.24 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.98 -175.82 15.29 Favored Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 167.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.2 69.29 1.21 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.36 -176.96 5.68 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.45 -21.95 61.89 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.324 1.05 . . . . 0.0 113.366 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -81.95 -23.44 36.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -77.55 -37.55 50.48 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.0 m -69.46 -37.09 77.17 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -77.12 -30.71 55.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 119.456 -0.307 . . . . 0.0 110.339 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -70.33 -35.27 73.51 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.0 tt -85.96 -25.97 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 120.605 0.241 . . . . 0.0 110.89 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 mmt -76.49 -31.21 57.61 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.79 -0.569 . . . . 0.0 109.777 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -69.57 -38.64 77.48 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.159 0.984 . . . . 0.0 112.172 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -71.11 -52.04 21.59 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.465 1.106 . . . . 0.0 110.865 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.24 -26.28 39.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.145 0.578 . . . . 0.0 109.543 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.65 63.24 1.29 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 164.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.16 23.35 1.86 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.684 1.231 . . . . 0.0 108.335 174.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -84.23 -9.48 58.48 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.532 1.933 . . . . 0.0 109.696 167.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.9 t -120.22 107.77 39.0 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.82 165.45 84.87 Favored 'Cis proline' 0 N--CA 1.448 -1.184 0 CA-C-N 122.593 1.962 . . . . 0.0 107.557 -18.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.9 m -61.38 120.51 10.59 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.798 0.839 . . . . 0.0 110.757 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -79.4 144.12 34.42 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -75.19 -40.2 59.56 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 123.097 0.559 . . . . 0.0 111.762 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.26 133.76 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.8 121.09 4.85 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -102.35 115.47 30.63 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.004 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.0 120.25 26.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -101.81 146.71 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 2.1 m-70 -132.49 127.92 36.26 Favored 'General case' 0 CA--C 1.485 -1.521 0 C-N-CA 124.672 1.189 . . . . 0.0 108.574 -172.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.72 -143.85 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 105.374 -3.09 . . . . 0.0 105.374 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -95.27 148.61 22.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -88.69 -17.96 28.88 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -69.55 -36.01 75.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.9 t -74.61 -36.13 62.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 117.335 -1.317 . . . . 0.0 111.006 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 tp -64.85 -46.52 91.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.301 0 CA-C-N 119.542 1.065 . . . . 0.0 111.047 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -61.54 -41.88 97.99 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.747 1.219 . . . . 0.0 111.243 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.62 2.39 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.5 mm -74.48 -36.32 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.8 m -85.81 -31.49 22.28 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -102.07 57.31 0.81 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 117.796 0.271 . . . . 0.0 111.242 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 34.81 65.48 0.35 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 130.174 3.389 . . . . 0.0 115.54 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.94 -58.76 0.96 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -99.51 -44.43 6.17 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 154.58 21.55 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.588 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.27 154.16 42.3 Favored Pre-proline 0 N--CA 1.434 -1.247 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.75 137.31 22.16 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.984 2.456 . . . . 0.0 107.105 -175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.5 73.49 1.19 Allowed 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 69.49 -101.28 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 126.325 1.85 . . . . 0.0 113.551 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.96 77.21 1.23 Allowed 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 123.935 0.894 . . . . 0.0 108.759 -163.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.319 6.4 p30 71.92 11.56 6.18 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 129.421 3.089 . . . . 0.0 114.222 170.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.24 157.33 16.86 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -140.11 119.33 12.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -88.76 143.35 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.3 p -83.85 169.01 15.58 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -134.63 3.79 3.3 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.4 m -105.39 79.55 1.48 Allowed 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -53.24 128.43 28.03 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 127.506 2.322 . . . . 0.0 112.18 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -108.86 158.96 17.17 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -170.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 8.5 mt-30 -77.57 145.35 36.92 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.88 142.06 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -171.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.9 m -134.5 102.51 5.34 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 102.097 -3.298 . . . . 0.0 102.097 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 106.79 14.29 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.9 m -89.24 113.04 24.22 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -124.61 136.78 54.23 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -169.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.3 tp -78.64 123.63 27.33 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -138.06 52.65 1.84 Allowed 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.95 -88.2 2.01 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.66 -16.79 4.01 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -83.92 136.62 41.3 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -81.17 -23.4 5.28 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 121.83 1.687 . . . . 0.0 108.422 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -105.33 164.46 15.04 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -74.26 143.7 32.1 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 107.035 -1.948 . . . . 0.0 107.035 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -82.9 160.97 75.3 Favored 'Cis proline' 0 N--CA 1.435 -1.913 0 CA-C-N 123.062 2.129 . . . . 0.0 109.583 7.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.1 m -125.24 138.68 54.11 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -173.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.61 99.73 11.81 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -94.16 111.83 23.59 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -87.65 124.99 34.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.94 125.8 29.85 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.4 m -110.19 87.26 2.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.18 131.17 34.83 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -172.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.58 -162.35 9.2 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.049 -2.021 . . . . 0.0 108.049 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -155.21 102.32 2.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -137.91 155.62 48.73 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -158.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -74.36 127.82 33.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.54 131.55 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -92.47 113.22 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.443 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.14 141.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 173.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 114' ' ' HIS . . . -92.24 127.69 37.81 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.7 m -108.65 151.66 25.85 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 121.836 0.827 . . . . 0.0 112.004 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.33 127.15 14.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 15.3 p30 60.01 25.38 14.6 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 128.054 2.542 . . . . 0.0 115.422 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.18 20.71 60.18 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.87 138.59 19.98 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.62 117.77 1.77 Allowed 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 121.535 1.584 . . . . 0.0 108.947 -170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -93.83 -23.08 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 123.572 0.545 . . . . 0.0 112.246 -176.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.428 ' CD2' HG21 ' A' ' 113' ' ' VAL . 55.9 m-70 -143.0 -177.73 5.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -170.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.4 tp -139.07 143.09 38.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 123.98 33.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -112.17 11.7 20.35 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 t -90.79 -32.43 16.11 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -25.52 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 C-N-CA 124.304 1.042 . . . . 0.0 110.749 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.086 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.7 -30.21 16.42 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 164.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -49.19 77.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 125.726 1.61 . . . . 0.0 109.549 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -51.27 -62.85 1.37 Allowed 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 127.443 2.297 . . . . 0.0 113.542 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -70.86 -10.09 58.9 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -83.33 -39.5 20.68 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.597 1.09 . . . . 0.0 109.566 171.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.12 -37.88 81.35 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 109.617 168.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -74.03 -31.41 62.89 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 125.849 1.66 . . . . 0.0 113.576 178.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 p -75.26 -39.24 60.02 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 120.702 1.592 . . . . 0.0 110.646 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.36 -56.95 7.61 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 123.609 0.568 . . . . 0.0 111.253 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -89.67 -48.71 7.1 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.69 -167.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 24.5 t80 -70.68 119.46 14.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.955 1.252 . . . . 0.0 110.608 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -137.6 97.78 3.53 Favored 'General case' 0 N--CA 1.424 -1.77 1 N-CA-C 99.673 -4.195 . . . . 0.0 99.673 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.56 -41.69 10.17 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.502 2.321 . . . . 0.0 117.225 -166.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -159.57 131.09 3.98 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 168.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -70.91 180.0 3.88 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 123.146 2.564 . . . . 0.0 114.946 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.87 -77.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.76 -1.564 . . . . 0.0 106.949 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.06 -173.38 14.37 Favored Glycine 0 CA--C 1.478 -2.233 1 N-CA-C 102.284 -4.326 . . . . 0.0 102.284 162.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.29 72.29 0.86 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -143.91 179.71 7.01 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.52 -41.71 73.5 Favored 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 127.926 2.491 . . . . 0.0 112.931 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -79.21 -21.13 46.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.027 0.531 . . . . 0.0 111.904 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.4 -41.77 55.34 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.5 m -68.37 -37.21 80.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.755 0.659 . . . . 0.0 112.143 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.61 -37.92 70.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.805 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.8 m -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 13.2 tt -81.72 -29.76 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 CA-C-N 118.197 0.453 . . . . 0.0 109.87 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -25.58 51.7 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.943 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -75.92 -33.22 59.86 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.295 0.498 . . . . 0.0 111.109 173.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.17 -48.92 21.27 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.134 0.573 . . . . 0.0 110.833 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -78.41 -26.74 46.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 110.528 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.14 55.24 2.0 Favored Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 mt -116.12 13.77 15.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.56 -12.67 53.67 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.064 0.546 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 m -121.12 102.25 43.75 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.13 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 167.82 79.22 Favored 'Cis proline' 0 N--CA 1.445 -1.334 0 N-CA-C 107.049 -1.943 . . . . 0.0 107.049 -22.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.0 m -59.47 122.21 13.44 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.865 0.866 . . . . 0.0 111.331 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.44 143.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.65 -37.22 31.36 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 119.769 -0.158 . . . . 0.0 110.611 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.73 130.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -143.79 121.6 11.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.6 m -92.39 105.66 17.8 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.24 116.28 23.5 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.19 150.47 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 1.9 m-70 -141.87 136.04 30.13 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 125.268 1.427 . . . . 0.0 108.151 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.49 -104.6 0.24 Allowed Glycine 0 CA--C 1.483 -1.918 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -147.84 127.12 13.01 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -86.18 -3.86 59.05 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.255 -0.278 . . . . 0.0 111.601 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -30.57 35.54 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 p -85.54 -23.31 27.74 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 117.695 -1.145 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.2 mm -59.68 -54.26 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-N 119.086 0.857 . . . . 0.0 108.715 167.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -58.38 -42.83 87.94 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.418 1.487 . . . . 0.0 112.447 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 14.94 2.33 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.54 -38.37 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.43 44.34 1.02 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.009 0.433 . . . . 0.0 110.583 -171.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -133.37 21.37 4.0 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 164.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 41.46 44.05 2.38 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.292 3.437 . . . . 0.0 114.159 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.54 -45.01 7.59 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -120.03 8.92 11.07 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.78 -169.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.02 163.73 30.22 Favored Glycine 0 CA--C 1.485 -1.791 0 C-N-CA 118.872 -1.632 . . . . 0.0 109.079 -175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -112.05 156.74 41.38 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.14 135.0 24.18 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 122.666 2.244 . . . . 0.0 106.364 166.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -129.65 133.78 47.31 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 64.59 -102.65 0.09 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.426 1.49 . . . . 0.0 111.396 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -154.88 112.56 3.42 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.342 5.8 p30 68.44 15.15 9.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 129.642 3.177 . . . . 0.0 114.55 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.86 167.93 9.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 103.306 -2.85 . . . . 0.0 103.306 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.39 109.44 4.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -172.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 tt -91.02 146.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -82.21 177.21 8.92 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.478 1.132 . . . . 0.0 111.471 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -148.68 -0.08 0.55 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -119.76 90.14 3.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 130.01 44.76 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 125.937 1.695 . . . . 0.0 112.648 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.71 158.74 18.3 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 2.0 tt0 -79.74 141.07 36.68 Favored 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.17 142.82 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -166.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -130.68 109.17 10.43 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 166.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.0 m -82.33 100.86 10.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.2 m -86.76 112.28 21.53 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.21 141.94 49.46 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.75 121.49 24.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -135.56 50.45 2.11 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.53 -63.64 0.83 Allowed Glycine 0 CA--C 1.482 -1.977 0 N-CA-C 105.401 -3.08 . . . . 0.0 105.401 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.91 -15.93 21.04 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 p -86.3 140.49 34.34 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -81.32 -22.37 5.82 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.833 1.689 . . . . 0.0 108.664 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -105.55 162.57 19.33 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.423 -168.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -74.02 146.95 37.8 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.401 2.068 . . . . 0.0 108.106 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -83.07 164.49 71.24 Favored 'Cis proline' 0 CA--C 1.49 -1.722 0 CA-C-N 122.753 2.019 . . . . 0.0 109.197 5.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 39.5 m -128.24 130.11 47.45 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -95.61 120.54 36.05 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.32 117.34 32.22 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -93.09 135.54 34.17 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.52 139.4 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.553 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 m -124.13 98.74 5.91 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 171.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 147.16 28.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.075 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.61 36.5 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -152.58 100.9 2.6 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -152.31 170.36 20.23 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.808 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -75.61 129.87 37.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 108.912 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.42 141.98 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.72 113.06 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.21 147.61 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.92 121.01 31.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.33 126.98 52.91 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 123.856 0.723 . . . . 0.0 110.741 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.61 132.82 54.46 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 5.5 p30 75.03 0.48 3.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 167.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 23.1 11.06 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.1 tp -141.1 127.49 11.51 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -78.8 102.14 1.51 Allowed 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -91.07 -23.13 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 123.694 0.798 . . . . 0.0 111.631 -166.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.448 ' CD2' HG21 ' A' ' 113' ' ' VAL . 17.3 m-70 -138.37 -177.6 4.92 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -124.65 135.91 53.48 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.91 138.2 31.74 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.56 51.24 0.77 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.3 t -81.41 -49.54 10.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.327 0.651 . . . . 0.0 109.953 -171.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.87 -28.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -173.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 N--CA 1.428 -1.569 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.3 -163.897 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 CA--C 1.498 -1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -88.24 -20.8 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -75.49 -21.02 58.39 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.259 1.023 . . . . 0.0 110.407 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -76.29 -39.05 55.24 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.777 1.231 . . . . 0.0 108.232 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -80.31 -10.6 59.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.22 0.918 . . . . 0.0 113.464 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -75.04 -46.35 35.5 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.94 -34.45 71.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.249 2.22 . . . . 0.0 111.631 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.332 0.0 OUTLIER -106.97 -4.66 18.82 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.753 0.821 . . . . 0.0 111.726 -173.254 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 t -83.64 -28.74 28.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 169.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -67.82 -70.33 0.26 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 163.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -105.48 12.95 30.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -155.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 36.7 t80 -112.33 128.05 56.17 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.187 1.358 . . . . 0.0 109.33 169.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -145.34 100.9 3.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 166.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.16 -39.57 6.26 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 -166.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -154.81 137.3 10.02 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 171.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 40.9 Cg_endo -86.25 174.53 6.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 121.731 1.621 . . . . 0.0 108.72 -171.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -74.33 -50.54 18.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 172.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.23 -174.07 28.48 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -114.6 66.43 0.68 Allowed 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -150.58 173.48 14.07 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -172.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.11 -23.39 63.03 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.82 1.248 . . . . 0.0 113.185 -171.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.09 30.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -74.12 -43.85 56.0 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.3 m -67.34 -36.02 80.58 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.79 -34.37 62.41 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.39 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.5 t -69.21 -36.62 77.45 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 tt -82.4 -28.08 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 117.873 0.306 . . . . 0.0 111.017 -175.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mmt -78.33 -24.75 46.42 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.832 176.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -42.4 63.81 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 172.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -45.1 30.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.527 0.331 . . . . 0.0 111.761 -169.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.17 -22.03 53.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.13 56.22 1.62 Allowed Glycine 0 C--N 1.352 1.454 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.326 4.0 mm? -108.73 -16.71 14.12 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 124.532 1.133 . . . . 0.0 108.855 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -76.19 -11.47 59.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.577 1.551 . . . . 0.0 112.883 -164.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t -124.79 108.52 28.38 Favored Pre-proline 0 N--CA 1.438 -1.025 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.838 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.72 157.66 98.41 Favored 'Cis proline' 0 N--CA 1.447 -1.227 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 -23.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.7 m -54.89 129.98 39.54 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 125.43 1.492 . . . . 0.0 113.258 -173.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -77.27 132.91 38.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 171.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.64 -38.55 58.79 Favored 'General case' 0 CA--C 1.487 -1.477 0 O-C-N 123.495 0.497 . . . . 0.0 110.871 -169.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.48 135.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 174.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.09 120.03 7.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.2 m -96.73 107.62 20.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.09 117.22 25.68 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.0 mt -98.44 147.68 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -175.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -137.62 129.93 29.36 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 125.392 1.477 . . . . 0.0 108.797 -169.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.57 -134.98 3.59 Favored Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 106.006 -2.838 . . . . 0.0 106.006 173.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.94 142.38 29.74 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 173.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.88 -21.22 29.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -74.08 -30.36 62.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.094 1.358 . . . . 0.0 109.437 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.2 m -77.2 -33.22 56.33 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 117.414 -1.279 . . . . 0.0 110.871 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -56.01 -56.14 14.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 119.037 0.835 . . . . 0.0 110.11 172.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -56.59 -41.24 76.64 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.92 15.39 1.1 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.8 mt -81.16 -34.21 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 168.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.44 -44.67 62.05 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.782 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.49 156.46 22.84 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.91 87.12 7.25 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.057 0.456 . . . . 0.0 109.933 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.73 -47.52 1.04 Allowed 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.99 58.55 1.35 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 177.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.49 151.42 10.91 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 174.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -115.71 157.95 43.19 Favored Pre-proline 0 N--CA 1.432 -1.362 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -74.3 143.24 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.898 2.399 . . . . 0.0 106.506 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -142.03 127.38 18.77 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? 65.2 -107.39 0.14 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.026 1.33 . . . . 0.0 110.375 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.89 101.02 3.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.364 2.3 p-10 63.82 25.84 14.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 129.08 2.952 . . . . 0.0 114.505 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.09 157.4 17.87 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 168.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -138.14 120.97 16.46 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 tt -88.61 145.59 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.6 p -88.15 165.45 15.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.649 0.738 . . . . 0.0 109.914 -175.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.96 11.77 5.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -123.06 96.17 4.9 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.6 m -62.26 131.63 50.02 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 124.368 1.067 . . . . 0.0 110.645 175.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -112.58 155.87 23.64 Favored 'General case' 0 CA--C 1.473 -1.999 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -77.55 138.53 39.22 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 140.84 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -167.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.0 m -129.3 105.67 8.29 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 167.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 m -85.55 99.98 11.62 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.1 m -85.65 112.1 20.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -117.74 145.99 44.09 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.268 17.1 mt -65.82 135.71 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.029 0.442 . . . . 0.0 110.365 175.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.35 45.44 2.76 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 156.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.01 -83.35 1.42 Allowed Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.08 -25.8 5.7 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -85.35 131.47 48.0 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -84.01 -14.77 7.18 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.097 1.865 . . . . 0.0 108.561 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -100.35 168.05 9.98 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.64 143.77 34.52 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.61 163.98 51.46 Favored 'Cis proline' 0 N--CA 1.436 -1.883 0 CA-C-N 122.35 1.875 . . . . 0.0 108.008 10.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.9 m -128.75 125.99 39.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -172.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -95.38 128.0 41.88 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -120.07 126.06 49.83 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -90.96 129.78 36.95 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.09 129.58 34.86 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -120.44 90.26 3.29 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.86 150.89 23.24 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.354 0.597 . . . . 0.0 110.742 -172.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.53 -170.38 20.28 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -144.08 90.19 2.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -124.39 145.99 49.14 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -159.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -80.89 128.79 34.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.29 138.91 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.604 -164.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -95.24 113.55 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.63 141.51 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 172.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.64 128.16 36.53 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.0 m -108.11 154.01 22.33 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.139 0.899 . . . . 0.0 110.893 -175.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -147.13 127.41 13.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.321 8.6 p30 69.75 11.97 7.93 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.784 2.034 . . . . 0.0 114.679 177.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.86 55.45 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tp -141.46 142.26 25.78 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -70.75 152.53 64.24 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 CA-C-N 121.946 1.731 . . . . 0.0 111.564 -173.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -134.72 -25.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.407 -178.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.435 ' CD2' HG21 ' A' ' 113' ' ' VAL . 36.8 m-70 -143.18 178.02 8.0 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -173.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.65 139.9 36.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -173.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.26 121.58 29.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -107.6 10.28 29.18 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -93.18 -20.39 20.52 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -36.71 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.797 0 C-N-CA 123.623 0.769 . . . . 0.0 110.933 173.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -170.31 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -90.88 -14.24 32.11 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.017 177.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.421 HH21 ' CE1' ' A' ' 114' ' ' HIS . 29.1 tpt180 -74.1 -45.32 49.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.61 -55.31 35.61 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-O 116.551 -1.69 . . . . 0.0 111.493 168.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -81.78 -1.22 46.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 122.011 2.187 . . . . 0.0 115.659 -170.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -85.61 -30.69 23.09 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.63 -28.98 70.28 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.307 0.643 . . . . 0.0 111.205 164.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -23.47 28.7 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.327 0.967 . . . . 0.0 112.252 177.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -72.77 -38.19 67.4 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 120.323 1.42 . . . . 0.0 109.106 174.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HG3' HD22 ' A' ' 43' ' ' ASN . 2.0 tp-100 -65.37 -58.2 6.46 Favored 'General case' 0 N--CA 1.413 -2.282 0 C-N-CA 124.724 1.209 . . . . 0.0 112.498 172.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -125.62 27.99 6.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -160.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -133.66 136.42 44.74 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 166.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -152.85 108.61 3.31 Favored 'General case' 0 N--CA 1.423 -1.811 1 N-CA-C 100.172 -4.011 . . . . 0.0 100.172 169.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -36.02 5.21 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 118.702 2.852 . . . . 0.0 118.702 -164.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -145.65 154.91 52.75 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 19.7 Cg_endo -70.92 143.08 44.34 Favored 'Trans proline' 0 N--CA 1.431 -2.203 0 C-N-CA 123.423 2.749 . . . . 0.0 107.6 165.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -80.35 -50.83 9.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 168.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.07 179.45 17.34 Favored Glycine 0 CA--C 1.478 -2.233 0 N-CA-C 103.994 -3.643 . . . . 0.0 103.994 163.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -123.36 53.59 1.32 Allowed 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -140.03 -179.08 5.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -170.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.25 -23.1 63.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.841 1.256 . . . . 0.0 113.084 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -86.53 -20.03 28.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 122.962 0.505 . . . . 0.0 110.178 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.55 -41.53 46.25 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -69.15 -35.62 76.55 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 123.797 0.685 . . . . 0.0 112.768 -177.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.7 -39.11 67.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -75.43 -24.3 57.06 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.261 12.7 tt -82.86 -33.04 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.612 0 CA-C-N 118.852 0.751 . . . . 0.0 109.563 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mmt -77.91 -20.84 52.16 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.624 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -72.1 -44.81 62.64 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.239 0.472 . . . . 0.0 111.858 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.69 -39.8 50.89 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.924 0.489 . . . . 0.0 111.964 -173.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -75.78 -29.98 58.95 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 123.316 0.646 . . . . 0.0 110.222 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 52.41 2.49 Favored Glycine 0 CA--C 1.491 -1.43 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 170.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.6 mt -121.85 18.28 11.01 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -91.85 -10.76 38.56 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.4 1.08 . . . . 0.0 108.802 -173.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -129.57 105.22 17.33 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.1 159.36 95.67 Favored 'Cis proline' 0 N--CA 1.444 -1.425 0 N-CA-C 107.133 -1.91 . . . . 0.0 107.133 -19.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 m -63.05 123.09 17.69 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.968 0.907 . . . . 0.0 109.522 -177.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -71.42 140.78 50.22 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.02 -46.73 50.37 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.965 0.506 . . . . 0.0 111.049 -172.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 132.52 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.406 HD22 ' HG3' ' A' ' 12' ' ' GLN . 7.3 t-20 -151.16 119.15 6.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -96.22 112.84 24.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -177.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -87.6 118.48 27.11 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 171.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.17 152.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -177.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.524 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 7.3 m-70 -136.26 133.18 36.72 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 124.648 1.179 . . . . 0.0 108.195 -171.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.83 -119.66 0.88 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -132.6 138.72 47.5 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -86.74 -7.14 58.54 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.451 -172.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -80.27 -32.52 38.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -36.93 73.6 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 123.996 0.919 . . . . 0.0 110.543 174.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.41 -53.1 51.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 C-N-CA 124.906 1.282 . . . . 0.0 111.38 174.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.75 -39.24 76.92 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.285 1.034 . . . . 0.0 113.038 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.41 9.4 11.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.602 0.761 . . . . 0.0 112.978 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mm -78.56 -28.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 168.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.02 -21.01 51.41 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -80.51 170.8 15.87 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -88.1 5.89 38.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.834 0.854 . . . . 0.0 110.685 -178.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -75.02 -63.24 1.31 Allowed 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 123.842 0.857 . . . . 0.0 110.169 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -89.0 -50.58 6.09 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -176.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.1 149.21 19.12 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -163.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -102.98 154.57 37.45 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -178.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.03 141.58 33.16 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 123.102 2.535 . . . . 0.0 106.828 175.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -134.99 34.68 3.1 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -169.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 62.21 156.56 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 129.072 2.949 . . . . 0.0 114.05 -176.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 42.89 54.58 4.68 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 129.209 3.004 . . . . 0.0 115.831 176.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.311 2.7 p-10 52.58 34.46 15.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.622 2.769 . . . . 0.0 114.764 -176.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.92 151.54 25.65 Favored 'General case' 0 CA--C 1.478 -1.813 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -140.62 118.26 11.61 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -175.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -85.69 146.15 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 176.32 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.6 p -92.69 169.0 10.83 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -131.23 -6.17 3.83 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -106.28 78.86 1.33 Allowed 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.6 t -46.74 127.76 10.03 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 128.324 2.65 . . . . 0.0 113.218 -177.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.73 157.69 18.32 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -170.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 139.58 41.45 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.5 140.98 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -170.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -132.45 110.56 10.61 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 164.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -88.7 101.19 13.75 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.35 114.36 22.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -121.72 129.1 52.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -168.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.5 tp -72.98 114.9 11.64 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.989 1.316 . . . . 0.0 108.09 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -138.68 95.9 3.05 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 -176.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.12 -41.41 0.05 OUTLIER Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 -177.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.42 41.23 6.58 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -177.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -117.81 106.6 45.64 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -82.76 -21.66 4.83 Favored 'Trans proline' 0 N--CA 1.439 -1.708 0 CA-C-N 121.535 1.584 . . . . 0.0 108.935 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -107.24 161.69 22.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.98 142.52 31.43 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.498 2.132 . . . . 0.0 107.486 -176.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -82.77 161.58 75.36 Favored 'Cis proline' 0 CA--C 1.486 -1.876 0 CA-C-N 123.06 2.128 . . . . 0.0 108.798 4.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.1 m -109.41 159.22 17.2 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -173.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -116.58 90.28 3.3 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.02 117.45 30.69 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -102.53 132.25 48.71 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 131.08 35.28 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -117.39 86.34 2.5 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.02 148.48 21.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.999 -172.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -152.69 -163.37 11.6 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -146.72 98.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 101.033 -3.691 . . . . 0.0 101.033 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -133.16 144.49 49.9 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -162.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 HD21 HD11 ' A' ' 71' ' ' ILE . 2.3 p-10 -74.85 124.58 27.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.95 140.66 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.313 -165.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.07 114.91 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 165.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.6 141.84 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 114' ' ' HIS . . . -101.52 113.44 26.56 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.6 p -113.99 163.64 14.86 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 122.319 1.057 . . . . 0.0 113.085 -173.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -153.64 136.46 15.34 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.354 7.9 p30 71.72 2.95 4.49 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.716 2.406 . . . . 0.0 116.092 174.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.6 -2.41 34.32 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.41 128.7 25.8 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -73.58 119.65 6.05 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.682 -2.084 . . . . 0.0 106.682 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -105.62 -17.01 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 123.952 0.783 . . . . 0.0 110.021 -167.533 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.537 ' CD2' HG21 ' A' ' 113' ' ' VAL . 70.5 m-70 -153.34 177.17 11.17 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.29 142.03 35.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -174.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.74 126.68 37.94 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 167.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -108.88 10.9 26.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -173.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -87.72 -25.68 23.32 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.17 0.51 . . . . 0.0 109.789 -166.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -21.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 C-N-CA 124.161 0.984 . . . . 0.0 109.889 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -169.388 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 m -94.02 0.46 56.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.801 1.24 . . . . 0.0 109.934 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.449 ' HE ' ' CE1' ' A' ' 114' ' ' HIS . 30.7 tpt180 -75.86 -39.52 56.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -46.63 69.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 124.15 0.98 . . . . 0.0 109.868 176.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.408 0.2 OUTLIER -83.89 -2.23 56.05 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -179.085 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -83.88 -30.09 26.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.538 1.063 . . . . 0.0 109.291 165.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 10' ' ' LEU . 2.3 t80 -61.45 -35.37 77.42 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.153 0.981 . . . . 0.0 109.034 164.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.405 HD21 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -83.43 -18.68 37.87 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.079 177.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -69.07 -52.26 30.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-N 119.79 1.177 . . . . 0.0 108.481 176.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.465 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 15.7 tt0 -77.28 -38.02 51.66 Favored 'General case' 0 N--CA 1.404 -2.742 0 C-N-CA 124.286 1.034 . . . . 0.0 110.437 -173.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 70.0 m-70 -98.31 -54.96 2.9 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.48 -175.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -77.63 119.98 21.94 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 119.98 1.264 . . . . 0.0 108.738 -167.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -137.14 98.37 3.72 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 100.682 -3.821 . . . . 0.0 100.682 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.64 -42.55 0.8 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -165.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -144.11 151.94 53.35 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 165.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.515 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 11.9 Cg_endo -71.81 155.43 58.2 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 123.859 3.039 . . . . 0.0 109.916 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -78.64 -53.45 7.16 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 170.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.74 -179.88 17.76 Favored Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 166.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -121.4 61.72 0.92 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -178.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.3 -179.42 7.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.57 -10.47 59.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -78.36 -33.23 49.14 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -75.63 -39.16 58.23 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.02 -42.95 79.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.3 -31.85 62.65 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 122.799 0.44 . . . . 0.0 110.597 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -67.46 -38.72 84.89 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.478 176.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 14.6 tt -80.31 -25.34 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 CA-C-N 118.042 0.383 . . . . 0.0 111.385 -176.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -29.89 61.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.774 -1.57 . . . . 0.0 111.536 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -75.66 -29.91 59.25 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.199 0.454 . . . . 0.0 112.22 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -78.97 -44.83 21.6 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.77 0.828 . . . . 0.0 110.746 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -81.05 -26.21 36.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.639 0.376 . . . . 0.0 110.438 -172.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.37 49.04 3.34 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 171.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.61 14.86 15.52 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 t -86.49 -13.31 46.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.08 0.952 . . . . 0.0 108.727 -176.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 m -122.38 103.63 38.3 Favored Pre-proline 0 N--CA 1.424 -1.73 0 CA-C-O 117.867 -1.064 . . . . 0.0 108.495 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.34 161.05 95.31 Favored 'Cis proline' 0 N--CA 1.441 -1.6 0 N-CA-C 106.888 -2.005 . . . . 0.0 106.888 -23.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -60.39 124.49 20.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.813 1.245 . . . . 0.0 111.118 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -73.02 135.48 44.92 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -75.0 -39.64 61.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.312 -170.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.6 tt -148.69 133.91 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -151.53 121.34 7.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.5 112.1 24.24 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.27 116.26 23.51 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.55 151.37 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.515 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.9 m-70 -144.15 140.68 29.52 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.61 1.62 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 107.115 -2.394 . . . . 0.0 107.115 175.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.494 HD21 ' HG ' ' A' ' 52' ' ' SER . 54.9 t30 -119.79 137.0 54.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -85.58 -20.67 29.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 120.959 0.409 . . . . 0.0 110.636 -166.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -79.82 -22.47 42.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.494 ' HG ' HD21 ' A' ' 49' ' ' ASN . 72.5 m -76.09 -34.36 59.53 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.967 171.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.18 -51.23 73.52 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 119.829 1.195 . . . . 0.0 110.073 171.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.93 -40.42 93.18 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.673 0.789 . . . . 0.0 111.16 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.72 21.06 1.96 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.94 -28.7 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 t -78.15 -41.5 34.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.895 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -79.22 149.87 31.78 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 170.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -78.77 104.22 9.24 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -160.14 -57.74 0.06 Allowed 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -177.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -136.88 22.31 3.07 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.67 -178.82 21.47 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 105.288 -3.125 . . . . 0.0 105.288 166.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -137.2 161.28 61.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -171.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -74.49 147.3 36.11 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.884 2.389 . . . . 0.0 107.323 162.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -139.44 101.48 4.24 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 65.54 -102.26 0.08 Allowed 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 111.144 -177.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.24 102.38 3.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -174.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 2.8 p-10 65.34 22.26 12.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 129.896 3.278 . . . . 0.0 114.625 173.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.13 158.35 17.49 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 100.63 -3.841 . . . . 0.0 100.63 163.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -141.9 111.46 6.58 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -171.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 tt -94.25 140.37 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -87.68 167.47 13.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 121.387 0.613 . . . . 0.0 110.329 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 -1.49 4.37 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -113.43 86.6 2.42 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 173.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.0 m -53.44 137.95 34.61 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.058 2.143 . . . . 0.0 113.16 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -111.16 155.64 22.59 Favored 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -75.42 141.69 43.16 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 175.07 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.53 145.96 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -168.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -130.99 107.16 8.89 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 167.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -85.51 100.35 11.85 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.8 m -84.16 113.95 21.44 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -121.03 129.95 53.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 -176.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 tp -69.01 116.76 9.83 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.825 1.25 . . . . 0.0 109.257 -174.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -135.87 99.0 4.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -175.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.69 -42.12 0.18 Allowed Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 -178.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.38 43.59 7.35 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 t -112.72 108.82 53.54 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -86.1 -17.67 3.75 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 CA-C-N 122.193 1.819 . . . . 0.0 109.064 -176.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.75 160.65 28.85 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-O 117.43 -1.271 . . . . 0.0 107.954 -168.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.66 145.9 33.48 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.674 2.25 . . . . 0.0 108.425 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -81.17 164.31 77.62 Favored 'Cis proline' 0 N--CA 1.437 -1.841 0 CA-C-N 122.299 1.857 . . . . 0.0 108.176 -4.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.8 m -107.46 156.13 19.3 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.458 -170.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -110.54 118.39 36.11 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.71 148.3 41.2 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.69 119.87 40.13 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 166.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.26 115.84 26.04 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -110.69 87.97 2.66 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.64 143.57 26.7 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.265 0.555 . . . . 0.0 110.769 -171.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -149.41 -163.72 11.19 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 178.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -146.67 101.21 3.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -138.22 147.63 43.95 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -164.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -74.22 128.7 36.22 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.504 1.121 . . . . 0.0 108.515 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.16 137.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.16 -167.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.53 110.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 165.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.23 152.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.0 136.12 33.24 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 168.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.9 t -126.52 138.64 53.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 123.527 0.517 . . . . 0.0 109.701 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.74 133.56 44.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 170.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.301 14.2 p30 63.22 23.79 14.02 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 117.068 2.248 . . . . 0.0 117.068 171.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.52 19.15 57.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.45 116.12 5.43 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -170.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -72.02 111.49 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 CA-C-N 122.091 1.782 . . . . 0.0 111.39 -170.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.419 HG21 ' CD2' ' A' ' 114' ' ' HIS . 1.0 OUTLIER -89.9 -24.32 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.376 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.449 ' CE1' ' HE ' ' A' ' 5' ' ' ARG . 28.5 m-70 -151.88 -168.65 3.13 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.66 149.56 40.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -175.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.22 127.76 43.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 171.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -110.78 13.77 22.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -86.01 -32.34 21.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -172.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.6 OUTLIER -78.5 -23.34 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 C-N-CA 125.513 1.525 . . . . 0.0 111.817 177.747 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 106.49 -1.671 . . . . 0.0 106.49 -167.403 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -92.37 -29.93 16.06 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -70.47 -40.77 73.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.312 0.645 . . . . 0.0 109.427 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -46.56 -65.66 0.52 Allowed 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 126.602 1.961 . . . . 0.0 111.168 166.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.297 5.4 p -70.43 -11.84 61.18 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -83.71 -36.61 23.56 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.126 0.876 . . . . 0.0 109.521 173.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.24 -35.53 81.11 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.701 1.6 . . . . 0.0 110.515 170.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' THR 0.271 0.2 OUTLIER -67.06 -38.04 85.1 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 128.709 2.803 . . . . 0.0 112.452 174.667 . . . . . . . . 4 4 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -66.64 -51.87 51.35 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 12.6 tt0 -77.86 -29.09 50.23 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 124.114 0.966 . . . . 0.0 112.439 -170.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 89.0 m-70 -105.78 -58.25 1.93 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.001 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -72.6 111.93 8.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.73 0.776 . . . . 0.0 110.689 -163.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -134.96 98.28 3.97 Favored 'General case' 0 N--CA 1.421 -1.878 1 N-CA-C 98.553 -4.61 . . . . 0.0 98.553 176.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -33.65 3.8 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -163.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.91 154.18 46.8 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.9 Cg_endo -69.53 145.08 57.39 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 123.642 2.895 . . . . 0.0 109.164 171.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -86.04 -46.85 10.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 169.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.24 -177.21 14.82 Favored Glycine 0 CA--C 1.48 -2.133 0 N-CA-C 103.364 -3.894 . . . . 0.0 103.364 164.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -133.98 35.22 3.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -121.45 -179.22 4.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -35.88 79.77 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 125.973 1.709 . . . . 0.0 112.812 -171.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -81.82 -22.17 37.21 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.084 0.554 . . . . 0.0 110.033 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.85 -42.22 61.12 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.437 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -83.54 -19.97 34.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.729 -0.789 . . . . 0.0 113.045 -170.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.02 -39.42 66.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.3 t -67.15 -38.28 85.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 26' ' ' CYS 0.282 15.2 tt -86.74 -25.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 CA-C-N 118.358 0.527 . . . . 0.0 112.024 -175.464 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 mmt -77.49 -25.64 50.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.707 173.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -72.16 -38.3 69.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.131 0.572 . . . . 0.0 111.821 173.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -79.99 -40.1 28.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 122.607 0.363 . . . . 0.0 110.698 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -23.08 40.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.036 0.534 . . . . 0.0 110.571 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.8 47.57 4.18 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.36 6.76 12.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 t -94.61 -0.6 54.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 m -122.09 102.14 40.85 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 117.768 -1.11 . . . . 0.0 108.668 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.74 158.06 98.84 Favored 'Cis proline' 0 N--CA 1.441 -1.58 0 N-CA-C 106.842 -2.022 . . . . 0.0 106.842 -23.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.0 m -63.21 118.97 8.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 124.707 1.203 . . . . 0.0 111.914 -170.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.39 134.11 45.25 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -72.68 -36.35 67.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 124.567 1.167 . . . . 0.0 112.89 -166.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -154.77 123.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -153.3 151.63 30.22 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.515 177.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.8 m -112.21 136.61 51.42 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.503 -168.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -99.33 116.74 32.19 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 162.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.2 mt -89.89 150.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.483 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 -178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.518 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.6 m-70 -139.95 139.77 36.2 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 125.143 1.377 . . . . 0.0 108.863 -175.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.07 5.79 Favored Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 105.734 -2.946 . . . . 0.0 105.734 173.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -102.68 147.93 26.21 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 170.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -85.45 -16.28 40.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.99 -33.17 59.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.693 1.597 . . . . 0.0 107.071 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.9 m -75.73 -34.56 60.33 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.005 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 mm -54.95 -55.37 16.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 CA-C-N 119.349 0.977 . . . . 0.0 110.155 172.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.39 -35.01 77.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 123.875 0.87 . . . . 0.0 113.23 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.48 -0.25 19.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.6 mm -73.66 -27.51 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.74 9.01 38.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.125 0.488 . . . . 0.0 111.599 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -88.56 162.09 16.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 160.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.47 HD21 HH12 ' A' ' 70' ' ' ARG . 9.6 t-20 -88.18 -9.8 51.93 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -68.4 -50.48 52.6 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.252 1.421 . . . . 0.0 110.178 178.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -123.76 37.5 4.4 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -168.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.5 152.67 10.9 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 171.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -105.77 156.44 36.57 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -176.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -74.75 140.44 26.21 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 123.003 2.469 . . . . 0.0 106.821 172.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -136.67 133.7 36.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -176.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 62.11 -103.26 0.13 Allowed 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.899 1.68 . . . . 0.0 112.219 169.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.79 103.8 2.64 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.362 2.5 p-10 62.0 30.78 18.06 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 129.139 2.975 . . . . 0.0 113.883 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.2 mt -115.13 170.19 8.55 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 171.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.47 HH12 HD21 ' A' ' 59' ' ' ASN . 21.9 mmt180 -147.17 116.4 6.95 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -174.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -93.87 136.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.5 p -83.56 160.91 21.35 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.45 -25.53 11.83 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.698 174.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -104.87 89.17 3.08 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 p -49.62 129.71 19.74 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 127.229 2.212 . . . . 0.0 111.916 171.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -105.19 156.44 18.11 Favored 'General case' 0 CA--C 1.478 -1.815 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -170.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 6.4 mt-30 -78.9 148.16 32.83 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 174.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.76 146.97 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -166.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.5 m -134.38 99.68 4.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 167.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -89.64 104.24 16.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -177.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.73 122.41 36.17 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -106.87 132.83 52.38 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.63 117.12 18.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.476 1.51 . . . . 0.0 109.007 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -112.1 152.41 28.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.34 -97.97 0.22 Allowed Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 106.014 -2.835 . . . . 0.0 106.014 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.03 1.5 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 -178.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.5 t -84.68 130.01 54.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -83.19 -20.9 4.83 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.989 1.793 . . . . 0.0 108.279 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -96.47 159.9 30.81 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -76.18 148.12 30.47 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.309 2.006 . . . . 0.0 107.221 -176.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -85.54 165.09 56.38 Favored 'Cis proline' 0 N--CA 1.438 -1.74 0 CA-C-N 123.035 2.12 . . . . 0.0 108.133 13.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.1 m -154.87 130.3 9.78 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -165.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.79 103.01 15.4 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -85.83 120.81 27.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -92.47 112.57 24.57 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.45 130.65 35.29 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.028 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -118.72 108.61 15.1 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.268 -2.494 . . . . 0.0 104.268 175.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.68 129.31 35.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.74 169.5 23.17 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 106.002 -2.839 . . . . 0.0 106.002 178.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -149.22 105.86 3.55 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -152.44 158.69 42.98 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 121.884 0.85 . . . . 0.0 110.32 -168.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.0 129.55 34.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.319 175.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.8 148.17 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.737 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.5 t -106.5 92.45 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -93.3 139.16 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.16 126.29 31.88 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.48 135.99 48.84 Favored 'General case' 0 CA--C 1.49 -1.34 0 O-C-N 123.875 0.734 . . . . 0.0 110.497 -175.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.22 137.5 39.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.299 16.5 p30 60.15 26.45 15.85 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 127.05 2.14 . . . . 0.0 116.101 175.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.56 22.76 59.58 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 177.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 135.07 9.72 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -77.72 111.58 3.15 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 CA-C-N 122.354 1.876 . . . . 0.0 110.972 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.438 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -86.78 -26.84 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 123.838 0.711 . . . . 0.0 111.693 -174.664 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 113' ' ' VAL . 53.0 m-70 -146.52 -171.72 3.8 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -171.262 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 132.01 4.11 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 177.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -74.41 135.81 42.38 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.322 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -96.8 36.89 1.34 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.9 p -95.66 -19.71 19.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -23.23 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 CA--C 1.478 -1.79 0 C-N-CA 125.332 1.453 . . . . 0.0 108.448 -178.503 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -93.39 -9.04 40.09 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -20.92 58.23 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.704 1.602 . . . . 0.0 109.678 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.79 -41.25 62.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 C-N-CA 125.188 1.395 . . . . 0.0 108.039 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.36 -12.81 59.91 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 177.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.4 m170 -73.67 -47.32 40.62 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.74 -46.35 74.27 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 126.401 1.88 . . . . 0.0 110.221 173.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.43 0.1 OUTLIER -93.25 -4.54 51.69 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.759 . . . . . . . . 4 4 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -78.65 -43.81 25.28 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 120.655 1.57 . . . . 0.0 107.782 166.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.81 -46.27 79.26 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.401 ' CE1' HD22 ' A' ' 43' ' ' ASN . 93.3 m-70 -97.16 -48.55 5.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.882 -172.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 45.8 t80 -78.68 117.15 19.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 119.963 1.256 . . . . 0.0 110.397 -168.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -134.61 96.4 3.56 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 174.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.37 -43.66 3.64 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 128.278 2.631 . . . . 0.0 117.724 -166.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -155.25 144.25 14.98 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 67.5 Cg_exo -74.74 174.79 12.07 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.863 1.708 . . . . 0.0 113.736 -177.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -70.73 -67.84 0.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 168.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.61 -175.16 13.69 Favored Glycine 0 CA--C 1.475 -2.451 1 N-CA-C 101.618 -4.593 . . . . 0.0 101.618 163.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -115.87 73.64 0.85 Allowed 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.34 176.7 9.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.38 -21.59 61.99 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.476 1.111 . . . . 0.0 112.884 -171.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -75.8 -30.27 58.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.238 177.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.95 -40.62 53.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 m -69.65 -35.32 75.07 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.17 -36.8 69.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 123.375 0.422 . . . . 0.0 110.308 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -69.45 -35.65 75.87 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 122.909 0.484 . . . . 0.0 112.214 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 HG13 HH21 ' A' ' 33' ' ' ARG 0.25 12.7 tt -84.15 -27.95 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-N 117.707 0.23 . . . . 0.0 111.227 -174.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.07 -25.17 47.53 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.483 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.408 HH12 ' HA ' ' A' ' 91' ' ' PRO . 16.6 tpp180 -68.68 -43.6 75.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.214 0.606 . . . . 0.0 110.995 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -75.84 -44.77 39.29 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 123.646 0.778 . . . . 0.0 112.352 -172.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.432 HH21 HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -77.11 -18.1 58.19 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.0 44.75 4.68 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 168.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.4 mt -117.65 15.81 14.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 176.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -94.06 -11.41 30.73 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.6 m -125.53 101.03 31.04 Favored Pre-proline 0 N--CA 1.426 -1.659 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.548 -174.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.06 165.14 85.9 Favored 'Cis proline' 0 N--CA 1.445 -1.373 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 -21.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 m -60.28 120.58 10.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 124.063 0.945 . . . . 0.0 110.173 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -74.63 136.67 41.96 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 177.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.68 -45.63 61.33 Favored 'General case' 0 N--CA 1.433 -1.287 0 O-C-N 123.956 0.785 . . . . 0.0 110.45 -171.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.46 126.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.401 HD22 ' CE1' ' A' ' 13' ' ' HIS . 12.7 t-20 -148.51 127.88 13.06 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -94.23 122.18 36.5 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.734 -178.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -90.52 121.33 32.37 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.7 148.82 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.9 m-70 -136.57 137.37 40.13 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 124.834 1.253 . . . . 0.0 107.95 -175.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.79 -126.94 1.62 Allowed Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 175.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -118.28 141.65 48.31 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 171.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.51 -3.07 58.96 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -76.49 -31.65 57.85 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 168.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -80.5 -32.26 37.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 118.115 -0.945 . . . . 0.0 109.982 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.52 -52.62 54.86 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.204 1.001 . . . . 0.0 110.467 171.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -53.84 -44.09 70.02 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.42 1.488 . . . . 0.0 112.05 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.02 16.02 0.61 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.25 -40.54 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 165.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 36.3 t -88.72 -30.26 19.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.454 -156.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -95.74 51.26 1.26 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -170.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 m120 49.26 50.88 17.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 129.516 3.127 . . . . 0.0 113.329 174.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -148.84 163.67 36.73 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 97.594 -4.965 . . . . 0.0 97.594 172.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.259 8.1 p-10 14.52 56.54 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 131.043 3.737 . . . . 0.0 117.799 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.91 137.24 2.29 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 106.001 -2.839 . . . . 0.0 106.001 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -106.13 157.45 34.82 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -72.06 135.55 25.41 Favored 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 123.095 2.53 . . . . 0.0 107.225 170.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -131.23 107.37 8.94 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -175.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 63.42 -108.61 0.24 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 112.989 174.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -127.39 87.01 2.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -166.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.343 1.8 p-10 64.01 27.62 14.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 128.913 2.885 . . . . 0.0 113.947 173.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 mt -110.4 163.84 13.28 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 173.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -146.78 120.58 9.26 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.08 143.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -177.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.7 p -84.43 159.92 20.69 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -174.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -122.62 -3.18 8.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 t -119.02 88.15 2.87 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 173.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.3 p -61.56 141.36 57.79 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.561 1.544 . . . . 0.0 111.862 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -114.04 161.68 17.41 Favored 'General case' 0 CA--C 1.474 -1.967 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -168.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 7.7 mt-30 -77.91 144.63 36.72 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.73 143.38 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.7 m -131.35 107.61 9.06 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 167.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -83.14 101.03 10.92 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.6 114.97 24.7 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -121.06 132.47 54.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -170.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.28 114.24 7.35 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 125.105 1.362 . . . . 0.0 108.527 -177.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -126.76 57.26 1.45 Allowed 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -118.31 -84.2 0.95 Allowed Glycine 0 CA--C 1.482 -2.021 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.21 -15.09 4.25 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 178.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -86.91 132.34 42.28 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -81.02 -21.71 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.755 1.636 . . . . 0.0 108.93 176.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -102.24 165.05 14.55 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.13 142.12 33.71 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.222 1.948 . . . . 0.0 107.159 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.8 Cg_endo -87.63 164.39 45.6 Favored 'Cis proline' 0 N--CA 1.435 -1.923 0 CA-C-N 122.655 1.984 . . . . 0.0 108.397 12.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 37.7 m -128.07 131.95 49.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -170.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -98.15 123.04 42.0 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.59 122.42 44.57 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -93.06 127.27 38.53 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.99 133.12 35.27 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.6 m -120.04 97.24 5.51 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 171.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.6 139.01 38.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.03 -171.16 18.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -155.78 100.05 2.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 101.28 -3.6 . . . . 0.0 101.28 -178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -139.44 148.73 43.14 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -161.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -80.73 132.5 35.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.862 1.265 . . . . 0.0 108.442 175.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.18 142.36 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.612 -164.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.74 95.68 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.1 m -94.71 136.7 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.31 126.53 37.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.2 167.5 17.55 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -172.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.38 132.81 18.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.364 6.4 p30 75.94 -12.0 1.06 Allowed 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 170.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.02 9.08 9.09 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -141.99 127.9 10.84 Favored Pre-proline 0 N--CA 1.435 -1.196 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -67.35 163.8 33.14 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.566 1.511 . . . . 0.0 114.029 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -132.3 -19.67 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 113' ' ' VAL . 74.9 m-70 -158.68 -175.3 5.23 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -169.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 136.8 3.78 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 -179.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.94 134.64 37.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.966 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -100.07 40.19 1.27 Allowed 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.7 m -97.1 -31.57 12.41 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -33.98 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.61 169.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -172.196 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 111.331 0.123 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -89.95 -17.12 28.52 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -69.97 -30.27 67.58 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.303 1.441 . . . . 0.0 110.624 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.49 ' HH ' ' HZ1' ' A' ' 50' ' ' LYS . 52.2 t80 -68.49 -48.3 64.79 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -76.12 -10.01 59.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -80.74 -43.68 19.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 119.352 0.978 . . . . 0.0 108.468 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -57.89 -38.23 75.43 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.791 1.637 . . . . 0.0 110.195 170.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -78.8 -29.62 45.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.546 1.538 . . . . 0.0 113.493 -179.149 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -80.06 -32.59 39.33 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 119.773 1.17 . . . . 0.0 109.38 -174.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 27.0 tt0 -82.36 -45.01 15.43 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 118.511 -0.757 . . . . 0.0 109.726 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 82.9 m-70 -95.12 -46.82 6.63 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 119.429 1.013 . . . . 0.0 112.442 -172.08 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 9.3 t80 -70.65 118.32 13.3 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 119.766 1.166 . . . . 0.0 110.925 -174.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -139.8 99.04 3.6 Favored 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 172.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 -39.26 9.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -164.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -142.84 148.65 46.77 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.519 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.0 Cg_endo -72.7 153.42 54.02 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 123.515 2.81 . . . . 0.0 109.291 170.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -77.8 -57.65 3.69 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.95 179.35 17.23 Favored Glycine 0 CA--C 1.477 -2.3 0 N-CA-C 103.726 -3.749 . . . . 0.0 103.726 165.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -122.9 61.27 1.01 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -141.54 176.84 8.56 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -171.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.94 -24.46 62.44 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 124.879 1.272 . . . . 0.0 112.245 -169.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -85.4 -20.14 30.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 122.966 0.506 . . . . 0.0 110.097 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -79.18 -35.89 41.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.0 -33.92 51.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -171.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.18 -48.12 74.57 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 125.841 1.657 . . . . 0.0 109.687 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 m -74.97 -22.97 58.23 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 118.112 -0.946 . . . . 0.0 113.496 -175.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 14.0 tt -87.09 -24.96 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 119.241 0.928 . . . . 0.0 110.65 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.68 -29.22 62.17 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.265 -1.374 . . . . 0.0 110.259 171.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -80.19 -32.43 38.67 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -83.72 -33.12 25.18 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 118.655 0.661 . . . . 0.0 111.07 -175.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -80.45 -19.25 46.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.5 47.57 3.46 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.6 mt -122.77 14.14 10.03 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -90.63 -9.73 45.88 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -175.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m -122.54 101.37 40.34 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.788 -174.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.57 166.37 83.07 Favored 'Cis proline' 0 N--CA 1.444 -1.429 0 CA-C-N 122.83 2.047 . . . . 0.0 107.217 -21.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.68 122.09 13.27 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 124.361 1.064 . . . . 0.0 110.987 -173.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -75.07 133.64 41.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -70.22 -40.47 74.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.336 1.022 . . . . 0.0 112.01 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.37 130.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 176.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -145.43 128.74 16.81 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -96.66 112.32 24.11 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.11 111.05 20.54 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 174.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.1 150.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.519 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-70 -142.88 135.73 27.95 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 125.172 1.389 . . . . 0.0 107.941 -174.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.91 -136.52 4.61 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 173.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -96.56 145.64 25.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.49 ' HZ1' ' HH ' ' A' ' 6' ' ' TYR . 64.5 tttm -86.99 -21.94 25.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -79.6 -24.77 41.76 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -76.02 -35.52 59.48 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.716 172.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.88 -51.47 36.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.459 0 C-N-CA 124.921 1.289 . . . . 0.0 110.221 170.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.68 -39.74 94.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.143 0.977 . . . . 0.0 111.105 -176.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.98 10.58 4.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.06 -24.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.5 m -78.65 -23.55 45.7 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.019 177.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.5 143.89 44.37 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 167.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -98.56 25.42 6.43 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.222 -178.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -90.55 -47.66 7.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -113.71 51.2 0.87 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -176.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.5 172.65 39.13 Favored Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 103.266 -3.934 . . . . 0.0 103.266 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -126.56 152.93 75.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.02 132.78 14.43 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 106.077 -2.316 . . . . 0.0 106.077 172.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -99.58 156.17 17.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 174.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -36.42 -69.88 0.1 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 129.578 3.151 . . . . 0.0 116.394 -173.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -104.24 75.36 1.25 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -171.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 65.54 15.12 9.88 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.483 3.113 . . . . 0.0 116.353 165.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.98 173.23 6.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 -169.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -139.18 107.28 5.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 tt -86.47 143.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 177.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.7 p -89.47 168.06 12.49 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.441 0.639 . . . . 0.0 111.286 -172.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -124.05 -14.99 6.96 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 t -115.27 93.69 4.4 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -51.06 133.99 26.96 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 127.24 2.216 . . . . 0.0 112.633 174.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.14 157.75 19.05 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -172.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.72 135.16 35.95 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 174.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.21 142.7 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 -173.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.2 m -130.49 102.98 6.39 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -89.16 112.67 23.72 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.8 m -91.05 118.04 30.08 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -115.04 140.07 49.35 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.47 131.88 34.71 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -169.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.58 -179.56 5.76 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.31 -86.83 0.48 Allowed Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 -178.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.74 -7.41 0.68 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -78.92 128.12 77.61 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.073 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.57 -27.69 2.07 Favored 'Trans proline' 0 N--CA 1.436 -1.896 0 N-CA-C 107.862 -1.63 . . . . 0.0 107.862 173.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -98.01 162.87 20.69 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -169.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.78 144.34 34.87 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 122.366 2.044 . . . . 0.0 107.53 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -82.57 163.25 74.7 Favored 'Cis proline' 0 N--CA 1.438 -1.739 0 CA-C-N 123.222 2.187 . . . . 0.0 109.845 8.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.3 138.28 54.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.81 -168.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -101.96 107.15 18.21 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -103.04 123.24 46.26 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -88.18 122.4 31.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.87 132.55 34.62 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.18 104.53 7.36 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.3 135.74 34.23 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.08 146.36 16.83 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -99.15 103.87 15.8 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -143.05 155.72 44.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -167.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -78.94 130.81 35.99 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.76 142.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.465 -168.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.9 t -100.39 120.46 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -113.69 160.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 114' ' ' HIS . . . -110.23 132.44 54.17 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 171.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 99.1 m -107.93 150.89 26.52 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -169.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -150.24 122.17 8.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.2 p30 67.13 10.23 7.54 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.475 2.31 . . . . 0.0 116.282 173.234 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.48 -3.15 39.73 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.7 mt -117.1 135.17 23.01 Favored Pre-proline 0 CA--C 1.484 -1.592 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 176.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 15.5 Cg_exo -77.44 127.85 9.23 Favored 'Trans proline' 0 N--CA 1.421 -2.778 0 CA-C-N 122.413 1.898 . . . . 0.0 107.169 175.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -95.3 -17.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 124.16 0.913 . . . . 0.0 109.468 -175.122 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.502 ' CD2' HG21 ' A' ' 113' ' ' VAL . 84.2 m-70 -149.54 -177.69 6.01 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -169.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.92 135.83 23.51 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -173.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.39 127.06 37.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.05 22.07 16.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.119 0.568 . . . . 0.0 110.192 -170.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -86.64 -28.81 22.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -170.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -25.18 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.783 0 C-N-CA 124.739 1.216 . . . . 0.0 110.146 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 . . . . . 0 N--CA 1.43 -1.426 0 O-C-N 123.234 0.334 . . . . 0.0 110.391 -165.948 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -91.13 0.78 57.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -75.41 -42.8 52.75 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.2 -48.18 82.73 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.801 172.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.521 0.8 OUTLIER -90.37 8.68 32.31 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 119.903 1.229 . . . . 0.0 114.21 -179.497 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -77.52 -40.0 44.21 Favored 'General case' 0 CA--C 1.494 -1.203 0 O-C-N 120.451 -1.406 . . . . 0.0 107.881 155.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.95 -28.8 70.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.303 1.041 . . . . 0.0 111.208 171.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.92 -10.57 36.04 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -68.48 -42.2 79.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 166.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 93.0 mm-40 -66.92 -68.28 0.39 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.728 171.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 88.8 m-70 -107.83 6.93 27.9 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -153.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -100.84 137.12 39.64 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-N 120.36 1.436 . . . . 0.0 107.635 165.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -151.49 104.25 3.05 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 162.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.94 -51.05 13.95 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -148.66 140.66 14.59 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 76.2 Cg_exo -75.06 177.16 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.5 2.134 . . . . 0.0 113.532 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.45 -67.24 0.74 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.1 -175.19 13.91 Favored Glycine 0 CA--C 1.479 -2.214 1 N-CA-C 103.092 -4.003 . . . . 0.0 103.092 166.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.6 mtm105 -121.88 71.21 0.98 Allowed 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -144.22 -178.45 5.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.338 -171.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.89 -32.71 74.55 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 125.744 1.617 . . . . 0.0 112.733 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 -16.47 38.53 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -177.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.25 -41.67 48.34 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 m -70.14 -32.7 70.82 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.37 -46.3 67.28 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -74.34 -26.17 59.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.26 16.9 tt -82.59 -33.17 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-N 118.589 0.632 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 93.5 mtp -84.89 -10.09 57.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.335 179.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -81.33 -40.61 23.32 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 122.005 -0.434 . . . . 0.0 110.41 169.121 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.57 -37.53 24.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 119.091 -0.481 . . . . 0.0 112.124 -172.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.4 -30.67 67.63 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 118.431 0.56 . . . . 0.0 110.005 170.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.25 48.08 3.89 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 169.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.3 mt -110.4 8.53 23.28 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -97.63 2.09 49.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.8 t -132.27 104.93 13.51 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.68 156.68 97.2 Favored 'Cis proline' 0 N--CA 1.444 -1.427 0 N-CA-C 106.68 -2.085 . . . . 0.0 106.68 -21.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.75 114.37 6.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 123.967 0.792 . . . . 0.0 111.895 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -75.64 132.23 40.47 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 173.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -83.02 -15.31 51.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -166.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 133.64 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.23 119.81 7.46 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 m -95.03 108.46 20.53 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.66 126.03 34.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mt -107.91 144.74 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -173.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 2.8 m-70 -131.72 127.11 36.16 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.062 -168.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.3 -130.68 2.14 Favored Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 145.99 39.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -84.82 -14.55 47.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 119.29 -0.385 . . . . 0.0 110.594 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.65 49.09 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.3 m -73.94 -42.27 60.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 117.595 -1.193 . . . . 0.0 109.14 175.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 mm -54.43 -54.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 C-N-CA 124.593 1.157 . . . . 0.0 111.953 176.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -58.17 -46.8 85.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 125.202 1.401 . . . . 0.0 111.509 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.55 12.94 1.78 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.55 -30.61 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 168.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.5 m -80.24 -21.19 43.07 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -82.95 163.51 21.01 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.35 -17.3 39.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.593 -175.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -87.99 128.49 35.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 165.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.6 t30 84.95 -8.44 0.89 Allowed 'General case' 0 C--N 1.356 0.865 0 C-N-CA 128.935 2.894 . . . . 0.0 113.441 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.8 -174.11 22.19 Favored Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 172.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -157.32 157.45 30.28 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.44 157.6 25.56 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.255 1.97 . . . . 0.0 108.244 -176.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 69' ' ' LEU . 13.8 p-80 -128.57 42.55 3.3 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 167.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.488 0.0 OUTLIER 53.82 152.27 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.285 1 C-N-CA 132.69 4.396 . . . . 0.0 119.334 -177.396 . . . . . . . . 4 3 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.57 50.15 3.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 110.842 -2.89 . . . . 0.0 111.917 171.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 83.89 1.45 0.96 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.045 2.938 . . . . 0.0 115.655 177.086 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 2.8 mm? -105.96 149.65 26.43 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -173.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -141.01 123.62 16.01 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -172.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tt -97.12 146.53 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.1 p -85.95 173.31 10.03 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-O 121.457 0.646 . . . . 0.0 111.395 -175.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.97 4.81 3.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.4 t -113.66 86.21 2.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -49.76 123.65 8.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.885 2.474 . . . . 0.0 113.347 -179.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.49 156.29 20.29 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 7.2 tt0 -83.37 143.53 30.27 Favored 'General case' 0 CA--C 1.466 -2.275 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.07 141.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -168.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -129.16 107.85 9.89 Favored 'General case' 0 CA--C 1.478 -1.811 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 166.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -84.01 100.66 11.21 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.4 m -84.19 106.42 15.81 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -118.8 142.23 47.9 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 -171.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -83.99 121.48 27.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.854 0.835 . . . . 0.0 109.014 -171.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.02 55.96 1.87 Allowed 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.42 -63.94 0.26 Allowed Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 105.125 -3.19 . . . . 0.0 105.125 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.08 27.32 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 173.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -89.99 138.87 27.41 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -83.0 -20.84 5.02 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.671 1.581 . . . . 0.0 109.242 172.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -108.03 156.86 37.53 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-O 117.615 -1.183 . . . . 0.0 108.84 -165.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -75.14 148.59 34.96 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.654 2.236 . . . . 0.0 108.719 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -81.62 166.56 72.31 Favored 'Cis proline' 0 N--CA 1.438 -1.751 0 CA-C-N 122.324 1.866 . . . . 0.0 108.654 -1.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.2 m -138.94 126.22 21.49 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -173.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -90.02 98.37 11.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -176.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -85.14 133.81 34.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -100.66 131.44 46.56 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 174.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.45 35.71 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.838 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -120.86 90.49 3.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 172.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.88 148.95 22.86 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.494 -171.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.05 -172.5 18.11 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 107.473 -2.251 . . . . 0.0 107.473 178.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -149.89 100.28 2.93 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -148.05 172.25 14.55 Favored 'General case' 0 CA--C 1.482 -1.64 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.418 -173.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -85.07 117.28 23.94 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -90.56 139.22 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.566 ' CG1' ' HE1' ' A' ' 65' ' ' HIS . 59.9 t -94.82 123.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.26 150.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 170.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.53 127.78 40.7 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 175.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.07 155.7 23.42 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.001 0.905 . . . . 0.0 112.0 -171.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -160.39 126.31 4.07 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.487 -2.783 . . . . 0.0 103.487 173.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 11.9 p30 66.91 14.35 9.79 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.863 2.465 . . . . 0.0 115.764 175.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.67 61.53 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.26 2.2 mp -107.64 138.2 19.93 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 177.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.37 112.63 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 N-CA-C 104.892 -2.772 . . . . 0.0 104.892 168.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -92.97 -18.6 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.814 -172.422 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.462 ' CD2' HG21 ' A' ' 113' ' ' VAL . 21.2 m-70 -151.33 -179.57 7.48 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.0 141.54 51.24 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.11 124.27 30.94 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 165.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -115.65 56.71 0.75 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 t -89.25 -51.56 5.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -28.86 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -170.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.424 -1.771 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.985 -165.448 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -90.7 -26.39 19.58 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.67 39.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.284 9.5 t80 -51.41 -64.44 0.81 Allowed 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 125.972 1.709 . . . . 0.0 109.897 164.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -80.24 1.23 29.3 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -169.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -92.02 -26.33 18.4 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 119.897 1.226 . . . . 0.0 109.083 169.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.51 -36.33 80.22 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 161.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -28.69 51.5 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.587 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.8 m -65.08 -50.9 64.36 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 119.47 1.032 . . . . 0.0 109.819 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 72.3 mt-30 -68.35 -44.58 74.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 O-C-N 123.712 0.633 . . . . 0.0 112.675 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 92.6 m-70 -103.07 -55.54 2.4 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.7 -167.128 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -76.66 117.1 17.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.013 0.911 . . . . 0.0 109.586 -167.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -134.02 96.15 3.58 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 101.045 -3.687 . . . . 0.0 101.045 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.98 -41.7 1.71 Allowed 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 128.659 2.784 . . . . 0.0 117.539 -168.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -157.57 144.8 13.52 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -76.74 -176.46 3.16 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.391 2.061 . . . . 0.0 114.078 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -72.59 -73.36 0.2 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 165.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.37 -174.32 13.59 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 102.437 -4.265 . . . . 0.0 102.437 164.443 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -111.8 75.97 0.95 Allowed 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 176.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -142.65 177.13 8.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.938 -173.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -56.06 -43.1 77.61 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 127.81 2.444 . . . . 0.0 112.169 -175.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -77.57 -23.95 49.88 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.036 0.935 . . . . 0.0 110.968 -176.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -71.83 -47.88 50.1 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' HA ' HG21 ' A' ' 29' ' ' ILE . 5.9 t -81.41 -22.77 38.03 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.61 -169.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.9 -47.9 81.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 123.725 0.81 . . . . 0.0 109.654 170.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.9 m -68.13 -36.41 79.66 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 26' ' ' CYS . 14.2 tt -80.49 -27.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-N 118.894 0.77 . . . . 0.0 110.917 -176.209 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.7 mmt -71.36 -36.97 71.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 118.327 0.512 . . . . 0.0 109.934 175.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.29 -28.08 61.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -75.96 -50.57 14.57 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 118.822 0.737 . . . . 0.0 110.355 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -23.47 60.07 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.804 0.842 . . . . 0.0 112.175 -172.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 51.98 2.68 Favored Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 170.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.1 mt -113.66 9.81 17.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 p -100.9 15.57 28.09 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 124.016 0.926 . . . . 0.0 108.959 178.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -124.2 94.5 45.18 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.81 166.79 81.76 Favored 'Cis proline' 0 N--CA 1.443 -1.468 0 N-CA-C 107.021 -1.954 . . . . 0.0 107.021 -24.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.6 m -62.78 120.04 10.5 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 124.36 1.064 . . . . 0.0 112.882 -172.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -72.4 139.64 47.93 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.576 -178.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -71.83 -43.15 66.06 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.391 0.677 . . . . 0.0 111.682 -172.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.84 128.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -143.49 130.21 20.31 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -100.3 116.32 32.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.85 124.78 35.43 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mm -93.57 150.95 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -142.96 127.74 18.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -177.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.04 -137.2 4.16 Favored Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 172.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -106.3 144.39 33.07 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.78 -20.95 32.41 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.471 -167.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.62 -10.2 44.16 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.0 m -76.44 -38.06 56.06 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.648 166.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.76 -52.32 62.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-N 118.907 0.776 . . . . 0.0 110.542 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.26 -45.95 89.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 125.084 1.354 . . . . 0.0 111.342 -175.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.13 21.97 1.03 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.41 ' HB ' HH11 ' A' ' 70' ' ' ARG . 42.8 mt -78.55 -27.11 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 165.069 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.14 -39.59 90.61 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 122.449 0.3 . . . . 0.0 111.517 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -104.97 171.26 7.41 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.408 0.623 . . . . 0.0 110.24 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.6 t30 73.33 -136.9 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.532 1.533 . . . . 0.0 114.694 153.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -136.01 0.42 2.62 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 -164.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.22 -20.84 36.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.58 -176.03 19.16 Favored Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 164.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.52 154.08 32.95 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.16 147.02 23.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 122.523 2.149 . . . . 0.0 107.441 -175.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -135.59 125.34 25.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? 64.66 -107.01 0.15 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.069 1.347 . . . . 0.0 111.489 171.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.96 97.21 3.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.357 2.1 p-10 64.84 24.72 12.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 129.105 2.962 . . . . 0.0 114.112 175.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 mt -111.87 168.8 9.3 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 101.196 -3.631 . . . . 0.0 101.196 172.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.438 HH22 ' CB ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -155.5 129.63 8.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.446 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 tt -101.01 143.43 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -175.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -82.56 165.44 20.1 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-O 122.261 1.029 . . . . 0.0 111.417 -176.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -128.74 4.56 5.49 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 178.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -122.26 88.95 3.03 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 175.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -59.63 132.13 53.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.661 1.584 . . . . 0.0 112.5 -177.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -109.54 158.24 18.2 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 139.35 38.36 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 174.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.21 144.65 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -171.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -128.53 108.04 10.2 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -87.78 102.59 14.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 177.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -95.58 137.67 34.31 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -177.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -128.15 141.85 51.36 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.27 133.19 40.13 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 126.32 1.848 . . . . 0.0 108.031 -175.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -136.04 164.08 28.83 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.84 -44.58 1.44 Allowed Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 -176.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.59 17.48 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -107.35 122.52 41.02 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -79.22 -29.28 3.22 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 N-CA-C 107.612 -1.726 . . . . 0.0 107.612 173.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -101.44 156.72 34.84 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -171.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -75.05 148.2 34.78 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 122.594 2.196 . . . . 0.0 107.493 -174.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -84.11 164.08 66.2 Favored 'Cis proline' 0 CA--C 1.49 -1.675 0 CA-C-N 123.133 2.155 . . . . 0.0 109.392 10.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 m -151.86 118.88 5.85 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -167.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -93.99 119.74 33.29 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -98.53 123.2 42.56 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -87.12 118.01 26.23 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.83 137.63 32.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.651 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 m -120.82 112.27 18.61 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.64 148.14 28.14 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.268 0.556 . . . . 0.0 110.032 -176.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.96 32.73 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -155.32 107.49 2.67 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.17 -3.27 . . . . 0.0 102.17 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -153.51 170.35 20.97 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.797 -174.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.46 124.41 31.32 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -99.04 142.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -166.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.09 122.37 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 170.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.71 160.39 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 102.434 -3.173 . . . . 0.0 102.434 173.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.07 131.94 54.61 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 119.021 0.828 . . . . 0.0 109.146 176.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.9 t -97.6 148.87 22.84 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.13 1.372 . . . . 0.0 109.174 -174.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.5 123.89 12.35 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 164.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.312 13.8 p30 64.84 19.63 11.9 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 128.209 2.604 . . . . 0.0 116.679 174.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.3 19.69 51.71 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.331 1.3 tp -129.51 146.71 62.21 Favored Pre-proline 0 CA--C 1.481 -1.68 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 177.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' CB ' HH22 ' A' ' 70' ' ' ARG . 82.0 Cg_exo -69.46 147.04 63.91 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 121.457 1.438 . . . . 0.0 108.891 162.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -129.09 -30.96 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 O-C-N 123.708 0.63 . . . . 0.0 109.338 175.508 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.409 ' CD2' HG21 ' A' ' 113' ' ' VAL . 88.2 m-70 -145.33 175.73 10.08 Favored 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.965 -165.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 tp -125.3 139.18 53.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.82 128.06 35.64 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 167.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -108.84 52.05 0.72 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -87.42 -44.94 10.97 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -173.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.78 -28.51 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -173.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.426 -1.629 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.819 -165.808 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -91.65 -29.66 16.75 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.521 HH21 ' HE2' ' A' ' 114' ' ' HIS . 79.0 mtp180 -66.23 -45.69 79.81 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.199 1.4 . . . . 0.0 109.401 179.412 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -50.54 -62.21 1.73 Allowed 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.689 1.996 . . . . 0.0 113.881 170.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -70.34 -13.88 62.34 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -81.33 -39.25 25.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 119.848 1.204 . . . . 0.0 110.055 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.65 -34.42 74.26 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.11 1.364 . . . . 0.0 109.646 169.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -77.25 -24.39 51.13 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 125.855 1.662 . . . . 0.0 113.341 177.313 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -66.2 -58.08 6.19 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.28 -52.08 63.49 Favored 'General case' 0 CA--C 1.484 -1.587 0 O-C-N 124.051 0.844 . . . . 0.0 113.046 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -101.3 -15.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -163.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 28.9 t80 -93.99 137.15 33.52 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 122.936 2.607 . . . . 0.0 109.738 177.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -151.79 100.4 2.67 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 165.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.58 -49.41 2.17 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -164.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -145.47 149.95 42.44 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 167.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 51.4 Cg_endo -84.07 169.71 11.37 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.42 2.08 . . . . 0.0 107.922 -175.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.87 -70.53 0.35 Allowed 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.73 15.0 Favored Glycine 0 CA--C 1.475 -2.436 1 N-CA-C 102.768 -4.133 . . . . 0.0 102.768 164.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -116.66 73.62 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 177.05 9.81 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -174.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.36 -18.87 62.35 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.575 1.15 . . . . 0.0 112.717 -173.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.48 -22.12 30.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 122.797 0.439 . . . . 0.0 110.183 178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -77.44 -42.02 37.56 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.1 m -67.02 -37.16 83.66 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 123.829 0.706 . . . . 0.0 112.54 -178.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.29 -42.71 87.98 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 123.679 0.792 . . . . 0.0 110.36 175.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 m -69.89 -32.32 70.59 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.457 HD13 HH21 ' A' ' 33' ' ' ARG . 6.9 tt -81.87 -33.48 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 118.915 0.78 . . . . 0.0 110.61 -176.119 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.0 mmt -73.63 -31.58 63.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.064 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -74.83 -34.68 62.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -70.94 -56.88 5.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.078 0.951 . . . . 0.0 110.596 -172.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.457 HH21 HD13 ' A' ' 29' ' ' ILE . 10.0 ptp180 -85.38 -18.09 34.76 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.077 -175.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.64 71.12 1.31 Allowed Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 166.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -118.41 11.89 13.15 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 173.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.8 t -96.81 3.96 51.98 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.143 0.977 . . . . 0.0 108.99 -171.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -129.52 103.09 17.92 Favored Pre-proline 0 N--CA 1.427 -1.607 0 CA-C-O 117.81 -1.091 . . . . 0.0 108.667 -177.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.71 159.19 97.1 Favored 'Cis proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.52 -2.146 . . . . 0.0 106.52 -22.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.07 119.55 16.42 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 111.994 -166.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -79.55 134.12 36.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 172.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.9 -15.3 48.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.847 -164.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.63 125.88 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -139.08 128.81 24.73 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 169.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -96.27 117.85 31.64 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -93.64 120.36 33.82 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.5 145.1 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -174.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.435 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m-70 -133.16 128.93 37.11 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -174.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.66 -132.39 2.9 Favored Glycine 0 CA--C 1.483 -1.955 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 176.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.19 144.48 43.12 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -84.0 -15.17 48.67 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -74.68 -35.69 62.77 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.502 1.121 . . . . 0.0 108.612 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.1 m -72.15 -37.14 69.46 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.287 176.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 mm -56.55 -55.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 123.912 0.885 . . . . 0.0 111.842 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -58.92 -40.01 83.26 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.422 1.089 . . . . 0.0 112.889 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -18.72 46.86 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.8 -26.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 119.718 1.145 . . . . 0.0 110.683 -176.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.4 t -77.5 -12.08 59.92 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 118.579 0.627 . . . . 0.0 111.933 -178.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.45 -178.94 7.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.181 0.991 . . . . 0.0 108.72 168.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.05 -28.66 61.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.88 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -74.14 154.93 38.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 172.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 t30 61.78 21.21 12.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.633 2.373 . . . . 0.0 116.127 171.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.87 177.47 41.5 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -143.72 157.07 59.15 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -72.39 148.18 48.28 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.382 2.055 . . . . 0.0 109.671 -176.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -134.92 127.2 30.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 62.08 -106.45 0.21 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 125.726 1.61 . . . . 0.0 112.117 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -151.95 108.76 3.5 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 2.0 p-10 66.25 24.1 10.74 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 129.727 3.211 . . . . 0.0 113.87 176.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 mt -116.15 170.86 8.19 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 171.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.488 HH12 ' HG3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -149.85 146.1 26.93 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 166.356 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.34 151.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 175.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -74.48 177.99 5.6 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.297 1.046 . . . . 0.0 112.725 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -142.04 7.13 1.8 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.4 t -130.58 94.53 3.66 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 171.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 p -57.09 130.19 45.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.065 1.746 . . . . 0.0 112.717 -177.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.86 156.0 17.79 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -175.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 138.58 39.5 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 175.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.54 142.48 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.015 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.2 m -130.62 108.51 9.97 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 167.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.6 m -81.76 101.74 10.32 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 75.9 m -88.15 110.37 20.63 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 178.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.06 145.79 49.01 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 151.38 29.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.088 0.947 . . . . 0.0 112.62 -172.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -125.18 44.12 2.88 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.66 -108.48 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.336 0 C-N-CA 129.454 3.407 . . . . 0.0 113.378 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.75 -51.08 4.37 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 112.436 -1.882 . . . . 0.0 111.531 -162.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 p -175.86 152.66 1.3 Allowed Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 -173.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -86.03 -13.32 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.226 1.95 . . . . 0.0 108.658 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.33 159.42 32.03 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -75.28 142.93 27.61 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 121.998 1.799 . . . . 0.0 107.507 -172.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -82.06 161.16 78.45 Favored 'Cis proline' 0 CA--C 1.487 -1.827 0 CA-C-N 123.538 2.299 . . . . 0.0 110.794 8.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 m -142.87 122.41 13.23 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -166.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -85.58 109.19 18.36 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -99.61 121.53 41.33 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -98.83 152.67 19.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.38 31.2 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.2 m -126.56 98.24 5.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 167.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.77 32.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.153 0.501 . . . . 0.0 109.967 -175.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.49 20.84 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -151.65 92.51 1.76 Allowed 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 101.627 -3.471 . . . . 0.0 101.627 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -136.99 154.4 50.42 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -161.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -68.14 128.88 38.18 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.9 m -93.03 120.48 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -174.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.2 t -86.84 118.39 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.84 157.96 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 176.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 128.53 40.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.8 t -107.45 136.75 46.7 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.148 0.979 . . . . 0.0 108.847 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.45 138.98 50.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 169.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 14.0 p30 65.64 17.7 10.98 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 127.17 2.188 . . . . 0.0 116.644 172.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.83 23.71 48.55 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 28.3 tp -141.14 151.05 60.82 Favored Pre-proline 0 CA--C 1.486 -1.484 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HG3' HH12 ' A' ' 70' ' ' ARG . 74.1 Cg_exo -66.94 162.88 35.93 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 122.552 1.947 . . . . 0.0 109.791 164.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -147.4 -27.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 O-C-N 121.616 -0.677 . . . . 0.0 111.274 176.245 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.521 ' HE2' HH21 ' A' ' 5' ' ' ARG . 88.8 m-70 -144.08 172.03 13.45 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 -173.473 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.0 134.28 54.33 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 175.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.63 121.03 27.73 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 174.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -103.94 45.67 0.95 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p -98.74 -30.41 12.45 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 175.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -23.5 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.872 -172.837 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.59 -18.5 26.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.164 179.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -68.44 -43.66 76.59 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.513 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.252 8.6 t80 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.402 -2.837 0 C-N-CA 124.768 1.227 . . . . 0.0 111.142 174.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -173.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -82.34 -32.36 29.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 119.479 1.036 . . . . 0.0 109.091 170.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CD2' ' CD1' ' A' ' 10' ' ' LEU . 1.9 t80 -58.22 -38.98 77.87 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.13 164.354 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 8.4 mp -83.38 -11.51 57.53 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 119.651 1.114 . . . . 0.0 113.495 178.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.2 m -70.66 -45.25 65.44 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 119.564 1.075 . . . . 0.0 108.298 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.12 -41.35 67.32 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.044 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' A' ' 115' ' ' LEU . 93.5 m-70 -101.56 -54.5 2.74 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.096 -169.028 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 9.6 t80 -72.45 126.41 29.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 120.45 1.477 . . . . 0.0 112.776 -165.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -149.17 104.37 3.41 Favored 'General case' 0 N--CA 1.424 -1.75 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 172.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.2 -32.28 10.12 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -162.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 152.38 42.9 Favored Pre-proline 0 N--CA 1.432 -1.37 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.528 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 17.2 Cg_endo -71.31 144.1 45.14 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 C-N-CA 123.265 2.643 . . . . 0.0 107.519 167.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -77.52 -51.63 10.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.6 179.68 17.35 Favored Glycine 0 CA--C 1.478 -2.259 1 N-CA-C 103.091 -4.004 . . . . 0.0 103.091 161.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.92 55.03 0.94 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.49 179.81 6.58 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -170.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -67.95 -23.94 65.11 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 125.352 1.461 . . . . 0.0 113.204 -172.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -25.76 37.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.51 -44.78 49.76 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.9 m -65.07 -38.07 89.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.35 -33.81 55.31 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 119.117 -0.468 . . . . 0.0 111.072 -178.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -76.57 -29.87 56.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 118.78 -0.628 . . . . 0.0 112.023 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 13.5 tt -75.92 -38.58 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.611 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.7 mtm -79.27 -23.23 43.76 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 118.136 -1.425 . . . . 0.0 113.447 -176.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -72.39 -36.81 68.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 170.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.18 -45.66 32.26 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.537 0.735 . . . . 0.0 111.479 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -76.78 -25.43 53.36 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.744 1.618 . . . . 0.0 109.344 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.12 44.48 3.8 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 163.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.8 mt -118.54 19.77 13.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -90.08 -11.33 41.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.619 1.168 . . . . 0.0 108.244 -176.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 m -121.3 105.0 39.92 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.61 161.31 94.91 Favored 'Cis proline' 0 N--CA 1.441 -1.612 0 N-CA-C 107.018 -1.955 . . . . 0.0 107.018 -22.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.95 125.54 24.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.202 1.001 . . . . 0.0 109.586 -177.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.78 142.38 38.67 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.7 -36.47 57.2 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.76 128.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -161.36 144.48 12.56 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.506 ' HG1' HE22 ' A' ' 117' ' ' GLN . 85.0 m -106.87 138.88 42.2 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 -170.103 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -101.87 129.77 48.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 162.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.67 150.89 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.637 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -174.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.528 ' CG ' ' HD3' ' A' ' 18' ' ' PRO 0.252 7.9 m-70 -140.25 153.12 46.42 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.741 -174.024 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.04 -124.24 3.89 Favored Glycine 0 CA--C 1.478 -2.246 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 169.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 135.58 42.93 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.968 1.366 . . . . 0.0 109.707 -177.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.27 -29.11 34.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.602 -1.636 . . . . 0.0 106.857 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -29.11 64.85 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.9 m -76.88 -36.79 56.47 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 116.663 -1.637 . . . . 0.0 111.485 176.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.268 6.6 tp -65.03 -46.34 91.77 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 0 CA-C-N 120.193 1.361 . . . . 0.0 110.592 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -60.61 -43.48 97.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.428 1.091 . . . . 0.0 110.808 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.18 11.46 2.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.56 -35.99 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.097 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 167.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -96.74 5.29 50.91 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -112.38 18.65 18.33 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.087 0.946 . . . . 0.0 108.461 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 32.1 47.58 0.09 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 131.686 3.994 . . . . 0.0 115.744 -170.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.78 -60.7 2.21 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.55 64.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.163 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.19 146.84 8.58 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 173.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -102.49 164.06 16.42 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.92 144.01 42.19 Favored 'Trans proline' 0 N--CA 1.437 -1.797 0 C-N-CA 122.692 2.262 . . . . 0.0 106.886 166.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -136.23 33.69 2.81 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 -178.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.6 mmt-85 61.12 157.62 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 129.017 2.927 . . . . 0.0 114.73 178.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 52.84 46.77 26.09 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 128.126 2.57 . . . . 0.0 113.882 175.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.316 2.8 p-10 51.48 40.35 26.61 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.785 2.434 . . . . 0.0 114.192 -174.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.88 153.81 32.91 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 100.799 -3.778 . . . . 0.0 100.799 177.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -146.26 125.17 12.72 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -90.59 143.19 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 179.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.0 p -80.88 158.16 25.41 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.693 0.758 . . . . 0.0 112.75 -175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -108.11 -19.97 13.32 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -104.93 82.45 1.87 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 p -52.43 132.06 34.27 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 127.023 2.129 . . . . 0.0 112.413 178.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -107.26 160.42 15.61 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -79.76 144.3 33.72 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.77 142.14 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 m -131.54 104.56 7.03 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 169.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.0 m -86.32 105.26 16.55 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.34 111.25 20.89 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -111.36 131.52 55.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 -171.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.5 118.01 11.83 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 123.64 0.776 . . . . 0.0 108.935 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -130.93 71.38 1.47 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -175.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.19 -45.97 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 105.156 -3.178 . . . . 0.0 105.156 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.02 37.03 8.6 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 p -103.57 122.29 45.37 Favored Pre-proline 0 N--CA 1.434 -1.246 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -83.54 -20.21 4.88 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 CA-C-N 121.587 1.602 . . . . 0.0 108.614 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -110.9 158.44 35.74 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.318 -167.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.25 147.01 36.81 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.824 2.35 . . . . 0.0 108.382 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -82.06 165.75 72.34 Favored 'Cis proline' 0 N--CA 1.438 -1.761 0 CA-C-N 122.401 1.893 . . . . 0.0 108.489 -1.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.1 m -113.12 157.91 21.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.703 1.252 . . . . 0.0 107.637 -172.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -111.57 135.59 51.93 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -133.71 122.58 23.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -89.06 125.12 34.88 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.09 122.34 27.21 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -115.24 88.07 2.79 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.48 142.34 27.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.009 -172.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.11 -177.09 14.94 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 177.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -140.44 97.62 3.25 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 175.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -158.34 -179.66 8.31 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -164.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -79.91 146.84 31.92 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.053 -173.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.43 151.95 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -114.06 95.02 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 163.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.3 136.6 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.53 130.17 34.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 174.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 57.1 m -109.66 149.64 29.43 Favored 'General case' 0 CA--C 1.489 -1.376 0 O-C-N 124.136 0.897 . . . . 0.0 110.688 -173.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.21 124.97 7.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.2 p30 65.89 18.32 11.06 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.782 2.433 . . . . 0.0 116.338 171.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.3 -7.02 59.83 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -103.06 148.76 36.11 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 177.611 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -70.89 143.46 45.46 Favored 'Trans proline' 0 N--CA 1.435 -1.968 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 156.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.22 -22.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -154.25 -167.35 2.61 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -167.88 136.75 2.49 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 -179.656 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -80.5 139.66 36.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.864 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.506 HE22 ' HG1' ' A' ' 44' ' ' THR . 29.7 mm100 -101.88 40.77 1.28 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 172.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.3 m -96.22 -30.19 13.61 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -175.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -35.41 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.941 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.241 172.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -168.37 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 . . . . . 0 CA--C 1.487 -1.45 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 59.34 71.83 0.56 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 126.397 1.879 . . . . 0.0 111.577 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 93.15 -28.84 0.03 OUTLIER 'General case' 0 C--N 1.358 0.937 0 C-N-CA 127.613 2.365 . . . . 0.0 110.621 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -90.38 -1.64 57.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.45 -45.35 59.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.55 -52.72 63.72 Favored 'General case' 0 N--CA 1.412 -2.344 0 C-N-CA 125.538 1.535 . . . . 0.0 112.366 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.449 1.8 t -87.97 9.8 21.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.99 -42.2 33.45 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 120.207 -1.558 . . . . 0.0 107.463 157.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -59.77 -36.91 77.64 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.982 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 20.2 mt -83.77 -15.91 46.71 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 119.567 1.076 . . . . 0.0 113.863 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.7 m -65.8 -48.61 71.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 119.911 1.232 . . . . 0.0 108.908 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -72.91 -37.25 67.31 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -104.34 -53.64 2.68 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.251 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 14.8 t80 -76.61 115.33 16.27 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 119.232 0.924 . . . . 0.0 110.123 -168.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -134.76 98.73 4.12 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.11 -38.01 16.72 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -165.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -159.77 134.52 5.52 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -71.54 178.05 6.09 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 123.051 2.501 . . . . 0.0 114.66 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.31 -59.63 2.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -179.36 22.73 Favored Glycine 0 CA--C 1.478 -2.228 0 N-CA-C 104.403 -3.479 . . . . 0.0 104.403 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.507 HH21 ' HG3' ' A' ' 77' ' ' GLN . 11.1 mpt_? -106.84 73.46 0.94 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -156.92 173.46 16.97 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.41 -20.77 62.9 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 125.373 1.469 . . . . 0.0 113.963 -169.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -80.46 -29.61 37.47 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.32 -41.58 66.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . 0.27 0.7 OUTLIER -80.34 -25.39 39.27 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.729 -1.188 . . . . 0.0 113.097 -170.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.01 -36.48 69.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 118.99 -0.528 . . . . 0.0 110.175 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.4 t -65.65 -42.96 90.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 tt -80.37 -28.09 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 117.83 0.286 . . . . 0.0 111.199 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 mmt -74.25 -29.99 61.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.035 -0.415 . . . . 0.0 110.325 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.424 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.3 tpp180 -66.43 -45.75 78.82 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.774 0.83 . . . . 0.0 111.869 172.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -80.22 -39.68 28.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -170.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.47 -39.65 74.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.46 68.82 1.34 Allowed Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 mt -113.94 21.83 14.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 163.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -94.6 -5.78 45.01 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 109.085 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -132.6 102.66 13.75 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.86 163.31 89.39 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.484 -1.776 . . . . 0.0 107.484 -18.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 m -59.62 125.75 24.87 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 124.492 1.117 . . . . 0.0 110.693 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -76.19 138.46 40.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.83 -40.71 60.89 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 123.432 0.457 . . . . 0.0 111.256 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.91 128.0 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -148.79 131.72 16.17 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 m -96.97 124.38 40.92 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.645 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.98 120.08 30.88 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.77 149.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.636 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -143.37 138.46 29.43 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.98 -140.28 6.78 Favored Glycine 0 CA--C 1.484 -1.871 0 N-CA-C 106.651 -2.579 . . . . 0.0 106.651 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.38 146.55 25.07 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 1.2 tmtp? -83.89 -25.4 30.23 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -70.75 -34.23 71.63 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.006 1.323 . . . . 0.0 108.708 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -69.93 -41.44 74.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 117.614 -1.184 . . . . 0.0 110.459 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.74 -50.73 76.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 123.837 0.855 . . . . 0.0 111.909 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -63.87 -37.67 88.24 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.343 0.657 . . . . 0.0 111.188 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.35 4.81 8.15 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.0 mm -77.3 -26.85 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.7 t -82.74 -15.02 53.42 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.152 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.47 154.41 38.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -83.34 -7.49 59.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.757 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -80.41 -41.84 23.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.921 0.488 . . . . 0.0 109.769 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -123.29 31.46 5.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.67 136.95 3.37 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -90.01 154.02 47.27 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.572 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 37.2 Cg_endo -74.79 138.43 23.58 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 122.335 2.024 . . . . 0.0 106.974 169.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -130.67 104.77 7.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.47 ' CD ' ' H ' ' A' ' 67' ' ' GLU 0.398 0.0 OUTLIER 46.31 -109.59 0.23 Allowed 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 127.806 2.442 . . . . 0.0 115.661 -177.862 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 50.2 mt-10 -107.33 77.47 1.15 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.766 1.226 . . . . 0.0 108.763 -165.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.372 1.2 p-10 76.59 12.12 2.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 129.102 2.961 . . . . 0.0 114.345 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.3 mp -95.82 154.17 17.36 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HE ' ' HA ' ' A' ' 64' ' ' PRO . 13.8 mmp_? -136.57 112.64 9.7 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -95.73 132.21 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.2 p -82.45 157.05 23.79 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.652 0.739 . . . . 0.0 112.424 -168.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -108.94 -15.93 14.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.533 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -112.91 90.57 3.38 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.8 m -50.92 133.23 27.05 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 127.402 2.281 . . . . 0.0 112.419 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.4 161.3 15.43 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.507 ' HG3' HH21 ' A' ' 21' ' ' ARG . 0.3 OUTLIER -82.16 126.77 32.44 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 175.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 108.5 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.2 m -94.82 108.31 20.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.1 m -91.83 102.9 15.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.2 m -93.3 117.65 30.33 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.54 144.73 37.43 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -78.98 126.67 30.99 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.72 52.58 2.04 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.69 -70.54 1.18 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.71 -32.44 4.44 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.9 t -87.48 135.34 34.47 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -78.38 -22.65 9.35 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.161 1.908 . . . . 0.0 109.074 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -95.32 167.4 12.89 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -72.32 142.63 37.69 Favored 'Trans proline' 0 N--CA 1.438 -1.788 0 C-N-CA 122.028 1.819 . . . . 0.0 107.526 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.424 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.0 Cg_endo -88.15 164.56 42.96 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 CA-C-N 122.63 1.975 . . . . 0.0 108.775 15.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.7 m -130.01 122.66 28.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -94.87 117.35 30.0 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -107.28 122.6 46.88 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -96.79 121.4 38.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.67 130.33 35.02 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.9 m -118.05 95.4 4.89 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.94 34.27 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.105 -173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.94 -176.18 19.61 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.328 -3.109 . . . . 0.0 105.328 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -148.43 109.71 4.37 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.568 -3.123 . . . . 0.0 102.568 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -162.12 175.11 12.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.971 0.891 . . . . 0.0 109.018 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -77.56 142.24 39.11 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 125.244 1.418 . . . . 0.0 110.675 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.38 150.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.12 91.73 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 166.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.64 132.62 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.52 125.02 36.97 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.3 t -108.67 131.24 55.09 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -126.19 136.84 53.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 13.1 p30 65.05 18.98 11.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 127.514 2.326 . . . . 0.0 117.083 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.9 54.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 0.4 OUTLIER -134.47 132.2 20.76 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 -178.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.95 108.21 2.6 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 N-CA-C 105.78 -2.431 . . . . 0.0 105.78 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 m -94.27 -11.72 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -172.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.455 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 61.9 t60 -153.85 179.53 8.79 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -169.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.455 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -164.21 130.58 3.06 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.85 135.02 36.92 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.251 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -100.86 41.84 1.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.3 t -96.38 -32.39 12.39 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.89 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.837 172.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.06 43.4 1.11 Allowed 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -94.35 -42.15 9.05 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.7 tpp85 -133.99 101.85 12.45 Favored Pre-proline 0 N--CA 1.43 -1.464 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.432 -2.117 0 N-CA-C 105.927 -2.374 . . . . 0.0 105.927 -174.444 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.544 HE22 ' CE1' ' A' ' 8' ' ' HIS . 83.2 mt-30 . . . . . 0 CA--C 1.487 -1.449 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -149.84 100.07 2.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.319 0.5 OUTLIER 109.36 -26.04 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 129.613 3.165 . . . . 0.0 107.893 176.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 m -92.19 -13.82 29.98 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -43.68 67.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.268 41.4 t80 -56.82 -51.96 66.95 Favored 'General case' 0 N--CA 1.399 -3.012 0 C-N-CA 126.623 1.969 . . . . 0.0 113.422 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.42 ' HA ' ' HG ' ' A' ' 10' ' ' LEU 0.252 1.5 p -82.06 -3.24 54.22 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.544 ' CE1' HE22 ' A' ' 1' ' ' GLN . 22.2 m170 -85.63 -31.21 22.7 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 120.136 1.335 . . . . 0.0 108.229 167.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -65.18 -36.98 85.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.407 1.083 . . . . 0.0 109.405 167.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.295 8.9 mt -69.25 -31.15 69.5 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 170.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.6 m -65.26 -44.28 88.61 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 119.509 1.049 . . . . 0.0 108.936 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.465 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 66.5 mt-30 -70.0 -55.16 10.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 123.556 0.535 . . . . 0.0 111.92 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 91.1 m-70 -96.49 -49.44 5.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.913 -162.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -71.15 115.09 9.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 120.065 1.302 . . . . 0.0 112.635 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -138.56 98.05 3.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 100.789 -3.782 . . . . 0.0 100.789 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.82 -40.69 10.09 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.515 2.326 . . . . 0.0 117.055 -168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -157.63 144.11 13.04 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -76.51 178.39 7.61 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.507 2.138 . . . . 0.0 112.916 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.64 -74.99 0.17 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.74 -176.44 14.74 Favored Glycine 0 CA--C 1.477 -2.336 1 N-CA-C 102.557 -4.217 . . . . 0.0 102.557 163.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -118.16 72.56 0.87 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -145.01 177.8 8.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.72 -22.33 63.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.704 1.202 . . . . 0.0 113.595 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.8 -29.45 40.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -41.87 69.48 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.43 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.282 0.8 OUTLIER -79.69 -26.92 40.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.227 -170.585 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.66 -35.47 70.36 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.286 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -67.73 -38.91 84.17 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 26' ' ' CYS . 4.1 tt -79.69 -30.85 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 118.535 0.607 . . . . 0.0 110.629 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -74.4 -30.09 61.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 122.392 -0.192 . . . . 0.0 111.0 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -68.43 -44.85 74.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.467 0.707 . . . . 0.0 111.873 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -71.2 -48.99 48.21 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.913 0.885 . . . . 0.0 112.277 -173.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -36.82 75.35 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.201 0.6 . . . . 0.0 110.408 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.58 68.79 1.36 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -114.91 22.48 13.41 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -91.25 -10.21 42.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 124.267 1.027 . . . . 0.0 109.132 -172.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -129.99 104.54 16.82 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.65 160.01 95.66 Favored 'Cis proline' 0 N--CA 1.444 -1.404 0 N-CA-C 107.073 -1.934 . . . . 0.0 107.073 -20.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.5 m -62.92 125.26 23.37 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.059 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.01 143.17 45.67 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.03 -39.14 61.23 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.161 0.584 . . . . 0.0 111.541 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 tt -149.11 128.83 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -147.26 125.73 12.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 m -101.51 114.36 28.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.586 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -85.67 125.96 33.57 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.41 146.37 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.726 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -136.91 127.45 26.86 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 125.311 1.444 . . . . 0.0 107.949 -174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.65 -148.49 17.67 Favored Glycine 0 CA--C 1.483 -1.91 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -84.02 140.5 31.82 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 122.2 1.0 . . . . 0.0 108.33 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -85.27 -15.78 42.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.308 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -79.32 -31.42 43.18 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 125.317 1.447 . . . . 0.0 107.857 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.7 m -73.37 -36.47 66.11 Favored 'General case' 0 N--CA 1.424 -1.744 0 C-N-CA 124.177 0.991 . . . . 0.0 109.992 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.7 mt -59.9 -52.25 63.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.996 0 C-N-CA 123.379 0.672 . . . . 0.0 110.992 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.05 -39.7 79.11 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.821 0.849 . . . . 0.0 112.849 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.69 10.35 3.34 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.9 mt -78.63 -30.53 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.0 t -68.08 -41.27 82.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.36 154.98 28.64 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.26 99.22 8.5 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -159.77 -49.08 0.05 Allowed 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.34 47.24 1.39 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.94 129.53 1.54 Allowed Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.76 160.63 32.66 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -72.64 138.26 28.98 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 122.914 2.409 . . . . 0.0 107.971 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -141.32 129.63 22.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -171.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 65.66 -108.72 0.16 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.052 1.341 . . . . 0.0 111.447 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -140.67 95.15 2.81 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.345 1.6 p-10 64.15 23.38 13.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 128.92 2.888 . . . . 0.0 114.327 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.9 mt -106.46 168.48 9.13 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -141.13 124.75 16.82 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.53 142.52 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.3 p -84.31 175.16 9.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.826 0.822 . . . . 0.0 110.418 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -131.45 -1.18 3.94 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -109.54 74.02 0.87 Allowed 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.4 p -51.19 123.89 10.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.137 1.775 . . . . 0.0 113.544 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -108.6 160.99 15.49 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.68 136.45 35.49 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.47 110.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -172.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.0 m -93.64 110.63 22.23 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.1 m -88.95 104.63 17.14 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.4 m -94.19 115.47 27.75 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.423 ' HZ2' ' HE2' ' A' ' 84' ' ' HIS . 6.9 mtmp? -110.13 147.66 33.25 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 tp -79.99 112.91 17.74 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.423 ' HE2' ' HZ2' ' A' ' 82' ' ' LYS . 88.2 m-70 -132.81 96.54 3.82 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.85 -40.92 0.06 OUTLIER Glycine 0 CA--C 1.479 -2.197 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.6 42.48 6.46 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.8 m -114.61 107.19 51.25 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -83.76 -20.53 4.53 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 CA-C-N 122.213 1.826 . . . . 0.0 108.398 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -110.17 161.32 24.93 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -73.96 144.45 34.32 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.665 2.244 . . . . 0.0 108.31 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -81.89 163.63 76.49 Favored 'Cis proline' 0 N--CA 1.437 -1.848 0 CA-C-N 122.641 1.979 . . . . 0.0 108.731 -1.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.1 m -108.53 159.41 16.72 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.739 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.18 98.7 7.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.77 128.3 44.32 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -101.34 121.03 41.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.46 132.67 35.2 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 48.4 m -116.12 105.52 12.69 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.1 125.53 29.48 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.3 177.99 18.75 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 105.691 -2.963 . . . . 0.0 105.691 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -158.95 111.13 2.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -161.21 171.12 18.98 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.24 133.77 42.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.852 172.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.65 149.51 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.424 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.98 122.38 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.35 138.94 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.21 132.16 36.28 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.5 t -104.42 133.81 48.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 124.744 1.278 . . . . 0.0 109.903 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -132.57 141.37 48.68 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 164.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.326 11.2 p30 66.34 17.79 10.76 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.301 2.24 . . . . 0.0 116.503 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.12 50.77 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.267 3.5 tp -143.43 149.84 49.21 Favored Pre-proline 0 CA--C 1.484 -1.591 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -67.19 147.21 78.5 Favored 'Trans proline' 0 N--CA 1.436 -1.898 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 164.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.28 -19.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 42.1 t60 -155.86 178.79 9.87 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 -165.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -159.32 146.43 16.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -173.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -95.44 141.23 29.23 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -115.56 20.71 14.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.301 1.04 . . . . 0.0 110.029 -170.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.3 m -95.13 -20.75 19.01 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 118.94 0.791 . . . . 0.0 109.938 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -33.0 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.42 1.088 . . . . 0.0 111.036 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -93.71 -9.09 38.89 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -77.31 -66.41 0.83 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.47 128.98 30.07 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.434 -2.026 0 N-CA-C 105.723 -2.453 . . . . 0.0 105.723 -179.471 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -102.74 68.01 1.01 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -109.31 -0.03 19.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.9 m -88.76 -26.52 21.7 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.13 -49.88 68.2 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.76 -57.3 11.37 Favored 'General case' 0 N--CA 1.4 -2.949 0 C-N-CA 127.209 2.204 . . . . 0.0 114.327 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -82.64 -2.34 53.67 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -86.12 -31.33 21.92 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -64.07 -41.18 97.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.373 166.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . 0.335 0.7 OUTLIER -61.16 -39.81 91.51 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 172.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -69.65 -46.22 66.64 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 120.072 1.305 . . . . 0.0 110.463 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.92 -5.18 59.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -127.29 -62.94 1.07 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.591 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -67.43 118.3 10.57 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.957 1.253 . . . . 0.0 112.02 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -147.27 99.29 3.13 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.94 -29.58 0.85 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -163.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -153.06 157.1 33.05 Favored Pre-proline 0 N--CA 1.434 -1.234 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.5 Cg_endo -74.41 157.5 45.2 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 123.188 2.592 . . . . 0.0 108.859 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.97 -63.22 1.31 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.62 177.0 18.64 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 103.072 -4.011 . . . . 0.0 103.072 161.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' HE ' ' HB3' ' A' ' 98' ' ' ALA . 77.8 mtp180 -109.53 68.28 0.67 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.06 173.9 14.87 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -170.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.82 -14.94 61.18 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.66 1.184 . . . . 0.0 113.093 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -32.29 53.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.112 0.565 . . . . 0.0 109.621 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.95 -41.47 61.97 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . 0.268 0.1 OUTLIER -78.45 -26.68 46.25 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 118.451 -1.299 . . . . 0.0 114.042 -170.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 -34.14 59.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.161 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -69.81 -32.56 71.06 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.286 14.6 tt -79.97 -35.12 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.198 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -22.31 59.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.223 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.82 -29.75 29.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 119.433 1.015 . . . . 0.0 112.959 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.6 -41.95 20.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 118.758 0.708 . . . . 0.0 110.91 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -72.42 -38.59 68.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.329 1.052 . . . . 0.0 109.54 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.73 68.01 1.41 Allowed Glycine 0 CA--C 1.48 -2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.83 17.66 16.9 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 t -90.54 -10.33 43.9 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 p -126.55 102.21 26.39 Favored Pre-proline 0 N--CA 1.428 -1.547 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.84 161.72 93.66 Favored 'Cis proline' 0 N--CA 1.445 -1.372 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -21.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.4 m -61.08 120.42 10.24 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.239 1.015 . . . . 0.0 109.673 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -79.82 145.82 32.59 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -68.78 -42.93 76.72 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.239 1.015 . . . . 0.0 113.103 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -156.4 134.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -147.91 137.01 22.15 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.4 m -99.62 122.97 43.43 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.13 122.25 35.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.4 144.45 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.508 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 20.8 m-70 -134.04 131.65 39.1 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 124.067 0.947 . . . . 0.0 108.454 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.34 -151.42 21.7 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 104.317 -3.513 . . . . 0.0 104.317 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' HB2' ' HG ' ' A' ' 52' ' ' SER . 3.2 m120 -89.83 152.88 21.06 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 171.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.62 -8.74 51.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -36.73 49.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.412 ' HG ' ' HB2' ' A' ' 49' ' ' ASN . 72.7 p -78.62 -28.47 45.64 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.798 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -66.14 -44.31 91.75 Favored 'Isoleucine or valine' 0 C--N 1.368 1.399 0 CA-C-N 120.324 1.42 . . . . 0.0 110.381 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.73 -33.67 76.15 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.49 1.116 . . . . 0.0 111.437 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 8.4 5.08 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.77 -19.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.1 m -75.76 -12.77 60.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.76 156.52 32.33 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -85.94 -13.4 47.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.224 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.83 -34.0 22.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 123.06 0.544 . . . . 0.0 109.875 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -124.23 45.02 2.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.75 141.26 3.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -89.84 154.29 47.73 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.83 138.37 28.65 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.771 2.314 . . . . 0.0 106.246 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -137.94 123.08 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 60.5 -109.81 0.42 Allowed 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 125.883 1.673 . . . . 0.0 112.451 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -134.77 95.18 3.29 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.348 1.2 p-10 69.83 16.55 7.77 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 129.253 3.021 . . . . 0.0 114.531 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.2 167.32 10.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -140.56 117.41 11.05 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.54 145.82 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -91.13 152.21 20.68 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.436 0.636 . . . . 0.0 111.653 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.76 -17.55 14.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 t -108.93 85.28 2.07 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 p -50.2 135.47 21.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 127.516 2.326 . . . . 0.0 113.093 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.31 161.67 16.37 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 4.2 mt-30 -82.11 136.03 35.23 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.94 100.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m -91.56 111.47 23.0 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.0 m -94.54 102.35 14.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.9 m -96.53 122.23 39.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -118.78 144.08 46.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.1 tp -77.29 104.44 7.8 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.791 1.236 . . . . 0.0 108.852 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -87.15 155.13 20.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.28 -76.13 0.51 Allowed Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.42 38.78 2.95 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 106.758 -2.537 . . . . 0.0 106.758 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 t -94.11 117.73 67.15 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.23 -12.29 5.87 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 CA-C-N 121.897 1.713 . . . . 0.0 108.041 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -103.89 161.78 21.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -75.01 145.7 31.73 Favored 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.028 1.818 . . . . 0.0 107.424 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -83.44 165.26 67.93 Favored 'Cis proline' 0 N--CA 1.439 -1.713 0 CA-C-N 122.997 2.106 . . . . 0.0 109.623 7.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.6 m -120.66 141.26 50.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.29 100.52 10.42 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.35 108.49 21.02 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -92.68 124.05 36.41 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.63 130.08 34.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.535 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.8 m -117.7 93.34 4.12 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.425 ' HB3' ' HE ' ' A' ' 21' ' ' ARG . . . -82.19 134.79 35.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 -170.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.71 -173.25 12.94 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -159.77 108.62 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.34 178.22 5.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.974 0.893 . . . . 0.0 109.371 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -69.6 140.81 53.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.576 1.95 . . . . 0.0 111.853 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.73 152.66 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.7 t -108.3 90.47 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.36 131.36 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.08 35.65 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.8 t -106.17 133.89 50.16 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.486 1.116 . . . . 0.0 110.689 -167.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.05 125.47 33.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 13.0 p30 66.87 15.78 10.22 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 127.632 2.373 . . . . 0.0 116.748 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.58 40.86 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.9 tp -135.22 123.28 15.49 Favored Pre-proline 0 N--CA 1.435 -1.222 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.13 107.77 2.1 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 106.038 -2.331 . . . . 0.0 106.038 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.96 -18.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 123.38 0.425 . . . . 0.0 110.927 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 46.3 t60 -146.27 177.03 9.32 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.39 129.62 6.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.38 150.62 36.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.2 59.53 0.68 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -171.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.0 t -65.45 -67.06 0.47 Allowed 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.789 1.236 . . . . 0.0 111.164 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 pt -100.78 1.34 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -99.78 4.69 45.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -167.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -104.42 -23.96 13.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 146.86 59.74 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 172.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 N--CA 1.435 -1.967 0 N-CA-C 106.437 -2.178 . . . . 0.0 106.437 178.433 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 . . . . . 0 CA--C 1.486 -1.497 0 CA-C-O 120.667 0.27 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -157.02 105.45 2.15 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 103.139 -2.912 . . . . 0.0 103.139 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.7 t30 111.67 -35.32 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 129.188 2.995 . . . . 0.0 105.57 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.531 1.133 . . . . 0.0 109.932 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.402 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -64.14 -54.23 37.01 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.297 1.439 . . . . 0.0 107.893 170.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.63 -41.75 95.96 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.04 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.447 0.3 OUTLIER -85.95 -3.72 58.99 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -77.47 -36.85 52.42 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 119.54 1.064 . . . . 0.0 108.911 163.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.434 ' CD2' HD21 ' A' ' 10' ' ' LEU . 7.3 t80 -59.48 -37.23 77.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.099 0.96 . . . . 0.0 110.214 168.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD21 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -82.77 -18.69 39.78 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 119.236 0.926 . . . . 0.0 113.03 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 m -69.08 -51.83 34.72 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 12.9 pt20 -85.61 -12.35 51.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.453 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 94.7 m-70 -117.76 -51.57 2.47 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 119.08 0.855 . . . . 0.0 111.278 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -79.1 119.28 21.99 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.824 1.193 . . . . 0.0 109.58 -167.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -136.27 96.76 3.44 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 100.678 -3.823 . . . . 0.0 100.678 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.02 -45.52 2.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 128.449 2.7 . . . . 0.0 117.424 -168.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 141.94 14.17 Favored Pre-proline 0 N--CA 1.433 -1.324 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 164.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -74.18 -179.07 4.36 Favored 'Trans proline' 0 N--CA 1.437 -1.827 0 C-N-CA 122.628 2.219 . . . . 0.0 114.125 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.1 -76.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.1 -174.96 13.9 Favored Glycine 0 CA--C 1.476 -2.348 1 N-CA-C 101.399 -4.68 . . . . 0.0 101.399 160.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -112.63 74.47 0.86 Allowed 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -137.81 178.13 7.35 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -72.09 -26.03 61.99 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 124.084 0.953 . . . . 0.0 111.641 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -81.52 -23.19 37.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 123.341 0.656 . . . . 0.0 109.65 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -73.64 -45.68 51.35 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.259 2.0 t -78.69 -23.99 45.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.768 -173.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.91 -40.4 79.13 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -68.29 -41.51 80.84 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 26' ' ' CYS . 16.3 tt -78.18 -32.06 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 117.85 0.296 . . . . 0.0 110.827 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 47.1 mtp -78.56 -27.46 45.81 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.2 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -67.34 -41.1 85.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -75.84 -46.65 29.27 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.4 HH21 HG13 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -68.5 -32.67 72.8 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 123.289 0.636 . . . . 0.0 111.366 176.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.76 62.63 1.59 Allowed Glycine 0 CA--C 1.478 -2.258 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.4 mt -112.88 20.36 16.49 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 163.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -96.3 -8.01 33.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 p -125.05 99.84 34.02 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 167.22 81.11 Favored 'Cis proline' 0 N--CA 1.446 -1.322 0 N-CA-C 107.384 -1.814 . . . . 0.0 107.384 -22.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.47 121.91 11.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.344 1.058 . . . . 0.0 111.316 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.63 136.85 38.28 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.13 -39.46 63.29 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 123.781 0.676 . . . . 0.0 112.222 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -153.76 125.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -144.01 134.17 24.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.184 0.516 . . . . 0.0 109.886 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.3 m -101.41 114.95 29.41 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.959 0.903 . . . . 0.0 110.339 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -90.58 119.84 31.16 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.72 150.94 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -141.88 139.52 32.63 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.6 -135.23 3.83 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.31 140.86 32.87 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -85.69 -19.6 30.65 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.31 96.46 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.546 1.938 . . . . 0.0 108.084 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -71.45 -37.55 71.38 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.97 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.3 mm -55.63 -55.75 15.77 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 119.631 1.105 . . . . 0.0 110.958 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -58.27 -42.97 87.69 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.525 1.13 . . . . 0.0 111.416 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 15.58 1.75 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mm -78.52 -23.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.14 -15.96 48.64 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.873 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.42 150.06 43.7 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -77.39 -19.61 55.91 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 124.51 1.124 . . . . 0.0 111.311 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -77.54 -40.16 43.54 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 123.159 0.584 . . . . 0.0 109.977 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -119.47 34.02 5.39 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.17 129.15 1.08 Allowed Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 106.661 -2.576 . . . . 0.0 106.661 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -99.27 159.24 30.62 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -71.85 131.17 17.9 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 122.911 2.407 . . . . 0.0 106.822 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -125.54 126.05 44.2 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 65.51 -102.49 0.08 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.26 1.424 . . . . 0.0 110.99 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.78 105.68 3.45 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 3.5 p30 75.58 1.9 3.68 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.503 3.121 . . . . 0.0 114.717 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.32 171.63 8.07 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -144.71 119.04 9.56 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -170.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 tt -98.1 138.71 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -77.34 165.39 24.52 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.615 0.721 . . . . 0.0 112.785 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.24 -27.74 11.36 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -106.1 81.12 1.59 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 p -41.1 120.11 1.3 Allowed 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.987 2.515 . . . . 0.0 113.816 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.37 158.24 16.48 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 6.1 mt-30 -79.92 149.49 30.86 Favored 'General case' 0 CA--C 1.472 -2.031 0 CA-C-N 113.912 -1.495 . . . . 0.0 107.384 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.504 ' HB ' HH12 ' A' ' 101' ' ' ARG . 0.9 OUTLIER -150.3 148.51 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -126.53 105.49 8.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 165.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -88.51 98.48 11.66 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.84 119.49 29.38 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -108.76 142.37 39.39 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 85' ' ' GLY . 2.2 tm? -78.37 125.68 29.71 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.52 1.528 . . . . 0.0 107.459 -175.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.39 47.06 2.57 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.407 ' H ' HD12 ' A' ' 83' ' ' LEU . . . -85.71 -69.44 1.35 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.68 -31.06 5.69 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 p -85.55 145.4 41.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -79.57 -23.5 7.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.024 1.816 . . . . 0.0 108.773 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -99.61 165.84 13.95 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 117.979 -1.01 . . . . 0.0 108.994 -168.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -71.91 144.83 44.06 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.604 2.202 . . . . 0.0 108.141 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -86.22 165.17 52.32 Favored 'Cis proline' 0 N--CA 1.438 -1.756 0 CA-C-N 122.432 1.904 . . . . 0.0 107.914 9.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 63.9 m -132.57 126.49 32.91 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -89.8 136.75 32.85 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -124.67 122.6 37.96 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.88 115.15 27.82 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 126.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 m -117.58 103.55 10.17 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.56 130.49 35.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 120.819 0.342 . . . . 0.0 110.38 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.01 172.86 16.61 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -154.3 99.82 2.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.504 HH12 ' HB ' ' A' ' 78' ' ' VAL 0.256 0.0 OUTLIER -161.65 -179.78 7.54 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.623 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.13 133.14 47.64 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.124 0.969 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.9 142.77 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.5 t -104.66 110.09 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 165.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -106.65 152.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.03 49.19 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.2 t -109.72 131.28 55.21 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 124.745 1.278 . . . . 0.0 111.229 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -124.27 136.54 54.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 164.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.304 14.2 p30 64.15 21.56 12.6 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.9 16.87 57.41 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.29 0.9 OUTLIER -135.33 134.29 21.18 Favored Pre-proline 0 CA--C 1.487 -1.478 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.02 109.67 2.93 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 106.173 -2.28 . . . . 0.0 106.173 168.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -94.46 -12.16 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 118.11 0.413 . . . . 0.0 110.438 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -150.66 155.74 39.96 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -165.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.85 125.34 52.67 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -80.94 128.68 33.95 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -106.59 51.04 0.75 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 t -87.19 -47.23 9.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -32.12 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -87.57 -10.23 52.14 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.304 -163.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.08 -33.83 61.71 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.382 0.427 . . . . 0.0 110.221 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.39 128.52 84.15 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 N-CA-C 106.669 -2.089 . . . . 0.0 106.669 -174.325 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 . . . . . 0 CA--C 1.489 -1.383 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.27 90.19 1.79 Allowed 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 81.71 5.78 1.21 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 127.396 2.278 . . . . 0.0 108.002 -170.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 t -91.2 -30.63 16.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.29 -41.15 66.97 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -52.29 -60.65 2.96 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 127.311 2.244 . . . . 0.0 113.665 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.458 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 30.9 p -69.65 -20.96 63.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -78.71 -37.02 42.53 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 119.352 0.978 . . . . 0.0 110.155 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.83 -41.71 87.53 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.601 1.56 . . . . 0.0 109.625 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.397 0.3 OUTLIER -91.23 -4.46 55.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.849 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.3 m -75.9 -43.32 45.82 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 166.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.21 -40.54 86.45 Favored 'General case' 0 CA--C 1.488 -1.421 0 O-C-N 123.605 0.565 . . . . 0.0 111.201 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -106.75 -56.98 2.12 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.661 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 9.5 t80 -74.51 114.26 12.7 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.989 1.268 . . . . 0.0 110.438 -168.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.81 94.5 3.4 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.3 -33.54 0.65 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -163.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -151.34 155.99 34.77 Favored Pre-proline 0 N--CA 1.432 -1.326 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.458 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -73.3 156.87 50.51 Favored 'Trans proline' 0 N--CA 1.433 -2.073 0 C-N-CA 123.215 2.61 . . . . 0.0 110.049 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.46 -60.7 2.22 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 164.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.09 -177.01 14.66 Favored Glycine 0 CA--C 1.479 -2.19 1 N-CA-C 103.019 -4.032 . . . . 0.0 103.019 163.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -125.46 67.65 1.15 Allowed 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.64 179.12 6.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.43 -24.17 63.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -84.89 -21.28 29.78 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.75 -43.72 58.24 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.443 ' HA ' HG21 ' A' ' 29' ' ' ILE . 4.3 t -81.3 -21.66 39.13 Favored 'General case' 0 N--CA 1.412 -2.359 0 C-N-CA 117.936 -1.506 . . . . 0.0 112.543 -171.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.75 -34.34 66.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 121.879 -0.513 . . . . 0.0 110.417 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 t -70.58 -35.15 72.89 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 26' ' ' CYS . 20.1 tt -86.28 -25.26 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-N 118.214 0.461 . . . . 0.0 110.943 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 mmt -77.31 -28.82 53.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 121.7 -0.625 . . . . 0.0 109.789 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.26 -38.51 71.89 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.054 0.942 . . . . 0.0 112.204 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -70.4 -51.63 28.22 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 124.531 1.132 . . . . 0.0 110.893 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -30.52 62.28 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.882 0.873 . . . . 0.0 109.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.65 60.49 2.97 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.57 16.17 22.39 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 t -100.04 0.47 40.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -129.79 104.08 17.25 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.96 156.48 99.41 Favored 'Cis proline' 0 N--CA 1.442 -1.508 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -20.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 m -66.81 116.38 7.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.132 0.973 . . . . 0.0 111.107 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -82.27 146.2 29.59 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -75.06 -29.75 60.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.901 1.28 . . . . 0.0 113.064 -170.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 128.25 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -141.9 137.15 31.13 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.7 m -103.78 129.95 51.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -103.97 115.24 30.09 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mm -80.3 149.81 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 C-N-CA 126.132 1.773 . . . . 0.0 107.029 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.458 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.4 m-70 -136.35 131.49 34.35 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.54 -145.84 9.9 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -105.08 148.24 27.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -84.37 -18.07 37.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -82.34 -21.82 35.81 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -72.81 -39.83 66.32 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 118.462 -0.78 . . . . 0.0 108.996 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.73 -50.98 75.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.579 1.151 . . . . 0.0 111.01 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.46 -39.36 90.58 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.783 0.833 . . . . 0.0 112.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.07 6.45 5.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.82 -30.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 m -82.73 -7.08 59.67 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -80.05 159.03 26.31 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -87.49 -4.59 58.99 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.548 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -80.69 -45.68 16.76 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -122.59 39.91 3.81 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -169.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.59 166.84 32.48 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.95 159.29 35.93 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -76.96 137.71 17.77 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.218 1.945 . . . . 0.0 107.671 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -124.83 139.09 54.16 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 66.29 -103.21 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.423 1.089 . . . . 0.0 110.227 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -163.36 113.75 1.37 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.374 0.8 OUTLIER 74.13 7.29 4.75 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 129.528 3.131 . . . . 0.0 114.376 177.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.51 164.7 11.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.31 105.49 3.35 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -166.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -85.64 138.58 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -79.88 166.17 21.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.412 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -112.92 -16.2 12.74 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -109.93 87.85 2.61 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.8 t -46.79 124.21 5.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.958 2.503 . . . . 0.0 112.238 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -104.66 155.98 18.39 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 4.6 mt-30 -80.28 152.08 29.23 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.36 151.19 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -168.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -132.47 102.61 5.79 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 165.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.1 m -86.38 102.08 13.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.02 128.17 37.76 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -113.96 147.42 38.59 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.27 128.93 37.16 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -142.1 46.85 1.63 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.54 -65.57 0.9 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.28 -23.78 11.06 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -85.7 143.33 38.05 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -79.65 -22.98 7.42 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 122.049 1.833 . . . . 0.0 108.725 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -106.28 157.3 35.25 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.637 -168.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.44 150.34 36.2 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.441 2.094 . . . . 0.0 108.401 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -83.32 167.33 64.01 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 CA-C-N 122.423 1.901 . . . . 0.0 108.742 1.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.3 m -147.75 141.61 25.79 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -87.23 146.79 25.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.65 118.57 23.14 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -79.27 108.53 12.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.82 126.75 34.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -116.68 108.66 16.18 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.79 122.22 24.46 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.95 179.46 16.22 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -162.28 101.61 1.09 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.727 -3.434 . . . . 0.0 101.727 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 170.28 22.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.814 -171.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -75.01 130.71 39.82 Favored 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 124.225 1.01 . . . . 0.0 109.556 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.7 130.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.2 t -102.89 80.45 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.3 m -95.88 142.59 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.96 39.15 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.5 m -100.04 141.81 32.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 124.298 0.999 . . . . 0.0 111.237 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.73 130.41 19.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 12.1 p30 62.59 18.25 10.34 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 128.153 2.581 . . . . 0.0 115.372 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.62 -10.67 61.04 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mt -102.76 144.04 27.81 Favored Pre-proline 0 CA--C 1.478 -1.797 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.83 114.66 4.09 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 N-CA-C 105.269 -2.627 . . . . 0.0 105.269 161.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 m -99.77 -15.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 69.1 t60 -149.03 175.41 11.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -169.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.62 129.12 2.59 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.26 135.81 39.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.926 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.18 37.44 1.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 t -95.75 -16.6 21.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pt -95.53 -21.39 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.246 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.28 -23.94 12.42 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.72 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -134.16 73.06 1.48 Allowed 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -69.83 129.35 91.17 Favored Pre-proline 0 N--CA 1.432 -1.349 0 CA-C-N 113.042 -1.89 . . . . 0.0 107.983 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.433 -2.037 0 N-CA-C 106.279 -2.239 . . . . 0.0 106.279 -176.612 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 CA--C 1.487 -1.458 0 CA-C-O 120.683 0.278 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.5 59.99 0.74 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.98 -24.1 19.34 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -91.44 -1.8 57.45 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.826 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -74.32 -43.76 55.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -58.76 -52.67 64.72 Favored 'General case' 0 N--CA 1.41 -2.449 0 C-N-CA 124.939 1.295 . . . . 0.0 111.633 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.51 2.5 t -89.94 12.77 16.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -82.19 -40.23 22.02 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.204 -1.56 . . . . 0.0 108.1 156.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.92 -41.64 83.13 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.366 1.066 . . . . 0.0 109.525 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 19.4 mt -83.84 -13.84 52.69 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -65.55 -53.21 45.24 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 120.411 1.46 . . . . 0.0 107.811 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.524 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 4.9 pt20 -81.64 -17.14 49.13 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.524 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 84.4 m-70 -110.97 -55.03 2.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 118.965 0.802 . . . . 0.0 111.151 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 43.7 t80 -76.34 122.27 24.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.683 1.128 . . . . 0.0 109.208 -168.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -136.21 97.58 3.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.59 -38.45 4.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -166.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 140.57 9.92 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 165.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 81.1 Cg_exo -73.18 175.83 9.98 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 122.794 2.33 . . . . 0.0 113.794 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -73.21 -73.05 0.22 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.3 -176.66 14.61 Favored Glycine 0 CA--C 1.478 -2.249 1 N-CA-C 102.428 -4.269 . . . . 0.0 102.428 163.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -115.16 72.81 0.81 Allowed 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -147.83 -179.34 6.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.1 -21.66 62.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.714 1.206 . . . . 0.0 112.867 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -88.79 -15.47 34.54 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.1 -39.04 34.71 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 m -68.79 -34.32 75.34 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -66.85 -44.93 79.73 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 123.551 0.741 . . . . 0.0 109.587 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -64.75 -35.68 81.86 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.384 0.673 . . . . 0.0 112.54 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.29 13.3 tt -83.72 -28.97 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.973 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 -23.55 43.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 117.657 -1.617 . . . . 0.0 111.724 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -79.4 -32.9 43.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 118.995 0.816 . . . . 0.0 111.042 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -47.97 15.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.327 0.651 . . . . 0.0 110.064 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -76.81 -32.04 57.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.68 66.7 1.53 Allowed Glycine 0 CA--C 1.476 -2.347 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.9 31.13 6.75 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 162.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.64 2.65 44.69 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 p -124.64 94.77 43.95 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.48 167.1 81.05 Favored 'Cis proline' 0 N--CA 1.443 -1.498 0 N-CA-C 106.981 -1.969 . . . . 0.0 106.981 -24.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.2 m -63.3 116.05 5.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 124.352 1.061 . . . . 0.0 111.115 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.26 134.62 42.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -71.15 -35.4 71.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 124.373 1.045 . . . . 0.0 112.295 -168.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.43 136.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -147.58 122.11 9.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.7 m -90.89 106.33 18.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -85.88 121.37 28.42 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.0 148.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.432 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -141.15 132.87 27.27 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.36 -137.32 4.59 Favored Glycine 0 CA--C 1.483 -1.935 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -113.43 144.62 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -85.45 -17.5 36.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.906 -169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -82.26 -26.65 32.99 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.8 p -77.67 -30.11 51.83 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.658 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.93 -46.34 96.67 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 CA-C-N 119.403 1.001 . . . . 0.0 110.627 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 3.3 ttmp? -60.42 -38.82 85.26 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.487 1.115 . . . . 0.0 111.828 178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 9.85 5.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.705 1.202 . . . . 0.0 113.889 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.48 -17.92 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.6 t -66.37 -69.94 0.27 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.452 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -141.19 118.95 11.71 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.419 ' H ' ' H ' ' A' ' 60' ' ' LYS . 54.8 t30 -159.88 -3.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 164.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.419 ' H ' ' H ' ' A' ' 59' ' ' ASN 0.386 62.5 pttt 57.81 26.96 13.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.859 2.064 . . . . 0.0 111.748 -156.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -105.57 -14.74 15.19 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 167.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.77 139.98 10.87 Favored Glycine 0 CA--C 1.488 -1.636 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 160.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.39 153.88 43.23 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -69.68 143.27 50.68 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.824 2.349 . . . . 0.0 108.513 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -145.56 130.84 18.55 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 66.39 -103.59 0.08 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.884 1.273 . . . . 0.0 109.549 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -156.66 102.64 2.05 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER 90.93 -12.7 0.26 Allowed 'General case' 0 C--N 1.354 0.798 0 C-N-CA 128.323 2.649 . . . . 0.0 112.526 173.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.36 158.61 16.44 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -143.67 114.97 7.98 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -92.12 141.15 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -80.8 166.35 21.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.708 0.766 . . . . 0.0 110.823 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -120.6 -14.77 8.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.4 t -109.82 86.49 2.31 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.6 p -51.75 131.6 30.51 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 127.028 2.131 . . . . 0.0 112.293 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.16 156.69 19.56 Favored 'General case' 0 CA--C 1.476 -1.896 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 -171.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.61 142.03 40.84 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.9 143.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -166.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.6 m -131.01 108.39 9.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.61 -3.107 . . . . 0.0 102.61 168.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -82.69 101.38 10.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 71.8 m -88.91 111.42 22.07 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -109.5 137.69 46.97 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -76.3 112.33 12.68 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 125.172 1.389 . . . . 0.0 108.366 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -90.81 147.76 22.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 -74.24 0.21 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 28.68 4.31 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.6 p -92.09 127.19 50.35 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -80.44 -29.76 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 N-CA-C 107.735 -1.679 . . . . 0.0 107.735 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -99.35 148.07 34.17 Favored Pre-proline 0 N--CA 1.427 -1.591 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.476 -168.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -74.91 144.37 30.51 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.643 2.229 . . . . 0.0 107.0 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -81.74 160.98 79.84 Favored 'Cis proline' 0 CA--C 1.486 -1.884 0 CA-C-N 123.705 2.359 . . . . 0.0 109.982 10.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.9 m -146.94 146.97 30.3 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -167.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -102.52 154.19 19.35 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -137.66 125.12 22.0 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -104.68 130.69 52.68 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.24 138.96 31.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 122.826 0.451 . . . . 0.0 110.737 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.2 m -133.25 95.07 3.45 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.75 153.31 17.83 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.664 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.46 -163.63 12.14 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -149.59 97.9 2.69 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.5 ttt-85 -140.65 158.89 43.31 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -165.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.55 137.32 57.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.667 1.187 . . . . 0.0 109.679 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.46 136.87 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -104.02 91.37 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.86 138.77 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.65 123.63 32.04 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.5 t -103.25 125.93 50.16 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.589 1.181 . . . . 0.0 109.493 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -109.58 126.88 54.07 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 163.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.307 0.4 OUTLIER 31.95 68.55 0.13 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 128.622 2.769 . . . . 0.0 118.359 175.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.42 4.74 90.04 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.23 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.27 0.8 OUTLIER -138.2 135.32 18.34 Favored Pre-proline 0 CA--C 1.486 -1.486 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -63.53 132.95 37.59 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.817 2.345 . . . . 0.0 106.387 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.61 -18.57 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 20.7 t60 -151.92 179.8 8.14 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 -170.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 5.6 tp -151.83 132.47 13.97 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.56 123.57 27.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.89 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -103.56 24.02 11.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.788 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.6 p -81.71 -31.58 32.06 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 121.48 -0.763 . . . . 0.0 113.056 -167.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -32.58 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -84.21 -21.77 31.1 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.0 -165.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -81.54 -60.22 2.34 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -124.2 107.82 30.05 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo . . . . . 0 N--CA 1.435 -1.967 0 N-CA-C 105.949 -2.366 . . . . 0.0 105.949 172.195 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 CA--C 1.487 -1.443 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.31 60.69 0.61 Allowed 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.62 -23.36 19.03 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -88.78 0.25 56.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.761 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -68.14 -52.23 37.02 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -60.87 -50.72 72.27 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 117.333 -1.318 . . . . 0.0 113.164 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.527 2.3 t -90.82 11.36 22.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -81.69 -38.4 25.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 120.087 -1.633 . . . . 0.0 108.381 155.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.02 0.928 . . . . 0.0 109.686 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.66 -12.55 53.69 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.5 m -65.55 -52.22 54.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 120.68 1.582 . . . . 0.0 108.074 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.9 pt20 -79.31 -28.54 42.18 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 87.0 m-70 -100.1 -53.98 3.0 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 119.044 0.838 . . . . 0.0 110.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -73.66 134.62 43.65 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 120.296 1.407 . . . . 0.0 111.481 -166.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.62 99.92 2.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.84 -50.93 1.73 Allowed 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 128.061 2.544 . . . . 0.0 117.843 -166.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -142.69 146.59 38.82 Favored Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.7 Cg_endo -81.38 171.75 13.34 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 123.086 2.524 . . . . 0.0 108.662 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.08 -77.97 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.59 -178.88 15.59 Favored Glycine 0 CA--C 1.475 -2.427 1 N-CA-C 101.464 -4.654 . . . . 0.0 101.464 159.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.15 74.67 0.89 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -136.06 173.1 12.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -74.06 -21.27 60.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.886 0.874 . . . . 0.0 113.23 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -14.18 29.92 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.31 -41.71 63.22 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . 0.257 0.6 OUTLIER -77.06 -25.42 52.39 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 113.054 -174.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.81 -39.51 73.03 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 m -70.19 -33.06 71.26 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 tt -85.28 -29.74 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 118.644 0.656 . . . . 0.0 110.369 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mmt -71.78 -34.76 69.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -67.04 -45.94 75.92 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.265 1.026 . . . . 0.0 113.389 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -83.37 -32.52 26.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -74.52 -38.16 62.88 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.59 68.96 1.4 Allowed Glycine 0 CA--C 1.475 -2.451 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.96 29.17 5.24 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 163.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -81.91 -13.48 57.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 111.721 -2.491 . . . . 0.0 109.963 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -119.83 106.99 40.82 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.974 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 162.89 90.92 Favored 'Cis proline' 0 N--CA 1.444 -1.399 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 -22.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 70.2 m -61.3 121.97 13.93 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.139 0.976 . . . . 0.0 110.631 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -72.79 134.65 45.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -72.44 -39.11 68.07 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 123.631 0.582 . . . . 0.0 111.555 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.95 129.08 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 172.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -144.9 120.56 10.47 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 m -96.1 116.64 29.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.5 127.27 34.85 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mm -102.35 147.4 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.464 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.432 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -138.06 133.45 33.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.18 -125.36 1.41 Allowed Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.5 147.28 46.55 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.7 mtpt -86.26 -3.04 58.9 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -43.05 65.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.657 1.583 . . . . 0.0 107.089 172.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -80.52 -25.27 38.8 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.681 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.78 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 CA-C-N 119.079 0.854 . . . . 0.0 110.195 168.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -55.77 -39.35 71.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 126.02 1.728 . . . . 0.0 112.405 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.74 11.48 2.58 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.67 -31.9 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.7 m -79.0 -23.1 44.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.63 156.1 17.86 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -86.57 87.6 7.48 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.951 0.882 . . . . 0.0 109.306 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -141.06 -46.51 0.39 Allowed 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.73 58.52 1.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.43 151.88 9.54 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -107.42 157.83 34.68 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 140.0 32.18 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.766 2.31 . . . . 0.0 106.248 160.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -139.82 118.1 12.04 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -103.91 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 108.989 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -151.87 102.76 2.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 1.9 p-10 66.24 18.1 10.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 129.516 3.126 . . . . 0.0 114.582 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.0 mt -107.35 158.73 16.93 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 100.407 -3.923 . . . . 0.0 100.407 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -146.11 119.29 8.88 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.104 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.53 145.51 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 92.5 p -93.71 149.45 21.22 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -102.46 -8.31 21.2 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.7 t -106.69 85.75 2.21 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.0 m -57.35 126.43 27.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 125.566 1.546 . . . . 0.0 110.501 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.71 159.69 15.41 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -72.8 135.88 45.32 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 170.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.73 147.92 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -165.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.3 m -134.95 107.22 7.22 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 103.474 -2.788 . . . . 0.0 103.474 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.4 m -86.43 105.62 16.88 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.1 m -99.42 116.77 32.33 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -116.97 130.31 56.61 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.3 tp -74.02 118.03 16.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 124.916 1.286 . . . . 0.0 108.716 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.35 115.5 27.59 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 158.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.76 94.03 1.78 Allowed Glycine 0 CA--C 1.482 -2.011 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -167.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.89 49.86 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 166.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 t -163.51 110.74 0.98 Allowed Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -80.08 -16.31 11.2 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 110.411 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.03 168.08 9.54 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.44 145.54 30.09 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.06 1.84 . . . . 0.0 108.13 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -81.76 163.81 76.62 Favored 'Cis proline' 0 N--CA 1.436 -1.872 0 CA-C-N 122.228 1.831 . . . . 0.0 107.923 -4.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -106.09 174.47 5.87 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -133.58 115.35 14.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -104.17 149.47 25.23 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -100.97 147.35 26.27 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 160.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.11 126.41 52.78 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -107.63 108.46 19.74 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.88 141.8 34.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.2 -175.46 30.17 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -157.69 99.68 1.73 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.905 -2.998 . . . . 0.0 102.905 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -161.61 173.78 14.27 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.81 0.814 . . . . 0.0 109.846 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -78.3 151.38 33.0 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.406 1.482 . . . . 0.0 111.148 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.96 159.18 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.12 96.26 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 165.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.79 132.35 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.51 122.58 32.14 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.42 142.29 30.22 Favored 'General case' 0 CA--C 1.488 -1.43 0 O-C-N 124.603 1.189 . . . . 0.0 110.153 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.09 129.42 18.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 167.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.337 11.2 p30 67.54 15.24 9.77 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 128.1 2.56 . . . . 0.0 115.287 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.22 62.08 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 0.9 OUTLIER -113.92 138.41 22.78 Favored Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -70.34 111.55 2.95 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 N-CA-C 107.048 -1.943 . . . . 0.0 107.048 166.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.46 -14.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 119.173 0.897 . . . . 0.0 110.077 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 38.6 t60 -155.06 178.52 10.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 8.9 tp -158.9 133.57 8.07 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.66 131.12 34.24 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -106.06 41.06 1.47 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -97.01 -26.26 15.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -171.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.22 -33.99 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.706 0 C-N-CA 123.935 0.894 . . . . 0.0 109.215 176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.39 19.17 21.03 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -40.05 68.28 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 124.9 1.28 . . . . 0.0 108.593 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -72.06 137.53 81.96 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 N--CA 1.431 -2.177 0 N-CA-C 104.698 -2.847 . . . . 0.0 104.698 172.336 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 . . . . . 0 CA--C 1.486 -1.51 0 CA-C-O 120.696 0.284 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -123.19 49.15 1.71 Allowed 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -107.69 -5.3 17.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.4 m -90.21 -33.13 16.3 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -69.29 -35.46 76.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.199 1.0 . . . . 0.0 111.1 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.401 ' CE2' HD11 ' A' ' 10' ' ' LEU . 52.7 t80 -74.29 -46.09 43.43 Favored 'General case' 0 N--CA 1.398 -3.053 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 33.7 p -73.72 -17.87 61.06 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -84.42 -35.89 22.76 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 119.514 1.052 . . . . 0.0 109.42 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -56.69 -45.79 81.58 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.531 1.532 . . . . 0.0 108.519 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.471 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.2 OUTLIER -65.82 -29.91 70.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 126.854 2.062 . . . . 0.0 115.109 178.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.7 m -66.93 -52.58 41.3 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.0 pt20 -85.22 -5.05 59.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.49 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 88.8 m-70 -123.64 -55.59 1.72 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.762 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 13.6 t80 -71.29 123.86 23.24 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 120.583 1.538 . . . . 0.0 111.919 -169.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.88 97.11 3.12 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.19 -41.51 8.3 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -167.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -158.43 140.09 9.87 Favored Pre-proline 0 N--CA 1.434 -1.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 163.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -74.44 -178.86 4.28 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.651 2.234 . . . . 0.0 114.168 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -71.92 -64.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.21 -176.39 16.35 Favored Glycine 0 CA--C 1.476 -2.382 1 N-CA-C 102.343 -4.303 . . . . 0.0 102.343 164.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -109.38 75.53 0.95 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -145.5 176.42 9.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.17 -22.75 62.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 124.327 1.051 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -89.27 -17.21 29.45 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.08 -40.86 52.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.2 m -70.3 -33.28 71.35 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -68.06 -43.58 78.29 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.939 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.8 p -76.06 -23.88 55.09 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.274 12.5 tt -85.87 -28.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 119.081 0.855 . . . . 0.0 110.06 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.4 mmm -79.1 -24.05 43.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.621 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.485 HH12 ' HA ' ' A' ' 91' ' ' PRO . 14.7 tpt180 -74.53 -49.33 22.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 122.605 0.362 . . . . 0.0 111.694 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -86.44 -32.6 20.77 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.273 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -76.79 -33.84 58.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.89 71.23 1.29 Allowed Glycine 0 CA--C 1.478 -2.238 0 C-N-CA 124.987 1.279 . . . . 0.0 112.028 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.331 2.5 mm? -108.08 0.02 21.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 167.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -80.31 -3.78 50.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.005 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -129.42 108.16 17.51 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.66 153.77 98.76 Favored 'Cis proline' 0 N--CA 1.443 -1.447 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 -22.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.2 m -62.77 123.27 18.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 125.483 1.513 . . . . 0.0 112.197 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -74.12 139.62 44.69 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.8 -41.52 44.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.644 0.778 . . . . 0.0 111.899 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 tt -154.6 134.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -154.52 167.23 30.78 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.0 m -128.89 127.27 41.48 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.91 127.53 39.72 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.273 4.9 mm -94.35 146.03 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 2.2 m-70 -139.8 127.77 22.19 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.06 -151.58 18.84 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.23 144.37 25.92 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.24 -22.0 45.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -70.54 -33.98 71.74 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 124.441 1.096 . . . . 0.0 110.532 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 p -76.68 -31.39 57.24 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 116.906 -1.521 . . . . 0.0 111.265 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -48.71 84.36 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-N 119.739 1.154 . . . . 0.0 110.996 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.29 -36.6 84.58 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.34 0.656 . . . . 0.0 111.657 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.78 4.91 10.56 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mm -75.94 -24.92 16.82 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.9 m -73.72 -24.59 59.94 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 122.124 -0.36 . . . . 0.0 111.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -79.68 164.8 23.46 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -93.2 0.0 56.99 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.429 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.57 -33.11 28.17 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 122.899 0.48 . . . . 0.0 110.848 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -134.73 7.31 3.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.08 -162.91 10.61 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 104.831 -3.307 . . . . 0.0 104.831 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.59 158.25 27.32 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -74.02 135.36 20.97 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.761 2.307 . . . . 0.0 107.162 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -123.07 104.61 9.32 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 69.85 -97.13 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.846 1.659 . . . . 0.0 110.528 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.45 106.51 3.13 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.358 4.5 p30 75.76 2.81 3.77 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 129.725 3.21 . . . . 0.0 114.594 169.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 mt -104.43 158.91 16.15 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -142.97 116.15 8.94 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 tt -89.32 142.14 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -81.01 161.41 24.25 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.779 0.8 . . . . 0.0 112.454 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -110.2 -17.95 13.41 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.6 t -110.06 87.87 2.62 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -52.03 129.67 27.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.671 1.989 . . . . 0.0 111.608 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -106.02 157.37 17.56 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 5.0 tp60 -75.33 131.99 40.66 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 175.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.94 126.43 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 -165.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.7 m -119.21 110.18 16.72 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -83.13 105.17 13.89 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.81 114.63 23.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.81 136.46 53.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.44 127.67 32.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.42 1.088 . . . . 0.0 109.069 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.411 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 93.5 m-70 -119.47 171.69 8.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.61 -94.24 1.02 Allowed Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 105.939 -2.865 . . . . 0.0 105.939 -173.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.6 -6.97 1.26 Allowed Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 p -79.0 132.92 62.27 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -91.28 -9.22 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.922 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -109.76 155.58 41.24 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.95 146.19 29.12 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.369 2.046 . . . . 0.0 107.397 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.485 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.7 Cg_endo -85.99 163.4 56.19 Favored 'Cis proline' 0 N--CA 1.436 -1.899 0 CA-C-N 122.888 2.067 . . . . 0.0 108.521 12.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.8 m -150.99 126.24 9.97 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -85.81 129.23 34.89 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.93 133.24 56.17 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.411 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 81.8 mtp180 -111.72 137.51 49.52 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.74 140.55 31.17 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.157 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.7 m -123.34 110.3 15.0 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.62 155.85 23.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.549 0.69 . . . . 0.0 109.9 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.96 176.1 37.58 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 106.914 -2.474 . . . . 0.0 106.914 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -150.11 91.63 1.79 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 101.932 -3.358 . . . . 0.0 101.932 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -146.73 169.21 19.52 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -168.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.03 145.44 48.29 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.427 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.99 138.39 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.04 87.78 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.82 132.88 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.82 125.29 40.28 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.9 m -109.03 153.79 23.12 Favored 'General case' 0 CA--C 1.485 -1.533 0 O-C-N 124.414 1.071 . . . . 0.0 110.985 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.33 129.73 23.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 171.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 9.4 p30 68.16 12.44 8.77 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 13.15 60.1 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.64 144.89 52.69 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -68.84 150.94 74.15 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 121.858 1.705 . . . . 0.0 110.694 -175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.57 -14.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 51.1 t60 -158.07 174.91 14.5 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -169.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.1 128.68 6.28 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.35 137.2 38.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.67 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -105.41 42.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -91.92 -33.77 14.76 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 -29.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.896 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.298 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -109.64 32.72 4.82 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -169.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -86.08 -44.76 12.01 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 144.94 40.71 Favored Pre-proline 0 N--CA 1.427 -1.579 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.433 -2.076 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 -177.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.488 -1.437 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.34 62.96 0.61 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -100.17 -22.78 15.04 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -89.52 -7.43 54.96 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.924 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -72.75 -42.92 63.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -59.23 -48.23 82.4 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.409 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.465 2.9 t -89.86 10.75 22.53 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -78.16 -42.07 32.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.193 -1.567 . . . . 0.0 107.34 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.14 -35.18 76.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.037 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.15 -15.42 41.09 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 119.444 1.02 . . . . 0.0 113.399 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -65.8 -49.0 69.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 119.827 1.194 . . . . 0.0 108.703 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.59 -42.66 67.48 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -99.45 -51.42 3.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.695 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -77.07 116.39 17.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 119.278 0.945 . . . . 0.0 110.7 -167.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.12 100.35 4.69 Favored 'General case' 0 N--CA 1.421 -1.921 1 N-CA-C 98.538 -4.615 . . . . 0.0 98.538 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.35 -33.5 9.09 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -165.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -154.79 144.46 15.4 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 168.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 10.7 Cg_endo -74.41 154.72 45.71 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 122.979 2.453 . . . . 0.0 109.638 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.88 -60.84 2.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.05 178.28 16.95 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 103.304 -3.919 . . . . 0.0 103.304 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -123.74 57.91 1.17 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.34 177.75 8.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -172.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.71 -18.96 62.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.591 1.156 . . . . 0.0 113.736 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -82.5 -28.03 31.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -41.31 63.32 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.421 ' HA ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -81.2 -25.21 36.91 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.561 -171.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.87 -45.37 82.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -64.94 -41.13 95.78 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 HG21 ' HA ' ' A' ' 26' ' ' CYS . 10.3 tt -79.51 -29.58 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.141 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -26.22 58.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.468 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -77.53 -34.18 54.01 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 117.962 0.346 . . . . 0.0 110.866 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -73.75 -52.63 12.56 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.332 0.653 . . . . 0.0 111.639 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.4 HH21 HG13 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -68.01 -36.38 79.88 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 123.269 0.628 . . . . 0.0 111.561 178.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.05 71.65 1.31 Allowed Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.321 3.4 mm? -97.99 -8.87 27.09 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 164.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -81.0 1.64 30.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.623 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 p -119.22 98.82 50.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.741 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.3 163.16 90.53 Favored 'Cis proline' 0 N--CA 1.443 -1.493 0 N-CA-C 106.595 -2.117 . . . . 0.0 106.595 -27.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.3 m -64.85 121.82 15.5 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -166.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -70.51 140.68 51.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 126.622 1.969 . . . . 0.0 107.661 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -70.87 -46.97 61.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 123.725 0.81 . . . . 0.0 113.14 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 tt -149.64 129.61 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -154.84 137.44 15.15 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.2 m -101.5 137.02 40.38 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.953 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -100.43 119.96 39.27 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 167.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.92 150.31 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.484 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -142.59 139.74 31.45 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.286 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.8 -136.34 5.12 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.439 ' HB3' ' H ' ' A' ' 52' ' ' SER . 1.2 m120 -95.3 140.06 30.72 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.34 -21.01 29.09 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HB3' HD21 ' A' ' 49' ' ' ASN . 65.5 ttt180 -70.2 -36.38 74.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.368 1.867 . . . . 0.0 108.874 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.439 ' H ' ' HB3' ' A' ' 49' ' ' ASN . 39.5 m -72.5 -38.41 68.12 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.776 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.7 -48.47 85.83 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 CA-C-N 118.904 0.775 . . . . 0.0 111.402 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.06 -42.1 98.83 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.147 0.579 . . . . 0.0 111.473 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.24 7.59 5.0 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.0 mm -74.74 -32.33 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.2 t -71.88 -34.28 69.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.149 0.281 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.09 160.21 33.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.451 0.643 . . . . 0.0 110.032 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -75.96 -28.91 58.09 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.823 0.849 . . . . 0.0 109.389 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -77.12 124.65 28.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 44.2 t30 73.64 36.14 0.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 128.058 2.543 . . . . 0.0 112.679 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 148.88 5.58 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -98.36 152.09 37.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.45 131.35 18.73 Favored 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 122.858 2.372 . . . . 0.0 106.272 162.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -121.56 103.05 8.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HG3' ' H ' ' A' ' 67' ' ' GLU 0.338 14.5 ptp180 49.47 -107.33 0.24 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 128.077 2.551 . . . . 0.0 115.264 177.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 34.2 tt0 -103.74 77.53 1.48 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.516 1.126 . . . . 0.0 108.058 -167.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.317 1.6 p-10 62.25 26.65 15.98 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.45 3.1 . . . . 0.0 114.713 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.71 164.41 12.26 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -142.94 122.45 13.2 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.3 138.14 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -82.81 153.98 24.94 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 121.818 0.818 . . . . 0.0 112.655 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 -27.23 14.95 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.955 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 p -105.77 84.02 2.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.6 p -51.17 130.84 27.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.9 1.68 . . . . 0.0 111.152 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.59 163.92 12.66 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -165.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.7 mt-30 -75.68 141.94 42.62 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.38 145.37 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -169.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.0 m -134.8 103.92 5.81 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.2 m -87.34 106.37 17.89 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.0 m -99.74 128.25 45.85 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -118.8 138.41 52.72 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.69 116.73 14.63 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 125.703 1.601 . . . . 0.0 110.022 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.57 110.14 18.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.26 93.17 1.81 Allowed Glycine 0 CA--C 1.484 -1.858 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.08 -11.49 49.13 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 104.888 -3.285 . . . . 0.0 104.888 161.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -165.19 132.93 2.41 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -78.15 -25.38 7.3 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.319 2.012 . . . . 0.0 109.328 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -89.58 160.27 42.12 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.26 147.13 32.59 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.282 1.988 . . . . 0.0 108.132 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -82.98 165.69 69.64 Favored 'Cis proline' 0 N--CA 1.439 -1.7 0 CA-C-N 122.879 2.064 . . . . 0.0 108.932 5.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.3 m -145.15 125.96 14.34 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -169.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.75 131.75 36.0 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.74 120.63 42.17 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -88.32 117.93 27.57 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 137.69 35.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.883 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -120.32 106.66 12.09 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 170.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.38 149.95 30.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.108 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.04 -175.14 34.62 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -150.86 97.87 2.53 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.241 -3.615 . . . . 0.0 101.241 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -144.25 150.81 38.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -159.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -83.24 144.98 29.39 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.752 1.221 . . . . 0.0 109.165 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.98 153.37 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.46 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 162.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.4 m -91.29 134.97 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.36 133.4 36.65 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.33 134.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.168 0.918 . . . . 0.0 111.317 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -127.44 136.59 52.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.328 5.0 p30 73.54 4.41 4.77 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.891 2.077 . . . . 0.0 116.582 168.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.78 19.69 28.56 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.254 0.7 OUTLIER -136.86 133.09 18.61 Favored Pre-proline 0 CA--C 1.49 -1.357 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.98 113.47 3.8 Favored 'Trans proline' 0 N--CA 1.435 -1.944 0 N-CA-C 106.482 -2.161 . . . . 0.0 106.482 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -96.53 -7.38 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 49.7 t60 -159.0 177.5 11.07 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 -168.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -167.0 133.59 2.32 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 102.822 -3.029 . . . . 0.0 102.822 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -78.26 138.03 38.41 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.071 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -101.3 41.76 1.17 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -98.48 -32.22 11.58 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -36.91 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.771 170.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.39 34.1 3.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -97.18 -27.64 14.46 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 133.26 79.74 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 N--CA 1.434 -1.98 0 N-CA-C 105.287 -2.62 . . . . 0.0 105.287 177.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 CA--C 1.484 -1.57 0 CA-C-O 120.594 0.235 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -120.4 47.62 1.74 Allowed 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -109.61 -3.64 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 t -91.53 -27.52 18.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -68.4 -50.56 52.03 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.367 1.067 . . . . 0.0 111.836 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.269 76.9 t80 -53.07 -53.76 45.51 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.697 169.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -69.16 -15.95 63.52 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -83.77 -36.36 23.65 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.912 1.233 . . . . 0.0 110.267 173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.732 1.213 . . . . 0.0 109.915 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -79.53 -26.94 41.36 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.83 2.052 . . . . 0.0 112.239 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -68.4 -52.48 32.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.427 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 40.3 mt-30 -68.53 -42.27 78.7 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.427 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 85.8 m-70 -105.38 -41.67 5.45 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.343 -165.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 14.6 t80 -76.02 120.16 20.96 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 120.805 1.639 . . . . 0.0 111.731 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -140.8 99.72 3.68 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 100.82 -3.77 . . . . 0.0 100.82 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -40.92 11.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.423 2.289 . . . . 0.0 117.115 -167.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.42 144.89 14.55 Favored Pre-proline 0 N--CA 1.433 -1.297 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 83.0 Cg_exo -76.65 176.84 9.58 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.654 1.569 . . . . 0.0 113.787 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -73.93 -60.2 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 165.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -151.07 -175.01 22.54 Favored Glycine 0 CA--C 1.477 -2.287 0 N-CA-C 103.322 -3.911 . . . . 0.0 103.322 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.03 74.4 0.86 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.08 170.89 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.75 -22.21 61.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -169.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -79.75 -26.57 40.68 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.124 0.42 . . . . 0.0 110.214 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.89 -43.71 62.15 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.27 0.5 OUTLIER -80.57 -25.36 38.6 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 119.02 -1.072 . . . . 0.0 113.061 -169.794 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.19 -36.79 69.31 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.307 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -69.86 -35.19 74.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 26' ' ' CYS . 15.2 tt -83.15 -29.22 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.332 0 CA-C-N 118.338 0.517 . . . . 0.0 110.096 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.4 mmt -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.328 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.502 HH22 ' H ' ' A' ' 92' ' ' CYS . 17.4 tpp180 -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.013 0.925 . . . . 0.0 111.844 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -74.04 -49.05 25.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 123.865 0.866 . . . . 0.0 110.796 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -70.82 -37.89 73.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.199 1.0 . . . . 0.0 109.99 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.98 70.16 1.26 Allowed Glycine 0 CA--C 1.481 -2.061 0 C-N-CA 124.275 0.941 . . . . 0.0 111.266 168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.361 2.5 mm? -104.52 -2.41 25.27 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 163.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.1 t -78.32 -8.57 58.56 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.086 -159.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -131.92 107.37 13.94 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 117.925 -1.036 . . . . 0.0 108.724 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.88 156.66 95.74 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.162 -1.899 . . . . 0.0 107.162 -19.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.1 m -57.8 122.91 14.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.616 1.567 . . . . 0.0 110.454 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 135.87 45.63 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -72.73 -38.89 67.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.632 0.773 . . . . 0.0 112.385 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -146.89 132.51 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -149.57 128.69 12.75 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.381 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 m -101.66 116.18 32.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.656 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.62 122.33 30.38 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.94 148.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.412 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -138.35 128.6 25.89 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.996 1.318 . . . . 0.0 108.42 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.01 -130.83 2.1 Favored Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 51' ' ' ARG . 6.1 t30 -119.64 144.35 47.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.27 -2.75 58.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.031 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HB3' HD21 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -81.02 -30.08 34.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -75.11 -31.31 61.11 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.127 0.971 . . . . 0.0 110.342 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.12 -58.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 124.089 0.956 . . . . 0.0 110.245 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.14 -38.19 73.14 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.33 59.49 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 126.102 1.761 . . . . 0.0 113.83 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.55 -39.98 65.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 C-N-CA 125.484 1.513 . . . . 0.0 111.11 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.27 -21.06 29.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.58 53.12 0.7 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.943 0.401 . . . . 0.0 111.288 -171.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 79.44 -35.97 0.16 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.775 2.43 . . . . 0.0 115.023 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.59 154.98 38.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 26.96 55.7 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 129.377 3.071 . . . . 0.0 116.038 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.57 146.5 4.93 Favored Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -128.98 164.75 36.79 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.05 137.47 19.5 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.063 1.842 . . . . 0.0 107.816 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -106.74 161.03 15.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.214 -2.514 . . . . 0.0 104.214 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -70.81 150.99 45.28 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.285 0.634 . . . . 0.0 111.693 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 69.14 55.43 0.41 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.355 2.662 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.273 3.0 p-10 51.65 45.49 28.03 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.473 2.709 . . . . 0.0 114.095 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 mt -124.89 178.69 5.36 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 -171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -151.17 112.41 4.35 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -171.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.55 150.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.4 p -99.74 161.46 13.6 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.18 18.41 5.98 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 p -117.23 100.16 7.51 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.762 -3.792 . . . . 0.0 100.762 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 120.12 11.99 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.192 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -102.76 158.4 16.28 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.06 140.86 36.32 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.34 144.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -132.8 102.3 5.6 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 170.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -84.19 103.26 13.24 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 35.1 m -94.61 116.8 29.2 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -105.11 140.61 38.03 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.91 136.57 33.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -134.04 174.6 10.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.73 -101.39 0.72 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 106.092 -2.803 . . . . 0.0 106.092 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.15 -26.97 0.17 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.1 m -81.82 130.69 59.88 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -81.11 -25.37 4.06 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 121.968 1.779 . . . . 0.0 108.138 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -89.76 165.29 25.57 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.79 144.6 35.24 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 N-CA-C 107.584 -1.737 . . . . 0.0 107.584 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.484 ' HA ' HH12 ' A' ' 31' ' ' ARG . 48.7 Cg_endo -86.8 162.47 51.43 Favored 'Cis proline' 0 N--CA 1.435 -1.928 0 CA-C-N 122.457 1.913 . . . . 0.0 109.257 19.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.502 ' H ' HH22 ' A' ' 31' ' ' ARG . 46.2 m -119.07 158.09 26.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -172.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -135.79 93.09 2.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.05 123.62 34.08 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.932 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -102.05 125.57 48.77 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.86 135.87 33.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.181 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.0 m -123.51 113.51 18.83 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.93 145.52 29.35 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.241 0.543 . . . . 0.0 110.024 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.7 168.46 30.5 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 105.13 -3.188 . . . . 0.0 105.13 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.02 103.04 3.7 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.84 174.88 14.32 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.051 -171.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.55 135.48 50.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 124.536 1.134 . . . . 0.0 110.233 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.91 138.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.18 110.76 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.71 151.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.83 140.3 31.6 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 166.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.5 t -119.61 146.42 45.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 124.899 1.374 . . . . 0.0 111.41 -170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.42 122.14 11.88 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.35 6.2 p30 72.32 3.13 4.58 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 127.917 2.487 . . . . 0.0 115.838 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.2 38.18 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 108.426 -1.869 . . . . 0.0 108.426 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.47 117.12 23.04 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.19 120.97 5.54 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 CA-C-N 122.594 1.962 . . . . 0.0 107.9 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.97 -12.71 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 124.171 0.92 . . . . 0.0 111.712 -169.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.408 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.9 t60 -152.26 170.0 21.1 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -166.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 6.7 tp -140.44 136.14 32.73 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -84.12 134.16 34.6 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -110.59 40.23 2.03 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -99.25 -29.42 12.83 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -33.21 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.97 171.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -105.29 47.88 0.86 Allowed 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -128.37 -53.37 1.27 Allowed 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -127.38 115.17 21.4 Favored Pre-proline 0 N--CA 1.428 -1.551 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 N--CA 1.434 -2.019 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 -174.268 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 CA--C 1.486 -1.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -115.01 53.17 0.82 Allowed 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -113.39 2.56 15.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -90.5 -30.56 17.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -62.38 -51.2 68.53 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.463 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.416 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 45.5 t80 -53.9 -62.54 1.59 Allowed 'General case' 0 N--CA 1.404 -2.757 0 C-N-CA 127.103 2.161 . . . . 0.0 114.483 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.468 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 24.2 p -69.56 -16.39 63.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -81.81 -37.91 26.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 120.074 1.306 . . . . 0.0 110.02 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.85 -41.3 82.1 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.105 1.362 . . . . 0.0 109.902 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.402 0.0 OUTLIER -92.95 -6.37 48.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 118.084 0.402 . . . . 0.0 111.245 -173.25 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.7 m -73.47 -48.97 29.29 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.52 -1.363 . . . . 0.0 107.341 166.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -65.94 -41.9 90.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 126.291 1.836 . . . . 0.0 111.958 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.15 -50.28 3.2 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.562 -171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 53.9 t80 -77.88 120.98 23.52 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.585 1.538 . . . . 0.0 110.338 -168.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -139.25 94.25 2.78 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -35.5 -53.53 0.67 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 128.583 2.753 . . . . 0.0 118.338 -166.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -147.96 147.36 26.48 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 168.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -75.46 175.34 11.41 Favored 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 122.214 1.942 . . . . 0.0 113.322 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -76.05 -69.41 0.5 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.21 -176.89 14.6 Favored Glycine 0 CA--C 1.478 -2.252 1 N-CA-C 102.873 -4.091 . . . . 0.0 102.873 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -121.56 69.35 0.92 Allowed 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.63 174.65 11.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.42 -19.93 62.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.81 1.244 . . . . 0.0 113.3 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -81.31 -27.33 35.08 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.92 -34.62 51.26 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -34.03 54.93 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 123.327 0.651 . . . . 0.0 109.3 -170.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.02 -38.71 66.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.56 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -69.67 -30.82 68.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.267 14.2 tt -85.99 -27.38 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-N 118.504 0.593 . . . . 0.0 110.762 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.66 -29.41 64.58 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 118.628 -1.229 . . . . 0.0 110.066 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.63 HH22 ' H ' ' A' ' 92' ' ' CYS . 40.9 ttm-85 -81.43 -42.16 20.79 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -86.79 -28.0 23.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.44 -171.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -75.86 -36.08 59.68 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.63 72.0 1.23 Allowed Glycine 0 CA--C 1.473 -2.55 0 C-N-CA 125.164 1.364 . . . . 0.0 110.072 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.04 28.72 5.02 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 165.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -5.76 59.31 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.241 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.4 m -114.57 104.71 54.27 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.22 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 162.78 91.64 Favored 'Cis proline' 0 N--CA 1.44 -1.63 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 -24.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -70.3 114.35 8.35 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 123.677 0.791 . . . . 0.0 109.659 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -82.39 152.21 26.29 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.5 -74.38 0.1 Allowed 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.244 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -120.6 125.96 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -165.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -144.79 142.35 29.92 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.7 m -107.51 125.48 51.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.992 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.81 121.17 36.13 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.267 5.7 mm -93.63 147.64 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.81 133.07 35.53 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.97 -141.59 6.83 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 105.526 -3.029 . . . . 0.0 105.526 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -96.05 149.85 21.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.81 -18.74 27.06 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -71.31 -37.08 71.8 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -72.07 -38.33 69.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 117.375 -1.298 . . . . 0.0 111.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tp -65.54 -47.5 86.27 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 CA-C-N 119.242 0.928 . . . . 0.0 109.967 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.96 -39.37 91.9 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.661 1.584 . . . . 0.0 111.476 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.46 9.1 2.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.88 -44.04 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 165.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.3 m -99.64 42.93 1.08 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.87 24.1 3.94 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 40.38 61.98 1.45 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.5 3.12 . . . . 0.0 113.856 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -133.06 -35.39 1.05 Allowed 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -127.92 31.45 5.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -175.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.12 149.13 12.45 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.93 147.26 64.81 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.31 132.71 15.31 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.757 2.305 . . . . 0.0 107.919 -163.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -108.68 85.07 2.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 72.12 -101.53 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.935 1.694 . . . . 0.0 111.975 172.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -116.26 81.68 1.65 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -165.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 1.5 p-10 63.83 22.54 13.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 129.196 2.998 . . . . 0.0 114.534 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.1 164.54 11.73 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.756 -3.794 . . . . 0.0 100.756 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.31 113.95 4.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 117.3 -1.76 . . . . 0.0 109.171 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 tt -85.66 139.69 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -80.66 171.38 15.1 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 0.0 111.367 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.65 -9.3 10.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -127.19 96.49 4.61 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -48.15 127.76 13.0 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 127.614 2.365 . . . . 0.0 112.939 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.31 154.14 19.33 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.28 148.17 33.98 Favored 'General case' 0 CA--C 1.469 -2.152 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.88 144.37 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -168.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.3 m -135.99 101.91 4.87 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.2 m -86.25 111.99 20.95 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 69.0 m -88.72 116.15 26.77 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -111.75 142.6 43.9 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -75.86 121.64 22.93 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -130.95 64.77 1.57 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.5 -48.88 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 105.314 -3.115 . . . . 0.0 105.314 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.29 11.94 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -106.25 124.19 36.59 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -79.98 -27.31 3.88 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 121.56 1.593 . . . . 0.0 108.078 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -105.42 147.82 35.27 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 117.386 -1.293 . . . . 0.0 107.846 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.87 144.09 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.381 2.054 . . . . 0.0 107.09 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -82.32 161.1 77.5 Favored 'Cis proline' 0 CA--C 1.487 -1.853 0 CA-C-N 123.683 2.351 . . . . 0.0 110.697 10.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.63 ' H ' HH22 ' A' ' 31' ' ' ARG . 56.3 m -147.3 125.29 12.04 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.973 -166.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -84.55 129.34 34.86 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.23 120.05 36.52 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -97.69 127.76 43.88 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.52 127.25 33.57 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -113.25 100.09 8.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 172.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.87 130.51 35.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.93 -177.28 14.83 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -163.53 106.25 0.98 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.0 170.44 22.31 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.176 -172.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.23 131.75 44.69 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 124.195 0.998 . . . . 0.0 109.597 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.82 133.49 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.22 84.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.67 138.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.26 136.74 40.61 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.6 149.78 22.42 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 124.059 0.849 . . . . 0.0 111.458 -168.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -148.23 123.51 10.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.1 p30 64.41 18.69 11.47 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.571 2.349 . . . . 0.0 115.071 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.14 22.15 55.42 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 19.2 tp -132.24 130.21 21.9 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.37 109.23 2.28 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 123.49 2.282 . . . . 0.0 107.482 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.07 -12.42 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 O-C-N 123.731 0.644 . . . . 0.0 111.376 -171.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 59.1 t60 -143.55 176.55 9.12 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.64 131.26 2.99 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.81 125.19 28.27 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.48 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -94.04 12.65 25.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.209 1.004 . . . . 0.0 108.951 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -92.37 -6.42 50.16 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.58 0.752 . . . . 0.0 109.827 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.27 -25.05 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.29 -19.65 16.25 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.68 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -75.93 -44.06 41.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -78.87 143.19 61.65 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.432 -2.12 0 N-CA-C 105.566 -2.513 . . . . 0.0 105.566 173.82 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.537 ' H1 ' ' HB3' ' A' ' 4' ' ' SER . 4.1 mp0 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.33 64.72 0.16 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 126.658 1.983 . . . . 0.0 108.531 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 77.15 -3.81 2.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.624 2.369 . . . . 0.0 112.427 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.537 ' HB3' ' H1 ' ' A' ' 1' ' ' GLN . 20.5 t -93.36 -13.28 28.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -25.78 63.35 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.122 1.369 . . . . 0.0 110.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.13 -41.64 66.95 Favored 'General case' 0 N--CA 1.407 -2.606 0 C-N-CA 125.914 1.685 . . . . 0.0 108.94 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.0 -7.63 59.6 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -76.28 -47.23 24.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -57.36 -41.65 80.53 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 126.977 2.111 . . . . 0.0 110.632 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.399 0.1 OUTLIER -99.39 -5.29 29.79 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.457 -173.539 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.1 t -79.55 -38.86 33.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.727 1.603 . . . . 0.0 107.064 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.6 pt20 -82.98 -28.07 29.99 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.458 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 79.9 m-70 -103.65 -50.31 3.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 49.3 t80 -76.59 118.07 18.87 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 120.038 1.29 . . . . 0.0 110.837 -168.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -136.08 97.59 3.65 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.34 -42.09 4.37 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -166.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -160.08 134.9 5.53 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -73.76 -179.8 4.91 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 122.757 2.304 . . . . 0.0 114.012 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -74.86 -71.54 0.35 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.99 -177.48 14.9 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 103.343 -3.903 . . . . 0.0 103.343 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -121.64 72.51 1.02 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.98 177.99 7.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.61 -14.44 61.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -77.54 -33.96 53.99 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.63 -39.23 62.23 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.0 t -68.52 -43.08 77.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.0 111.81 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.1 -35.46 66.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.033 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -73.21 -30.17 63.33 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.87 -28.75 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-N 118.501 0.592 . . . . 0.0 109.528 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.8 mmt -70.33 -33.29 71.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.229 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -44.47 64.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.401 0.681 . . . . 0.0 111.406 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.44 -39.56 58.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -35.59 63.75 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.18 75.54 1.05 Allowed Glycine 0 CA--C 1.479 -2.217 0 C-N-CA 124.789 1.185 . . . . 0.0 111.274 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.354 2.6 mm? -104.86 -3.69 23.14 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -78.88 -5.1 52.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.792 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 m -119.66 103.27 46.47 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.583 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.59 164.06 88.95 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 CA-C-N 122.96 2.093 . . . . 0.0 107.054 -23.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.8 m -57.14 125.1 21.19 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.563 -171.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -76.86 141.6 40.55 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -77.18 -39.86 47.42 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.354 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.73 128.9 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -148.87 125.67 11.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -98.58 119.97 38.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.064 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.6 114.09 23.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.05 149.45 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.64 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -139.05 136.16 34.97 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 124.581 1.153 . . . . 0.0 108.063 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.09 -143.77 8.65 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.91 147.01 24.41 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -86.23 -12.81 48.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.32 -36.29 71.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.436 1.494 . . . . 0.0 109.338 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 p -81.19 -25.69 36.55 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.307 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -56.93 -50.99 73.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.297 0 CA-C-N 120.232 1.378 . . . . 0.0 110.356 166.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -62.61 -40.67 97.7 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 123.464 0.706 . . . . 0.0 112.212 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.03 29.9 0.62 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 122.958 0.503 . . . . 0.0 112.082 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.4 mm -87.64 -30.13 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 160.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.0 t -83.15 -57.16 3.39 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.399 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.89 107.44 19.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -168.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 56.25 -87.51 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.575 2.75 . . . . 0.0 116.792 163.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.27 145.13 55.47 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.222 1.409 . . . . 0.0 107.839 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.331 6.8 p-10 43.83 39.4 2.57 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 130.873 3.669 . . . . 0.0 117.473 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.58 134.8 2.27 Favored Glycine 0 CA--C 1.489 -1.542 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 168.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -122.62 162.88 36.02 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -164.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 149.13 34.24 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.653 2.236 . . . . 0.0 108.491 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -148.28 116.82 6.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -168.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 66.68 -111.44 0.17 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.211 1.404 . . . . 0.0 110.792 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -136.16 95.21 3.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.359 2.2 p-10 64.98 23.13 12.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 129.161 2.985 . . . . 0.0 114.587 172.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -106.76 163.32 13.02 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 167.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -142.41 124.73 15.56 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.09 144.75 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 97.7 p -83.33 158.0 22.36 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 121.748 0.785 . . . . 0.0 110.686 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -117.18 -5.06 11.37 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -116.5 88.94 3.0 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -55.69 128.8 36.48 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.058 1.743 . . . . 0.0 110.954 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -108.32 158.71 17.25 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 5.6 mt-30 -76.89 146.31 37.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.48 146.85 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -131.8 101.95 5.67 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 164.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -79.24 103.75 9.38 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 32.2 m -90.11 112.09 23.44 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -121.5 140.21 52.48 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 25.9 tp -79.3 120.32 23.59 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -135.28 56.28 1.85 Allowed 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.54 -86.56 1.81 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 106.272 -2.731 . . . . 0.0 106.272 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.66 -16.67 3.31 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 m -85.41 134.02 41.18 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -79.67 -27.56 3.97 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.848 1.698 . . . . 0.0 108.209 170.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -97.7 163.36 19.74 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.263 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.54 144.13 35.47 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 122.268 1.979 . . . . 0.0 107.431 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -83.07 163.15 72.95 Favored 'Cis proline' 0 CA--C 1.489 -1.775 0 CA-C-N 123.164 2.166 . . . . 0.0 109.936 9.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.57 122.59 36.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -88.93 113.06 24.05 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.18 126.11 51.82 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -89.89 126.28 35.66 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 131.16 35.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.0 m -119.66 90.83 3.41 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.547 -2.761 . . . . 0.0 103.547 172.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.53 130.01 36.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.51 -165.67 10.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -157.51 101.09 1.83 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.442 -3.911 . . . . 0.0 100.442 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -138.19 149.32 45.71 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -165.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -77.3 134.21 38.59 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.596 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.23 153.37 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.08 115.94 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 102.01 -3.329 . . . . 0.0 102.01 161.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.43 161.44 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -106.03 144.7 32.38 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 163.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.6 t -123.33 138.83 54.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.527 1.142 . . . . 0.0 110.068 -170.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -127.43 132.99 49.99 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.308 5.6 p30 73.74 6.32 4.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.93 20.33 21.58 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.76 144.94 18.24 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -71.12 154.63 62.18 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 122.417 1.899 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.25 -17.38 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -149.81 166.93 27.99 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -164.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -127.64 130.66 49.33 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.9 120.1 24.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 21.57 17.19 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -173.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -90.57 -16.1 29.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.697 -174.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.09 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.26 -11.0 31.08 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.609 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -78.42 -35.11 47.46 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -78.4 139.47 59.71 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.432 -2.104 0 N-CA-C 106.047 -2.328 . . . . 0.0 106.047 -179.202 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 CA--C 1.485 -1.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -123.11 42.21 3.26 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.28 -8.65 19.15 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.0 p -91.64 -17.05 26.11 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -76.44 -32.84 58.68 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 123.353 0.661 . . . . 0.0 110.457 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -68.01 -37.94 82.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.65 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -74.68 -19.19 60.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -72.3 -45.57 59.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.98 0.809 . . . . 0.0 108.86 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -56.69 -40.49 75.68 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.176 1.79 . . . . 0.0 111.27 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.415 0.2 OUTLIER -96.88 -2.52 43.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 118.44 0.564 . . . . 0.0 111.732 -173.328 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.6 m -76.63 -42.97 40.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -68.75 -46.49 68.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.873 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -102.68 -41.33 6.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 118.448 -0.786 . . . . 0.0 111.173 -167.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 39.4 t80 -80.84 117.09 21.18 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.558 1.527 . . . . 0.0 111.124 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.07 96.29 3.48 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 100.958 -3.719 . . . . 0.0 100.958 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.27 6.12 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 127.937 2.495 . . . . 0.0 117.573 -165.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -151.69 138.82 12.23 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -74.71 179.55 5.87 Favored 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 122.824 2.35 . . . . 0.0 113.834 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.3 -70.19 0.38 Allowed 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.74 -175.35 13.96 Favored Glycine 0 CA--C 1.477 -2.332 1 N-CA-C 101.995 -4.442 . . . . 0.0 101.995 163.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -116.1 72.57 0.81 Allowed 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.32 -179.7 6.15 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.488 -170.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.55 -39.34 87.58 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 127.457 2.303 . . . . 0.0 111.836 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -83.72 -16.02 46.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 110.775 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -77.73 -40.48 41.0 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 m -69.51 -34.68 74.64 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 123.485 0.491 . . . . 0.0 111.98 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.05 -37.71 72.52 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.409 0.443 . . . . 0.0 110.04 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -70.74 -31.08 67.78 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.275 14.5 tt -86.25 -27.84 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.067 0.394 . . . . 0.0 111.713 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.76 -19.56 48.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.552 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -75.79 -42.09 51.04 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 118.781 0.719 . . . . 0.0 109.425 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -75.73 -48.42 21.96 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.865 0.866 . . . . 0.0 111.505 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.87 -27.96 44.12 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.97 65.61 1.59 Allowed Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.91 22.48 14.85 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 165.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -89.37 -12.27 40.89 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -129.83 105.95 16.88 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.4 160.17 96.25 Favored 'Cis proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 -19.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.7 m -61.1 121.67 13.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.443 1.097 . . . . 0.0 110.258 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -73.65 133.52 43.45 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -72.83 -42.31 63.93 Favored 'General case' 0 CA--C 1.491 -1.316 0 O-C-N 123.766 0.666 . . . . 0.0 112.456 -169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 tt -154.49 126.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -154.77 129.31 9.17 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -94.86 125.14 39.32 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.32 120.67 33.87 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 167.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -98.08 148.59 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -135.51 133.4 38.42 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.352 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.93 -140.59 6.39 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 104.451 -3.459 . . . . 0.0 104.451 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -105.11 148.38 26.9 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 168.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -87.43 0.48 55.44 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.186 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.36 -34.98 58.91 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 167.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -77.22 -33.26 56.22 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.458 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mm -59.26 -50.03 81.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 124.335 1.054 . . . . 0.0 110.386 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -61.33 -33.83 74.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.171 0.988 . . . . 0.0 113.275 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 7.38 8.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 mm -84.83 -21.29 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.3 t -80.16 -19.46 47.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 122.064 -0.398 . . . . 0.0 110.736 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.64 142.9 51.59 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 165.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.42 -7.43 59.58 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.742 0.817 . . . . 0.0 112.699 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -81.26 -41.77 21.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.11 15.58 16.04 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -167.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.25 112.45 0.4 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 172.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -96.01 152.15 38.75 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.44 118.46 5.61 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 122.635 2.224 . . . . 0.0 106.373 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.647 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 15.8 p-80 -91.13 119.97 31.69 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 61.84 -96.67 0.06 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.784 1.634 . . . . 0.0 112.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -122.28 82.02 1.91 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -171.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 0.7 OUTLIER 65.88 11.75 7.88 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 129.192 2.997 . . . . 0.0 117.826 160.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.9 OUTLIER -102.84 148.33 25.77 Favored 'General case' 0 CA--C 1.476 -1.887 1 N-CA-C 99.0 -4.445 . . . . 0.0 99.0 174.372 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -124.44 118.48 26.76 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -158.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.6 tt -95.61 137.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.5 p -80.34 164.25 23.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.626 0.727 . . . . 0.0 111.914 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.06 -11.78 8.83 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -103.69 83.33 2.12 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.8 m -47.52 124.81 7.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 127.126 2.17 . . . . 0.0 112.048 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.68 158.08 16.5 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -78.96 143.36 35.84 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.13 141.23 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -167.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.8 m -129.62 105.77 8.28 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -81.66 100.11 9.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 99.9 m -86.84 112.33 21.63 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -111.35 143.09 42.7 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.16 109.72 17.42 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -94.5 158.68 15.44 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.2 -91.13 1.48 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.71 39.65 0.46 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.3 p -92.9 120.63 67.0 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.43 -8.64 4.49 Favored 'Trans proline' 0 N--CA 1.438 -1.781 0 CA-C-N 121.618 1.614 . . . . 0.0 108.036 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -110.6 161.84 23.07 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.04 146.14 36.52 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.454 2.102 . . . . 0.0 107.684 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.79 164.25 67.63 Favored 'Cis proline' 0 N--CA 1.435 -1.925 0 CA-C-N 122.073 1.776 . . . . 0.0 107.934 3.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.54 159.78 21.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -117.02 129.12 55.81 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -124.24 124.3 42.14 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -100.65 127.85 46.9 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.48 130.98 35.92 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.027 0.442 . . . . 0.0 109.964 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -119.1 89.55 3.15 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.49 136.85 33.25 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.104 0.478 . . . . 0.0 109.907 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.19 179.26 18.82 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -143.56 101.21 3.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -160.82 175.05 12.99 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -70.56 145.88 50.5 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 124.811 1.244 . . . . 0.0 111.539 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.37 147.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.586 HG13 ' HE1' ' A' ' 65' ' ' HIS . 56.0 t -110.25 94.19 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 165.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 m -96.5 133.17 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.96 132.01 43.18 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.05 134.96 52.24 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 124.548 1.155 . . . . 0.0 111.289 -166.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.74 135.23 45.62 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 10.2 p30 68.87 12.6 8.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.395 2.278 . . . . 0.0 116.411 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.93 19.51 46.92 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.2 19.86 Favored Pre-proline 0 CA--C 1.491 -1.32 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.06 113.21 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.59 -6.98 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.7 t60 -155.04 174.83 14.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -168.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.429 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -165.98 131.58 2.45 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.94 141.58 35.9 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.529 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -103.84 44.28 1.03 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -95.2 -34.41 12.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -33.84 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 C-N-CA 125.143 1.377 . . . . 0.0 109.498 172.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -106.92 30.63 5.98 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -85.91 -63.58 1.3 Allowed 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.74 151.71 54.1 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 170.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.433 -2.076 0 N-CA-C 105.065 -2.706 . . . . 0.0 105.065 175.76 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.487 -1.474 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -127.46 84.03 2.22 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 80.83 2.61 1.72 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 127.833 2.453 . . . . 0.0 111.133 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -91.59 -7.06 51.23 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 124.356 1.062 . . . . 0.0 109.13 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -43.15 62.59 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -59.67 -50.84 72.28 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-O 117.523 -1.227 . . . . 0.0 112.309 173.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.433 3.4 t -87.16 9.04 21.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -76.68 -44.67 32.8 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 119.958 -1.713 . . . . 0.0 107.916 156.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.2 -31.86 70.55 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.597 1.159 . . . . 0.0 111.462 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.31 -23.77 23.35 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.691 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -71.03 -35.65 72.08 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 120.102 1.319 . . . . 0.0 109.82 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -69.29 -63.62 1.03 Allowed 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.924 168.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -88.8 -49.11 7.03 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -162.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -76.44 118.19 18.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.991 1.723 . . . . 0.0 110.14 -171.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -137.31 98.29 3.68 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.67 -34.71 0.4 Allowed 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 119.942 3.312 . . . . 0.0 119.942 -165.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -150.13 156.62 37.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 16.8 Cg_endo -72.18 149.76 52.37 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 123.246 2.631 . . . . 0.0 108.964 170.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -84.06 -50.91 7.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 166.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.38 -179.01 16.04 Favored Glycine 0 CA--C 1.48 -2.115 0 N-CA-C 103.621 -3.792 . . . . 0.0 103.621 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -126.6 53.03 1.69 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -141.07 -179.26 5.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.67 -38.59 72.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 128.437 2.695 . . . . 0.0 112.734 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -79.23 -23.93 43.41 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 124.129 0.971 . . . . 0.0 111.025 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -76.65 -38.94 53.75 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.3 m -69.81 -35.94 75.23 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 123.613 0.571 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.88 -35.7 64.72 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 t -70.51 -32.59 70.13 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 122.78 0.432 . . . . 0.0 111.998 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.295 10.5 tt -82.69 -30.83 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.077 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.15 -18.72 52.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.216 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -74.42 -37.15 63.41 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 119.062 0.846 . . . . 0.0 111.296 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -51.67 14.97 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.806 0.443 . . . . 0.0 110.107 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.91 -36.74 67.33 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.736 0.814 . . . . 0.0 110.646 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.98 67.02 1.57 Allowed Glycine 0 CA--C 1.479 -2.173 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.1 mt -114.46 22.88 13.27 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 164.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -99.06 2.56 46.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -146.54 103.85 3.98 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 159.05 94.83 Favored 'Cis proline' 0 N--CA 1.447 -1.246 0 CA-C-N 122.127 1.795 . . . . 0.0 107.636 -16.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.3 m -61.83 124.88 21.98 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 123.974 0.796 . . . . 0.0 110.148 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -77.95 132.28 37.8 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 171.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.17 -42.32 69.24 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.048 0.842 . . . . 0.0 112.455 -165.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.68 126.47 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -145.61 126.33 14.31 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.408 ' HG1' HE22 ' A' ' 117' ' ' GLN . 18.3 m -95.24 118.64 32.37 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.739 -174.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.54 115.47 28.07 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.2 mm -92.13 146.13 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.522 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.3 m-70 -134.58 138.44 44.58 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.0 -153.46 24.71 Favored Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.34 138.56 34.48 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.62 -9.08 57.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -37.33 73.51 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.6 m -76.34 -30.81 57.78 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.288 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -57.28 11.83 Favored 'Isoleucine or valine' 0 C--N 1.363 1.161 0 CA-C-N 119.558 1.072 . . . . 0.0 110.377 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HZ1' ' HB2' ' A' ' 54' ' ' LYS . 3.5 ttmp? -68.12 -38.43 82.22 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.09 1.314 . . . . 0.0 110.958 -172.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.66 -0.15 22.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.869 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.286 0.6 OUTLIER -79.57 -24.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.296 0 C-N-CA 116.532 -2.067 . . . . 0.0 110.113 170.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 92.8 m -98.8 34.88 1.97 Allowed 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.39 0.995 . . . . 0.0 111.074 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -118.35 21.72 12.51 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.273 13.5 p-10 26.23 46.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.551 1 C-N-CA 132.021 4.128 . . . . 0.0 116.122 -167.122 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.49 -19.37 14.42 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -127.22 28.97 5.65 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.77 161.67 31.36 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -122.56 148.41 52.92 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-O 116.092 -1.909 . . . . 0.0 106.021 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -69.92 154.82 66.69 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.767 2.311 . . . . 0.0 111.806 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -125.57 57.8 1.33 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.27 15.7 tpp180 81.56 -100.31 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.152 2.181 . . . . 0.0 113.044 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.34 78.03 1.34 Allowed 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 124.049 0.94 . . . . 0.0 109.318 -166.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.336 1.3 p-10 74.33 8.68 4.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 129.291 3.037 . . . . 0.0 113.749 169.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.17 158.78 16.07 Favored 'General case' 0 CA--C 1.466 -2.252 1 N-CA-C 98.794 -4.521 . . . . 0.0 98.794 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.469 HH22 HG21 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -152.09 138.19 18.26 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -174.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.19 136.64 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.0 p -84.38 163.2 19.69 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.39 0.614 . . . . 0.0 110.696 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -126.7 -0.97 6.74 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.0 t -101.33 92.49 4.97 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 162.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.1 m -58.33 126.58 28.13 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.28 1.432 . . . . 0.0 110.373 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -107.85 161.0 15.31 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 4.4 mt-30 -79.88 151.4 30.2 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.98 146.36 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -168.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.0 m -135.19 103.51 5.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 165.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.8 m -84.31 101.62 12.08 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.7 m -85.72 113.75 22.15 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -122.66 135.77 54.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.271 19.3 mt -65.4 118.28 9.15 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.106 0.479 . . . . 0.0 110.621 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -88.54 126.81 35.44 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 169.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.18 -84.86 0.38 Allowed Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 106.519 -2.633 . . . . 0.0 106.519 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.98 37.86 1.09 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.7 t -86.9 123.91 69.73 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.92 3.63 3.0 Favored 'Trans proline' 0 N--CA 1.437 -1.837 0 CA-C-N 122.192 1.818 . . . . 0.0 108.492 -171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.35 160.71 38.53 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.19 146.17 31.67 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.73 1.62 . . . . 0.0 108.215 -171.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -82.74 161.71 75.41 Favored 'Cis proline' 0 N--CA 1.437 -1.834 0 CA-C-N 122.656 1.984 . . . . 0.0 109.482 7.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 m -119.95 111.81 18.4 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -85.76 122.4 29.79 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -121.11 111.21 17.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -85.75 129.75 34.74 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.11 127.35 32.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.7 m -114.6 92.59 4.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.14 29.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.024 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.7 -172.83 18.92 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -156.4 106.34 2.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.49 25.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.803 0.811 . . . . 0.0 109.97 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 129.38 34.49 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.053 1.341 . . . . 0.0 109.429 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.4 m -89.41 143.1 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.163 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.32 97.46 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 HH22 ' A' ' 70' ' ' ARG . 25.6 m -105.58 138.38 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.67 134.55 39.78 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.3 m -106.53 153.35 22.44 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.612 1.195 . . . . 0.0 110.135 -171.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -151.07 128.55 11.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.86 -2.645 . . . . 0.0 103.86 167.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.329 12.9 p30 66.02 17.55 10.81 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.216 2.607 . . . . 0.0 115.672 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.55 0.87 62.45 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.54 139.82 21.18 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.03 114.83 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 N-CA-C 105.224 -2.644 . . . . 0.0 105.224 164.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 m -100.32 -10.77 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 80.9 t60 -158.53 175.65 13.4 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -165.67 125.23 1.72 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.53 130.77 34.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.408 HE22 ' HG1' ' A' ' 44' ' ' THR . 1.0 OUTLIER -99.96 43.16 1.07 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.4 p -95.04 -18.01 21.4 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pt -97.03 -19.04 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.94 48.47 0.89 Allowed 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 106.014 -1.846 . . . . 0.0 106.014 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -116.33 -3.56 11.93 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.87 138.0 69.63 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.434 -1.974 0 C-N-CA 122.613 2.209 . . . . 0.0 106.542 -164.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 CA--C 1.487 -1.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -114.61 53.68 0.8 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 169.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -111.66 0.01 16.2 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 t -93.08 -24.99 18.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 171.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -68.59 -37.94 80.24 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.167 1.387 . . . . 0.0 109.383 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 42.9 t80 -50.32 -60.65 2.77 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 127.642 2.377 . . . . 0.0 114.191 166.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.28 -16.58 64.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -70.84 -51.34 27.13 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.531 1.059 . . . . 0.0 109.063 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.09 -34.34 70.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 126.95 2.1 . . . . 0.0 111.555 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.43 0.0 OUTLIER -98.53 -8.91 25.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 118.698 0.681 . . . . 0.0 110.441 -171.774 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -76.52 -45.07 32.39 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 168.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -45.65 86.57 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.987 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -106.15 -49.02 3.45 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-O 118.547 -0.739 . . . . 0.0 111.782 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 60.5 t80 -76.48 121.9 23.78 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 120.136 1.335 . . . . 0.0 110.05 -167.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.72 97.17 3.2 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 102.063 -3.31 . . . . 0.0 102.063 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.29 -43.5 1.15 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 128.594 2.758 . . . . 0.0 118.291 -168.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.09 148.77 17.98 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 165.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -74.14 168.95 23.56 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 121.63 1.553 . . . . 0.0 112.443 -176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.96 -67.02 0.57 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.59 -178.46 15.44 Favored Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 102.159 -4.376 . . . . 0.0 102.159 163.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -113.3 72.91 0.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.14 175.76 11.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.08 -24.87 63.3 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.707 1.203 . . . . 0.0 113.176 -171.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -86.85 -18.31 31.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -41.53 62.26 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.29 0.5 OUTLIER -76.95 -26.51 54.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.167 -1.413 . . . . 0.0 113.605 -173.978 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.56 -39.33 81.08 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.293 170.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -66.88 -38.04 85.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 26' ' ' CYS . 20.2 tt -80.95 -27.09 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 117.851 0.296 . . . . 0.0 110.504 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -24.58 55.73 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.186 -1.006 . . . . 0.0 112.03 174.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -75.63 -34.54 60.56 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 118.608 0.64 . . . . 0.0 111.82 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -76.99 -46.17 24.82 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 118.27 0.486 . . . . 0.0 111.769 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.28 -34.44 65.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 72.59 1.19 Allowed Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.6 mt -113.25 20.14 16.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -89.01 -7.11 56.59 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.7 m -125.65 100.86 30.87 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.553 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.52 167.48 80.19 Favored 'Cis proline' 0 N--CA 1.445 -1.359 0 N-CA-C 107.066 -1.936 . . . . 0.0 107.066 -22.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 m -60.02 126.65 28.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 124.031 0.932 . . . . 0.0 111.034 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.29 139.43 46.11 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.95 -51.94 16.45 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 123.581 0.551 . . . . 0.0 110.091 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 tt -147.83 135.58 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -152.26 130.1 11.69 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.2 m -97.21 120.52 37.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.186 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -90.62 126.46 35.97 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.262 5.9 mm -89.95 148.94 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 3.2 m-70 -138.49 139.25 38.71 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.61 -114.32 0.6 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 106.479 -2.648 . . . . 0.0 106.479 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -134.08 134.73 42.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.04 3.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.674 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -84.79 -28.29 26.26 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.1 m -84.62 -25.29 28.67 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -71.19 -41.94 75.28 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -61.77 -52.36 64.56 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.949 0.899 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.6 3.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.747 1.219 . . . . 0.0 113.399 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 tp -76.93 -33.92 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.2 m -94.23 9.67 37.09 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -166.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -104.44 23.11 13.74 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.79 0.805 . . . . 0.0 110.737 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.4 m120 42.63 38.04 1.18 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 130.81 3.644 . . . . 0.0 114.002 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.49 -35.24 7.95 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -120.98 26.15 9.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 149.97 17.99 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 119.178 -1.486 . . . . 0.0 110.729 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -100.46 125.36 39.51 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-O 116.529 -1.7 . . . . 0.0 107.934 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.8 141.62 34.08 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.648 2.899 . . . . 0.0 108.167 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -123.76 80.39 1.8 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 65.76 -99.49 0.06 Allowed 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 126.479 1.911 . . . . 0.0 114.516 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.42 72.39 1.41 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -164.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.309 2.6 p-10 57.31 30.6 18.76 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 129.495 3.118 . . . . 0.0 114.832 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.0 161.36 20.34 Favored 'General case' 0 CA--C 1.47 -2.101 1 N-CA-C 98.677 -4.564 . . . . 0.0 98.677 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.594 HH12 HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -156.82 148.55 22.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -171.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -114.31 126.07 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 p -69.07 160.4 31.08 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -117.54 -18.75 9.67 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.143 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 t -103.44 84.02 2.25 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.2 p -52.18 136.47 30.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.179 2.192 . . . . 0.0 112.701 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.82 163.58 14.87 Favored 'General case' 0 CA--C 1.473 -2.011 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -168.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 5.6 mt-30 -78.33 148.26 33.85 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -145.66 146.32 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -167.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.6 m -138.5 104.84 5.25 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 m -90.17 99.8 12.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.8 m -92.49 123.57 35.89 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -115.16 146.36 41.45 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.468 1.107 . . . . 0.0 108.584 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -94.2 156.52 16.5 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.82 -79.6 0.34 Allowed Glycine 0 CA--C 1.486 -1.776 0 N-CA-C 106.036 -2.826 . . . . 0.0 106.036 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.06 27.39 6.6 Favored Glycine 0 CA--C 1.488 -1.644 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -89.38 127.28 55.55 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 171.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -80.14 -20.63 8.49 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 CA-C-N 122.686 1.995 . . . . 0.0 108.849 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -101.21 163.62 17.59 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.94 144.58 34.62 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 N-CA-C 107.516 -1.763 . . . . 0.0 107.516 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -84.08 163.19 67.82 Favored 'Cis proline' 0 CA--C 1.489 -1.746 0 CA-C-N 123.174 2.169 . . . . 0.0 110.423 13.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 m -126.24 117.31 22.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.77 83.97 1.85 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.648 1.213 . . . . 0.0 108.067 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -70.0 130.66 42.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -97.18 120.52 37.68 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.53 135.73 33.71 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -115.31 98.97 7.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.85 141.72 35.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.96 -163.01 13.91 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -162.38 108.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -146.26 151.12 37.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -167.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -75.21 135.16 41.04 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -96.31 136.79 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.725 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.46 ' H ' HD13 ' A' ' 119' ' ' ILE . 89.3 t -91.81 105.74 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 164.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.594 HG22 HH12 ' A' ' 70' ' ' ARG . 16.2 m -117.06 155.68 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.29 133.3 53.22 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.3 m -102.67 153.95 19.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 124.717 1.261 . . . . 0.0 111.295 -170.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -147.85 123.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 167.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.0 p30 69.63 15.76 8.11 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.307 2.243 . . . . 0.0 115.069 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.83 55.64 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.417 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 7.6 tp -128.56 133.48 25.23 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -77.33 118.56 4.68 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 CA-C-N 124.181 2.529 . . . . 0.0 106.381 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.79 -11.34 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 O-C-N 123.635 0.584 . . . . 0.0 109.802 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -145.26 152.05 39.34 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.74 127.35 55.31 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 117.53 30.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -100.75 37.93 1.63 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -166.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.2 p -87.39 -20.83 26.13 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 121.747 -0.596 . . . . 0.0 109.411 -174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -86.15 -23.5 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.105 0 C-N-CA 123.87 0.868 . . . . 0.0 109.579 173.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -106.97 54.26 0.68 Allowed 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -164.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 62.57 77.69 0.32 Allowed 'General case' 0 CA--C 1.485 -1.52 0 C-N-CA 129.057 2.943 . . . . 0.0 109.523 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -57.71 125.72 73.71 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.515 171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 N--CA 1.433 -2.069 0 N-CA-C 105.633 -2.487 . . . . 0.0 105.633 177.517 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 . . . . . 0 CA--C 1.486 -1.514 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -110.77 62.6 0.61 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -94.8 -15.99 23.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -87.92 -17.09 32.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.533 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -73.28 -41.79 63.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CG ' ' HG ' ' A' ' 111' ' ' LEU . 2.4 t80 -64.53 -48.02 76.67 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.836 173.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -79.78 -10.41 59.78 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 120.304 1.411 . . . . 0.0 114.506 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -82.82 -30.56 28.66 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 119.093 0.86 . . . . 0.0 108.81 171.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' CD2' HD13 ' A' ' 10' ' ' LEU . 3.3 t80 -60.25 -34.94 74.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.492 0.717 . . . . 0.0 109.986 165.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD13 ' CD2' ' A' ' 9' ' ' PHE . 10.8 mp -81.03 -23.3 38.7 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.9 p -75.11 -30.65 60.91 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 120.495 1.498 . . . . 0.0 110.881 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -72.74 -55.16 7.17 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -95.66 -54.04 3.5 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.708 -162.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 23.4 t80 -78.45 112.2 15.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.926 1.239 . . . . 0.0 109.977 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.43 94.07 3.58 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 101.445 -3.539 . . . . 0.0 101.445 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.9 -38.02 0.89 Allowed 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 120.141 3.386 . . . . 0.0 120.141 -162.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.7 154.38 47.92 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.9 Cg_endo -75.0 163.16 35.89 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 123.613 2.875 . . . . 0.0 109.883 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -75.16 -71.39 0.36 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 166.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.91 178.42 16.44 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.459 -3.856 . . . . 0.0 103.459 164.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -114.68 70.61 0.74 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.68 174.98 14.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.72 -16.75 62.81 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.814 1.246 . . . . 0.0 113.535 -170.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -81.75 -28.83 33.12 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -76.99 -34.3 57.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -33.57 42.07 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -169.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.58 -46.27 80.09 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 124.631 1.172 . . . . 0.0 109.34 170.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.1 t -64.33 -36.75 85.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.9 tt -83.08 -28.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 CA-C-N 118.023 0.374 . . . . 0.0 111.21 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.0 mmt -73.28 -23.88 60.35 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.117 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -82.6 -29.32 30.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 118.903 0.774 . . . . 0.0 112.58 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -80.74 -37.35 30.68 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.402 0.546 . . . . 0.0 111.122 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -22.67 55.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.671 0.388 . . . . 0.0 110.306 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.3 5.66 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.62 16.55 19.66 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -91.1 -11.71 37.79 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 m -126.42 102.9 26.0 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.74 161.48 94.12 Favored 'Cis proline' 0 N--CA 1.443 -1.494 0 N-CA-C 106.865 -2.013 . . . . 0.0 106.865 -20.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 m -62.12 120.62 11.23 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.96 0.904 . . . . 0.0 110.339 -175.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -72.0 138.9 48.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.32 -40.98 57.87 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 123.557 0.536 . . . . 0.0 111.338 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.15 128.25 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -148.39 127.14 12.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 170.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.463 ' HG1' HG21 ' A' ' 80' ' ' THR . 28.1 m -97.48 123.84 41.49 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.085 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -94.6 113.23 25.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.8 mm -87.37 145.34 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.53 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.498 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 8.9 m-70 -133.8 133.62 41.88 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.61 -147.12 12.43 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.313 -2.315 . . . . 0.0 107.313 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.423 HD21 ' HD3' ' A' ' 51' ' ' ARG . 4.5 m120 -94.92 149.04 21.67 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.07 -17.85 34.01 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HD3' HD21 ' A' ' 49' ' ' ASN . 9.0 mpt_? -68.85 -40.84 79.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.439 1.896 . . . . 0.0 106.565 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.1 m -70.21 -41.95 72.97 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 116.645 -1.645 . . . . 0.0 111.665 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.1 mm -53.97 -58.18 4.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 124.368 1.067 . . . . 0.0 111.478 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.03 -42.55 90.48 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.062 1.345 . . . . 0.0 111.489 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.65 4.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mm -77.59 -31.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.2 m -94.58 7.68 44.84 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.624 0.249 . . . . 0.0 111.502 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -91.09 173.26 8.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 158.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -85.55 1.8 47.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.344 0.658 . . . . 0.0 111.555 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -77.52 -60.01 2.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.243 0.617 . . . . 0.0 111.32 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -89.34 -49.51 6.67 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.55 147.81 18.65 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -168.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.71 156.66 35.27 Favored Pre-proline 0 N--CA 1.434 -1.262 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -73.92 125.44 9.9 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 122.663 2.242 . . . . 0.0 107.629 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -117.71 123.35 45.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 66.46 -107.2 0.11 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.912 1.285 . . . . 0.0 112.124 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.75 95.61 2.88 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.333 2.2 p-10 60.31 35.55 20.71 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 128.666 2.786 . . . . 0.0 113.602 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -117.67 165.69 13.3 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 101.31 -3.589 . . . . 0.0 101.31 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.8 mtt85 -145.14 127.59 15.96 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -95.58 134.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -81.84 160.21 23.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.351 0.596 . . . . 0.0 111.054 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.97 -1.87 9.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -106.37 77.26 1.2 Allowed 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -59.69 138.06 57.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 125.898 1.679 . . . . 0.0 111.912 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -113.43 158.85 20.13 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -166.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 8.7 mt-30 -79.89 138.9 37.26 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.22 105.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -171.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.0 m -97.98 106.31 18.58 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.463 HG21 ' HG1' ' A' ' 44' ' ' THR . 25.4 m -87.39 112.19 21.88 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -89.38 116.29 27.47 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -121.47 142.33 50.15 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.2 tp -80.36 110.54 15.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -93.13 155.02 17.74 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.91 -89.79 1.52 Allowed Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.33 38.41 0.59 Allowed Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -80.15 126.08 80.14 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -84.88 -19.96 3.79 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 122.165 1.809 . . . . 0.0 108.314 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -110.47 160.66 27.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 117.618 -1.182 . . . . 0.0 107.962 -168.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -73.25 142.04 33.17 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 C-N-CA 122.695 2.263 . . . . 0.0 106.767 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -82.04 159.47 79.43 Favored 'Cis proline' 0 N--CA 1.435 -1.944 0 CA-C-N 123.027 2.117 . . . . 0.0 108.949 4.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.6 m -109.52 170.27 8.17 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -125.48 109.92 13.29 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -105.84 113.98 27.86 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -89.04 125.61 35.08 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.72 125.69 29.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 m -106.53 87.22 2.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.75 129.21 34.4 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.08 -167.13 14.4 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -157.32 114.26 3.01 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -155.14 156.18 35.29 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -168.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.57 139.58 42.19 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.61 172.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.22 147.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.08 94.7 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 165.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 m -91.6 136.11 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.5 m -107.03 142.62 36.38 Favored 'General case' 0 CA--C 1.485 -1.556 0 O-C-N 124.42 1.075 . . . . 0.0 110.577 -172.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -150.77 130.49 13.17 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.322 14.8 p30 64.37 20.44 12.17 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 115.553 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.77 -3.07 70.54 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HG ' ' CG ' ' A' ' 6' ' ' TYR 0.261 0.3 OUTLIER -102.73 142.42 24.53 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 176.789 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.72 109.85 2.93 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 N-CA-C 105.386 -2.582 . . . . 0.0 105.386 160.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.473 HG21 ' CD2' ' A' ' 114' ' ' HIS . 2.8 m -85.98 -22.58 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.623 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.473 ' CD2' HG21 ' A' ' 113' ' ' VAL . 54.6 m-70 -156.37 -163.4 1.45 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 132.88 1.06 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.54 127.29 32.76 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -97.55 16.94 18.9 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 m -91.84 -20.85 21.03 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 118.765 0.711 . . . . 0.0 110.376 -165.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -26.71 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 C-N-CA 123.672 0.789 . . . . 0.0 109.03 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -98.55 -4.01 35.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -91.42 -66.91 0.89 Allowed 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -113.1 112.65 49.72 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.433 -2.054 0 N-CA-C 105.338 -2.601 . . . . 0.0 105.338 177.362 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -120.07 43.06 2.78 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -110.32 -4.12 15.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -90.05 -27.02 19.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -71.65 -41.66 68.5 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.177 0.591 . . . . 0.0 109.437 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -55.0 -56.81 15.59 Favored 'General case' 0 N--CA 1.398 -3.032 0 C-N-CA 126.158 1.783 . . . . 0.0 113.957 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -78.72 -6.16 55.08 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -86.28 -35.63 19.82 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 120.582 1.537 . . . . 0.0 108.496 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -41.34 87.69 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.547 1.139 . . . . 0.0 109.416 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.392 0.0 OUTLIER -97.34 0.02 47.22 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 118.267 0.485 . . . . 0.0 111.168 -174.027 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -71.22 -53.91 12.75 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 161.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.12 -40.58 94.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 124.053 0.846 . . . . 0.0 112.94 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -121.25 4.86 10.29 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.245 -162.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 30.7 t80 -110.29 130.0 55.63 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 120.173 1.351 . . . . 0.0 109.438 167.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.82 104.6 3.33 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 164.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.88 -43.38 4.05 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 118.321 2.712 . . . . 0.0 118.321 -164.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -142.24 156.49 64.4 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -71.04 147.28 54.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.584 2.856 . . . . 0.0 108.838 172.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -80.02 -53.51 6.66 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.04 -178.38 15.57 Favored Glycine 0 CA--C 1.48 -2.125 0 N-CA-C 103.331 -3.908 . . . . 0.0 103.331 164.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.11 48.01 2.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.95 179.33 6.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.896 -168.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.68 -41.52 77.47 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.707 2.403 . . . . 0.0 112.926 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -81.63 -18.93 42.96 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.865 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -74.29 -44.59 52.09 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.3 m -68.66 -36.93 79.2 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 124.238 0.961 . . . . 0.0 112.869 -175.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.57 -41.87 75.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 123.371 0.42 . . . . 0.0 110.275 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.9 m -73.06 -23.17 60.53 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.827 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.429 HD13 HH21 ' A' ' 33' ' ' ARG 0.288 9.9 tt -85.74 -36.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 119.77 1.168 . . . . 0.0 110.965 -179.483 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.1 mmm -72.05 -30.77 65.49 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.19 -39.32 55.04 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.53 -48.56 26.27 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.407 -170.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.429 HH21 HD13 ' A' ' 29' ' ' ILE . 11.1 ptp180 -79.66 -23.77 42.29 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.152 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.37 61.95 1.52 Allowed Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 161.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.69 15.3 5.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 t -84.33 8.83 14.79 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.705 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.6 m -113.18 106.27 54.88 Favored Pre-proline 0 N--CA 1.428 -1.575 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.368 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.7 162.24 93.09 Favored 'Cis proline' 0 N--CA 1.443 -1.474 0 CA-C-N 123.401 2.25 . . . . 0.0 107.262 -22.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.28 117.48 7.9 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.58 1.152 . . . . 0.0 111.819 -168.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -73.93 137.15 43.42 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -75.09 -35.19 61.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.371 1.044 . . . . 0.0 112.629 -168.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.21 130.63 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -154.1 119.4 5.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -102.88 120.59 40.89 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.647 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.39 116.29 26.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.04 149.03 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.51 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m-70 -131.6 132.92 44.45 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.641 -172.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.85 -116.56 0.72 Allowed Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -133.5 140.69 47.38 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -88.36 -0.75 57.51 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -79.62 -31.06 41.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -78.16 -28.51 48.34 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.674 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.16 -41.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 CA-C-N 119.142 0.883 . . . . 0.0 110.609 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -58.96 -43.31 91.3 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.744 1.217 . . . . 0.0 111.122 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.94 13.6 1.35 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.1 mm -83.11 -22.88 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.6 m -84.55 -11.03 56.85 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.62 166.61 15.24 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.26 -17.06 47.28 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -81.33 -30.49 33.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -130.4 37.86 3.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.73 128.25 1.04 Allowed Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -104.89 156.05 36.61 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.04 122.17 6.57 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 122.496 2.131 . . . . 0.0 107.036 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -106.23 127.82 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 63.46 -105.2 0.15 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.415 1.486 . . . . 0.0 112.058 170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -139.75 97.77 3.33 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.341 1.9 p-10 64.37 26.72 13.62 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 129.033 2.933 . . . . 0.0 114.343 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.18 167.83 9.73 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.51 115.55 8.82 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.1 tt -96.61 139.89 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.8 p -81.32 164.86 21.88 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.591 0.71 . . . . 0.0 111.833 -173.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -115.13 -12.68 11.88 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -116.86 90.65 3.38 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -49.9 132.92 22.71 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.543 2.337 . . . . 0.0 113.656 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.11 157.64 19.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -81.05 149.14 29.36 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.71 141.62 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -166.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.9 m -134.3 104.93 6.37 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.4 m -85.67 104.05 15.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 70.2 m -83.32 114.74 21.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -111.34 142.29 43.77 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -93.43 136.67 33.47 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 95.0 m-70 -140.83 172.6 12.46 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.39 -91.22 0.6 Allowed Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.62 -11.33 1.12 Allowed Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -78.46 134.86 61.53 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -80.35 -30.35 2.07 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.682 1.588 . . . . 0.0 108.093 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -97.14 154.88 37.99 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.44 -168.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.57 150.19 27.73 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 122.292 1.995 . . . . 0.0 107.429 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -81.7 165.04 74.67 Favored 'Cis proline' 0 CA--C 1.49 -1.707 0 CA-C-N 123.028 2.117 . . . . 0.0 109.462 7.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.7 m -149.84 141.49 23.55 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -167.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.73 141.33 30.63 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -134.35 110.01 9.17 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 3.8 mpt_? -91.16 132.71 35.9 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.76 130.49 35.38 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.618 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -113.9 95.63 5.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.78 141.7 34.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.41 -173.8 23.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -160.62 107.97 1.55 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.33 164.04 39.3 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.247 -173.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.81 123.78 28.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.718 1.207 . . . . 0.0 108.745 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -96.02 139.61 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.664 -163.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.6 t -96.36 112.06 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.276 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -105.06 148.13 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 170.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.24 36.61 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.95 151.15 24.96 Favored 'General case' 0 CA--C 1.494 -1.209 0 O-C-N 124.237 0.96 . . . . 0.0 110.636 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -148.76 128.74 13.51 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.346 8.2 p30 70.77 7.85 6.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.592 2.357 . . . . 0.0 115.557 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.37 2.79 57.73 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.263 5.5 tp -113.99 154.72 45.99 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -72.0 159.35 50.45 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.054 1.836 . . . . 0.0 108.263 163.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -138.27 -20.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.493 175.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.435 ' CD2' HG21 ' A' ' 113' ' ' VAL . 41.1 m-70 -149.86 177.71 9.57 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -126.74 136.07 51.94 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.52 118.73 28.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.08 40.26 1.36 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -173.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.0 m -96.76 -28.32 14.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 pt -91.47 -20.78 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -97.83 -9.67 26.04 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -71.76 -37.03 70.58 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -73.24 129.72 85.6 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 N--CA 1.434 -1.986 0 N-CA-C 106.158 -2.285 . . . . 0.0 106.158 -171.163 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 . . . . . 0 CA--C 1.488 -1.44 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.02 61.86 0.66 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -88.61 -28.27 20.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.31 -6.63 49.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -33.46 44.39 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.68 -50.25 67.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.055 1.342 . . . . 0.0 109.0 173.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.484 1.7 t -88.06 10.85 17.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -80.49 -40.78 25.51 Favored 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 119.974 -1.704 . . . . 0.0 107.836 157.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.95 -40.25 80.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.117 1.367 . . . . 0.0 109.588 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 18.0 mt -83.28 -15.65 49.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.3 m -65.86 -47.71 74.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-N 120.465 1.484 . . . . 0.0 109.224 169.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 12.4 tt0 -77.83 -40.3 40.77 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 124.212 1.005 . . . . 0.0 111.187 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.511 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 80.1 m-70 -96.17 -54.92 3.13 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 118.482 0.583 . . . . 0.0 110.377 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 50.5 t80 -77.66 118.77 20.37 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.982 0.896 . . . . 0.0 110.382 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.07 98.11 3.79 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.45 -41.24 6.12 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 -165.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -156.26 139.27 10.8 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 164.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -85.54 170.96 8.85 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.876 1.717 . . . . 0.0 108.663 -169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -73.25 -79.77 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -177.03 20.05 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 103.494 -3.842 . . . . 0.0 103.494 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -127.38 70.87 1.32 Allowed 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -147.46 -178.76 6.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -66.21 -26.2 67.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.824 1.249 . . . . 0.0 113.777 -171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -81.25 -27.08 35.33 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 122.599 0.36 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -72.11 -42.72 65.77 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' HA ' HG21 ' A' ' 29' ' ' ILE 0.259 0.1 OUTLIER -81.25 -24.99 36.97 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 119.081 -1.048 . . . . 0.0 113.371 -170.064 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.06 -36.6 66.91 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.467 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -69.62 -34.19 73.73 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' A' ' 26' ' ' CYS . 19.3 tt -85.19 -24.75 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 CA-C-N 118.308 0.504 . . . . 0.0 110.579 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -31.09 63.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.588 172.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -73.75 -36.63 65.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -81.54 -41.91 20.95 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -77.63 -21.15 52.7 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.233 0.469 . . . . 0.0 111.904 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.67 50.69 1.94 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.344 4.0 mm? -108.09 -14.65 14.68 Favored 'General case' 0 CA--C 1.48 -1.749 0 C-N-CA 124.216 1.006 . . . . 0.0 108.636 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 t -74.6 -15.34 60.84 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.897 1.679 . . . . 0.0 112.735 -163.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -121.84 108.3 35.0 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.78 156.22 99.69 Favored 'Cis proline' 0 N--CA 1.441 -1.594 0 N-CA-C 106.722 -2.068 . . . . 0.0 106.722 -25.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.1 m -59.9 127.91 34.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 125.518 1.527 . . . . 0.0 112.026 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -80.3 140.27 36.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -77.06 -37.62 54.25 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.774 -168.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.56 129.7 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -152.38 130.0 11.53 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 170.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -97.64 128.72 44.55 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.893 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -94.83 118.04 31.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -87.14 148.07 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 3.4 m-70 -142.86 130.09 20.93 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.719 -176.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 -129.98 1.84 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 106.579 -2.609 . . . . 0.0 106.579 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -115.36 145.08 42.86 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.01 -18.83 29.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.02 0.438 . . . . 0.0 109.907 -170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -80.26 -24.64 39.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -71.07 -40.65 71.49 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 117.312 -1.328 . . . . 0.0 110.076 172.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.19 -53.87 34.31 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 C-N-CA 124.844 1.258 . . . . 0.0 111.165 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.56 -43.26 89.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.189 1.396 . . . . 0.0 111.517 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.24 8.41 9.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mm -75.37 -27.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.5 t -72.85 -29.03 62.88 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 117.564 0.165 . . . . 0.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.34 153.72 42.13 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.03 8.76 33.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.666 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.04 -50.86 7.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -110.76 -3.88 15.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.684 -166.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.31 -159.12 7.99 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 103.894 -3.682 . . . . 0.0 103.894 168.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -162.26 152.95 14.54 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -73.5 137.89 26.09 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.995 2.463 . . . . 0.0 107.503 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -129.61 122.78 29.77 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? 67.94 -100.26 0.05 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 125.181 1.393 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -162.57 108.8 1.22 Allowed 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.412 0.5 OUTLIER 86.71 -6.66 0.71 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 129.857 3.263 . . . . 0.0 114.145 173.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.8 156.82 17.27 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -141.75 115.72 9.28 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.26 141.95 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -84.47 162.71 19.81 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.63 0.729 . . . . 0.0 112.181 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.89 -27.28 9.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 m -103.03 79.78 1.79 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -47.4 133.81 12.29 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 128.336 2.654 . . . . 0.0 113.502 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -112.3 158.73 19.41 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -167.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 4.9 tp60 -79.92 125.19 29.42 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.11 103.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.9 m -90.6 107.77 19.38 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -87.41 105.59 17.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.1 m -97.4 114.49 26.32 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -114.76 136.85 52.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.86 118.66 10.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.832 1.653 . . . . 0.0 107.824 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -136.39 97.5 3.6 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.32 -42.61 0.07 OUTLIER Glycine 0 CA--C 1.48 -2.136 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.72 6.18 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 m -112.13 109.92 54.17 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -85.2 -20.46 3.38 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 121.769 1.668 . . . . 0.0 108.51 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -112.1 159.46 33.62 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -169.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -75.11 145.36 30.98 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.563 2.176 . . . . 0.0 107.929 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -81.91 162.68 77.74 Favored 'Cis proline' 0 N--CA 1.436 -1.91 0 CA-C-N 122.437 1.906 . . . . 0.0 107.969 -1.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.0 m -108.45 166.03 11.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -171.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -122.27 116.75 24.64 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.76 133.02 54.98 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -99.47 117.06 33.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 165.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.39 131.68 34.66 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 m -123.31 107.83 12.09 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.45 135.01 36.55 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.898 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.72 -174.89 13.57 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 106.09 -2.804 . . . . 0.0 106.09 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.48 106.18 1.9 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -156.88 168.92 26.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -78.1 132.67 37.79 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.569 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.46 138.89 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.391 -170.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.9 t -101.22 96.13 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.24 136.65 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.58 143.54 30.07 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.8 t -136.42 137.02 40.03 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.178 0.513 . . . . 0.0 110.624 -170.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -128.23 131.73 48.8 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.306 14.1 p30 64.47 21.19 12.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 117.106 2.262 . . . . 0.0 117.106 171.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.56 53.73 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tp -144.63 118.49 5.69 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -172.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -71.51 118.29 5.58 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 CA-C-N 121.817 1.685 . . . . 0.0 111.416 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -26.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 118.816 0.735 . . . . 0.0 112.664 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -149.3 -166.2 2.49 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.1 133.56 4.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.65 141.02 34.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.509 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -105.16 42.09 1.27 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.0 m -95.87 -29.07 14.4 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -32.67 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 124.981 1.312 . . . . 0.0 109.475 170.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -105.61 41.45 1.38 Allowed 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.36 -37.23 20.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -82.94 150.35 61.53 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.432 -2.128 0 N-CA-C 104.202 -3.038 . . . . 0.0 104.202 162.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 . . . . . 0 CA--C 1.486 -1.511 0 CA-C-O 120.902 0.382 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.56 48.18 2.09 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -109.59 -2.46 17.52 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t -93.59 -28.12 16.21 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 167.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -34.46 63.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.084 0.954 . . . . 0.0 108.803 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -46.46 -60.32 2.42 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 127.053 2.141 . . . . 0.0 111.796 162.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 p -72.73 -12.56 61.06 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -76.62 -41.91 44.22 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.799 1.181 . . . . 0.0 109.824 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -63.03 -36.27 83.0 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.995 1.718 . . . . 0.0 109.342 171.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -73.67 -26.7 60.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.034 1.333 . . . . 0.0 114.493 177.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 79.8 m -69.81 -51.31 34.81 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.572 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.4 pt20 -84.82 -10.25 57.36 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.572 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 83.7 m-70 -138.03 2.67 2.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 36.2 t80 -107.07 132.34 53.09 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 120.52 1.509 . . . . 0.0 108.834 171.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.33 104.36 3.09 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 167.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -37.92 16.77 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -162.14 138.13 5.8 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 86.0 Cg_exo -74.01 173.58 13.83 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.274 1.983 . . . . 0.0 114.465 -172.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.78 -73.87 0.24 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.98 -175.82 15.29 Favored Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 167.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.2 69.29 1.21 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.36 -176.96 5.68 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.45 -21.95 61.89 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.324 1.05 . . . . 0.0 113.366 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -81.95 -23.44 36.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -77.55 -37.55 50.48 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.0 m -69.46 -37.09 77.17 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -77.12 -30.71 55.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 119.456 -0.307 . . . . 0.0 110.339 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -70.33 -35.27 73.51 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.0 tt -85.96 -25.97 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 120.605 0.241 . . . . 0.0 110.89 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 mmt -76.49 -31.21 57.61 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.79 -0.569 . . . . 0.0 109.777 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -69.57 -38.64 77.48 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.159 0.984 . . . . 0.0 112.172 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -71.11 -52.04 21.59 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.465 1.106 . . . . 0.0 110.865 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.24 -26.28 39.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.145 0.578 . . . . 0.0 109.543 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.65 63.24 1.29 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 164.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.16 23.35 1.86 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.684 1.231 . . . . 0.0 108.335 174.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -84.23 -9.48 58.48 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.532 1.933 . . . . 0.0 109.696 167.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.9 t -120.22 107.77 39.0 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.82 165.45 84.87 Favored 'Cis proline' 0 N--CA 1.448 -1.184 0 CA-C-N 122.593 1.962 . . . . 0.0 107.557 -18.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.9 m -61.38 120.51 10.59 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.798 0.839 . . . . 0.0 110.757 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -79.4 144.12 34.42 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -75.19 -40.2 59.56 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 123.097 0.559 . . . . 0.0 111.762 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.26 133.76 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.8 121.09 4.85 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -102.35 115.47 30.63 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.004 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.0 120.25 26.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -101.81 146.71 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 2.1 m-70 -132.49 127.92 36.26 Favored 'General case' 0 CA--C 1.485 -1.521 0 C-N-CA 124.672 1.189 . . . . 0.0 108.574 -172.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.72 -143.85 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 105.374 -3.09 . . . . 0.0 105.374 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -95.27 148.61 22.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -88.69 -17.96 28.88 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -69.55 -36.01 75.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.9 t -74.61 -36.13 62.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 117.335 -1.317 . . . . 0.0 111.006 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 tp -64.85 -46.52 91.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.301 0 CA-C-N 119.542 1.065 . . . . 0.0 111.047 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -61.54 -41.88 97.99 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.747 1.219 . . . . 0.0 111.243 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.62 2.39 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.5 mm -74.48 -36.32 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.8 m -85.81 -31.49 22.28 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -102.07 57.31 0.81 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 117.796 0.271 . . . . 0.0 111.242 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 34.81 65.48 0.35 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 130.174 3.389 . . . . 0.0 115.54 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.94 -58.76 0.96 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -99.51 -44.43 6.17 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 154.58 21.55 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.588 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.27 154.16 42.3 Favored Pre-proline 0 N--CA 1.434 -1.247 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.75 137.31 22.16 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.984 2.456 . . . . 0.0 107.105 -175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.5 73.49 1.19 Allowed 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 69.49 -101.28 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 126.325 1.85 . . . . 0.0 113.551 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.96 77.21 1.23 Allowed 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 123.935 0.894 . . . . 0.0 108.759 -163.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.319 6.4 p30 71.92 11.56 6.18 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 129.421 3.089 . . . . 0.0 114.222 170.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.24 157.33 16.86 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -140.11 119.33 12.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -88.76 143.35 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.3 p -83.85 169.01 15.58 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -134.63 3.79 3.3 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.4 m -105.39 79.55 1.48 Allowed 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -53.24 128.43 28.03 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 127.506 2.322 . . . . 0.0 112.18 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -108.86 158.96 17.17 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -170.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 8.5 mt-30 -77.57 145.35 36.92 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.88 142.06 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -171.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.9 m -134.5 102.51 5.34 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 102.097 -3.298 . . . . 0.0 102.097 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 106.79 14.29 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.9 m -89.24 113.04 24.22 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -124.61 136.78 54.23 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -169.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.3 tp -78.64 123.63 27.33 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -138.06 52.65 1.84 Allowed 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.95 -88.2 2.01 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.66 -16.79 4.01 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -83.92 136.62 41.3 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -81.17 -23.4 5.28 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 121.83 1.687 . . . . 0.0 108.422 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -105.33 164.46 15.04 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -74.26 143.7 32.1 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 107.035 -1.948 . . . . 0.0 107.035 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -82.9 160.97 75.3 Favored 'Cis proline' 0 N--CA 1.435 -1.913 0 CA-C-N 123.062 2.129 . . . . 0.0 109.583 7.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.1 m -125.24 138.68 54.11 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -173.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.61 99.73 11.81 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -94.16 111.83 23.59 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -87.65 124.99 34.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.94 125.8 29.85 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.4 m -110.19 87.26 2.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.18 131.17 34.83 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -172.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.58 -162.35 9.2 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.049 -2.021 . . . . 0.0 108.049 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -155.21 102.32 2.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -137.91 155.62 48.73 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -158.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -74.36 127.82 33.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.54 131.55 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -92.47 113.22 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.443 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.14 141.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 173.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.416 ' HB2' ' HB2' ' A' ' 114' ' ' HIS . . . -92.24 127.69 37.81 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.7 m -108.65 151.66 25.85 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 121.836 0.827 . . . . 0.0 112.004 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.33 127.15 14.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 15.3 p30 60.01 25.38 14.6 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 128.054 2.542 . . . . 0.0 115.422 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.18 20.71 60.18 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.87 138.59 19.98 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.62 117.77 1.77 Allowed 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 121.535 1.584 . . . . 0.0 108.947 -170.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.428 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -93.83 -23.08 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 123.572 0.545 . . . . 0.0 112.246 -176.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.428 ' CD2' HG21 ' A' ' 113' ' ' VAL . 55.9 m-70 -143.0 -177.73 5.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -170.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.4 tp -139.07 143.09 38.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 123.98 33.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -112.17 11.7 20.35 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 t -90.79 -32.43 16.11 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -25.52 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 C-N-CA 124.304 1.042 . . . . 0.0 110.749 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -100.44 25.16 7.97 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -84.3 -73.61 0.42 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.33 122.36 63.22 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 174.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.437 -1.851 0 C-N-CA 122.431 2.087 . . . . 0.0 107.443 -168.281 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 . . . . . 0 CA--C 1.489 -1.393 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -145.96 89.73 1.91 Allowed 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 82.65 6.25 0.92 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 127.452 2.301 . . . . 0.0 108.018 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.7 -30.21 16.42 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 164.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -49.19 77.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 125.726 1.61 . . . . 0.0 109.549 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -51.27 -62.85 1.37 Allowed 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 127.443 2.297 . . . . 0.0 113.542 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -70.86 -10.09 58.9 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -83.33 -39.5 20.68 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.597 1.09 . . . . 0.0 109.566 171.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -60.12 -37.88 81.35 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 109.617 168.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.455 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -74.03 -31.41 62.89 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 125.849 1.66 . . . . 0.0 113.576 178.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 p -75.26 -39.24 60.02 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 120.702 1.592 . . . . 0.0 110.646 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.36 -56.95 7.61 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 123.609 0.568 . . . . 0.0 111.253 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -89.67 -48.71 7.1 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.69 -167.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 24.5 t80 -70.68 119.46 14.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.955 1.252 . . . . 0.0 110.608 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -137.6 97.78 3.53 Favored 'General case' 0 N--CA 1.424 -1.77 1 N-CA-C 99.673 -4.195 . . . . 0.0 99.673 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.56 -41.69 10.17 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.502 2.321 . . . . 0.0 117.225 -166.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -159.57 131.09 3.98 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 168.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -70.91 180.0 3.88 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 123.146 2.564 . . . . 0.0 114.946 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.87 -77.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.76 -1.564 . . . . 0.0 106.949 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.06 -173.38 14.37 Favored Glycine 0 CA--C 1.478 -2.233 1 N-CA-C 102.284 -4.326 . . . . 0.0 102.284 162.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.29 72.29 0.86 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -143.91 179.71 7.01 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.52 -41.71 73.5 Favored 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 127.926 2.491 . . . . 0.0 112.931 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -79.21 -21.13 46.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.027 0.531 . . . . 0.0 111.904 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.4 -41.77 55.34 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.5 m -68.37 -37.21 80.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.755 0.659 . . . . 0.0 112.143 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.61 -37.92 70.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.805 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.8 m -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 13.2 tt -81.72 -29.76 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 CA-C-N 118.197 0.453 . . . . 0.0 109.87 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -25.58 51.7 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.943 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -75.92 -33.22 59.86 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.295 0.498 . . . . 0.0 111.109 173.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.17 -48.92 21.27 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.134 0.573 . . . . 0.0 110.833 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -78.41 -26.74 46.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 110.528 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.14 55.24 2.0 Favored Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 mt -116.12 13.77 15.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.56 -12.67 53.67 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.064 0.546 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 m -121.12 102.25 43.75 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.13 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 167.82 79.22 Favored 'Cis proline' 0 N--CA 1.445 -1.334 0 N-CA-C 107.049 -1.943 . . . . 0.0 107.049 -22.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.0 m -59.47 122.21 13.44 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.865 0.866 . . . . 0.0 111.331 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.44 143.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.65 -37.22 31.36 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 119.769 -0.158 . . . . 0.0 110.611 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.73 130.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -143.79 121.6 11.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.6 m -92.39 105.66 17.8 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.24 116.28 23.5 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.19 150.47 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 1.9 m-70 -141.87 136.04 30.13 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 125.268 1.427 . . . . 0.0 108.151 -175.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.49 -104.6 0.24 Allowed Glycine 0 CA--C 1.483 -1.918 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -147.84 127.12 13.01 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -86.18 -3.86 59.05 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.255 -0.278 . . . . 0.0 111.601 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -30.57 35.54 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 p -85.54 -23.31 27.74 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 117.695 -1.145 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.2 mm -59.68 -54.26 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-N 119.086 0.857 . . . . 0.0 108.715 167.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -58.38 -42.83 87.94 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.418 1.487 . . . . 0.0 112.447 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 14.94 2.33 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.54 -38.37 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.43 44.34 1.02 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.009 0.433 . . . . 0.0 110.583 -171.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -133.37 21.37 4.0 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 164.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 41.46 44.05 2.38 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.292 3.437 . . . . 0.0 114.159 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.54 -45.01 7.59 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -120.03 8.92 11.07 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.78 -169.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.02 163.73 30.22 Favored Glycine 0 CA--C 1.485 -1.791 0 C-N-CA 118.872 -1.632 . . . . 0.0 109.079 -175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -112.05 156.74 41.38 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.14 135.0 24.18 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 122.666 2.244 . . . . 0.0 106.364 166.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -129.65 133.78 47.31 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 64.59 -102.65 0.09 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.426 1.49 . . . . 0.0 111.396 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -154.88 112.56 3.42 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.342 5.8 p30 68.44 15.15 9.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 129.642 3.177 . . . . 0.0 114.55 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.86 167.93 9.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 103.306 -2.85 . . . . 0.0 103.306 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.39 109.44 4.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -172.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 tt -91.02 146.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -82.21 177.21 8.92 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.478 1.132 . . . . 0.0 111.471 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -148.68 -0.08 0.55 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.3 t -119.76 90.14 3.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 130.01 44.76 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 125.937 1.695 . . . . 0.0 112.648 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.71 158.74 18.3 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 2.0 tt0 -79.74 141.07 36.68 Favored 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.17 142.82 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -166.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -130.68 109.17 10.43 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 166.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.0 m -82.33 100.86 10.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.2 m -86.76 112.28 21.53 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.21 141.94 49.46 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.75 121.49 24.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -135.56 50.45 2.11 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.53 -63.64 0.83 Allowed Glycine 0 CA--C 1.482 -1.977 0 N-CA-C 105.401 -3.08 . . . . 0.0 105.401 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.91 -15.93 21.04 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 p -86.3 140.49 34.34 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -81.32 -22.37 5.82 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.833 1.689 . . . . 0.0 108.664 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -105.55 162.57 19.33 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.423 -168.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -74.02 146.95 37.8 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.401 2.068 . . . . 0.0 108.106 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -83.07 164.49 71.24 Favored 'Cis proline' 0 CA--C 1.49 -1.722 0 CA-C-N 122.753 2.019 . . . . 0.0 109.197 5.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 39.5 m -128.24 130.11 47.45 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -95.61 120.54 36.05 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.32 117.34 32.22 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -93.09 135.54 34.17 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.52 139.4 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.553 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 m -124.13 98.74 5.91 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 171.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 147.16 28.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.075 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.61 36.5 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -152.58 100.9 2.6 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -152.31 170.36 20.23 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.808 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -75.61 129.87 37.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 108.912 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.42 141.98 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.72 113.06 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.21 147.61 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.92 121.01 31.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.33 126.98 52.91 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 123.856 0.723 . . . . 0.0 110.741 -176.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.61 132.82 54.46 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 5.5 p30 75.03 0.48 3.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 167.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 23.1 11.06 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.1 tp -141.1 127.49 11.51 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -78.8 102.14 1.51 Allowed 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -91.07 -23.13 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 123.694 0.798 . . . . 0.0 111.631 -166.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.448 ' CD2' HG21 ' A' ' 113' ' ' VAL . 17.3 m-70 -138.37 -177.6 4.92 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -124.65 135.91 53.48 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.91 138.2 31.74 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.56 51.24 0.77 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.3 t -81.41 -49.54 10.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.327 0.651 . . . . 0.0 109.953 -171.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.87 -28.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -173.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.19 -21.96 39.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.3 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -84.84 -30.8 24.21 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 123.144 0.278 . . . . 0.0 111.202 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 146.47 69.85 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.433 -2.061 0 N-CA-C 106.081 -2.315 . . . . 0.0 106.081 176.14 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 CA--C 1.489 -1.386 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.498 ' H ' ' HB2' ' A' ' 5' ' ' ARG . 2.8 m-20 66.64 83.1 0.17 Allowed 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 127.198 2.199 . . . . 0.0 109.197 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 t30 101.14 -32.83 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 128.935 2.894 . . . . 0.0 107.908 -175.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -88.24 -20.8 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' HB2' ' H ' ' A' ' 2' ' ' ASP . 1.1 tmt_? -75.49 -21.02 58.39 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.259 1.023 . . . . 0.0 110.407 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -76.29 -39.05 55.24 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.777 1.231 . . . . 0.0 108.232 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -80.31 -10.6 59.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.22 0.918 . . . . 0.0 113.464 176.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -75.04 -46.35 35.5 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.94 -34.45 71.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.249 2.22 . . . . 0.0 111.631 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.332 0.0 OUTLIER -106.97 -4.66 18.82 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.753 0.821 . . . . 0.0 111.726 -173.254 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 t -83.64 -28.74 28.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 169.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -67.82 -70.33 0.26 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 163.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -105.48 12.95 30.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -155.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 36.7 t80 -112.33 128.05 56.17 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.187 1.358 . . . . 0.0 109.33 169.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -145.34 100.9 3.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 166.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.16 -39.57 6.26 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 -166.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -154.81 137.3 10.02 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 171.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 40.9 Cg_endo -86.25 174.53 6.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 121.731 1.621 . . . . 0.0 108.72 -171.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -74.33 -50.54 18.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 172.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.23 -174.07 28.48 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -114.6 66.43 0.68 Allowed 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -150.58 173.48 14.07 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -172.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.11 -23.39 63.03 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.82 1.248 . . . . 0.0 113.185 -171.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.09 30.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -74.12 -43.85 56.0 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.3 m -67.34 -36.02 80.58 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.79 -34.37 62.41 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.39 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.5 t -69.21 -36.62 77.45 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 tt -82.4 -28.08 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 117.873 0.306 . . . . 0.0 111.017 -175.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mmt -78.33 -24.75 46.42 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.832 176.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -42.4 63.81 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 172.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -45.1 30.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.527 0.331 . . . . 0.0 111.761 -169.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.17 -22.03 53.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.13 56.22 1.62 Allowed Glycine 0 C--N 1.352 1.454 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.326 4.0 mm? -108.73 -16.71 14.12 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 124.532 1.133 . . . . 0.0 108.855 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -76.19 -11.47 59.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.577 1.551 . . . . 0.0 112.883 -164.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t -124.79 108.52 28.38 Favored Pre-proline 0 N--CA 1.438 -1.025 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.838 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.72 157.66 98.41 Favored 'Cis proline' 0 N--CA 1.447 -1.227 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 -23.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.7 m -54.89 129.98 39.54 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 125.43 1.492 . . . . 0.0 113.258 -173.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -77.27 132.91 38.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 171.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.64 -38.55 58.79 Favored 'General case' 0 CA--C 1.487 -1.477 0 O-C-N 123.495 0.497 . . . . 0.0 110.871 -169.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.48 135.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 174.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.09 120.03 7.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.2 m -96.73 107.62 20.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.09 117.22 25.68 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.0 mt -98.44 147.68 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -175.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -137.62 129.93 29.36 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 125.392 1.477 . . . . 0.0 108.797 -169.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.57 -134.98 3.59 Favored Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 106.006 -2.838 . . . . 0.0 106.006 173.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.94 142.38 29.74 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 173.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.88 -21.22 29.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -74.08 -30.36 62.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.094 1.358 . . . . 0.0 109.437 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.2 m -77.2 -33.22 56.33 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 117.414 -1.279 . . . . 0.0 110.871 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -56.01 -56.14 14.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 119.037 0.835 . . . . 0.0 110.11 172.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -56.59 -41.24 76.64 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.92 15.39 1.1 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.8 mt -81.16 -34.21 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 168.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.44 -44.67 62.05 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.782 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.49 156.46 22.84 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.91 87.12 7.25 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.057 0.456 . . . . 0.0 109.933 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.73 -47.52 1.04 Allowed 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.99 58.55 1.35 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 177.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.49 151.42 10.91 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 174.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -115.71 157.95 43.19 Favored Pre-proline 0 N--CA 1.432 -1.362 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -74.3 143.24 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.898 2.399 . . . . 0.0 106.506 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -142.03 127.38 18.77 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? 65.2 -107.39 0.14 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.026 1.33 . . . . 0.0 110.375 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.89 101.02 3.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.364 2.3 p-10 63.82 25.84 14.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 129.08 2.952 . . . . 0.0 114.505 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.09 157.4 17.87 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 168.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -138.14 120.97 16.46 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 tt -88.61 145.59 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.6 p -88.15 165.45 15.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.649 0.738 . . . . 0.0 109.914 -175.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.96 11.77 5.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -123.06 96.17 4.9 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.6 m -62.26 131.63 50.02 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 124.368 1.067 . . . . 0.0 110.645 175.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -112.58 155.87 23.64 Favored 'General case' 0 CA--C 1.473 -1.999 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -77.55 138.53 39.22 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 140.84 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -167.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.0 m -129.3 105.67 8.29 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 167.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 m -85.55 99.98 11.62 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.1 m -85.65 112.1 20.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -117.74 145.99 44.09 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.268 17.1 mt -65.82 135.71 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.029 0.442 . . . . 0.0 110.365 175.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.35 45.44 2.76 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 156.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.01 -83.35 1.42 Allowed Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.08 -25.8 5.7 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -85.35 131.47 48.0 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -84.01 -14.77 7.18 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.097 1.865 . . . . 0.0 108.561 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -100.35 168.05 9.98 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.64 143.77 34.52 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.61 163.98 51.46 Favored 'Cis proline' 0 N--CA 1.436 -1.883 0 CA-C-N 122.35 1.875 . . . . 0.0 108.008 10.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.9 m -128.75 125.99 39.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -172.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -95.38 128.0 41.88 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -120.07 126.06 49.83 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -90.96 129.78 36.95 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.09 129.58 34.86 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -120.44 90.26 3.29 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.86 150.89 23.24 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.354 0.597 . . . . 0.0 110.742 -172.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.53 -170.38 20.28 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -144.08 90.19 2.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -124.39 145.99 49.14 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -159.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -80.89 128.79 34.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.29 138.91 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.604 -164.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -95.24 113.55 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.63 141.51 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 172.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.64 128.16 36.53 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.0 m -108.11 154.01 22.33 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.139 0.899 . . . . 0.0 110.893 -175.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -147.13 127.41 13.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.321 8.6 p30 69.75 11.97 7.93 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.784 2.034 . . . . 0.0 114.679 177.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.86 55.45 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tp -141.46 142.26 25.78 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -70.75 152.53 64.24 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 CA-C-N 121.946 1.731 . . . . 0.0 111.564 -173.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -134.72 -25.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.407 -178.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.435 ' CD2' HG21 ' A' ' 113' ' ' VAL . 36.8 m-70 -143.18 178.02 8.0 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -173.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.65 139.9 36.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -173.22 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.26 121.58 29.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -107.6 10.28 29.18 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -93.18 -20.39 20.52 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -36.71 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.797 0 C-N-CA 123.623 0.769 . . . . 0.0 110.933 173.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -92.22 -6.79 49.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -170.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -127.07 62.45 1.34 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.448 -2.426 . . . . 0.0 104.448 176.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -76.29 147.61 79.65 Favored Pre-proline 0 N--CA 1.432 -1.349 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.875 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 N--CA 1.433 -2.075 0 N-CA-C 106.008 -2.343 . . . . 0.0 106.008 173.661 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 . . . . . 0 CA--C 1.485 -1.554 0 CA-C-O 120.578 0.228 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -120.74 50.9 1.28 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 170.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -101.85 -10.52 19.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 169.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -90.88 -14.24 32.11 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.017 177.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.421 HH21 ' CE1' ' A' ' 114' ' ' HIS . 29.1 tpt180 -74.1 -45.32 49.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.61 -55.31 35.61 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-O 116.551 -1.69 . . . . 0.0 111.493 168.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -81.78 -1.22 46.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 122.011 2.187 . . . . 0.0 115.659 -170.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -85.61 -30.69 23.09 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.63 -28.98 70.28 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.307 0.643 . . . . 0.0 111.205 164.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -23.47 28.7 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.327 0.967 . . . . 0.0 112.252 177.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -72.77 -38.19 67.4 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 120.323 1.42 . . . . 0.0 109.106 174.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HG3' HD22 ' A' ' 43' ' ' ASN . 2.0 tp-100 -65.37 -58.2 6.46 Favored 'General case' 0 N--CA 1.413 -2.282 0 C-N-CA 124.724 1.209 . . . . 0.0 112.498 172.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -125.62 27.99 6.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -160.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -133.66 136.42 44.74 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 166.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -152.85 108.61 3.31 Favored 'General case' 0 N--CA 1.423 -1.811 1 N-CA-C 100.172 -4.011 . . . . 0.0 100.172 169.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -36.02 5.21 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 118.702 2.852 . . . . 0.0 118.702 -164.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -145.65 154.91 52.75 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 19.7 Cg_endo -70.92 143.08 44.34 Favored 'Trans proline' 0 N--CA 1.431 -2.203 0 C-N-CA 123.423 2.749 . . . . 0.0 107.6 165.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -80.35 -50.83 9.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 168.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.07 179.45 17.34 Favored Glycine 0 CA--C 1.478 -2.233 0 N-CA-C 103.994 -3.643 . . . . 0.0 103.994 163.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -123.36 53.59 1.32 Allowed 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -140.03 -179.08 5.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -170.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.25 -23.1 63.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.841 1.256 . . . . 0.0 113.084 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -86.53 -20.03 28.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 122.962 0.505 . . . . 0.0 110.178 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.55 -41.53 46.25 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -69.15 -35.62 76.55 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 123.797 0.685 . . . . 0.0 112.768 -177.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.7 -39.11 67.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -75.43 -24.3 57.06 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.261 12.7 tt -82.86 -33.04 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.612 0 CA-C-N 118.852 0.751 . . . . 0.0 109.563 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mmt -77.91 -20.84 52.16 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.624 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -72.1 -44.81 62.64 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.239 0.472 . . . . 0.0 111.858 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.69 -39.8 50.89 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.924 0.489 . . . . 0.0 111.964 -173.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -75.78 -29.98 58.95 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 123.316 0.646 . . . . 0.0 110.222 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 52.41 2.49 Favored Glycine 0 CA--C 1.491 -1.43 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 170.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.6 mt -121.85 18.28 11.01 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -91.85 -10.76 38.56 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.4 1.08 . . . . 0.0 108.802 -173.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -129.57 105.22 17.33 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.1 159.36 95.67 Favored 'Cis proline' 0 N--CA 1.444 -1.425 0 N-CA-C 107.133 -1.91 . . . . 0.0 107.133 -19.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 m -63.05 123.09 17.69 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.968 0.907 . . . . 0.0 109.522 -177.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -71.42 140.78 50.22 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.02 -46.73 50.37 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.965 0.506 . . . . 0.0 111.049 -172.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 132.52 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.406 HD22 ' HG3' ' A' ' 12' ' ' GLN . 7.3 t-20 -151.16 119.15 6.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -96.22 112.84 24.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -177.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -87.6 118.48 27.11 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 171.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.17 152.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -177.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.524 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 7.3 m-70 -136.26 133.18 36.72 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 124.648 1.179 . . . . 0.0 108.195 -171.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.83 -119.66 0.88 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -132.6 138.72 47.5 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -86.74 -7.14 58.54 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.451 -172.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -80.27 -32.52 38.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -36.93 73.6 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 123.996 0.919 . . . . 0.0 110.543 174.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.41 -53.1 51.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 C-N-CA 124.906 1.282 . . . . 0.0 111.38 174.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.75 -39.24 76.92 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.285 1.034 . . . . 0.0 113.038 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.41 9.4 11.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.602 0.761 . . . . 0.0 112.978 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.3 mm -78.56 -28.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 168.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.02 -21.01 51.41 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -80.51 170.8 15.87 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -88.1 5.89 38.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.834 0.854 . . . . 0.0 110.685 -178.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -75.02 -63.24 1.31 Allowed 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 123.842 0.857 . . . . 0.0 110.169 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -89.0 -50.58 6.09 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -176.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.1 149.21 19.12 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -163.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -102.98 154.57 37.45 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -178.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.03 141.58 33.16 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 123.102 2.535 . . . . 0.0 106.828 175.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -134.99 34.68 3.1 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -169.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 62.21 156.56 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 129.072 2.949 . . . . 0.0 114.05 -176.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 42.89 54.58 4.68 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 129.209 3.004 . . . . 0.0 115.831 176.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.311 2.7 p-10 52.58 34.46 15.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.622 2.769 . . . . 0.0 114.764 -176.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.92 151.54 25.65 Favored 'General case' 0 CA--C 1.478 -1.813 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -140.62 118.26 11.61 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -175.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -85.69 146.15 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 176.32 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.6 p -92.69 169.0 10.83 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -131.23 -6.17 3.83 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -106.28 78.86 1.33 Allowed 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.6 t -46.74 127.76 10.03 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 128.324 2.65 . . . . 0.0 113.218 -177.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.73 157.69 18.32 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -170.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 139.58 41.45 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.5 140.98 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -170.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -132.45 110.56 10.61 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 164.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -88.7 101.19 13.75 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.35 114.36 22.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -121.72 129.1 52.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -168.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.5 tp -72.98 114.9 11.64 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.989 1.316 . . . . 0.0 108.09 -178.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -138.68 95.9 3.05 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 -176.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.12 -41.41 0.05 OUTLIER Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 -177.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.42 41.23 6.58 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -177.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -117.81 106.6 45.64 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -82.76 -21.66 4.83 Favored 'Trans proline' 0 N--CA 1.439 -1.708 0 CA-C-N 121.535 1.584 . . . . 0.0 108.935 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -107.24 161.69 22.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.98 142.52 31.43 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.498 2.132 . . . . 0.0 107.486 -176.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -82.77 161.58 75.36 Favored 'Cis proline' 0 CA--C 1.486 -1.876 0 CA-C-N 123.06 2.128 . . . . 0.0 108.798 4.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.1 m -109.41 159.22 17.2 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -173.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -116.58 90.28 3.3 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.02 117.45 30.69 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -102.53 132.25 48.71 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 131.08 35.28 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -117.39 86.34 2.5 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.02 148.48 21.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.999 -172.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -152.69 -163.37 11.6 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -146.72 98.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 101.033 -3.691 . . . . 0.0 101.033 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -133.16 144.49 49.9 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -162.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 HD21 HD11 ' A' ' 71' ' ' ILE . 2.3 p-10 -74.85 124.58 27.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.95 140.66 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.313 -165.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.07 114.91 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 165.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.6 141.84 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 114' ' ' HIS . . . -101.52 113.44 26.56 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.6 p -113.99 163.64 14.86 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 122.319 1.057 . . . . 0.0 113.085 -173.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -153.64 136.46 15.34 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.354 7.9 p30 71.72 2.95 4.49 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.716 2.406 . . . . 0.0 116.092 174.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.6 -2.41 34.32 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.41 128.7 25.8 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -73.58 119.65 6.05 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.682 -2.084 . . . . 0.0 106.682 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -105.62 -17.01 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 123.952 0.783 . . . . 0.0 110.021 -167.533 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.537 ' CD2' HG21 ' A' ' 113' ' ' VAL . 70.5 m-70 -153.34 177.17 11.17 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.29 142.03 35.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -174.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.74 126.68 37.94 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 167.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -108.88 10.9 26.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -173.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -87.72 -25.68 23.32 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.17 0.51 . . . . 0.0 109.789 -166.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -21.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 C-N-CA 124.161 0.984 . . . . 0.0 109.889 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -103.0 52.98 0.78 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.352 16.4 ptm180 57.9 61.94 2.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 129.184 2.994 . . . . 0.0 113.301 176.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -138.28 102.54 8.12 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 164.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo . . . . . 0 N--CA 1.435 -1.955 0 N-CA-C 105.823 -2.414 . . . . 0.0 105.823 174.402 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -125.26 34.98 4.84 Favored 'General case' 0 CA--C 1.475 -1.932 0 CA-C-O 123.426 1.584 . . . . 0.0 107.388 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -95.97 -23.73 16.71 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 111.528 -2.578 . . . . 0.0 104.651 160.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 m -94.02 0.46 56.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.801 1.24 . . . . 0.0 109.934 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.449 ' HE ' ' CE1' ' A' ' 114' ' ' HIS . 30.7 tpt180 -75.86 -39.52 56.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -46.63 69.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 124.15 0.98 . . . . 0.0 109.868 176.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.408 0.2 OUTLIER -83.89 -2.23 56.05 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -179.085 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -83.88 -30.09 26.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.538 1.063 . . . . 0.0 109.291 165.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 10' ' ' LEU . 2.3 t80 -61.45 -35.37 77.42 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.153 0.981 . . . . 0.0 109.034 164.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.405 HD21 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -83.43 -18.68 37.87 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.079 177.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -69.07 -52.26 30.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-N 119.79 1.177 . . . . 0.0 108.481 176.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.465 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 15.7 tt0 -77.28 -38.02 51.66 Favored 'General case' 0 N--CA 1.404 -2.742 0 C-N-CA 124.286 1.034 . . . . 0.0 110.437 -173.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 70.0 m-70 -98.31 -54.96 2.9 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.48 -175.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -77.63 119.98 21.94 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 119.98 1.264 . . . . 0.0 108.738 -167.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -137.14 98.37 3.72 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 100.682 -3.821 . . . . 0.0 100.682 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.64 -42.55 0.8 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -165.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -144.11 151.94 53.35 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 165.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.515 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 11.9 Cg_endo -71.81 155.43 58.2 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 123.859 3.039 . . . . 0.0 109.916 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -78.64 -53.45 7.16 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 170.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.74 -179.88 17.76 Favored Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 166.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -121.4 61.72 0.92 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -178.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.3 -179.42 7.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.57 -10.47 59.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -78.36 -33.23 49.14 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -75.63 -39.16 58.23 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.02 -42.95 79.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.3 -31.85 62.65 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 122.799 0.44 . . . . 0.0 110.597 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -67.46 -38.72 84.89 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.478 176.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 14.6 tt -80.31 -25.34 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 CA-C-N 118.042 0.383 . . . . 0.0 111.385 -176.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -29.89 61.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.774 -1.57 . . . . 0.0 111.536 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -75.66 -29.91 59.25 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.199 0.454 . . . . 0.0 112.22 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -78.97 -44.83 21.6 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.77 0.828 . . . . 0.0 110.746 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -81.05 -26.21 36.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.639 0.376 . . . . 0.0 110.438 -172.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.37 49.04 3.34 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 171.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.61 14.86 15.52 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 t -86.49 -13.31 46.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.08 0.952 . . . . 0.0 108.727 -176.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 m -122.38 103.63 38.3 Favored Pre-proline 0 N--CA 1.424 -1.73 0 CA-C-O 117.867 -1.064 . . . . 0.0 108.495 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.34 161.05 95.31 Favored 'Cis proline' 0 N--CA 1.441 -1.6 0 N-CA-C 106.888 -2.005 . . . . 0.0 106.888 -23.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -60.39 124.49 20.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.813 1.245 . . . . 0.0 111.118 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -73.02 135.48 44.92 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -75.0 -39.64 61.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.312 -170.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.6 tt -148.69 133.91 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -151.53 121.34 7.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.5 112.1 24.24 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.27 116.26 23.51 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.55 151.37 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.515 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.9 m-70 -144.15 140.68 29.52 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.61 1.62 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 107.115 -2.394 . . . . 0.0 107.115 175.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.494 HD21 ' HG ' ' A' ' 52' ' ' SER . 54.9 t30 -119.79 137.0 54.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -85.58 -20.67 29.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 120.959 0.409 . . . . 0.0 110.636 -166.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -79.82 -22.47 42.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.494 ' HG ' HD21 ' A' ' 49' ' ' ASN . 72.5 m -76.09 -34.36 59.53 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.967 171.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.18 -51.23 73.52 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 119.829 1.195 . . . . 0.0 110.073 171.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.93 -40.42 93.18 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.673 0.789 . . . . 0.0 111.16 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.72 21.06 1.96 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.94 -28.7 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 t -78.15 -41.5 34.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.895 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -79.22 149.87 31.78 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 170.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -78.77 104.22 9.24 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -160.14 -57.74 0.06 Allowed 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -177.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -136.88 22.31 3.07 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.67 -178.82 21.47 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 105.288 -3.125 . . . . 0.0 105.288 166.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -137.2 161.28 61.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -171.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -74.49 147.3 36.11 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.884 2.389 . . . . 0.0 107.323 162.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -139.44 101.48 4.24 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 65.54 -102.26 0.08 Allowed 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 111.144 -177.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.24 102.38 3.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -174.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 2.8 p-10 65.34 22.26 12.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 129.896 3.278 . . . . 0.0 114.625 173.14 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.13 158.35 17.49 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 100.63 -3.841 . . . . 0.0 100.63 163.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -141.9 111.46 6.58 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -171.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 tt -94.25 140.37 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -87.68 167.47 13.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 121.387 0.613 . . . . 0.0 110.329 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 -1.49 4.37 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -113.43 86.6 2.42 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 173.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.0 m -53.44 137.95 34.61 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.058 2.143 . . . . 0.0 113.16 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -111.16 155.64 22.59 Favored 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -75.42 141.69 43.16 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 175.07 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.53 145.96 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -168.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -130.99 107.16 8.89 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 167.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -85.51 100.35 11.85 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.8 m -84.16 113.95 21.44 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -121.03 129.95 53.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 -176.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 tp -69.01 116.76 9.83 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.825 1.25 . . . . 0.0 109.257 -174.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -135.87 99.0 4.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -175.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.69 -42.12 0.18 Allowed Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 -178.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.38 43.59 7.35 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 t -112.72 108.82 53.54 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -86.1 -17.67 3.75 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 CA-C-N 122.193 1.819 . . . . 0.0 109.064 -176.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.75 160.65 28.85 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-O 117.43 -1.271 . . . . 0.0 107.954 -168.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.66 145.9 33.48 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.674 2.25 . . . . 0.0 108.425 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -81.17 164.31 77.62 Favored 'Cis proline' 0 N--CA 1.437 -1.841 0 CA-C-N 122.299 1.857 . . . . 0.0 108.176 -4.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.8 m -107.46 156.13 19.3 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.458 -170.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -110.54 118.39 36.11 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.71 148.3 41.2 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.69 119.87 40.13 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 166.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.26 115.84 26.04 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -110.69 87.97 2.66 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.64 143.57 26.7 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.265 0.555 . . . . 0.0 110.769 -171.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -149.41 -163.72 11.19 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 178.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -146.67 101.21 3.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -138.22 147.63 43.95 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -164.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -74.22 128.7 36.22 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.504 1.121 . . . . 0.0 108.515 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.16 137.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.16 -167.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.53 110.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 165.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.23 152.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.0 136.12 33.24 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 168.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.9 t -126.52 138.64 53.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 123.527 0.517 . . . . 0.0 109.701 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.74 133.56 44.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 170.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.301 14.2 p30 63.22 23.79 14.02 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 117.068 2.248 . . . . 0.0 117.068 171.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.52 19.15 57.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.45 116.12 5.43 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -170.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -72.02 111.49 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 CA-C-N 122.091 1.782 . . . . 0.0 111.39 -170.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.419 HG21 ' CD2' ' A' ' 114' ' ' HIS . 1.0 OUTLIER -89.9 -24.32 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.376 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.449 ' CE1' ' HE ' ' A' ' 5' ' ' ARG . 28.5 m-70 -151.88 -168.65 3.13 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.66 149.56 40.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -175.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.22 127.76 43.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 171.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -110.78 13.77 22.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -86.01 -32.34 21.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -172.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.6 OUTLIER -78.5 -23.34 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 C-N-CA 125.513 1.525 . . . . 0.0 111.817 177.747 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -105.97 56.8 0.67 Allowed 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.49 -1.671 . . . . 0.0 106.49 -167.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.282 14.9 ptm180 52.61 61.88 2.97 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 129.363 3.065 . . . . 0.0 113.211 172.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -68.41 128.84 93.02 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.433 -2.073 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 177.628 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 . . . . . 0 CA--C 1.485 -1.547 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -118.36 51.53 1.08 Allowed 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -113.72 1.85 15.01 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 173.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -92.37 -29.93 16.06 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -70.47 -40.77 73.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.312 0.645 . . . . 0.0 109.427 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -46.56 -65.66 0.52 Allowed 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 126.602 1.961 . . . . 0.0 111.168 166.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.297 5.4 p -70.43 -11.84 61.18 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -83.71 -36.61 23.56 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.126 0.876 . . . . 0.0 109.521 173.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.24 -35.53 81.11 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.701 1.6 . . . . 0.0 110.515 170.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' THR 0.271 0.2 OUTLIER -67.06 -38.04 85.1 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 128.709 2.803 . . . . 0.0 112.452 174.667 . . . . . . . . 4 4 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -66.64 -51.87 51.35 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 12.6 tt0 -77.86 -29.09 50.23 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 124.114 0.966 . . . . 0.0 112.439 -170.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 89.0 m-70 -105.78 -58.25 1.93 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.001 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -72.6 111.93 8.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.73 0.776 . . . . 0.0 110.689 -163.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -134.96 98.28 3.97 Favored 'General case' 0 N--CA 1.421 -1.878 1 N-CA-C 98.553 -4.61 . . . . 0.0 98.553 176.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -33.65 3.8 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -163.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.91 154.18 46.8 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.9 Cg_endo -69.53 145.08 57.39 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 123.642 2.895 . . . . 0.0 109.164 171.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -86.04 -46.85 10.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 169.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.24 -177.21 14.82 Favored Glycine 0 CA--C 1.48 -2.133 0 N-CA-C 103.364 -3.894 . . . . 0.0 103.364 164.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -133.98 35.22 3.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -121.45 -179.22 4.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -35.88 79.77 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 125.973 1.709 . . . . 0.0 112.812 -171.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -81.82 -22.17 37.21 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.084 0.554 . . . . 0.0 110.033 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.85 -42.22 61.12 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' HA ' HG23 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -83.54 -19.97 34.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.729 -0.789 . . . . 0.0 113.045 -170.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.02 -39.42 66.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.3 t -67.15 -38.28 85.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 26' ' ' CYS 0.282 15.2 tt -86.74 -25.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 CA-C-N 118.358 0.527 . . . . 0.0 112.024 -175.464 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 mmt -77.49 -25.64 50.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.707 173.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -72.16 -38.3 69.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.131 0.572 . . . . 0.0 111.821 173.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -79.99 -40.1 28.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 122.607 0.363 . . . . 0.0 110.698 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -23.08 40.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.036 0.534 . . . . 0.0 110.571 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.8 47.57 4.18 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.36 6.76 12.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 t -94.61 -0.6 54.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 m -122.09 102.14 40.85 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 117.768 -1.11 . . . . 0.0 108.668 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.74 158.06 98.84 Favored 'Cis proline' 0 N--CA 1.441 -1.58 0 N-CA-C 106.842 -2.022 . . . . 0.0 106.842 -23.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.0 m -63.21 118.97 8.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 124.707 1.203 . . . . 0.0 111.914 -170.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.39 134.11 45.25 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -72.68 -36.35 67.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 124.567 1.167 . . . . 0.0 112.89 -166.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -154.77 123.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -153.3 151.63 30.22 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.515 177.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.8 m -112.21 136.61 51.42 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.503 -168.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -99.33 116.74 32.19 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 162.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.2 mt -89.89 150.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.483 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 -178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.518 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.6 m-70 -139.95 139.77 36.2 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 125.143 1.377 . . . . 0.0 108.863 -175.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.07 5.79 Favored Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 105.734 -2.946 . . . . 0.0 105.734 173.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -102.68 147.93 26.21 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 170.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -85.45 -16.28 40.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.99 -33.17 59.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.693 1.597 . . . . 0.0 107.071 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.9 m -75.73 -34.56 60.33 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.005 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 mm -54.95 -55.37 16.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 CA-C-N 119.349 0.977 . . . . 0.0 110.155 172.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.39 -35.01 77.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 123.875 0.87 . . . . 0.0 113.23 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.48 -0.25 19.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.6 mm -73.66 -27.51 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.74 9.01 38.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.125 0.488 . . . . 0.0 111.599 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -88.56 162.09 16.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 160.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.47 HD21 HH12 ' A' ' 70' ' ' ARG . 9.6 t-20 -88.18 -9.8 51.93 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -68.4 -50.48 52.6 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.252 1.421 . . . . 0.0 110.178 178.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -123.76 37.5 4.4 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -168.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.5 152.67 10.9 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 171.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -105.77 156.44 36.57 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -176.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -74.75 140.44 26.21 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 123.003 2.469 . . . . 0.0 106.821 172.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -136.67 133.7 36.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -176.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 62.11 -103.26 0.13 Allowed 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.899 1.68 . . . . 0.0 112.219 169.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.79 103.8 2.64 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.362 2.5 p-10 62.0 30.78 18.06 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 129.139 2.975 . . . . 0.0 113.883 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.2 mt -115.13 170.19 8.55 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 171.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.47 HH12 HD21 ' A' ' 59' ' ' ASN . 21.9 mmt180 -147.17 116.4 6.95 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -174.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -93.87 136.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.5 p -83.56 160.91 21.35 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.45 -25.53 11.83 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.698 174.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -104.87 89.17 3.08 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 p -49.62 129.71 19.74 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 127.229 2.212 . . . . 0.0 111.916 171.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -105.19 156.44 18.11 Favored 'General case' 0 CA--C 1.478 -1.815 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -170.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 6.4 mt-30 -78.9 148.16 32.83 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 174.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.76 146.97 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -166.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.5 m -134.38 99.68 4.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 167.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -89.64 104.24 16.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -177.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.73 122.41 36.17 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -106.87 132.83 52.38 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.63 117.12 18.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.476 1.51 . . . . 0.0 109.007 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -112.1 152.41 28.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.34 -97.97 0.22 Allowed Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 106.014 -2.835 . . . . 0.0 106.014 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.03 1.5 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 -178.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.5 t -84.68 130.01 54.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -83.19 -20.9 4.83 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.989 1.793 . . . . 0.0 108.279 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -96.47 159.9 30.81 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -76.18 148.12 30.47 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.309 2.006 . . . . 0.0 107.221 -176.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -85.54 165.09 56.38 Favored 'Cis proline' 0 N--CA 1.438 -1.74 0 CA-C-N 123.035 2.12 . . . . 0.0 108.133 13.078 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.1 m -154.87 130.3 9.78 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -165.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.79 103.01 15.4 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -85.83 120.81 27.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -92.47 112.57 24.57 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.45 130.65 35.29 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.028 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -118.72 108.61 15.1 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.268 -2.494 . . . . 0.0 104.268 175.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.68 129.31 35.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.74 169.5 23.17 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 106.002 -2.839 . . . . 0.0 106.002 178.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -149.22 105.86 3.55 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -152.44 158.69 42.98 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 121.884 0.85 . . . . 0.0 110.32 -168.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.0 129.55 34.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.319 175.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.8 148.17 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.737 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.5 t -106.5 92.45 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -93.3 139.16 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.16 126.29 31.88 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.9 t -108.48 135.99 48.84 Favored 'General case' 0 CA--C 1.49 -1.34 0 O-C-N 123.875 0.734 . . . . 0.0 110.497 -175.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.22 137.5 39.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.299 16.5 p30 60.15 26.45 15.85 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 127.05 2.14 . . . . 0.0 116.101 175.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.56 22.76 59.58 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 177.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 135.07 9.72 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -77.72 111.58 3.15 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 CA-C-N 122.354 1.876 . . . . 0.0 110.972 -177.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.438 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -86.78 -26.84 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 123.838 0.711 . . . . 0.0 111.693 -174.664 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.438 ' CD2' HG21 ' A' ' 113' ' ' VAL . 53.0 m-70 -146.52 -171.72 3.8 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -171.262 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 132.01 4.11 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 177.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -74.41 135.81 42.38 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.322 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -96.8 36.89 1.34 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.9 p -95.66 -19.71 19.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.64 -23.23 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 178.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -108.99 38.67 2.22 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 125.332 1.453 . . . . 0.0 108.448 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -98.14 -27.01 14.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 168.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -83.12 142.08 43.86 Favored Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 N-CA-C 106.056 -2.325 . . . . 0.0 106.056 -178.258 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 CA--C 1.486 -1.5 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 61.36 65.79 0.93 Allowed 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 126.804 2.041 . . . . 0.0 110.521 175.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 81.36 -6.71 1.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 127.612 2.365 . . . . 0.0 112.441 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -93.39 -9.04 40.09 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -20.92 58.23 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.704 1.602 . . . . 0.0 109.678 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.79 -41.25 62.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 C-N-CA 125.188 1.395 . . . . 0.0 108.039 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.36 -12.81 59.91 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 177.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.4 m170 -73.67 -47.32 40.62 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.74 -46.35 74.27 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 126.401 1.88 . . . . 0.0 110.221 173.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.43 0.1 OUTLIER -93.25 -4.54 51.69 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.759 . . . . . . . . 4 4 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -78.65 -43.81 25.28 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 120.655 1.57 . . . . 0.0 107.782 166.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.81 -46.27 79.26 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.401 ' CE1' HD22 ' A' ' 43' ' ' ASN . 93.3 m-70 -97.16 -48.55 5.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.882 -172.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 45.8 t80 -78.68 117.15 19.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 119.963 1.256 . . . . 0.0 110.397 -168.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -134.61 96.4 3.56 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 174.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.37 -43.66 3.64 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 128.278 2.631 . . . . 0.0 117.724 -166.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -155.25 144.25 14.98 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 67.5 Cg_exo -74.74 174.79 12.07 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.863 1.708 . . . . 0.0 113.736 -177.054 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -70.73 -67.84 0.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 168.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.61 -175.16 13.69 Favored Glycine 0 CA--C 1.475 -2.451 1 N-CA-C 101.618 -4.593 . . . . 0.0 101.618 163.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -115.87 73.64 0.85 Allowed 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.34 176.7 9.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.38 -21.59 61.99 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.476 1.111 . . . . 0.0 112.884 -171.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -75.8 -30.27 58.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.238 177.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.95 -40.62 53.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 m -69.65 -35.32 75.07 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.17 -36.8 69.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 123.375 0.422 . . . . 0.0 110.308 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -69.45 -35.65 75.87 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 122.909 0.484 . . . . 0.0 112.214 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 HG13 HH21 ' A' ' 33' ' ' ARG 0.25 12.7 tt -84.15 -27.95 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-N 117.707 0.23 . . . . 0.0 111.227 -174.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.07 -25.17 47.53 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.483 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.408 HH12 ' HA ' ' A' ' 91' ' ' PRO . 16.6 tpp180 -68.68 -43.6 75.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.214 0.606 . . . . 0.0 110.995 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -75.84 -44.77 39.29 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 123.646 0.778 . . . . 0.0 112.352 -172.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.432 HH21 HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -77.11 -18.1 58.19 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.955 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.0 44.75 4.68 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 168.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.4 mt -117.65 15.81 14.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 176.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -94.06 -11.41 30.73 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.6 m -125.53 101.03 31.04 Favored Pre-proline 0 N--CA 1.426 -1.659 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.548 -174.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.06 165.14 85.9 Favored 'Cis proline' 0 N--CA 1.445 -1.373 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 -21.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.9 m -60.28 120.58 10.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 124.063 0.945 . . . . 0.0 110.173 -175.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -74.63 136.67 41.96 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 177.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.68 -45.63 61.33 Favored 'General case' 0 N--CA 1.433 -1.287 0 O-C-N 123.956 0.785 . . . . 0.0 110.45 -171.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.46 126.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.401 HD22 ' CE1' ' A' ' 13' ' ' HIS . 12.7 t-20 -148.51 127.88 13.06 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.2 m -94.23 122.18 36.5 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.734 -178.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -90.52 121.33 32.37 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.7 148.82 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.9 m-70 -136.57 137.37 40.13 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 124.834 1.253 . . . . 0.0 107.95 -175.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.79 -126.94 1.62 Allowed Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 175.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -118.28 141.65 48.31 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 171.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.51 -3.07 58.96 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -76.49 -31.65 57.85 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 168.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -80.5 -32.26 37.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 118.115 -0.945 . . . . 0.0 109.982 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.52 -52.62 54.86 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.204 1.001 . . . . 0.0 110.467 171.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -53.84 -44.09 70.02 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.42 1.488 . . . . 0.0 112.05 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.02 16.02 0.61 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.25 -40.54 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 165.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 36.3 t -88.72 -30.26 19.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.454 -156.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -95.74 51.26 1.26 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -170.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 m120 49.26 50.88 17.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 129.516 3.127 . . . . 0.0 113.329 174.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -148.84 163.67 36.73 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 97.594 -4.965 . . . . 0.0 97.594 172.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.259 8.1 p-10 14.52 56.54 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 131.043 3.737 . . . . 0.0 117.799 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.91 137.24 2.29 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 106.001 -2.839 . . . . 0.0 106.001 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -106.13 157.45 34.82 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -72.06 135.55 25.41 Favored 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 123.095 2.53 . . . . 0.0 107.225 170.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -131.23 107.37 8.94 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -175.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 63.42 -108.61 0.24 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 112.989 174.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -127.39 87.01 2.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -166.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.343 1.8 p-10 64.01 27.62 14.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 128.913 2.885 . . . . 0.0 113.947 173.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 mt -110.4 163.84 13.28 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 173.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -146.78 120.58 9.26 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.08 143.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -177.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.7 p -84.43 159.92 20.69 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -174.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -122.62 -3.18 8.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 t -119.02 88.15 2.87 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 173.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.3 p -61.56 141.36 57.79 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.561 1.544 . . . . 0.0 111.862 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -114.04 161.68 17.41 Favored 'General case' 0 CA--C 1.474 -1.967 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -168.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 7.7 mt-30 -77.91 144.63 36.72 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.73 143.38 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.7 m -131.35 107.61 9.06 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 167.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -83.14 101.03 10.92 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.6 114.97 24.7 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -121.06 132.47 54.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -170.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.9 tp -69.28 114.24 7.35 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 125.105 1.362 . . . . 0.0 108.527 -177.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -126.76 57.26 1.45 Allowed 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -118.31 -84.2 0.95 Allowed Glycine 0 CA--C 1.482 -2.021 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.21 -15.09 4.25 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 178.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -86.91 132.34 42.28 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -81.02 -21.71 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.755 1.636 . . . . 0.0 108.93 176.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -102.24 165.05 14.55 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.13 142.12 33.71 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.222 1.948 . . . . 0.0 107.159 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.8 Cg_endo -87.63 164.39 45.6 Favored 'Cis proline' 0 N--CA 1.435 -1.923 0 CA-C-N 122.655 1.984 . . . . 0.0 108.397 12.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 37.7 m -128.07 131.95 49.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -170.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -98.15 123.04 42.0 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.59 122.42 44.57 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -93.06 127.27 38.53 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.99 133.12 35.27 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.467 ' HG1' ' HB2' ' A' ' 123' ' ' PRO . 36.6 m -120.04 97.24 5.51 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 171.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.6 139.01 38.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.03 -171.16 18.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -155.78 100.05 2.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 101.28 -3.6 . . . . 0.0 101.28 -178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -139.44 148.73 43.14 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -161.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -80.73 132.5 35.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.862 1.265 . . . . 0.0 108.442 175.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.18 142.36 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.612 -164.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.74 95.68 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.1 m -94.71 136.7 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.31 126.53 37.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 31.7 p -129.2 167.5 17.55 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -172.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.38 132.81 18.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.364 6.4 p30 75.94 -12.0 1.06 Allowed 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 170.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.02 9.08 9.09 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -141.99 127.9 10.84 Favored Pre-proline 0 N--CA 1.435 -1.196 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -67.35 163.8 33.14 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.566 1.511 . . . . 0.0 114.029 -178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -132.3 -19.67 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 113' ' ' VAL . 74.9 m-70 -158.68 -175.3 5.23 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -169.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 136.8 3.78 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 -179.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.94 134.64 37.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.966 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -100.07 40.19 1.27 Allowed 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.7 m -97.1 -31.57 12.41 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.3 -33.98 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.61 169.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -106.12 40.1 1.66 Allowed 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -172.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -87.55 -44.28 11.39 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -95.34 149.17 35.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HB2' ' HG1' ' A' ' 97' ' ' THR . 21.2 Cg_endo . . . . . 0 N--CA 1.433 -2.055 0 N-CA-C 105.946 -2.367 . . . . 0.0 105.946 175.007 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.1 t70 75.15 78.32 0.1 Allowed 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 126.64 1.976 . . . . 0.0 109.16 177.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 79.21 -2.43 2.22 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 127.686 2.394 . . . . 0.0 111.331 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -89.95 -17.12 28.52 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -69.97 -30.27 67.58 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.303 1.441 . . . . 0.0 110.624 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.49 ' HH ' ' HZ1' ' A' ' 50' ' ' LYS . 52.2 t80 -68.49 -48.3 64.79 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -76.12 -10.01 59.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -80.74 -43.68 19.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 119.352 0.978 . . . . 0.0 108.468 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -57.89 -38.23 75.43 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.791 1.637 . . . . 0.0 110.195 170.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -78.8 -29.62 45.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.546 1.538 . . . . 0.0 113.493 -179.149 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -80.06 -32.59 39.33 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 119.773 1.17 . . . . 0.0 109.38 -174.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 27.0 tt0 -82.36 -45.01 15.43 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 118.511 -0.757 . . . . 0.0 109.726 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 82.9 m-70 -95.12 -46.82 6.63 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 119.429 1.013 . . . . 0.0 112.442 -172.08 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 9.3 t80 -70.65 118.32 13.3 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 119.766 1.166 . . . . 0.0 110.925 -174.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -139.8 99.04 3.6 Favored 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 172.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 -39.26 9.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -164.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -142.84 148.65 46.77 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.519 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.0 Cg_endo -72.7 153.42 54.02 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 123.515 2.81 . . . . 0.0 109.291 170.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -77.8 -57.65 3.69 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.95 179.35 17.23 Favored Glycine 0 CA--C 1.477 -2.3 0 N-CA-C 103.726 -3.749 . . . . 0.0 103.726 165.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -122.9 61.27 1.01 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -141.54 176.84 8.56 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -171.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.94 -24.46 62.44 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 124.879 1.272 . . . . 0.0 112.245 -169.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -85.4 -20.14 30.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 122.966 0.506 . . . . 0.0 110.097 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -79.18 -35.89 41.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.0 -33.92 51.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -171.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.18 -48.12 74.57 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 125.841 1.657 . . . . 0.0 109.687 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 m -74.97 -22.97 58.23 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 118.112 -0.946 . . . . 0.0 113.496 -175.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 14.0 tt -87.09 -24.96 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 119.241 0.928 . . . . 0.0 110.65 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.68 -29.22 62.17 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.265 -1.374 . . . . 0.0 110.259 171.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -80.19 -32.43 38.67 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -83.72 -33.12 25.18 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 118.655 0.661 . . . . 0.0 111.07 -175.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -80.45 -19.25 46.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.5 47.57 3.46 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.6 mt -122.77 14.14 10.03 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -90.63 -9.73 45.88 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -175.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m -122.54 101.37 40.34 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.788 -174.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.57 166.37 83.07 Favored 'Cis proline' 0 N--CA 1.444 -1.429 0 CA-C-N 122.83 2.047 . . . . 0.0 107.217 -21.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.68 122.09 13.27 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 124.361 1.064 . . . . 0.0 110.987 -173.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -75.07 133.64 41.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -70.22 -40.47 74.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.336 1.022 . . . . 0.0 112.01 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.37 130.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 176.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -145.43 128.74 16.81 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -96.66 112.32 24.11 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.11 111.05 20.54 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 174.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.1 150.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.519 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-70 -142.88 135.73 27.95 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 125.172 1.389 . . . . 0.0 107.941 -174.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.91 -136.52 4.61 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 173.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -96.56 145.64 25.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.49 ' HZ1' ' HH ' ' A' ' 6' ' ' TYR . 64.5 tttm -86.99 -21.94 25.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -79.6 -24.77 41.76 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -76.02 -35.52 59.48 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.716 172.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -52.88 -51.47 36.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.459 0 C-N-CA 124.921 1.289 . . . . 0.0 110.221 170.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.68 -39.74 94.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.143 0.977 . . . . 0.0 111.105 -176.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.98 10.58 4.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.06 -24.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.5 m -78.65 -23.55 45.7 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.019 177.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.5 143.89 44.37 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 167.113 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -98.56 25.42 6.43 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.222 -178.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -90.55 -47.66 7.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -113.71 51.2 0.87 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -176.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.5 172.65 39.13 Favored Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 103.266 -3.934 . . . . 0.0 103.266 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -126.56 152.93 75.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.02 132.78 14.43 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 106.077 -2.316 . . . . 0.0 106.077 172.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -99.58 156.17 17.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 174.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -36.42 -69.88 0.1 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 129.578 3.151 . . . . 0.0 116.394 -173.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -104.24 75.36 1.25 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -171.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 65.54 15.12 9.88 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.483 3.113 . . . . 0.0 116.353 165.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.98 173.23 6.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 -169.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -139.18 107.28 5.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 tt -86.47 143.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 177.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.7 p -89.47 168.06 12.49 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.441 0.639 . . . . 0.0 111.286 -172.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -124.05 -14.99 6.96 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 t -115.27 93.69 4.4 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -51.06 133.99 26.96 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 127.24 2.216 . . . . 0.0 112.633 174.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -110.14 157.75 19.05 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -172.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.72 135.16 35.95 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 174.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.21 142.7 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 -173.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.2 m -130.49 102.98 6.39 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -89.16 112.67 23.72 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.8 m -91.05 118.04 30.08 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -115.04 140.07 49.35 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.47 131.88 34.71 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -169.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.58 -179.56 5.76 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.31 -86.83 0.48 Allowed Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 -178.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.74 -7.41 0.68 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -78.92 128.12 77.61 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.073 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.57 -27.69 2.07 Favored 'Trans proline' 0 N--CA 1.436 -1.896 0 N-CA-C 107.862 -1.63 . . . . 0.0 107.862 173.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -98.01 162.87 20.69 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -169.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.78 144.34 34.87 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 122.366 2.044 . . . . 0.0 107.53 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -82.57 163.25 74.7 Favored 'Cis proline' 0 N--CA 1.438 -1.739 0 CA-C-N 123.222 2.187 . . . . 0.0 109.845 8.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.3 138.28 54.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.81 -168.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -101.96 107.15 18.21 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -103.04 123.24 46.26 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -88.18 122.4 31.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.87 132.55 34.62 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.18 104.53 7.36 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.3 135.74 34.23 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.08 146.36 16.83 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -99.15 103.87 15.8 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -143.05 155.72 44.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -167.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -78.94 130.81 35.99 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.76 142.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.465 -168.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.9 t -100.39 120.46 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -113.69 160.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 114' ' ' HIS . . . -110.23 132.44 54.17 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 171.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 99.1 m -107.93 150.89 26.52 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -169.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -150.24 122.17 8.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.2 p30 67.13 10.23 7.54 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.475 2.31 . . . . 0.0 116.282 173.234 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.48 -3.15 39.73 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.7 mt -117.1 135.17 23.01 Favored Pre-proline 0 CA--C 1.484 -1.592 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 176.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 15.5 Cg_exo -77.44 127.85 9.23 Favored 'Trans proline' 0 N--CA 1.421 -2.778 0 CA-C-N 122.413 1.898 . . . . 0.0 107.169 175.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -95.3 -17.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 124.16 0.913 . . . . 0.0 109.468 -175.122 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.502 ' CD2' HG21 ' A' ' 113' ' ' VAL . 84.2 m-70 -149.54 -177.69 6.01 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -169.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.92 135.83 23.51 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -173.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.39 127.06 37.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.05 22.07 16.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.119 0.568 . . . . 0.0 110.192 -170.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -86.64 -28.81 22.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -170.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.82 -25.18 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.783 0 C-N-CA 124.739 1.216 . . . . 0.0 110.146 178.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -97.48 37.79 1.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 123.234 0.334 . . . . 0.0 110.391 -165.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 61.26 67.39 0.8 Allowed 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 127.065 2.146 . . . . 0.0 109.582 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 121.86 59.69 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.021 170.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.433 -2.035 0 N-CA-C 105.429 -2.566 . . . . 0.0 105.429 178.304 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 . . . . . 0 CA--C 1.488 -1.434 0 CA-C-O 120.734 0.302 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.26 55.75 0.84 Allowed 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 166.622 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -91.33 -23.77 20.0 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -91.13 0.78 57.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -75.41 -42.8 52.75 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.2 -48.18 82.73 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.801 172.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.521 0.8 OUTLIER -90.37 8.68 32.31 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 119.903 1.229 . . . . 0.0 114.21 -179.497 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -77.52 -40.0 44.21 Favored 'General case' 0 CA--C 1.494 -1.203 0 O-C-N 120.451 -1.406 . . . . 0.0 107.881 155.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.95 -28.8 70.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.303 1.041 . . . . 0.0 111.208 171.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.92 -10.57 36.04 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -68.48 -42.2 79.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 166.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 93.0 mm-40 -66.92 -68.28 0.39 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.728 171.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 88.8 m-70 -107.83 6.93 27.9 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -153.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -100.84 137.12 39.64 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-N 120.36 1.436 . . . . 0.0 107.635 165.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -151.49 104.25 3.05 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 162.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.94 -51.05 13.95 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -148.66 140.66 14.59 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 76.2 Cg_exo -75.06 177.16 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.5 2.134 . . . . 0.0 113.532 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.45 -67.24 0.74 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.1 -175.19 13.91 Favored Glycine 0 CA--C 1.479 -2.214 1 N-CA-C 103.092 -4.003 . . . . 0.0 103.092 166.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.6 mtm105 -121.88 71.21 0.98 Allowed 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -144.22 -178.45 5.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.338 -171.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.89 -32.71 74.55 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 125.744 1.617 . . . . 0.0 112.733 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 -16.47 38.53 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -177.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.25 -41.67 48.34 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 m -70.14 -32.7 70.82 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.37 -46.3 67.28 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -74.34 -26.17 59.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.26 16.9 tt -82.59 -33.17 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-N 118.589 0.632 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 93.5 mtp -84.89 -10.09 57.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.335 179.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -81.33 -40.61 23.32 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 122.005 -0.434 . . . . 0.0 110.41 169.121 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.57 -37.53 24.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 119.091 -0.481 . . . . 0.0 112.124 -172.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.4 -30.67 67.63 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 118.431 0.56 . . . . 0.0 110.005 170.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.25 48.08 3.89 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 169.062 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.3 mt -110.4 8.53 23.28 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -97.63 2.09 49.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.8 t -132.27 104.93 13.51 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.68 156.68 97.2 Favored 'Cis proline' 0 N--CA 1.444 -1.427 0 N-CA-C 106.68 -2.085 . . . . 0.0 106.68 -21.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.75 114.37 6.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 123.967 0.792 . . . . 0.0 111.895 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -75.64 132.23 40.47 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 173.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -83.02 -15.31 51.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -166.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 133.64 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.23 119.81 7.46 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 m -95.03 108.46 20.53 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.66 126.03 34.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mt -107.91 144.74 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -173.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 77' ' ' GLN . 2.8 m-70 -131.72 127.11 36.16 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.062 -168.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.3 -130.68 2.14 Favored Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 145.99 39.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -84.82 -14.55 47.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 119.29 -0.385 . . . . 0.0 110.594 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.65 49.09 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.3 m -73.94 -42.27 60.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 117.595 -1.193 . . . . 0.0 109.14 175.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 mm -54.43 -54.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 C-N-CA 124.593 1.157 . . . . 0.0 111.953 176.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -58.17 -46.8 85.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 125.202 1.401 . . . . 0.0 111.509 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.55 12.94 1.78 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -75.55 -30.61 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 168.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.5 m -80.24 -21.19 43.07 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -82.95 163.51 21.01 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.35 -17.3 39.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.593 -175.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -87.99 128.49 35.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 165.322 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.6 t30 84.95 -8.44 0.89 Allowed 'General case' 0 C--N 1.356 0.865 0 C-N-CA 128.935 2.894 . . . . 0.0 113.441 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.8 -174.11 22.19 Favored Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 172.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -157.32 157.45 30.28 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.44 157.6 25.56 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.255 1.97 . . . . 0.0 108.244 -176.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 69' ' ' LEU . 13.8 p-80 -128.57 42.55 3.3 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 167.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.488 0.0 OUTLIER 53.82 152.27 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.285 1 C-N-CA 132.69 4.396 . . . . 0.0 119.334 -177.396 . . . . . . . . 4 3 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.57 50.15 3.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 110.842 -2.89 . . . . 0.0 111.917 171.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 83.89 1.45 0.96 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.045 2.938 . . . . 0.0 115.655 177.086 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 2.8 mm? -105.96 149.65 26.43 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -173.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -141.01 123.62 16.01 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -172.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tt -97.12 146.53 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.1 p -85.95 173.31 10.03 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-O 121.457 0.646 . . . . 0.0 111.395 -175.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.97 4.81 3.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.4 t -113.66 86.21 2.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -49.76 123.65 8.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.885 2.474 . . . . 0.0 113.347 -179.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.49 156.29 20.29 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . 7.2 tt0 -83.37 143.53 30.27 Favored 'General case' 0 CA--C 1.466 -2.275 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.07 141.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -168.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -129.16 107.85 9.89 Favored 'General case' 0 CA--C 1.478 -1.811 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 166.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -84.01 100.66 11.21 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.4 m -84.19 106.42 15.81 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -118.8 142.23 47.9 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 -171.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -83.99 121.48 27.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.854 0.835 . . . . 0.0 109.014 -171.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.02 55.96 1.87 Allowed 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.42 -63.94 0.26 Allowed Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 105.125 -3.19 . . . . 0.0 105.125 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.08 27.32 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 173.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -89.99 138.87 27.41 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -83.0 -20.84 5.02 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.671 1.581 . . . . 0.0 109.242 172.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -108.03 156.86 37.53 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-O 117.615 -1.183 . . . . 0.0 108.84 -165.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -75.14 148.59 34.96 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.654 2.236 . . . . 0.0 108.719 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -81.62 166.56 72.31 Favored 'Cis proline' 0 N--CA 1.438 -1.751 0 CA-C-N 122.324 1.866 . . . . 0.0 108.654 -1.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.2 m -138.94 126.22 21.49 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -173.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -90.02 98.37 11.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -176.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -85.14 133.81 34.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -100.66 131.44 46.56 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 174.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.45 35.71 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.838 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -120.86 90.49 3.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 172.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.88 148.95 22.86 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.494 -171.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.05 -172.5 18.11 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 107.473 -2.251 . . . . 0.0 107.473 178.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -149.89 100.28 2.93 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -148.05 172.25 14.55 Favored 'General case' 0 CA--C 1.482 -1.64 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.418 -173.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -85.07 117.28 23.94 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -90.56 139.22 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.566 ' CG1' ' HE1' ' A' ' 65' ' ' HIS . 59.9 t -94.82 123.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.26 150.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 170.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.53 127.78 40.7 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 175.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.07 155.7 23.42 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.001 0.905 . . . . 0.0 112.0 -171.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -160.39 126.31 4.07 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.487 -2.783 . . . . 0.0 103.487 173.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 11.9 p30 66.91 14.35 9.79 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.863 2.465 . . . . 0.0 115.764 175.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.67 61.53 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.26 2.2 mp -107.64 138.2 19.93 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 177.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.37 112.63 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 N-CA-C 104.892 -2.772 . . . . 0.0 104.892 168.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -92.97 -18.6 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.814 -172.422 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.462 ' CD2' HG21 ' A' ' 113' ' ' VAL . 21.2 m-70 -151.33 -179.57 7.48 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.0 141.54 51.24 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.11 124.27 30.94 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 165.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -115.65 56.71 0.75 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 t -89.25 -51.56 5.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -28.86 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -170.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -84.02 -22.25 31.37 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.985 -165.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -64.47 0.87 Allowed 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.048 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -146.07 148.07 34.07 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 174.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 N--CA 1.432 -2.093 0 N-CA-C 105.742 -2.445 . . . . 0.0 105.742 177.977 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 . . . . . 0 CA--C 1.487 -1.462 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -129.84 48.6 2.36 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -93.2 -13.64 28.11 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -90.7 -26.39 19.58 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.67 39.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.284 9.5 t80 -51.41 -64.44 0.81 Allowed 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 125.972 1.709 . . . . 0.0 109.897 164.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -80.24 1.23 29.3 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -169.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -92.02 -26.33 18.4 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 119.897 1.226 . . . . 0.0 109.083 169.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.51 -36.33 80.22 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 161.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -28.69 51.5 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.587 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.8 m -65.08 -50.9 64.36 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 119.47 1.032 . . . . 0.0 109.819 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.434 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 72.3 mt-30 -68.35 -44.58 74.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 O-C-N 123.712 0.633 . . . . 0.0 112.675 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 92.6 m-70 -103.07 -55.54 2.4 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.7 -167.128 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -76.66 117.1 17.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.013 0.911 . . . . 0.0 109.586 -167.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -134.02 96.15 3.58 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 101.045 -3.687 . . . . 0.0 101.045 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.98 -41.7 1.71 Allowed 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 128.659 2.784 . . . . 0.0 117.539 -168.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -157.57 144.8 13.52 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -76.74 -176.46 3.16 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.391 2.061 . . . . 0.0 114.078 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -72.59 -73.36 0.2 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 165.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.37 -174.32 13.59 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 102.437 -4.265 . . . . 0.0 102.437 164.443 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -111.8 75.97 0.95 Allowed 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 176.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -142.65 177.13 8.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.938 -173.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -56.06 -43.1 77.61 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 127.81 2.444 . . . . 0.0 112.169 -175.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -77.57 -23.95 49.88 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.036 0.935 . . . . 0.0 110.968 -176.242 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -71.83 -47.88 50.1 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' HA ' HG21 ' A' ' 29' ' ' ILE . 5.9 t -81.41 -22.77 38.03 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.61 -169.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.9 -47.9 81.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 123.725 0.81 . . . . 0.0 109.654 170.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.9 m -68.13 -36.41 79.66 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 26' ' ' CYS . 14.2 tt -80.49 -27.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-N 118.894 0.77 . . . . 0.0 110.917 -176.209 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.7 mmt -71.36 -36.97 71.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 118.327 0.512 . . . . 0.0 109.934 175.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.29 -28.08 61.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -75.96 -50.57 14.57 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 118.822 0.737 . . . . 0.0 110.355 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -23.47 60.07 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.804 0.842 . . . . 0.0 112.175 -172.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 51.98 2.68 Favored Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 170.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.1 mt -113.66 9.81 17.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 p -100.9 15.57 28.09 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 124.016 0.926 . . . . 0.0 108.959 178.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -124.2 94.5 45.18 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.81 166.79 81.76 Favored 'Cis proline' 0 N--CA 1.443 -1.468 0 N-CA-C 107.021 -1.954 . . . . 0.0 107.021 -24.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.6 m -62.78 120.04 10.5 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 124.36 1.064 . . . . 0.0 112.882 -172.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -72.4 139.64 47.93 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.576 -178.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -71.83 -43.15 66.06 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.391 0.677 . . . . 0.0 111.682 -172.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.84 128.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -143.49 130.21 20.31 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -100.3 116.32 32.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.85 124.78 35.43 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mm -93.57 150.95 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -142.96 127.74 18.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -177.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.04 -137.2 4.16 Favored Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 172.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -106.3 144.39 33.07 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.78 -20.95 32.41 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.471 -167.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.62 -10.2 44.16 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.0 m -76.44 -38.06 56.06 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.648 166.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.76 -52.32 62.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-N 118.907 0.776 . . . . 0.0 110.542 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.26 -45.95 89.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 125.084 1.354 . . . . 0.0 111.342 -175.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.13 21.97 1.03 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' HB ' HH11 ' A' ' 70' ' ' ARG . 42.8 mt -78.55 -27.11 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 165.069 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.14 -39.59 90.61 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 122.449 0.3 . . . . 0.0 111.517 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -104.97 171.26 7.41 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.408 0.623 . . . . 0.0 110.24 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.6 t30 73.33 -136.9 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.532 1.533 . . . . 0.0 114.694 153.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -136.01 0.42 2.62 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 -164.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -82.22 -20.84 36.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 171.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.58 -176.03 19.16 Favored Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 164.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.52 154.08 32.95 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.16 147.02 23.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 122.523 2.149 . . . . 0.0 107.441 -175.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -135.59 125.34 25.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? 64.66 -107.01 0.15 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.069 1.347 . . . . 0.0 111.489 171.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.96 97.21 3.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.357 2.1 p-10 64.84 24.72 12.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 129.105 2.962 . . . . 0.0 114.112 175.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 mt -111.87 168.8 9.3 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 101.196 -3.631 . . . . 0.0 101.196 172.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.438 HH22 ' CB ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -155.5 129.63 8.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.446 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 tt -101.01 143.43 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -175.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 85.6 p -82.56 165.44 20.1 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-O 122.261 1.029 . . . . 0.0 111.417 -176.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -128.74 4.56 5.49 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 178.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -122.26 88.95 3.03 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 175.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -59.63 132.13 53.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.661 1.584 . . . . 0.0 112.5 -177.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -109.54 158.24 18.2 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 139.35 38.36 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 174.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.21 144.65 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -171.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -128.53 108.04 10.2 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -87.78 102.59 14.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 177.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -95.58 137.67 34.31 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -177.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -128.15 141.85 51.36 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.27 133.19 40.13 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 126.32 1.848 . . . . 0.0 108.031 -175.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -136.04 164.08 28.83 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.84 -44.58 1.44 Allowed Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 -176.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.59 17.48 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -107.35 122.52 41.02 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -79.22 -29.28 3.22 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 N-CA-C 107.612 -1.726 . . . . 0.0 107.612 173.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -101.44 156.72 34.84 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -171.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -75.05 148.2 34.78 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 122.594 2.196 . . . . 0.0 107.493 -174.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -84.11 164.08 66.2 Favored 'Cis proline' 0 CA--C 1.49 -1.675 0 CA-C-N 123.133 2.155 . . . . 0.0 109.392 10.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 m -151.86 118.88 5.85 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -167.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -93.99 119.74 33.29 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -98.53 123.2 42.56 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -87.12 118.01 26.23 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.83 137.63 32.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.651 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 m -120.82 112.27 18.61 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.64 148.14 28.14 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.268 0.556 . . . . 0.0 110.032 -176.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.96 32.73 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -155.32 107.49 2.67 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.17 -3.27 . . . . 0.0 102.17 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -153.51 170.35 20.97 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.797 -174.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.46 124.41 31.32 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -99.04 142.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -166.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.09 122.37 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 170.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.71 160.39 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 102.434 -3.173 . . . . 0.0 102.434 173.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.07 131.94 54.61 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 119.021 0.828 . . . . 0.0 109.146 176.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.9 t -97.6 148.87 22.84 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.13 1.372 . . . . 0.0 109.174 -174.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.5 123.89 12.35 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 164.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.312 13.8 p30 64.84 19.63 11.9 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 128.209 2.604 . . . . 0.0 116.679 174.002 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.3 19.69 51.71 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.331 1.3 tp -129.51 146.71 62.21 Favored Pre-proline 0 CA--C 1.481 -1.68 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 177.475 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' CB ' HH22 ' A' ' 70' ' ' ARG . 82.0 Cg_exo -69.46 147.04 63.91 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 121.457 1.438 . . . . 0.0 108.891 162.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -129.09 -30.96 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 O-C-N 123.708 0.63 . . . . 0.0 109.338 175.508 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.409 ' CD2' HG21 ' A' ' 113' ' ' VAL . 88.2 m-70 -145.33 175.73 10.08 Favored 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.965 -165.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 tp -125.3 139.18 53.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.82 128.06 35.64 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 167.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -108.84 52.05 0.72 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -87.42 -44.94 10.97 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -173.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.78 -28.51 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -173.462 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -84.54 -22.1 30.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.819 -165.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -80.0 -34.34 38.59 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 173.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -78.87 147.45 70.49 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -177.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 N-CA-C 105.676 -2.471 . . . . 0.0 105.676 173.457 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -143.07 95.88 2.84 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 84.88 11.2 0.31 Allowed 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.41 2.284 . . . . 0.0 107.91 -179.005 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -91.65 -29.66 16.75 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.521 HH21 ' HE2' ' A' ' 114' ' ' HIS . 79.0 mtp180 -66.23 -45.69 79.81 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.199 1.4 . . . . 0.0 109.401 179.412 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -50.54 -62.21 1.73 Allowed 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.689 1.996 . . . . 0.0 113.881 170.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -70.34 -13.88 62.34 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -81.33 -39.25 25.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 119.848 1.204 . . . . 0.0 110.055 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.65 -34.42 74.26 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.11 1.364 . . . . 0.0 109.646 169.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.447 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -77.25 -24.39 51.13 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 125.855 1.662 . . . . 0.0 113.341 177.313 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -66.2 -58.08 6.19 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.28 -52.08 63.49 Favored 'General case' 0 CA--C 1.484 -1.587 0 O-C-N 124.051 0.844 . . . . 0.0 113.046 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -101.3 -15.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -163.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 28.9 t80 -93.99 137.15 33.52 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 122.936 2.607 . . . . 0.0 109.738 177.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -151.79 100.4 2.67 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 165.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.58 -49.41 2.17 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -164.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -145.47 149.95 42.44 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 167.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 51.4 Cg_endo -84.07 169.71 11.37 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.42 2.08 . . . . 0.0 107.922 -175.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.87 -70.53 0.35 Allowed 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.73 15.0 Favored Glycine 0 CA--C 1.475 -2.436 1 N-CA-C 102.768 -4.133 . . . . 0.0 102.768 164.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -116.66 73.62 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 177.05 9.81 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -174.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.36 -18.87 62.35 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.575 1.15 . . . . 0.0 112.717 -173.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.48 -22.12 30.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 122.797 0.439 . . . . 0.0 110.183 178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -77.44 -42.02 37.56 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.1 m -67.02 -37.16 83.66 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 123.829 0.706 . . . . 0.0 112.54 -178.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.29 -42.71 87.98 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 123.679 0.792 . . . . 0.0 110.36 175.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 m -69.89 -32.32 70.59 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.457 HD13 HH21 ' A' ' 33' ' ' ARG . 6.9 tt -81.87 -33.48 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 118.915 0.78 . . . . 0.0 110.61 -176.119 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.0 mmt -73.63 -31.58 63.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.064 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -74.83 -34.68 62.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -70.94 -56.88 5.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.078 0.951 . . . . 0.0 110.596 -172.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.457 HH21 HD13 ' A' ' 29' ' ' ILE . 10.0 ptp180 -85.38 -18.09 34.76 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.077 -175.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.64 71.12 1.31 Allowed Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 166.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -118.41 11.89 13.15 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 173.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.8 t -96.81 3.96 51.98 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.143 0.977 . . . . 0.0 108.99 -171.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -129.52 103.09 17.92 Favored Pre-proline 0 N--CA 1.427 -1.607 0 CA-C-O 117.81 -1.091 . . . . 0.0 108.667 -177.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.71 159.19 97.1 Favored 'Cis proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.52 -2.146 . . . . 0.0 106.52 -22.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.07 119.55 16.42 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 111.994 -166.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -79.55 134.12 36.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 172.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.9 -15.3 48.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.847 -164.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.63 125.88 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -139.08 128.81 24.73 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 169.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -96.27 117.85 31.64 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -93.64 120.36 33.82 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.5 145.1 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -174.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.435 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m-70 -133.16 128.93 37.11 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -174.446 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.66 -132.39 2.9 Favored Glycine 0 CA--C 1.483 -1.955 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 176.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.19 144.48 43.12 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -84.0 -15.17 48.67 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -74.68 -35.69 62.77 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.502 1.121 . . . . 0.0 108.612 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.1 m -72.15 -37.14 69.46 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.287 176.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 mm -56.55 -55.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 123.912 0.885 . . . . 0.0 111.842 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -58.92 -40.01 83.26 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.422 1.089 . . . . 0.0 112.889 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -18.72 46.86 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.8 -26.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 119.718 1.145 . . . . 0.0 110.683 -176.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.4 t -77.5 -12.08 59.92 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 118.579 0.627 . . . . 0.0 111.933 -178.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.45 -178.94 7.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.181 0.991 . . . . 0.0 108.72 168.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.05 -28.66 61.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.88 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -74.14 154.93 38.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 172.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 t30 61.78 21.21 12.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.633 2.373 . . . . 0.0 116.127 171.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.87 177.47 41.5 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -143.72 157.07 59.15 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -72.39 148.18 48.28 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.382 2.055 . . . . 0.0 109.671 -176.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -134.92 127.2 30.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 62.08 -106.45 0.21 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 125.726 1.61 . . . . 0.0 112.117 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -151.95 108.76 3.5 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 2.0 p-10 66.25 24.1 10.74 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 129.727 3.211 . . . . 0.0 113.87 176.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 mt -116.15 170.86 8.19 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 171.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.488 HH12 ' HG3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -149.85 146.1 26.93 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 166.356 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.34 151.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 175.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -74.48 177.99 5.6 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.297 1.046 . . . . 0.0 112.725 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -142.04 7.13 1.8 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.4 t -130.58 94.53 3.66 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 171.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 p -57.09 130.19 45.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.065 1.746 . . . . 0.0 112.717 -177.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.86 156.0 17.79 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -175.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 138.58 39.5 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 175.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.54 142.48 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.015 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.2 m -130.62 108.51 9.97 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 167.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.6 m -81.76 101.74 10.32 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 75.9 m -88.15 110.37 20.63 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 178.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.06 145.79 49.01 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 151.38 29.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.088 0.947 . . . . 0.0 112.62 -172.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -125.18 44.12 2.88 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.66 -108.48 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.336 0 C-N-CA 129.454 3.407 . . . . 0.0 113.378 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.75 -51.08 4.37 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 112.436 -1.882 . . . . 0.0 111.531 -162.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 p -175.86 152.66 1.3 Allowed Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 -173.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -86.03 -13.32 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.226 1.95 . . . . 0.0 108.658 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.33 159.42 32.03 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -75.28 142.93 27.61 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 121.998 1.799 . . . . 0.0 107.507 -172.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -82.06 161.16 78.45 Favored 'Cis proline' 0 CA--C 1.487 -1.827 0 CA-C-N 123.538 2.299 . . . . 0.0 110.794 8.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 m -142.87 122.41 13.23 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -166.436 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -85.58 109.19 18.36 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -99.61 121.53 41.33 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -98.83 152.67 19.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.38 31.2 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.2 m -126.56 98.24 5.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 167.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.77 32.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.153 0.501 . . . . 0.0 109.967 -175.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.49 20.84 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -151.65 92.51 1.76 Allowed 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 101.627 -3.471 . . . . 0.0 101.627 179.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -136.99 154.4 50.42 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -161.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -68.14 128.88 38.18 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.9 m -93.03 120.48 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -174.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.2 t -86.84 118.39 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.84 157.96 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 176.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 128.53 40.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.8 t -107.45 136.75 46.7 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.148 0.979 . . . . 0.0 108.847 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.45 138.98 50.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 169.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 14.0 p30 65.64 17.7 10.98 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 127.17 2.188 . . . . 0.0 116.644 172.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.83 23.71 48.55 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 28.3 tp -141.14 151.05 60.82 Favored Pre-proline 0 CA--C 1.486 -1.484 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.488 ' HG3' HH12 ' A' ' 70' ' ' ARG . 74.1 Cg_exo -66.94 162.88 35.93 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 122.552 1.947 . . . . 0.0 109.791 164.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.459 HG21 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -147.4 -27.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 O-C-N 121.616 -0.677 . . . . 0.0 111.274 176.245 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.521 ' HE2' HH21 ' A' ' 5' ' ' ARG . 88.8 m-70 -144.08 172.03 13.45 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 -173.473 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.0 134.28 54.33 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 175.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.63 121.03 27.73 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 174.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -103.94 45.67 0.95 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p -98.74 -30.41 12.45 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 175.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -23.5 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -101.31 -5.24 25.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.872 -172.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -68.85 -41.59 78.27 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -75.22 119.41 76.85 Favored Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 170.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.434 -1.993 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 -164.667 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 . . . . . 0 CA--C 1.486 -1.49 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -108.55 58.77 0.61 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -115.82 4.16 13.89 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.59 -18.5 26.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.164 179.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -68.44 -43.66 76.59 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.513 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.252 8.6 t80 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.402 -2.837 0 C-N-CA 124.768 1.227 . . . . 0.0 111.142 174.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -173.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -82.34 -32.36 29.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 119.479 1.036 . . . . 0.0 109.091 170.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' CD2' ' CD1' ' A' ' 10' ' ' LEU . 1.9 t80 -58.22 -38.98 77.87 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.13 164.354 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 8.4 mp -83.38 -11.51 57.53 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 119.651 1.114 . . . . 0.0 113.495 178.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.2 m -70.66 -45.25 65.44 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 119.564 1.075 . . . . 0.0 108.298 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.12 -41.35 67.32 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.044 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' A' ' 115' ' ' LEU . 93.5 m-70 -101.56 -54.5 2.74 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.096 -169.028 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 9.6 t80 -72.45 126.41 29.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 120.45 1.477 . . . . 0.0 112.776 -165.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -149.17 104.37 3.41 Favored 'General case' 0 N--CA 1.424 -1.75 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 172.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.2 -32.28 10.12 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -162.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 152.38 42.9 Favored Pre-proline 0 N--CA 1.432 -1.37 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.528 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 17.2 Cg_endo -71.31 144.1 45.14 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 C-N-CA 123.265 2.643 . . . . 0.0 107.519 167.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -77.52 -51.63 10.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.6 179.68 17.35 Favored Glycine 0 CA--C 1.478 -2.259 1 N-CA-C 103.091 -4.004 . . . . 0.0 103.091 161.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.92 55.03 0.94 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.49 179.81 6.58 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -170.553 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -67.95 -23.94 65.11 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 125.352 1.461 . . . . 0.0 113.204 -172.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -25.76 37.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.51 -44.78 49.76 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.9 m -65.07 -38.07 89.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.35 -33.81 55.31 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 119.117 -0.468 . . . . 0.0 111.072 -178.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -76.57 -29.87 56.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 118.78 -0.628 . . . . 0.0 112.023 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 13.5 tt -75.92 -38.58 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.611 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.7 mtm -79.27 -23.23 43.76 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 118.136 -1.425 . . . . 0.0 113.447 -176.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -72.39 -36.81 68.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 170.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.18 -45.66 32.26 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.537 0.735 . . . . 0.0 111.479 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -76.78 -25.43 53.36 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.744 1.618 . . . . 0.0 109.344 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.12 44.48 3.8 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 163.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.8 mt -118.54 19.77 13.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -90.08 -11.33 41.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.619 1.168 . . . . 0.0 108.244 -176.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 m -121.3 105.0 39.92 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.61 161.31 94.91 Favored 'Cis proline' 0 N--CA 1.441 -1.612 0 N-CA-C 107.018 -1.955 . . . . 0.0 107.018 -22.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.95 125.54 24.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.202 1.001 . . . . 0.0 109.586 -177.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.78 142.38 38.67 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.7 -36.47 57.2 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.76 128.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -161.36 144.48 12.56 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.506 ' HG1' HE22 ' A' ' 117' ' ' GLN . 85.0 m -106.87 138.88 42.2 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 -170.103 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -101.87 129.77 48.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 162.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.67 150.89 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.637 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -174.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.528 ' CG ' ' HD3' ' A' ' 18' ' ' PRO 0.252 7.9 m-70 -140.25 153.12 46.42 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.741 -174.024 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.04 -124.24 3.89 Favored Glycine 0 CA--C 1.478 -2.246 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 169.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 135.58 42.93 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.968 1.366 . . . . 0.0 109.707 -177.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.27 -29.11 34.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.602 -1.636 . . . . 0.0 106.857 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -29.11 64.85 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.9 m -76.88 -36.79 56.47 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 116.663 -1.637 . . . . 0.0 111.485 176.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.268 6.6 tp -65.03 -46.34 91.77 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 0 CA-C-N 120.193 1.361 . . . . 0.0 110.592 -178.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -60.61 -43.48 97.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.428 1.091 . . . . 0.0 110.808 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.18 11.46 2.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.56 -35.99 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.097 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 167.127 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -96.74 5.29 50.91 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -112.38 18.65 18.33 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.087 0.946 . . . . 0.0 108.461 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 32.1 47.58 0.09 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 131.686 3.994 . . . . 0.0 115.744 -170.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.78 -60.7 2.21 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.55 64.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.163 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.19 146.84 8.58 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 173.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -102.49 164.06 16.42 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.92 144.01 42.19 Favored 'Trans proline' 0 N--CA 1.437 -1.797 0 C-N-CA 122.692 2.262 . . . . 0.0 106.886 166.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -136.23 33.69 2.81 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 -178.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.6 mmt-85 61.12 157.62 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 129.017 2.927 . . . . 0.0 114.73 178.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 52.84 46.77 26.09 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 128.126 2.57 . . . . 0.0 113.882 175.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.316 2.8 p-10 51.48 40.35 26.61 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.785 2.434 . . . . 0.0 114.192 -174.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.88 153.81 32.91 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 100.799 -3.778 . . . . 0.0 100.799 177.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -146.26 125.17 12.72 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -90.59 143.19 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 179.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.0 p -80.88 158.16 25.41 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.693 0.758 . . . . 0.0 112.75 -175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -108.11 -19.97 13.32 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -104.93 82.45 1.87 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 p -52.43 132.06 34.27 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 127.023 2.129 . . . . 0.0 112.413 178.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -107.26 160.42 15.61 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -79.76 144.3 33.72 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.77 142.14 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 m -131.54 104.56 7.03 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 169.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.0 m -86.32 105.26 16.55 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.34 111.25 20.89 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -111.36 131.52 55.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 -171.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.5 118.01 11.83 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 123.64 0.776 . . . . 0.0 108.935 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -130.93 71.38 1.47 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -175.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.19 -45.97 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 105.156 -3.178 . . . . 0.0 105.156 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.02 37.03 8.6 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 p -103.57 122.29 45.37 Favored Pre-proline 0 N--CA 1.434 -1.246 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -83.54 -20.21 4.88 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 CA-C-N 121.587 1.602 . . . . 0.0 108.614 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -110.9 158.44 35.74 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.318 -167.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.25 147.01 36.81 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.824 2.35 . . . . 0.0 108.382 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -82.06 165.75 72.34 Favored 'Cis proline' 0 N--CA 1.438 -1.761 0 CA-C-N 122.401 1.893 . . . . 0.0 108.489 -1.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.1 m -113.12 157.91 21.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.703 1.252 . . . . 0.0 107.637 -172.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -111.57 135.59 51.93 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -133.71 122.58 23.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -89.06 125.12 34.88 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.09 122.34 27.21 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -115.24 88.07 2.79 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.48 142.34 27.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.009 -172.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.11 -177.09 14.94 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 177.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -140.44 97.62 3.25 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 175.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -158.34 -179.66 8.31 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -164.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -79.91 146.84 31.92 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.053 -173.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.43 151.95 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -114.06 95.02 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 163.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.3 136.6 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.53 130.17 34.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 174.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 57.1 m -109.66 149.64 29.43 Favored 'General case' 0 CA--C 1.489 -1.376 0 O-C-N 124.136 0.897 . . . . 0.0 110.688 -173.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.21 124.97 7.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.2 p30 65.89 18.32 11.06 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.782 2.433 . . . . 0.0 116.338 171.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.3 -7.02 59.83 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -103.06 148.76 36.11 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 177.611 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -70.89 143.46 45.46 Favored 'Trans proline' 0 N--CA 1.435 -1.968 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 156.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -121.22 -22.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.369 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -154.25 -167.35 2.61 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -167.88 136.75 2.49 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 -179.656 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -80.5 139.66 36.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.864 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.506 HE22 ' HG1' ' A' ' 44' ' ' THR . 29.7 mm100 -101.88 40.77 1.28 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 172.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.3 m -96.22 -30.19 13.61 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -175.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.71 -35.41 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.941 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.241 172.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -103.43 43.47 1.08 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -168.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -153.34 -50.03 0.1 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 171.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -112.35 112.44 51.88 Favored Pre-proline 0 N--CA 1.431 -1.381 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.432 -2.103 0 N-CA-C 106.167 -2.282 . . . . 0.0 106.167 -176.485 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 CA--C 1.501 -0.936 0 N-CA-C 110.621 -0.141 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -90.38 -1.64 57.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.45 -45.35 59.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.55 -52.72 63.72 Favored 'General case' 0 N--CA 1.412 -2.344 0 C-N-CA 125.538 1.535 . . . . 0.0 112.366 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.449 1.8 t -87.97 9.8 21.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.99 -42.2 33.45 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 120.207 -1.558 . . . . 0.0 107.463 157.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -59.77 -36.91 77.64 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.982 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 14' ' ' TYR . 20.2 mt -83.77 -15.91 46.71 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 119.567 1.076 . . . . 0.0 113.863 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.7 m -65.8 -48.61 71.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 119.911 1.232 . . . . 0.0 108.908 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -72.91 -37.25 67.31 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -104.34 -53.64 2.68 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.251 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 14.8 t80 -76.61 115.33 16.27 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 119.232 0.924 . . . . 0.0 110.123 -168.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -134.76 98.73 4.12 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.11 -38.01 16.72 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -165.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -159.77 134.52 5.52 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -71.54 178.05 6.09 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 123.051 2.501 . . . . 0.0 114.66 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.31 -59.63 2.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -179.36 22.73 Favored Glycine 0 CA--C 1.478 -2.228 0 N-CA-C 104.403 -3.479 . . . . 0.0 104.403 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.519 HH21 ' HG3' ' A' ' 77' ' ' GLN . 11.1 mpt_? -106.84 73.46 0.94 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -156.92 173.46 16.97 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.41 -20.77 62.9 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 125.373 1.469 . . . . 0.0 113.963 -169.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -80.46 -29.61 37.47 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.32 -41.58 66.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.7 OUTLIER -80.34 -25.39 39.27 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.729 -1.188 . . . . 0.0 113.097 -170.953 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.01 -36.48 69.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 118.99 -0.528 . . . . 0.0 110.175 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.4 t -65.65 -42.96 90.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.3 tt -80.37 -28.09 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 117.83 0.286 . . . . 0.0 111.199 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 mmt -74.25 -29.99 61.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.035 -0.415 . . . . 0.0 110.325 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.457 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.3 tpp180 -66.43 -45.75 78.82 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.774 0.83 . . . . 0.0 111.869 172.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -80.22 -39.68 28.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -170.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.47 -39.65 74.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.46 68.82 1.34 Allowed Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 mt -113.94 21.83 14.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 163.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -94.6 -5.78 45.01 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 109.085 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -132.6 102.66 13.75 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.86 163.31 89.39 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.484 -1.776 . . . . 0.0 107.484 -18.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 83' ' ' LEU . 33.9 m -59.62 125.75 24.87 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 124.492 1.117 . . . . 0.0 110.693 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -76.19 138.46 40.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.83 -40.71 60.89 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 123.432 0.457 . . . . 0.0 111.256 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.91 128.0 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -148.79 131.72 16.17 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 m -96.97 124.38 40.92 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.645 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.98 120.08 30.88 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.77 149.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.636 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -143.37 138.46 29.43 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.98 -140.28 6.78 Favored Glycine 0 CA--C 1.484 -1.871 0 N-CA-C 106.651 -2.579 . . . . 0.0 106.651 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.38 146.55 25.07 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 1.2 tmtp? -83.89 -25.4 30.23 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -70.75 -34.23 71.63 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.006 1.323 . . . . 0.0 108.708 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -69.93 -41.44 74.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 117.614 -1.184 . . . . 0.0 110.459 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.74 -50.73 76.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 123.837 0.855 . . . . 0.0 111.909 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -63.87 -37.67 88.24 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.343 0.657 . . . . 0.0 111.188 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.35 4.81 8.15 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HB2' ' A' ' 72' ' ' SER . 23.0 mm -77.3 -26.85 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.7 t -82.74 -15.02 53.42 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.152 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.47 154.41 38.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -83.34 -7.49 59.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.757 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -80.41 -41.84 23.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.921 0.488 . . . . 0.0 109.769 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -123.29 31.46 5.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.67 136.95 3.37 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -90.01 154.02 47.27 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 37.2 Cg_endo -74.79 138.43 23.58 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 122.335 2.024 . . . . 0.0 106.974 169.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -130.67 104.77 7.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' CD ' ' H ' ' A' ' 67' ' ' GLU 0.398 0.0 OUTLIER 46.31 -109.59 0.23 Allowed 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 127.806 2.442 . . . . 0.0 115.661 -177.862 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 50.2 mt-10 -107.33 77.47 1.15 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.766 1.226 . . . . 0.0 108.763 -165.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.372 1.2 p-10 76.59 12.12 2.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 129.102 2.961 . . . . 0.0 114.345 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.3 mp -95.82 154.17 17.36 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 64' ' ' PRO . 13.8 mmp_? -136.57 112.64 9.7 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -95.73 132.21 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.422 ' HB2' HD12 ' A' ' 56' ' ' ILE . 96.2 p -82.45 157.05 23.79 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.652 0.739 . . . . 0.0 112.424 -168.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -108.94 -15.93 14.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.533 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -112.91 90.57 3.38 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.8 m -50.92 133.23 27.05 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 127.402 2.281 . . . . 0.0 112.419 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.4 161.3 15.43 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' HG3' HH21 ' A' ' 21' ' ' ARG . 0.3 OUTLIER -82.16 126.77 32.44 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 175.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 108.5 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.2 m -94.82 108.31 20.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.1 m -91.83 102.9 15.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.2 m -93.3 117.65 30.33 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.54 144.73 37.43 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 39' ' ' CYS . 41.2 tp -78.98 126.67 30.99 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.72 52.58 2.04 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.69 -70.54 1.18 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.71 -32.44 4.44 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.9 t -87.48 135.34 34.47 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -78.38 -22.65 9.35 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.161 1.908 . . . . 0.0 109.074 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -95.32 167.4 12.89 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -72.32 142.63 37.69 Favored 'Trans proline' 0 N--CA 1.438 -1.788 0 C-N-CA 122.028 1.819 . . . . 0.0 107.526 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.0 Cg_endo -88.15 164.56 42.96 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 CA-C-N 122.63 1.975 . . . . 0.0 108.775 15.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.7 m -130.01 122.66 28.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -94.87 117.35 30.0 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -107.28 122.6 46.88 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -96.79 121.4 38.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.67 130.33 35.02 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.9 m -118.05 95.4 4.89 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.94 34.27 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.105 -173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.94 -176.18 19.61 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.328 -3.109 . . . . 0.0 105.328 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -148.43 109.71 4.37 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.568 -3.123 . . . . 0.0 102.568 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -162.12 175.11 12.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.971 0.891 . . . . 0.0 109.018 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -77.56 142.24 39.11 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 125.244 1.418 . . . . 0.0 110.675 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.38 150.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.12 91.73 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 166.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.64 132.62 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.52 125.02 36.97 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.3 t -108.67 131.24 55.09 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -126.19 136.84 53.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 13.1 p30 65.05 18.98 11.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 127.514 2.326 . . . . 0.0 117.083 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.9 54.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 0.4 OUTLIER -134.47 132.2 20.76 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 -178.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.95 108.21 2.6 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 N-CA-C 105.78 -2.431 . . . . 0.0 105.78 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 m -94.27 -11.72 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -172.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.455 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 61.9 t60 -153.85 179.53 8.79 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -169.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.455 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -164.21 130.58 3.06 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.85 135.02 36.92 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.251 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -100.86 41.84 1.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.3 t -96.38 -32.39 12.39 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.47 -35.89 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.837 172.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.422 -1.854 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -171.434 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.319 0.5 OUTLIER . . . . . 0 CA--C 1.489 -1.393 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 m -92.19 -13.82 29.98 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -43.68 67.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.268 41.4 t80 -56.82 -51.96 66.95 Favored 'General case' 0 N--CA 1.399 -3.012 0 C-N-CA 126.623 1.969 . . . . 0.0 113.422 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.482 ' HA ' ' HG ' ' A' ' 10' ' ' LEU 0.252 1.5 p -82.06 -3.24 54.22 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -31.21 22.7 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 120.136 1.335 . . . . 0.0 108.229 167.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 115' ' ' LEU . 16.0 t80 -65.18 -36.98 85.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.407 1.083 . . . . 0.0 109.405 167.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.295 8.9 mt -69.25 -31.15 69.5 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 170.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.6 m -65.26 -44.28 88.61 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 119.509 1.049 . . . . 0.0 108.936 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 66.5 mt-30 -70.0 -55.16 10.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 123.556 0.535 . . . . 0.0 111.92 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.463 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 91.1 m-70 -96.49 -49.44 5.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.913 -162.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HB2' HD22 ' A' ' 10' ' ' LEU . 29.2 t80 -71.15 115.09 9.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 120.065 1.302 . . . . 0.0 112.635 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -138.56 98.05 3.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 100.789 -3.782 . . . . 0.0 100.789 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.82 -40.69 10.09 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.515 2.326 . . . . 0.0 117.055 -168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -157.63 144.11 13.04 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 69.0 Cg_exo -76.51 178.39 7.61 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.507 2.138 . . . . 0.0 112.916 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.64 -74.99 0.17 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.74 -176.44 14.74 Favored Glycine 0 CA--C 1.477 -2.336 1 N-CA-C 102.557 -4.217 . . . . 0.0 102.557 163.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -118.16 72.56 0.87 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -145.01 177.8 8.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.72 -22.33 63.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.704 1.202 . . . . 0.0 113.595 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.8 -29.45 40.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -41.87 69.48 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.282 0.8 OUTLIER -79.69 -26.92 40.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.227 -170.585 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.66 -35.47 70.36 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.286 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -67.73 -38.91 84.17 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 26' ' ' CYS . 4.1 tt -79.69 -30.85 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 118.535 0.607 . . . . 0.0 110.629 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -74.4 -30.09 61.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 122.392 -0.192 . . . . 0.0 111.0 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -68.43 -44.85 74.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.467 0.707 . . . . 0.0 111.873 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -71.2 -48.99 48.21 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.913 0.885 . . . . 0.0 112.277 -173.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -36.82 75.35 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.201 0.6 . . . . 0.0 110.408 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.58 68.79 1.36 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -114.91 22.48 13.41 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -91.25 -10.21 42.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 124.267 1.027 . . . . 0.0 109.132 -172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -129.99 104.54 16.82 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.65 160.01 95.66 Favored 'Cis proline' 0 N--CA 1.444 -1.404 0 N-CA-C 107.073 -1.934 . . . . 0.0 107.073 -20.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' HD13 ' A' ' 83' ' ' LEU . 59.5 m -62.92 125.26 23.37 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.059 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.01 143.17 45.67 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.03 -39.14 61.23 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.161 0.584 . . . . 0.0 111.541 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 tt -149.11 128.83 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -147.26 125.73 12.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 m -101.51 114.36 28.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.586 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -85.67 125.96 33.57 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.41 146.37 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.726 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -136.91 127.45 26.86 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 125.311 1.444 . . . . 0.0 107.949 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.65 -148.49 17.67 Favored Glycine 0 CA--C 1.483 -1.91 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -84.02 140.5 31.82 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 122.2 1.0 . . . . 0.0 108.33 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -85.27 -15.78 42.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.308 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -79.32 -31.42 43.18 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 125.317 1.447 . . . . 0.0 107.857 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.7 m -73.37 -36.47 66.11 Favored 'General case' 0 N--CA 1.424 -1.744 0 C-N-CA 124.177 0.991 . . . . 0.0 109.992 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 112' ' ' PRO . 87.7 mt -59.9 -52.25 63.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.996 0 C-N-CA 123.379 0.672 . . . . 0.0 110.992 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.05 -39.7 79.11 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.821 0.849 . . . . 0.0 112.849 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.69 10.35 3.34 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.9 mt -78.63 -30.53 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.0 t -68.08 -41.27 82.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.36 154.98 28.64 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.26 99.22 8.5 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -159.77 -49.08 0.05 Allowed 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.34 47.24 1.39 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.94 129.53 1.54 Allowed Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.76 160.63 32.66 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -72.64 138.26 28.98 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 122.914 2.409 . . . . 0.0 107.971 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -141.32 129.63 22.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 65.66 -108.72 0.16 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.052 1.341 . . . . 0.0 111.447 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -140.67 95.15 2.81 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.345 1.6 p-10 64.15 23.38 13.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 128.92 2.888 . . . . 0.0 114.327 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.9 mt -106.46 168.48 9.13 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -141.13 124.75 16.82 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.53 142.52 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.3 p -84.31 175.16 9.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.826 0.822 . . . . 0.0 110.418 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -131.45 -1.18 3.94 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -109.54 74.02 0.87 Allowed 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.4 p -51.19 123.89 10.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.137 1.775 . . . . 0.0 113.544 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -108.6 160.99 15.49 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.68 136.45 35.49 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.47 110.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -172.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.0 m -93.64 110.63 22.23 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.1 m -88.95 104.63 17.14 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.4 m -94.19 115.47 27.75 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -110.13 147.66 33.25 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB3' ' A' ' 39' ' ' CYS . 36.7 tp -79.99 112.91 17.74 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -132.81 96.54 3.82 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.85 -40.92 0.06 OUTLIER Glycine 0 CA--C 1.479 -2.197 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.6 42.48 6.46 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.8 m -114.61 107.19 51.25 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -83.76 -20.53 4.53 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 CA-C-N 122.213 1.826 . . . . 0.0 108.398 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -110.17 161.32 24.93 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -73.96 144.45 34.32 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.665 2.244 . . . . 0.0 108.31 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -81.89 163.63 76.49 Favored 'Cis proline' 0 N--CA 1.437 -1.848 0 CA-C-N 122.641 1.979 . . . . 0.0 108.731 -1.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.1 m -108.53 159.41 16.72 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.739 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.18 98.7 7.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.77 128.3 44.32 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -101.34 121.03 41.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.46 132.67 35.2 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 48.4 m -116.12 105.52 12.69 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.1 125.53 29.48 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.3 177.99 18.75 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 105.691 -2.963 . . . . 0.0 105.691 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -158.95 111.13 2.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -161.21 171.12 18.98 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.24 133.77 42.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.852 172.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.65 149.51 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.424 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.98 122.38 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.35 138.94 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.21 132.16 36.28 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.5 t -104.42 133.81 48.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 124.744 1.278 . . . . 0.0 109.903 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -132.57 141.37 48.68 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 164.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.326 11.2 p30 66.34 17.79 10.76 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.301 2.24 . . . . 0.0 116.503 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.12 50.77 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.267 3.5 tp -143.43 149.84 49.21 Favored Pre-proline 0 CA--C 1.484 -1.591 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HG2' HG22 ' A' ' 53' ' ' ILE . 50.1 Cg_exo -67.19 147.21 78.5 Favored 'Trans proline' 0 N--CA 1.436 -1.898 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 164.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.28 -19.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 42.1 t60 -155.86 178.79 9.87 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 -165.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.447 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -159.32 146.43 16.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -173.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -95.44 141.23 29.23 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -115.56 20.71 14.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.301 1.04 . . . . 0.0 110.029 -170.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.3 m -95.13 -20.75 19.01 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 118.94 0.791 . . . . 0.0 109.938 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.83 -33.0 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.42 1.088 . . . . 0.0 111.036 177.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -169.234 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.9 m -88.76 -26.52 21.7 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.13 -49.88 68.2 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.76 -57.3 11.37 Favored 'General case' 0 N--CA 1.4 -2.949 0 C-N-CA 127.209 2.204 . . . . 0.0 114.327 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.432 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 14.9 p -82.64 -2.34 53.67 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -64.07 -41.18 97.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.373 166.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.335 0.7 OUTLIER -61.16 -39.81 91.51 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 172.981 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -69.65 -46.22 66.64 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 120.072 1.305 . . . . 0.0 110.463 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.92 -5.18 59.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -127.29 -62.94 1.07 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.591 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -67.43 118.3 10.57 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.957 1.253 . . . . 0.0 112.02 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -147.27 99.29 3.13 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.94 -29.58 0.85 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -163.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -153.06 157.1 33.05 Favored Pre-proline 0 N--CA 1.434 -1.234 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.5 Cg_endo -74.41 157.5 45.2 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 123.188 2.592 . . . . 0.0 108.859 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.97 -63.22 1.31 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.62 177.0 18.64 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 103.072 -4.011 . . . . 0.0 103.072 161.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' HE ' ' HB1' ' A' ' 98' ' ' ALA . 77.8 mtp180 -109.53 68.28 0.67 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.06 173.9 14.87 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -170.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.82 -14.94 61.18 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.66 1.184 . . . . 0.0 113.093 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -32.29 53.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.112 0.565 . . . . 0.0 109.621 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.95 -41.47 61.97 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.268 0.1 OUTLIER -78.45 -26.68 46.25 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 118.451 -1.299 . . . . 0.0 114.042 -170.77 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 -34.14 59.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.161 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -69.81 -32.56 71.06 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.286 14.6 tt -79.97 -35.12 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.198 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -22.31 59.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.223 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.82 -29.75 29.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 119.433 1.015 . . . . 0.0 112.959 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.6 -41.95 20.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 118.758 0.708 . . . . 0.0 110.91 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -72.42 -38.59 68.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.329 1.052 . . . . 0.0 109.54 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.73 68.01 1.41 Allowed Glycine 0 CA--C 1.48 -2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.83 17.66 16.9 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 t -90.54 -10.33 43.9 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 p -126.55 102.21 26.39 Favored Pre-proline 0 N--CA 1.428 -1.547 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.84 161.72 93.66 Favored 'Cis proline' 0 N--CA 1.445 -1.372 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -21.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.446 ' HB3' HD13 ' A' ' 83' ' ' LEU . 35.4 m -61.08 120.42 10.24 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.239 1.015 . . . . 0.0 109.673 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -79.82 145.82 32.59 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -68.78 -42.93 76.72 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.239 1.015 . . . . 0.0 113.103 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -156.4 134.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -147.91 137.01 22.15 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.4 m -99.62 122.97 43.43 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.13 122.25 35.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.4 144.45 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.552 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 20.8 m-70 -134.04 131.65 39.1 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 124.067 0.947 . . . . 0.0 108.454 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.34 -151.42 21.7 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 104.317 -3.513 . . . . 0.0 104.317 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -89.83 152.88 21.06 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.62 -8.74 51.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -36.73 49.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 p -78.62 -28.47 45.64 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.798 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 53' ' ' ILE . 4.2 tp -66.14 -44.31 91.75 Favored 'Isoleucine or valine' 0 C--N 1.368 1.399 0 CA-C-N 120.324 1.42 . . . . 0.0 110.381 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.73 -33.67 76.15 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.49 1.116 . . . . 0.0 111.437 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 8.4 5.08 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.77 -19.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.1 m -75.76 -12.77 60.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.76 156.52 32.33 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -85.94 -13.4 47.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.224 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.83 -34.0 22.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 123.06 0.544 . . . . 0.0 109.875 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -124.23 45.02 2.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.75 141.26 3.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -89.84 154.29 47.73 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.83 138.37 28.65 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.771 2.314 . . . . 0.0 106.246 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -137.94 123.08 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 60.5 -109.81 0.42 Allowed 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 125.883 1.673 . . . . 0.0 112.451 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -134.77 95.18 3.29 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.348 1.2 p-10 69.83 16.55 7.77 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 129.253 3.021 . . . . 0.0 114.531 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.2 167.32 10.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -140.56 117.41 11.05 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.54 145.82 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -91.13 152.21 20.68 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.436 0.636 . . . . 0.0 111.653 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.76 -17.55 14.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 t -108.93 85.28 2.07 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 p -50.2 135.47 21.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 127.516 2.326 . . . . 0.0 113.093 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.31 161.67 16.37 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 4.2 mt-30 -82.11 136.03 35.23 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.94 100.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m -91.56 111.47 23.0 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.0 m -94.54 102.35 14.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.9 m -96.53 122.23 39.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -118.78 144.08 46.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.1 tp -77.29 104.44 7.8 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.791 1.236 . . . . 0.0 108.852 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -87.15 155.13 20.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.28 -76.13 0.51 Allowed Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.42 38.78 2.95 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 106.758 -2.537 . . . . 0.0 106.758 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 t -94.11 117.73 67.15 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.23 -12.29 5.87 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 CA-C-N 121.897 1.713 . . . . 0.0 108.041 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -103.89 161.78 21.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -75.01 145.7 31.73 Favored 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.028 1.818 . . . . 0.0 107.424 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -83.44 165.26 67.93 Favored 'Cis proline' 0 N--CA 1.439 -1.713 0 CA-C-N 122.997 2.106 . . . . 0.0 109.623 7.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.6 m -120.66 141.26 50.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.29 100.52 10.42 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.35 108.49 21.02 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -92.68 124.05 36.41 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.63 130.08 34.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.535 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.8 m -117.7 93.34 4.12 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' HB1' ' HE ' ' A' ' 21' ' ' ARG . . . -82.19 134.79 35.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 -170.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.71 -173.25 12.94 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -159.77 108.62 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.34 178.22 5.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.974 0.893 . . . . 0.0 109.371 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -69.6 140.81 53.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.576 1.95 . . . . 0.0 111.853 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.73 152.66 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.7 t -108.3 90.47 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.36 131.36 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.08 35.65 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.8 t -106.17 133.89 50.16 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.486 1.116 . . . . 0.0 110.689 -167.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.05 125.47 33.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 13.0 p30 66.87 15.78 10.22 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 127.632 2.373 . . . . 0.0 116.748 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.58 40.86 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.9 tp -135.22 123.28 15.49 Favored Pre-proline 0 N--CA 1.435 -1.222 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.13 107.77 2.1 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 106.038 -2.331 . . . . 0.0 106.038 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.96 -18.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 123.38 0.425 . . . . 0.0 110.927 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 46.3 t60 -146.27 177.03 9.32 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.39 129.62 6.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.38 150.62 36.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.2 59.53 0.68 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -171.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.0 t -65.45 -67.06 0.47 Allowed 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.789 1.236 . . . . 0.0 111.164 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 pt -100.78 1.34 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -167.725 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.7 t30 . . . . . 0 CA--C 1.493 -1.213 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.531 1.133 . . . . 0.0 109.932 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -64.14 -54.23 37.01 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.297 1.439 . . . . 0.0 107.893 170.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.63 -41.75 95.96 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.04 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.447 0.3 OUTLIER -85.95 -3.72 58.99 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -36.85 52.42 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 119.54 1.064 . . . . 0.0 108.911 163.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 10' ' ' LEU . 7.3 t80 -59.48 -37.23 77.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.099 0.96 . . . . 0.0 110.214 168.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -82.77 -18.69 39.78 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 119.236 0.926 . . . . 0.0 113.03 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 m -69.08 -51.83 34.72 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 12.9 pt20 -85.61 -12.35 51.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 94.7 m-70 -117.76 -51.57 2.47 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 119.08 0.855 . . . . 0.0 111.278 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -79.1 119.28 21.99 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.824 1.193 . . . . 0.0 109.58 -167.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -136.27 96.76 3.44 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 100.678 -3.823 . . . . 0.0 100.678 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.02 -45.52 2.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 128.449 2.7 . . . . 0.0 117.424 -168.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 141.94 14.17 Favored Pre-proline 0 N--CA 1.433 -1.324 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 164.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 34.4 Cg_exo -74.18 -179.07 4.36 Favored 'Trans proline' 0 N--CA 1.437 -1.827 0 C-N-CA 122.628 2.219 . . . . 0.0 114.125 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.1 -76.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.1 -174.96 13.9 Favored Glycine 0 CA--C 1.476 -2.348 1 N-CA-C 101.399 -4.68 . . . . 0.0 101.399 160.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -112.63 74.47 0.86 Allowed 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -137.81 178.13 7.35 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -72.09 -26.03 61.99 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 124.084 0.953 . . . . 0.0 111.641 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -81.52 -23.19 37.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 123.341 0.656 . . . . 0.0 109.65 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -73.64 -45.68 51.35 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 2.0 t -78.69 -23.99 45.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.768 -173.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.91 -40.4 79.13 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -68.29 -41.51 80.84 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 26' ' ' CYS . 16.3 tt -78.18 -32.06 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 117.85 0.296 . . . . 0.0 110.827 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 47.1 mtp -78.56 -27.46 45.81 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.2 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -67.34 -41.1 85.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -75.84 -46.65 29.27 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -32.67 72.8 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 123.289 0.636 . . . . 0.0 111.366 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.76 62.63 1.59 Allowed Glycine 0 CA--C 1.478 -2.258 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.4 mt -112.88 20.36 16.49 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 163.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -96.3 -8.01 33.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 p -125.05 99.84 34.02 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 167.22 81.11 Favored 'Cis proline' 0 N--CA 1.446 -1.322 0 N-CA-C 107.384 -1.814 . . . . 0.0 107.384 -22.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.47 121.91 11.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.344 1.058 . . . . 0.0 111.316 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.63 136.85 38.28 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.13 -39.46 63.29 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 123.781 0.676 . . . . 0.0 112.222 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -153.76 125.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -144.01 134.17 24.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.184 0.516 . . . . 0.0 109.886 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 78' ' ' VAL . 55.3 m -101.41 114.95 29.41 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.959 0.903 . . . . 0.0 110.339 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -90.58 119.84 31.16 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.72 150.94 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -141.88 139.52 32.63 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.6 -135.23 3.83 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.31 140.86 32.87 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -85.69 -19.6 30.65 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.31 96.46 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.546 1.938 . . . . 0.0 108.084 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -71.45 -37.55 71.38 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.97 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.3 mm -55.63 -55.75 15.77 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 119.631 1.105 . . . . 0.0 110.958 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -58.27 -42.97 87.69 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.525 1.13 . . . . 0.0 111.416 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 15.58 1.75 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mm -78.52 -23.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.14 -15.96 48.64 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.873 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.42 150.06 43.7 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -77.39 -19.61 55.91 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 124.51 1.124 . . . . 0.0 111.311 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -77.54 -40.16 43.54 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 123.159 0.584 . . . . 0.0 109.977 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -119.47 34.02 5.39 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.17 129.15 1.08 Allowed Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 106.661 -2.576 . . . . 0.0 106.661 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -99.27 159.24 30.62 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -71.85 131.17 17.9 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 122.911 2.407 . . . . 0.0 106.822 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -125.54 126.05 44.2 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 65.51 -102.49 0.08 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.26 1.424 . . . . 0.0 110.99 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.78 105.68 3.45 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 3.5 p30 75.58 1.9 3.68 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.503 3.121 . . . . 0.0 114.717 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.32 171.63 8.07 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -144.71 119.04 9.56 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -170.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 tt -98.1 138.71 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -77.34 165.39 24.52 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.615 0.721 . . . . 0.0 112.785 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.24 -27.74 11.36 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -106.1 81.12 1.59 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 p -41.1 120.11 1.3 Allowed 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.987 2.515 . . . . 0.0 113.816 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.37 158.24 16.48 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.1 mt-30 -79.92 149.49 30.86 Favored 'General case' 0 CA--C 1.472 -2.031 0 CA-C-N 113.912 -1.495 . . . . 0.0 107.384 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG21 HH22 ' A' ' 101' ' ' ARG . 0.9 OUTLIER -150.3 148.51 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -126.53 105.49 8.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 165.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -88.51 98.48 11.66 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.84 119.49 29.38 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -108.76 142.37 39.39 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.37 125.68 29.71 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.52 1.528 . . . . 0.0 107.459 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.39 47.06 2.57 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.71 -69.44 1.35 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.68 -31.06 5.69 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 p -85.55 145.4 41.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -79.57 -23.5 7.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.024 1.816 . . . . 0.0 108.773 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -99.61 165.84 13.95 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 117.979 -1.01 . . . . 0.0 108.994 -168.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -71.91 144.83 44.06 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.604 2.202 . . . . 0.0 108.141 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -86.22 165.17 52.32 Favored 'Cis proline' 0 N--CA 1.438 -1.756 0 CA-C-N 122.432 1.904 . . . . 0.0 107.914 9.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 63.9 m -132.57 126.49 32.91 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -89.8 136.75 32.85 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -124.67 122.6 37.96 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.88 115.15 27.82 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 126.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 m -117.58 103.55 10.17 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.56 130.49 35.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 120.819 0.342 . . . . 0.0 110.38 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.01 172.86 16.61 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.0 t80 -154.3 99.82 2.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.606 HH22 HG21 ' A' ' 78' ' ' VAL 0.256 0.0 OUTLIER -161.65 -179.78 7.54 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.623 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.13 133.14 47.64 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.124 0.969 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.9 142.77 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.5 t -104.66 110.09 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 165.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -106.65 152.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.03 49.19 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.2 t -109.72 131.28 55.21 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 124.745 1.278 . . . . 0.0 111.229 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -124.27 136.54 54.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 164.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.304 14.2 p30 64.15 21.56 12.6 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.9 16.87 57.41 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.29 0.9 OUTLIER -135.33 134.29 21.18 Favored Pre-proline 0 CA--C 1.487 -1.478 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.02 109.67 2.93 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 106.173 -2.28 . . . . 0.0 106.173 168.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -94.46 -12.16 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 118.11 0.413 . . . . 0.0 110.438 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -150.66 155.74 39.96 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -165.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.85 125.34 52.67 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -80.94 128.68 33.95 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -106.59 51.04 0.75 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 t -87.19 -47.23 9.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -32.12 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 . . . . . 0 N--CA 1.427 -1.605 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.304 -163.663 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 t -91.2 -30.63 16.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.29 -41.15 66.97 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.621 ' CE1' HD22 ' A' ' 111' ' ' LEU . 67.3 t80 -52.29 -60.65 2.96 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 127.311 2.244 . . . . 0.0 113.665 170.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.558 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 30.9 p -69.65 -20.96 63.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -78.71 -37.02 42.53 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 119.352 0.978 . . . . 0.0 110.155 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.83 -41.71 87.53 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.601 1.56 . . . . 0.0 109.625 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.397 0.3 OUTLIER -91.23 -4.46 55.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.849 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.3 m -75.9 -43.32 45.82 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 166.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.21 -40.54 86.45 Favored 'General case' 0 CA--C 1.488 -1.421 0 O-C-N 123.605 0.565 . . . . 0.0 111.201 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -106.75 -56.98 2.12 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.661 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 9.5 t80 -74.51 114.26 12.7 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.989 1.268 . . . . 0.0 110.438 -168.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.81 94.5 3.4 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.3 -33.54 0.65 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -163.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -151.34 155.99 34.77 Favored Pre-proline 0 N--CA 1.432 -1.326 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -73.3 156.87 50.51 Favored 'Trans proline' 0 N--CA 1.433 -2.073 0 C-N-CA 123.215 2.61 . . . . 0.0 110.049 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.46 -60.7 2.22 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 164.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.09 -177.01 14.66 Favored Glycine 0 CA--C 1.479 -2.19 1 N-CA-C 103.019 -4.032 . . . . 0.0 103.019 163.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -125.46 67.65 1.15 Allowed 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.64 179.12 6.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.43 -24.17 63.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -84.89 -21.28 29.78 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.75 -43.72 58.24 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.3 t -81.3 -21.66 39.13 Favored 'General case' 0 N--CA 1.412 -2.359 0 C-N-CA 117.936 -1.506 . . . . 0.0 112.543 -171.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.75 -34.34 66.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 121.879 -0.513 . . . . 0.0 110.417 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 t -70.58 -35.15 72.89 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.1 tt -86.28 -25.26 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-N 118.214 0.461 . . . . 0.0 110.943 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 mmt -77.31 -28.82 53.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 121.7 -0.625 . . . . 0.0 109.789 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.26 -38.51 71.89 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.054 0.942 . . . . 0.0 112.204 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -70.4 -51.63 28.22 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 124.531 1.132 . . . . 0.0 110.893 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -30.52 62.28 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.882 0.873 . . . . 0.0 109.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.65 60.49 2.97 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.57 16.17 22.39 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 t -100.04 0.47 40.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -129.79 104.08 17.25 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.96 156.48 99.41 Favored 'Cis proline' 0 N--CA 1.442 -1.508 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -20.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.428 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -66.81 116.38 7.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.132 0.973 . . . . 0.0 111.107 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -82.27 146.2 29.59 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -75.06 -29.75 60.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.901 1.28 . . . . 0.0 113.064 -170.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 128.25 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -141.9 137.15 31.13 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.7 m -103.78 129.95 51.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -103.97 115.24 30.09 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mm -80.3 149.81 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 C-N-CA 126.132 1.773 . . . . 0.0 107.029 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.53 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.4 m-70 -136.35 131.49 34.35 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.54 -145.84 9.9 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -105.08 148.24 27.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -84.37 -18.07 37.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -82.34 -21.82 35.81 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -72.81 -39.83 66.32 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 118.462 -0.78 . . . . 0.0 108.996 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.73 -50.98 75.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.579 1.151 . . . . 0.0 111.01 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.46 -39.36 90.58 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.783 0.833 . . . . 0.0 112.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.07 6.45 5.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.82 -30.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 m -82.73 -7.08 59.67 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -80.05 159.03 26.31 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -87.49 -4.59 58.99 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.548 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -80.69 -45.68 16.76 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -122.59 39.91 3.81 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.59 166.84 32.48 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.95 159.29 35.93 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -76.96 137.71 17.77 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.218 1.945 . . . . 0.0 107.671 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -124.83 139.09 54.16 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 66.29 -103.21 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.423 1.089 . . . . 0.0 110.227 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -163.36 113.75 1.37 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.374 0.8 OUTLIER 74.13 7.29 4.75 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 129.528 3.131 . . . . 0.0 114.376 177.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 HG12 ' A' ' 104' ' ' VAL . 2.5 mm? -107.51 164.7 11.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.31 105.49 3.35 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -166.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -85.64 138.58 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -79.88 166.17 21.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.412 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -112.92 -16.2 12.74 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -109.93 87.85 2.61 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.8 t -46.79 124.21 5.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.958 2.503 . . . . 0.0 112.238 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -104.66 155.98 18.39 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.421 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 4.6 mt-30 -80.28 152.08 29.23 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.36 151.19 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -168.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -132.47 102.61 5.79 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 165.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.1 m -86.38 102.08 13.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.02 128.17 37.76 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -113.96 147.42 38.59 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.5 tp -72.27 128.93 37.16 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -142.1 46.85 1.63 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.54 -65.57 0.9 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.28 -23.78 11.06 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -85.7 143.33 38.05 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -79.65 -22.98 7.42 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 122.049 1.833 . . . . 0.0 108.725 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -106.28 157.3 35.25 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.637 -168.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.44 150.34 36.2 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.441 2.094 . . . . 0.0 108.401 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -83.32 167.33 64.01 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 CA-C-N 122.423 1.901 . . . . 0.0 108.742 1.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.3 m -147.75 141.61 25.79 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -87.23 146.79 25.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.65 118.57 23.14 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -79.27 108.53 12.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.82 126.75 34.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -116.68 108.66 16.18 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.79 122.22 24.46 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.95 179.46 16.22 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.8 t80 -162.28 101.61 1.09 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.727 -3.434 . . . . 0.0 101.727 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 170.28 22.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.814 -171.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -75.01 130.71 39.82 Favored 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 124.225 1.01 . . . . 0.0 109.556 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.7 130.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HD12 ' A' ' 69' ' ' LEU . 59.2 t -102.89 80.45 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.3 m -95.88 142.59 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.96 39.15 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.5 m -100.04 141.81 32.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 124.298 0.999 . . . . 0.0 111.237 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.73 130.41 19.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 12.1 p30 62.59 18.25 10.34 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 128.153 2.581 . . . . 0.0 115.372 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.62 -10.67 61.04 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 6' ' ' TYR . 7.3 mt -102.76 144.04 27.81 Favored Pre-proline 0 CA--C 1.478 -1.797 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.83 114.66 4.09 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 N-CA-C 105.269 -2.627 . . . . 0.0 105.269 161.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 m -99.77 -15.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 69.1 t60 -149.03 175.41 11.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -169.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.62 129.12 2.59 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.26 135.81 39.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.926 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -96.18 37.44 1.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 t -95.75 -16.6 21.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 119' ' ' ILE . 1.7 pt -95.53 -21.39 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.246 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 . . . . . 0 N--CA 1.426 -1.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.72 -170.174 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -91.44 -1.8 57.45 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.826 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -74.32 -43.76 55.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 4.6 t80 -58.76 -52.67 64.72 Favored 'General case' 0 N--CA 1.41 -2.449 0 C-N-CA 124.939 1.295 . . . . 0.0 111.633 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.51 2.5 t -89.94 12.77 16.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -82.19 -40.23 22.02 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.204 -1.56 . . . . 0.0 108.1 156.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.92 -41.64 83.13 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.366 1.066 . . . . 0.0 109.525 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 19.4 mt -83.84 -13.84 52.69 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -65.55 -53.21 45.24 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 120.411 1.46 . . . . 0.0 107.811 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 4.9 pt20 -81.64 -17.14 49.13 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 84.4 m-70 -110.97 -55.03 2.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 118.965 0.802 . . . . 0.0 111.151 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 43.7 t80 -76.34 122.27 24.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.683 1.128 . . . . 0.0 109.208 -168.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -136.21 97.58 3.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.59 -38.45 4.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -166.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 140.57 9.92 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 165.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 81.1 Cg_exo -73.18 175.83 9.98 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 122.794 2.33 . . . . 0.0 113.794 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -73.21 -73.05 0.22 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.3 -176.66 14.61 Favored Glycine 0 CA--C 1.478 -2.249 1 N-CA-C 102.428 -4.269 . . . . 0.0 102.428 163.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -115.16 72.81 0.81 Allowed 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -147.83 -179.34 6.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.1 -21.66 62.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.714 1.206 . . . . 0.0 112.867 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -88.79 -15.47 34.54 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.1 -39.04 34.71 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 m -68.79 -34.32 75.34 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -66.85 -44.93 79.73 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 123.551 0.741 . . . . 0.0 109.587 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -64.75 -35.68 81.86 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.384 0.673 . . . . 0.0 112.54 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.29 13.3 tt -83.72 -28.97 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.973 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 -23.55 43.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 117.657 -1.617 . . . . 0.0 111.724 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -79.4 -32.9 43.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 118.995 0.816 . . . . 0.0 111.042 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -47.97 15.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.327 0.651 . . . . 0.0 110.064 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -76.81 -32.04 57.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.68 66.7 1.53 Allowed Glycine 0 CA--C 1.476 -2.347 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.9 31.13 6.75 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 162.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.64 2.65 44.69 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 p -124.64 94.77 43.95 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.48 167.1 81.05 Favored 'Cis proline' 0 N--CA 1.443 -1.498 0 N-CA-C 106.981 -1.969 . . . . 0.0 106.981 -24.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.2 m -63.3 116.05 5.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 124.352 1.061 . . . . 0.0 111.115 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.26 134.62 42.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -71.15 -35.4 71.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 124.373 1.045 . . . . 0.0 112.295 -168.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.43 136.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -147.58 122.11 9.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.7 m -90.89 106.33 18.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -85.88 121.37 28.42 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.0 148.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.44 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -141.15 132.87 27.27 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.36 -137.32 4.59 Favored Glycine 0 CA--C 1.483 -1.935 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -113.43 144.62 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -85.45 -17.5 36.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.906 -169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -82.26 -26.65 32.99 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.8 p -77.67 -30.11 51.83 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.658 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.93 -46.34 96.67 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 CA-C-N 119.403 1.001 . . . . 0.0 110.627 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -60.42 -38.82 85.26 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.487 1.115 . . . . 0.0 111.828 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 9.85 5.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.705 1.202 . . . . 0.0 113.889 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.48 -17.92 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.6 t -66.37 -69.94 0.27 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.452 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -141.19 118.95 11.71 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' H ' ' H ' ' A' ' 60' ' ' LYS . 54.8 t30 -159.88 -3.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 164.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' A' ' 59' ' ' ASN 0.386 62.5 pttt 57.81 26.96 13.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.859 2.064 . . . . 0.0 111.748 -156.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -105.57 -14.74 15.19 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 167.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.77 139.98 10.87 Favored Glycine 0 CA--C 1.488 -1.636 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 160.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.39 153.88 43.23 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -69.68 143.27 50.68 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.824 2.349 . . . . 0.0 108.513 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -145.56 130.84 18.55 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 66.39 -103.59 0.08 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.884 1.273 . . . . 0.0 109.549 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -156.66 102.64 2.05 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER 90.93 -12.7 0.26 Allowed 'General case' 0 C--N 1.354 0.798 0 C-N-CA 128.323 2.649 . . . . 0.0 112.526 173.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.36 158.61 16.44 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -143.67 114.97 7.98 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -92.12 141.15 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -80.8 166.35 21.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.708 0.766 . . . . 0.0 110.823 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -120.6 -14.77 8.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.4 t -109.82 86.49 2.31 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.6 p -51.75 131.6 30.51 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 127.028 2.131 . . . . 0.0 112.293 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.16 156.69 19.56 Favored 'General case' 0 CA--C 1.476 -1.896 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 -171.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.61 142.03 40.84 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.9 143.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -166.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.6 m -131.01 108.39 9.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.61 -3.107 . . . . 0.0 102.61 168.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -82.69 101.38 10.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 71.8 m -88.91 111.42 22.07 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -109.5 137.69 46.97 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -76.3 112.33 12.68 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 125.172 1.389 . . . . 0.0 108.366 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -90.81 147.76 22.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 -74.24 0.21 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 28.68 4.31 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.6 p -92.09 127.19 50.35 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -80.44 -29.76 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 N-CA-C 107.735 -1.679 . . . . 0.0 107.735 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -99.35 148.07 34.17 Favored Pre-proline 0 N--CA 1.427 -1.591 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.476 -168.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -74.91 144.37 30.51 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.643 2.229 . . . . 0.0 107.0 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -81.74 160.98 79.84 Favored 'Cis proline' 0 CA--C 1.486 -1.884 0 CA-C-N 123.705 2.359 . . . . 0.0 109.982 10.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.9 m -146.94 146.97 30.3 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -167.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -102.52 154.19 19.35 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -137.66 125.12 22.0 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -104.68 130.69 52.68 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.24 138.96 31.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 122.826 0.451 . . . . 0.0 110.737 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.2 m -133.25 95.07 3.45 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.75 153.31 17.83 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.664 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.46 -163.63 12.14 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -149.59 97.9 2.69 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.5 ttt-85 -140.65 158.89 43.31 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -165.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.55 137.32 57.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.667 1.187 . . . . 0.0 109.679 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.46 136.87 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -104.02 91.37 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.86 138.77 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.65 123.63 32.04 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.5 t -103.25 125.93 50.16 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.589 1.181 . . . . 0.0 109.493 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -109.58 126.88 54.07 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 163.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.307 0.4 OUTLIER 31.95 68.55 0.13 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 128.622 2.769 . . . . 0.0 118.359 175.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.42 4.74 90.04 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.23 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.27 0.8 OUTLIER -138.2 135.32 18.34 Favored Pre-proline 0 CA--C 1.486 -1.486 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -63.53 132.95 37.59 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.817 2.345 . . . . 0.0 106.387 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.61 -18.57 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 20.7 t60 -151.92 179.8 8.14 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 -170.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 5.6 tp -151.83 132.47 13.97 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.56 123.57 27.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.89 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -103.56 24.02 11.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.788 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.6 p -81.71 -31.58 32.06 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 121.48 -0.763 . . . . 0.0 113.056 -167.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -32.58 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.427 -1.615 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.0 -165.811 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -88.78 0.25 56.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.761 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -68.14 -52.23 37.02 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -60.87 -50.72 72.27 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 117.333 -1.318 . . . . 0.0 113.164 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.527 2.3 t -90.82 11.36 22.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -81.69 -38.4 25.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 120.087 -1.633 . . . . 0.0 108.381 155.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.02 0.928 . . . . 0.0 109.686 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.66 -12.55 53.69 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.5 m -65.55 -52.22 54.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 120.68 1.582 . . . . 0.0 108.074 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.9 pt20 -79.31 -28.54 42.18 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.567 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 87.0 m-70 -100.1 -53.98 3.0 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 119.044 0.838 . . . . 0.0 110.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 48.5 t80 -73.66 134.62 43.65 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 120.296 1.407 . . . . 0.0 111.481 -166.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.62 99.92 2.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.84 -50.93 1.73 Allowed 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 128.061 2.544 . . . . 0.0 117.843 -166.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -142.69 146.59 38.82 Favored Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.7 Cg_endo -81.38 171.75 13.34 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 123.086 2.524 . . . . 0.0 108.662 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.08 -77.97 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.59 -178.88 15.59 Favored Glycine 0 CA--C 1.475 -2.427 1 N-CA-C 101.464 -4.654 . . . . 0.0 101.464 159.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.15 74.67 0.89 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -136.06 173.1 12.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -74.06 -21.27 60.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.886 0.874 . . . . 0.0 113.23 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -14.18 29.92 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.31 -41.71 63.22 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.257 0.6 OUTLIER -77.06 -25.42 52.39 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 113.054 -174.798 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.81 -39.51 73.03 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 m -70.19 -33.06 71.26 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.7 tt -85.28 -29.74 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 118.644 0.656 . . . . 0.0 110.369 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mmt -71.78 -34.76 69.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -67.04 -45.94 75.92 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.265 1.026 . . . . 0.0 113.389 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -83.37 -32.52 26.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -74.52 -38.16 62.88 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.59 68.96 1.4 Allowed Glycine 0 CA--C 1.475 -2.451 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.96 29.17 5.24 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 163.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -81.91 -13.48 57.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 111.721 -2.491 . . . . 0.0 109.963 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -119.83 106.99 40.82 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.974 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 162.89 90.92 Favored 'Cis proline' 0 N--CA 1.444 -1.399 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 -22.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB3' HD13 ' A' ' 83' ' ' LEU . 70.2 m -61.3 121.97 13.93 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.139 0.976 . . . . 0.0 110.631 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -72.79 134.65 45.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -72.44 -39.11 68.07 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 123.631 0.582 . . . . 0.0 111.555 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.95 129.08 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 172.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -144.9 120.56 10.47 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 m -96.1 116.64 29.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.5 127.27 34.85 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 53' ' ' ILE . 9.8 mm -102.35 147.4 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.464 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -170.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.509 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -138.06 133.45 33.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.18 -125.36 1.41 Allowed Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -122.5 147.28 46.55 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 14' ' ' TYR . 21.7 mtpt -86.26 -3.04 58.9 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -43.05 65.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.657 1.583 . . . . 0.0 107.089 172.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -80.52 -25.27 38.8 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.681 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 112' ' ' PRO . 18.0 mm -59.78 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 CA-C-N 119.079 0.854 . . . . 0.0 110.195 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -55.77 -39.35 71.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 126.02 1.728 . . . . 0.0 112.405 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.74 11.48 2.58 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.67 -31.9 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.7 m -79.0 -23.1 44.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.63 156.1 17.86 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -86.57 87.6 7.48 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.951 0.882 . . . . 0.0 109.306 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -141.06 -46.51 0.39 Allowed 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.73 58.52 1.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.43 151.88 9.54 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -107.42 157.83 34.68 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 140.0 32.18 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.766 2.31 . . . . 0.0 106.248 160.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -139.82 118.1 12.04 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -103.91 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 108.989 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -151.87 102.76 2.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 1.9 p-10 66.24 18.1 10.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 129.516 3.126 . . . . 0.0 114.582 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.0 mt -107.35 158.73 16.93 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 100.407 -3.923 . . . . 0.0 100.407 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -146.11 119.29 8.88 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.104 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.53 145.51 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 92.5 p -93.71 149.45 21.22 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -102.46 -8.31 21.2 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.7 t -106.69 85.75 2.21 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.0 m -57.35 126.43 27.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 125.566 1.546 . . . . 0.0 110.501 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.71 159.69 15.41 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.403 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 9.2 mm-40 -72.8 135.88 45.32 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 170.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.73 147.92 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -165.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.3 m -134.95 107.22 7.22 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 103.474 -2.788 . . . . 0.0 103.474 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.4 m -86.43 105.62 16.88 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.1 m -99.42 116.77 32.33 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -116.97 130.31 56.61 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 39' ' ' CYS . 22.3 tp -74.02 118.03 16.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 124.916 1.286 . . . . 0.0 108.716 -176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -90.35 115.5 27.59 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 158.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.76 94.03 1.78 Allowed Glycine 0 CA--C 1.482 -2.011 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -167.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.89 49.86 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 166.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 t -163.51 110.74 0.98 Allowed Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -80.08 -16.31 11.2 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 110.411 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.03 168.08 9.54 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.44 145.54 30.09 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.06 1.84 . . . . 0.0 108.13 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -81.76 163.81 76.62 Favored 'Cis proline' 0 N--CA 1.436 -1.872 0 CA-C-N 122.228 1.831 . . . . 0.0 107.923 -4.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -106.09 174.47 5.87 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -133.58 115.35 14.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -104.17 149.47 25.23 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -100.97 147.35 26.27 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 160.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.11 126.41 52.78 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -107.63 108.46 19.74 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.88 141.8 34.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.2 -175.46 30.17 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.4 t80 -157.69 99.68 1.73 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.905 -2.998 . . . . 0.0 102.905 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -161.61 173.78 14.27 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.81 0.814 . . . . 0.0 109.846 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -78.3 151.38 33.0 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.406 1.482 . . . . 0.0 111.148 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.96 159.18 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.12 96.26 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 165.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.79 132.35 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.51 122.58 32.14 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.42 142.29 30.22 Favored 'General case' 0 CA--C 1.488 -1.43 0 O-C-N 124.603 1.189 . . . . 0.0 110.153 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.09 129.42 18.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 167.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.337 11.2 p30 67.54 15.24 9.77 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 128.1 2.56 . . . . 0.0 115.287 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.22 62.08 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 0.9 OUTLIER -113.92 138.41 22.78 Favored Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 53' ' ' ILE . 81.8 Cg_exo -70.34 111.55 2.95 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 N-CA-C 107.048 -1.943 . . . . 0.0 107.048 166.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.46 -14.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 119.173 0.897 . . . . 0.0 110.077 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 38.6 t60 -155.06 178.52 10.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 8.9 tp -158.9 133.57 8.07 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.66 131.12 34.24 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -106.06 41.06 1.47 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -97.01 -26.26 15.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -171.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -79.22 -33.99 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.706 0 C-N-CA 123.935 0.894 . . . . 0.0 109.215 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -168.804 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.4 m -90.21 -33.13 16.3 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -69.29 -35.46 76.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.199 1.0 . . . . 0.0 111.1 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' A' ' 10' ' ' LEU . 52.7 t80 -74.29 -46.09 43.43 Favored 'General case' 0 N--CA 1.398 -3.053 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 33.7 p -73.72 -17.87 61.06 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -84.42 -35.89 22.76 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 119.514 1.052 . . . . 0.0 109.42 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -56.69 -45.79 81.58 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.531 1.532 . . . . 0.0 108.519 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -65.82 -29.91 70.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 126.854 2.062 . . . . 0.0 115.109 178.228 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.7 m -66.93 -52.58 41.3 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -85.22 -5.05 59.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -123.64 -55.59 1.72 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.762 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 13.6 t80 -71.29 123.86 23.24 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 120.583 1.538 . . . . 0.0 111.919 -169.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.88 97.11 3.12 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.19 -41.51 8.3 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -167.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -158.43 140.09 9.87 Favored Pre-proline 0 N--CA 1.434 -1.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 163.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -74.44 -178.86 4.28 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.651 2.234 . . . . 0.0 114.168 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -71.92 -64.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.21 -176.39 16.35 Favored Glycine 0 CA--C 1.476 -2.382 1 N-CA-C 102.343 -4.303 . . . . 0.0 102.343 164.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -109.38 75.53 0.95 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -145.5 176.42 9.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.17 -22.75 62.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 124.327 1.051 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -89.27 -17.21 29.45 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.08 -40.86 52.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.2 m -70.3 -33.28 71.35 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -68.06 -43.58 78.29 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.939 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.8 p -76.06 -23.88 55.09 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.274 12.5 tt -85.87 -28.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 119.081 0.855 . . . . 0.0 110.06 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.4 mmm -79.1 -24.05 43.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.621 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.505 HH12 ' HA ' ' A' ' 91' ' ' PRO . 14.7 tpt180 -74.53 -49.33 22.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 122.605 0.362 . . . . 0.0 111.694 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -86.44 -32.6 20.77 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.273 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -76.79 -33.84 58.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.89 71.23 1.29 Allowed Glycine 0 CA--C 1.478 -2.238 0 C-N-CA 124.987 1.279 . . . . 0.0 112.028 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.331 2.5 mm? -108.08 0.02 21.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 167.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -80.31 -3.78 50.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.005 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -129.42 108.16 17.51 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.66 153.77 98.76 Favored 'Cis proline' 0 N--CA 1.443 -1.447 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 -22.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.2 m -62.77 123.27 18.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 125.483 1.513 . . . . 0.0 112.197 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -74.12 139.62 44.69 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.8 -41.52 44.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.644 0.778 . . . . 0.0 111.899 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 tt -154.6 134.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -154.52 167.23 30.78 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.0 m -128.89 127.27 41.48 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.91 127.53 39.72 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.273 4.9 mm -94.35 146.03 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -139.8 127.77 22.19 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.06 -151.58 18.84 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.23 144.37 25.92 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.24 -22.0 45.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -70.54 -33.98 71.74 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 124.441 1.096 . . . . 0.0 110.532 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 p -76.68 -31.39 57.24 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 116.906 -1.521 . . . . 0.0 111.265 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -48.71 84.36 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-N 119.739 1.154 . . . . 0.0 110.996 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.29 -36.6 84.58 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.34 0.656 . . . . 0.0 111.657 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.78 4.91 10.56 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mm -75.94 -24.92 16.82 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.9 m -73.72 -24.59 59.94 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 122.124 -0.36 . . . . 0.0 111.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -79.68 164.8 23.46 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -93.2 0.0 56.99 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.429 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.57 -33.11 28.17 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 122.899 0.48 . . . . 0.0 110.848 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -134.73 7.31 3.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.08 -162.91 10.61 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 104.831 -3.307 . . . . 0.0 104.831 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -159.59 158.25 27.32 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -74.02 135.36 20.97 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.761 2.307 . . . . 0.0 107.162 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -123.07 104.61 9.32 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 69.85 -97.13 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.846 1.659 . . . . 0.0 110.528 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.45 106.51 3.13 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.358 4.5 p30 75.76 2.81 3.77 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 129.725 3.21 . . . . 0.0 114.594 169.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 mt -104.43 158.91 16.15 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -142.97 116.15 8.94 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 tt -89.32 142.14 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -81.01 161.41 24.25 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.779 0.8 . . . . 0.0 112.454 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -110.2 -17.95 13.41 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.6 t -110.06 87.87 2.62 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -52.03 129.67 27.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.671 1.989 . . . . 0.0 111.608 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -106.02 157.37 17.56 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.33 131.99 40.66 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.94 126.43 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 -165.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.7 m -119.21 110.18 16.72 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -83.13 105.17 13.89 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.81 114.63 23.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.81 136.46 53.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.44 127.67 32.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.42 1.088 . . . . 0.0 109.069 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -119.47 171.69 8.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.61 -94.24 1.02 Allowed Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 105.939 -2.865 . . . . 0.0 105.939 -173.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.6 -6.97 1.26 Allowed Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 p -79.0 132.92 62.27 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -91.28 -9.22 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.922 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -109.76 155.58 41.24 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.95 146.19 29.12 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.369 2.046 . . . . 0.0 107.397 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.7 Cg_endo -85.99 163.4 56.19 Favored 'Cis proline' 0 N--CA 1.436 -1.899 0 CA-C-N 122.888 2.067 . . . . 0.0 108.521 12.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.8 m -150.99 126.24 9.97 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -85.81 129.23 34.89 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.93 133.24 56.17 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -111.72 137.51 49.52 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.74 140.55 31.17 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.157 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.7 m -123.34 110.3 15.0 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.62 155.85 23.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.549 0.69 . . . . 0.0 109.9 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.96 176.1 37.58 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 106.914 -2.474 . . . . 0.0 106.914 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -150.11 91.63 1.79 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 101.932 -3.358 . . . . 0.0 101.932 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -146.73 169.21 19.52 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -168.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.03 145.44 48.29 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.427 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.99 138.39 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.04 87.78 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.82 132.88 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.82 125.29 40.28 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 38.9 m -109.03 153.79 23.12 Favored 'General case' 0 CA--C 1.485 -1.533 0 O-C-N 124.414 1.071 . . . . 0.0 110.985 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.33 129.73 23.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 171.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 9.4 p30 68.16 12.44 8.77 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 13.15 60.1 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.64 144.89 52.69 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 67.1 Cg_exo -68.84 150.94 74.15 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 121.858 1.705 . . . . 0.0 110.694 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.57 -14.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 51.1 t60 -158.07 174.91 14.5 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -169.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.1 128.68 6.28 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.35 137.2 38.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.67 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -105.41 42.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -91.92 -33.77 14.76 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 -29.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.896 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.298 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -169.869 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.3 t30 . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -89.52 -7.43 54.96 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.924 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -72.75 -42.92 63.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -59.23 -48.23 82.4 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.409 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.465 2.9 t -89.86 10.75 22.53 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -78.16 -42.07 32.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.193 -1.567 . . . . 0.0 107.34 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.14 -35.18 76.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.037 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 14' ' ' TYR . 21.8 mt -86.15 -15.42 41.09 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 119.444 1.02 . . . . 0.0 113.399 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -65.8 -49.0 69.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 119.827 1.194 . . . . 0.0 108.703 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.59 -42.66 67.48 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -99.45 -51.42 3.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.695 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HD22 ' A' ' 10' ' ' LEU . 23.2 t80 -77.07 116.39 17.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 119.278 0.945 . . . . 0.0 110.7 -167.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.12 100.35 4.69 Favored 'General case' 0 N--CA 1.421 -1.921 1 N-CA-C 98.538 -4.615 . . . . 0.0 98.538 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.35 -33.5 9.09 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -165.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -154.79 144.46 15.4 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 168.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 10.7 Cg_endo -74.41 154.72 45.71 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 122.979 2.453 . . . . 0.0 109.638 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.88 -60.84 2.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.05 178.28 16.95 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 103.304 -3.919 . . . . 0.0 103.304 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -123.74 57.91 1.17 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.34 177.75 8.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -172.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.71 -18.96 62.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.591 1.156 . . . . 0.0 113.736 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -82.5 -28.03 31.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -41.31 63.32 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -81.2 -25.21 36.91 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.561 -171.093 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.87 -45.37 82.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -64.94 -41.13 95.78 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 26' ' ' CYS . 10.3 tt -79.51 -29.58 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.141 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -26.22 58.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.468 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -77.53 -34.18 54.01 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 117.962 0.346 . . . . 0.0 110.866 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -73.75 -52.63 12.56 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.332 0.653 . . . . 0.0 111.639 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.01 -36.38 79.88 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 123.269 0.628 . . . . 0.0 111.561 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.05 71.65 1.31 Allowed Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.321 3.4 mm? -97.99 -8.87 27.09 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 164.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -81.0 1.64 30.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.623 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 p -119.22 98.82 50.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.741 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.3 163.16 90.53 Favored 'Cis proline' 0 N--CA 1.443 -1.493 0 N-CA-C 106.595 -2.117 . . . . 0.0 106.595 -27.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.3 m -64.85 121.82 15.5 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -166.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -70.51 140.68 51.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 126.622 1.969 . . . . 0.0 107.661 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -70.87 -46.97 61.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 123.725 0.81 . . . . 0.0 113.14 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 tt -149.64 129.61 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -154.84 137.44 15.15 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.2 m -101.5 137.02 40.38 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.953 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -100.43 119.96 39.27 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 167.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.92 150.31 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.571 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -142.59 139.74 31.45 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.286 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.8 -136.34 5.12 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -95.3 140.06 30.72 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.34 -21.01 29.09 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -70.2 -36.38 74.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.368 1.867 . . . . 0.0 108.874 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 49' ' ' ASN . 39.5 m -72.5 -38.41 68.12 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.776 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.7 -48.47 85.83 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 CA-C-N 118.904 0.775 . . . . 0.0 111.402 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.06 -42.1 98.83 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.147 0.579 . . . . 0.0 111.473 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.24 7.59 5.0 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 72' ' ' SER . 24.0 mm -74.74 -32.33 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.2 t -71.88 -34.28 69.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.149 0.281 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.09 160.21 33.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.451 0.643 . . . . 0.0 110.032 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -75.96 -28.91 58.09 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.823 0.849 . . . . 0.0 109.389 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -77.12 124.65 28.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 44.2 t30 73.64 36.14 0.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 128.058 2.543 . . . . 0.0 112.679 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 148.88 5.58 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -98.36 152.09 37.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.45 131.35 18.73 Favored 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 122.858 2.372 . . . . 0.0 106.272 162.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -121.56 103.05 8.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 67' ' ' GLU 0.338 14.5 ptp180 49.47 -107.33 0.24 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 128.077 2.551 . . . . 0.0 115.264 177.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 34.2 tt0 -103.74 77.53 1.48 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.516 1.126 . . . . 0.0 108.058 -167.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.317 1.6 p-10 62.25 26.65 15.98 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.45 3.1 . . . . 0.0 114.713 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.71 164.41 12.26 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -142.94 122.45 13.2 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.3 138.14 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 56' ' ' ILE . 82.8 p -82.81 153.98 24.94 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 121.818 0.818 . . . . 0.0 112.655 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 -27.23 14.95 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.955 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 p -105.77 84.02 2.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.6 p -51.17 130.84 27.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.9 1.68 . . . . 0.0 111.152 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.59 163.92 12.66 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -165.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.42 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 10.7 mt-30 -75.68 141.94 42.62 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.38 145.37 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -169.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.0 m -134.8 103.92 5.81 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.2 m -87.34 106.37 17.89 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.0 m -99.74 128.25 45.85 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -118.8 138.41 52.72 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.69 116.73 14.63 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 125.703 1.601 . . . . 0.0 110.022 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.57 110.14 18.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.26 93.17 1.81 Allowed Glycine 0 CA--C 1.484 -1.858 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.08 -11.49 49.13 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 104.888 -3.285 . . . . 0.0 104.888 161.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -165.19 132.93 2.41 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -78.15 -25.38 7.3 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.319 2.012 . . . . 0.0 109.328 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -89.58 160.27 42.12 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.26 147.13 32.59 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.282 1.988 . . . . 0.0 108.132 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -82.98 165.69 69.64 Favored 'Cis proline' 0 N--CA 1.439 -1.7 0 CA-C-N 122.879 2.064 . . . . 0.0 108.932 5.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.3 m -145.15 125.96 14.34 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -169.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.75 131.75 36.0 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.74 120.63 42.17 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -88.32 117.93 27.57 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 137.69 35.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.883 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -120.32 106.66 12.09 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 170.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.38 149.95 30.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.108 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.04 -175.14 34.62 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.7 t80 -150.86 97.87 2.53 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.241 -3.615 . . . . 0.0 101.241 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -144.25 150.81 38.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -159.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -83.24 144.98 29.39 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.752 1.221 . . . . 0.0 109.165 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.98 153.37 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.46 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 162.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.4 m -91.29 134.97 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.36 133.4 36.65 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.33 134.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.168 0.918 . . . . 0.0 111.317 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -127.44 136.59 52.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.328 5.0 p30 73.54 4.41 4.77 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.891 2.077 . . . . 0.0 116.582 168.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.78 19.69 28.56 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.254 0.7 OUTLIER -136.86 133.09 18.61 Favored Pre-proline 0 CA--C 1.49 -1.357 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.98 113.47 3.8 Favored 'Trans proline' 0 N--CA 1.435 -1.944 0 N-CA-C 106.482 -2.161 . . . . 0.0 106.482 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -96.53 -7.38 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 13.1 t-80 -159.0 177.5 11.07 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 -168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -167.0 133.59 2.32 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 102.822 -3.029 . . . . 0.0 102.822 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -78.26 138.03 38.41 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.071 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -101.3 41.76 1.17 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -98.48 -32.22 11.58 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -72.27 -36.91 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.771 170.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 N--CA 1.422 -1.864 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.535 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 t -91.53 -27.52 18.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -68.4 -50.56 52.03 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.367 1.067 . . . . 0.0 111.836 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.45 ' HB2' HD23 ' A' ' 111' ' ' LEU 0.269 76.9 t80 -53.07 -53.76 45.51 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.697 169.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -69.16 -15.95 63.52 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -83.77 -36.36 23.65 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.912 1.233 . . . . 0.0 110.267 173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.732 1.213 . . . . 0.0 109.915 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -79.53 -26.94 41.36 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.83 2.052 . . . . 0.0 112.239 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -68.4 -52.48 32.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 40.3 mt-30 -68.53 -42.27 78.7 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 85.8 m-70 -105.38 -41.67 5.45 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.343 -165.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 14.6 t80 -76.02 120.16 20.96 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 120.805 1.639 . . . . 0.0 111.731 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -140.8 99.72 3.68 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 100.82 -3.77 . . . . 0.0 100.82 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -40.92 11.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.423 2.289 . . . . 0.0 117.115 -167.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.42 144.89 14.55 Favored Pre-proline 0 N--CA 1.433 -1.297 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 83.0 Cg_exo -76.65 176.84 9.58 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.654 1.569 . . . . 0.0 113.787 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -73.93 -60.2 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 165.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -151.07 -175.01 22.54 Favored Glycine 0 CA--C 1.477 -2.287 0 N-CA-C 103.322 -3.911 . . . . 0.0 103.322 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.03 74.4 0.86 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.08 170.89 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.75 -22.21 61.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -169.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -79.75 -26.57 40.68 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.124 0.42 . . . . 0.0 110.214 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.89 -43.71 62.15 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.5 OUTLIER -80.57 -25.36 38.6 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 119.02 -1.072 . . . . 0.0 113.061 -169.794 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.19 -36.79 69.31 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.307 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -69.86 -35.19 74.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 26' ' ' CYS . 15.2 tt -83.15 -29.22 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.332 0 CA-C-N 118.338 0.517 . . . . 0.0 110.096 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.4 mmt -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.328 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.527 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.4 tpp180 -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.013 0.925 . . . . 0.0 111.844 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -74.04 -49.05 25.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 123.865 0.866 . . . . 0.0 110.796 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -70.82 -37.89 73.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.199 1.0 . . . . 0.0 109.99 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.98 70.16 1.26 Allowed Glycine 0 CA--C 1.481 -2.061 0 C-N-CA 124.275 0.941 . . . . 0.0 111.266 168.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.361 2.5 mm? -104.52 -2.41 25.27 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 163.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.1 t -78.32 -8.57 58.56 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.086 -159.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -131.92 107.37 13.94 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 117.925 -1.036 . . . . 0.0 108.724 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.88 156.66 95.74 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.162 -1.899 . . . . 0.0 107.162 -19.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.1 m -57.8 122.91 14.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.616 1.567 . . . . 0.0 110.454 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 135.87 45.63 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -72.73 -38.89 67.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.632 0.773 . . . . 0.0 112.385 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -146.89 132.51 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.57 128.69 12.75 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.381 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 m -101.66 116.18 32.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.656 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.62 122.33 30.38 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.94 148.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.427 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -138.35 128.6 25.89 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.996 1.318 . . . . 0.0 108.42 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.01 -130.83 2.1 Favored Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -119.64 144.35 47.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.27 -2.75 58.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.031 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.02 -30.08 34.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -75.11 -31.31 61.11 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.127 0.971 . . . . 0.0 110.342 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.12 -58.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 124.089 0.956 . . . . 0.0 110.245 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.14 -38.19 73.14 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.33 59.49 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 126.102 1.761 . . . . 0.0 113.83 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.55 -39.98 65.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 C-N-CA 125.484 1.513 . . . . 0.0 111.11 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.27 -21.06 29.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.58 53.12 0.7 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.943 0.401 . . . . 0.0 111.288 -171.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 79.44 -35.97 0.16 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.775 2.43 . . . . 0.0 115.023 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.59 154.98 38.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 p30 26.96 55.7 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 129.377 3.071 . . . . 0.0 116.038 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.57 146.5 4.93 Favored Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -128.98 164.75 36.79 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.05 137.47 19.5 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.063 1.842 . . . . 0.0 107.816 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -106.74 161.03 15.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.214 -2.514 . . . . 0.0 104.214 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -70.81 150.99 45.28 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.285 0.634 . . . . 0.0 111.693 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 69.14 55.43 0.41 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.355 2.662 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.273 3.0 p-10 51.65 45.49 28.03 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.473 2.709 . . . . 0.0 114.095 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 106' ' ' ALA . 9.2 mt -124.89 178.69 5.36 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 -171.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -151.17 112.41 4.35 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.55 150.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.4 p -99.74 161.46 13.6 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.18 18.41 5.98 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 p -117.23 100.16 7.51 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.762 -3.792 . . . . 0.0 100.762 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 120.12 11.99 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.192 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -102.76 158.4 16.28 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.06 140.86 36.32 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.34 144.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -132.8 102.3 5.6 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 170.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -84.19 103.26 13.24 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 35.1 m -94.61 116.8 29.2 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -105.11 140.61 38.03 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.91 136.57 33.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -134.04 174.6 10.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.73 -101.39 0.72 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 106.092 -2.803 . . . . 0.0 106.092 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.15 -26.97 0.17 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.1 m -81.82 130.69 59.88 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -81.11 -25.37 4.06 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 121.968 1.779 . . . . 0.0 108.138 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -89.76 165.29 25.57 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.79 144.6 35.24 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 N-CA-C 107.584 -1.737 . . . . 0.0 107.584 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HA ' HH12 ' A' ' 31' ' ' ARG . 48.7 Cg_endo -86.8 162.47 51.43 Favored 'Cis proline' 0 N--CA 1.435 -1.928 0 CA-C-N 122.457 1.913 . . . . 0.0 109.257 19.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.523 ' H ' HH22 ' A' ' 31' ' ' ARG . 46.2 m -119.07 158.09 26.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -172.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -135.79 93.09 2.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.05 123.62 34.08 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.932 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -102.05 125.57 48.77 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.86 135.87 33.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.181 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.0 m -123.51 113.51 18.83 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.93 145.52 29.35 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.241 0.543 . . . . 0.0 110.024 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.7 168.46 30.5 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 105.13 -3.188 . . . . 0.0 105.13 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.02 103.04 3.7 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.84 174.88 14.32 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.051 -171.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.55 135.48 50.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 124.536 1.134 . . . . 0.0 110.233 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.91 138.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.18 110.76 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 6.5 m -107.71 151.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -96.83 140.3 31.6 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 166.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 1.5 t -119.61 146.42 45.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 124.899 1.374 . . . . 0.0 111.41 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.42 122.14 11.88 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.35 6.2 p30 72.32 3.13 4.58 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 127.917 2.487 . . . . 0.0 115.838 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.2 38.18 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 108.426 -1.869 . . . . 0.0 108.426 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 6' ' ' TYR . 1.4 mp -126.47 117.12 23.04 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 9.9 Cg_endo -77.19 120.97 5.54 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 CA-C-N 122.594 1.962 . . . . 0.0 107.9 -173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.97 -12.71 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 124.171 0.92 . . . . 0.0 111.712 -169.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 76.9 t60 -152.26 170.0 21.1 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -166.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.408 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 6.7 tp -140.44 136.14 32.73 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -84.12 134.16 34.6 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -110.59 40.23 2.03 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -99.25 -29.42 12.83 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -33.21 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.97 171.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.418 -2.033 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -170.835 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -90.5 -30.56 17.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -62.38 -51.2 68.53 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.463 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 45.5 t80 -53.9 -62.54 1.59 Allowed 'General case' 0 N--CA 1.404 -2.757 0 C-N-CA 127.103 2.161 . . . . 0.0 114.483 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.605 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 24.2 p -69.56 -16.39 63.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -81.81 -37.91 26.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 120.074 1.306 . . . . 0.0 110.02 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.85 -41.3 82.1 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.105 1.362 . . . . 0.0 109.902 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.402 0.0 OUTLIER -92.95 -6.37 48.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 118.084 0.402 . . . . 0.0 111.245 -173.25 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.7 m -73.47 -48.97 29.29 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.52 -1.363 . . . . 0.0 107.341 166.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -65.94 -41.9 90.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 126.291 1.836 . . . . 0.0 111.958 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -106.15 -50.28 3.2 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.562 -171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.511 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 53.9 t80 -77.88 120.98 23.52 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.585 1.538 . . . . 0.0 110.338 -168.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -139.25 94.25 2.78 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -35.5 -53.53 0.67 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 128.583 2.753 . . . . 0.0 118.338 -166.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -147.96 147.36 26.48 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 168.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -75.46 175.34 11.41 Favored 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 122.214 1.942 . . . . 0.0 113.322 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -76.05 -69.41 0.5 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.21 -176.89 14.6 Favored Glycine 0 CA--C 1.478 -2.252 1 N-CA-C 102.873 -4.091 . . . . 0.0 102.873 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -121.56 69.35 0.92 Allowed 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.63 174.65 11.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.42 -19.93 62.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.81 1.244 . . . . 0.0 113.3 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -81.31 -27.33 35.08 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.92 -34.62 51.26 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -34.03 54.93 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 123.327 0.651 . . . . 0.0 109.3 -170.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.02 -38.71 66.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.56 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -69.67 -30.82 68.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.267 14.2 tt -85.99 -27.38 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-N 118.504 0.593 . . . . 0.0 110.762 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.66 -29.41 64.58 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 118.628 -1.229 . . . . 0.0 110.066 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.64 HH22 ' H ' ' A' ' 92' ' ' CYS . 40.9 ttm-85 -81.43 -42.16 20.79 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -86.79 -28.0 23.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.44 -171.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -75.86 -36.08 59.68 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.63 72.0 1.23 Allowed Glycine 0 CA--C 1.473 -2.55 0 C-N-CA 125.164 1.364 . . . . 0.0 110.072 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.04 28.72 5.02 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 165.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -5.76 59.31 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.241 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.4 m -114.57 104.71 54.27 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.22 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 162.78 91.64 Favored 'Cis proline' 0 N--CA 1.44 -1.63 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 -24.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -70.3 114.35 8.35 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 123.677 0.791 . . . . 0.0 109.659 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -82.39 152.21 26.29 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.5 -74.38 0.1 Allowed 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.244 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -120.6 125.96 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -165.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -144.79 142.35 29.92 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.7 m -107.51 125.48 51.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.992 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.81 121.17 36.13 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.267 5.7 mm -93.63 147.64 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.81 133.07 35.53 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.97 -141.59 6.83 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 105.526 -3.029 . . . . 0.0 105.526 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -96.05 149.85 21.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.81 -18.74 27.06 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -71.31 -37.08 71.8 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -72.07 -38.33 69.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 117.375 -1.298 . . . . 0.0 111.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 53' ' ' ILE . 5.5 tp -65.54 -47.5 86.27 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 CA-C-N 119.242 0.928 . . . . 0.0 109.967 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.96 -39.37 91.9 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.661 1.584 . . . . 0.0 111.476 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.46 9.1 2.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.88 -44.04 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 165.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.3 m -99.64 42.93 1.08 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.87 24.1 3.94 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 40.38 61.98 1.45 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.5 3.12 . . . . 0.0 113.856 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' ASN . 33.6 mmtp -133.06 -35.39 1.05 Allowed 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 60' ' ' LYS . 55.0 t30 -127.92 31.45 5.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.12 149.13 12.45 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.93 147.26 64.81 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.31 132.71 15.31 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.757 2.305 . . . . 0.0 107.919 -163.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -108.68 85.07 2.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 72.12 -101.53 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.935 1.694 . . . . 0.0 111.975 172.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -116.26 81.68 1.65 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -165.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 1.5 p-10 63.83 22.54 13.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 129.196 2.998 . . . . 0.0 114.534 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.1 164.54 11.73 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.756 -3.794 . . . . 0.0 100.756 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.31 113.95 4.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 117.3 -1.76 . . . . 0.0 109.171 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 tt -85.66 139.69 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -80.66 171.38 15.1 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 0.0 111.367 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.65 -9.3 10.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -127.19 96.49 4.61 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -48.15 127.76 13.0 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 127.614 2.365 . . . . 0.0 112.939 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.31 154.14 19.33 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 3.4 mt-30 -78.28 148.17 33.98 Favored 'General case' 0 CA--C 1.469 -2.152 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.88 144.37 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -168.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.3 m -135.99 101.91 4.87 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.2 m -86.25 111.99 20.95 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 69.0 m -88.72 116.15 26.77 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -111.75 142.6 43.9 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -75.86 121.64 22.93 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -130.95 64.77 1.57 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.5 -48.88 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 105.314 -3.115 . . . . 0.0 105.314 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.29 11.94 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -106.25 124.19 36.59 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -79.98 -27.31 3.88 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 121.56 1.593 . . . . 0.0 108.078 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -105.42 147.82 35.27 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 117.386 -1.293 . . . . 0.0 107.846 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.87 144.09 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.381 2.054 . . . . 0.0 107.09 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' HH12 ' A' ' 31' ' ' ARG . 51.7 Cg_exo -82.32 161.1 77.5 Favored 'Cis proline' 0 CA--C 1.487 -1.853 0 CA-C-N 123.683 2.351 . . . . 0.0 110.697 10.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.64 ' H ' HH22 ' A' ' 31' ' ' ARG . 56.3 m -147.3 125.29 12.04 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.973 -166.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -84.55 129.34 34.86 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.23 120.05 36.52 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -97.69 127.76 43.88 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.52 127.25 33.57 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -113.25 100.09 8.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 172.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.87 130.51 35.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.93 -177.28 14.83 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 80.1 t80 -163.53 106.25 0.98 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.0 170.44 22.31 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.176 -172.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.23 131.75 44.69 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 124.195 0.998 . . . . 0.0 109.597 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.82 133.49 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.22 84.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.67 138.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.26 136.74 40.61 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.6 149.78 22.42 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 124.059 0.849 . . . . 0.0 111.458 -168.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -148.23 123.51 10.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.1 p30 64.41 18.69 11.47 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.571 2.349 . . . . 0.0 115.071 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.14 22.15 55.42 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 19.2 tp -132.24 130.21 21.9 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.37 109.23 2.28 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 123.49 2.282 . . . . 0.0 107.482 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.07 -12.42 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 O-C-N 123.731 0.644 . . . . 0.0 111.376 -171.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 59.1 t60 -143.55 176.55 9.12 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.64 131.26 2.99 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.81 125.19 28.27 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.48 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -94.04 12.65 25.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.209 1.004 . . . . 0.0 108.951 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -92.37 -6.42 50.16 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.58 0.752 . . . . 0.0 109.827 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.27 -25.05 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 N--CA 1.423 -1.788 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.68 -170.717 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 . . . . . 0 CA--C 1.502 -0.898 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t -93.36 -13.28 28.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -25.78 63.35 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.122 1.369 . . . . 0.0 110.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.13 -41.64 66.95 Favored 'General case' 0 N--CA 1.407 -2.606 0 C-N-CA 125.914 1.685 . . . . 0.0 108.94 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -81.0 -7.63 59.6 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -76.28 -47.23 24.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -57.36 -41.65 80.53 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 126.977 2.111 . . . . 0.0 110.632 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.399 0.1 OUTLIER -99.39 -5.29 29.79 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.457 -173.539 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.1 t -79.55 -38.86 33.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.727 1.603 . . . . 0.0 107.064 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -82.98 -28.07 29.99 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.458 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 44' ' ' THR . 74.7 m80 -103.65 -50.31 3.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 49.3 t80 -76.59 118.07 18.87 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 120.038 1.29 . . . . 0.0 110.837 -168.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -136.08 97.59 3.65 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.34 -42.09 4.37 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -166.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -160.08 134.9 5.53 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 45.6 Cg_exo -73.76 -179.8 4.91 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 122.757 2.304 . . . . 0.0 114.012 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -74.86 -71.54 0.35 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.99 -177.48 14.9 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 103.343 -3.903 . . . . 0.0 103.343 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -121.64 72.51 1.02 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.98 177.99 7.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.61 -14.44 61.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -77.54 -33.96 53.99 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.63 -39.23 62.23 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.0 t -68.52 -43.08 77.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.0 111.81 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.1 -35.46 66.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.033 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -73.21 -30.17 63.33 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.87 -28.75 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-N 118.501 0.592 . . . . 0.0 109.528 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.8 mmt -70.33 -33.29 71.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.229 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -44.47 64.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.401 0.681 . . . . 0.0 111.406 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.44 -39.56 58.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -35.59 63.75 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.18 75.54 1.05 Allowed Glycine 0 CA--C 1.479 -2.217 0 C-N-CA 124.789 1.185 . . . . 0.0 111.274 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.354 2.6 mm? -104.86 -3.69 23.14 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -78.88 -5.1 52.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.792 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 m -119.66 103.27 46.47 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.583 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.59 164.06 88.95 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 CA-C-N 122.96 2.093 . . . . 0.0 107.054 -23.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 83' ' ' LEU . 31.8 m -57.14 125.1 21.19 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.563 -171.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -76.86 141.6 40.55 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -77.18 -39.86 47.42 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.354 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.73 128.9 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -148.87 125.67 11.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 13' ' ' HIS . 89.8 m -98.58 119.97 38.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.064 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.6 114.09 23.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.05 149.45 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.64 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -139.05 136.16 34.97 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 124.581 1.153 . . . . 0.0 108.063 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.09 -143.77 8.65 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.91 147.01 24.41 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -86.23 -12.81 48.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.32 -36.29 71.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.436 1.494 . . . . 0.0 109.338 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 p -81.19 -25.69 36.55 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.307 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -56.93 -50.99 73.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.297 0 CA-C-N 120.232 1.378 . . . . 0.0 110.356 166.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -62.61 -40.67 97.7 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 123.464 0.706 . . . . 0.0 112.212 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.03 29.9 0.62 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 122.958 0.503 . . . . 0.0 112.082 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 72' ' ' SER . 12.4 mm -87.64 -30.13 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 160.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.0 t -83.15 -57.16 3.39 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.399 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.89 107.44 19.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -168.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 56.25 -87.51 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.575 2.75 . . . . 0.0 116.792 163.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.27 145.13 55.47 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.222 1.409 . . . . 0.0 107.839 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.331 6.8 p-10 43.83 39.4 2.57 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 130.873 3.669 . . . . 0.0 117.473 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.58 134.8 2.27 Favored Glycine 0 CA--C 1.489 -1.542 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 168.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -122.62 162.88 36.02 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -164.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 149.13 34.24 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.653 2.236 . . . . 0.0 108.491 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -148.28 116.82 6.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -168.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 66.68 -111.44 0.17 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.211 1.404 . . . . 0.0 110.792 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -136.16 95.21 3.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.359 2.2 p-10 64.98 23.13 12.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 129.161 2.985 . . . . 0.0 114.587 172.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -106.76 163.32 13.02 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 167.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -142.41 124.73 15.56 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.09 144.75 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 56' ' ' ILE . 97.7 p -83.33 158.0 22.36 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 121.748 0.785 . . . . 0.0 110.686 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -117.18 -5.06 11.37 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -116.5 88.94 3.0 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -55.69 128.8 36.48 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.058 1.743 . . . . 0.0 110.954 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -108.32 158.71 17.25 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.416 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 5.6 mt-30 -76.89 146.31 37.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.48 146.85 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -131.8 101.95 5.67 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 164.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -79.24 103.75 9.38 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 32.2 m -90.11 112.09 23.44 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -121.5 140.21 52.48 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 39' ' ' CYS . 25.9 tp -79.3 120.32 23.59 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -135.28 56.28 1.85 Allowed 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.54 -86.56 1.81 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 106.272 -2.731 . . . . 0.0 106.272 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.66 -16.67 3.31 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 m -85.41 134.02 41.18 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -79.67 -27.56 3.97 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.848 1.698 . . . . 0.0 108.209 170.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -97.7 163.36 19.74 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.263 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.54 144.13 35.47 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 122.268 1.979 . . . . 0.0 107.431 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -83.07 163.15 72.95 Favored 'Cis proline' 0 CA--C 1.489 -1.775 0 CA-C-N 123.164 2.166 . . . . 0.0 109.936 9.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.57 122.59 36.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -88.93 113.06 24.05 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.18 126.11 51.82 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -89.89 126.28 35.66 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 131.16 35.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.0 m -119.66 90.83 3.41 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.547 -2.761 . . . . 0.0 103.547 172.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.53 130.01 36.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.51 -165.67 10.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.416 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 86.2 t80 -157.51 101.09 1.83 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.442 -3.911 . . . . 0.0 100.442 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -138.19 149.32 45.71 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -165.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -77.3 134.21 38.59 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.596 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.23 153.37 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.08 115.94 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 102.01 -3.329 . . . . 0.0 102.01 161.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.43 161.44 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -106.03 144.7 32.38 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 163.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.6 t -123.33 138.83 54.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.527 1.142 . . . . 0.0 110.068 -170.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -127.43 132.99 49.99 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.308 5.6 p30 73.74 6.32 4.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.93 20.33 21.58 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.76 144.94 18.24 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -71.12 154.63 62.18 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 122.417 1.899 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.25 -17.38 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.65 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 82.0 t60 -149.81 166.93 27.99 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -164.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -127.64 130.66 49.33 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.9 120.1 24.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 21.57 17.19 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -173.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -90.57 -16.1 29.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.697 -174.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.09 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.424 -1.77 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.609 -175.702 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.0 p -91.64 -17.05 26.11 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -76.44 -32.84 58.68 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 123.353 0.661 . . . . 0.0 110.457 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -68.01 -37.94 82.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.65 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.468 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -74.68 -19.19 60.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -72.3 -45.57 59.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.98 0.809 . . . . 0.0 108.86 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -56.69 -40.49 75.68 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.176 1.79 . . . . 0.0 111.27 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.415 0.2 OUTLIER -96.88 -2.52 43.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 118.44 0.564 . . . . 0.0 111.732 -173.328 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.6 m -76.63 -42.97 40.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -68.75 -46.49 68.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.873 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -102.68 -41.33 6.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 118.448 -0.786 . . . . 0.0 111.173 -167.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 39.4 t80 -80.84 117.09 21.18 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.558 1.527 . . . . 0.0 111.124 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.07 96.29 3.48 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 100.958 -3.719 . . . . 0.0 100.958 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.27 6.12 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 127.937 2.495 . . . . 0.0 117.573 -165.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -151.69 138.82 12.23 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 39.7 Cg_exo -74.71 179.55 5.87 Favored 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 122.824 2.35 . . . . 0.0 113.834 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.3 -70.19 0.38 Allowed 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.74 -175.35 13.96 Favored Glycine 0 CA--C 1.477 -2.332 1 N-CA-C 101.995 -4.442 . . . . 0.0 101.995 163.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -116.1 72.57 0.81 Allowed 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.32 -179.7 6.15 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.488 -170.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.55 -39.34 87.58 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 127.457 2.303 . . . . 0.0 111.836 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -83.72 -16.02 46.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 110.775 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -77.73 -40.48 41.0 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 m -69.51 -34.68 74.64 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 123.485 0.491 . . . . 0.0 111.98 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.05 -37.71 72.52 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.409 0.443 . . . . 0.0 110.04 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -70.74 -31.08 67.78 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.275 14.5 tt -86.25 -27.84 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.067 0.394 . . . . 0.0 111.713 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.76 -19.56 48.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.552 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -75.79 -42.09 51.04 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 118.781 0.719 . . . . 0.0 109.425 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -75.73 -48.42 21.96 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.865 0.866 . . . . 0.0 111.505 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.87 -27.96 44.12 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.97 65.61 1.59 Allowed Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.91 22.48 14.85 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 165.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -89.37 -12.27 40.89 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -129.83 105.95 16.88 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.4 160.17 96.25 Favored 'Cis proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 -19.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.7 m -61.1 121.67 13.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.443 1.097 . . . . 0.0 110.258 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -73.65 133.52 43.45 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -72.83 -42.31 63.93 Favored 'General case' 0 CA--C 1.491 -1.316 0 O-C-N 123.766 0.666 . . . . 0.0 112.456 -169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 tt -154.49 126.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -154.77 129.31 9.17 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -94.86 125.14 39.32 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.32 120.67 33.87 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 167.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -98.08 148.59 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -135.51 133.4 38.42 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.352 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.93 -140.59 6.39 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 104.451 -3.459 . . . . 0.0 104.451 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -105.11 148.38 26.9 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 168.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -87.43 0.48 55.44 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.186 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.36 -34.98 58.91 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 167.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -77.22 -33.26 56.22 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.458 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mm -59.26 -50.03 81.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 124.335 1.054 . . . . 0.0 110.386 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -61.33 -33.83 74.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.171 0.988 . . . . 0.0 113.275 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 7.38 8.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 mm -84.83 -21.29 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.3 t -80.16 -19.46 47.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 122.064 -0.398 . . . . 0.0 110.736 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.64 142.9 51.59 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 165.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.42 -7.43 59.58 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.742 0.817 . . . . 0.0 112.699 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -81.26 -41.77 21.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.11 15.58 16.04 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -167.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.25 112.45 0.4 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 172.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -96.01 152.15 38.75 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.44 118.46 5.61 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 122.635 2.224 . . . . 0.0 106.373 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 69' ' ' LEU . 7.8 p80 -91.13 119.97 31.69 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 61.84 -96.67 0.06 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.784 1.634 . . . . 0.0 112.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -122.28 82.02 1.91 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -171.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 0.7 OUTLIER 65.88 11.75 7.88 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 129.192 2.997 . . . . 0.0 117.826 160.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.431 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.9 OUTLIER -102.84 148.33 25.77 Favored 'General case' 0 CA--C 1.476 -1.887 1 N-CA-C 99.0 -4.445 . . . . 0.0 99.0 174.372 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -124.44 118.48 26.76 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -158.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.6 tt -95.61 137.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.5 p -80.34 164.25 23.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.626 0.727 . . . . 0.0 111.914 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.06 -11.78 8.83 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -103.69 83.33 2.12 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.8 m -47.52 124.81 7.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 127.126 2.17 . . . . 0.0 112.048 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.68 158.08 16.5 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -78.96 143.36 35.84 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.13 141.23 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -167.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.8 m -129.62 105.77 8.28 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -81.66 100.11 9.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 99.9 m -86.84 112.33 21.63 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -111.35 143.09 42.7 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.16 109.72 17.42 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -94.5 158.68 15.44 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.2 -91.13 1.48 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.71 39.65 0.46 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.3 p -92.9 120.63 67.0 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.43 -8.64 4.49 Favored 'Trans proline' 0 N--CA 1.438 -1.781 0 CA-C-N 121.618 1.614 . . . . 0.0 108.036 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -110.6 161.84 23.07 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.04 146.14 36.52 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.454 2.102 . . . . 0.0 107.684 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.79 164.25 67.63 Favored 'Cis proline' 0 N--CA 1.435 -1.925 0 CA-C-N 122.073 1.776 . . . . 0.0 107.934 3.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.54 159.78 21.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -117.02 129.12 55.81 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -124.24 124.3 42.14 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -100.65 127.85 46.9 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.48 130.98 35.92 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.027 0.442 . . . . 0.0 109.964 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -119.1 89.55 3.15 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.49 136.85 33.25 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.104 0.478 . . . . 0.0 109.907 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.19 179.26 18.82 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 88.4 t80 -143.56 101.21 3.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -160.82 175.05 12.99 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -70.56 145.88 50.5 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 124.811 1.244 . . . . 0.0 111.539 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.37 147.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -110.25 94.19 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 165.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 m -96.5 133.17 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.96 132.01 43.18 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.05 134.96 52.24 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 124.548 1.155 . . . . 0.0 111.289 -166.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.74 135.23 45.62 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 10.2 p30 68.87 12.6 8.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.395 2.278 . . . . 0.0 116.411 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.93 19.51 46.92 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.2 19.86 Favored Pre-proline 0 CA--C 1.491 -1.32 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.06 113.21 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.59 -6.98 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.7 t60 -155.04 174.83 14.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -168.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.429 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -165.98 131.58 2.45 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.94 141.58 35.9 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.529 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -103.84 44.28 1.03 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -95.2 -34.41 12.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -73.42 -33.84 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 C-N-CA 125.143 1.377 . . . . 0.0 109.498 172.013 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 . . . . . 0 N--CA 1.421 -1.906 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -169.1 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 120.673 0.273 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -91.59 -7.06 51.23 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 124.356 1.062 . . . . 0.0 109.13 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -43.15 62.59 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -59.67 -50.84 72.28 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-O 117.523 -1.227 . . . . 0.0 112.309 173.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.433 3.4 t -87.16 9.04 21.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -76.68 -44.67 32.8 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 119.958 -1.713 . . . . 0.0 107.916 156.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.2 -31.86 70.55 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.597 1.159 . . . . 0.0 111.462 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 14' ' ' TYR . 17.3 mt -88.31 -23.77 23.35 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.691 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -71.03 -35.65 72.08 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 120.102 1.319 . . . . 0.0 109.82 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -69.29 -63.62 1.03 Allowed 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.924 168.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -88.8 -49.11 7.03 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -162.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' HD22 ' A' ' 10' ' ' LEU . 83.9 t80 -76.44 118.19 18.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.991 1.723 . . . . 0.0 110.14 -171.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -137.31 98.29 3.68 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.67 -34.71 0.4 Allowed 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 119.942 3.312 . . . . 0.0 119.942 -165.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -150.13 156.62 37.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 16.8 Cg_endo -72.18 149.76 52.37 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 123.246 2.631 . . . . 0.0 108.964 170.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -84.06 -50.91 7.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 166.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.38 -179.01 16.04 Favored Glycine 0 CA--C 1.48 -2.115 0 N-CA-C 103.621 -3.792 . . . . 0.0 103.621 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -126.6 53.03 1.69 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -141.07 -179.26 5.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.67 -38.59 72.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 128.437 2.695 . . . . 0.0 112.734 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -79.23 -23.93 43.41 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 124.129 0.971 . . . . 0.0 111.025 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -76.65 -38.94 53.75 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.3 m -69.81 -35.94 75.23 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 123.613 0.571 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.88 -35.7 64.72 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 t -70.51 -32.59 70.13 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 122.78 0.432 . . . . 0.0 111.998 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.295 10.5 tt -82.69 -30.83 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.077 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.15 -18.72 52.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.216 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -74.42 -37.15 63.41 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 119.062 0.846 . . . . 0.0 111.296 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -51.67 14.97 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.806 0.443 . . . . 0.0 110.107 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.91 -36.74 67.33 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.736 0.814 . . . . 0.0 110.646 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.98 67.02 1.57 Allowed Glycine 0 CA--C 1.479 -2.173 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.1 mt -114.46 22.88 13.27 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 164.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -99.06 2.56 46.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -146.54 103.85 3.98 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 159.05 94.83 Favored 'Cis proline' 0 N--CA 1.447 -1.246 0 CA-C-N 122.127 1.795 . . . . 0.0 107.636 -16.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.3 m -61.83 124.88 21.98 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 123.974 0.796 . . . . 0.0 110.148 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -77.95 132.28 37.8 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 171.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.17 -42.32 69.24 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.048 0.842 . . . . 0.0 112.455 -165.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.68 126.47 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -145.61 126.33 14.31 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -95.24 118.64 32.37 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.739 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.54 115.47 28.07 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.2 mm -92.13 146.13 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.582 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.3 m-70 -134.58 138.44 44.58 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.0 -153.46 24.71 Favored Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.34 138.56 34.48 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.62 -9.08 57.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -37.33 73.51 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.6 m -76.34 -30.81 57.78 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.288 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -57.28 11.83 Favored 'Isoleucine or valine' 0 C--N 1.363 1.161 0 CA-C-N 119.558 1.072 . . . . 0.0 110.377 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -68.12 -38.43 82.22 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.09 1.314 . . . . 0.0 110.958 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.66 -0.15 22.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.869 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.286 0.6 OUTLIER -79.57 -24.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.296 0 C-N-CA 116.532 -2.067 . . . . 0.0 110.113 170.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 92.8 m -98.8 34.88 1.97 Allowed 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.39 0.995 . . . . 0.0 111.074 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -118.35 21.72 12.51 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.273 13.5 p-10 26.23 46.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.551 1 C-N-CA 132.021 4.128 . . . . 0.0 116.122 -167.122 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.49 -19.37 14.42 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -127.22 28.97 5.65 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.77 161.67 31.36 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -122.56 148.41 52.92 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-O 116.092 -1.909 . . . . 0.0 106.021 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -69.92 154.82 66.69 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.767 2.311 . . . . 0.0 111.806 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -125.57 57.8 1.33 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.27 15.7 tpp180 81.56 -100.31 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.152 2.181 . . . . 0.0 113.044 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.34 78.03 1.34 Allowed 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 124.049 0.94 . . . . 0.0 109.318 -166.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.336 1.3 p-10 74.33 8.68 4.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 129.291 3.037 . . . . 0.0 113.749 169.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.17 158.78 16.07 Favored 'General case' 0 CA--C 1.466 -2.252 1 N-CA-C 98.794 -4.521 . . . . 0.0 98.794 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -152.09 138.19 18.26 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -174.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.19 136.64 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.0 p -84.38 163.2 19.69 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.39 0.614 . . . . 0.0 110.696 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -126.7 -0.97 6.74 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.0 t -101.33 92.49 4.97 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 162.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.1 m -58.33 126.58 28.13 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.28 1.432 . . . . 0.0 110.373 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -107.85 161.0 15.31 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -79.88 151.4 30.2 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.98 146.36 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -168.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.0 m -135.19 103.51 5.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 165.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.8 m -84.31 101.62 12.08 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.7 m -85.72 113.75 22.15 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -122.66 135.77 54.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.271 19.3 mt -65.4 118.28 9.15 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.106 0.479 . . . . 0.0 110.621 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -88.54 126.81 35.44 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 169.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.18 -84.86 0.38 Allowed Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 106.519 -2.633 . . . . 0.0 106.519 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.98 37.86 1.09 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.7 t -86.9 123.91 69.73 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.92 3.63 3.0 Favored 'Trans proline' 0 N--CA 1.437 -1.837 0 CA-C-N 122.192 1.818 . . . . 0.0 108.492 -171.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.35 160.71 38.53 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.19 146.17 31.67 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.73 1.62 . . . . 0.0 108.215 -171.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -82.74 161.71 75.41 Favored 'Cis proline' 0 N--CA 1.437 -1.834 0 CA-C-N 122.656 1.984 . . . . 0.0 109.482 7.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 m -119.95 111.81 18.4 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -85.76 122.4 29.79 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -121.11 111.21 17.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -85.75 129.75 34.74 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.11 127.35 32.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.7 m -114.6 92.59 4.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.14 29.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.024 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.7 -172.83 18.92 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -156.4 106.34 2.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.49 25.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.803 0.811 . . . . 0.0 109.97 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 129.38 34.49 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.053 1.341 . . . . 0.0 109.429 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.4 m -89.41 143.1 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.163 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.32 97.46 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 HH22 ' A' ' 70' ' ' ARG . 25.6 m -105.58 138.38 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.67 134.55 39.78 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.3 m -106.53 153.35 22.44 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.612 1.195 . . . . 0.0 110.135 -171.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -151.07 128.55 11.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.86 -2.645 . . . . 0.0 103.86 167.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.329 12.9 p30 66.02 17.55 10.81 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.216 2.607 . . . . 0.0 115.672 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.55 0.87 62.45 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.54 139.82 21.18 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.03 114.83 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 N-CA-C 105.224 -2.644 . . . . 0.0 105.224 164.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 m -100.32 -10.77 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 80.9 t60 -158.53 175.65 13.4 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -165.67 125.23 1.72 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.53 130.77 34.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -99.96 43.16 1.07 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.4 p -95.04 -18.01 21.4 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pt -97.03 -19.04 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 106.014 -1.846 . . . . 0.0 106.014 178.363 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.487 -1.465 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 t -93.08 -24.99 18.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 171.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -68.59 -37.94 80.24 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.167 1.387 . . . . 0.0 109.383 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 42.9 t80 -50.32 -60.65 2.77 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 127.642 2.377 . . . . 0.0 114.191 166.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -67.28 -16.58 64.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -70.84 -51.34 27.13 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.531 1.059 . . . . 0.0 109.063 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.09 -34.34 70.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 126.95 2.1 . . . . 0.0 111.555 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.0 OUTLIER -98.53 -8.91 25.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 118.698 0.681 . . . . 0.0 110.441 -171.774 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -76.52 -45.07 32.39 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 168.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -45.65 86.57 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.987 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.53 ' CD2' HD12 ' A' ' 115' ' ' LEU . 74.5 m80 -106.15 -49.02 3.45 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-O 118.547 -0.739 . . . . 0.0 111.782 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 60.5 t80 -76.48 121.9 23.78 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 120.136 1.335 . . . . 0.0 110.05 -167.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.72 97.17 3.2 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 102.063 -3.31 . . . . 0.0 102.063 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.29 -43.5 1.15 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 128.594 2.758 . . . . 0.0 118.291 -168.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.09 148.77 17.98 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 165.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -74.14 168.95 23.56 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 121.63 1.553 . . . . 0.0 112.443 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.96 -67.02 0.57 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.59 -178.46 15.44 Favored Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 102.159 -4.376 . . . . 0.0 102.159 163.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -113.3 72.91 0.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.14 175.76 11.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.08 -24.87 63.3 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.707 1.203 . . . . 0.0 113.176 -171.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -86.85 -18.31 31.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -41.53 62.26 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.471 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.29 0.5 OUTLIER -76.95 -26.51 54.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.167 -1.413 . . . . 0.0 113.605 -173.978 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.56 -39.33 81.08 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.293 170.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -66.88 -38.04 85.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.2 tt -80.95 -27.09 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 117.851 0.296 . . . . 0.0 110.504 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -24.58 55.73 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.186 -1.006 . . . . 0.0 112.03 174.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -75.63 -34.54 60.56 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 118.608 0.64 . . . . 0.0 111.82 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -76.99 -46.17 24.82 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 118.27 0.486 . . . . 0.0 111.769 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.28 -34.44 65.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 72.59 1.19 Allowed Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.6 mt -113.25 20.14 16.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -89.01 -7.11 56.59 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.7 m -125.65 100.86 30.87 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.553 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.52 167.48 80.19 Favored 'Cis proline' 0 N--CA 1.445 -1.359 0 N-CA-C 107.066 -1.936 . . . . 0.0 107.066 -22.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 83' ' ' LEU . 39.9 m -60.02 126.65 28.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 124.031 0.932 . . . . 0.0 111.034 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.29 139.43 46.11 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.95 -51.94 16.45 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 123.581 0.551 . . . . 0.0 110.091 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 tt -147.83 135.58 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -152.26 130.1 11.69 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HD2' ' A' ' 13' ' ' HIS . 49.2 m -97.21 120.52 37.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.186 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -90.62 126.46 35.97 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.262 5.9 mm -89.95 148.94 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.2 m-70 -138.49 139.25 38.71 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.61 -114.32 0.6 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 106.479 -2.648 . . . . 0.0 106.479 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -134.08 134.73 42.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.04 3.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.674 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -84.79 -28.29 26.26 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.1 m -84.62 -25.29 28.67 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 53' ' ' ILE . 1.5 tp -71.19 -41.94 75.28 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -61.77 -52.36 64.56 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.949 0.899 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.6 3.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.747 1.219 . . . . 0.0 113.399 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 72' ' ' SER . 1.5 tp -76.93 -33.92 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.2 m -94.23 9.67 37.09 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -166.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -104.44 23.11 13.74 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.79 0.805 . . . . 0.0 110.737 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.4 m120 42.63 38.04 1.18 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 130.81 3.644 . . . . 0.0 114.002 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.49 -35.24 7.95 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -120.98 26.15 9.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 149.97 17.99 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 119.178 -1.486 . . . . 0.0 110.729 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -100.46 125.36 39.51 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-O 116.529 -1.7 . . . . 0.0 107.934 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.8 141.62 34.08 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.648 2.899 . . . . 0.0 108.167 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -123.76 80.39 1.8 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 65.76 -99.49 0.06 Allowed 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 126.479 1.911 . . . . 0.0 114.516 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.42 72.39 1.41 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -164.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.309 2.6 p-10 57.31 30.6 18.76 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 129.495 3.118 . . . . 0.0 114.832 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.0 161.36 20.34 Favored 'General case' 0 CA--C 1.47 -2.101 1 N-CA-C 98.677 -4.564 . . . . 0.0 98.677 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.716 HH12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -156.82 148.55 22.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -171.172 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.427 HG12 HG22 ' A' ' 104' ' ' VAL . 12.6 mt -114.31 126.07 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 56' ' ' ILE . 57.8 p -69.07 160.4 31.08 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -117.54 -18.75 9.67 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.143 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 t -103.44 84.02 2.25 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.2 p -52.18 136.47 30.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.179 2.192 . . . . 0.0 112.701 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.82 163.58 14.87 Favored 'General case' 0 CA--C 1.473 -2.011 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -168.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -78.33 148.26 33.85 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -145.66 146.32 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -167.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.6 m -138.5 104.84 5.25 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 m -90.17 99.8 12.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.8 m -92.49 123.57 35.89 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -115.16 146.36 41.45 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 39' ' ' CYS . 48.8 tp -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.468 1.107 . . . . 0.0 108.584 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -94.2 156.52 16.5 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.82 -79.6 0.34 Allowed Glycine 0 CA--C 1.486 -1.776 0 N-CA-C 106.036 -2.826 . . . . 0.0 106.036 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.06 27.39 6.6 Favored Glycine 0 CA--C 1.488 -1.644 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -89.38 127.28 55.55 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 171.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -80.14 -20.63 8.49 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 CA-C-N 122.686 1.995 . . . . 0.0 108.849 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -101.21 163.62 17.59 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.94 144.58 34.62 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 N-CA-C 107.516 -1.763 . . . . 0.0 107.516 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -84.08 163.19 67.82 Favored 'Cis proline' 0 CA--C 1.489 -1.746 0 CA-C-N 123.174 2.169 . . . . 0.0 110.423 13.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 m -126.24 117.31 22.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.77 83.97 1.85 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.648 1.213 . . . . 0.0 108.067 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -70.0 130.66 42.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -97.18 120.52 37.68 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.53 135.73 33.71 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -115.31 98.97 7.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.85 141.72 35.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.96 -163.01 13.91 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -162.38 108.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -146.26 151.12 37.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -167.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -75.21 135.16 41.04 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -96.31 136.79 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.725 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 119' ' ' ILE . 89.3 t -91.81 105.74 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 164.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.716 HG23 HH12 ' A' ' 70' ' ' ARG . 16.2 m -117.06 155.68 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.29 133.3 53.22 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.3 m -102.67 153.95 19.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 124.717 1.261 . . . . 0.0 111.295 -170.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -147.85 123.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 167.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.0 p30 69.63 15.76 8.11 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.307 2.243 . . . . 0.0 115.069 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.83 55.64 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 7.6 tp -128.56 133.48 25.23 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -77.33 118.56 4.68 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 CA-C-N 124.181 2.529 . . . . 0.0 106.381 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.79 -11.34 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 O-C-N 123.635 0.584 . . . . 0.0 109.802 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -145.26 152.05 39.34 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.53 HD12 ' CD2' ' A' ' 13' ' ' HIS . 0.8 OUTLIER -110.74 127.35 55.31 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 117.53 30.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -100.75 37.93 1.63 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -166.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.2 p -87.39 -20.83 26.13 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 121.747 -0.596 . . . . 0.0 109.411 -174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.616 HD11 ' H ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -86.15 -23.5 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.105 0 C-N-CA 123.87 0.868 . . . . 0.0 109.579 173.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.404 ' CE1' HD12 ' A' ' 119' ' ' ILE . 22.6 m-30 . . . . . 0 N--CA 1.419 -2.008 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -164.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -87.92 -17.09 32.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.533 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -73.28 -41.79 63.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.53 -48.02 76.67 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.836 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -79.78 -10.41 59.78 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 120.304 1.411 . . . . 0.0 114.506 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -82.82 -30.56 28.66 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 119.093 0.86 . . . . 0.0 108.81 171.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 10' ' ' LEU . 3.3 t80 -60.25 -34.94 74.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.492 0.717 . . . . 0.0 109.986 165.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 mp -81.03 -23.3 38.7 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.9 p -75.11 -30.65 60.91 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 120.495 1.498 . . . . 0.0 110.881 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -72.74 -55.16 7.17 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -95.66 -54.04 3.5 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.708 -162.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 23.4 t80 -78.45 112.2 15.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.926 1.239 . . . . 0.0 109.977 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.43 94.07 3.58 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 101.445 -3.539 . . . . 0.0 101.445 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.9 -38.02 0.89 Allowed 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 120.141 3.386 . . . . 0.0 120.141 -162.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.7 154.38 47.92 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.9 Cg_endo -75.0 163.16 35.89 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 123.613 2.875 . . . . 0.0 109.883 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -75.16 -71.39 0.36 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 166.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.91 178.42 16.44 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.459 -3.856 . . . . 0.0 103.459 164.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -114.68 70.61 0.74 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.68 174.98 14.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.72 -16.75 62.81 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.814 1.246 . . . . 0.0 113.535 -170.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -81.75 -28.83 33.12 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -76.99 -34.3 57.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -33.57 42.07 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -169.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.58 -46.27 80.09 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 124.631 1.172 . . . . 0.0 109.34 170.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.1 t -64.33 -36.75 85.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.9 tt -83.08 -28.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 CA-C-N 118.023 0.374 . . . . 0.0 111.21 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.0 mmt -73.28 -23.88 60.35 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.117 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -82.6 -29.32 30.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 118.903 0.774 . . . . 0.0 112.58 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -80.74 -37.35 30.68 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.402 0.546 . . . . 0.0 111.122 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -22.67 55.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.671 0.388 . . . . 0.0 110.306 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.3 5.66 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.62 16.55 19.66 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -91.1 -11.71 37.79 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 m -126.42 102.9 26.0 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.74 161.48 94.12 Favored 'Cis proline' 0 N--CA 1.443 -1.494 0 N-CA-C 106.865 -2.013 . . . . 0.0 106.865 -20.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.2 m -62.12 120.62 11.23 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.96 0.904 . . . . 0.0 110.339 -175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -72.0 138.9 48.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.32 -40.98 57.87 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 123.557 0.536 . . . . 0.0 111.338 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.15 128.25 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -148.39 127.14 12.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 170.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -97.48 123.84 41.49 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.085 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -94.6 113.23 25.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.8 mm -87.37 145.34 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.53 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.565 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 8.9 m-70 -133.8 133.62 41.88 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.61 -147.12 12.43 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.313 -2.315 . . . . 0.0 107.313 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.92 149.04 21.67 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.07 -17.85 34.01 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -68.85 -40.84 79.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.439 1.896 . . . . 0.0 106.565 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.1 m -70.21 -41.95 72.97 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 116.645 -1.645 . . . . 0.0 111.665 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.1 mm -53.97 -58.18 4.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 124.368 1.067 . . . . 0.0 111.478 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.03 -42.55 90.48 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.062 1.345 . . . . 0.0 111.489 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.65 4.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mm -77.59 -31.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.2 m -94.58 7.68 44.84 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.624 0.249 . . . . 0.0 111.502 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -91.09 173.26 8.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 158.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -85.55 1.8 47.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.344 0.658 . . . . 0.0 111.555 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -77.52 -60.01 2.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.243 0.617 . . . . 0.0 111.32 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -89.34 -49.51 6.67 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.55 147.81 18.65 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -168.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.71 156.66 35.27 Favored Pre-proline 0 N--CA 1.434 -1.262 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -73.92 125.44 9.9 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 122.663 2.242 . . . . 0.0 107.629 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -117.71 123.35 45.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 66.46 -107.2 0.11 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.912 1.285 . . . . 0.0 112.124 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.75 95.61 2.88 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.333 2.2 p-10 60.31 35.55 20.71 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 128.666 2.786 . . . . 0.0 113.602 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -117.67 165.69 13.3 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 101.31 -3.589 . . . . 0.0 101.31 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.8 mtt85 -145.14 127.59 15.96 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -95.58 134.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -81.84 160.21 23.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.351 0.596 . . . . 0.0 111.054 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.97 -1.87 9.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -106.37 77.26 1.2 Allowed 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -59.69 138.06 57.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 125.898 1.679 . . . . 0.0 111.912 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -113.43 158.85 20.13 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -166.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 8.7 mt-30 -79.89 138.9 37.26 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.22 105.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -171.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.0 m -97.98 106.31 18.58 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m -87.39 112.19 21.88 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -89.38 116.29 27.47 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -121.47 142.33 50.15 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.2 tp -80.36 110.54 15.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -93.13 155.02 17.74 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.91 -89.79 1.52 Allowed Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.33 38.41 0.59 Allowed Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -80.15 126.08 80.14 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -84.88 -19.96 3.79 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 122.165 1.809 . . . . 0.0 108.314 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -110.47 160.66 27.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 117.618 -1.182 . . . . 0.0 107.962 -168.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -73.25 142.04 33.17 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 C-N-CA 122.695 2.263 . . . . 0.0 106.767 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -82.04 159.47 79.43 Favored 'Cis proline' 0 N--CA 1.435 -1.944 0 CA-C-N 123.027 2.117 . . . . 0.0 108.949 4.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.6 m -109.52 170.27 8.17 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -125.48 109.92 13.29 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -105.84 113.98 27.86 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -89.04 125.61 35.08 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.72 125.69 29.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 m -106.53 87.22 2.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.75 129.21 34.4 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.08 -167.13 14.4 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -157.32 114.26 3.01 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -155.14 156.18 35.29 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -168.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.57 139.58 42.19 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.61 172.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.22 147.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.08 94.7 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 165.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 m -91.6 136.11 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.5 m -107.03 142.62 36.38 Favored 'General case' 0 CA--C 1.485 -1.556 0 O-C-N 124.42 1.075 . . . . 0.0 110.577 -172.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -150.77 130.49 13.17 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.322 14.8 p30 64.37 20.44 12.17 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 115.553 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.77 -3.07 70.54 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER -102.73 142.42 24.53 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 176.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.72 109.85 2.93 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 N-CA-C 105.386 -2.582 . . . . 0.0 105.386 160.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.98 -22.58 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.623 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 23.2 m80 -156.37 -163.4 1.45 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 132.88 1.06 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.54 127.29 32.76 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -97.55 16.94 18.9 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 m -91.84 -20.85 21.03 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 118.765 0.711 . . . . 0.0 110.376 -165.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -26.71 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 C-N-CA 123.672 0.789 . . . . 0.0 109.03 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.14 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -90.05 -27.02 19.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -71.65 -41.66 68.5 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.177 0.591 . . . . 0.0 109.437 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -55.0 -56.81 15.59 Favored 'General case' 0 N--CA 1.398 -3.032 0 C-N-CA 126.158 1.783 . . . . 0.0 113.957 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 17.8 p -78.72 -6.16 55.08 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.28 -35.63 19.82 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 120.582 1.537 . . . . 0.0 108.496 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -41.34 87.69 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.547 1.139 . . . . 0.0 109.416 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.392 0.0 OUTLIER -97.34 0.02 47.22 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 118.267 0.485 . . . . 0.0 111.168 -174.027 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -71.22 -53.91 12.75 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 161.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.12 -40.58 94.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 124.053 0.846 . . . . 0.0 112.94 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -121.25 4.86 10.29 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.245 -162.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 30.7 t80 -110.29 130.0 55.63 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 120.173 1.351 . . . . 0.0 109.438 167.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.82 104.6 3.33 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 164.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.88 -43.38 4.05 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 118.321 2.712 . . . . 0.0 118.321 -164.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -142.24 156.49 64.4 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -71.04 147.28 54.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.584 2.856 . . . . 0.0 108.838 172.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -80.02 -53.51 6.66 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.04 -178.38 15.57 Favored Glycine 0 CA--C 1.48 -2.125 0 N-CA-C 103.331 -3.908 . . . . 0.0 103.331 164.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.11 48.01 2.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.95 179.33 6.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.896 -168.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.68 -41.52 77.47 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.707 2.403 . . . . 0.0 112.926 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -81.63 -18.93 42.96 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.865 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -74.29 -44.59 52.09 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 2.3 m -68.66 -36.93 79.2 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 124.238 0.961 . . . . 0.0 112.869 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.57 -41.87 75.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 123.371 0.42 . . . . 0.0 110.275 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.9 m -73.06 -23.17 60.53 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.827 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 9.9 tt -85.74 -36.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 119.77 1.168 . . . . 0.0 110.965 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.1 mmm -72.05 -30.77 65.49 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.19 -39.32 55.04 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.53 -48.56 26.27 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.407 -170.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -79.66 -23.77 42.29 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.152 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.37 61.95 1.52 Allowed Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 161.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.69 15.3 5.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 t -84.33 8.83 14.79 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.705 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.6 m -113.18 106.27 54.88 Favored Pre-proline 0 N--CA 1.428 -1.575 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.368 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.7 162.24 93.09 Favored 'Cis proline' 0 N--CA 1.443 -1.474 0 CA-C-N 123.401 2.25 . . . . 0.0 107.262 -22.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.28 117.48 7.9 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.58 1.152 . . . . 0.0 111.819 -168.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -73.93 137.15 43.42 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -75.09 -35.19 61.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.371 1.044 . . . . 0.0 112.629 -168.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.21 130.63 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -154.1 119.4 5.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -102.88 120.59 40.89 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.647 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.39 116.29 26.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.04 149.03 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.553 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m-70 -131.6 132.92 44.45 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.641 -172.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.85 -116.56 0.72 Allowed Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -133.5 140.69 47.38 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -88.36 -0.75 57.51 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -79.62 -31.06 41.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -78.16 -28.51 48.34 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.674 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.16 -41.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 CA-C-N 119.142 0.883 . . . . 0.0 110.609 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -58.96 -43.31 91.3 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.744 1.217 . . . . 0.0 111.122 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.94 13.6 1.35 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 72' ' ' SER . 20.1 mm -83.11 -22.88 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.6 m -84.55 -11.03 56.85 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.62 166.61 15.24 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.26 -17.06 47.28 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -81.33 -30.49 33.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -130.4 37.86 3.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.73 128.25 1.04 Allowed Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.89 156.05 36.61 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.04 122.17 6.57 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 122.496 2.131 . . . . 0.0 107.036 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -106.23 127.82 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 63.46 -105.2 0.15 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.415 1.486 . . . . 0.0 112.058 170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -139.75 97.77 3.33 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.341 1.9 p-10 64.37 26.72 13.62 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 129.033 2.933 . . . . 0.0 114.343 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.18 167.83 9.73 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.51 115.55 8.82 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.1 tt -96.61 139.89 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' HD12 ' A' ' 56' ' ' ILE . 93.8 p -81.32 164.86 21.88 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.591 0.71 . . . . 0.0 111.833 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -115.13 -12.68 11.88 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -116.86 90.65 3.38 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -49.9 132.92 22.71 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.543 2.337 . . . . 0.0 113.656 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.11 157.64 19.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 2.9 mt-30 -81.05 149.14 29.36 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.71 141.62 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -166.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.9 m -134.3 104.93 6.37 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.4 m -85.67 104.05 15.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 70.2 m -83.32 114.74 21.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -111.34 142.29 43.77 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -93.43 136.67 33.47 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -140.83 172.6 12.46 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.39 -91.22 0.6 Allowed Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.62 -11.33 1.12 Allowed Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -78.46 134.86 61.53 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -80.35 -30.35 2.07 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.682 1.588 . . . . 0.0 108.093 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -97.14 154.88 37.99 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.44 -168.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.57 150.19 27.73 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 122.292 1.995 . . . . 0.0 107.429 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -81.7 165.04 74.67 Favored 'Cis proline' 0 CA--C 1.49 -1.707 0 CA-C-N 123.028 2.117 . . . . 0.0 109.462 7.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.7 m -149.84 141.49 23.55 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -167.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.73 141.33 30.63 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 36.9 m-85 -134.35 110.01 9.17 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -91.16 132.71 35.9 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.76 130.49 35.38 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.618 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -113.9 95.63 5.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.78 141.7 34.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.41 -173.8 23.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 84.7 t80 -160.62 107.97 1.55 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.33 164.04 39.3 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.247 -173.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.81 123.78 28.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.718 1.207 . . . . 0.0 108.745 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -96.02 139.61 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.664 -163.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.6 t -96.36 112.06 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.276 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -105.06 148.13 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 170.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.24 36.61 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.95 151.15 24.96 Favored 'General case' 0 CA--C 1.494 -1.209 0 O-C-N 124.237 0.96 . . . . 0.0 110.636 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -148.76 128.74 13.51 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.346 8.2 p30 70.77 7.85 6.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.592 2.357 . . . . 0.0 115.557 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.37 2.79 57.73 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.263 5.5 tp -113.99 154.72 45.99 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -72.0 159.35 50.45 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.054 1.836 . . . . 0.0 108.263 163.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -138.27 -20.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.493 175.144 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 113' ' ' VAL . 41.1 m-70 -149.86 177.71 9.57 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -126.74 136.07 51.94 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.52 118.73 28.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.08 40.26 1.36 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.0 m -96.76 -28.32 14.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 pt -91.47 -20.78 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.449 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.31 -6.63 49.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -33.46 44.39 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 0.7 OUTLIER -64.68 -50.25 67.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.055 1.342 . . . . 0.0 109.0 173.265 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.484 1.7 t -88.06 10.85 17.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -80.49 -40.78 25.51 Favored 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 119.974 -1.704 . . . . 0.0 107.836 157.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.95 -40.25 80.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.117 1.367 . . . . 0.0 109.588 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 14' ' ' TYR . 18.0 mt -83.28 -15.65 49.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.3 m -65.86 -47.71 74.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-N 120.465 1.484 . . . . 0.0 109.224 169.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -77.83 -40.3 40.77 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 124.212 1.005 . . . . 0.0 111.187 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -96.17 -54.92 3.13 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 118.482 0.583 . . . . 0.0 110.377 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB2' HD22 ' A' ' 10' ' ' LEU . 50.5 t80 -77.66 118.77 20.37 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.982 0.896 . . . . 0.0 110.382 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.07 98.11 3.79 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.45 -41.24 6.12 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 -165.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -156.26 139.27 10.8 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 164.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.2 Cg_endo -85.54 170.96 8.85 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.876 1.717 . . . . 0.0 108.663 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -73.25 -79.77 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -177.03 20.05 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 103.494 -3.842 . . . . 0.0 103.494 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -127.38 70.87 1.32 Allowed 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -147.46 -178.76 6.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -66.21 -26.2 67.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.824 1.249 . . . . 0.0 113.777 -171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -81.25 -27.08 35.33 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 122.599 0.36 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -72.11 -42.72 65.77 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 0.1 OUTLIER -81.25 -24.99 36.97 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 119.081 -1.048 . . . . 0.0 113.371 -170.064 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.06 -36.6 66.91 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.467 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -69.62 -34.19 73.73 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.3 tt -85.19 -24.75 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 CA-C-N 118.308 0.504 . . . . 0.0 110.579 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -31.09 63.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.588 172.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -73.75 -36.63 65.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -81.54 -41.91 20.95 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -77.63 -21.15 52.7 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.233 0.469 . . . . 0.0 111.904 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.67 50.69 1.94 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.344 4.0 mm? -108.09 -14.65 14.68 Favored 'General case' 0 CA--C 1.48 -1.749 0 C-N-CA 124.216 1.006 . . . . 0.0 108.636 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 t -74.6 -15.34 60.84 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.897 1.679 . . . . 0.0 112.735 -163.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -121.84 108.3 35.0 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.78 156.22 99.69 Favored 'Cis proline' 0 N--CA 1.441 -1.594 0 N-CA-C 106.722 -2.068 . . . . 0.0 106.722 -25.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.1 m -59.9 127.91 34.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 125.518 1.527 . . . . 0.0 112.026 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -80.3 140.27 36.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -77.06 -37.62 54.25 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.774 -168.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.56 129.7 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -152.38 130.0 11.53 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 170.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -97.64 128.72 44.55 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.893 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -94.83 118.04 31.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -87.14 148.07 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -142.86 130.09 20.93 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.719 -176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 -129.98 1.84 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 106.579 -2.609 . . . . 0.0 106.579 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -115.36 145.08 42.86 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.01 -18.83 29.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.02 0.438 . . . . 0.0 109.907 -170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -80.26 -24.64 39.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -71.07 -40.65 71.49 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 117.312 -1.328 . . . . 0.0 110.076 172.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.19 -53.87 34.31 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 C-N-CA 124.844 1.258 . . . . 0.0 111.165 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.56 -43.26 89.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.189 1.396 . . . . 0.0 111.517 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.24 8.41 9.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mm -75.37 -27.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.5 t -72.85 -29.03 62.88 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 117.564 0.165 . . . . 0.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.34 153.72 42.13 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.03 8.76 33.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.666 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.04 -50.86 7.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -110.76 -3.88 15.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.684 -166.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.31 -159.12 7.99 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 103.894 -3.682 . . . . 0.0 103.894 168.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -162.26 152.95 14.54 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -73.5 137.89 26.09 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.995 2.463 . . . . 0.0 107.503 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -129.61 122.78 29.77 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? 67.94 -100.26 0.05 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 125.181 1.393 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -162.57 108.8 1.22 Allowed 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.412 0.5 OUTLIER 86.71 -6.66 0.71 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 129.857 3.263 . . . . 0.0 114.145 173.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.8 156.82 17.27 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -141.75 115.72 9.28 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.26 141.95 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -84.47 162.71 19.81 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.63 0.729 . . . . 0.0 112.181 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.89 -27.28 9.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 m -103.03 79.78 1.79 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -47.4 133.81 12.29 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 128.336 2.654 . . . . 0.0 113.502 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -112.3 158.73 19.41 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -167.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -79.92 125.19 29.42 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.11 103.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.9 m -90.6 107.77 19.38 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -87.41 105.59 17.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.1 m -97.4 114.49 26.32 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -114.76 136.85 52.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.86 118.66 10.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.832 1.653 . . . . 0.0 107.824 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -136.39 97.5 3.6 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.32 -42.61 0.07 OUTLIER Glycine 0 CA--C 1.48 -2.136 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.72 6.18 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 m -112.13 109.92 54.17 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -85.2 -20.46 3.38 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 121.769 1.668 . . . . 0.0 108.51 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -112.1 159.46 33.62 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -169.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -75.11 145.36 30.98 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.563 2.176 . . . . 0.0 107.929 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -81.91 162.68 77.74 Favored 'Cis proline' 0 N--CA 1.436 -1.91 0 CA-C-N 122.437 1.906 . . . . 0.0 107.969 -1.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.0 m -108.45 166.03 11.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -171.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -122.27 116.75 24.64 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.76 133.02 54.98 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -99.47 117.06 33.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 165.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.39 131.68 34.66 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 m -123.31 107.83 12.09 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.45 135.01 36.55 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.898 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.72 -174.89 13.57 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 106.09 -2.804 . . . . 0.0 106.09 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.48 106.18 1.9 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -156.88 168.92 26.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -78.1 132.67 37.79 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.569 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.46 138.89 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.391 -170.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.9 t -101.22 96.13 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.24 136.65 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.58 143.54 30.07 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.8 t -136.42 137.02 40.03 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.178 0.513 . . . . 0.0 110.624 -170.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -128.23 131.73 48.8 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.306 14.1 p30 64.47 21.19 12.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 117.106 2.262 . . . . 0.0 117.106 171.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.56 53.73 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tp -144.63 118.49 5.69 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -172.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -71.51 118.29 5.58 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 CA-C-N 121.817 1.685 . . . . 0.0 111.416 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -26.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 118.816 0.735 . . . . 0.0 112.664 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -149.3 -166.2 2.49 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.1 133.56 4.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.65 141.02 34.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.509 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -105.16 42.09 1.27 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.0 m -95.87 -29.07 14.4 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -32.67 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 124.981 1.312 . . . . 0.0 109.475 170.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -171.762 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.428 -1.55 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t -93.59 -28.12 16.21 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 167.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -34.46 63.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.084 0.954 . . . . 0.0 108.803 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.481 ' HB2' HD21 ' A' ' 111' ' ' LEU . 63.3 t80 -46.46 -60.32 2.42 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 127.053 2.141 . . . . 0.0 111.796 162.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 1.6 p -72.73 -12.56 61.06 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -76.62 -41.91 44.22 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.799 1.181 . . . . 0.0 109.824 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -63.03 -36.27 83.0 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.995 1.718 . . . . 0.0 109.342 171.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -73.67 -26.7 60.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.034 1.333 . . . . 0.0 114.493 177.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 79.8 m -69.81 -51.31 34.81 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.4 pt20 -84.82 -10.25 57.36 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.613 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 83.7 m-70 -138.03 2.67 2.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 36.2 t80 -107.07 132.34 53.09 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 120.52 1.509 . . . . 0.0 108.834 171.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.33 104.36 3.09 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 167.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -37.92 16.77 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -162.14 138.13 5.8 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 86.0 Cg_exo -74.01 173.58 13.83 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.274 1.983 . . . . 0.0 114.465 -172.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.78 -73.87 0.24 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.98 -175.82 15.29 Favored Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 167.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.2 69.29 1.21 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.36 -176.96 5.68 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.45 -21.95 61.89 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.324 1.05 . . . . 0.0 113.366 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -81.95 -23.44 36.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -77.55 -37.55 50.48 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.0 m -69.46 -37.09 77.17 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -77.12 -30.71 55.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 119.456 -0.307 . . . . 0.0 110.339 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -70.33 -35.27 73.51 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.0 tt -85.96 -25.97 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 120.605 0.241 . . . . 0.0 110.89 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 mmt -76.49 -31.21 57.61 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.79 -0.569 . . . . 0.0 109.777 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -69.57 -38.64 77.48 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.159 0.984 . . . . 0.0 112.172 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -71.11 -52.04 21.59 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.465 1.106 . . . . 0.0 110.865 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.24 -26.28 39.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.145 0.578 . . . . 0.0 109.543 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.65 63.24 1.29 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 164.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.16 23.35 1.86 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.684 1.231 . . . . 0.0 108.335 174.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -84.23 -9.48 58.48 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.532 1.933 . . . . 0.0 109.696 167.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.9 t -120.22 107.77 39.0 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.82 165.45 84.87 Favored 'Cis proline' 0 N--CA 1.448 -1.184 0 CA-C-N 122.593 1.962 . . . . 0.0 107.557 -18.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 83' ' ' LEU . 49.9 m -61.38 120.51 10.59 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.798 0.839 . . . . 0.0 110.757 -175.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -79.4 144.12 34.42 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -75.19 -40.2 59.56 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 123.097 0.559 . . . . 0.0 111.762 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.26 133.76 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.8 121.09 4.85 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -102.35 115.47 30.63 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.004 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.0 120.25 26.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -101.81 146.71 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -132.49 127.92 36.26 Favored 'General case' 0 CA--C 1.485 -1.521 0 C-N-CA 124.672 1.189 . . . . 0.0 108.574 -172.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.72 -143.85 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 105.374 -3.09 . . . . 0.0 105.374 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -95.27 148.61 22.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -88.69 -17.96 28.88 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -69.55 -36.01 75.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.9 t -74.61 -36.13 62.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 117.335 -1.317 . . . . 0.0 111.006 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 53' ' ' ILE . 3.2 tp -64.85 -46.52 91.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.301 0 CA-C-N 119.542 1.065 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -61.54 -41.88 97.99 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.747 1.219 . . . . 0.0 111.243 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.62 2.39 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.5 mm -74.48 -36.32 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.8 m -85.81 -31.49 22.28 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -102.07 57.31 0.81 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 117.796 0.271 . . . . 0.0 111.242 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 34.81 65.48 0.35 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 130.174 3.389 . . . . 0.0 115.54 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.94 -58.76 0.96 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -99.51 -44.43 6.17 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 154.58 21.55 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.588 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.27 154.16 42.3 Favored Pre-proline 0 N--CA 1.434 -1.247 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.75 137.31 22.16 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.984 2.456 . . . . 0.0 107.105 -175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.5 73.49 1.19 Allowed 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 69.49 -101.28 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 126.325 1.85 . . . . 0.0 113.551 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.96 77.21 1.23 Allowed 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 123.935 0.894 . . . . 0.0 108.759 -163.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.319 6.4 p30 71.92 11.56 6.18 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 129.421 3.089 . . . . 0.0 114.222 170.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.24 157.33 16.86 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -140.11 119.33 12.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -88.76 143.35 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.3 p -83.85 169.01 15.58 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -134.63 3.79 3.3 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.4 m -105.39 79.55 1.48 Allowed 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -53.24 128.43 28.03 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 127.506 2.322 . . . . 0.0 112.18 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -108.86 158.96 17.17 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -170.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 8.5 mt-30 -77.57 145.35 36.92 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.88 142.06 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -171.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.9 m -134.5 102.51 5.34 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 102.097 -3.298 . . . . 0.0 102.097 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 106.79 14.29 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.9 m -89.24 113.04 24.22 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -124.61 136.78 54.23 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -169.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 39' ' ' CYS . 42.3 tp -78.64 123.63 27.33 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -138.06 52.65 1.84 Allowed 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.95 -88.2 2.01 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.66 -16.79 4.01 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -83.92 136.62 41.3 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -81.17 -23.4 5.28 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 121.83 1.687 . . . . 0.0 108.422 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -105.33 164.46 15.04 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -74.26 143.7 32.1 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 107.035 -1.948 . . . . 0.0 107.035 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -82.9 160.97 75.3 Favored 'Cis proline' 0 N--CA 1.435 -1.913 0 CA-C-N 123.062 2.129 . . . . 0.0 109.583 7.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.1 m -125.24 138.68 54.11 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -173.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.61 99.73 11.81 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -94.16 111.83 23.59 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -87.65 124.99 34.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.94 125.8 29.85 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.4 m -110.19 87.26 2.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.18 131.17 34.83 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -172.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.58 -162.35 9.2 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.049 -2.021 . . . . 0.0 108.049 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.413 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.9 t80 -155.21 102.32 2.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -137.91 155.62 48.73 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -158.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -74.36 127.82 33.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.54 131.55 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -92.47 113.22 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.443 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.14 141.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 173.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.24 127.69 37.81 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.7 m -108.65 151.66 25.85 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 121.836 0.827 . . . . 0.0 112.004 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.33 127.15 14.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 15.3 p30 60.01 25.38 14.6 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 128.054 2.542 . . . . 0.0 115.422 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.18 20.71 60.18 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -139.87 138.59 19.98 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.158 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.62 117.77 1.77 Allowed 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 121.535 1.584 . . . . 0.0 108.947 -170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 -23.08 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 123.572 0.545 . . . . 0.0 112.246 -176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 28.4 m80 -143.0 -177.73 5.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -170.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.4 tp -139.07 143.09 38.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 123.98 33.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -112.17 11.7 20.35 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 t -90.79 -32.43 16.11 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -25.52 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 C-N-CA 124.304 1.042 . . . . 0.0 110.749 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.086 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.7 -30.21 16.42 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 164.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -49.19 77.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 125.726 1.61 . . . . 0.0 109.549 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HB2' HD21 ' A' ' 111' ' ' LEU . 49.8 t80 -51.27 -62.85 1.37 Allowed 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 127.443 2.297 . . . . 0.0 113.542 172.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -70.86 -10.09 58.9 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -83.33 -39.5 20.68 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.597 1.09 . . . . 0.0 109.566 171.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 1.9 t80 -60.12 -37.88 81.35 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 109.617 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -74.03 -31.41 62.89 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 125.849 1.66 . . . . 0.0 113.576 178.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 p -75.26 -39.24 60.02 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 120.702 1.592 . . . . 0.0 110.646 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -67.36 -56.95 7.61 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 123.609 0.568 . . . . 0.0 111.253 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -89.67 -48.71 7.1 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.69 -167.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.451 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 24.5 t80 -70.68 119.46 14.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.955 1.252 . . . . 0.0 110.608 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -137.6 97.78 3.53 Favored 'General case' 0 N--CA 1.424 -1.77 1 N-CA-C 99.673 -4.195 . . . . 0.0 99.673 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.56 -41.69 10.17 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.502 2.321 . . . . 0.0 117.225 -166.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -159.57 131.09 3.98 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 168.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -70.91 180.0 3.88 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 123.146 2.564 . . . . 0.0 114.946 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.87 -77.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.76 -1.564 . . . . 0.0 106.949 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.06 -173.38 14.37 Favored Glycine 0 CA--C 1.478 -2.233 1 N-CA-C 102.284 -4.326 . . . . 0.0 102.284 162.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.29 72.29 0.86 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -143.91 179.71 7.01 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.52 -41.71 73.5 Favored 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 127.926 2.491 . . . . 0.0 112.931 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -79.21 -21.13 46.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.027 0.531 . . . . 0.0 111.904 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.4 -41.77 55.34 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.5 m -68.37 -37.21 80.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.755 0.659 . . . . 0.0 112.143 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.61 -37.92 70.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.805 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.8 m -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 13.2 tt -81.72 -29.76 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 CA-C-N 118.197 0.453 . . . . 0.0 109.87 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -25.58 51.7 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.943 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -75.92 -33.22 59.86 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.295 0.498 . . . . 0.0 111.109 173.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.17 -48.92 21.27 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.134 0.573 . . . . 0.0 110.833 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -78.41 -26.74 46.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 110.528 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.14 55.24 2.0 Favored Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 mt -116.12 13.77 15.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.56 -12.67 53.67 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.064 0.546 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 m -121.12 102.25 43.75 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.13 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 167.82 79.22 Favored 'Cis proline' 0 N--CA 1.445 -1.334 0 N-CA-C 107.049 -1.943 . . . . 0.0 107.049 -22.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.0 m -59.47 122.21 13.44 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.865 0.866 . . . . 0.0 111.331 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.44 143.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.65 -37.22 31.36 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 119.769 -0.158 . . . . 0.0 110.611 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.73 130.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -143.79 121.6 11.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.6 m -92.39 105.66 17.8 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.24 116.28 23.5 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.19 150.47 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -141.87 136.04 30.13 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 125.268 1.427 . . . . 0.0 108.151 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.49 -104.6 0.24 Allowed Glycine 0 CA--C 1.483 -1.918 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -147.84 127.12 13.01 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -86.18 -3.86 59.05 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.255 -0.278 . . . . 0.0 111.601 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -30.57 35.54 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 p -85.54 -23.31 27.74 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 117.695 -1.145 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.2 mm -59.68 -54.26 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-N 119.086 0.857 . . . . 0.0 108.715 167.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -58.38 -42.83 87.94 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.418 1.487 . . . . 0.0 112.447 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 14.94 2.33 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.54 -38.37 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.43 44.34 1.02 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.009 0.433 . . . . 0.0 110.583 -171.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -133.37 21.37 4.0 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 164.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 41.46 44.05 2.38 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.292 3.437 . . . . 0.0 114.159 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.54 -45.01 7.59 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -120.03 8.92 11.07 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.78 -169.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.02 163.73 30.22 Favored Glycine 0 CA--C 1.485 -1.791 0 C-N-CA 118.872 -1.632 . . . . 0.0 109.079 -175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -112.05 156.74 41.38 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.14 135.0 24.18 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 122.666 2.244 . . . . 0.0 106.364 166.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -129.65 133.78 47.31 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 64.59 -102.65 0.09 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.426 1.49 . . . . 0.0 111.396 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -154.88 112.56 3.42 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.342 5.8 p30 68.44 15.15 9.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 129.642 3.177 . . . . 0.0 114.55 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.86 167.93 9.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 103.306 -2.85 . . . . 0.0 103.306 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.39 109.44 4.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -172.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 tt -91.02 146.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -82.21 177.21 8.92 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.478 1.132 . . . . 0.0 111.471 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' H ' ' H ' ' A' ' 74' ' ' SER . 20.4 tptm -148.68 -0.08 0.55 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.435 ' H ' ' H ' ' A' ' 73' ' ' LYS . 36.3 t -119.76 90.14 3.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 130.01 44.76 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 125.937 1.695 . . . . 0.0 112.648 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.71 158.74 18.3 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -79.74 141.07 36.68 Favored 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.17 142.82 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -166.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -130.68 109.17 10.43 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 166.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.0 m -82.33 100.86 10.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.2 m -86.76 112.28 21.53 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.21 141.94 49.46 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 39' ' ' CYS . 28.9 tp -77.75 121.49 24.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -172.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -135.56 50.45 2.11 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.53 -63.64 0.83 Allowed Glycine 0 CA--C 1.482 -1.977 0 N-CA-C 105.401 -3.08 . . . . 0.0 105.401 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.91 -15.93 21.04 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 p -86.3 140.49 34.34 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -81.32 -22.37 5.82 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.833 1.689 . . . . 0.0 108.664 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -105.55 162.57 19.33 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.423 -168.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -74.02 146.95 37.8 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.401 2.068 . . . . 0.0 108.106 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -83.07 164.49 71.24 Favored 'Cis proline' 0 CA--C 1.49 -1.722 0 CA-C-N 122.753 2.019 . . . . 0.0 109.197 5.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 39.5 m -128.24 130.11 47.45 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -95.61 120.54 36.05 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.32 117.34 32.22 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -93.09 135.54 34.17 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.52 139.4 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.553 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 m -124.13 98.74 5.91 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 171.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 147.16 28.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.075 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.61 36.5 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -152.58 100.9 2.6 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -152.31 170.36 20.23 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.808 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -75.61 129.87 37.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 108.912 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.42 141.98 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.72 113.06 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.421 HG12 HD13 ' A' ' 115' ' ' LEU . 18.1 m -107.21 147.61 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.92 121.01 31.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 40.4 t -106.33 126.98 52.91 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 123.856 0.723 . . . . 0.0 110.741 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.61 132.82 54.46 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 5.5 p30 75.03 0.48 3.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 167.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 23.1 11.06 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 6' ' ' TYR . 19.1 tp -141.1 127.49 11.51 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 14.2 Cg_endo -78.8 102.14 1.51 Allowed 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -23.13 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 123.694 0.798 . . . . 0.0 111.631 -166.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -138.37 -177.6 4.92 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 5.2 tp -124.65 135.91 53.48 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.91 138.2 31.74 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.56 51.24 0.77 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.3 t -81.41 -49.54 10.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.327 0.651 . . . . 0.0 109.953 -171.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.87 -28.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -173.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 N--CA 1.428 -1.569 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.3 -163.897 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 CA--C 1.498 -1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -88.24 -20.8 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -75.49 -21.02 58.39 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.259 1.023 . . . . 0.0 110.407 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -76.29 -39.05 55.24 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.777 1.231 . . . . 0.0 108.232 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.478 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -80.31 -10.6 59.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.22 0.918 . . . . 0.0 113.464 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -75.04 -46.35 35.5 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.94 -34.45 71.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.249 2.22 . . . . 0.0 111.631 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.332 0.0 OUTLIER -106.97 -4.66 18.82 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.753 0.821 . . . . 0.0 111.726 -173.254 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 t -83.64 -28.74 28.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 169.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -67.82 -70.33 0.26 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 163.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -105.48 12.95 30.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -155.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 36.7 t80 -112.33 128.05 56.17 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.187 1.358 . . . . 0.0 109.33 169.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -145.34 100.9 3.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 166.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.16 -39.57 6.26 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 -166.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -154.81 137.3 10.02 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 171.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 40.9 Cg_endo -86.25 174.53 6.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 121.731 1.621 . . . . 0.0 108.72 -171.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -74.33 -50.54 18.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 172.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.23 -174.07 28.48 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -114.6 66.43 0.68 Allowed 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -150.58 173.48 14.07 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -172.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.11 -23.39 63.03 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.82 1.248 . . . . 0.0 113.185 -171.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.09 30.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -74.12 -43.85 56.0 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.3 m -67.34 -36.02 80.58 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.79 -34.37 62.41 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.39 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.5 t -69.21 -36.62 77.45 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 tt -82.4 -28.08 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 117.873 0.306 . . . . 0.0 111.017 -175.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mmt -78.33 -24.75 46.42 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.832 176.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -42.4 63.81 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 172.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -45.1 30.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.527 0.331 . . . . 0.0 111.761 -169.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.17 -22.03 53.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.13 56.22 1.62 Allowed Glycine 0 C--N 1.352 1.454 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.326 4.0 mm? -108.73 -16.71 14.12 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 124.532 1.133 . . . . 0.0 108.855 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -76.19 -11.47 59.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.577 1.551 . . . . 0.0 112.883 -164.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t -124.79 108.52 28.38 Favored Pre-proline 0 N--CA 1.438 -1.025 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.838 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.72 157.66 98.41 Favored 'Cis proline' 0 N--CA 1.447 -1.227 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 -23.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.7 m -54.89 129.98 39.54 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 125.43 1.492 . . . . 0.0 113.258 -173.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -77.27 132.91 38.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 171.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.64 -38.55 58.79 Favored 'General case' 0 CA--C 1.487 -1.477 0 O-C-N 123.495 0.497 . . . . 0.0 110.871 -169.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.48 135.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 174.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.09 120.03 7.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.2 m -96.73 107.62 20.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.09 117.22 25.68 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.0 mt -98.44 147.68 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -175.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.51 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -137.62 129.93 29.36 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 125.392 1.477 . . . . 0.0 108.797 -169.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.57 -134.98 3.59 Favored Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 106.006 -2.838 . . . . 0.0 106.006 173.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.94 142.38 29.74 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 173.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.88 -21.22 29.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -74.08 -30.36 62.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.094 1.358 . . . . 0.0 109.437 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.2 m -77.2 -33.22 56.33 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 117.414 -1.279 . . . . 0.0 110.871 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -56.01 -56.14 14.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 119.037 0.835 . . . . 0.0 110.11 172.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -56.59 -41.24 76.64 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.92 15.39 1.1 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.8 mt -81.16 -34.21 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 168.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.44 -44.67 62.05 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.782 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.49 156.46 22.84 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.91 87.12 7.25 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.057 0.456 . . . . 0.0 109.933 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.73 -47.52 1.04 Allowed 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.99 58.55 1.35 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 177.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.49 151.42 10.91 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 174.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -115.71 157.95 43.19 Favored Pre-proline 0 N--CA 1.432 -1.362 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -74.3 143.24 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.898 2.399 . . . . 0.0 106.506 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -142.03 127.38 18.77 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? 65.2 -107.39 0.14 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.026 1.33 . . . . 0.0 110.375 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.89 101.02 3.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.364 2.3 p-10 63.82 25.84 14.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 129.08 2.952 . . . . 0.0 114.505 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.09 157.4 17.87 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 168.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -138.14 120.97 16.46 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 tt -88.61 145.59 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.6 p -88.15 165.45 15.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.649 0.738 . . . . 0.0 109.914 -175.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.96 11.77 5.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -123.06 96.17 4.9 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.6 m -62.26 131.63 50.02 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 124.368 1.067 . . . . 0.0 110.645 175.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -112.58 155.87 23.64 Favored 'General case' 0 CA--C 1.473 -1.999 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 138.53 39.22 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 140.84 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -167.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.0 m -129.3 105.67 8.29 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 167.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 m -85.55 99.98 11.62 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.1 m -85.65 112.1 20.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -117.74 145.99 44.09 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.268 17.1 mt -65.82 135.71 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.029 0.442 . . . . 0.0 110.365 175.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.35 45.44 2.76 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 156.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.01 -83.35 1.42 Allowed Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.08 -25.8 5.7 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -85.35 131.47 48.0 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -84.01 -14.77 7.18 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.097 1.865 . . . . 0.0 108.561 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -100.35 168.05 9.98 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.64 143.77 34.52 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.61 163.98 51.46 Favored 'Cis proline' 0 N--CA 1.436 -1.883 0 CA-C-N 122.35 1.875 . . . . 0.0 108.008 10.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.9 m -128.75 125.99 39.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -172.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -95.38 128.0 41.88 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -120.07 126.06 49.83 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -90.96 129.78 36.95 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.09 129.58 34.86 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -120.44 90.26 3.29 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.86 150.89 23.24 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.354 0.597 . . . . 0.0 110.742 -172.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.53 -170.38 20.28 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -144.08 90.19 2.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -124.39 145.99 49.14 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -159.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -80.89 128.79 34.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.29 138.91 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.604 -164.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -95.24 113.55 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.63 141.51 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 172.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.64 128.16 36.53 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.0 m -108.11 154.01 22.33 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.139 0.899 . . . . 0.0 110.893 -175.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -147.13 127.41 13.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.321 8.6 p30 69.75 11.97 7.93 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.784 2.034 . . . . 0.0 114.679 177.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.86 55.45 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tp -141.46 142.26 25.78 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -70.75 152.53 64.24 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 CA-C-N 121.946 1.731 . . . . 0.0 111.564 -173.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 -25.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.407 -178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -143.18 178.02 8.0 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.65 139.9 36.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -173.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.26 121.58 29.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -107.6 10.28 29.18 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -93.18 -20.39 20.52 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -76.0 -36.71 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.797 0 C-N-CA 123.623 0.769 . . . . 0.0 110.933 173.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -170.31 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -90.88 -14.24 32.11 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.017 177.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -74.1 -45.32 49.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.61 -55.31 35.61 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-O 116.551 -1.69 . . . . 0.0 111.493 168.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -81.78 -1.22 46.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 122.011 2.187 . . . . 0.0 115.659 -170.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.61 -30.69 23.09 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.63 -28.98 70.28 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.307 0.643 . . . . 0.0 111.205 164.168 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.535 HD12 ' HE3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -84.98 -23.47 28.7 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.327 0.967 . . . . 0.0 112.252 177.792 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -72.77 -38.19 67.4 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 120.323 1.42 . . . . 0.0 109.106 174.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -65.37 -58.2 6.46 Favored 'General case' 0 N--CA 1.413 -2.282 0 C-N-CA 124.724 1.209 . . . . 0.0 112.498 172.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -125.62 27.99 6.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -160.152 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -133.66 136.42 44.74 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 166.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -152.85 108.61 3.31 Favored 'General case' 0 N--CA 1.423 -1.811 1 N-CA-C 100.172 -4.011 . . . . 0.0 100.172 169.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -36.02 5.21 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 118.702 2.852 . . . . 0.0 118.702 -164.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -145.65 154.91 52.75 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 19.7 Cg_endo -70.92 143.08 44.34 Favored 'Trans proline' 0 N--CA 1.431 -2.203 0 C-N-CA 123.423 2.749 . . . . 0.0 107.6 165.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -80.35 -50.83 9.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 168.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.07 179.45 17.34 Favored Glycine 0 CA--C 1.478 -2.233 0 N-CA-C 103.994 -3.643 . . . . 0.0 103.994 163.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -123.36 53.59 1.32 Allowed 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -140.03 -179.08 5.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -170.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.25 -23.1 63.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.841 1.256 . . . . 0.0 113.084 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -86.53 -20.03 28.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 122.962 0.505 . . . . 0.0 110.178 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.55 -41.53 46.25 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -69.15 -35.62 76.55 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 123.797 0.685 . . . . 0.0 112.768 -177.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.7 -39.11 67.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -75.43 -24.3 57.06 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.261 12.7 tt -82.86 -33.04 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.612 0 CA-C-N 118.852 0.751 . . . . 0.0 109.563 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mmt -77.91 -20.84 52.16 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.624 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -72.1 -44.81 62.64 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.239 0.472 . . . . 0.0 111.858 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.69 -39.8 50.89 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.924 0.489 . . . . 0.0 111.964 -173.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -75.78 -29.98 58.95 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 123.316 0.646 . . . . 0.0 110.222 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 52.41 2.49 Favored Glycine 0 CA--C 1.491 -1.43 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 170.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.6 mt -121.85 18.28 11.01 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -91.85 -10.76 38.56 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.4 1.08 . . . . 0.0 108.802 -173.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -129.57 105.22 17.33 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.1 159.36 95.67 Favored 'Cis proline' 0 N--CA 1.444 -1.425 0 N-CA-C 107.133 -1.91 . . . . 0.0 107.133 -19.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.406 ' HB3' HD13 ' A' ' 83' ' ' LEU . 44.4 m -63.05 123.09 17.69 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.968 0.907 . . . . 0.0 109.522 -177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -71.42 140.78 50.22 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.02 -46.73 50.37 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.965 0.506 . . . . 0.0 111.049 -172.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 132.52 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -151.16 119.15 6.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -96.22 112.84 24.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -177.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -87.6 118.48 27.11 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 171.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.17 152.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -177.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.583 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 7.3 m-70 -136.26 133.18 36.72 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 124.648 1.179 . . . . 0.0 108.195 -171.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.83 -119.66 0.88 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -132.6 138.72 47.5 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HE3' HD12 ' A' ' 10' ' ' LEU . 30.8 mtpt -86.74 -7.14 58.54 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.451 -172.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -80.27 -32.52 38.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -36.93 73.6 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 123.996 0.919 . . . . 0.0 110.543 174.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.41 -53.1 51.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 C-N-CA 124.906 1.282 . . . . 0.0 111.38 174.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.75 -39.24 76.92 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.285 1.034 . . . . 0.0 113.038 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.41 9.4 11.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.602 0.761 . . . . 0.0 112.978 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 72' ' ' SER . 22.3 mm -78.56 -28.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 168.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.02 -21.01 51.41 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -80.51 170.8 15.87 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -88.1 5.89 38.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.834 0.854 . . . . 0.0 110.685 -178.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -75.02 -63.24 1.31 Allowed 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 123.842 0.857 . . . . 0.0 110.169 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -89.0 -50.58 6.09 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -176.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.1 149.21 19.12 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -163.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -102.98 154.57 37.45 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -178.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.03 141.58 33.16 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 123.102 2.535 . . . . 0.0 106.828 175.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -134.99 34.68 3.1 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -169.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 62.21 156.56 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 129.072 2.949 . . . . 0.0 114.05 -176.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 42.89 54.58 4.68 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 129.209 3.004 . . . . 0.0 115.831 176.04 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.311 2.7 p-10 52.58 34.46 15.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.622 2.769 . . . . 0.0 114.764 -176.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.92 151.54 25.65 Favored 'General case' 0 CA--C 1.478 -1.813 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -140.62 118.26 11.61 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -175.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.69 146.15 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 176.32 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.414 ' HB2' HD12 ' A' ' 56' ' ' ILE . 83.6 p -92.69 169.0 10.83 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -131.23 -6.17 3.83 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -106.28 78.86 1.33 Allowed 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.275 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.6 t -46.74 127.76 10.03 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 128.324 2.65 . . . . 0.0 113.218 -177.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.73 157.69 18.32 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -170.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 139.58 41.45 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.07 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.5 140.98 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -170.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -132.45 110.56 10.61 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 164.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -88.7 101.19 13.75 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.35 114.36 22.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -121.72 129.1 52.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -168.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 39' ' ' CYS . 34.5 tp -72.98 114.9 11.64 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.989 1.316 . . . . 0.0 108.09 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -138.68 95.9 3.05 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 -176.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.12 -41.41 0.05 OUTLIER Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 -177.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.42 41.23 6.58 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -177.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -117.81 106.6 45.64 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -82.76 -21.66 4.83 Favored 'Trans proline' 0 N--CA 1.439 -1.708 0 CA-C-N 121.535 1.584 . . . . 0.0 108.935 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -107.24 161.69 22.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.98 142.52 31.43 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.498 2.132 . . . . 0.0 107.486 -176.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -82.77 161.58 75.36 Favored 'Cis proline' 0 CA--C 1.486 -1.876 0 CA-C-N 123.06 2.128 . . . . 0.0 108.798 4.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.1 m -109.41 159.22 17.2 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -173.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -116.58 90.28 3.3 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.02 117.45 30.69 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -102.53 132.25 48.71 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 131.08 35.28 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -117.39 86.34 2.5 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.02 148.48 21.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.999 -172.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -152.69 -163.37 11.6 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -146.72 98.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 101.033 -3.691 . . . . 0.0 101.033 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -133.16 144.49 49.9 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -162.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -74.85 124.58 27.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.722 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.95 140.66 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.313 -165.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.07 114.91 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 165.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.6 141.84 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -101.52 113.44 26.56 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.6 p -113.99 163.64 14.86 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 122.319 1.057 . . . . 0.0 113.085 -173.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -153.64 136.46 15.34 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.354 7.9 p30 71.72 2.95 4.49 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.716 2.406 . . . . 0.0 116.092 174.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.6 -2.41 34.32 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.41 128.7 25.8 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -73.58 119.65 6.05 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.682 -2.084 . . . . 0.0 106.682 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.465 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -105.62 -17.01 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 123.952 0.783 . . . . 0.0 110.021 -167.533 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.465 ' ND1' HG23 ' A' ' 113' ' ' VAL . 29.1 m80 -153.34 177.17 11.17 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.29 142.03 35.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -174.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.74 126.68 37.94 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 167.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -108.88 10.9 26.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -173.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -87.72 -25.68 23.32 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.17 0.51 . . . . 0.0 109.789 -166.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -21.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 C-N-CA 124.161 0.984 . . . . 0.0 109.889 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -169.388 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 m -94.02 0.46 56.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.801 1.24 . . . . 0.0 109.934 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -75.86 -39.52 56.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -46.63 69.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 124.15 0.98 . . . . 0.0 109.868 176.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.408 0.2 OUTLIER -83.89 -2.23 56.05 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -179.085 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -83.88 -30.09 26.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.538 1.063 . . . . 0.0 109.291 165.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD2' HD23 ' A' ' 10' ' ' LEU . 2.3 t80 -61.45 -35.37 77.42 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.153 0.981 . . . . 0.0 109.034 164.6 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.45 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -83.43 -18.68 37.87 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.079 177.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -69.07 -52.26 30.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-N 119.79 1.177 . . . . 0.0 108.481 176.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 15.7 tt0 -77.28 -38.02 51.66 Favored 'General case' 0 N--CA 1.404 -2.742 0 C-N-CA 124.286 1.034 . . . . 0.0 110.437 -173.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 70.0 m-70 -98.31 -54.96 2.9 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.48 -175.251 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -77.63 119.98 21.94 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 119.98 1.264 . . . . 0.0 108.738 -167.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -137.14 98.37 3.72 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 100.682 -3.821 . . . . 0.0 100.682 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.64 -42.55 0.8 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -165.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -144.11 151.94 53.35 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 165.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 11.9 Cg_endo -71.81 155.43 58.2 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 123.859 3.039 . . . . 0.0 109.916 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -78.64 -53.45 7.16 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 170.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.74 -179.88 17.76 Favored Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 166.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -121.4 61.72 0.92 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -178.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.3 -179.42 7.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.57 -10.47 59.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -78.36 -33.23 49.14 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -75.63 -39.16 58.23 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.02 -42.95 79.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.3 -31.85 62.65 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 122.799 0.44 . . . . 0.0 110.597 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -67.46 -38.72 84.89 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.478 176.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 14.6 tt -80.31 -25.34 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 CA-C-N 118.042 0.383 . . . . 0.0 111.385 -176.045 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -29.89 61.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.774 -1.57 . . . . 0.0 111.536 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -75.66 -29.91 59.25 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.199 0.454 . . . . 0.0 112.22 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -78.97 -44.83 21.6 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.77 0.828 . . . . 0.0 110.746 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -81.05 -26.21 36.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.639 0.376 . . . . 0.0 110.438 -172.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.37 49.04 3.34 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 171.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.61 14.86 15.52 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 t -86.49 -13.31 46.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.08 0.952 . . . . 0.0 108.727 -176.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 m -122.38 103.63 38.3 Favored Pre-proline 0 N--CA 1.424 -1.73 0 CA-C-O 117.867 -1.064 . . . . 0.0 108.495 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.34 161.05 95.31 Favored 'Cis proline' 0 N--CA 1.441 -1.6 0 N-CA-C 106.888 -2.005 . . . . 0.0 106.888 -23.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -60.39 124.49 20.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.813 1.245 . . . . 0.0 111.118 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -73.02 135.48 44.92 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -75.0 -39.64 61.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.312 -170.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.6 tt -148.69 133.91 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -151.53 121.34 7.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.5 112.1 24.24 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.27 116.26 23.51 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.55 151.37 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.605 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.9 m-70 -144.15 140.68 29.52 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.61 1.62 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 107.115 -2.394 . . . . 0.0 107.115 175.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -119.79 137.0 54.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -85.58 -20.67 29.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 120.959 0.409 . . . . 0.0 110.636 -166.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -79.82 -22.47 42.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.5 m -76.09 -34.36 59.53 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.967 171.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.18 -51.23 73.52 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 119.829 1.195 . . . . 0.0 110.073 171.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.93 -40.42 93.18 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.673 0.789 . . . . 0.0 111.16 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.72 21.06 1.96 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.94 -28.7 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 t -78.15 -41.5 34.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.895 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -79.22 149.87 31.78 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 170.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -78.77 104.22 9.24 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -160.14 -57.74 0.06 Allowed 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -177.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -136.88 22.31 3.07 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.67 -178.82 21.47 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 105.288 -3.125 . . . . 0.0 105.288 166.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -137.2 161.28 61.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -171.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -74.49 147.3 36.11 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.884 2.389 . . . . 0.0 107.323 162.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -139.44 101.48 4.24 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 65.54 -102.26 0.08 Allowed 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 111.144 -177.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.24 102.38 3.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -174.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 2.8 p-10 65.34 22.26 12.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 129.896 3.278 . . . . 0.0 114.625 173.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.13 158.35 17.49 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 100.63 -3.841 . . . . 0.0 100.63 163.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -141.9 111.46 6.58 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -171.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 tt -94.25 140.37 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -87.68 167.47 13.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 121.387 0.613 . . . . 0.0 110.329 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 -1.49 4.37 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -113.43 86.6 2.42 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 173.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.0 m -53.44 137.95 34.61 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.058 2.143 . . . . 0.0 113.16 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -111.16 155.64 22.59 Favored 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.42 141.69 43.16 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 175.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.53 145.96 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -168.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -130.99 107.16 8.89 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 167.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -85.51 100.35 11.85 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.8 m -84.16 113.95 21.44 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -121.03 129.95 53.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 -176.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 tp -69.01 116.76 9.83 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.825 1.25 . . . . 0.0 109.257 -174.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -135.87 99.0 4.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -175.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.69 -42.12 0.18 Allowed Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 -178.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.38 43.59 7.35 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 t -112.72 108.82 53.54 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -86.1 -17.67 3.75 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 CA-C-N 122.193 1.819 . . . . 0.0 109.064 -176.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.75 160.65 28.85 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-O 117.43 -1.271 . . . . 0.0 107.954 -168.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.66 145.9 33.48 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.674 2.25 . . . . 0.0 108.425 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -81.17 164.31 77.62 Favored 'Cis proline' 0 N--CA 1.437 -1.841 0 CA-C-N 122.299 1.857 . . . . 0.0 108.176 -4.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.8 m -107.46 156.13 19.3 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.458 -170.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -110.54 118.39 36.11 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.71 148.3 41.2 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.69 119.87 40.13 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 166.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.26 115.84 26.04 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -110.69 87.97 2.66 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.64 143.57 26.7 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.265 0.555 . . . . 0.0 110.769 -171.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -149.41 -163.72 11.19 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 178.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -146.67 101.21 3.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -138.22 147.63 43.95 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -164.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -74.22 128.7 36.22 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.504 1.121 . . . . 0.0 108.515 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.16 137.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.16 -167.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.53 110.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 165.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.23 152.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.0 136.12 33.24 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 168.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.9 t -126.52 138.64 53.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 123.527 0.517 . . . . 0.0 109.701 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.74 133.56 44.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 170.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.301 14.2 p30 63.22 23.79 14.02 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 117.068 2.248 . . . . 0.0 117.068 171.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.52 19.15 57.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.45 116.12 5.43 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -170.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -72.02 111.49 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 CA-C-N 122.091 1.782 . . . . 0.0 111.39 -170.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.9 -24.32 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -151.88 -168.65 3.13 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.66 149.56 40.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -175.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.22 127.76 43.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 171.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -110.78 13.77 22.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -86.01 -32.34 21.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -172.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -23.34 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 C-N-CA 125.513 1.525 . . . . 0.0 111.817 177.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 106.49 -1.671 . . . . 0.0 106.49 -167.403 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -92.37 -29.93 16.06 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -70.47 -40.77 73.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.312 0.645 . . . . 0.0 109.427 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 111' ' ' LEU . 61.4 t80 -46.56 -65.66 0.52 Allowed 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 126.602 1.961 . . . . 0.0 111.168 166.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.715 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.297 5.4 p -70.43 -11.84 61.18 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.702 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -83.71 -36.61 23.56 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.126 0.876 . . . . 0.0 109.521 173.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.24 -35.53 81.11 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.701 1.6 . . . . 0.0 110.515 170.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.715 ' HB2' ' HA ' ' A' ' 7' ' ' THR 0.271 0.2 OUTLIER -67.06 -38.04 85.1 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 128.709 2.803 . . . . 0.0 112.452 174.667 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -66.64 -51.87 51.35 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.86 -29.09 50.23 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 124.114 0.966 . . . . 0.0 112.439 -170.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -105.78 -58.25 1.93 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.001 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -72.6 111.93 8.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.73 0.776 . . . . 0.0 110.689 -163.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -134.96 98.28 3.97 Favored 'General case' 0 N--CA 1.421 -1.878 1 N-CA-C 98.553 -4.61 . . . . 0.0 98.553 176.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -33.65 3.8 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -163.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.91 154.18 46.8 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.9 Cg_endo -69.53 145.08 57.39 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 123.642 2.895 . . . . 0.0 109.164 171.367 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -86.04 -46.85 10.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 169.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.24 -177.21 14.82 Favored Glycine 0 CA--C 1.48 -2.133 0 N-CA-C 103.364 -3.894 . . . . 0.0 103.364 164.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -133.98 35.22 3.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -121.45 -179.22 4.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -35.88 79.77 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 125.973 1.709 . . . . 0.0 112.812 -171.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -81.82 -22.17 37.21 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.084 0.554 . . . . 0.0 110.033 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.85 -42.22 61.12 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -83.54 -19.97 34.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.729 -0.789 . . . . 0.0 113.045 -170.873 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.02 -39.42 66.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.3 t -67.15 -38.28 85.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.282 15.2 tt -86.74 -25.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 CA-C-N 118.358 0.527 . . . . 0.0 112.024 -175.464 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 mmt -77.49 -25.64 50.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.707 173.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -72.16 -38.3 69.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.131 0.572 . . . . 0.0 111.821 173.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -79.99 -40.1 28.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 122.607 0.363 . . . . 0.0 110.698 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -23.08 40.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.036 0.534 . . . . 0.0 110.571 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.8 47.57 4.18 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.36 6.76 12.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 t -94.61 -0.6 54.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 m -122.09 102.14 40.85 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 117.768 -1.11 . . . . 0.0 108.668 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.74 158.06 98.84 Favored 'Cis proline' 0 N--CA 1.441 -1.58 0 N-CA-C 106.842 -2.022 . . . . 0.0 106.842 -23.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.0 m -63.21 118.97 8.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 124.707 1.203 . . . . 0.0 111.914 -170.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.39 134.11 45.25 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -72.68 -36.35 67.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 124.567 1.167 . . . . 0.0 112.89 -166.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -154.77 123.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.3 151.63 30.22 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.515 177.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.8 m -112.21 136.61 51.42 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.503 -168.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -99.33 116.74 32.19 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 162.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.2 mt -89.89 150.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.483 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 -178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.581 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.6 m-70 -139.95 139.77 36.2 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 125.143 1.377 . . . . 0.0 108.863 -175.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.07 5.79 Favored Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 105.734 -2.946 . . . . 0.0 105.734 173.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -102.68 147.93 26.21 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 170.749 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -85.45 -16.28 40.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.99 -33.17 59.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.693 1.597 . . . . 0.0 107.071 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.9 m -75.73 -34.56 60.33 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.005 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 mm -54.95 -55.37 16.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 CA-C-N 119.349 0.977 . . . . 0.0 110.155 172.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.39 -35.01 77.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 123.875 0.87 . . . . 0.0 113.23 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.48 -0.25 19.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' ARG . 13.6 mm -73.66 -27.51 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.74 9.01 38.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.125 0.488 . . . . 0.0 111.599 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -88.56 162.09 16.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 160.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -88.18 -9.8 51.93 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -68.4 -50.48 52.6 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.252 1.421 . . . . 0.0 110.178 178.092 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -123.76 37.5 4.4 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -168.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.5 152.67 10.9 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 171.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -105.77 156.44 36.57 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -176.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -74.75 140.44 26.21 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 123.003 2.469 . . . . 0.0 106.821 172.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -136.67 133.7 36.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -176.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 62.11 -103.26 0.13 Allowed 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.899 1.68 . . . . 0.0 112.219 169.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.79 103.8 2.64 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.362 2.5 p-10 62.0 30.78 18.06 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 129.139 2.975 . . . . 0.0 113.883 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.2 mt -115.13 170.19 8.55 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 171.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HB3' HG22 ' A' ' 56' ' ' ILE . 21.9 mmt180 -147.17 116.4 6.95 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -174.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -93.87 136.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.5 p -83.56 160.91 21.35 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.45 -25.53 11.83 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.698 174.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -104.87 89.17 3.08 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 p -49.62 129.71 19.74 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 127.229 2.212 . . . . 0.0 111.916 171.357 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -105.19 156.44 18.11 Favored 'General case' 0 CA--C 1.478 -1.815 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -170.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.434 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.4 mt-30 -78.9 148.16 32.83 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 174.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.76 146.97 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -166.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.5 m -134.38 99.68 4.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 167.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -89.64 104.24 16.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -177.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.73 122.41 36.17 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -106.87 132.83 52.38 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.63 117.12 18.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.476 1.51 . . . . 0.0 109.007 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -112.1 152.41 28.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.34 -97.97 0.22 Allowed Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 106.014 -2.835 . . . . 0.0 106.014 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.03 1.5 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 -178.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.5 t -84.68 130.01 54.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -83.19 -20.9 4.83 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.989 1.793 . . . . 0.0 108.279 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -96.47 159.9 30.81 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -76.18 148.12 30.47 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.309 2.006 . . . . 0.0 107.221 -176.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -85.54 165.09 56.38 Favored 'Cis proline' 0 N--CA 1.438 -1.74 0 CA-C-N 123.035 2.12 . . . . 0.0 108.133 13.078 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.1 m -154.87 130.3 9.78 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -165.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.79 103.01 15.4 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -85.83 120.81 27.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -92.47 112.57 24.57 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.45 130.65 35.29 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.028 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -118.72 108.61 15.1 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.268 -2.494 . . . . 0.0 104.268 175.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.68 129.31 35.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.265 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.74 169.5 23.17 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 106.002 -2.839 . . . . 0.0 106.002 178.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 85.0 t80 -149.22 105.86 3.55 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -152.44 158.69 42.98 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 121.884 0.85 . . . . 0.0 110.32 -168.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.0 129.55 34.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.319 175.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.8 148.17 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.737 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.5 t -106.5 92.45 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -93.3 139.16 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.16 126.29 31.88 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 46.9 t -108.48 135.99 48.84 Favored 'General case' 0 CA--C 1.49 -1.34 0 O-C-N 123.875 0.734 . . . . 0.0 110.497 -175.541 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.22 137.5 39.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.299 16.5 p30 60.15 26.45 15.85 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 127.05 2.14 . . . . 0.0 116.101 175.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.56 22.76 59.58 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 177.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -149.91 135.07 9.72 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.038 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 98.0 Cg_exo -77.72 111.58 3.15 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 CA-C-N 122.354 1.876 . . . . 0.0 110.972 -177.519 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.78 -26.84 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 123.838 0.711 . . . . 0.0 111.693 -174.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -146.52 -171.72 3.8 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -171.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 132.01 4.11 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 177.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -74.41 135.81 42.38 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.322 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -96.8 36.89 1.34 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.9 p -95.66 -19.71 19.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -92.64 -23.23 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 178.641 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 CA--C 1.478 -1.79 0 C-N-CA 125.332 1.453 . . . . 0.0 108.448 -178.503 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -93.39 -9.04 40.09 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -20.92 58.23 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.704 1.602 . . . . 0.0 109.678 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.79 -41.25 62.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 C-N-CA 125.188 1.395 . . . . 0.0 108.039 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -79.36 -12.81 59.91 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 177.603 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -73.67 -47.32 40.62 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.74 -46.35 74.27 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 126.401 1.88 . . . . 0.0 110.221 173.114 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.1 OUTLIER -93.25 -4.54 51.69 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.759 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -78.65 -43.81 25.28 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 120.655 1.57 . . . . 0.0 107.782 166.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -65.81 -46.27 79.26 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -97.16 -48.55 5.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.882 -172.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 45.8 t80 -78.68 117.15 19.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 119.963 1.256 . . . . 0.0 110.397 -168.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -134.61 96.4 3.56 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 174.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.37 -43.66 3.64 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 128.278 2.631 . . . . 0.0 117.724 -166.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -155.25 144.25 14.98 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 67.5 Cg_exo -74.74 174.79 12.07 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.863 1.708 . . . . 0.0 113.736 -177.054 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -70.73 -67.84 0.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 168.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.61 -175.16 13.69 Favored Glycine 0 CA--C 1.475 -2.451 1 N-CA-C 101.618 -4.593 . . . . 0.0 101.618 163.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -115.87 73.64 0.85 Allowed 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.34 176.7 9.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.38 -21.59 61.99 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.476 1.111 . . . . 0.0 112.884 -171.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -75.8 -30.27 58.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.238 177.178 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.95 -40.62 53.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 m -69.65 -35.32 75.07 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.17 -36.8 69.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 123.375 0.422 . . . . 0.0 110.308 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -69.45 -35.65 75.87 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 122.909 0.484 . . . . 0.0 112.214 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.426 HG13 HH21 ' A' ' 33' ' ' ARG 0.25 12.7 tt -84.15 -27.95 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-N 117.707 0.23 . . . . 0.0 111.227 -174.954 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.07 -25.17 47.53 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.483 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 91' ' ' PRO . 16.6 tpp180 -68.68 -43.6 75.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.214 0.606 . . . . 0.0 110.995 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -75.84 -44.77 39.29 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 123.646 0.778 . . . . 0.0 112.352 -172.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.426 HH21 HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -77.11 -18.1 58.19 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.955 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.0 44.75 4.68 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 168.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.4 mt -117.65 15.81 14.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 176.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -94.06 -11.41 30.73 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.6 m -125.53 101.03 31.04 Favored Pre-proline 0 N--CA 1.426 -1.659 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.548 -174.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.06 165.14 85.9 Favored 'Cis proline' 0 N--CA 1.445 -1.373 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 -21.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -60.28 120.58 10.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 124.063 0.945 . . . . 0.0 110.173 -175.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -74.63 136.67 41.96 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 177.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.68 -45.63 61.33 Favored 'General case' 0 N--CA 1.433 -1.287 0 O-C-N 123.956 0.785 . . . . 0.0 110.45 -171.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.46 126.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -148.51 127.88 13.06 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.482 HG23 HG13 ' A' ' 78' ' ' VAL . 17.2 m -94.23 122.18 36.5 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.734 -178.299 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -90.52 121.33 32.37 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.7 148.82 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.9 m-70 -136.57 137.37 40.13 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 124.834 1.253 . . . . 0.0 107.95 -175.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.79 -126.94 1.62 Allowed Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 175.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -118.28 141.65 48.31 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 171.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.51 -3.07 58.96 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -76.49 -31.65 57.85 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 168.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -80.5 -32.26 37.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 118.115 -0.945 . . . . 0.0 109.982 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.52 -52.62 54.86 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.204 1.001 . . . . 0.0 110.467 171.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -53.84 -44.09 70.02 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.42 1.488 . . . . 0.0 112.05 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.02 16.02 0.61 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.25 -40.54 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 165.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 36.3 t -88.72 -30.26 19.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.454 -156.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -95.74 51.26 1.26 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -170.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 m120 49.26 50.88 17.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 129.516 3.127 . . . . 0.0 113.329 174.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -148.84 163.67 36.73 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 97.594 -4.965 . . . . 0.0 97.594 172.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.259 8.1 p-10 14.52 56.54 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 131.043 3.737 . . . . 0.0 117.799 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.91 137.24 2.29 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 106.001 -2.839 . . . . 0.0 106.001 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -106.13 157.45 34.82 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -72.06 135.55 25.41 Favored 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 123.095 2.53 . . . . 0.0 107.225 170.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -131.23 107.37 8.94 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -175.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 63.42 -108.61 0.24 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 112.989 174.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -127.39 87.01 2.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -166.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.343 1.8 p-10 64.01 27.62 14.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 128.913 2.885 . . . . 0.0 113.947 173.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 mt -110.4 163.84 13.28 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 173.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -146.78 120.58 9.26 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.08 143.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -177.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.7 p -84.43 159.92 20.69 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -174.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -122.62 -3.18 8.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 t -119.02 88.15 2.87 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 173.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.3 p -61.56 141.36 57.79 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.561 1.544 . . . . 0.0 111.862 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -114.04 161.68 17.41 Favored 'General case' 0 CA--C 1.474 -1.967 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -168.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 7.7 mt-30 -77.91 144.63 36.72 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -141.73 143.38 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.89 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.7 m -131.35 107.61 9.06 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 167.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -83.14 101.03 10.92 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.6 114.97 24.7 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -121.06 132.47 54.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -170.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.9 tp -69.28 114.24 7.35 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 125.105 1.362 . . . . 0.0 108.527 -177.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -126.76 57.26 1.45 Allowed 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -118.31 -84.2 0.95 Allowed Glycine 0 CA--C 1.482 -2.021 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.21 -15.09 4.25 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 178.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -86.91 132.34 42.28 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -81.02 -21.71 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.755 1.636 . . . . 0.0 108.93 176.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -102.24 165.05 14.55 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.13 142.12 33.71 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.222 1.948 . . . . 0.0 107.159 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.8 Cg_endo -87.63 164.39 45.6 Favored 'Cis proline' 0 N--CA 1.435 -1.923 0 CA-C-N 122.655 1.984 . . . . 0.0 108.397 12.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 37.7 m -128.07 131.95 49.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -170.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -98.15 123.04 42.0 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.59 122.42 44.57 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -93.06 127.27 38.53 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.99 133.12 35.27 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.6 m -120.04 97.24 5.51 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 171.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.6 139.01 38.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.03 -171.16 18.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 92.3 t80 -155.78 100.05 2.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 101.28 -3.6 . . . . 0.0 101.28 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -139.44 148.73 43.14 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -161.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -80.73 132.5 35.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.862 1.265 . . . . 0.0 108.442 175.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.18 142.36 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.612 -164.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.74 95.68 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.1 m -94.71 136.7 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.31 126.53 37.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 31.7 p -129.2 167.5 17.55 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -172.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.38 132.81 18.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.362 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.364 6.4 p30 75.94 -12.0 1.06 Allowed 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 170.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.02 9.08 9.09 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -141.99 127.9 10.84 Favored Pre-proline 0 N--CA 1.435 -1.196 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 8.8 Cg_exo -67.35 163.8 33.14 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.566 1.511 . . . . 0.0 114.029 -178.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 -19.67 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 30.8 m80 -158.68 -175.3 5.23 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -169.595 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 136.8 3.78 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 -179.043 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.94 134.64 37.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.966 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -100.07 40.19 1.27 Allowed 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.7 m -97.1 -31.57 12.41 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -75.3 -33.98 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.61 169.832 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -172.196 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 111.331 0.123 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -89.95 -17.12 28.52 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -69.97 -30.27 67.58 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.303 1.441 . . . . 0.0 110.624 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CE1' HD22 ' A' ' 111' ' ' LEU . 52.2 t80 -68.49 -48.3 64.79 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -76.12 -10.01 59.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.057 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -80.74 -43.68 19.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 119.352 0.978 . . . . 0.0 108.468 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -57.89 -38.23 75.43 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.791 1.637 . . . . 0.0 110.195 170.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.48 HD13 ' CE2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -78.8 -29.62 45.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.546 1.538 . . . . 0.0 113.493 -179.149 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -80.06 -32.59 39.33 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 119.773 1.17 . . . . 0.0 109.38 -174.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.36 -45.01 15.43 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 118.511 -0.757 . . . . 0.0 109.726 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -95.12 -46.82 6.63 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 119.429 1.013 . . . . 0.0 112.442 -172.08 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 9.3 t80 -70.65 118.32 13.3 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 119.766 1.166 . . . . 0.0 110.925 -174.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -139.8 99.04 3.6 Favored 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 172.153 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 -39.26 9.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -164.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -142.84 148.65 46.77 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.0 Cg_endo -72.7 153.42 54.02 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 123.515 2.81 . . . . 0.0 109.291 170.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -77.8 -57.65 3.69 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.012 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.95 179.35 17.23 Favored Glycine 0 CA--C 1.477 -2.3 0 N-CA-C 103.726 -3.749 . . . . 0.0 103.726 165.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -122.9 61.27 1.01 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -141.54 176.84 8.56 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -171.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.94 -24.46 62.44 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 124.879 1.272 . . . . 0.0 112.245 -169.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -85.4 -20.14 30.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 122.966 0.506 . . . . 0.0 110.097 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -79.18 -35.89 41.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.0 -33.92 51.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -171.203 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.18 -48.12 74.57 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 125.841 1.657 . . . . 0.0 109.687 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 m -74.97 -22.97 58.23 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 118.112 -0.946 . . . . 0.0 113.496 -175.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 14.0 tt -87.09 -24.96 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 119.241 0.928 . . . . 0.0 110.65 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.68 -29.22 62.17 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.265 -1.374 . . . . 0.0 110.259 171.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -80.19 -32.43 38.67 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -83.72 -33.12 25.18 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 118.655 0.661 . . . . 0.0 111.07 -175.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -80.45 -19.25 46.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.5 47.57 3.46 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.6 mt -122.77 14.14 10.03 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -90.63 -9.73 45.88 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -175.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m -122.54 101.37 40.34 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.788 -174.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.57 166.37 83.07 Favored 'Cis proline' 0 N--CA 1.444 -1.429 0 CA-C-N 122.83 2.047 . . . . 0.0 107.217 -21.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.68 122.09 13.27 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 124.361 1.064 . . . . 0.0 110.987 -173.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -75.07 133.64 41.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -70.22 -40.47 74.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.336 1.022 . . . . 0.0 112.01 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.37 130.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 176.055 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -145.43 128.74 16.81 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -96.66 112.32 24.11 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.11 111.05 20.54 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 174.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.1 150.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.606 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-70 -142.88 135.73 27.95 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 125.172 1.389 . . . . 0.0 107.941 -174.2 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.91 -136.52 4.61 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 173.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -96.56 145.64 25.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.99 -21.94 25.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -79.6 -24.77 41.76 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -76.02 -35.52 59.48 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.716 172.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.444 HD12 ' CE2' ' A' ' 76' ' ' PHE . 1.1 mp -52.88 -51.47 36.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.459 0 C-N-CA 124.921 1.289 . . . . 0.0 110.221 170.17 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.68 -39.74 94.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.143 0.977 . . . . 0.0 111.105 -176.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.98 10.58 4.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 72' ' ' SER . 16.3 mm -80.06 -24.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.673 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.5 m -78.65 -23.55 45.7 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.019 177.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.5 143.89 44.37 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 167.113 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -98.56 25.42 6.43 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.222 -178.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -90.55 -47.66 7.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -113.71 51.2 0.87 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -176.111 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.5 172.65 39.13 Favored Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 103.266 -3.934 . . . . 0.0 103.266 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -126.56 152.93 75.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.02 132.78 14.43 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 106.077 -2.316 . . . . 0.0 106.077 172.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.58 156.17 17.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 174.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -36.42 -69.88 0.1 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 129.578 3.151 . . . . 0.0 116.394 -173.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -104.24 75.36 1.25 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -171.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 65.54 15.12 9.88 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.483 3.113 . . . . 0.0 116.353 165.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.98 173.23 6.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 -169.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -139.18 107.28 5.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 tt -86.47 143.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 177.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' HD12 ' A' ' 56' ' ' ILE . 93.7 p -89.47 168.06 12.49 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.441 0.639 . . . . 0.0 111.286 -172.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -124.05 -14.99 6.96 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 t -115.27 93.69 4.4 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -51.06 133.99 26.96 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 127.24 2.216 . . . . 0.0 112.633 174.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CE2' HD12 ' A' ' 53' ' ' ILE . 88.0 m-85 -110.14 157.75 19.05 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -172.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.72 135.16 35.95 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 174.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.21 142.7 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 -173.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.2 m -130.49 102.98 6.39 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -89.16 112.67 23.72 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.8 m -91.05 118.04 30.08 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -115.04 140.07 49.35 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.47 131.88 34.71 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -169.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.58 -179.56 5.76 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.31 -86.83 0.48 Allowed Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 -178.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.74 -7.41 0.68 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -78.92 128.12 77.61 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.073 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.57 -27.69 2.07 Favored 'Trans proline' 0 N--CA 1.436 -1.896 0 N-CA-C 107.862 -1.63 . . . . 0.0 107.862 173.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -98.01 162.87 20.69 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -169.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.78 144.34 34.87 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 122.366 2.044 . . . . 0.0 107.53 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -82.57 163.25 74.7 Favored 'Cis proline' 0 N--CA 1.438 -1.739 0 CA-C-N 123.222 2.187 . . . . 0.0 109.845 8.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.3 138.28 54.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.81 -168.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -101.96 107.15 18.21 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -103.04 123.24 46.26 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.221 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -88.18 122.4 31.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.87 132.55 34.62 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.18 104.53 7.36 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.3 135.74 34.23 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.08 146.36 16.83 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -99.15 103.87 15.8 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -143.05 155.72 44.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -167.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -78.94 130.81 35.99 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.76 142.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.465 -168.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.9 t -100.39 120.46 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -113.69 160.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.23 132.44 54.17 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 171.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 99.1 m -107.93 150.89 26.52 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -169.592 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -150.24 122.17 8.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.2 p30 67.13 10.23 7.54 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.475 2.31 . . . . 0.0 116.282 173.234 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.48 -3.15 39.73 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' CE1' ' A' ' 6' ' ' TYR . 16.7 mt -117.1 135.17 23.01 Favored Pre-proline 0 CA--C 1.484 -1.592 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 15.5 Cg_exo -77.44 127.85 9.23 Favored 'Trans proline' 0 N--CA 1.421 -2.778 0 CA-C-N 122.413 1.898 . . . . 0.0 107.169 175.28 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.441 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -95.3 -17.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 124.16 0.913 . . . . 0.0 109.468 -175.122 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 35.7 m80 -149.54 -177.69 6.01 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -169.031 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.92 135.83 23.51 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -173.161 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.39 127.06 37.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.05 22.07 16.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.119 0.568 . . . . 0.0 110.192 -170.173 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -86.64 -28.81 22.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -170.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -82.82 -25.18 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.783 0 C-N-CA 124.739 1.216 . . . . 0.0 110.146 178.558 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 . . . . . 0 N--CA 1.43 -1.426 0 O-C-N 123.234 0.334 . . . . 0.0 110.391 -165.948 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -91.13 0.78 57.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -75.41 -42.8 52.75 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.2 -48.18 82.73 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.801 172.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.521 0.8 OUTLIER -90.37 8.68 32.31 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 119.903 1.229 . . . . 0.0 114.21 -179.497 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -77.52 -40.0 44.21 Favored 'General case' 0 CA--C 1.494 -1.203 0 O-C-N 120.451 -1.406 . . . . 0.0 107.881 155.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.95 -28.8 70.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.303 1.041 . . . . 0.0 111.208 171.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.92 -10.57 36.04 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -68.48 -42.2 79.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 166.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 93.0 mm-40 -66.92 -68.28 0.39 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.728 171.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 88.8 m-70 -107.83 6.93 27.9 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -153.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' CD2' ' HE2' ' A' ' 50' ' ' LYS . 27.0 t80 -100.84 137.12 39.64 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-N 120.36 1.436 . . . . 0.0 107.635 165.303 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -151.49 104.25 3.05 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 162.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.94 -51.05 13.95 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -148.66 140.66 14.59 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 76.2 Cg_exo -75.06 177.16 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.5 2.134 . . . . 0.0 113.532 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.45 -67.24 0.74 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.1 -175.19 13.91 Favored Glycine 0 CA--C 1.479 -2.214 1 N-CA-C 103.092 -4.003 . . . . 0.0 103.092 166.559 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.6 mtm105 -121.88 71.21 0.98 Allowed 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -144.22 -178.45 5.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.338 -171.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.89 -32.71 74.55 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 125.744 1.617 . . . . 0.0 112.733 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 -16.47 38.53 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -177.197 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.25 -41.67 48.34 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 m -70.14 -32.7 70.82 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.37 -46.3 67.28 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -74.34 -26.17 59.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.157 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.26 16.9 tt -82.59 -33.17 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-N 118.589 0.632 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 93.5 mtp -84.89 -10.09 57.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.335 179.201 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -81.33 -40.61 23.32 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 122.005 -0.434 . . . . 0.0 110.41 169.121 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.57 -37.53 24.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 119.091 -0.481 . . . . 0.0 112.124 -172.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.4 -30.67 67.63 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 118.431 0.56 . . . . 0.0 110.005 170.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.25 48.08 3.89 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 169.062 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.3 mt -110.4 8.53 23.28 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -97.63 2.09 49.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.8 t -132.27 104.93 13.51 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.68 156.68 97.2 Favored 'Cis proline' 0 N--CA 1.444 -1.427 0 N-CA-C 106.68 -2.085 . . . . 0.0 106.68 -21.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.75 114.37 6.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 123.967 0.792 . . . . 0.0 111.895 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -75.64 132.23 40.47 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 173.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -83.02 -15.31 51.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -166.113 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 133.64 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.23 119.81 7.46 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.307 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 m -95.03 108.46 20.53 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.66 126.03 34.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mt -107.91 144.74 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -173.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.8 m-70 -131.72 127.11 36.16 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.062 -168.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.3 -130.68 2.14 Favored Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 145.99 39.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HE2' ' CD2' ' A' ' 14' ' ' TYR . 33.1 mttt -84.82 -14.55 47.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 119.29 -0.385 . . . . 0.0 110.594 -179.238 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.65 49.09 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.3 m -73.94 -42.27 60.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 117.595 -1.193 . . . . 0.0 109.14 175.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 mm -54.43 -54.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 C-N-CA 124.593 1.157 . . . . 0.0 111.953 176.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -58.17 -46.8 85.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 125.202 1.401 . . . . 0.0 111.509 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.55 12.94 1.78 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD12 ' CB ' ' A' ' 72' ' ' SER . 15.1 mm -75.55 -30.61 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 168.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.5 m -80.24 -21.19 43.07 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -82.95 163.51 21.01 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.35 -17.3 39.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.593 -175.622 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -87.99 128.49 35.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 165.322 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.6 t30 84.95 -8.44 0.89 Allowed 'General case' 0 C--N 1.356 0.865 0 C-N-CA 128.935 2.894 . . . . 0.0 113.441 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.8 -174.11 22.19 Favored Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 172.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -157.32 157.45 30.28 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.44 157.6 25.56 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.255 1.97 . . . . 0.0 108.244 -176.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' A' ' 69' ' ' LEU . 4.5 p80 -128.57 42.55 3.3 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 167.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.488 0.0 OUTLIER 53.82 152.27 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.285 1 C-N-CA 132.69 4.396 . . . . 0.0 119.334 -177.396 . . . . . . . . 4 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.57 50.15 3.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 110.842 -2.89 . . . . 0.0 111.917 171.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 83.89 1.45 0.96 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.045 2.938 . . . . 0.0 115.655 177.086 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 2.8 mm? -105.96 149.65 26.43 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -173.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -141.01 123.62 16.01 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -172.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tt -97.12 146.53 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.443 ' CB ' HD12 ' A' ' 56' ' ' ILE . 85.1 p -85.95 173.31 10.03 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-O 121.457 0.646 . . . . 0.0 111.395 -175.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.97 4.81 3.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.017 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.4 t -113.66 86.21 2.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -49.76 123.65 8.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.885 2.474 . . . . 0.0 113.347 -179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.49 156.29 20.29 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -83.37 143.53 30.27 Favored 'General case' 0 CA--C 1.466 -2.275 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.07 141.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -168.395 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -129.16 107.85 9.89 Favored 'General case' 0 CA--C 1.478 -1.811 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 166.317 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -84.01 100.66 11.21 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.4 m -84.19 106.42 15.81 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -118.8 142.23 47.9 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 -171.532 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -83.99 121.48 27.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.854 0.835 . . . . 0.0 109.014 -171.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -133.02 55.96 1.87 Allowed 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.42 -63.94 0.26 Allowed Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 105.125 -3.19 . . . . 0.0 105.125 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.08 27.32 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 173.585 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -89.99 138.87 27.41 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -83.0 -20.84 5.02 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.671 1.581 . . . . 0.0 109.242 172.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -108.03 156.86 37.53 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-O 117.615 -1.183 . . . . 0.0 108.84 -165.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -75.14 148.59 34.96 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.654 2.236 . . . . 0.0 108.719 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -81.62 166.56 72.31 Favored 'Cis proline' 0 N--CA 1.438 -1.751 0 CA-C-N 122.324 1.866 . . . . 0.0 108.654 -1.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.2 m -138.94 126.22 21.49 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -173.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -90.02 98.37 11.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -176.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -85.14 133.81 34.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -100.66 131.44 46.56 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 174.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.45 35.71 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.838 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -120.86 90.49 3.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 172.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.88 148.95 22.86 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.494 -171.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.05 -172.5 18.11 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 107.473 -2.251 . . . . 0.0 107.473 178.105 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -149.89 100.28 2.93 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -148.05 172.25 14.55 Favored 'General case' 0 CA--C 1.482 -1.64 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.418 -173.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -85.07 117.28 23.94 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -90.56 139.22 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.135 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.82 123.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.26 150.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 170.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.53 127.78 40.7 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 175.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.07 155.7 23.42 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.001 0.905 . . . . 0.0 112.0 -171.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -160.39 126.31 4.07 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.487 -2.783 . . . . 0.0 103.487 173.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 11.9 p30 66.91 14.35 9.79 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.863 2.465 . . . . 0.0 115.764 175.159 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.67 61.53 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.26 2.2 mp -107.64 138.2 19.93 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 177.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.37 112.63 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 N-CA-C 104.892 -2.772 . . . . 0.0 104.892 168.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.405 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -92.97 -18.6 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.814 -172.422 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.405 ' ND1' HG23 ' A' ' 113' ' ' VAL . 13.6 m80 -151.33 -179.57 7.48 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.0 141.54 51.24 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.11 124.27 30.94 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 165.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -115.65 56.71 0.75 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 t -89.25 -51.56 5.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -28.86 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -170.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.424 -1.771 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.985 -165.448 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -90.7 -26.39 19.58 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.67 39.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.39 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.284 9.5 t80 -51.41 -64.44 0.81 Allowed 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 125.972 1.709 . . . . 0.0 109.897 164.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -80.24 1.23 29.3 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -169.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -92.02 -26.33 18.4 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 119.897 1.226 . . . . 0.0 109.083 169.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.51 -36.33 80.22 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 161.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -28.69 51.5 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.587 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.8 m -65.08 -50.9 64.36 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 119.47 1.032 . . . . 0.0 109.819 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 72.3 mt-30 -68.35 -44.58 74.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 O-C-N 123.712 0.633 . . . . 0.0 112.675 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 92.6 m-70 -103.07 -55.54 2.4 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.7 -167.128 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -76.66 117.1 17.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.013 0.911 . . . . 0.0 109.586 -167.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -134.02 96.15 3.58 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 101.045 -3.687 . . . . 0.0 101.045 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.98 -41.7 1.71 Allowed 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 128.659 2.784 . . . . 0.0 117.539 -168.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -157.57 144.8 13.52 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 65.1 Cg_exo -76.74 -176.46 3.16 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.391 2.061 . . . . 0.0 114.078 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -72.59 -73.36 0.2 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 165.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.37 -174.32 13.59 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 102.437 -4.265 . . . . 0.0 102.437 164.443 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -111.8 75.97 0.95 Allowed 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 176.889 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -142.65 177.13 8.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.938 -173.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -56.06 -43.1 77.61 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 127.81 2.444 . . . . 0.0 112.169 -175.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -77.57 -23.95 49.88 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.036 0.935 . . . . 0.0 110.968 -176.242 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -71.83 -47.88 50.1 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.531 ' HA ' HG22 ' A' ' 29' ' ' ILE . 5.9 t -81.41 -22.77 38.03 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.61 -169.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.9 -47.9 81.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 123.725 0.81 . . . . 0.0 109.654 170.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.9 m -68.13 -36.41 79.66 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.671 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 26' ' ' CYS . 14.2 tt -80.49 -27.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-N 118.894 0.77 . . . . 0.0 110.917 -176.209 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.428 ' HE2' ' HB3' ' A' ' 43' ' ' ASN . 3.7 mmt -71.36 -36.97 71.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 118.327 0.512 . . . . 0.0 109.934 175.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.29 -28.08 61.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -75.96 -50.57 14.57 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 118.822 0.737 . . . . 0.0 110.355 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -23.47 60.07 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.804 0.842 . . . . 0.0 112.175 -172.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 51.98 2.68 Favored Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 170.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.1 mt -113.66 9.81 17.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 p -100.9 15.57 28.09 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 124.016 0.926 . . . . 0.0 108.959 178.007 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -124.2 94.5 45.18 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.81 166.79 81.76 Favored 'Cis proline' 0 N--CA 1.443 -1.468 0 N-CA-C 107.021 -1.954 . . . . 0.0 107.021 -24.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.6 m -62.78 120.04 10.5 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 124.36 1.064 . . . . 0.0 112.882 -172.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -72.4 139.64 47.93 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.576 -178.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -71.83 -43.15 66.06 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.391 0.677 . . . . 0.0 111.682 -172.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.84 128.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 5.4 t30 -143.49 130.21 20.31 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -100.3 116.32 32.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.537 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.85 124.78 35.43 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mm -93.57 150.95 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.5 m-70 -142.96 127.74 18.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -177.636 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.04 -137.2 4.16 Favored Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 172.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -106.3 144.39 33.07 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.78 -20.95 32.41 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.471 -167.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.62 -10.2 44.16 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.327 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.0 m -76.44 -38.06 56.06 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.648 166.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.76 -52.32 62.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-N 118.907 0.776 . . . . 0.0 110.542 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.26 -45.95 89.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 125.084 1.354 . . . . 0.0 111.342 -175.271 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.13 21.97 1.03 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.45 ' HB ' HH11 ' A' ' 70' ' ' ARG . 42.8 mt -78.55 -27.11 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 165.069 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.14 -39.59 90.61 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 122.449 0.3 . . . . 0.0 111.517 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -104.97 171.26 7.41 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.408 0.623 . . . . 0.0 110.24 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.6 t30 73.33 -136.9 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.532 1.533 . . . . 0.0 114.694 153.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 61' ' ' ASN . 83.8 tttt -136.01 0.42 2.62 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 -164.356 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 60' ' ' LYS . 20.6 t30 -82.22 -20.84 36.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.58 -176.03 19.16 Favored Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 164.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.52 154.08 32.95 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.16 147.02 23.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 122.523 2.149 . . . . 0.0 107.441 -175.547 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -135.59 125.34 25.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? 64.66 -107.01 0.15 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.069 1.347 . . . . 0.0 111.489 171.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.96 97.21 3.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.132 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.357 2.1 p-10 64.84 24.72 12.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 129.105 2.962 . . . . 0.0 114.112 175.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 mt -111.87 168.8 9.3 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 101.196 -3.631 . . . . 0.0 101.196 172.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 ' CB ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -155.5 129.63 8.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.446 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 tt -101.01 143.43 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -175.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 56' ' ' ILE . 85.6 p -82.56 165.44 20.1 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-O 122.261 1.029 . . . . 0.0 111.417 -176.184 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -128.74 4.56 5.49 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 178.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -122.26 88.95 3.03 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 175.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -59.63 132.13 53.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.661 1.584 . . . . 0.0 112.5 -177.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -109.54 158.24 18.2 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 139.35 38.36 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 174.492 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.21 144.65 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -171.014 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -128.53 108.04 10.2 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -87.78 102.59 14.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 177.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -95.58 137.67 34.31 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -177.134 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -128.15 141.85 51.36 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.27 133.19 40.13 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 126.32 1.848 . . . . 0.0 108.031 -175.295 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -136.04 164.08 28.83 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.84 -44.58 1.44 Allowed Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 -176.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.59 17.48 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -107.35 122.52 41.02 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -79.22 -29.28 3.22 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 N-CA-C 107.612 -1.726 . . . . 0.0 107.612 173.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -101.44 156.72 34.84 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -171.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -75.05 148.2 34.78 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 122.594 2.196 . . . . 0.0 107.493 -174.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -84.11 164.08 66.2 Favored 'Cis proline' 0 CA--C 1.49 -1.675 0 CA-C-N 123.133 2.155 . . . . 0.0 109.392 10.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 m -151.86 118.88 5.85 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -167.369 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -93.99 119.74 33.29 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -98.53 123.2 42.56 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -87.12 118.01 26.23 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.83 137.63 32.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.651 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 m -120.82 112.27 18.61 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.64 148.14 28.14 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.268 0.556 . . . . 0.0 110.032 -176.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.96 32.73 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -155.32 107.49 2.67 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.17 -3.27 . . . . 0.0 102.17 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -153.51 170.35 20.97 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.797 -174.052 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.46 124.41 31.32 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -99.04 142.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -166.501 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.09 122.37 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 170.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -122.71 160.39 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 102.434 -3.173 . . . . 0.0 102.434 173.101 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.07 131.94 54.61 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 119.021 0.828 . . . . 0.0 109.146 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.9 t -97.6 148.87 22.84 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.13 1.372 . . . . 0.0 109.174 -174.61 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.5 123.89 12.35 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 164.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.312 13.8 p30 64.84 19.63 11.9 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 128.209 2.604 . . . . 0.0 116.679 174.002 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.3 19.69 51.71 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.331 1.3 tp -129.51 146.71 62.21 Favored Pre-proline 0 CA--C 1.481 -1.68 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 177.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.46 ' CB ' HH22 ' A' ' 70' ' ' ARG . 82.0 Cg_exo -69.46 147.04 63.91 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 121.457 1.438 . . . . 0.0 108.891 162.324 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -30.96 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 O-C-N 123.708 0.63 . . . . 0.0 109.338 175.508 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 32.5 m80 -145.33 175.73 10.08 Favored 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.965 -165.6 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.406 HD13 HG12 ' A' ' 105' ' ' VAL . 2.8 tp -125.3 139.18 53.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.82 128.06 35.64 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 167.142 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -108.84 52.05 0.72 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -87.42 -44.94 10.97 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -173.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.78 -28.51 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -173.462 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.426 -1.629 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.819 -165.808 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -91.65 -29.66 16.75 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -66.23 -45.69 79.81 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.199 1.4 . . . . 0.0 109.401 179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 10' ' ' LEU . 65.8 t80 -50.54 -62.21 1.73 Allowed 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.689 1.996 . . . . 0.0 113.881 170.179 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -70.34 -13.88 62.34 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.52 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -81.33 -39.25 25.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 119.848 1.204 . . . . 0.0 110.055 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.65 -34.42 74.26 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.11 1.364 . . . . 0.0 109.646 169.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -77.25 -24.39 51.13 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 125.855 1.662 . . . . 0.0 113.341 177.313 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -66.2 -58.08 6.19 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.315 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -63.28 -52.08 63.49 Favored 'General case' 0 CA--C 1.484 -1.587 0 O-C-N 124.051 0.844 . . . . 0.0 113.046 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -101.3 -15.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -163.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 28.9 t80 -93.99 137.15 33.52 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 122.936 2.607 . . . . 0.0 109.738 177.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -151.79 100.4 2.67 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 165.035 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.58 -49.41 2.17 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -164.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -145.47 149.95 42.44 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 167.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 51.4 Cg_endo -84.07 169.71 11.37 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.42 2.08 . . . . 0.0 107.922 -175.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.87 -70.53 0.35 Allowed 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.73 15.0 Favored Glycine 0 CA--C 1.475 -2.436 1 N-CA-C 102.768 -4.133 . . . . 0.0 102.768 164.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -116.66 73.62 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 177.05 9.81 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -174.426 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.36 -18.87 62.35 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.575 1.15 . . . . 0.0 112.717 -173.035 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.48 -22.12 30.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 122.797 0.439 . . . . 0.0 110.183 178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -77.44 -42.02 37.56 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.1 m -67.02 -37.16 83.66 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 123.829 0.706 . . . . 0.0 112.54 -178.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.29 -42.71 87.98 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 123.679 0.792 . . . . 0.0 110.36 175.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 m -69.89 -32.32 70.59 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD11 HH21 ' A' ' 33' ' ' ARG . 6.9 tt -81.87 -33.48 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 118.915 0.78 . . . . 0.0 110.61 -176.119 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.0 mmt -73.63 -31.58 63.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.064 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -74.83 -34.68 62.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -70.94 -56.88 5.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.078 0.951 . . . . 0.0 110.596 -172.573 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.423 HH21 HD11 ' A' ' 29' ' ' ILE . 10.0 ptp180 -85.38 -18.09 34.76 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.077 -175.243 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.64 71.12 1.31 Allowed Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 166.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -118.41 11.89 13.15 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 173.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.8 t -96.81 3.96 51.98 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.143 0.977 . . . . 0.0 108.99 -171.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -129.52 103.09 17.92 Favored Pre-proline 0 N--CA 1.427 -1.607 0 CA-C-O 117.81 -1.091 . . . . 0.0 108.667 -177.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.71 159.19 97.1 Favored 'Cis proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.52 -2.146 . . . . 0.0 106.52 -22.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.07 119.55 16.42 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 111.994 -166.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -79.55 134.12 36.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 172.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.9 -15.3 48.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.847 -164.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.63 125.88 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -139.08 128.81 24.73 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 169.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -96.27 117.85 31.64 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -93.64 120.36 33.82 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.5 145.1 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -174.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.495 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m-70 -133.16 128.93 37.11 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -174.446 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.66 -132.39 2.9 Favored Glycine 0 CA--C 1.483 -1.955 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 176.183 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.19 144.48 43.12 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.133 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -84.0 -15.17 48.67 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -74.68 -35.69 62.77 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.502 1.121 . . . . 0.0 108.612 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.1 m -72.15 -37.14 69.46 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.287 176.436 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 mm -56.55 -55.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 123.912 0.885 . . . . 0.0 111.842 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -58.92 -40.01 83.26 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.422 1.089 . . . . 0.0 112.889 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -18.72 46.86 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.8 -26.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 119.718 1.145 . . . . 0.0 110.683 -176.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.4 t -77.5 -12.08 59.92 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 118.579 0.627 . . . . 0.0 111.933 -178.439 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.45 -178.94 7.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.181 0.991 . . . . 0.0 108.72 168.278 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.05 -28.66 61.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.88 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -74.14 154.93 38.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 172.604 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 t30 61.78 21.21 12.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.633 2.373 . . . . 0.0 116.127 171.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.87 177.47 41.5 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.1 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -143.72 157.07 59.15 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -72.39 148.18 48.28 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.382 2.055 . . . . 0.0 109.671 -176.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -134.92 127.2 30.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 62.08 -106.45 0.21 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 125.726 1.61 . . . . 0.0 112.117 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -151.95 108.76 3.5 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 2.0 p-10 66.25 24.1 10.74 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 129.727 3.211 . . . . 0.0 113.87 176.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 mt -116.15 170.86 8.19 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 171.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.464 HH12 ' HG3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -149.85 146.1 26.93 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 166.356 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.34 151.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 175.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -74.48 177.99 5.6 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.297 1.046 . . . . 0.0 112.725 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -142.04 7.13 1.8 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.4 t -130.58 94.53 3.66 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 171.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 p -57.09 130.19 45.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.065 1.746 . . . . 0.0 112.717 -177.011 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.86 156.0 17.79 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -175.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -77.24 138.58 39.5 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 175.777 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.54 142.48 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.015 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.2 m -130.62 108.51 9.97 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 167.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.6 m -81.76 101.74 10.32 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 75.9 m -88.15 110.37 20.63 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 178.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.06 145.79 49.01 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 151.38 29.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.088 0.947 . . . . 0.0 112.62 -172.608 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -125.18 44.12 2.88 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.66 -108.48 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.336 0 C-N-CA 129.454 3.407 . . . . 0.0 113.378 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.75 -51.08 4.37 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 112.436 -1.882 . . . . 0.0 111.531 -162.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 p -175.86 152.66 1.3 Allowed Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 -173.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -86.03 -13.32 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.226 1.95 . . . . 0.0 108.658 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.33 159.42 32.03 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -75.28 142.93 27.61 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 121.998 1.799 . . . . 0.0 107.507 -172.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -82.06 161.16 78.45 Favored 'Cis proline' 0 CA--C 1.487 -1.827 0 CA-C-N 123.538 2.299 . . . . 0.0 110.794 8.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 m -142.87 122.41 13.23 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -166.436 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -85.58 109.19 18.36 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -99.61 121.53 41.33 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -98.83 152.67 19.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.38 31.2 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.2 m -126.56 98.24 5.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 167.256 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.77 32.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.153 0.501 . . . . 0.0 109.967 -175.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.49 20.84 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 70.5 t80 -151.65 92.51 1.76 Allowed 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 101.627 -3.471 . . . . 0.0 101.627 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -136.99 154.4 50.42 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -161.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -68.14 128.88 38.18 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.9 m -93.03 120.48 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -174.525 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.2 t -86.84 118.39 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.585 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -122.84 157.96 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 176.394 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 128.53 40.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.8 t -107.45 136.75 46.7 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.148 0.979 . . . . 0.0 108.847 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.45 138.98 50.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 169.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 14.0 p30 65.64 17.7 10.98 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 127.17 2.188 . . . . 0.0 116.644 172.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.83 23.71 48.55 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 28.3 tp -141.14 151.05 60.82 Favored Pre-proline 0 CA--C 1.486 -1.484 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 105' ' ' VAL . 74.1 Cg_exo -66.94 162.88 35.93 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 122.552 1.947 . . . . 0.0 109.791 164.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -147.4 -27.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 O-C-N 121.616 -0.677 . . . . 0.0 111.274 176.245 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.554 ' CD2' HG23 ' A' ' 113' ' ' VAL . 88.8 m-70 -144.08 172.03 13.45 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 -173.473 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.0 134.28 54.33 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 175.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.63 121.03 27.73 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 174.232 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -103.94 45.67 0.95 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p -98.74 -30.41 12.45 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 175.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -23.5 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.635 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.872 -172.837 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.59 -18.5 26.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.164 179.001 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -68.44 -43.66 76.59 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.513 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.252 8.6 t80 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.402 -2.837 0 C-N-CA 124.768 1.227 . . . . 0.0 111.142 174.405 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -173.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -82.34 -32.36 29.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 119.479 1.036 . . . . 0.0 109.091 170.725 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' A' ' 10' ' ' LEU . 1.9 t80 -58.22 -38.98 77.87 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.13 164.354 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 8.4 mp -83.38 -11.51 57.53 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 119.651 1.114 . . . . 0.0 113.495 178.403 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.2 m -70.66 -45.25 65.44 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 119.564 1.075 . . . . 0.0 108.298 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.12 -41.35 67.32 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.044 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.56 -54.5 2.74 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.096 -169.028 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.672 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 9.6 t80 -72.45 126.41 29.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 120.45 1.477 . . . . 0.0 112.776 -165.158 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -149.17 104.37 3.41 Favored 'General case' 0 N--CA 1.424 -1.75 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 172.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.2 -32.28 10.12 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -162.44 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 152.38 42.9 Favored Pre-proline 0 N--CA 1.432 -1.37 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 17.2 Cg_endo -71.31 144.1 45.14 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 C-N-CA 123.265 2.643 . . . . 0.0 107.519 167.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -77.52 -51.63 10.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.6 179.68 17.35 Favored Glycine 0 CA--C 1.478 -2.259 1 N-CA-C 103.091 -4.004 . . . . 0.0 103.091 161.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.92 55.03 0.94 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.49 179.81 6.58 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -170.553 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -67.95 -23.94 65.11 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 125.352 1.461 . . . . 0.0 113.204 -172.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -25.76 37.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.51 -44.78 49.76 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.9 m -65.07 -38.07 89.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.35 -33.81 55.31 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 119.117 -0.468 . . . . 0.0 111.072 -178.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -76.57 -29.87 56.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 118.78 -0.628 . . . . 0.0 112.023 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 13.5 tt -75.92 -38.58 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.611 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.7 mtm -79.27 -23.23 43.76 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 118.136 -1.425 . . . . 0.0 113.447 -176.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -72.39 -36.81 68.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 170.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.18 -45.66 32.26 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.537 0.735 . . . . 0.0 111.479 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -76.78 -25.43 53.36 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.744 1.618 . . . . 0.0 109.344 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.12 44.48 3.8 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 163.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.8 mt -118.54 19.77 13.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -90.08 -11.33 41.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.619 1.168 . . . . 0.0 108.244 -176.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 m -121.3 105.0 39.92 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.61 161.31 94.91 Favored 'Cis proline' 0 N--CA 1.441 -1.612 0 N-CA-C 107.018 -1.955 . . . . 0.0 107.018 -22.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.95 125.54 24.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.202 1.001 . . . . 0.0 109.586 -177.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.78 142.38 38.67 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.282 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.7 -36.47 57.2 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.76 128.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -161.36 144.48 12.56 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.0 m -106.87 138.88 42.2 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 -170.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -101.87 129.77 48.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 162.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.67 150.89 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.637 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -174.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.794 ' HB2' ' HB2' ' A' ' 77' ' ' GLN 0.252 7.9 m-70 -140.25 153.12 46.42 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.741 -174.024 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.04 -124.24 3.89 Favored Glycine 0 CA--C 1.478 -2.246 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 169.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 135.58 42.93 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.968 1.366 . . . . 0.0 109.707 -177.122 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.27 -29.11 34.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.602 -1.636 . . . . 0.0 106.857 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -29.11 64.85 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.9 m -76.88 -36.79 56.47 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 116.663 -1.637 . . . . 0.0 111.485 176.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 53' ' ' ILE 0.268 6.6 tp -65.03 -46.34 91.77 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 0 CA-C-N 120.193 1.361 . . . . 0.0 110.592 -178.672 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -60.61 -43.48 97.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.428 1.091 . . . . 0.0 110.808 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.18 11.46 2.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.56 -35.99 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.097 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 167.127 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -96.74 5.29 50.91 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -112.38 18.65 18.33 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.087 0.946 . . . . 0.0 108.461 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 32.1 47.58 0.09 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 131.686 3.994 . . . . 0.0 115.744 -170.533 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.78 -60.7 2.21 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.55 64.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.163 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.19 146.84 8.58 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 173.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -102.49 164.06 16.42 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.381 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.92 144.01 42.19 Favored 'Trans proline' 0 N--CA 1.437 -1.797 0 C-N-CA 122.692 2.262 . . . . 0.0 106.886 166.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -136.23 33.69 2.81 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 -178.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.6 mmt-85 61.12 157.62 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 129.017 2.927 . . . . 0.0 114.73 178.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 52.84 46.77 26.09 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 128.126 2.57 . . . . 0.0 113.882 175.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.316 2.8 p-10 51.48 40.35 26.61 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.785 2.434 . . . . 0.0 114.192 -174.02 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.88 153.81 32.91 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 100.799 -3.778 . . . . 0.0 100.799 177.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -146.26 125.17 12.72 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -90.59 143.19 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 179.481 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.0 p -80.88 158.16 25.41 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.693 0.758 . . . . 0.0 112.75 -175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -108.11 -19.97 13.32 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -104.93 82.45 1.87 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 p -52.43 132.06 34.27 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 127.023 2.129 . . . . 0.0 112.413 178.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -107.26 160.42 15.61 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.794 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 7.3 mm-40 -79.76 144.3 33.72 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.77 142.14 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 m -131.54 104.56 7.03 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 169.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.0 m -86.32 105.26 16.55 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.34 111.25 20.89 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -111.36 131.52 55.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 -171.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.5 118.01 11.83 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 123.64 0.776 . . . . 0.0 108.935 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -130.93 71.38 1.47 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -175.17 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.19 -45.97 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 105.156 -3.178 . . . . 0.0 105.156 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.02 37.03 8.6 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 p -103.57 122.29 45.37 Favored Pre-proline 0 N--CA 1.434 -1.246 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -83.54 -20.21 4.88 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 CA-C-N 121.587 1.602 . . . . 0.0 108.614 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -110.9 158.44 35.74 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.318 -167.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.25 147.01 36.81 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.824 2.35 . . . . 0.0 108.382 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -82.06 165.75 72.34 Favored 'Cis proline' 0 N--CA 1.438 -1.761 0 CA-C-N 122.401 1.893 . . . . 0.0 108.489 -1.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.1 m -113.12 157.91 21.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.703 1.252 . . . . 0.0 107.637 -172.04 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -111.57 135.59 51.93 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -133.71 122.58 23.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -89.06 125.12 34.88 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.09 122.34 27.21 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -115.24 88.07 2.79 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.48 142.34 27.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.009 -172.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.11 -177.09 14.94 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 177.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -140.44 97.62 3.25 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 175.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -158.34 -179.66 8.31 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -164.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -79.91 146.84 31.92 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.053 -173.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.43 151.95 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -114.06 95.02 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 163.043 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.3 136.6 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.53 130.17 34.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 174.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 57.1 m -109.66 149.64 29.43 Favored 'General case' 0 CA--C 1.489 -1.376 0 O-C-N 124.136 0.897 . . . . 0.0 110.688 -173.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.21 124.97 7.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.2 p30 65.89 18.32 11.06 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.782 2.433 . . . . 0.0 116.338 171.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.3 -7.02 59.83 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -103.06 148.76 36.11 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 177.611 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -70.89 143.46 45.46 Favored 'Trans proline' 0 N--CA 1.435 -1.968 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 156.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.9 OUTLIER -121.22 -22.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.369 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 113' ' ' VAL . 31.2 m-70 -154.25 -167.35 2.61 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.88 136.75 2.49 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -80.5 139.66 36.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.864 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -101.88 40.77 1.28 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 172.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.3 m -96.22 -30.19 13.61 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -175.237 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.71 -35.41 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.941 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.241 172.411 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -168.37 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 . . . . . 0 CA--C 1.487 -1.45 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 59.34 71.83 0.56 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 126.397 1.879 . . . . 0.0 111.577 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 93.15 -28.84 0.03 OUTLIER 'General case' 0 C--N 1.358 0.937 0 C-N-CA 127.613 2.365 . . . . 0.0 110.621 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -90.38 -1.64 57.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.45 -45.35 59.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.55 -52.72 63.72 Favored 'General case' 0 N--CA 1.412 -2.344 0 C-N-CA 125.538 1.535 . . . . 0.0 112.366 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.449 1.8 t -87.97 9.8 21.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.99 -42.2 33.45 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 120.207 -1.558 . . . . 0.0 107.463 157.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -59.77 -36.91 77.64 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.982 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 14' ' ' TYR . 20.2 mt -83.77 -15.91 46.71 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 119.567 1.076 . . . . 0.0 113.863 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.7 m -65.8 -48.61 71.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 119.911 1.232 . . . . 0.0 108.908 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -72.91 -37.25 67.31 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -104.34 -53.64 2.68 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.251 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 14.8 t80 -76.61 115.33 16.27 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 119.232 0.924 . . . . 0.0 110.123 -168.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -134.76 98.73 4.12 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.11 -38.01 16.72 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -165.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -159.77 134.52 5.52 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -71.54 178.05 6.09 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 123.051 2.501 . . . . 0.0 114.66 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.31 -59.63 2.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -179.36 22.73 Favored Glycine 0 CA--C 1.478 -2.228 0 N-CA-C 104.403 -3.479 . . . . 0.0 104.403 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.519 HH21 ' HG3' ' A' ' 77' ' ' GLN . 11.1 mpt_? -106.84 73.46 0.94 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -156.92 173.46 16.97 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.41 -20.77 62.9 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 125.373 1.469 . . . . 0.0 113.963 -169.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -80.46 -29.61 37.47 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.32 -41.58 66.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.7 OUTLIER -80.34 -25.39 39.27 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.729 -1.188 . . . . 0.0 113.097 -170.953 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.01 -36.48 69.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 118.99 -0.528 . . . . 0.0 110.175 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.4 t -65.65 -42.96 90.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.3 tt -80.37 -28.09 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 117.83 0.286 . . . . 0.0 111.199 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 mmt -74.25 -29.99 61.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.035 -0.415 . . . . 0.0 110.325 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.457 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.3 tpp180 -66.43 -45.75 78.82 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.774 0.83 . . . . 0.0 111.869 172.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -80.22 -39.68 28.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -170.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.47 -39.65 74.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.46 68.82 1.34 Allowed Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 mt -113.94 21.83 14.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 163.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -94.6 -5.78 45.01 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 109.085 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -132.6 102.66 13.75 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.86 163.31 89.39 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.484 -1.776 . . . . 0.0 107.484 -18.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 83' ' ' LEU . 33.9 m -59.62 125.75 24.87 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 124.492 1.117 . . . . 0.0 110.693 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -76.19 138.46 40.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.83 -40.71 60.89 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 123.432 0.457 . . . . 0.0 111.256 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.91 128.0 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -148.79 131.72 16.17 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 m -96.97 124.38 40.92 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.645 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.98 120.08 30.88 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.77 149.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.636 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -143.37 138.46 29.43 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.98 -140.28 6.78 Favored Glycine 0 CA--C 1.484 -1.871 0 N-CA-C 106.651 -2.579 . . . . 0.0 106.651 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.38 146.55 25.07 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 1.2 tmtp? -83.89 -25.4 30.23 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -70.75 -34.23 71.63 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.006 1.323 . . . . 0.0 108.708 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -69.93 -41.44 74.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 117.614 -1.184 . . . . 0.0 110.459 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.74 -50.73 76.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 123.837 0.855 . . . . 0.0 111.909 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -63.87 -37.67 88.24 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.343 0.657 . . . . 0.0 111.188 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.35 4.81 8.15 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HB2' ' A' ' 72' ' ' SER . 23.0 mm -77.3 -26.85 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.7 t -82.74 -15.02 53.42 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.152 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.47 154.41 38.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -83.34 -7.49 59.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.757 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -80.41 -41.84 23.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.921 0.488 . . . . 0.0 109.769 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -123.29 31.46 5.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.67 136.95 3.37 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -90.01 154.02 47.27 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 37.2 Cg_endo -74.79 138.43 23.58 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 122.335 2.024 . . . . 0.0 106.974 169.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -130.67 104.77 7.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' CD ' ' H ' ' A' ' 67' ' ' GLU 0.398 0.0 OUTLIER 46.31 -109.59 0.23 Allowed 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 127.806 2.442 . . . . 0.0 115.661 -177.862 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 50.2 mt-10 -107.33 77.47 1.15 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.766 1.226 . . . . 0.0 108.763 -165.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.372 1.2 p-10 76.59 12.12 2.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 129.102 2.961 . . . . 0.0 114.345 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.3 mp -95.82 154.17 17.36 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 64' ' ' PRO . 13.8 mmp_? -136.57 112.64 9.7 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -95.73 132.21 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.422 ' HB2' HD12 ' A' ' 56' ' ' ILE . 96.2 p -82.45 157.05 23.79 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.652 0.739 . . . . 0.0 112.424 -168.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -108.94 -15.93 14.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.533 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -112.91 90.57 3.38 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.8 m -50.92 133.23 27.05 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 127.402 2.281 . . . . 0.0 112.419 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.4 161.3 15.43 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.519 ' HG3' HH21 ' A' ' 21' ' ' ARG . 0.3 OUTLIER -82.16 126.77 32.44 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 175.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 108.5 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.2 m -94.82 108.31 20.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.1 m -91.83 102.9 15.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.2 m -93.3 117.65 30.33 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.54 144.73 37.43 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 39' ' ' CYS . 41.2 tp -78.98 126.67 30.99 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -134.72 52.58 2.04 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.69 -70.54 1.18 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.71 -32.44 4.44 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.9 t -87.48 135.34 34.47 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -78.38 -22.65 9.35 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.161 1.908 . . . . 0.0 109.074 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -95.32 167.4 12.89 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -72.32 142.63 37.69 Favored 'Trans proline' 0 N--CA 1.438 -1.788 0 C-N-CA 122.028 1.819 . . . . 0.0 107.526 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.0 Cg_endo -88.15 164.56 42.96 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 CA-C-N 122.63 1.975 . . . . 0.0 108.775 15.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.7 m -130.01 122.66 28.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -94.87 117.35 30.0 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -107.28 122.6 46.88 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -96.79 121.4 38.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.67 130.33 35.02 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.9 m -118.05 95.4 4.89 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.94 34.27 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.105 -173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.94 -176.18 19.61 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.328 -3.109 . . . . 0.0 105.328 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -148.43 109.71 4.37 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.568 -3.123 . . . . 0.0 102.568 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -162.12 175.11 12.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.971 0.891 . . . . 0.0 109.018 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -77.56 142.24 39.11 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 125.244 1.418 . . . . 0.0 110.675 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.38 150.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.12 91.73 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 166.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.64 132.62 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.52 125.02 36.97 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.3 t -108.67 131.24 55.09 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -126.19 136.84 53.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 13.1 p30 65.05 18.98 11.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 127.514 2.326 . . . . 0.0 117.083 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.9 54.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 0.4 OUTLIER -134.47 132.2 20.76 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 -178.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.95 108.21 2.6 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 N-CA-C 105.78 -2.431 . . . . 0.0 105.78 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 m -94.27 -11.72 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -172.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.455 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 61.9 t60 -153.85 179.53 8.79 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -169.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.455 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -164.21 130.58 3.06 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.85 135.02 36.92 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.251 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -100.86 41.84 1.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.3 t -96.38 -32.39 12.39 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.47 -35.89 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.837 172.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.06 43.4 1.11 Allowed 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -94.35 -42.15 9.05 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.7 tpp85 -133.99 101.85 12.45 Favored Pre-proline 0 N--CA 1.43 -1.464 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.432 -2.117 0 N-CA-C 105.927 -2.374 . . . . 0.0 105.927 -174.444 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 CA--C 1.487 -1.449 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -149.84 100.07 2.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.319 0.0 OUTLIER 109.36 -26.04 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 129.613 3.165 . . . . 0.0 107.893 176.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 m -92.19 -13.82 29.98 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -43.68 67.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.268 41.4 t80 -56.82 -51.96 66.95 Favored 'General case' 0 N--CA 1.399 -3.012 0 C-N-CA 126.623 1.969 . . . . 0.0 113.422 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.482 ' HA ' ' HG ' ' A' ' 10' ' ' LEU 0.252 1.5 p -82.06 -3.24 54.22 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.63 -31.21 22.7 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 120.136 1.335 . . . . 0.0 108.229 167.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 115' ' ' LEU . 16.0 t80 -65.18 -36.98 85.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.407 1.083 . . . . 0.0 109.405 167.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.295 8.9 mt -69.25 -31.15 69.5 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 170.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.6 m -65.26 -44.28 88.61 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 119.509 1.049 . . . . 0.0 108.936 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 66.5 mt-30 -70.0 -55.16 10.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 123.556 0.535 . . . . 0.0 111.92 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.463 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 91.1 m-70 -96.49 -49.44 5.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.913 -162.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HB2' HD22 ' A' ' 10' ' ' LEU . 29.2 t80 -71.15 115.09 9.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 120.065 1.302 . . . . 0.0 112.635 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -138.56 98.05 3.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 100.789 -3.782 . . . . 0.0 100.789 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.82 -40.69 10.09 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.515 2.326 . . . . 0.0 117.055 -168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -157.63 144.11 13.04 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 69.0 Cg_exo -76.51 178.39 7.61 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.507 2.138 . . . . 0.0 112.916 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.64 -74.99 0.17 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.74 -176.44 14.74 Favored Glycine 0 CA--C 1.477 -2.336 1 N-CA-C 102.557 -4.217 . . . . 0.0 102.557 163.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -118.16 72.56 0.87 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -145.01 177.8 8.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.72 -22.33 63.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.704 1.202 . . . . 0.0 113.595 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.8 -29.45 40.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -41.87 69.48 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.282 0.8 OUTLIER -79.69 -26.92 40.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.227 -170.585 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.66 -35.47 70.36 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.286 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -67.73 -38.91 84.17 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 26' ' ' CYS . 4.1 tt -79.69 -30.85 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 118.535 0.607 . . . . 0.0 110.629 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -74.4 -30.09 61.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 122.392 -0.192 . . . . 0.0 111.0 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -68.43 -44.85 74.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.467 0.707 . . . . 0.0 111.873 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -71.2 -48.99 48.21 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.913 0.885 . . . . 0.0 112.277 -173.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -36.82 75.35 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.201 0.6 . . . . 0.0 110.408 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.58 68.79 1.36 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -114.91 22.48 13.41 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -91.25 -10.21 42.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 124.267 1.027 . . . . 0.0 109.132 -172.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -129.99 104.54 16.82 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.65 160.01 95.66 Favored 'Cis proline' 0 N--CA 1.444 -1.404 0 N-CA-C 107.073 -1.934 . . . . 0.0 107.073 -20.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' HD13 ' A' ' 83' ' ' LEU . 59.5 m -62.92 125.26 23.37 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.059 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.01 143.17 45.67 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.03 -39.14 61.23 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.161 0.584 . . . . 0.0 111.541 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 tt -149.11 128.83 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -147.26 125.73 12.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 m -101.51 114.36 28.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.586 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -85.67 125.96 33.57 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.41 146.37 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.726 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -136.91 127.45 26.86 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 125.311 1.444 . . . . 0.0 107.949 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.65 -148.49 17.67 Favored Glycine 0 CA--C 1.483 -1.91 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -84.02 140.5 31.82 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 122.2 1.0 . . . . 0.0 108.33 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -85.27 -15.78 42.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.308 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -79.32 -31.42 43.18 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 125.317 1.447 . . . . 0.0 107.857 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.7 m -73.37 -36.47 66.11 Favored 'General case' 0 N--CA 1.424 -1.744 0 C-N-CA 124.177 0.991 . . . . 0.0 109.992 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 112' ' ' PRO . 87.7 mt -59.9 -52.25 63.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.996 0 C-N-CA 123.379 0.672 . . . . 0.0 110.992 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.05 -39.7 79.11 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.821 0.849 . . . . 0.0 112.849 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.69 10.35 3.34 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.9 mt -78.63 -30.53 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.0 t -68.08 -41.27 82.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.36 154.98 28.64 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.26 99.22 8.5 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -159.77 -49.08 0.05 Allowed 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.34 47.24 1.39 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.94 129.53 1.54 Allowed Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.76 160.63 32.66 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -72.64 138.26 28.98 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 122.914 2.409 . . . . 0.0 107.971 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -141.32 129.63 22.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -171.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 65.66 -108.72 0.16 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.052 1.341 . . . . 0.0 111.447 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -140.67 95.15 2.81 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.345 1.6 p-10 64.15 23.38 13.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 128.92 2.888 . . . . 0.0 114.327 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.9 mt -106.46 168.48 9.13 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -141.13 124.75 16.82 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.53 142.52 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.3 p -84.31 175.16 9.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.826 0.822 . . . . 0.0 110.418 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -131.45 -1.18 3.94 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -109.54 74.02 0.87 Allowed 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.4 p -51.19 123.89 10.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.137 1.775 . . . . 0.0 113.544 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -108.6 160.99 15.49 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.68 136.45 35.49 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.47 110.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -172.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.0 m -93.64 110.63 22.23 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.1 m -88.95 104.63 17.14 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.4 m -94.19 115.47 27.75 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -110.13 147.66 33.25 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB3' ' A' ' 39' ' ' CYS . 36.7 tp -79.99 112.91 17.74 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -132.81 96.54 3.82 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.85 -40.92 0.06 OUTLIER Glycine 0 CA--C 1.479 -2.197 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.6 42.48 6.46 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.8 m -114.61 107.19 51.25 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -83.76 -20.53 4.53 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 CA-C-N 122.213 1.826 . . . . 0.0 108.398 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -110.17 161.32 24.93 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -73.96 144.45 34.32 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.665 2.244 . . . . 0.0 108.31 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -81.89 163.63 76.49 Favored 'Cis proline' 0 N--CA 1.437 -1.848 0 CA-C-N 122.641 1.979 . . . . 0.0 108.731 -1.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.1 m -108.53 159.41 16.72 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.739 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.18 98.7 7.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.77 128.3 44.32 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -101.34 121.03 41.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.46 132.67 35.2 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 48.4 m -116.12 105.52 12.69 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.1 125.53 29.48 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.3 177.99 18.75 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 105.691 -2.963 . . . . 0.0 105.691 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -158.95 111.13 2.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -161.21 171.12 18.98 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.24 133.77 42.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.852 172.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.65 149.51 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.424 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.98 122.38 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.35 138.94 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.21 132.16 36.28 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.5 t -104.42 133.81 48.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 124.744 1.278 . . . . 0.0 109.903 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -132.57 141.37 48.68 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 164.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.326 11.2 p30 66.34 17.79 10.76 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.301 2.24 . . . . 0.0 116.503 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.12 50.77 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.267 3.5 tp -143.43 149.84 49.21 Favored Pre-proline 0 CA--C 1.484 -1.591 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HG2' HG22 ' A' ' 53' ' ' ILE . 50.1 Cg_exo -67.19 147.21 78.5 Favored 'Trans proline' 0 N--CA 1.436 -1.898 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 164.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.28 -19.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 42.1 t60 -155.86 178.79 9.87 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 -165.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -159.32 146.43 16.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -173.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -95.44 141.23 29.23 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -115.56 20.71 14.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.301 1.04 . . . . 0.0 110.029 -170.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.3 m -95.13 -20.75 19.01 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 118.94 0.791 . . . . 0.0 109.938 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.83 -33.0 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.42 1.088 . . . . 0.0 111.036 177.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -93.71 -9.09 38.89 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -77.31 -66.41 0.83 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.47 128.98 30.07 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.434 -2.026 0 N-CA-C 105.723 -2.453 . . . . 0.0 105.723 -179.471 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -102.74 68.01 1.01 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -109.31 -0.03 19.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.9 m -88.76 -26.52 21.7 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.13 -49.88 68.2 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.76 -57.3 11.37 Favored 'General case' 0 N--CA 1.4 -2.949 0 C-N-CA 127.209 2.204 . . . . 0.0 114.327 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.432 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 14.9 p -82.64 -2.34 53.67 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -86.12 -31.33 21.92 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -64.07 -41.18 97.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.373 166.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.335 0.7 OUTLIER -61.16 -39.81 91.51 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 172.981 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -69.65 -46.22 66.64 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 120.072 1.305 . . . . 0.0 110.463 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.92 -5.18 59.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -127.29 -62.94 1.07 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.591 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -67.43 118.3 10.57 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.957 1.253 . . . . 0.0 112.02 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -147.27 99.29 3.13 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.94 -29.58 0.85 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -163.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -153.06 157.1 33.05 Favored Pre-proline 0 N--CA 1.434 -1.234 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.5 Cg_endo -74.41 157.5 45.2 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 123.188 2.592 . . . . 0.0 108.859 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.97 -63.22 1.31 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.62 177.0 18.64 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 103.072 -4.011 . . . . 0.0 103.072 161.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' HE ' ' HB1' ' A' ' 98' ' ' ALA . 77.8 mtp180 -109.53 68.28 0.67 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.06 173.9 14.87 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -170.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.82 -14.94 61.18 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.66 1.184 . . . . 0.0 113.093 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -32.29 53.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.112 0.565 . . . . 0.0 109.621 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.95 -41.47 61.97 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.268 0.1 OUTLIER -78.45 -26.68 46.25 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 118.451 -1.299 . . . . 0.0 114.042 -170.77 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 -34.14 59.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.161 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -69.81 -32.56 71.06 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.286 14.6 tt -79.97 -35.12 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.198 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -22.31 59.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.223 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.82 -29.75 29.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 119.433 1.015 . . . . 0.0 112.959 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.6 -41.95 20.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 118.758 0.708 . . . . 0.0 110.91 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -72.42 -38.59 68.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.329 1.052 . . . . 0.0 109.54 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.73 68.01 1.41 Allowed Glycine 0 CA--C 1.48 -2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.83 17.66 16.9 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 t -90.54 -10.33 43.9 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 p -126.55 102.21 26.39 Favored Pre-proline 0 N--CA 1.428 -1.547 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.84 161.72 93.66 Favored 'Cis proline' 0 N--CA 1.445 -1.372 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -21.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.446 ' HB3' HD13 ' A' ' 83' ' ' LEU . 35.4 m -61.08 120.42 10.24 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.239 1.015 . . . . 0.0 109.673 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -79.82 145.82 32.59 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -68.78 -42.93 76.72 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.239 1.015 . . . . 0.0 113.103 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -156.4 134.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -147.91 137.01 22.15 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.4 m -99.62 122.97 43.43 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.13 122.25 35.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.4 144.45 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.552 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 20.8 m-70 -134.04 131.65 39.1 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 124.067 0.947 . . . . 0.0 108.454 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.34 -151.42 21.7 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 104.317 -3.513 . . . . 0.0 104.317 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -89.83 152.88 21.06 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.62 -8.74 51.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -36.73 49.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 p -78.62 -28.47 45.64 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.798 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 53' ' ' ILE . 4.2 tp -66.14 -44.31 91.75 Favored 'Isoleucine or valine' 0 C--N 1.368 1.399 0 CA-C-N 120.324 1.42 . . . . 0.0 110.381 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.73 -33.67 76.15 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.49 1.116 . . . . 0.0 111.437 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 8.4 5.08 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.77 -19.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.1 m -75.76 -12.77 60.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.76 156.52 32.33 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -85.94 -13.4 47.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.224 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.83 -34.0 22.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 123.06 0.544 . . . . 0.0 109.875 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -124.23 45.02 2.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.75 141.26 3.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -89.84 154.29 47.73 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.83 138.37 28.65 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.771 2.314 . . . . 0.0 106.246 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -137.94 123.08 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 60.5 -109.81 0.42 Allowed 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 125.883 1.673 . . . . 0.0 112.451 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -134.77 95.18 3.29 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.348 1.2 p-10 69.83 16.55 7.77 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 129.253 3.021 . . . . 0.0 114.531 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.2 167.32 10.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -140.56 117.41 11.05 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.54 145.82 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -91.13 152.21 20.68 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.436 0.636 . . . . 0.0 111.653 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.76 -17.55 14.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 t -108.93 85.28 2.07 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 p -50.2 135.47 21.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 127.516 2.326 . . . . 0.0 113.093 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.31 161.67 16.37 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 4.2 mt-30 -82.11 136.03 35.23 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.94 100.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m -91.56 111.47 23.0 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.0 m -94.54 102.35 14.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.9 m -96.53 122.23 39.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -118.78 144.08 46.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.1 tp -77.29 104.44 7.8 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.791 1.236 . . . . 0.0 108.852 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -87.15 155.13 20.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.28 -76.13 0.51 Allowed Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.42 38.78 2.95 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 106.758 -2.537 . . . . 0.0 106.758 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 t -94.11 117.73 67.15 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.23 -12.29 5.87 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 CA-C-N 121.897 1.713 . . . . 0.0 108.041 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -103.89 161.78 21.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -75.01 145.7 31.73 Favored 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.028 1.818 . . . . 0.0 107.424 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -83.44 165.26 67.93 Favored 'Cis proline' 0 N--CA 1.439 -1.713 0 CA-C-N 122.997 2.106 . . . . 0.0 109.623 7.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.6 m -120.66 141.26 50.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.29 100.52 10.42 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.35 108.49 21.02 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -92.68 124.05 36.41 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.63 130.08 34.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.535 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.8 m -117.7 93.34 4.12 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' HB1' ' HE ' ' A' ' 21' ' ' ARG . . . -82.19 134.79 35.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 -170.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.71 -173.25 12.94 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -159.77 108.62 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.34 178.22 5.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.974 0.893 . . . . 0.0 109.371 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -69.6 140.81 53.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.576 1.95 . . . . 0.0 111.853 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.73 152.66 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.7 t -108.3 90.47 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.36 131.36 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.08 35.65 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.8 t -106.17 133.89 50.16 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.486 1.116 . . . . 0.0 110.689 -167.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.05 125.47 33.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 13.0 p30 66.87 15.78 10.22 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 127.632 2.373 . . . . 0.0 116.748 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.58 40.86 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.9 tp -135.22 123.28 15.49 Favored Pre-proline 0 N--CA 1.435 -1.222 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.13 107.77 2.1 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 106.038 -2.331 . . . . 0.0 106.038 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.96 -18.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 123.38 0.425 . . . . 0.0 110.927 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 46.3 t60 -146.27 177.03 9.32 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.39 129.62 6.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.38 150.62 36.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.2 59.53 0.68 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -171.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.0 t -65.45 -67.06 0.47 Allowed 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.789 1.236 . . . . 0.0 111.164 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 pt -100.78 1.34 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -99.78 4.69 45.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -167.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -104.42 -23.96 13.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 146.86 59.74 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 172.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 N--CA 1.435 -1.967 0 N-CA-C 106.437 -2.178 . . . . 0.0 106.437 178.433 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 . . . . . 0 CA--C 1.486 -1.497 0 CA-C-O 120.667 0.27 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -157.02 105.45 2.15 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 103.139 -2.912 . . . . 0.0 103.139 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.7 t30 111.67 -35.32 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 129.188 2.995 . . . . 0.0 105.57 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.531 1.133 . . . . 0.0 109.932 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -64.14 -54.23 37.01 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.297 1.439 . . . . 0.0 107.893 170.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.63 -41.75 95.96 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.04 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.447 0.3 OUTLIER -85.95 -3.72 58.99 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.47 -36.85 52.42 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 119.54 1.064 . . . . 0.0 108.911 163.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 10' ' ' LEU . 7.3 t80 -59.48 -37.23 77.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.099 0.96 . . . . 0.0 110.214 168.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -82.77 -18.69 39.78 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 119.236 0.926 . . . . 0.0 113.03 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 m -69.08 -51.83 34.72 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 12.9 pt20 -85.61 -12.35 51.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 94.7 m-70 -117.76 -51.57 2.47 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 119.08 0.855 . . . . 0.0 111.278 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -79.1 119.28 21.99 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.824 1.193 . . . . 0.0 109.58 -167.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -136.27 96.76 3.44 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 100.678 -3.823 . . . . 0.0 100.678 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.02 -45.52 2.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 128.449 2.7 . . . . 0.0 117.424 -168.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 141.94 14.17 Favored Pre-proline 0 N--CA 1.433 -1.324 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 164.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 34.4 Cg_exo -74.18 -179.07 4.36 Favored 'Trans proline' 0 N--CA 1.437 -1.827 0 C-N-CA 122.628 2.219 . . . . 0.0 114.125 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.1 -76.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.1 -174.96 13.9 Favored Glycine 0 CA--C 1.476 -2.348 1 N-CA-C 101.399 -4.68 . . . . 0.0 101.399 160.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -112.63 74.47 0.86 Allowed 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -137.81 178.13 7.35 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -72.09 -26.03 61.99 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 124.084 0.953 . . . . 0.0 111.641 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -81.52 -23.19 37.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 123.341 0.656 . . . . 0.0 109.65 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -73.64 -45.68 51.35 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 2.0 t -78.69 -23.99 45.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.768 -173.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.91 -40.4 79.13 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -68.29 -41.51 80.84 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 26' ' ' CYS . 16.3 tt -78.18 -32.06 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 117.85 0.296 . . . . 0.0 110.827 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 47.1 mtp -78.56 -27.46 45.81 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.2 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -67.34 -41.1 85.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -75.84 -46.65 29.27 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -32.67 72.8 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 123.289 0.636 . . . . 0.0 111.366 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.76 62.63 1.59 Allowed Glycine 0 CA--C 1.478 -2.258 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.4 mt -112.88 20.36 16.49 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 163.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -96.3 -8.01 33.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 p -125.05 99.84 34.02 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 167.22 81.11 Favored 'Cis proline' 0 N--CA 1.446 -1.322 0 N-CA-C 107.384 -1.814 . . . . 0.0 107.384 -22.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.47 121.91 11.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.344 1.058 . . . . 0.0 111.316 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.63 136.85 38.28 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.13 -39.46 63.29 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 123.781 0.676 . . . . 0.0 112.222 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -153.76 125.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -144.01 134.17 24.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.184 0.516 . . . . 0.0 109.886 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 78' ' ' VAL . 55.3 m -101.41 114.95 29.41 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.959 0.903 . . . . 0.0 110.339 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -90.58 119.84 31.16 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.72 150.94 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -141.88 139.52 32.63 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.6 -135.23 3.83 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.31 140.86 32.87 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -85.69 -19.6 30.65 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.31 96.46 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.546 1.938 . . . . 0.0 108.084 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -71.45 -37.55 71.38 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.97 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.3 mm -55.63 -55.75 15.77 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 119.631 1.105 . . . . 0.0 110.958 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -58.27 -42.97 87.69 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.525 1.13 . . . . 0.0 111.416 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 15.58 1.75 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mm -78.52 -23.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.14 -15.96 48.64 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.873 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.42 150.06 43.7 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -77.39 -19.61 55.91 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 124.51 1.124 . . . . 0.0 111.311 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -77.54 -40.16 43.54 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 123.159 0.584 . . . . 0.0 109.977 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -119.47 34.02 5.39 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.17 129.15 1.08 Allowed Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 106.661 -2.576 . . . . 0.0 106.661 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -99.27 159.24 30.62 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -71.85 131.17 17.9 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 122.911 2.407 . . . . 0.0 106.822 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -125.54 126.05 44.2 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 65.51 -102.49 0.08 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.26 1.424 . . . . 0.0 110.99 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.78 105.68 3.45 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 3.5 p30 75.58 1.9 3.68 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.503 3.121 . . . . 0.0 114.717 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.32 171.63 8.07 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -144.71 119.04 9.56 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -170.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 tt -98.1 138.71 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -77.34 165.39 24.52 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.615 0.721 . . . . 0.0 112.785 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.24 -27.74 11.36 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -106.1 81.12 1.59 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 p -41.1 120.11 1.3 Allowed 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.987 2.515 . . . . 0.0 113.816 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.37 158.24 16.48 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.1 mt-30 -79.92 149.49 30.86 Favored 'General case' 0 CA--C 1.472 -2.031 0 CA-C-N 113.912 -1.495 . . . . 0.0 107.384 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG21 HH22 ' A' ' 101' ' ' ARG . 0.9 OUTLIER -150.3 148.51 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -126.53 105.49 8.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 165.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -88.51 98.48 11.66 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.84 119.49 29.38 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -108.76 142.37 39.39 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.37 125.68 29.71 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.52 1.528 . . . . 0.0 107.459 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.39 47.06 2.57 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.71 -69.44 1.35 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.68 -31.06 5.69 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 p -85.55 145.4 41.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -79.57 -23.5 7.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.024 1.816 . . . . 0.0 108.773 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -99.61 165.84 13.95 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 117.979 -1.01 . . . . 0.0 108.994 -168.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -71.91 144.83 44.06 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.604 2.202 . . . . 0.0 108.141 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -86.22 165.17 52.32 Favored 'Cis proline' 0 N--CA 1.438 -1.756 0 CA-C-N 122.432 1.904 . . . . 0.0 107.914 9.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 63.9 m -132.57 126.49 32.91 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -89.8 136.75 32.85 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -124.67 122.6 37.96 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.88 115.15 27.82 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 126.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 m -117.58 103.55 10.17 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.56 130.49 35.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 120.819 0.342 . . . . 0.0 110.38 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.01 172.86 16.61 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.0 t80 -154.3 99.82 2.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.606 HH22 HG21 ' A' ' 78' ' ' VAL 0.256 0.0 OUTLIER -161.65 -179.78 7.54 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.623 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.13 133.14 47.64 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.124 0.969 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.9 142.77 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.5 t -104.66 110.09 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 165.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -106.65 152.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.03 49.19 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.2 t -109.72 131.28 55.21 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 124.745 1.278 . . . . 0.0 111.229 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -124.27 136.54 54.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 164.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.304 14.2 p30 64.15 21.56 12.6 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.9 16.87 57.41 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.29 0.9 OUTLIER -135.33 134.29 21.18 Favored Pre-proline 0 CA--C 1.487 -1.478 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.02 109.67 2.93 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 106.173 -2.28 . . . . 0.0 106.173 168.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -94.46 -12.16 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 118.11 0.413 . . . . 0.0 110.438 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -150.66 155.74 39.96 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -165.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.85 125.34 52.67 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -80.94 128.68 33.95 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -106.59 51.04 0.75 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 t -87.19 -47.23 9.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -32.12 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -87.57 -10.23 52.14 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.304 -163.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.08 -33.83 61.71 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.382 0.427 . . . . 0.0 110.221 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.39 128.52 84.15 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 N-CA-C 106.669 -2.089 . . . . 0.0 106.669 -174.325 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 . . . . . 0 CA--C 1.489 -1.383 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.27 90.19 1.79 Allowed 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 81.71 5.78 1.21 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 127.396 2.278 . . . . 0.0 108.002 -170.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 t -91.2 -30.63 16.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.29 -41.15 66.97 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.621 ' CE1' HD22 ' A' ' 111' ' ' LEU . 67.3 t80 -52.29 -60.65 2.96 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 127.311 2.244 . . . . 0.0 113.665 170.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.558 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 30.9 p -69.65 -20.96 63.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -78.71 -37.02 42.53 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 119.352 0.978 . . . . 0.0 110.155 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.83 -41.71 87.53 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.601 1.56 . . . . 0.0 109.625 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.397 0.3 OUTLIER -91.23 -4.46 55.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.849 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.3 m -75.9 -43.32 45.82 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 166.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.21 -40.54 86.45 Favored 'General case' 0 CA--C 1.488 -1.421 0 O-C-N 123.605 0.565 . . . . 0.0 111.201 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -106.75 -56.98 2.12 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.661 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 9.5 t80 -74.51 114.26 12.7 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.989 1.268 . . . . 0.0 110.438 -168.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.81 94.5 3.4 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.3 -33.54 0.65 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -163.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -151.34 155.99 34.77 Favored Pre-proline 0 N--CA 1.432 -1.326 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -73.3 156.87 50.51 Favored 'Trans proline' 0 N--CA 1.433 -2.073 0 C-N-CA 123.215 2.61 . . . . 0.0 110.049 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.46 -60.7 2.22 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 164.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.09 -177.01 14.66 Favored Glycine 0 CA--C 1.479 -2.19 1 N-CA-C 103.019 -4.032 . . . . 0.0 103.019 163.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -125.46 67.65 1.15 Allowed 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.64 179.12 6.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.43 -24.17 63.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -84.89 -21.28 29.78 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.75 -43.72 58.24 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.3 t -81.3 -21.66 39.13 Favored 'General case' 0 N--CA 1.412 -2.359 0 C-N-CA 117.936 -1.506 . . . . 0.0 112.543 -171.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.75 -34.34 66.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 121.879 -0.513 . . . . 0.0 110.417 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 t -70.58 -35.15 72.89 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.1 tt -86.28 -25.26 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-N 118.214 0.461 . . . . 0.0 110.943 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 mmt -77.31 -28.82 53.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 121.7 -0.625 . . . . 0.0 109.789 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.26 -38.51 71.89 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.054 0.942 . . . . 0.0 112.204 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -70.4 -51.63 28.22 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 124.531 1.132 . . . . 0.0 110.893 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -30.52 62.28 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.882 0.873 . . . . 0.0 109.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.65 60.49 2.97 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.57 16.17 22.39 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 t -100.04 0.47 40.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -129.79 104.08 17.25 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.96 156.48 99.41 Favored 'Cis proline' 0 N--CA 1.442 -1.508 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -20.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.428 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -66.81 116.38 7.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.132 0.973 . . . . 0.0 111.107 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -82.27 146.2 29.59 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -75.06 -29.75 60.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.901 1.28 . . . . 0.0 113.064 -170.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 128.25 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -141.9 137.15 31.13 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.7 m -103.78 129.95 51.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -103.97 115.24 30.09 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mm -80.3 149.81 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 C-N-CA 126.132 1.773 . . . . 0.0 107.029 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.53 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.4 m-70 -136.35 131.49 34.35 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.54 -145.84 9.9 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -105.08 148.24 27.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -84.37 -18.07 37.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -82.34 -21.82 35.81 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -72.81 -39.83 66.32 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 118.462 -0.78 . . . . 0.0 108.996 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.73 -50.98 75.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.579 1.151 . . . . 0.0 111.01 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.46 -39.36 90.58 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.783 0.833 . . . . 0.0 112.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.07 6.45 5.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.82 -30.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 m -82.73 -7.08 59.67 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -80.05 159.03 26.31 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -87.49 -4.59 58.99 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.548 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -80.69 -45.68 16.76 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -122.59 39.91 3.81 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -169.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.59 166.84 32.48 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.95 159.29 35.93 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -76.96 137.71 17.77 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.218 1.945 . . . . 0.0 107.671 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -124.83 139.09 54.16 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 66.29 -103.21 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.423 1.089 . . . . 0.0 110.227 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -163.36 113.75 1.37 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.374 0.8 OUTLIER 74.13 7.29 4.75 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 129.528 3.131 . . . . 0.0 114.376 177.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 HG12 ' A' ' 104' ' ' VAL . 2.5 mm? -107.51 164.7 11.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.31 105.49 3.35 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -166.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -85.64 138.58 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -79.88 166.17 21.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.412 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -112.92 -16.2 12.74 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -109.93 87.85 2.61 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.8 t -46.79 124.21 5.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.958 2.503 . . . . 0.0 112.238 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -104.66 155.98 18.39 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.421 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 4.6 mt-30 -80.28 152.08 29.23 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.36 151.19 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -168.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -132.47 102.61 5.79 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 165.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.1 m -86.38 102.08 13.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.02 128.17 37.76 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -113.96 147.42 38.59 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.5 tp -72.27 128.93 37.16 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -142.1 46.85 1.63 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.54 -65.57 0.9 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.28 -23.78 11.06 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -85.7 143.33 38.05 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -79.65 -22.98 7.42 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 122.049 1.833 . . . . 0.0 108.725 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -106.28 157.3 35.25 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.637 -168.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.44 150.34 36.2 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.441 2.094 . . . . 0.0 108.401 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -83.32 167.33 64.01 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 CA-C-N 122.423 1.901 . . . . 0.0 108.742 1.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.3 m -147.75 141.61 25.79 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -87.23 146.79 25.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.65 118.57 23.14 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -79.27 108.53 12.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.82 126.75 34.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -116.68 108.66 16.18 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.79 122.22 24.46 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.95 179.46 16.22 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.8 t80 -162.28 101.61 1.09 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.727 -3.434 . . . . 0.0 101.727 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 170.28 22.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.814 -171.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -75.01 130.71 39.82 Favored 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 124.225 1.01 . . . . 0.0 109.556 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.7 130.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HD12 ' A' ' 69' ' ' LEU . 59.2 t -102.89 80.45 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.3 m -95.88 142.59 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.96 39.15 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.5 m -100.04 141.81 32.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 124.298 0.999 . . . . 0.0 111.237 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.73 130.41 19.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 12.1 p30 62.59 18.25 10.34 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 128.153 2.581 . . . . 0.0 115.372 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.62 -10.67 61.04 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 6' ' ' TYR . 7.3 mt -102.76 144.04 27.81 Favored Pre-proline 0 CA--C 1.478 -1.797 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.83 114.66 4.09 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 N-CA-C 105.269 -2.627 . . . . 0.0 105.269 161.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 m -99.77 -15.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 69.1 t60 -149.03 175.41 11.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -169.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.62 129.12 2.59 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.26 135.81 39.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.926 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -96.18 37.44 1.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 t -95.75 -16.6 21.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 119' ' ' ILE . 1.7 pt -95.53 -21.39 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.246 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.28 -23.94 12.42 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.72 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -134.16 73.06 1.48 Allowed 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -69.83 129.35 91.17 Favored Pre-proline 0 N--CA 1.432 -1.349 0 CA-C-N 113.042 -1.89 . . . . 0.0 107.983 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.433 -2.037 0 N-CA-C 106.279 -2.239 . . . . 0.0 106.279 -176.612 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 CA--C 1.487 -1.458 0 CA-C-O 120.683 0.278 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.5 59.99 0.74 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.98 -24.1 19.34 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -91.44 -1.8 57.45 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.826 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -74.32 -43.76 55.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 4.6 t80 -58.76 -52.67 64.72 Favored 'General case' 0 N--CA 1.41 -2.449 0 C-N-CA 124.939 1.295 . . . . 0.0 111.633 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.51 2.5 t -89.94 12.77 16.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -82.19 -40.23 22.02 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.204 -1.56 . . . . 0.0 108.1 156.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.92 -41.64 83.13 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.366 1.066 . . . . 0.0 109.525 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 19.4 mt -83.84 -13.84 52.69 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -65.55 -53.21 45.24 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 120.411 1.46 . . . . 0.0 107.811 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 4.9 pt20 -81.64 -17.14 49.13 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 84.4 m-70 -110.97 -55.03 2.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 118.965 0.802 . . . . 0.0 111.151 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 43.7 t80 -76.34 122.27 24.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.683 1.128 . . . . 0.0 109.208 -168.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -136.21 97.58 3.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.59 -38.45 4.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -166.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 140.57 9.92 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 165.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 81.1 Cg_exo -73.18 175.83 9.98 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 122.794 2.33 . . . . 0.0 113.794 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -73.21 -73.05 0.22 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.3 -176.66 14.61 Favored Glycine 0 CA--C 1.478 -2.249 1 N-CA-C 102.428 -4.269 . . . . 0.0 102.428 163.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -115.16 72.81 0.81 Allowed 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -147.83 -179.34 6.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.1 -21.66 62.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.714 1.206 . . . . 0.0 112.867 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -88.79 -15.47 34.54 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.1 -39.04 34.71 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 m -68.79 -34.32 75.34 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -66.85 -44.93 79.73 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 123.551 0.741 . . . . 0.0 109.587 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -64.75 -35.68 81.86 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.384 0.673 . . . . 0.0 112.54 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.29 13.3 tt -83.72 -28.97 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.973 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 -23.55 43.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 117.657 -1.617 . . . . 0.0 111.724 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -79.4 -32.9 43.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 118.995 0.816 . . . . 0.0 111.042 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -47.97 15.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.327 0.651 . . . . 0.0 110.064 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -76.81 -32.04 57.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.68 66.7 1.53 Allowed Glycine 0 CA--C 1.476 -2.347 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.9 31.13 6.75 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 162.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.64 2.65 44.69 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 p -124.64 94.77 43.95 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.48 167.1 81.05 Favored 'Cis proline' 0 N--CA 1.443 -1.498 0 N-CA-C 106.981 -1.969 . . . . 0.0 106.981 -24.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.2 m -63.3 116.05 5.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 124.352 1.061 . . . . 0.0 111.115 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.26 134.62 42.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -71.15 -35.4 71.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 124.373 1.045 . . . . 0.0 112.295 -168.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.43 136.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -147.58 122.11 9.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.7 m -90.89 106.33 18.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -85.88 121.37 28.42 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.0 148.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.44 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -141.15 132.87 27.27 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.36 -137.32 4.59 Favored Glycine 0 CA--C 1.483 -1.935 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -113.43 144.62 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -85.45 -17.5 36.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.906 -169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -82.26 -26.65 32.99 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.8 p -77.67 -30.11 51.83 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.658 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.93 -46.34 96.67 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 CA-C-N 119.403 1.001 . . . . 0.0 110.627 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -60.42 -38.82 85.26 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.487 1.115 . . . . 0.0 111.828 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 9.85 5.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.705 1.202 . . . . 0.0 113.889 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.48 -17.92 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.6 t -66.37 -69.94 0.27 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.452 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -141.19 118.95 11.71 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' H ' ' H ' ' A' ' 60' ' ' LYS . 54.8 t30 -159.88 -3.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 164.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' A' ' 59' ' ' ASN 0.386 62.5 pttt 57.81 26.96 13.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.859 2.064 . . . . 0.0 111.748 -156.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -105.57 -14.74 15.19 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 167.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.77 139.98 10.87 Favored Glycine 0 CA--C 1.488 -1.636 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 160.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.39 153.88 43.23 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -69.68 143.27 50.68 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.824 2.349 . . . . 0.0 108.513 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -145.56 130.84 18.55 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 66.39 -103.59 0.08 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.884 1.273 . . . . 0.0 109.549 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -156.66 102.64 2.05 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER 90.93 -12.7 0.26 Allowed 'General case' 0 C--N 1.354 0.798 0 C-N-CA 128.323 2.649 . . . . 0.0 112.526 173.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.36 158.61 16.44 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -143.67 114.97 7.98 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -92.12 141.15 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -80.8 166.35 21.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.708 0.766 . . . . 0.0 110.823 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -120.6 -14.77 8.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.4 t -109.82 86.49 2.31 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.6 p -51.75 131.6 30.51 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 127.028 2.131 . . . . 0.0 112.293 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.16 156.69 19.56 Favored 'General case' 0 CA--C 1.476 -1.896 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 -171.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.61 142.03 40.84 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.9 143.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -166.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.6 m -131.01 108.39 9.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.61 -3.107 . . . . 0.0 102.61 168.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -82.69 101.38 10.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 71.8 m -88.91 111.42 22.07 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -109.5 137.69 46.97 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -76.3 112.33 12.68 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 125.172 1.389 . . . . 0.0 108.366 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -90.81 147.76 22.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 -74.24 0.21 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 28.68 4.31 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.6 p -92.09 127.19 50.35 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -80.44 -29.76 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 N-CA-C 107.735 -1.679 . . . . 0.0 107.735 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -99.35 148.07 34.17 Favored Pre-proline 0 N--CA 1.427 -1.591 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.476 -168.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -74.91 144.37 30.51 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.643 2.229 . . . . 0.0 107.0 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -81.74 160.98 79.84 Favored 'Cis proline' 0 CA--C 1.486 -1.884 0 CA-C-N 123.705 2.359 . . . . 0.0 109.982 10.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.9 m -146.94 146.97 30.3 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -167.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -102.52 154.19 19.35 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -137.66 125.12 22.0 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -104.68 130.69 52.68 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.24 138.96 31.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 122.826 0.451 . . . . 0.0 110.737 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.2 m -133.25 95.07 3.45 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.75 153.31 17.83 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.664 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.46 -163.63 12.14 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -149.59 97.9 2.69 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.5 ttt-85 -140.65 158.89 43.31 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -165.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.55 137.32 57.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.667 1.187 . . . . 0.0 109.679 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.46 136.87 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -104.02 91.37 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.86 138.77 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.65 123.63 32.04 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.5 t -103.25 125.93 50.16 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.589 1.181 . . . . 0.0 109.493 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -109.58 126.88 54.07 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 163.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.307 0.4 OUTLIER 31.95 68.55 0.13 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 128.622 2.769 . . . . 0.0 118.359 175.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.42 4.74 90.04 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.23 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.27 0.8 OUTLIER -138.2 135.32 18.34 Favored Pre-proline 0 CA--C 1.486 -1.486 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -63.53 132.95 37.59 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.817 2.345 . . . . 0.0 106.387 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.61 -18.57 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 20.7 t60 -151.92 179.8 8.14 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 -170.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 5.6 tp -151.83 132.47 13.97 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.56 123.57 27.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.89 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -103.56 24.02 11.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.788 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.6 p -81.71 -31.58 32.06 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 121.48 -0.763 . . . . 0.0 113.056 -167.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -32.58 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -84.21 -21.77 31.1 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.0 -165.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -81.54 -60.22 2.34 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -124.2 107.82 30.05 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo . . . . . 0 N--CA 1.435 -1.967 0 N-CA-C 105.949 -2.366 . . . . 0.0 105.949 172.195 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 CA--C 1.487 -1.443 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.31 60.69 0.61 Allowed 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.62 -23.36 19.03 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -88.78 0.25 56.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.761 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -68.14 -52.23 37.02 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -60.87 -50.72 72.27 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 117.333 -1.318 . . . . 0.0 113.164 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.527 2.3 t -90.82 11.36 22.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -81.69 -38.4 25.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 120.087 -1.633 . . . . 0.0 108.381 155.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.02 0.928 . . . . 0.0 109.686 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.66 -12.55 53.69 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.5 m -65.55 -52.22 54.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 120.68 1.582 . . . . 0.0 108.074 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.9 pt20 -79.31 -28.54 42.18 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.567 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 87.0 m-70 -100.1 -53.98 3.0 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 119.044 0.838 . . . . 0.0 110.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 48.5 t80 -73.66 134.62 43.65 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 120.296 1.407 . . . . 0.0 111.481 -166.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.62 99.92 2.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.84 -50.93 1.73 Allowed 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 128.061 2.544 . . . . 0.0 117.843 -166.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -142.69 146.59 38.82 Favored Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.7 Cg_endo -81.38 171.75 13.34 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 123.086 2.524 . . . . 0.0 108.662 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.08 -77.97 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.59 -178.88 15.59 Favored Glycine 0 CA--C 1.475 -2.427 1 N-CA-C 101.464 -4.654 . . . . 0.0 101.464 159.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.15 74.67 0.89 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -136.06 173.1 12.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -74.06 -21.27 60.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.886 0.874 . . . . 0.0 113.23 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -14.18 29.92 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.31 -41.71 63.22 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.257 0.6 OUTLIER -77.06 -25.42 52.39 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 113.054 -174.798 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.81 -39.51 73.03 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 m -70.19 -33.06 71.26 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.7 tt -85.28 -29.74 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 118.644 0.656 . . . . 0.0 110.369 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mmt -71.78 -34.76 69.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -67.04 -45.94 75.92 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.265 1.026 . . . . 0.0 113.389 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -83.37 -32.52 26.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -74.52 -38.16 62.88 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.59 68.96 1.4 Allowed Glycine 0 CA--C 1.475 -2.451 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.96 29.17 5.24 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 163.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -81.91 -13.48 57.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 111.721 -2.491 . . . . 0.0 109.963 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -119.83 106.99 40.82 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.974 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 162.89 90.92 Favored 'Cis proline' 0 N--CA 1.444 -1.399 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 -22.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB3' HD13 ' A' ' 83' ' ' LEU . 70.2 m -61.3 121.97 13.93 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.139 0.976 . . . . 0.0 110.631 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -72.79 134.65 45.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -72.44 -39.11 68.07 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 123.631 0.582 . . . . 0.0 111.555 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.95 129.08 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 172.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -144.9 120.56 10.47 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 m -96.1 116.64 29.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.5 127.27 34.85 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 53' ' ' ILE . 9.8 mm -102.35 147.4 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.464 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -170.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.509 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -138.06 133.45 33.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.18 -125.36 1.41 Allowed Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -122.5 147.28 46.55 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 14' ' ' TYR . 21.7 mtpt -86.26 -3.04 58.9 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -43.05 65.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.657 1.583 . . . . 0.0 107.089 172.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -80.52 -25.27 38.8 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.681 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 112' ' ' PRO . 18.0 mm -59.78 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 CA-C-N 119.079 0.854 . . . . 0.0 110.195 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -55.77 -39.35 71.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 126.02 1.728 . . . . 0.0 112.405 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.74 11.48 2.58 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.67 -31.9 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.7 m -79.0 -23.1 44.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.63 156.1 17.86 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -86.57 87.6 7.48 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.951 0.882 . . . . 0.0 109.306 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -141.06 -46.51 0.39 Allowed 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.73 58.52 1.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.43 151.88 9.54 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -107.42 157.83 34.68 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 140.0 32.18 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.766 2.31 . . . . 0.0 106.248 160.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -139.82 118.1 12.04 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -103.91 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 108.989 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -151.87 102.76 2.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 1.9 p-10 66.24 18.1 10.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 129.516 3.126 . . . . 0.0 114.582 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.0 mt -107.35 158.73 16.93 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 100.407 -3.923 . . . . 0.0 100.407 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -146.11 119.29 8.88 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.104 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.53 145.51 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 92.5 p -93.71 149.45 21.22 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -102.46 -8.31 21.2 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.7 t -106.69 85.75 2.21 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.0 m -57.35 126.43 27.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 125.566 1.546 . . . . 0.0 110.501 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.71 159.69 15.41 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.403 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 9.2 mm-40 -72.8 135.88 45.32 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 170.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.73 147.92 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -165.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.3 m -134.95 107.22 7.22 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 103.474 -2.788 . . . . 0.0 103.474 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.4 m -86.43 105.62 16.88 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.1 m -99.42 116.77 32.33 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -116.97 130.31 56.61 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 39' ' ' CYS . 22.3 tp -74.02 118.03 16.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 124.916 1.286 . . . . 0.0 108.716 -176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -90.35 115.5 27.59 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 158.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.76 94.03 1.78 Allowed Glycine 0 CA--C 1.482 -2.011 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -167.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.89 49.86 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 166.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 t -163.51 110.74 0.98 Allowed Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -80.08 -16.31 11.2 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 110.411 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.03 168.08 9.54 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.44 145.54 30.09 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.06 1.84 . . . . 0.0 108.13 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -81.76 163.81 76.62 Favored 'Cis proline' 0 N--CA 1.436 -1.872 0 CA-C-N 122.228 1.831 . . . . 0.0 107.923 -4.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -106.09 174.47 5.87 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -133.58 115.35 14.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -104.17 149.47 25.23 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -100.97 147.35 26.27 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 160.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.11 126.41 52.78 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -107.63 108.46 19.74 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.88 141.8 34.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.2 -175.46 30.17 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.4 t80 -157.69 99.68 1.73 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.905 -2.998 . . . . 0.0 102.905 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -161.61 173.78 14.27 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.81 0.814 . . . . 0.0 109.846 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -78.3 151.38 33.0 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.406 1.482 . . . . 0.0 111.148 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.96 159.18 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.12 96.26 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 165.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.79 132.35 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.51 122.58 32.14 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.42 142.29 30.22 Favored 'General case' 0 CA--C 1.488 -1.43 0 O-C-N 124.603 1.189 . . . . 0.0 110.153 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.09 129.42 18.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 167.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.337 11.2 p30 67.54 15.24 9.77 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 128.1 2.56 . . . . 0.0 115.287 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.22 62.08 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 0.9 OUTLIER -113.92 138.41 22.78 Favored Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 53' ' ' ILE . 81.8 Cg_exo -70.34 111.55 2.95 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 N-CA-C 107.048 -1.943 . . . . 0.0 107.048 166.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.46 -14.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 119.173 0.897 . . . . 0.0 110.077 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 38.6 t60 -155.06 178.52 10.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 8.9 tp -158.9 133.57 8.07 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.66 131.12 34.24 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -106.06 41.06 1.47 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -97.01 -26.26 15.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -171.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -79.22 -33.99 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.706 0 C-N-CA 123.935 0.894 . . . . 0.0 109.215 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.39 19.17 21.03 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -40.05 68.28 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 124.9 1.28 . . . . 0.0 108.593 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -72.06 137.53 81.96 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 N--CA 1.431 -2.177 0 N-CA-C 104.698 -2.847 . . . . 0.0 104.698 172.336 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 . . . . . 0 CA--C 1.486 -1.51 0 CA-C-O 120.696 0.284 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -123.19 49.15 1.71 Allowed 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -107.69 -5.3 17.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.4 m -90.21 -33.13 16.3 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -69.29 -35.46 76.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.199 1.0 . . . . 0.0 111.1 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' A' ' 10' ' ' LEU . 52.7 t80 -74.29 -46.09 43.43 Favored 'General case' 0 N--CA 1.398 -3.053 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 33.7 p -73.72 -17.87 61.06 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -84.42 -35.89 22.76 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 119.514 1.052 . . . . 0.0 109.42 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -56.69 -45.79 81.58 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.531 1.532 . . . . 0.0 108.519 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -65.82 -29.91 70.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 126.854 2.062 . . . . 0.0 115.109 178.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.7 m -66.93 -52.58 41.3 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -85.22 -5.05 59.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -172.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -123.64 -55.59 1.72 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.762 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 13.6 t80 -71.29 123.86 23.24 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 120.583 1.538 . . . . 0.0 111.919 -169.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.88 97.11 3.12 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.19 -41.51 8.3 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -167.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -158.43 140.09 9.87 Favored Pre-proline 0 N--CA 1.434 -1.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 163.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -74.44 -178.86 4.28 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.651 2.234 . . . . 0.0 114.168 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -71.92 -64.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.21 -176.39 16.35 Favored Glycine 0 CA--C 1.476 -2.382 1 N-CA-C 102.343 -4.303 . . . . 0.0 102.343 164.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -109.38 75.53 0.95 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -145.5 176.42 9.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.17 -22.75 62.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 124.327 1.051 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -89.27 -17.21 29.45 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.08 -40.86 52.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.2 m -70.3 -33.28 71.35 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -68.06 -43.58 78.29 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.939 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.8 p -76.06 -23.88 55.09 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.274 12.5 tt -85.87 -28.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 119.081 0.855 . . . . 0.0 110.06 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.4 mmm -79.1 -24.05 43.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.621 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.505 HH12 ' HA ' ' A' ' 91' ' ' PRO . 14.7 tpt180 -74.53 -49.33 22.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 122.605 0.362 . . . . 0.0 111.694 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -86.44 -32.6 20.77 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.273 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -76.79 -33.84 58.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.89 71.23 1.29 Allowed Glycine 0 CA--C 1.478 -2.238 0 C-N-CA 124.987 1.279 . . . . 0.0 112.028 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.331 2.5 mm? -108.08 0.02 21.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 167.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -80.31 -3.78 50.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.005 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -129.42 108.16 17.51 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.66 153.77 98.76 Favored 'Cis proline' 0 N--CA 1.443 -1.447 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 -22.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.2 m -62.77 123.27 18.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 125.483 1.513 . . . . 0.0 112.197 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -74.12 139.62 44.69 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.8 -41.52 44.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.644 0.778 . . . . 0.0 111.899 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 tt -154.6 134.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -154.52 167.23 30.78 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.0 m -128.89 127.27 41.48 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.91 127.53 39.72 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.273 4.9 mm -94.35 146.03 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -139.8 127.77 22.19 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.06 -151.58 18.84 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.23 144.37 25.92 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.24 -22.0 45.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -70.54 -33.98 71.74 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 124.441 1.096 . . . . 0.0 110.532 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 p -76.68 -31.39 57.24 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 116.906 -1.521 . . . . 0.0 111.265 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -48.71 84.36 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-N 119.739 1.154 . . . . 0.0 110.996 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.29 -36.6 84.58 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.34 0.656 . . . . 0.0 111.657 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.78 4.91 10.56 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mm -75.94 -24.92 16.82 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.9 m -73.72 -24.59 59.94 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 122.124 -0.36 . . . . 0.0 111.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -79.68 164.8 23.46 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -93.2 0.0 56.99 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.429 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.57 -33.11 28.17 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 122.899 0.48 . . . . 0.0 110.848 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -134.73 7.31 3.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.08 -162.91 10.61 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 104.831 -3.307 . . . . 0.0 104.831 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -159.59 158.25 27.32 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -74.02 135.36 20.97 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.761 2.307 . . . . 0.0 107.162 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -123.07 104.61 9.32 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 69.85 -97.13 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.846 1.659 . . . . 0.0 110.528 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.45 106.51 3.13 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.358 4.5 p30 75.76 2.81 3.77 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 129.725 3.21 . . . . 0.0 114.594 169.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 mt -104.43 158.91 16.15 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -142.97 116.15 8.94 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 tt -89.32 142.14 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -81.01 161.41 24.25 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.779 0.8 . . . . 0.0 112.454 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -110.2 -17.95 13.41 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.6 t -110.06 87.87 2.62 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -52.03 129.67 27.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.671 1.989 . . . . 0.0 111.608 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -106.02 157.37 17.56 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.33 131.99 40.66 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.94 126.43 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 -165.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.7 m -119.21 110.18 16.72 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -83.13 105.17 13.89 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.81 114.63 23.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.81 136.46 53.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.44 127.67 32.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.42 1.088 . . . . 0.0 109.069 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -119.47 171.69 8.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.61 -94.24 1.02 Allowed Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 105.939 -2.865 . . . . 0.0 105.939 -173.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.6 -6.97 1.26 Allowed Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 p -79.0 132.92 62.27 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -91.28 -9.22 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.922 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -109.76 155.58 41.24 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.95 146.19 29.12 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.369 2.046 . . . . 0.0 107.397 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.7 Cg_endo -85.99 163.4 56.19 Favored 'Cis proline' 0 N--CA 1.436 -1.899 0 CA-C-N 122.888 2.067 . . . . 0.0 108.521 12.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.8 m -150.99 126.24 9.97 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -85.81 129.23 34.89 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.93 133.24 56.17 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -111.72 137.51 49.52 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.74 140.55 31.17 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.157 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.7 m -123.34 110.3 15.0 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.62 155.85 23.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.549 0.69 . . . . 0.0 109.9 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.96 176.1 37.58 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 106.914 -2.474 . . . . 0.0 106.914 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -150.11 91.63 1.79 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 101.932 -3.358 . . . . 0.0 101.932 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -146.73 169.21 19.52 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -168.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.03 145.44 48.29 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.427 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.99 138.39 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.04 87.78 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.82 132.88 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.82 125.29 40.28 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 38.9 m -109.03 153.79 23.12 Favored 'General case' 0 CA--C 1.485 -1.533 0 O-C-N 124.414 1.071 . . . . 0.0 110.985 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.33 129.73 23.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 171.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 9.4 p30 68.16 12.44 8.77 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 13.15 60.1 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.64 144.89 52.69 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 67.1 Cg_exo -68.84 150.94 74.15 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 121.858 1.705 . . . . 0.0 110.694 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.57 -14.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 51.1 t60 -158.07 174.91 14.5 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -169.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.1 128.68 6.28 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.35 137.2 38.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.67 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -105.41 42.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -91.92 -33.77 14.76 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 -29.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.896 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.298 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -109.64 32.72 4.82 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -169.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -86.08 -44.76 12.01 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 144.94 40.71 Favored Pre-proline 0 N--CA 1.427 -1.579 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.433 -2.076 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 -177.924 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.488 -1.437 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.34 62.96 0.61 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -100.17 -22.78 15.04 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -89.52 -7.43 54.96 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.924 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -72.75 -42.92 63.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -59.23 -48.23 82.4 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.409 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.465 2.9 t -89.86 10.75 22.53 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -78.16 -42.07 32.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.193 -1.567 . . . . 0.0 107.34 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.14 -35.18 76.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.037 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 14' ' ' TYR . 21.8 mt -86.15 -15.42 41.09 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 119.444 1.02 . . . . 0.0 113.399 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -65.8 -49.0 69.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 119.827 1.194 . . . . 0.0 108.703 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.59 -42.66 67.48 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -99.45 -51.42 3.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.695 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HD22 ' A' ' 10' ' ' LEU . 23.2 t80 -77.07 116.39 17.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 119.278 0.945 . . . . 0.0 110.7 -167.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.12 100.35 4.69 Favored 'General case' 0 N--CA 1.421 -1.921 1 N-CA-C 98.538 -4.615 . . . . 0.0 98.538 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.35 -33.5 9.09 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -165.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -154.79 144.46 15.4 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 168.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 10.7 Cg_endo -74.41 154.72 45.71 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 122.979 2.453 . . . . 0.0 109.638 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.88 -60.84 2.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.05 178.28 16.95 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 103.304 -3.919 . . . . 0.0 103.304 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -123.74 57.91 1.17 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.34 177.75 8.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -172.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.71 -18.96 62.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.591 1.156 . . . . 0.0 113.736 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -82.5 -28.03 31.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -41.31 63.32 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -81.2 -25.21 36.91 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.561 -171.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.87 -45.37 82.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -64.94 -41.13 95.78 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 26' ' ' CYS . 10.3 tt -79.51 -29.58 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.141 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -26.22 58.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.468 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -77.53 -34.18 54.01 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 117.962 0.346 . . . . 0.0 110.866 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -73.75 -52.63 12.56 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.332 0.653 . . . . 0.0 111.639 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.01 -36.38 79.88 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 123.269 0.628 . . . . 0.0 111.561 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.05 71.65 1.31 Allowed Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.321 3.4 mm? -97.99 -8.87 27.09 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 164.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -81.0 1.64 30.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.623 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 p -119.22 98.82 50.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.741 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.3 163.16 90.53 Favored 'Cis proline' 0 N--CA 1.443 -1.493 0 N-CA-C 106.595 -2.117 . . . . 0.0 106.595 -27.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.3 m -64.85 121.82 15.5 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -166.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -70.51 140.68 51.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 126.622 1.969 . . . . 0.0 107.661 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -70.87 -46.97 61.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 123.725 0.81 . . . . 0.0 113.14 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 tt -149.64 129.61 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -154.84 137.44 15.15 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.2 m -101.5 137.02 40.38 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.953 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -100.43 119.96 39.27 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 167.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.92 150.31 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.571 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -142.59 139.74 31.45 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.286 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.8 -136.34 5.12 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -95.3 140.06 30.72 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.34 -21.01 29.09 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -70.2 -36.38 74.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.368 1.867 . . . . 0.0 108.874 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 49' ' ' ASN . 39.5 m -72.5 -38.41 68.12 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.776 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.7 -48.47 85.83 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 CA-C-N 118.904 0.775 . . . . 0.0 111.402 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.06 -42.1 98.83 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.147 0.579 . . . . 0.0 111.473 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.24 7.59 5.0 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 72' ' ' SER . 24.0 mm -74.74 -32.33 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.2 t -71.88 -34.28 69.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.149 0.281 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.09 160.21 33.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.451 0.643 . . . . 0.0 110.032 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -75.96 -28.91 58.09 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.823 0.849 . . . . 0.0 109.389 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -77.12 124.65 28.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 44.2 t30 73.64 36.14 0.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 128.058 2.543 . . . . 0.0 112.679 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 148.88 5.58 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -98.36 152.09 37.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.45 131.35 18.73 Favored 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 122.858 2.372 . . . . 0.0 106.272 162.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -121.56 103.05 8.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 67' ' ' GLU 0.338 14.5 ptp180 49.47 -107.33 0.24 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 128.077 2.551 . . . . 0.0 115.264 177.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 34.2 tt0 -103.74 77.53 1.48 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.516 1.126 . . . . 0.0 108.058 -167.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.317 1.6 p-10 62.25 26.65 15.98 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.45 3.1 . . . . 0.0 114.713 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.71 164.41 12.26 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -142.94 122.45 13.2 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.3 138.14 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 56' ' ' ILE . 82.8 p -82.81 153.98 24.94 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 121.818 0.818 . . . . 0.0 112.655 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 -27.23 14.95 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.955 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 p -105.77 84.02 2.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.6 p -51.17 130.84 27.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.9 1.68 . . . . 0.0 111.152 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.59 163.92 12.66 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -165.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.42 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 10.7 mt-30 -75.68 141.94 42.62 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.38 145.37 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -169.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.0 m -134.8 103.92 5.81 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.2 m -87.34 106.37 17.89 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.0 m -99.74 128.25 45.85 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -118.8 138.41 52.72 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.69 116.73 14.63 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 125.703 1.601 . . . . 0.0 110.022 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.57 110.14 18.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.26 93.17 1.81 Allowed Glycine 0 CA--C 1.484 -1.858 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.08 -11.49 49.13 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 104.888 -3.285 . . . . 0.0 104.888 161.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -165.19 132.93 2.41 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -78.15 -25.38 7.3 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.319 2.012 . . . . 0.0 109.328 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -89.58 160.27 42.12 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.26 147.13 32.59 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.282 1.988 . . . . 0.0 108.132 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -82.98 165.69 69.64 Favored 'Cis proline' 0 N--CA 1.439 -1.7 0 CA-C-N 122.879 2.064 . . . . 0.0 108.932 5.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.3 m -145.15 125.96 14.34 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -169.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.75 131.75 36.0 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.74 120.63 42.17 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -88.32 117.93 27.57 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 137.69 35.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.883 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -120.32 106.66 12.09 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 170.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.38 149.95 30.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.108 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.04 -175.14 34.62 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.7 t80 -150.86 97.87 2.53 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.241 -3.615 . . . . 0.0 101.241 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -144.25 150.81 38.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -159.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -83.24 144.98 29.39 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.752 1.221 . . . . 0.0 109.165 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.98 153.37 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.46 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 162.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.4 m -91.29 134.97 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.36 133.4 36.65 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.33 134.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.168 0.918 . . . . 0.0 111.317 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -127.44 136.59 52.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.328 5.0 p30 73.54 4.41 4.77 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.891 2.077 . . . . 0.0 116.582 168.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.78 19.69 28.56 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.254 0.7 OUTLIER -136.86 133.09 18.61 Favored Pre-proline 0 CA--C 1.49 -1.357 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.98 113.47 3.8 Favored 'Trans proline' 0 N--CA 1.435 -1.944 0 N-CA-C 106.482 -2.161 . . . . 0.0 106.482 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -96.53 -7.38 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 13.1 t-80 -159.0 177.5 11.07 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 -168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -167.0 133.59 2.32 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 102.822 -3.029 . . . . 0.0 102.822 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -78.26 138.03 38.41 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.071 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -101.3 41.76 1.17 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -98.48 -32.22 11.58 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -72.27 -36.91 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.771 170.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.39 34.1 3.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -97.18 -27.64 14.46 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 133.26 79.74 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 N--CA 1.434 -1.98 0 N-CA-C 105.287 -2.62 . . . . 0.0 105.287 177.901 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 CA--C 1.484 -1.57 0 CA-C-O 120.594 0.235 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -120.4 47.62 1.74 Allowed 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -109.61 -3.64 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 t -91.53 -27.52 18.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -68.4 -50.56 52.03 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.367 1.067 . . . . 0.0 111.836 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.45 ' HB2' HD23 ' A' ' 111' ' ' LEU 0.269 76.9 t80 -53.07 -53.76 45.51 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.697 169.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -69.16 -15.95 63.52 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -83.77 -36.36 23.65 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.912 1.233 . . . . 0.0 110.267 173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.732 1.213 . . . . 0.0 109.915 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -79.53 -26.94 41.36 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.83 2.052 . . . . 0.0 112.239 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -68.4 -52.48 32.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 40.3 mt-30 -68.53 -42.27 78.7 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 85.8 m-70 -105.38 -41.67 5.45 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.343 -165.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 14.6 t80 -76.02 120.16 20.96 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 120.805 1.639 . . . . 0.0 111.731 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -140.8 99.72 3.68 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 100.82 -3.77 . . . . 0.0 100.82 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -40.92 11.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.423 2.289 . . . . 0.0 117.115 -167.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.42 144.89 14.55 Favored Pre-proline 0 N--CA 1.433 -1.297 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 83.0 Cg_exo -76.65 176.84 9.58 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.654 1.569 . . . . 0.0 113.787 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -73.93 -60.2 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 165.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -151.07 -175.01 22.54 Favored Glycine 0 CA--C 1.477 -2.287 0 N-CA-C 103.322 -3.911 . . . . 0.0 103.322 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.03 74.4 0.86 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.08 170.89 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.75 -22.21 61.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -169.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -79.75 -26.57 40.68 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.124 0.42 . . . . 0.0 110.214 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.89 -43.71 62.15 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.5 OUTLIER -80.57 -25.36 38.6 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 119.02 -1.072 . . . . 0.0 113.061 -169.794 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.19 -36.79 69.31 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.307 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -69.86 -35.19 74.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 26' ' ' CYS . 15.2 tt -83.15 -29.22 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.332 0 CA-C-N 118.338 0.517 . . . . 0.0 110.096 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.4 mmt -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.328 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.4 tpp180 -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.013 0.925 . . . . 0.0 111.844 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -74.04 -49.05 25.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 123.865 0.866 . . . . 0.0 110.796 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -70.82 -37.89 73.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.199 1.0 . . . . 0.0 109.99 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.98 70.16 1.26 Allowed Glycine 0 CA--C 1.481 -2.061 0 C-N-CA 124.275 0.941 . . . . 0.0 111.266 168.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.361 2.5 mm? -104.52 -2.41 25.27 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 163.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.1 t -78.32 -8.57 58.56 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.086 -159.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -131.92 107.37 13.94 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 117.925 -1.036 . . . . 0.0 108.724 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.88 156.66 95.74 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.162 -1.899 . . . . 0.0 107.162 -19.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.1 m -57.8 122.91 14.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.616 1.567 . . . . 0.0 110.454 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 135.87 45.63 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -72.73 -38.89 67.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.632 0.773 . . . . 0.0 112.385 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -146.89 132.51 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.57 128.69 12.75 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.381 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 m -101.66 116.18 32.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.656 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.62 122.33 30.38 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.94 148.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.427 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -138.35 128.6 25.89 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.996 1.318 . . . . 0.0 108.42 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.01 -130.83 2.1 Favored Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -119.64 144.35 47.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.27 -2.75 58.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.031 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.02 -30.08 34.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -75.11 -31.31 61.11 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.127 0.971 . . . . 0.0 110.342 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.12 -58.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 124.089 0.956 . . . . 0.0 110.245 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.14 -38.19 73.14 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.44 -25.33 59.49 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 126.102 1.761 . . . . 0.0 113.83 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.55 -39.98 65.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 C-N-CA 125.484 1.513 . . . . 0.0 111.11 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.27 -21.06 29.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.58 53.12 0.7 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.943 0.401 . . . . 0.0 111.288 -171.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 79.44 -35.97 0.16 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.775 2.43 . . . . 0.0 115.023 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.59 154.98 38.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 p30 26.96 55.7 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 129.377 3.071 . . . . 0.0 116.038 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.57 146.5 4.93 Favored Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -128.98 164.75 36.79 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.05 137.47 19.5 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.063 1.842 . . . . 0.0 107.816 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -106.74 161.03 15.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.214 -2.514 . . . . 0.0 104.214 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -70.81 150.99 45.28 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.285 0.634 . . . . 0.0 111.693 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 69.14 55.43 0.41 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.355 2.662 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.273 3.0 p-10 51.65 45.49 28.03 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.473 2.709 . . . . 0.0 114.095 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 106' ' ' ALA . 9.2 mt -124.89 178.69 5.36 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 -171.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -151.17 112.41 4.35 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -171.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.55 150.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.4 p -99.74 161.46 13.6 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.18 18.41 5.98 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 p -117.23 100.16 7.51 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.762 -3.792 . . . . 0.0 100.762 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 120.12 11.99 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.192 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -102.76 158.4 16.28 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.06 140.86 36.32 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.34 144.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -132.8 102.3 5.6 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 170.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -84.19 103.26 13.24 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 35.1 m -94.61 116.8 29.2 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -105.11 140.61 38.03 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.91 136.57 33.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -134.04 174.6 10.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.73 -101.39 0.72 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 106.092 -2.803 . . . . 0.0 106.092 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.15 -26.97 0.17 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.1 m -81.82 130.69 59.88 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -81.11 -25.37 4.06 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 121.968 1.779 . . . . 0.0 108.138 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -89.76 165.29 25.57 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.79 144.6 35.24 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 N-CA-C 107.584 -1.737 . . . . 0.0 107.584 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HA ' HH12 ' A' ' 31' ' ' ARG . 48.7 Cg_endo -86.8 162.47 51.43 Favored 'Cis proline' 0 N--CA 1.435 -1.928 0 CA-C-N 122.457 1.913 . . . . 0.0 109.257 19.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.523 ' H ' HH22 ' A' ' 31' ' ' ARG . 46.2 m -119.07 158.09 26.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -172.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -135.79 93.09 2.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.05 123.62 34.08 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.932 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -102.05 125.57 48.77 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 171.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.86 135.87 33.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.181 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.0 m -123.51 113.51 18.83 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.93 145.52 29.35 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.241 0.543 . . . . 0.0 110.024 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.7 168.46 30.5 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 105.13 -3.188 . . . . 0.0 105.13 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.02 103.04 3.7 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.84 174.88 14.32 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.051 -171.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.55 135.48 50.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 124.536 1.134 . . . . 0.0 110.233 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.91 138.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.18 110.76 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 6.5 m -107.71 151.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -96.83 140.3 31.6 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 166.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 1.5 t -119.61 146.42 45.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 124.899 1.374 . . . . 0.0 111.41 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.42 122.14 11.88 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.35 6.2 p30 72.32 3.13 4.58 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 127.917 2.487 . . . . 0.0 115.838 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.2 38.18 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 108.426 -1.869 . . . . 0.0 108.426 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 6' ' ' TYR . 1.4 mp -126.47 117.12 23.04 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 9.9 Cg_endo -77.19 120.97 5.54 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 CA-C-N 122.594 1.962 . . . . 0.0 107.9 -173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.97 -12.71 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 124.171 0.92 . . . . 0.0 111.712 -169.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 76.9 t60 -152.26 170.0 21.1 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -166.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 6.7 tp -140.44 136.14 32.73 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -84.12 134.16 34.6 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -110.59 40.23 2.03 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -99.25 -29.42 12.83 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -33.21 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.97 171.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -105.29 47.88 0.86 Allowed 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -128.37 -53.37 1.27 Allowed 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -127.38 115.17 21.4 Favored Pre-proline 0 N--CA 1.428 -1.551 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 N--CA 1.434 -2.019 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 -174.268 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 CA--C 1.486 -1.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -115.01 53.17 0.82 Allowed 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -113.39 2.56 15.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -90.5 -30.56 17.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -62.38 -51.2 68.53 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.463 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 45.5 t80 -53.9 -62.54 1.59 Allowed 'General case' 0 N--CA 1.404 -2.757 0 C-N-CA 127.103 2.161 . . . . 0.0 114.483 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.605 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 24.2 p -69.56 -16.39 63.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -81.81 -37.91 26.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 120.074 1.306 . . . . 0.0 110.02 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.85 -41.3 82.1 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.105 1.362 . . . . 0.0 109.902 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.402 0.0 OUTLIER -92.95 -6.37 48.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 118.084 0.402 . . . . 0.0 111.245 -173.25 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.7 m -73.47 -48.97 29.29 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.52 -1.363 . . . . 0.0 107.341 166.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -65.94 -41.9 90.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 126.291 1.836 . . . . 0.0 111.958 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -106.15 -50.28 3.2 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.562 -171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.511 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 53.9 t80 -77.88 120.98 23.52 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.585 1.538 . . . . 0.0 110.338 -168.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -139.25 94.25 2.78 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -35.5 -53.53 0.67 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 128.583 2.753 . . . . 0.0 118.338 -166.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -147.96 147.36 26.48 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 168.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -75.46 175.34 11.41 Favored 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 122.214 1.942 . . . . 0.0 113.322 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -76.05 -69.41 0.5 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.21 -176.89 14.6 Favored Glycine 0 CA--C 1.478 -2.252 1 N-CA-C 102.873 -4.091 . . . . 0.0 102.873 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -121.56 69.35 0.92 Allowed 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.63 174.65 11.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.42 -19.93 62.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.81 1.244 . . . . 0.0 113.3 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -81.31 -27.33 35.08 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.92 -34.62 51.26 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -34.03 54.93 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 123.327 0.651 . . . . 0.0 109.3 -170.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.02 -38.71 66.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.56 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -69.67 -30.82 68.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.267 14.2 tt -85.99 -27.38 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-N 118.504 0.593 . . . . 0.0 110.762 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.66 -29.41 64.58 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 118.628 -1.229 . . . . 0.0 110.066 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.64 HH22 ' H ' ' A' ' 92' ' ' CYS . 40.9 ttm-85 -81.43 -42.16 20.79 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -86.79 -28.0 23.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.44 -171.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -75.86 -36.08 59.68 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.63 72.0 1.23 Allowed Glycine 0 CA--C 1.473 -2.55 0 C-N-CA 125.164 1.364 . . . . 0.0 110.072 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.04 28.72 5.02 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 165.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -5.76 59.31 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.241 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.4 m -114.57 104.71 54.27 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.22 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 162.78 91.64 Favored 'Cis proline' 0 N--CA 1.44 -1.63 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 -24.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -70.3 114.35 8.35 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 123.677 0.791 . . . . 0.0 109.659 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -82.39 152.21 26.29 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.5 -74.38 0.1 Allowed 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.244 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -120.6 125.96 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -165.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -144.79 142.35 29.92 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.7 m -107.51 125.48 51.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.992 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.81 121.17 36.13 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.267 5.7 mm -93.63 147.64 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.81 133.07 35.53 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.97 -141.59 6.83 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 105.526 -3.029 . . . . 0.0 105.526 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -96.05 149.85 21.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.81 -18.74 27.06 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -71.31 -37.08 71.8 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -72.07 -38.33 69.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 117.375 -1.298 . . . . 0.0 111.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 53' ' ' ILE . 5.5 tp -65.54 -47.5 86.27 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 CA-C-N 119.242 0.928 . . . . 0.0 109.967 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.96 -39.37 91.9 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.661 1.584 . . . . 0.0 111.476 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.46 9.1 2.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.88 -44.04 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 165.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.3 m -99.64 42.93 1.08 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.87 24.1 3.94 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 40.38 61.98 1.45 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.5 3.12 . . . . 0.0 113.856 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' ASN . 33.6 mmtp -133.06 -35.39 1.05 Allowed 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 60' ' ' LYS . 55.0 t30 -127.92 31.45 5.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.12 149.13 12.45 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.93 147.26 64.81 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.31 132.71 15.31 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.757 2.305 . . . . 0.0 107.919 -163.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -108.68 85.07 2.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 72.12 -101.53 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.935 1.694 . . . . 0.0 111.975 172.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -116.26 81.68 1.65 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -165.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 1.5 p-10 63.83 22.54 13.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 129.196 2.998 . . . . 0.0 114.534 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.1 164.54 11.73 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.756 -3.794 . . . . 0.0 100.756 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.31 113.95 4.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 117.3 -1.76 . . . . 0.0 109.171 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 tt -85.66 139.69 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -80.66 171.38 15.1 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 0.0 111.367 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.65 -9.3 10.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -127.19 96.49 4.61 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -48.15 127.76 13.0 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 127.614 2.365 . . . . 0.0 112.939 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.31 154.14 19.33 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 3.4 mt-30 -78.28 148.17 33.98 Favored 'General case' 0 CA--C 1.469 -2.152 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.88 144.37 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -168.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.3 m -135.99 101.91 4.87 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.2 m -86.25 111.99 20.95 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 69.0 m -88.72 116.15 26.77 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -111.75 142.6 43.9 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -75.86 121.64 22.93 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -130.95 64.77 1.57 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.5 -48.88 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 105.314 -3.115 . . . . 0.0 105.314 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.29 11.94 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -106.25 124.19 36.59 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -79.98 -27.31 3.88 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 121.56 1.593 . . . . 0.0 108.078 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -105.42 147.82 35.27 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 117.386 -1.293 . . . . 0.0 107.846 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.87 144.09 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.381 2.054 . . . . 0.0 107.09 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' HH12 ' A' ' 31' ' ' ARG . 51.7 Cg_exo -82.32 161.1 77.5 Favored 'Cis proline' 0 CA--C 1.487 -1.853 0 CA-C-N 123.683 2.351 . . . . 0.0 110.697 10.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.64 ' H ' HH22 ' A' ' 31' ' ' ARG . 56.3 m -147.3 125.29 12.04 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.973 -166.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -84.55 129.34 34.86 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.23 120.05 36.52 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -97.69 127.76 43.88 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.52 127.25 33.57 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -113.25 100.09 8.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 172.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.87 130.51 35.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.93 -177.28 14.83 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 80.1 t80 -163.53 106.25 0.98 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.0 170.44 22.31 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.176 -172.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.23 131.75 44.69 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 124.195 0.998 . . . . 0.0 109.597 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.82 133.49 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.22 84.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.67 138.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.26 136.74 40.61 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.6 149.78 22.42 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 124.059 0.849 . . . . 0.0 111.458 -168.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -148.23 123.51 10.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.1 p30 64.41 18.69 11.47 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.571 2.349 . . . . 0.0 115.071 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.14 22.15 55.42 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 19.2 tp -132.24 130.21 21.9 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.37 109.23 2.28 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 123.49 2.282 . . . . 0.0 107.482 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.07 -12.42 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 O-C-N 123.731 0.644 . . . . 0.0 111.376 -171.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 59.1 t60 -143.55 176.55 9.12 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.64 131.26 2.99 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.81 125.19 28.27 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.48 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -94.04 12.65 25.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.209 1.004 . . . . 0.0 108.951 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -92.37 -6.42 50.16 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.58 0.752 . . . . 0.0 109.827 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.27 -25.05 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.29 -19.65 16.25 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.68 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -75.93 -44.06 41.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -78.87 143.19 61.65 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.432 -2.12 0 N-CA-C 105.566 -2.513 . . . . 0.0 105.566 173.82 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.33 64.72 0.16 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 126.658 1.983 . . . . 0.0 108.531 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 77.15 -3.81 2.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.624 2.369 . . . . 0.0 112.427 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t -93.36 -13.28 28.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -25.78 63.35 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.122 1.369 . . . . 0.0 110.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.13 -41.64 66.95 Favored 'General case' 0 N--CA 1.407 -2.606 0 C-N-CA 125.914 1.685 . . . . 0.0 108.94 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -81.0 -7.63 59.6 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -76.28 -47.23 24.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -57.36 -41.65 80.53 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 126.977 2.111 . . . . 0.0 110.632 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.399 0.1 OUTLIER -99.39 -5.29 29.79 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.457 -173.539 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.1 t -79.55 -38.86 33.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.727 1.603 . . . . 0.0 107.064 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -82.98 -28.07 29.99 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.458 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 44' ' ' THR . 74.7 m80 -103.65 -50.31 3.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 49.3 t80 -76.59 118.07 18.87 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 120.038 1.29 . . . . 0.0 110.837 -168.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -136.08 97.59 3.65 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.34 -42.09 4.37 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -166.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -160.08 134.9 5.53 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 45.6 Cg_exo -73.76 -179.8 4.91 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 122.757 2.304 . . . . 0.0 114.012 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -74.86 -71.54 0.35 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.99 -177.48 14.9 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 103.343 -3.903 . . . . 0.0 103.343 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -121.64 72.51 1.02 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.98 177.99 7.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.61 -14.44 61.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -77.54 -33.96 53.99 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.63 -39.23 62.23 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.0 t -68.52 -43.08 77.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.0 111.81 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.1 -35.46 66.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.033 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -73.21 -30.17 63.33 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.87 -28.75 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-N 118.501 0.592 . . . . 0.0 109.528 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.8 mmt -70.33 -33.29 71.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.229 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -44.47 64.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.401 0.681 . . . . 0.0 111.406 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.44 -39.56 58.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -35.59 63.75 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.18 75.54 1.05 Allowed Glycine 0 CA--C 1.479 -2.217 0 C-N-CA 124.789 1.185 . . . . 0.0 111.274 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.354 2.6 mm? -104.86 -3.69 23.14 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -78.88 -5.1 52.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.792 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 m -119.66 103.27 46.47 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.583 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.59 164.06 88.95 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 CA-C-N 122.96 2.093 . . . . 0.0 107.054 -23.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 83' ' ' LEU . 31.8 m -57.14 125.1 21.19 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.563 -171.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -76.86 141.6 40.55 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -77.18 -39.86 47.42 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.354 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.73 128.9 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -148.87 125.67 11.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.418 ' O ' ' HD2' ' A' ' 13' ' ' HIS . 89.8 m -98.58 119.97 38.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.064 -172.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.6 114.09 23.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.05 149.45 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.64 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -139.05 136.16 34.97 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 124.581 1.153 . . . . 0.0 108.063 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.09 -143.77 8.65 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.91 147.01 24.41 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -86.23 -12.81 48.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.32 -36.29 71.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.436 1.494 . . . . 0.0 109.338 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 p -81.19 -25.69 36.55 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.307 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -56.93 -50.99 73.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.297 0 CA-C-N 120.232 1.378 . . . . 0.0 110.356 166.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -62.61 -40.67 97.7 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 123.464 0.706 . . . . 0.0 112.212 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.03 29.9 0.62 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 122.958 0.503 . . . . 0.0 112.082 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 72' ' ' SER . 12.4 mm -87.64 -30.13 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 160.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.0 t -83.15 -57.16 3.39 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.399 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.89 107.44 19.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -168.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 56.25 -87.51 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.575 2.75 . . . . 0.0 116.792 163.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.27 145.13 55.47 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.222 1.409 . . . . 0.0 107.839 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.331 6.8 p-10 43.83 39.4 2.57 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 130.873 3.669 . . . . 0.0 117.473 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.58 134.8 2.27 Favored Glycine 0 CA--C 1.489 -1.542 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 168.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -122.62 162.88 36.02 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -164.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 149.13 34.24 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.653 2.236 . . . . 0.0 108.491 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -148.28 116.82 6.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -168.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 66.68 -111.44 0.17 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.211 1.404 . . . . 0.0 110.792 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -136.16 95.21 3.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.359 2.2 p-10 64.98 23.13 12.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 129.161 2.985 . . . . 0.0 114.587 172.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -106.76 163.32 13.02 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 167.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -142.41 124.73 15.56 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.09 144.75 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 56' ' ' ILE . 97.7 p -83.33 158.0 22.36 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 121.748 0.785 . . . . 0.0 110.686 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -117.18 -5.06 11.37 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -116.5 88.94 3.0 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -55.69 128.8 36.48 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.058 1.743 . . . . 0.0 110.954 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -108.32 158.71 17.25 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.416 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 5.6 mt-30 -76.89 146.31 37.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.48 146.85 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -131.8 101.95 5.67 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 164.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -79.24 103.75 9.38 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 32.2 m -90.11 112.09 23.44 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -121.5 140.21 52.48 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 39' ' ' CYS . 25.9 tp -79.3 120.32 23.59 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -135.28 56.28 1.85 Allowed 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.54 -86.56 1.81 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 106.272 -2.731 . . . . 0.0 106.272 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.66 -16.67 3.31 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 m -85.41 134.02 41.18 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -79.67 -27.56 3.97 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.848 1.698 . . . . 0.0 108.209 170.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -97.7 163.36 19.74 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.263 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.54 144.13 35.47 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 122.268 1.979 . . . . 0.0 107.431 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -83.07 163.15 72.95 Favored 'Cis proline' 0 CA--C 1.489 -1.775 0 CA-C-N 123.164 2.166 . . . . 0.0 109.936 9.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.57 122.59 36.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -88.93 113.06 24.05 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.18 126.11 51.82 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -89.89 126.28 35.66 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 131.16 35.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.0 m -119.66 90.83 3.41 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.547 -2.761 . . . . 0.0 103.547 172.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.53 130.01 36.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.51 -165.67 10.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.416 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 86.2 t80 -157.51 101.09 1.83 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.442 -3.911 . . . . 0.0 100.442 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -138.19 149.32 45.71 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -165.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -77.3 134.21 38.59 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.596 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.23 153.37 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.08 115.94 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 102.01 -3.329 . . . . 0.0 102.01 161.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.43 161.44 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -106.03 144.7 32.38 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 163.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.6 t -123.33 138.83 54.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.527 1.142 . . . . 0.0 110.068 -170.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -127.43 132.99 49.99 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.308 5.6 p30 73.74 6.32 4.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.93 20.33 21.58 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.76 144.94 18.24 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -71.12 154.63 62.18 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 122.417 1.899 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.25 -17.38 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.65 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 82.0 t60 -149.81 166.93 27.99 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -164.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -127.64 130.66 49.33 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.9 120.1 24.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 21.57 17.19 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -173.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -90.57 -16.1 29.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.697 -174.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.09 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.26 -11.0 31.08 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.609 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -78.42 -35.11 47.46 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -78.4 139.47 59.71 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.432 -2.104 0 N-CA-C 106.047 -2.328 . . . . 0.0 106.047 -179.202 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 CA--C 1.485 -1.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -123.11 42.21 3.26 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.28 -8.65 19.15 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.0 p -91.64 -17.05 26.11 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -76.44 -32.84 58.68 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 123.353 0.661 . . . . 0.0 110.457 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -68.01 -37.94 82.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.65 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -74.68 -19.19 60.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -72.3 -45.57 59.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.98 0.809 . . . . 0.0 108.86 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -56.69 -40.49 75.68 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.176 1.79 . . . . 0.0 111.27 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.415 0.2 OUTLIER -96.88 -2.52 43.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 118.44 0.564 . . . . 0.0 111.732 -173.328 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.6 m -76.63 -42.97 40.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -68.75 -46.49 68.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.873 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -102.68 -41.33 6.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 118.448 -0.786 . . . . 0.0 111.173 -167.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 39.4 t80 -80.84 117.09 21.18 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.558 1.527 . . . . 0.0 111.124 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.07 96.29 3.48 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 100.958 -3.719 . . . . 0.0 100.958 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.27 6.12 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 127.937 2.495 . . . . 0.0 117.573 -165.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -151.69 138.82 12.23 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 39.7 Cg_exo -74.71 179.55 5.87 Favored 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 122.824 2.35 . . . . 0.0 113.834 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.3 -70.19 0.38 Allowed 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.74 -175.35 13.96 Favored Glycine 0 CA--C 1.477 -2.332 1 N-CA-C 101.995 -4.442 . . . . 0.0 101.995 163.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -116.1 72.57 0.81 Allowed 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.32 -179.7 6.15 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.488 -170.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.55 -39.34 87.58 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 127.457 2.303 . . . . 0.0 111.836 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -83.72 -16.02 46.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 110.775 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -77.73 -40.48 41.0 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 m -69.51 -34.68 74.64 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 123.485 0.491 . . . . 0.0 111.98 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.05 -37.71 72.52 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.409 0.443 . . . . 0.0 110.04 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -70.74 -31.08 67.78 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.275 14.5 tt -86.25 -27.84 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.067 0.394 . . . . 0.0 111.713 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.76 -19.56 48.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.552 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -75.79 -42.09 51.04 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 118.781 0.719 . . . . 0.0 109.425 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -75.73 -48.42 21.96 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.865 0.866 . . . . 0.0 111.505 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.87 -27.96 44.12 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.97 65.61 1.59 Allowed Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.91 22.48 14.85 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 165.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -89.37 -12.27 40.89 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -129.83 105.95 16.88 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.4 160.17 96.25 Favored 'Cis proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 -19.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.7 m -61.1 121.67 13.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.443 1.097 . . . . 0.0 110.258 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -73.65 133.52 43.45 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -72.83 -42.31 63.93 Favored 'General case' 0 CA--C 1.491 -1.316 0 O-C-N 123.766 0.666 . . . . 0.0 112.456 -169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 tt -154.49 126.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -154.77 129.31 9.17 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -94.86 125.14 39.32 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.32 120.67 33.87 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 167.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -98.08 148.59 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -135.51 133.4 38.42 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.352 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.93 -140.59 6.39 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 104.451 -3.459 . . . . 0.0 104.451 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -105.11 148.38 26.9 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 168.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -87.43 0.48 55.44 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.186 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.36 -34.98 58.91 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 167.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -77.22 -33.26 56.22 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.458 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mm -59.26 -50.03 81.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 124.335 1.054 . . . . 0.0 110.386 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -61.33 -33.83 74.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.171 0.988 . . . . 0.0 113.275 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 7.38 8.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 mm -84.83 -21.29 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.3 t -80.16 -19.46 47.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 122.064 -0.398 . . . . 0.0 110.736 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.64 142.9 51.59 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 165.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.42 -7.43 59.58 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.742 0.817 . . . . 0.0 112.699 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -81.26 -41.77 21.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.11 15.58 16.04 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -167.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.25 112.45 0.4 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 172.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -96.01 152.15 38.75 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.44 118.46 5.61 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 122.635 2.224 . . . . 0.0 106.373 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 69' ' ' LEU . 7.8 p80 -91.13 119.97 31.69 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 61.84 -96.67 0.06 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.784 1.634 . . . . 0.0 112.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -122.28 82.02 1.91 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -171.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 0.7 OUTLIER 65.88 11.75 7.88 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 129.192 2.997 . . . . 0.0 117.826 160.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.9 OUTLIER -102.84 148.33 25.77 Favored 'General case' 0 CA--C 1.476 -1.887 1 N-CA-C 99.0 -4.445 . . . . 0.0 99.0 174.372 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -124.44 118.48 26.76 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -158.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.6 tt -95.61 137.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.5 p -80.34 164.25 23.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.626 0.727 . . . . 0.0 111.914 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.06 -11.78 8.83 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -103.69 83.33 2.12 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.8 m -47.52 124.81 7.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 127.126 2.17 . . . . 0.0 112.048 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.68 158.08 16.5 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -78.96 143.36 35.84 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.13 141.23 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -167.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.8 m -129.62 105.77 8.28 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -81.66 100.11 9.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 99.9 m -86.84 112.33 21.63 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -111.35 143.09 42.7 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.16 109.72 17.42 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -94.5 158.68 15.44 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.2 -91.13 1.48 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.71 39.65 0.46 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.3 p -92.9 120.63 67.0 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.43 -8.64 4.49 Favored 'Trans proline' 0 N--CA 1.438 -1.781 0 CA-C-N 121.618 1.614 . . . . 0.0 108.036 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -110.6 161.84 23.07 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.04 146.14 36.52 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.454 2.102 . . . . 0.0 107.684 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.79 164.25 67.63 Favored 'Cis proline' 0 N--CA 1.435 -1.925 0 CA-C-N 122.073 1.776 . . . . 0.0 107.934 3.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.54 159.78 21.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -117.02 129.12 55.81 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -124.24 124.3 42.14 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -100.65 127.85 46.9 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.48 130.98 35.92 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.027 0.442 . . . . 0.0 109.964 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -119.1 89.55 3.15 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.49 136.85 33.25 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.104 0.478 . . . . 0.0 109.907 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.19 179.26 18.82 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 88.4 t80 -143.56 101.21 3.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -160.82 175.05 12.99 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -70.56 145.88 50.5 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 124.811 1.244 . . . . 0.0 111.539 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.37 147.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -110.25 94.19 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 165.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 m -96.5 133.17 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.96 132.01 43.18 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.05 134.96 52.24 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 124.548 1.155 . . . . 0.0 111.289 -166.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.74 135.23 45.62 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 10.2 p30 68.87 12.6 8.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.395 2.278 . . . . 0.0 116.411 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.93 19.51 46.92 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.2 19.86 Favored Pre-proline 0 CA--C 1.491 -1.32 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.06 113.21 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.59 -6.98 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.7 t60 -155.04 174.83 14.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -168.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.429 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -165.98 131.58 2.45 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.94 141.58 35.9 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.529 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -103.84 44.28 1.03 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -95.2 -34.41 12.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -73.42 -33.84 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 C-N-CA 125.143 1.377 . . . . 0.0 109.498 172.013 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -106.92 30.63 5.98 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -85.91 -63.58 1.3 Allowed 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.74 151.71 54.1 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 170.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.433 -2.076 0 N-CA-C 105.065 -2.706 . . . . 0.0 105.065 175.76 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.487 -1.474 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -127.46 84.03 2.22 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 80.83 2.61 1.72 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 127.833 2.453 . . . . 0.0 111.133 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -91.59 -7.06 51.23 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 124.356 1.062 . . . . 0.0 109.13 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -43.15 62.59 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -59.67 -50.84 72.28 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-O 117.523 -1.227 . . . . 0.0 112.309 173.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.433 3.4 t -87.16 9.04 21.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -76.68 -44.67 32.8 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 119.958 -1.713 . . . . 0.0 107.916 156.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.2 -31.86 70.55 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.597 1.159 . . . . 0.0 111.462 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 14' ' ' TYR . 17.3 mt -88.31 -23.77 23.35 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.691 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -71.03 -35.65 72.08 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 120.102 1.319 . . . . 0.0 109.82 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -69.29 -63.62 1.03 Allowed 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.924 168.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -88.8 -49.11 7.03 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -162.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' HD22 ' A' ' 10' ' ' LEU . 83.9 t80 -76.44 118.19 18.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.991 1.723 . . . . 0.0 110.14 -171.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -137.31 98.29 3.68 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.67 -34.71 0.4 Allowed 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 119.942 3.312 . . . . 0.0 119.942 -165.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -150.13 156.62 37.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 16.8 Cg_endo -72.18 149.76 52.37 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 123.246 2.631 . . . . 0.0 108.964 170.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -84.06 -50.91 7.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 166.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.38 -179.01 16.04 Favored Glycine 0 CA--C 1.48 -2.115 0 N-CA-C 103.621 -3.792 . . . . 0.0 103.621 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -126.6 53.03 1.69 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -141.07 -179.26 5.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.67 -38.59 72.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 128.437 2.695 . . . . 0.0 112.734 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -79.23 -23.93 43.41 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 124.129 0.971 . . . . 0.0 111.025 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -76.65 -38.94 53.75 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.3 m -69.81 -35.94 75.23 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 123.613 0.571 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.88 -35.7 64.72 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 t -70.51 -32.59 70.13 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 122.78 0.432 . . . . 0.0 111.998 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.295 10.5 tt -82.69 -30.83 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.077 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.15 -18.72 52.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.216 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -74.42 -37.15 63.41 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 119.062 0.846 . . . . 0.0 111.296 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -51.67 14.97 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.806 0.443 . . . . 0.0 110.107 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.91 -36.74 67.33 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.736 0.814 . . . . 0.0 110.646 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.98 67.02 1.57 Allowed Glycine 0 CA--C 1.479 -2.173 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.1 mt -114.46 22.88 13.27 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 164.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -99.06 2.56 46.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -146.54 103.85 3.98 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 159.05 94.83 Favored 'Cis proline' 0 N--CA 1.447 -1.246 0 CA-C-N 122.127 1.795 . . . . 0.0 107.636 -16.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.3 m -61.83 124.88 21.98 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 123.974 0.796 . . . . 0.0 110.148 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -77.95 132.28 37.8 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 171.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.17 -42.32 69.24 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.048 0.842 . . . . 0.0 112.455 -165.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.68 126.47 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -145.61 126.33 14.31 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -95.24 118.64 32.37 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.739 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.54 115.47 28.07 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.2 mm -92.13 146.13 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.582 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.3 m-70 -134.58 138.44 44.58 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.0 -153.46 24.71 Favored Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.34 138.56 34.48 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.62 -9.08 57.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -37.33 73.51 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.6 m -76.34 -30.81 57.78 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.288 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -57.28 11.83 Favored 'Isoleucine or valine' 0 C--N 1.363 1.161 0 CA-C-N 119.558 1.072 . . . . 0.0 110.377 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -68.12 -38.43 82.22 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.09 1.314 . . . . 0.0 110.958 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.66 -0.15 22.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.869 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.286 0.6 OUTLIER -79.57 -24.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.296 0 C-N-CA 116.532 -2.067 . . . . 0.0 110.113 170.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 92.8 m -98.8 34.88 1.97 Allowed 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.39 0.995 . . . . 0.0 111.074 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -118.35 21.72 12.51 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.273 13.5 p-10 26.23 46.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.551 1 C-N-CA 132.021 4.128 . . . . 0.0 116.122 -167.122 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.49 -19.37 14.42 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -127.22 28.97 5.65 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.77 161.67 31.36 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -122.56 148.41 52.92 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-O 116.092 -1.909 . . . . 0.0 106.021 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -69.92 154.82 66.69 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.767 2.311 . . . . 0.0 111.806 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -125.57 57.8 1.33 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.27 15.7 tpp180 81.56 -100.31 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.152 2.181 . . . . 0.0 113.044 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.34 78.03 1.34 Allowed 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 124.049 0.94 . . . . 0.0 109.318 -166.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.336 1.3 p-10 74.33 8.68 4.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 129.291 3.037 . . . . 0.0 113.749 169.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.17 158.78 16.07 Favored 'General case' 0 CA--C 1.466 -2.252 1 N-CA-C 98.794 -4.521 . . . . 0.0 98.794 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -152.09 138.19 18.26 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -174.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.19 136.64 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.0 p -84.38 163.2 19.69 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.39 0.614 . . . . 0.0 110.696 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -126.7 -0.97 6.74 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.0 t -101.33 92.49 4.97 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 162.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.1 m -58.33 126.58 28.13 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.28 1.432 . . . . 0.0 110.373 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -107.85 161.0 15.31 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -79.88 151.4 30.2 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.98 146.36 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -168.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.0 m -135.19 103.51 5.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 165.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.8 m -84.31 101.62 12.08 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.7 m -85.72 113.75 22.15 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -122.66 135.77 54.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.271 19.3 mt -65.4 118.28 9.15 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.106 0.479 . . . . 0.0 110.621 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -88.54 126.81 35.44 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 169.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.18 -84.86 0.38 Allowed Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 106.519 -2.633 . . . . 0.0 106.519 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.98 37.86 1.09 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.7 t -86.9 123.91 69.73 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.92 3.63 3.0 Favored 'Trans proline' 0 N--CA 1.437 -1.837 0 CA-C-N 122.192 1.818 . . . . 0.0 108.492 -171.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.35 160.71 38.53 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.19 146.17 31.67 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.73 1.62 . . . . 0.0 108.215 -171.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -82.74 161.71 75.41 Favored 'Cis proline' 0 N--CA 1.437 -1.834 0 CA-C-N 122.656 1.984 . . . . 0.0 109.482 7.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 m -119.95 111.81 18.4 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -85.76 122.4 29.79 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -121.11 111.21 17.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -85.75 129.75 34.74 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.11 127.35 32.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.7 m -114.6 92.59 4.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.14 29.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.024 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.7 -172.83 18.92 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -156.4 106.34 2.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.49 25.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.803 0.811 . . . . 0.0 109.97 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 129.38 34.49 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.053 1.341 . . . . 0.0 109.429 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.4 m -89.41 143.1 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.163 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.32 97.46 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 HH22 ' A' ' 70' ' ' ARG . 25.6 m -105.58 138.38 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.67 134.55 39.78 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.3 m -106.53 153.35 22.44 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.612 1.195 . . . . 0.0 110.135 -171.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -151.07 128.55 11.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.86 -2.645 . . . . 0.0 103.86 167.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.329 12.9 p30 66.02 17.55 10.81 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.216 2.607 . . . . 0.0 115.672 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.55 0.87 62.45 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.54 139.82 21.18 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.03 114.83 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 N-CA-C 105.224 -2.644 . . . . 0.0 105.224 164.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 m -100.32 -10.77 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 80.9 t60 -158.53 175.65 13.4 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -165.67 125.23 1.72 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.53 130.77 34.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -99.96 43.16 1.07 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.4 p -95.04 -18.01 21.4 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pt -97.03 -19.04 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.94 48.47 0.89 Allowed 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 106.014 -1.846 . . . . 0.0 106.014 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -116.33 -3.56 11.93 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.87 138.0 69.63 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.434 -1.974 0 C-N-CA 122.613 2.209 . . . . 0.0 106.542 -164.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 CA--C 1.487 -1.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -114.61 53.68 0.8 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 169.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -111.66 0.01 16.2 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 t -93.08 -24.99 18.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 171.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -68.59 -37.94 80.24 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.167 1.387 . . . . 0.0 109.383 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 42.9 t80 -50.32 -60.65 2.77 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 127.642 2.377 . . . . 0.0 114.191 166.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -67.28 -16.58 64.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -70.84 -51.34 27.13 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.531 1.059 . . . . 0.0 109.063 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.09 -34.34 70.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 126.95 2.1 . . . . 0.0 111.555 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.0 OUTLIER -98.53 -8.91 25.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 118.698 0.681 . . . . 0.0 110.441 -171.774 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -76.52 -45.07 32.39 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 168.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -45.65 86.57 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.987 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.53 ' CD2' HD12 ' A' ' 115' ' ' LEU . 74.5 m80 -106.15 -49.02 3.45 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-O 118.547 -0.739 . . . . 0.0 111.782 -172.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 60.5 t80 -76.48 121.9 23.78 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 120.136 1.335 . . . . 0.0 110.05 -167.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.72 97.17 3.2 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 102.063 -3.31 . . . . 0.0 102.063 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.29 -43.5 1.15 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 128.594 2.758 . . . . 0.0 118.291 -168.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.09 148.77 17.98 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 165.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -74.14 168.95 23.56 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 121.63 1.553 . . . . 0.0 112.443 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.96 -67.02 0.57 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.59 -178.46 15.44 Favored Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 102.159 -4.376 . . . . 0.0 102.159 163.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -113.3 72.91 0.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.14 175.76 11.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.08 -24.87 63.3 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.707 1.203 . . . . 0.0 113.176 -171.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -86.85 -18.31 31.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -41.53 62.26 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.29 0.5 OUTLIER -76.95 -26.51 54.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.167 -1.413 . . . . 0.0 113.605 -173.978 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.56 -39.33 81.08 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.293 170.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -66.88 -38.04 85.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.2 tt -80.95 -27.09 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 117.851 0.296 . . . . 0.0 110.504 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -24.58 55.73 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.186 -1.006 . . . . 0.0 112.03 174.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -75.63 -34.54 60.56 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 118.608 0.64 . . . . 0.0 111.82 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -76.99 -46.17 24.82 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 118.27 0.486 . . . . 0.0 111.769 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.28 -34.44 65.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 72.59 1.19 Allowed Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.6 mt -113.25 20.14 16.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -89.01 -7.11 56.59 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.7 m -125.65 100.86 30.87 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.553 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.52 167.48 80.19 Favored 'Cis proline' 0 N--CA 1.445 -1.359 0 N-CA-C 107.066 -1.936 . . . . 0.0 107.066 -22.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 83' ' ' LEU . 39.9 m -60.02 126.65 28.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 124.031 0.932 . . . . 0.0 111.034 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.29 139.43 46.11 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.95 -51.94 16.45 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 123.581 0.551 . . . . 0.0 110.091 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 tt -147.83 135.58 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -152.26 130.1 11.69 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.454 ' O ' ' HD2' ' A' ' 13' ' ' HIS . 49.2 m -97.21 120.52 37.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.186 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -90.62 126.46 35.97 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.262 5.9 mm -89.95 148.94 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.2 m-70 -138.49 139.25 38.71 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.61 -114.32 0.6 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 106.479 -2.648 . . . . 0.0 106.479 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -134.08 134.73 42.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.04 3.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.674 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -84.79 -28.29 26.26 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.1 m -84.62 -25.29 28.67 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 53' ' ' ILE . 1.5 tp -71.19 -41.94 75.28 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -61.77 -52.36 64.56 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.949 0.899 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.6 3.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.747 1.219 . . . . 0.0 113.399 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 72' ' ' SER . 1.5 tp -76.93 -33.92 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.2 m -94.23 9.67 37.09 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -166.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -104.44 23.11 13.74 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.79 0.805 . . . . 0.0 110.737 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.4 m120 42.63 38.04 1.18 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 130.81 3.644 . . . . 0.0 114.002 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.49 -35.24 7.95 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -120.98 26.15 9.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 149.97 17.99 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 119.178 -1.486 . . . . 0.0 110.729 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -100.46 125.36 39.51 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-O 116.529 -1.7 . . . . 0.0 107.934 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.8 141.62 34.08 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.648 2.899 . . . . 0.0 108.167 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -123.76 80.39 1.8 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 65.76 -99.49 0.06 Allowed 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 126.479 1.911 . . . . 0.0 114.516 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.42 72.39 1.41 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -164.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.309 2.6 p-10 57.31 30.6 18.76 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 129.495 3.118 . . . . 0.0 114.832 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.0 161.36 20.34 Favored 'General case' 0 CA--C 1.47 -2.101 1 N-CA-C 98.677 -4.564 . . . . 0.0 98.677 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.716 HH12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -156.82 148.55 22.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -171.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.427 HG12 HG22 ' A' ' 104' ' ' VAL . 12.6 mt -114.31 126.07 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 56' ' ' ILE . 57.8 p -69.07 160.4 31.08 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -117.54 -18.75 9.67 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.143 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 t -103.44 84.02 2.25 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.2 p -52.18 136.47 30.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.179 2.192 . . . . 0.0 112.701 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.82 163.58 14.87 Favored 'General case' 0 CA--C 1.473 -2.011 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -168.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -78.33 148.26 33.85 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -145.66 146.32 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -167.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.6 m -138.5 104.84 5.25 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 m -90.17 99.8 12.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.8 m -92.49 123.57 35.89 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -115.16 146.36 41.45 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 39' ' ' CYS . 48.8 tp -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.468 1.107 . . . . 0.0 108.584 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -94.2 156.52 16.5 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.82 -79.6 0.34 Allowed Glycine 0 CA--C 1.486 -1.776 0 N-CA-C 106.036 -2.826 . . . . 0.0 106.036 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.06 27.39 6.6 Favored Glycine 0 CA--C 1.488 -1.644 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -89.38 127.28 55.55 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 171.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -80.14 -20.63 8.49 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 CA-C-N 122.686 1.995 . . . . 0.0 108.849 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -101.21 163.62 17.59 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.94 144.58 34.62 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 N-CA-C 107.516 -1.763 . . . . 0.0 107.516 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -84.08 163.19 67.82 Favored 'Cis proline' 0 CA--C 1.489 -1.746 0 CA-C-N 123.174 2.169 . . . . 0.0 110.423 13.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 m -126.24 117.31 22.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.77 83.97 1.85 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.648 1.213 . . . . 0.0 108.067 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -70.0 130.66 42.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -97.18 120.52 37.68 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.53 135.73 33.71 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -115.31 98.97 7.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.85 141.72 35.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.96 -163.01 13.91 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -162.38 108.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -146.26 151.12 37.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -167.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -75.21 135.16 41.04 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -96.31 136.79 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.725 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 119' ' ' ILE . 89.3 t -91.81 105.74 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 164.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.716 HG23 HH12 ' A' ' 70' ' ' ARG . 16.2 m -117.06 155.68 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.29 133.3 53.22 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.3 m -102.67 153.95 19.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 124.717 1.261 . . . . 0.0 111.295 -170.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -147.85 123.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 167.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.0 p30 69.63 15.76 8.11 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.307 2.243 . . . . 0.0 115.069 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.83 55.64 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 7.6 tp -128.56 133.48 25.23 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -77.33 118.56 4.68 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 CA-C-N 124.181 2.529 . . . . 0.0 106.381 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.79 -11.34 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 O-C-N 123.635 0.584 . . . . 0.0 109.802 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -145.26 152.05 39.34 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.53 HD12 ' CD2' ' A' ' 13' ' ' HIS . 0.8 OUTLIER -110.74 127.35 55.31 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 117.53 30.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -100.75 37.93 1.63 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -166.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.2 p -87.39 -20.83 26.13 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 121.747 -0.596 . . . . 0.0 109.411 -174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.616 HD11 ' H ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -86.15 -23.5 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.105 0 C-N-CA 123.87 0.868 . . . . 0.0 109.579 173.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.404 ' CE1' HD12 ' A' ' 119' ' ' ILE . 22.6 m-30 -106.97 54.26 0.68 Allowed 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -164.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 62.57 77.69 0.32 Allowed 'General case' 0 CA--C 1.485 -1.52 0 C-N-CA 129.057 2.943 . . . . 0.0 109.523 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -57.71 125.72 73.71 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.515 171.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 N--CA 1.433 -2.069 0 N-CA-C 105.633 -2.487 . . . . 0.0 105.633 177.517 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 . . . . . 0 CA--C 1.486 -1.514 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -110.77 62.6 0.61 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -94.8 -15.99 23.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -87.92 -17.09 32.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.533 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -73.28 -41.79 63.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.53 -48.02 76.67 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.836 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -79.78 -10.41 59.78 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 120.304 1.411 . . . . 0.0 114.506 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -82.82 -30.56 28.66 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 119.093 0.86 . . . . 0.0 108.81 171.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 10' ' ' LEU . 3.3 t80 -60.25 -34.94 74.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.492 0.717 . . . . 0.0 109.986 165.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 mp -81.03 -23.3 38.7 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.9 p -75.11 -30.65 60.91 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 120.495 1.498 . . . . 0.0 110.881 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -72.74 -55.16 7.17 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -95.66 -54.04 3.5 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.708 -162.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 23.4 t80 -78.45 112.2 15.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.926 1.239 . . . . 0.0 109.977 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.43 94.07 3.58 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 101.445 -3.539 . . . . 0.0 101.445 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.9 -38.02 0.89 Allowed 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 120.141 3.386 . . . . 0.0 120.141 -162.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.7 154.38 47.92 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.9 Cg_endo -75.0 163.16 35.89 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 123.613 2.875 . . . . 0.0 109.883 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -75.16 -71.39 0.36 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 166.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.91 178.42 16.44 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.459 -3.856 . . . . 0.0 103.459 164.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -114.68 70.61 0.74 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.68 174.98 14.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.72 -16.75 62.81 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.814 1.246 . . . . 0.0 113.535 -170.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -81.75 -28.83 33.12 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -76.99 -34.3 57.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -33.57 42.07 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -169.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.58 -46.27 80.09 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 124.631 1.172 . . . . 0.0 109.34 170.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.1 t -64.33 -36.75 85.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.9 tt -83.08 -28.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 CA-C-N 118.023 0.374 . . . . 0.0 111.21 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.0 mmt -73.28 -23.88 60.35 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.117 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -82.6 -29.32 30.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 118.903 0.774 . . . . 0.0 112.58 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -80.74 -37.35 30.68 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.402 0.546 . . . . 0.0 111.122 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -22.67 55.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.671 0.388 . . . . 0.0 110.306 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.3 5.66 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.62 16.55 19.66 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -91.1 -11.71 37.79 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 m -126.42 102.9 26.0 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.74 161.48 94.12 Favored 'Cis proline' 0 N--CA 1.443 -1.494 0 N-CA-C 106.865 -2.013 . . . . 0.0 106.865 -20.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.2 m -62.12 120.62 11.23 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.96 0.904 . . . . 0.0 110.339 -175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -72.0 138.9 48.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.32 -40.98 57.87 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 123.557 0.536 . . . . 0.0 111.338 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.15 128.25 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -148.39 127.14 12.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 170.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -97.48 123.84 41.49 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.085 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -94.6 113.23 25.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.8 mm -87.37 145.34 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.53 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.565 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 8.9 m-70 -133.8 133.62 41.88 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.61 -147.12 12.43 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.313 -2.315 . . . . 0.0 107.313 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.92 149.04 21.67 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.07 -17.85 34.01 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -68.85 -40.84 79.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.439 1.896 . . . . 0.0 106.565 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.1 m -70.21 -41.95 72.97 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 116.645 -1.645 . . . . 0.0 111.665 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.1 mm -53.97 -58.18 4.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 124.368 1.067 . . . . 0.0 111.478 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.03 -42.55 90.48 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.062 1.345 . . . . 0.0 111.489 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.65 4.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mm -77.59 -31.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.2 m -94.58 7.68 44.84 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.624 0.249 . . . . 0.0 111.502 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -91.09 173.26 8.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 158.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -85.55 1.8 47.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.344 0.658 . . . . 0.0 111.555 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -77.52 -60.01 2.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.243 0.617 . . . . 0.0 111.32 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -89.34 -49.51 6.67 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.55 147.81 18.65 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -168.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.71 156.66 35.27 Favored Pre-proline 0 N--CA 1.434 -1.262 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -73.92 125.44 9.9 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 122.663 2.242 . . . . 0.0 107.629 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -117.71 123.35 45.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 66.46 -107.2 0.11 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.912 1.285 . . . . 0.0 112.124 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.75 95.61 2.88 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.333 2.2 p-10 60.31 35.55 20.71 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 128.666 2.786 . . . . 0.0 113.602 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -117.67 165.69 13.3 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 101.31 -3.589 . . . . 0.0 101.31 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.8 mtt85 -145.14 127.59 15.96 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -95.58 134.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -81.84 160.21 23.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.351 0.596 . . . . 0.0 111.054 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.97 -1.87 9.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -106.37 77.26 1.2 Allowed 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -59.69 138.06 57.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 125.898 1.679 . . . . 0.0 111.912 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -113.43 158.85 20.13 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -166.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 8.7 mt-30 -79.89 138.9 37.26 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.22 105.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -171.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.0 m -97.98 106.31 18.58 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m -87.39 112.19 21.88 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -89.38 116.29 27.47 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -121.47 142.33 50.15 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.2 tp -80.36 110.54 15.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -93.13 155.02 17.74 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.91 -89.79 1.52 Allowed Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.33 38.41 0.59 Allowed Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -80.15 126.08 80.14 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -84.88 -19.96 3.79 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 122.165 1.809 . . . . 0.0 108.314 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -110.47 160.66 27.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 117.618 -1.182 . . . . 0.0 107.962 -168.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -73.25 142.04 33.17 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 C-N-CA 122.695 2.263 . . . . 0.0 106.767 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -82.04 159.47 79.43 Favored 'Cis proline' 0 N--CA 1.435 -1.944 0 CA-C-N 123.027 2.117 . . . . 0.0 108.949 4.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.6 m -109.52 170.27 8.17 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -125.48 109.92 13.29 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -105.84 113.98 27.86 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -89.04 125.61 35.08 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.72 125.69 29.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 m -106.53 87.22 2.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.75 129.21 34.4 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.08 -167.13 14.4 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -157.32 114.26 3.01 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -155.14 156.18 35.29 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -168.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.57 139.58 42.19 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.61 172.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.22 147.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.08 94.7 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 165.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 m -91.6 136.11 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.5 m -107.03 142.62 36.38 Favored 'General case' 0 CA--C 1.485 -1.556 0 O-C-N 124.42 1.075 . . . . 0.0 110.577 -172.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -150.77 130.49 13.17 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.322 14.8 p30 64.37 20.44 12.17 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 115.553 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.77 -3.07 70.54 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER -102.73 142.42 24.53 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 176.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.72 109.85 2.93 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 N-CA-C 105.386 -2.582 . . . . 0.0 105.386 160.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -85.98 -22.58 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.623 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 23.2 m80 -156.37 -163.4 1.45 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 132.88 1.06 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.54 127.29 32.76 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -97.55 16.94 18.9 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 m -91.84 -20.85 21.03 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 118.765 0.711 . . . . 0.0 110.376 -165.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -26.71 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 C-N-CA 123.672 0.789 . . . . 0.0 109.03 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -98.55 -4.01 35.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -91.42 -66.91 0.89 Allowed 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -113.1 112.65 49.72 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.433 -2.054 0 N-CA-C 105.338 -2.601 . . . . 0.0 105.338 177.362 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -120.07 43.06 2.78 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -110.32 -4.12 15.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -90.05 -27.02 19.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -71.65 -41.66 68.5 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.177 0.591 . . . . 0.0 109.437 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -55.0 -56.81 15.59 Favored 'General case' 0 N--CA 1.398 -3.032 0 C-N-CA 126.158 1.783 . . . . 0.0 113.957 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 17.8 p -78.72 -6.16 55.08 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -86.28 -35.63 19.82 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 120.582 1.537 . . . . 0.0 108.496 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -41.34 87.69 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.547 1.139 . . . . 0.0 109.416 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.392 0.0 OUTLIER -97.34 0.02 47.22 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 118.267 0.485 . . . . 0.0 111.168 -174.027 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -71.22 -53.91 12.75 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 161.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.12 -40.58 94.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 124.053 0.846 . . . . 0.0 112.94 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -121.25 4.86 10.29 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.245 -162.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 30.7 t80 -110.29 130.0 55.63 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 120.173 1.351 . . . . 0.0 109.438 167.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.82 104.6 3.33 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 164.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.88 -43.38 4.05 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 118.321 2.712 . . . . 0.0 118.321 -164.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -142.24 156.49 64.4 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -71.04 147.28 54.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.584 2.856 . . . . 0.0 108.838 172.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -80.02 -53.51 6.66 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.04 -178.38 15.57 Favored Glycine 0 CA--C 1.48 -2.125 0 N-CA-C 103.331 -3.908 . . . . 0.0 103.331 164.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.11 48.01 2.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.95 179.33 6.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.896 -168.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.68 -41.52 77.47 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.707 2.403 . . . . 0.0 112.926 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -81.63 -18.93 42.96 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.865 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -74.29 -44.59 52.09 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 2.3 m -68.66 -36.93 79.2 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 124.238 0.961 . . . . 0.0 112.869 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.57 -41.87 75.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 123.371 0.42 . . . . 0.0 110.275 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.9 m -73.06 -23.17 60.53 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.827 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 9.9 tt -85.74 -36.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 119.77 1.168 . . . . 0.0 110.965 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.1 mmm -72.05 -30.77 65.49 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.19 -39.32 55.04 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.53 -48.56 26.27 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.407 -170.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -79.66 -23.77 42.29 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.152 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.37 61.95 1.52 Allowed Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 161.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.69 15.3 5.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 t -84.33 8.83 14.79 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.705 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.6 m -113.18 106.27 54.88 Favored Pre-proline 0 N--CA 1.428 -1.575 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.368 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.7 162.24 93.09 Favored 'Cis proline' 0 N--CA 1.443 -1.474 0 CA-C-N 123.401 2.25 . . . . 0.0 107.262 -22.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.28 117.48 7.9 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.58 1.152 . . . . 0.0 111.819 -168.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -73.93 137.15 43.42 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -75.09 -35.19 61.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.371 1.044 . . . . 0.0 112.629 -168.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.21 130.63 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -154.1 119.4 5.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -102.88 120.59 40.89 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.647 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.39 116.29 26.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.04 149.03 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.553 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m-70 -131.6 132.92 44.45 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.641 -172.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.85 -116.56 0.72 Allowed Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -133.5 140.69 47.38 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -88.36 -0.75 57.51 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -79.62 -31.06 41.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -78.16 -28.51 48.34 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.674 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.16 -41.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 CA-C-N 119.142 0.883 . . . . 0.0 110.609 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -58.96 -43.31 91.3 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.744 1.217 . . . . 0.0 111.122 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.94 13.6 1.35 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 72' ' ' SER . 20.1 mm -83.11 -22.88 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.6 m -84.55 -11.03 56.85 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.62 166.61 15.24 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.26 -17.06 47.28 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -81.33 -30.49 33.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -130.4 37.86 3.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.73 128.25 1.04 Allowed Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -104.89 156.05 36.61 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.04 122.17 6.57 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 122.496 2.131 . . . . 0.0 107.036 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -106.23 127.82 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 63.46 -105.2 0.15 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.415 1.486 . . . . 0.0 112.058 170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -139.75 97.77 3.33 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.341 1.9 p-10 64.37 26.72 13.62 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 129.033 2.933 . . . . 0.0 114.343 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.18 167.83 9.73 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.51 115.55 8.82 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.1 tt -96.61 139.89 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' HD12 ' A' ' 56' ' ' ILE . 93.8 p -81.32 164.86 21.88 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.591 0.71 . . . . 0.0 111.833 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -115.13 -12.68 11.88 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -116.86 90.65 3.38 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -49.9 132.92 22.71 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.543 2.337 . . . . 0.0 113.656 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.11 157.64 19.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 2.9 mt-30 -81.05 149.14 29.36 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.71 141.62 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -166.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.9 m -134.3 104.93 6.37 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.4 m -85.67 104.05 15.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 70.2 m -83.32 114.74 21.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -111.34 142.29 43.77 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -93.43 136.67 33.47 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -140.83 172.6 12.46 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.39 -91.22 0.6 Allowed Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.62 -11.33 1.12 Allowed Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -78.46 134.86 61.53 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -80.35 -30.35 2.07 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.682 1.588 . . . . 0.0 108.093 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -97.14 154.88 37.99 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.44 -168.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.57 150.19 27.73 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 122.292 1.995 . . . . 0.0 107.429 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -81.7 165.04 74.67 Favored 'Cis proline' 0 CA--C 1.49 -1.707 0 CA-C-N 123.028 2.117 . . . . 0.0 109.462 7.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.7 m -149.84 141.49 23.55 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -167.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.73 141.33 30.63 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 36.9 m-85 -134.35 110.01 9.17 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -91.16 132.71 35.9 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.76 130.49 35.38 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.618 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -113.9 95.63 5.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.78 141.7 34.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.41 -173.8 23.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 84.7 t80 -160.62 107.97 1.55 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.33 164.04 39.3 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.247 -173.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.81 123.78 28.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.718 1.207 . . . . 0.0 108.745 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -96.02 139.61 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.664 -163.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.6 t -96.36 112.06 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.276 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -105.06 148.13 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 170.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.24 36.61 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.95 151.15 24.96 Favored 'General case' 0 CA--C 1.494 -1.209 0 O-C-N 124.237 0.96 . . . . 0.0 110.636 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -148.76 128.74 13.51 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.346 8.2 p30 70.77 7.85 6.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.592 2.357 . . . . 0.0 115.557 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.37 2.79 57.73 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.263 5.5 tp -113.99 154.72 45.99 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -72.0 159.35 50.45 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.054 1.836 . . . . 0.0 108.263 163.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -138.27 -20.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.493 175.144 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 113' ' ' VAL . 41.1 m-70 -149.86 177.71 9.57 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -126.74 136.07 51.94 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.52 118.73 28.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.08 40.26 1.36 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -173.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.0 m -96.76 -28.32 14.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 pt -91.47 -20.78 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -97.83 -9.67 26.04 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -71.76 -37.03 70.58 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -73.24 129.72 85.6 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 N--CA 1.434 -1.986 0 N-CA-C 106.158 -2.285 . . . . 0.0 106.158 -171.163 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 . . . . . 0 CA--C 1.488 -1.44 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.02 61.86 0.66 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -88.61 -28.27 20.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.31 -6.63 49.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -33.46 44.39 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 0.7 OUTLIER -64.68 -50.25 67.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.055 1.342 . . . . 0.0 109.0 173.265 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.484 1.7 t -88.06 10.85 17.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -80.49 -40.78 25.51 Favored 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 119.974 -1.704 . . . . 0.0 107.836 157.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.95 -40.25 80.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.117 1.367 . . . . 0.0 109.588 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 14' ' ' TYR . 18.0 mt -83.28 -15.65 49.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.3 m -65.86 -47.71 74.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-N 120.465 1.484 . . . . 0.0 109.224 169.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -77.83 -40.3 40.77 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 124.212 1.005 . . . . 0.0 111.187 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -96.17 -54.92 3.13 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 118.482 0.583 . . . . 0.0 110.377 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB2' HD22 ' A' ' 10' ' ' LEU . 50.5 t80 -77.66 118.77 20.37 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.982 0.896 . . . . 0.0 110.382 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.07 98.11 3.79 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.45 -41.24 6.12 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 -165.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -156.26 139.27 10.8 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 164.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.2 Cg_endo -85.54 170.96 8.85 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.876 1.717 . . . . 0.0 108.663 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -73.25 -79.77 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -177.03 20.05 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 103.494 -3.842 . . . . 0.0 103.494 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -127.38 70.87 1.32 Allowed 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -147.46 -178.76 6.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -66.21 -26.2 67.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.824 1.249 . . . . 0.0 113.777 -171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -81.25 -27.08 35.33 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 122.599 0.36 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -72.11 -42.72 65.77 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 0.1 OUTLIER -81.25 -24.99 36.97 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 119.081 -1.048 . . . . 0.0 113.371 -170.064 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.06 -36.6 66.91 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.467 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -69.62 -34.19 73.73 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.3 tt -85.19 -24.75 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 CA-C-N 118.308 0.504 . . . . 0.0 110.579 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -31.09 63.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.588 172.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -73.75 -36.63 65.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -81.54 -41.91 20.95 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -77.63 -21.15 52.7 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.233 0.469 . . . . 0.0 111.904 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.67 50.69 1.94 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.344 4.0 mm? -108.09 -14.65 14.68 Favored 'General case' 0 CA--C 1.48 -1.749 0 C-N-CA 124.216 1.006 . . . . 0.0 108.636 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 t -74.6 -15.34 60.84 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.897 1.679 . . . . 0.0 112.735 -163.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -121.84 108.3 35.0 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.78 156.22 99.69 Favored 'Cis proline' 0 N--CA 1.441 -1.594 0 N-CA-C 106.722 -2.068 . . . . 0.0 106.722 -25.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.1 m -59.9 127.91 34.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 125.518 1.527 . . . . 0.0 112.026 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -80.3 140.27 36.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -77.06 -37.62 54.25 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.774 -168.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.56 129.7 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -152.38 130.0 11.53 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 170.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -97.64 128.72 44.55 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.893 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -94.83 118.04 31.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -87.14 148.07 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -142.86 130.09 20.93 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.719 -176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 -129.98 1.84 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 106.579 -2.609 . . . . 0.0 106.579 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -115.36 145.08 42.86 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.01 -18.83 29.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.02 0.438 . . . . 0.0 109.907 -170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -80.26 -24.64 39.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -71.07 -40.65 71.49 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 117.312 -1.328 . . . . 0.0 110.076 172.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.19 -53.87 34.31 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 C-N-CA 124.844 1.258 . . . . 0.0 111.165 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.56 -43.26 89.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.189 1.396 . . . . 0.0 111.517 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.24 8.41 9.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mm -75.37 -27.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.5 t -72.85 -29.03 62.88 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 117.564 0.165 . . . . 0.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.34 153.72 42.13 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.03 8.76 33.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.666 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.04 -50.86 7.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -110.76 -3.88 15.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.684 -166.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.31 -159.12 7.99 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 103.894 -3.682 . . . . 0.0 103.894 168.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -162.26 152.95 14.54 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -73.5 137.89 26.09 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.995 2.463 . . . . 0.0 107.503 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -129.61 122.78 29.77 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? 67.94 -100.26 0.05 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 125.181 1.393 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -162.57 108.8 1.22 Allowed 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.412 0.5 OUTLIER 86.71 -6.66 0.71 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 129.857 3.263 . . . . 0.0 114.145 173.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.8 156.82 17.27 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -141.75 115.72 9.28 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.26 141.95 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -84.47 162.71 19.81 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.63 0.729 . . . . 0.0 112.181 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.89 -27.28 9.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 m -103.03 79.78 1.79 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -47.4 133.81 12.29 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 128.336 2.654 . . . . 0.0 113.502 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -112.3 158.73 19.41 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -167.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -79.92 125.19 29.42 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.11 103.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.9 m -90.6 107.77 19.38 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -87.41 105.59 17.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.1 m -97.4 114.49 26.32 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -114.76 136.85 52.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.86 118.66 10.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.832 1.653 . . . . 0.0 107.824 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -136.39 97.5 3.6 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.32 -42.61 0.07 OUTLIER Glycine 0 CA--C 1.48 -2.136 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.72 6.18 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 m -112.13 109.92 54.17 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -85.2 -20.46 3.38 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 121.769 1.668 . . . . 0.0 108.51 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -112.1 159.46 33.62 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -169.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -75.11 145.36 30.98 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.563 2.176 . . . . 0.0 107.929 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -81.91 162.68 77.74 Favored 'Cis proline' 0 N--CA 1.436 -1.91 0 CA-C-N 122.437 1.906 . . . . 0.0 107.969 -1.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.0 m -108.45 166.03 11.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -171.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -122.27 116.75 24.64 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.76 133.02 54.98 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -99.47 117.06 33.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 165.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.39 131.68 34.66 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 m -123.31 107.83 12.09 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.45 135.01 36.55 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.898 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.72 -174.89 13.57 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 106.09 -2.804 . . . . 0.0 106.09 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.48 106.18 1.9 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -156.88 168.92 26.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -78.1 132.67 37.79 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.569 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.46 138.89 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.391 -170.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.9 t -101.22 96.13 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.24 136.65 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.58 143.54 30.07 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.8 t -136.42 137.02 40.03 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.178 0.513 . . . . 0.0 110.624 -170.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -128.23 131.73 48.8 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.306 14.1 p30 64.47 21.19 12.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 117.106 2.262 . . . . 0.0 117.106 171.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.56 53.73 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tp -144.63 118.49 5.69 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -172.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -71.51 118.29 5.58 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 CA-C-N 121.817 1.685 . . . . 0.0 111.416 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -26.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 118.816 0.735 . . . . 0.0 112.664 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -149.3 -166.2 2.49 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.1 133.56 4.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.65 141.02 34.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.509 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -105.16 42.09 1.27 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.0 m -95.87 -29.07 14.4 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -32.67 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 124.981 1.312 . . . . 0.0 109.475 170.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -105.61 41.45 1.38 Allowed 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.36 -37.23 20.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -82.94 150.35 61.53 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.432 -2.128 0 N-CA-C 104.202 -3.038 . . . . 0.0 104.202 162.867 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 . . . . . 0 CA--C 1.486 -1.511 0 CA-C-O 120.902 0.382 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.56 48.18 2.09 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -109.59 -2.46 17.52 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t -93.59 -28.12 16.21 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 167.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -34.46 63.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.084 0.954 . . . . 0.0 108.803 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' HB2' HD21 ' A' ' 111' ' ' LEU . 63.3 t80 -46.46 -60.32 2.42 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 127.053 2.141 . . . . 0.0 111.796 162.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 1.6 p -72.73 -12.56 61.06 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -76.62 -41.91 44.22 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.799 1.181 . . . . 0.0 109.824 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -63.03 -36.27 83.0 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.995 1.718 . . . . 0.0 109.342 171.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -73.67 -26.7 60.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.034 1.333 . . . . 0.0 114.493 177.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 79.8 m -69.81 -51.31 34.81 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.4 pt20 -84.82 -10.25 57.36 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.613 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 83.7 m-70 -138.03 2.67 2.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 36.2 t80 -107.07 132.34 53.09 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 120.52 1.509 . . . . 0.0 108.834 171.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.33 104.36 3.09 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 167.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -37.92 16.77 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -162.14 138.13 5.8 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 86.0 Cg_exo -74.01 173.58 13.83 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.274 1.983 . . . . 0.0 114.465 -172.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.78 -73.87 0.24 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.98 -175.82 15.29 Favored Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 167.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.2 69.29 1.21 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.36 -176.96 5.68 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.45 -21.95 61.89 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.324 1.05 . . . . 0.0 113.366 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -81.95 -23.44 36.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -77.55 -37.55 50.48 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.0 m -69.46 -37.09 77.17 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -77.12 -30.71 55.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 119.456 -0.307 . . . . 0.0 110.339 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -70.33 -35.27 73.51 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.0 tt -85.96 -25.97 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 120.605 0.241 . . . . 0.0 110.89 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 mmt -76.49 -31.21 57.61 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.79 -0.569 . . . . 0.0 109.777 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -69.57 -38.64 77.48 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.159 0.984 . . . . 0.0 112.172 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -71.11 -52.04 21.59 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.465 1.106 . . . . 0.0 110.865 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.24 -26.28 39.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.145 0.578 . . . . 0.0 109.543 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.65 63.24 1.29 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 164.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.16 23.35 1.86 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.684 1.231 . . . . 0.0 108.335 174.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -84.23 -9.48 58.48 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.532 1.933 . . . . 0.0 109.696 167.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.9 t -120.22 107.77 39.0 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.82 165.45 84.87 Favored 'Cis proline' 0 N--CA 1.448 -1.184 0 CA-C-N 122.593 1.962 . . . . 0.0 107.557 -18.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 83' ' ' LEU . 49.9 m -61.38 120.51 10.59 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.798 0.839 . . . . 0.0 110.757 -175.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -79.4 144.12 34.42 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -75.19 -40.2 59.56 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 123.097 0.559 . . . . 0.0 111.762 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.26 133.76 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.8 121.09 4.85 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -102.35 115.47 30.63 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.004 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.0 120.25 26.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -101.81 146.71 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -132.49 127.92 36.26 Favored 'General case' 0 CA--C 1.485 -1.521 0 C-N-CA 124.672 1.189 . . . . 0.0 108.574 -172.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.72 -143.85 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 105.374 -3.09 . . . . 0.0 105.374 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -95.27 148.61 22.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -88.69 -17.96 28.88 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -69.55 -36.01 75.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.9 t -74.61 -36.13 62.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 117.335 -1.317 . . . . 0.0 111.006 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 53' ' ' ILE . 3.2 tp -64.85 -46.52 91.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.301 0 CA-C-N 119.542 1.065 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -61.54 -41.88 97.99 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.747 1.219 . . . . 0.0 111.243 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.62 2.39 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.5 mm -74.48 -36.32 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.8 m -85.81 -31.49 22.28 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -102.07 57.31 0.81 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 117.796 0.271 . . . . 0.0 111.242 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 34.81 65.48 0.35 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 130.174 3.389 . . . . 0.0 115.54 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.94 -58.76 0.96 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -99.51 -44.43 6.17 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 154.58 21.55 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.588 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.27 154.16 42.3 Favored Pre-proline 0 N--CA 1.434 -1.247 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.75 137.31 22.16 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.984 2.456 . . . . 0.0 107.105 -175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.5 73.49 1.19 Allowed 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 69.49 -101.28 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 126.325 1.85 . . . . 0.0 113.551 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.96 77.21 1.23 Allowed 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 123.935 0.894 . . . . 0.0 108.759 -163.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.319 6.4 p30 71.92 11.56 6.18 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 129.421 3.089 . . . . 0.0 114.222 170.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.24 157.33 16.86 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -140.11 119.33 12.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -88.76 143.35 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.3 p -83.85 169.01 15.58 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -134.63 3.79 3.3 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.4 m -105.39 79.55 1.48 Allowed 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -53.24 128.43 28.03 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 127.506 2.322 . . . . 0.0 112.18 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -108.86 158.96 17.17 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -170.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 8.5 mt-30 -77.57 145.35 36.92 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.88 142.06 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -171.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.9 m -134.5 102.51 5.34 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 102.097 -3.298 . . . . 0.0 102.097 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 106.79 14.29 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.9 m -89.24 113.04 24.22 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -124.61 136.78 54.23 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -169.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 39' ' ' CYS . 42.3 tp -78.64 123.63 27.33 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -138.06 52.65 1.84 Allowed 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.95 -88.2 2.01 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.66 -16.79 4.01 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -83.92 136.62 41.3 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -81.17 -23.4 5.28 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 121.83 1.687 . . . . 0.0 108.422 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -105.33 164.46 15.04 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -74.26 143.7 32.1 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 107.035 -1.948 . . . . 0.0 107.035 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -82.9 160.97 75.3 Favored 'Cis proline' 0 N--CA 1.435 -1.913 0 CA-C-N 123.062 2.129 . . . . 0.0 109.583 7.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.1 m -125.24 138.68 54.11 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -173.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.61 99.73 11.81 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -94.16 111.83 23.59 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -87.65 124.99 34.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.94 125.8 29.85 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.4 m -110.19 87.26 2.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.18 131.17 34.83 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -172.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.58 -162.35 9.2 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.049 -2.021 . . . . 0.0 108.049 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.413 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.9 t80 -155.21 102.32 2.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -137.91 155.62 48.73 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -158.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -74.36 127.82 33.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.54 131.55 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -92.47 113.22 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.443 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.14 141.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 173.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.24 127.69 37.81 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.7 m -108.65 151.66 25.85 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 121.836 0.827 . . . . 0.0 112.004 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.33 127.15 14.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 15.3 p30 60.01 25.38 14.6 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 128.054 2.542 . . . . 0.0 115.422 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.18 20.71 60.18 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -139.87 138.59 19.98 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.158 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.62 117.77 1.77 Allowed 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 121.535 1.584 . . . . 0.0 108.947 -170.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.83 -23.08 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 123.572 0.545 . . . . 0.0 112.246 -176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 28.4 m80 -143.0 -177.73 5.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -170.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.4 tp -139.07 143.09 38.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 123.98 33.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -112.17 11.7 20.35 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 t -90.79 -32.43 16.11 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -25.52 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 C-N-CA 124.304 1.042 . . . . 0.0 110.749 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -100.44 25.16 7.97 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -84.3 -73.61 0.42 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.33 122.36 63.22 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 174.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.437 -1.851 0 C-N-CA 122.431 2.087 . . . . 0.0 107.443 -168.281 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 . . . . . 0 CA--C 1.489 -1.393 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -145.96 89.73 1.91 Allowed 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 82.65 6.25 0.92 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 127.452 2.301 . . . . 0.0 108.018 -170.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.7 -30.21 16.42 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 164.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -49.19 77.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 125.726 1.61 . . . . 0.0 109.549 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HB2' HD21 ' A' ' 111' ' ' LEU . 49.8 t80 -51.27 -62.85 1.37 Allowed 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 127.443 2.297 . . . . 0.0 113.542 172.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -70.86 -10.09 58.9 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -83.33 -39.5 20.68 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.597 1.09 . . . . 0.0 109.566 171.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 1.9 t80 -60.12 -37.88 81.35 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 109.617 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -74.03 -31.41 62.89 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 125.849 1.66 . . . . 0.0 113.576 178.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 p -75.26 -39.24 60.02 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 120.702 1.592 . . . . 0.0 110.646 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -67.36 -56.95 7.61 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 123.609 0.568 . . . . 0.0 111.253 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -89.67 -48.71 7.1 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.69 -167.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.451 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 24.5 t80 -70.68 119.46 14.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.955 1.252 . . . . 0.0 110.608 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -137.6 97.78 3.53 Favored 'General case' 0 N--CA 1.424 -1.77 1 N-CA-C 99.673 -4.195 . . . . 0.0 99.673 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.56 -41.69 10.17 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.502 2.321 . . . . 0.0 117.225 -166.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -159.57 131.09 3.98 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 168.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -70.91 180.0 3.88 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 123.146 2.564 . . . . 0.0 114.946 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.87 -77.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.76 -1.564 . . . . 0.0 106.949 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.06 -173.38 14.37 Favored Glycine 0 CA--C 1.478 -2.233 1 N-CA-C 102.284 -4.326 . . . . 0.0 102.284 162.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.29 72.29 0.86 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -143.91 179.71 7.01 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.52 -41.71 73.5 Favored 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 127.926 2.491 . . . . 0.0 112.931 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -79.21 -21.13 46.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.027 0.531 . . . . 0.0 111.904 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.4 -41.77 55.34 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.5 m -68.37 -37.21 80.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.755 0.659 . . . . 0.0 112.143 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.61 -37.92 70.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.805 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.8 m -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 13.2 tt -81.72 -29.76 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 CA-C-N 118.197 0.453 . . . . 0.0 109.87 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -25.58 51.7 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.943 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -75.92 -33.22 59.86 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.295 0.498 . . . . 0.0 111.109 173.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.17 -48.92 21.27 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.134 0.573 . . . . 0.0 110.833 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -78.41 -26.74 46.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 110.528 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.14 55.24 2.0 Favored Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 mt -116.12 13.77 15.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.56 -12.67 53.67 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.064 0.546 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 m -121.12 102.25 43.75 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.13 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 167.82 79.22 Favored 'Cis proline' 0 N--CA 1.445 -1.334 0 N-CA-C 107.049 -1.943 . . . . 0.0 107.049 -22.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.0 m -59.47 122.21 13.44 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.865 0.866 . . . . 0.0 111.331 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.44 143.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.65 -37.22 31.36 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 119.769 -0.158 . . . . 0.0 110.611 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.73 130.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -143.79 121.6 11.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.6 m -92.39 105.66 17.8 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.24 116.28 23.5 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.19 150.47 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -141.87 136.04 30.13 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 125.268 1.427 . . . . 0.0 108.151 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.49 -104.6 0.24 Allowed Glycine 0 CA--C 1.483 -1.918 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -147.84 127.12 13.01 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -86.18 -3.86 59.05 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.255 -0.278 . . . . 0.0 111.601 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -30.57 35.54 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 p -85.54 -23.31 27.74 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 117.695 -1.145 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.2 mm -59.68 -54.26 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-N 119.086 0.857 . . . . 0.0 108.715 167.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -58.38 -42.83 87.94 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.418 1.487 . . . . 0.0 112.447 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 14.94 2.33 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.54 -38.37 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.43 44.34 1.02 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.009 0.433 . . . . 0.0 110.583 -171.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -133.37 21.37 4.0 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 164.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 41.46 44.05 2.38 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.292 3.437 . . . . 0.0 114.159 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.54 -45.01 7.59 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -120.03 8.92 11.07 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.78 -169.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.02 163.73 30.22 Favored Glycine 0 CA--C 1.485 -1.791 0 C-N-CA 118.872 -1.632 . . . . 0.0 109.079 -175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -112.05 156.74 41.38 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.14 135.0 24.18 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 122.666 2.244 . . . . 0.0 106.364 166.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -129.65 133.78 47.31 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 64.59 -102.65 0.09 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.426 1.49 . . . . 0.0 111.396 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -154.88 112.56 3.42 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.342 5.8 p30 68.44 15.15 9.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 129.642 3.177 . . . . 0.0 114.55 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.86 167.93 9.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 103.306 -2.85 . . . . 0.0 103.306 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.39 109.44 4.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -172.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 tt -91.02 146.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -82.21 177.21 8.92 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.478 1.132 . . . . 0.0 111.471 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' H ' ' H ' ' A' ' 74' ' ' SER . 20.4 tptm -148.68 -0.08 0.55 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.435 ' H ' ' H ' ' A' ' 73' ' ' LYS . 36.3 t -119.76 90.14 3.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 130.01 44.76 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 125.937 1.695 . . . . 0.0 112.648 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.71 158.74 18.3 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -79.74 141.07 36.68 Favored 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.17 142.82 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -166.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -130.68 109.17 10.43 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 166.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.0 m -82.33 100.86 10.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.2 m -86.76 112.28 21.53 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.21 141.94 49.46 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 39' ' ' CYS . 28.9 tp -77.75 121.49 24.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -172.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -135.56 50.45 2.11 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.53 -63.64 0.83 Allowed Glycine 0 CA--C 1.482 -1.977 0 N-CA-C 105.401 -3.08 . . . . 0.0 105.401 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.91 -15.93 21.04 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 p -86.3 140.49 34.34 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -81.32 -22.37 5.82 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.833 1.689 . . . . 0.0 108.664 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -105.55 162.57 19.33 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.423 -168.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -74.02 146.95 37.8 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.401 2.068 . . . . 0.0 108.106 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -83.07 164.49 71.24 Favored 'Cis proline' 0 CA--C 1.49 -1.722 0 CA-C-N 122.753 2.019 . . . . 0.0 109.197 5.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 39.5 m -128.24 130.11 47.45 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -95.61 120.54 36.05 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.32 117.34 32.22 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -93.09 135.54 34.17 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.52 139.4 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.553 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 m -124.13 98.74 5.91 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 171.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 147.16 28.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.075 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.61 36.5 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -152.58 100.9 2.6 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -152.31 170.36 20.23 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.808 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -75.61 129.87 37.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 108.912 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.42 141.98 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.72 113.06 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.421 HG12 HD13 ' A' ' 115' ' ' LEU . 18.1 m -107.21 147.61 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.92 121.01 31.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 40.4 t -106.33 126.98 52.91 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 123.856 0.723 . . . . 0.0 110.741 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.61 132.82 54.46 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 5.5 p30 75.03 0.48 3.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 167.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 23.1 11.06 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 6' ' ' TYR . 19.1 tp -141.1 127.49 11.51 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 14.2 Cg_endo -78.8 102.14 1.51 Allowed 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.07 -23.13 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 123.694 0.798 . . . . 0.0 111.631 -166.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -138.37 -177.6 4.92 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 5.2 tp -124.65 135.91 53.48 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.91 138.2 31.74 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.56 51.24 0.77 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.3 t -81.41 -49.54 10.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.327 0.651 . . . . 0.0 109.953 -171.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.87 -28.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -173.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.19 -21.96 39.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.3 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -84.84 -30.8 24.21 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 123.144 0.278 . . . . 0.0 111.202 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 146.47 69.85 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.433 -2.061 0 N-CA-C 106.081 -2.315 . . . . 0.0 106.081 176.14 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 CA--C 1.489 -1.386 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 5' ' ' ARG . 2.8 m-20 66.64 83.1 0.17 Allowed 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 127.198 2.199 . . . . 0.0 109.197 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 t30 101.14 -32.83 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 128.935 2.894 . . . . 0.0 107.908 -175.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -88.24 -20.8 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.49 ' HB2' ' H ' ' A' ' 2' ' ' ASP . 1.1 tmt_? -75.49 -21.02 58.39 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.259 1.023 . . . . 0.0 110.407 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -76.29 -39.05 55.24 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.777 1.231 . . . . 0.0 108.232 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.478 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -80.31 -10.6 59.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.22 0.918 . . . . 0.0 113.464 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -75.04 -46.35 35.5 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.94 -34.45 71.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.249 2.22 . . . . 0.0 111.631 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.332 0.0 OUTLIER -106.97 -4.66 18.82 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.753 0.821 . . . . 0.0 111.726 -173.254 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 t -83.64 -28.74 28.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 169.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -67.82 -70.33 0.26 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 163.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -105.48 12.95 30.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -155.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 36.7 t80 -112.33 128.05 56.17 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.187 1.358 . . . . 0.0 109.33 169.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -145.34 100.9 3.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 166.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.16 -39.57 6.26 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 -166.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -154.81 137.3 10.02 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 171.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 40.9 Cg_endo -86.25 174.53 6.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 121.731 1.621 . . . . 0.0 108.72 -171.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -74.33 -50.54 18.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 172.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.23 -174.07 28.48 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -114.6 66.43 0.68 Allowed 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -150.58 173.48 14.07 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -172.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.11 -23.39 63.03 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.82 1.248 . . . . 0.0 113.185 -171.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.09 30.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -74.12 -43.85 56.0 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.3 m -67.34 -36.02 80.58 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.79 -34.37 62.41 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.39 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.5 t -69.21 -36.62 77.45 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 tt -82.4 -28.08 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 117.873 0.306 . . . . 0.0 111.017 -175.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mmt -78.33 -24.75 46.42 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.832 176.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -42.4 63.81 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 172.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -45.1 30.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.527 0.331 . . . . 0.0 111.761 -169.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.17 -22.03 53.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.13 56.22 1.62 Allowed Glycine 0 C--N 1.352 1.454 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.326 4.0 mm? -108.73 -16.71 14.12 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 124.532 1.133 . . . . 0.0 108.855 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -76.19 -11.47 59.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.577 1.551 . . . . 0.0 112.883 -164.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t -124.79 108.52 28.38 Favored Pre-proline 0 N--CA 1.438 -1.025 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.838 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.72 157.66 98.41 Favored 'Cis proline' 0 N--CA 1.447 -1.227 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 -23.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.7 m -54.89 129.98 39.54 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 125.43 1.492 . . . . 0.0 113.258 -173.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -77.27 132.91 38.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 171.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.64 -38.55 58.79 Favored 'General case' 0 CA--C 1.487 -1.477 0 O-C-N 123.495 0.497 . . . . 0.0 110.871 -169.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.48 135.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 174.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.09 120.03 7.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.2 m -96.73 107.62 20.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.09 117.22 25.68 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.0 mt -98.44 147.68 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -175.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.51 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -137.62 129.93 29.36 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 125.392 1.477 . . . . 0.0 108.797 -169.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.57 -134.98 3.59 Favored Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 106.006 -2.838 . . . . 0.0 106.006 173.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.94 142.38 29.74 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 173.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.88 -21.22 29.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -74.08 -30.36 62.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.094 1.358 . . . . 0.0 109.437 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.2 m -77.2 -33.22 56.33 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 117.414 -1.279 . . . . 0.0 110.871 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -56.01 -56.14 14.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 119.037 0.835 . . . . 0.0 110.11 172.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -56.59 -41.24 76.64 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.92 15.39 1.1 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.8 mt -81.16 -34.21 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 168.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.44 -44.67 62.05 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.782 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.49 156.46 22.84 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.91 87.12 7.25 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.057 0.456 . . . . 0.0 109.933 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.73 -47.52 1.04 Allowed 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.99 58.55 1.35 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 177.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.49 151.42 10.91 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 174.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -115.71 157.95 43.19 Favored Pre-proline 0 N--CA 1.432 -1.362 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -74.3 143.24 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.898 2.399 . . . . 0.0 106.506 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -142.03 127.38 18.77 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? 65.2 -107.39 0.14 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.026 1.33 . . . . 0.0 110.375 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.89 101.02 3.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.364 2.3 p-10 63.82 25.84 14.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 129.08 2.952 . . . . 0.0 114.505 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.09 157.4 17.87 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 168.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -138.14 120.97 16.46 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 tt -88.61 145.59 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.6 p -88.15 165.45 15.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.649 0.738 . . . . 0.0 109.914 -175.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.96 11.77 5.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -123.06 96.17 4.9 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.6 m -62.26 131.63 50.02 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 124.368 1.067 . . . . 0.0 110.645 175.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -112.58 155.87 23.64 Favored 'General case' 0 CA--C 1.473 -1.999 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 138.53 39.22 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 140.84 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -167.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.0 m -129.3 105.67 8.29 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 167.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 m -85.55 99.98 11.62 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.1 m -85.65 112.1 20.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -117.74 145.99 44.09 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.268 17.1 mt -65.82 135.71 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.029 0.442 . . . . 0.0 110.365 175.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.35 45.44 2.76 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 156.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.01 -83.35 1.42 Allowed Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.08 -25.8 5.7 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -85.35 131.47 48.0 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -84.01 -14.77 7.18 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.097 1.865 . . . . 0.0 108.561 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -100.35 168.05 9.98 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.64 143.77 34.52 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.61 163.98 51.46 Favored 'Cis proline' 0 N--CA 1.436 -1.883 0 CA-C-N 122.35 1.875 . . . . 0.0 108.008 10.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.9 m -128.75 125.99 39.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -172.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -95.38 128.0 41.88 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -120.07 126.06 49.83 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -90.96 129.78 36.95 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.09 129.58 34.86 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -120.44 90.26 3.29 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.86 150.89 23.24 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.354 0.597 . . . . 0.0 110.742 -172.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.53 -170.38 20.28 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -144.08 90.19 2.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -124.39 145.99 49.14 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -159.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -80.89 128.79 34.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.29 138.91 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.604 -164.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -95.24 113.55 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.63 141.51 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 172.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.64 128.16 36.53 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.0 m -108.11 154.01 22.33 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.139 0.899 . . . . 0.0 110.893 -175.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -147.13 127.41 13.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.321 8.6 p30 69.75 11.97 7.93 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.784 2.034 . . . . 0.0 114.679 177.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.86 55.45 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tp -141.46 142.26 25.78 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -70.75 152.53 64.24 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 CA-C-N 121.946 1.731 . . . . 0.0 111.564 -173.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.72 -25.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.407 -178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -143.18 178.02 8.0 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -173.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.65 139.9 36.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -173.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.26 121.58 29.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -107.6 10.28 29.18 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -93.18 -20.39 20.52 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -76.0 -36.71 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.797 0 C-N-CA 123.623 0.769 . . . . 0.0 110.933 173.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -92.22 -6.79 49.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -170.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -127.07 62.45 1.34 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.448 -2.426 . . . . 0.0 104.448 176.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -76.29 147.61 79.65 Favored Pre-proline 0 N--CA 1.432 -1.349 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.875 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 N--CA 1.433 -2.075 0 N-CA-C 106.008 -2.343 . . . . 0.0 106.008 173.661 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 . . . . . 0 CA--C 1.485 -1.554 0 CA-C-O 120.578 0.228 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -120.74 50.9 1.28 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 170.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -101.85 -10.52 19.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 169.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -90.88 -14.24 32.11 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.017 177.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -74.1 -45.32 49.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.61 -55.31 35.61 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-O 116.551 -1.69 . . . . 0.0 111.493 168.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -81.78 -1.22 46.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 122.011 2.187 . . . . 0.0 115.659 -170.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -85.61 -30.69 23.09 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.63 -28.98 70.28 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.307 0.643 . . . . 0.0 111.205 164.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.535 HD12 ' HE3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -84.98 -23.47 28.7 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.327 0.967 . . . . 0.0 112.252 177.792 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -72.77 -38.19 67.4 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 120.323 1.42 . . . . 0.0 109.106 174.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -65.37 -58.2 6.46 Favored 'General case' 0 N--CA 1.413 -2.282 0 C-N-CA 124.724 1.209 . . . . 0.0 112.498 172.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -125.62 27.99 6.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -160.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -133.66 136.42 44.74 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 166.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -152.85 108.61 3.31 Favored 'General case' 0 N--CA 1.423 -1.811 1 N-CA-C 100.172 -4.011 . . . . 0.0 100.172 169.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -36.02 5.21 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 118.702 2.852 . . . . 0.0 118.702 -164.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -145.65 154.91 52.75 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 19.7 Cg_endo -70.92 143.08 44.34 Favored 'Trans proline' 0 N--CA 1.431 -2.203 0 C-N-CA 123.423 2.749 . . . . 0.0 107.6 165.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -80.35 -50.83 9.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 168.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.07 179.45 17.34 Favored Glycine 0 CA--C 1.478 -2.233 0 N-CA-C 103.994 -3.643 . . . . 0.0 103.994 163.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -123.36 53.59 1.32 Allowed 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -140.03 -179.08 5.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -170.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.25 -23.1 63.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.841 1.256 . . . . 0.0 113.084 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -86.53 -20.03 28.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 122.962 0.505 . . . . 0.0 110.178 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.55 -41.53 46.25 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -69.15 -35.62 76.55 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 123.797 0.685 . . . . 0.0 112.768 -177.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.7 -39.11 67.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -75.43 -24.3 57.06 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.261 12.7 tt -82.86 -33.04 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.612 0 CA-C-N 118.852 0.751 . . . . 0.0 109.563 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mmt -77.91 -20.84 52.16 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.624 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -72.1 -44.81 62.64 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.239 0.472 . . . . 0.0 111.858 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.69 -39.8 50.89 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.924 0.489 . . . . 0.0 111.964 -173.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -75.78 -29.98 58.95 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 123.316 0.646 . . . . 0.0 110.222 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 52.41 2.49 Favored Glycine 0 CA--C 1.491 -1.43 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 170.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.6 mt -121.85 18.28 11.01 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -91.85 -10.76 38.56 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.4 1.08 . . . . 0.0 108.802 -173.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -129.57 105.22 17.33 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.1 159.36 95.67 Favored 'Cis proline' 0 N--CA 1.444 -1.425 0 N-CA-C 107.133 -1.91 . . . . 0.0 107.133 -19.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.406 ' HB3' HD13 ' A' ' 83' ' ' LEU . 44.4 m -63.05 123.09 17.69 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.968 0.907 . . . . 0.0 109.522 -177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -71.42 140.78 50.22 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.02 -46.73 50.37 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.965 0.506 . . . . 0.0 111.049 -172.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 132.52 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -151.16 119.15 6.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -96.22 112.84 24.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -177.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -87.6 118.48 27.11 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 171.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.17 152.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -177.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.583 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 7.3 m-70 -136.26 133.18 36.72 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 124.648 1.179 . . . . 0.0 108.195 -171.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.83 -119.66 0.88 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -132.6 138.72 47.5 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HE3' HD12 ' A' ' 10' ' ' LEU . 30.8 mtpt -86.74 -7.14 58.54 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.451 -172.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -80.27 -32.52 38.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -36.93 73.6 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 123.996 0.919 . . . . 0.0 110.543 174.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.41 -53.1 51.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 C-N-CA 124.906 1.282 . . . . 0.0 111.38 174.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.75 -39.24 76.92 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.285 1.034 . . . . 0.0 113.038 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.41 9.4 11.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.602 0.761 . . . . 0.0 112.978 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 72' ' ' SER . 22.3 mm -78.56 -28.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 168.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.02 -21.01 51.41 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -80.51 170.8 15.87 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -88.1 5.89 38.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.834 0.854 . . . . 0.0 110.685 -178.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -75.02 -63.24 1.31 Allowed 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 123.842 0.857 . . . . 0.0 110.169 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -89.0 -50.58 6.09 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -176.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.1 149.21 19.12 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -163.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -102.98 154.57 37.45 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -178.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.03 141.58 33.16 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 123.102 2.535 . . . . 0.0 106.828 175.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -134.99 34.68 3.1 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -169.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 62.21 156.56 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 129.072 2.949 . . . . 0.0 114.05 -176.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 42.89 54.58 4.68 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 129.209 3.004 . . . . 0.0 115.831 176.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.311 2.7 p-10 52.58 34.46 15.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.622 2.769 . . . . 0.0 114.764 -176.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.92 151.54 25.65 Favored 'General case' 0 CA--C 1.478 -1.813 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -140.62 118.26 11.61 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -175.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.69 146.15 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 176.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.414 ' HB2' HD12 ' A' ' 56' ' ' ILE . 83.6 p -92.69 169.0 10.83 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -131.23 -6.17 3.83 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -106.28 78.86 1.33 Allowed 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.6 t -46.74 127.76 10.03 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 128.324 2.65 . . . . 0.0 113.218 -177.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.73 157.69 18.32 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -170.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 139.58 41.45 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.07 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.5 140.98 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -170.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -132.45 110.56 10.61 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 164.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -88.7 101.19 13.75 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.35 114.36 22.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -121.72 129.1 52.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -168.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 39' ' ' CYS . 34.5 tp -72.98 114.9 11.64 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.989 1.316 . . . . 0.0 108.09 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -138.68 95.9 3.05 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 -176.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.12 -41.41 0.05 OUTLIER Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 -177.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.42 41.23 6.58 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -177.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -117.81 106.6 45.64 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -82.76 -21.66 4.83 Favored 'Trans proline' 0 N--CA 1.439 -1.708 0 CA-C-N 121.535 1.584 . . . . 0.0 108.935 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -107.24 161.69 22.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.98 142.52 31.43 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.498 2.132 . . . . 0.0 107.486 -176.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -82.77 161.58 75.36 Favored 'Cis proline' 0 CA--C 1.486 -1.876 0 CA-C-N 123.06 2.128 . . . . 0.0 108.798 4.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.1 m -109.41 159.22 17.2 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -173.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -116.58 90.28 3.3 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.02 117.45 30.69 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -102.53 132.25 48.71 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 131.08 35.28 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -117.39 86.34 2.5 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.02 148.48 21.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.999 -172.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -152.69 -163.37 11.6 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -146.72 98.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 101.033 -3.691 . . . . 0.0 101.033 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -133.16 144.49 49.9 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -162.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -74.85 124.58 27.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.722 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.95 140.66 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.313 -165.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.07 114.91 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 165.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.6 141.84 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -101.52 113.44 26.56 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.6 p -113.99 163.64 14.86 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 122.319 1.057 . . . . 0.0 113.085 -173.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -153.64 136.46 15.34 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.354 7.9 p30 71.72 2.95 4.49 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.716 2.406 . . . . 0.0 116.092 174.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.6 -2.41 34.32 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.41 128.7 25.8 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -73.58 119.65 6.05 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.682 -2.084 . . . . 0.0 106.682 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.465 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -105.62 -17.01 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 123.952 0.783 . . . . 0.0 110.021 -167.533 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.465 ' ND1' HG23 ' A' ' 113' ' ' VAL . 29.1 m80 -153.34 177.17 11.17 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.29 142.03 35.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -174.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.74 126.68 37.94 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 167.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -108.88 10.9 26.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -173.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -87.72 -25.68 23.32 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.17 0.51 . . . . 0.0 109.789 -166.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -21.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 C-N-CA 124.161 0.984 . . . . 0.0 109.889 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -103.0 52.98 0.78 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.352 16.4 ptm180 57.9 61.94 2.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 129.184 2.994 . . . . 0.0 113.301 176.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -138.28 102.54 8.12 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 164.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo . . . . . 0 N--CA 1.435 -1.955 0 N-CA-C 105.823 -2.414 . . . . 0.0 105.823 174.402 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -125.26 34.98 4.84 Favored 'General case' 0 CA--C 1.475 -1.932 0 CA-C-O 123.426 1.584 . . . . 0.0 107.388 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -95.97 -23.73 16.71 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 111.528 -2.578 . . . . 0.0 104.651 160.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 m -94.02 0.46 56.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.801 1.24 . . . . 0.0 109.934 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -75.86 -39.52 56.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -46.63 69.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 124.15 0.98 . . . . 0.0 109.868 176.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.408 0.2 OUTLIER -83.89 -2.23 56.05 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -179.085 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -83.88 -30.09 26.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.538 1.063 . . . . 0.0 109.291 165.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD2' HD23 ' A' ' 10' ' ' LEU . 2.3 t80 -61.45 -35.37 77.42 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.153 0.981 . . . . 0.0 109.034 164.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.45 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -83.43 -18.68 37.87 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.079 177.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -69.07 -52.26 30.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-N 119.79 1.177 . . . . 0.0 108.481 176.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 15.7 tt0 -77.28 -38.02 51.66 Favored 'General case' 0 N--CA 1.404 -2.742 0 C-N-CA 124.286 1.034 . . . . 0.0 110.437 -173.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 70.0 m-70 -98.31 -54.96 2.9 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.48 -175.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -77.63 119.98 21.94 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 119.98 1.264 . . . . 0.0 108.738 -167.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -137.14 98.37 3.72 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 100.682 -3.821 . . . . 0.0 100.682 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.64 -42.55 0.8 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -165.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -144.11 151.94 53.35 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 165.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 11.9 Cg_endo -71.81 155.43 58.2 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 123.859 3.039 . . . . 0.0 109.916 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -78.64 -53.45 7.16 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 170.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.74 -179.88 17.76 Favored Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 166.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -121.4 61.72 0.92 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -178.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.3 -179.42 7.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.57 -10.47 59.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -78.36 -33.23 49.14 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -75.63 -39.16 58.23 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.02 -42.95 79.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.3 -31.85 62.65 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 122.799 0.44 . . . . 0.0 110.597 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -67.46 -38.72 84.89 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.478 176.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 14.6 tt -80.31 -25.34 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 CA-C-N 118.042 0.383 . . . . 0.0 111.385 -176.045 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -29.89 61.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.774 -1.57 . . . . 0.0 111.536 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -75.66 -29.91 59.25 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.199 0.454 . . . . 0.0 112.22 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -78.97 -44.83 21.6 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.77 0.828 . . . . 0.0 110.746 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -81.05 -26.21 36.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.639 0.376 . . . . 0.0 110.438 -172.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.37 49.04 3.34 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 171.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.61 14.86 15.52 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 t -86.49 -13.31 46.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.08 0.952 . . . . 0.0 108.727 -176.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 m -122.38 103.63 38.3 Favored Pre-proline 0 N--CA 1.424 -1.73 0 CA-C-O 117.867 -1.064 . . . . 0.0 108.495 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.34 161.05 95.31 Favored 'Cis proline' 0 N--CA 1.441 -1.6 0 N-CA-C 106.888 -2.005 . . . . 0.0 106.888 -23.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -60.39 124.49 20.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.813 1.245 . . . . 0.0 111.118 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -73.02 135.48 44.92 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -75.0 -39.64 61.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.312 -170.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.6 tt -148.69 133.91 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -151.53 121.34 7.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.5 112.1 24.24 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.27 116.26 23.51 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.55 151.37 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.605 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.9 m-70 -144.15 140.68 29.52 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.61 1.62 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 107.115 -2.394 . . . . 0.0 107.115 175.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -119.79 137.0 54.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -85.58 -20.67 29.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 120.959 0.409 . . . . 0.0 110.636 -166.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -79.82 -22.47 42.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.5 m -76.09 -34.36 59.53 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.967 171.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.18 -51.23 73.52 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 119.829 1.195 . . . . 0.0 110.073 171.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.93 -40.42 93.18 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.673 0.789 . . . . 0.0 111.16 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.72 21.06 1.96 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.94 -28.7 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 t -78.15 -41.5 34.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.895 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -79.22 149.87 31.78 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 170.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -78.77 104.22 9.24 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -160.14 -57.74 0.06 Allowed 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -177.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -136.88 22.31 3.07 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.67 -178.82 21.47 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 105.288 -3.125 . . . . 0.0 105.288 166.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -137.2 161.28 61.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -171.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -74.49 147.3 36.11 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.884 2.389 . . . . 0.0 107.323 162.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -139.44 101.48 4.24 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 65.54 -102.26 0.08 Allowed 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 111.144 -177.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.24 102.38 3.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -174.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 2.8 p-10 65.34 22.26 12.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 129.896 3.278 . . . . 0.0 114.625 173.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.13 158.35 17.49 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 100.63 -3.841 . . . . 0.0 100.63 163.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -141.9 111.46 6.58 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -171.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 tt -94.25 140.37 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -87.68 167.47 13.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 121.387 0.613 . . . . 0.0 110.329 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 -1.49 4.37 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -113.43 86.6 2.42 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 173.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.0 m -53.44 137.95 34.61 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.058 2.143 . . . . 0.0 113.16 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -111.16 155.64 22.59 Favored 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.42 141.69 43.16 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 175.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.53 145.96 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -168.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -130.99 107.16 8.89 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 167.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -85.51 100.35 11.85 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.8 m -84.16 113.95 21.44 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -121.03 129.95 53.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 -176.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 tp -69.01 116.76 9.83 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.825 1.25 . . . . 0.0 109.257 -174.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -135.87 99.0 4.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -175.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.69 -42.12 0.18 Allowed Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 -178.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.38 43.59 7.35 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 t -112.72 108.82 53.54 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -86.1 -17.67 3.75 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 CA-C-N 122.193 1.819 . . . . 0.0 109.064 -176.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.75 160.65 28.85 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-O 117.43 -1.271 . . . . 0.0 107.954 -168.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.66 145.9 33.48 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.674 2.25 . . . . 0.0 108.425 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -81.17 164.31 77.62 Favored 'Cis proline' 0 N--CA 1.437 -1.841 0 CA-C-N 122.299 1.857 . . . . 0.0 108.176 -4.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.8 m -107.46 156.13 19.3 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.458 -170.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -110.54 118.39 36.11 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.71 148.3 41.2 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.69 119.87 40.13 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 166.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.26 115.84 26.04 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -110.69 87.97 2.66 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.64 143.57 26.7 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.265 0.555 . . . . 0.0 110.769 -171.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -149.41 -163.72 11.19 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 178.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -146.67 101.21 3.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -138.22 147.63 43.95 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -164.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -74.22 128.7 36.22 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.504 1.121 . . . . 0.0 108.515 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.16 137.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.16 -167.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.53 110.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 165.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.23 152.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.0 136.12 33.24 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 168.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.9 t -126.52 138.64 53.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 123.527 0.517 . . . . 0.0 109.701 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.74 133.56 44.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 170.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.301 14.2 p30 63.22 23.79 14.02 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 117.068 2.248 . . . . 0.0 117.068 171.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.52 19.15 57.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.45 116.12 5.43 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -170.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -72.02 111.49 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 CA-C-N 122.091 1.782 . . . . 0.0 111.39 -170.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.9 -24.32 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -151.88 -168.65 3.13 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.66 149.56 40.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -175.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.22 127.76 43.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 171.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -110.78 13.77 22.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -86.01 -32.34 21.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -172.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -23.34 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 C-N-CA 125.513 1.525 . . . . 0.0 111.817 177.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -105.97 56.8 0.67 Allowed 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.49 -1.671 . . . . 0.0 106.49 -167.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.282 14.9 ptm180 52.61 61.88 2.97 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 129.363 3.065 . . . . 0.0 113.211 172.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -68.41 128.84 93.02 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.433 -2.073 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 177.628 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 . . . . . 0 CA--C 1.485 -1.547 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -118.36 51.53 1.08 Allowed 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -113.72 1.85 15.01 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 173.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -92.37 -29.93 16.06 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -70.47 -40.77 73.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.312 0.645 . . . . 0.0 109.427 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 111' ' ' LEU . 61.4 t80 -46.56 -65.66 0.52 Allowed 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 126.602 1.961 . . . . 0.0 111.168 166.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.715 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.297 5.4 p -70.43 -11.84 61.18 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.702 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -83.71 -36.61 23.56 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.126 0.876 . . . . 0.0 109.521 173.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.24 -35.53 81.11 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.701 1.6 . . . . 0.0 110.515 170.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.715 ' HB2' ' HA ' ' A' ' 7' ' ' THR 0.271 0.2 OUTLIER -67.06 -38.04 85.1 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 128.709 2.803 . . . . 0.0 112.452 174.667 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -66.64 -51.87 51.35 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.86 -29.09 50.23 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 124.114 0.966 . . . . 0.0 112.439 -170.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -105.78 -58.25 1.93 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.001 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -72.6 111.93 8.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.73 0.776 . . . . 0.0 110.689 -163.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -134.96 98.28 3.97 Favored 'General case' 0 N--CA 1.421 -1.878 1 N-CA-C 98.553 -4.61 . . . . 0.0 98.553 176.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -33.65 3.8 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -163.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.91 154.18 46.8 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.9 Cg_endo -69.53 145.08 57.39 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 123.642 2.895 . . . . 0.0 109.164 171.367 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -86.04 -46.85 10.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 169.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.24 -177.21 14.82 Favored Glycine 0 CA--C 1.48 -2.133 0 N-CA-C 103.364 -3.894 . . . . 0.0 103.364 164.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -133.98 35.22 3.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -121.45 -179.22 4.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -35.88 79.77 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 125.973 1.709 . . . . 0.0 112.812 -171.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -81.82 -22.17 37.21 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.084 0.554 . . . . 0.0 110.033 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.85 -42.22 61.12 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -83.54 -19.97 34.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.729 -0.789 . . . . 0.0 113.045 -170.873 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.02 -39.42 66.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.3 t -67.15 -38.28 85.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.282 15.2 tt -86.74 -25.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 CA-C-N 118.358 0.527 . . . . 0.0 112.024 -175.464 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 mmt -77.49 -25.64 50.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.707 173.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -72.16 -38.3 69.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.131 0.572 . . . . 0.0 111.821 173.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -79.99 -40.1 28.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 122.607 0.363 . . . . 0.0 110.698 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -23.08 40.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.036 0.534 . . . . 0.0 110.571 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.8 47.57 4.18 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.36 6.76 12.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 t -94.61 -0.6 54.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 m -122.09 102.14 40.85 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 117.768 -1.11 . . . . 0.0 108.668 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.74 158.06 98.84 Favored 'Cis proline' 0 N--CA 1.441 -1.58 0 N-CA-C 106.842 -2.022 . . . . 0.0 106.842 -23.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.0 m -63.21 118.97 8.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 124.707 1.203 . . . . 0.0 111.914 -170.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.39 134.11 45.25 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -72.68 -36.35 67.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 124.567 1.167 . . . . 0.0 112.89 -166.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -154.77 123.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.3 151.63 30.22 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.515 177.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.8 m -112.21 136.61 51.42 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.503 -168.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -99.33 116.74 32.19 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 162.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.2 mt -89.89 150.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.483 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 -178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.581 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.6 m-70 -139.95 139.77 36.2 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 125.143 1.377 . . . . 0.0 108.863 -175.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.07 5.79 Favored Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 105.734 -2.946 . . . . 0.0 105.734 173.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -102.68 147.93 26.21 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 170.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -85.45 -16.28 40.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.99 -33.17 59.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.693 1.597 . . . . 0.0 107.071 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.9 m -75.73 -34.56 60.33 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.005 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 mm -54.95 -55.37 16.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 CA-C-N 119.349 0.977 . . . . 0.0 110.155 172.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.39 -35.01 77.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 123.875 0.87 . . . . 0.0 113.23 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.48 -0.25 19.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' ARG . 13.6 mm -73.66 -27.51 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.74 9.01 38.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.125 0.488 . . . . 0.0 111.599 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -88.56 162.09 16.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 160.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -88.18 -9.8 51.93 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -68.4 -50.48 52.6 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.252 1.421 . . . . 0.0 110.178 178.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -123.76 37.5 4.4 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -168.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.5 152.67 10.9 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 171.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -105.77 156.44 36.57 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -176.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -74.75 140.44 26.21 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 123.003 2.469 . . . . 0.0 106.821 172.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -136.67 133.7 36.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -176.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 62.11 -103.26 0.13 Allowed 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.899 1.68 . . . . 0.0 112.219 169.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.79 103.8 2.64 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.362 2.5 p-10 62.0 30.78 18.06 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 129.139 2.975 . . . . 0.0 113.883 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.2 mt -115.13 170.19 8.55 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 171.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HB3' HG22 ' A' ' 56' ' ' ILE . 21.9 mmt180 -147.17 116.4 6.95 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -174.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -93.87 136.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.5 p -83.56 160.91 21.35 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.45 -25.53 11.83 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.698 174.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -104.87 89.17 3.08 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 p -49.62 129.71 19.74 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 127.229 2.212 . . . . 0.0 111.916 171.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -105.19 156.44 18.11 Favored 'General case' 0 CA--C 1.478 -1.815 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -170.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.434 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.4 mt-30 -78.9 148.16 32.83 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 174.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.76 146.97 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -166.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.5 m -134.38 99.68 4.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 167.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -89.64 104.24 16.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -177.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.73 122.41 36.17 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -106.87 132.83 52.38 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.63 117.12 18.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.476 1.51 . . . . 0.0 109.007 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -112.1 152.41 28.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.34 -97.97 0.22 Allowed Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 106.014 -2.835 . . . . 0.0 106.014 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.03 1.5 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 -178.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.5 t -84.68 130.01 54.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -83.19 -20.9 4.83 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.989 1.793 . . . . 0.0 108.279 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -96.47 159.9 30.81 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -76.18 148.12 30.47 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.309 2.006 . . . . 0.0 107.221 -176.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -85.54 165.09 56.38 Favored 'Cis proline' 0 N--CA 1.438 -1.74 0 CA-C-N 123.035 2.12 . . . . 0.0 108.133 13.078 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.1 m -154.87 130.3 9.78 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -165.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.79 103.01 15.4 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -85.83 120.81 27.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -92.47 112.57 24.57 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.45 130.65 35.29 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.028 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -118.72 108.61 15.1 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.268 -2.494 . . . . 0.0 104.268 175.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.68 129.31 35.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.74 169.5 23.17 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 106.002 -2.839 . . . . 0.0 106.002 178.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 85.0 t80 -149.22 105.86 3.55 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -152.44 158.69 42.98 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 121.884 0.85 . . . . 0.0 110.32 -168.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.0 129.55 34.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.319 175.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.8 148.17 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.737 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.5 t -106.5 92.45 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -93.3 139.16 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.16 126.29 31.88 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 46.9 t -108.48 135.99 48.84 Favored 'General case' 0 CA--C 1.49 -1.34 0 O-C-N 123.875 0.734 . . . . 0.0 110.497 -175.541 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.22 137.5 39.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.299 16.5 p30 60.15 26.45 15.85 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 127.05 2.14 . . . . 0.0 116.101 175.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.56 22.76 59.58 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 177.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -149.91 135.07 9.72 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.038 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 98.0 Cg_exo -77.72 111.58 3.15 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 CA-C-N 122.354 1.876 . . . . 0.0 110.972 -177.519 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.78 -26.84 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 123.838 0.711 . . . . 0.0 111.693 -174.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -146.52 -171.72 3.8 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -171.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 132.01 4.11 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 177.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -74.41 135.81 42.38 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.322 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -96.8 36.89 1.34 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.9 p -95.66 -19.71 19.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -92.64 -23.23 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 178.641 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -108.99 38.67 2.22 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 125.332 1.453 . . . . 0.0 108.448 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -98.14 -27.01 14.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 168.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -83.12 142.08 43.86 Favored Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 N-CA-C 106.056 -2.325 . . . . 0.0 106.056 -178.258 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 CA--C 1.486 -1.5 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 61.36 65.79 0.93 Allowed 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 126.804 2.041 . . . . 0.0 110.521 175.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 81.36 -6.71 1.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 127.612 2.365 . . . . 0.0 112.441 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -93.39 -9.04 40.09 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -20.92 58.23 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.704 1.602 . . . . 0.0 109.678 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.79 -41.25 62.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 C-N-CA 125.188 1.395 . . . . 0.0 108.039 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -79.36 -12.81 59.91 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 177.603 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -73.67 -47.32 40.62 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.74 -46.35 74.27 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 126.401 1.88 . . . . 0.0 110.221 173.114 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.1 OUTLIER -93.25 -4.54 51.69 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.759 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -78.65 -43.81 25.28 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 120.655 1.57 . . . . 0.0 107.782 166.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -65.81 -46.27 79.26 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -97.16 -48.55 5.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.882 -172.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 45.8 t80 -78.68 117.15 19.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 119.963 1.256 . . . . 0.0 110.397 -168.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -134.61 96.4 3.56 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 174.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.37 -43.66 3.64 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 128.278 2.631 . . . . 0.0 117.724 -166.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -155.25 144.25 14.98 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 67.5 Cg_exo -74.74 174.79 12.07 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.863 1.708 . . . . 0.0 113.736 -177.054 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -70.73 -67.84 0.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 168.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.61 -175.16 13.69 Favored Glycine 0 CA--C 1.475 -2.451 1 N-CA-C 101.618 -4.593 . . . . 0.0 101.618 163.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -115.87 73.64 0.85 Allowed 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.34 176.7 9.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.38 -21.59 61.99 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.476 1.111 . . . . 0.0 112.884 -171.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -75.8 -30.27 58.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.238 177.178 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.95 -40.62 53.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 m -69.65 -35.32 75.07 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.17 -36.8 69.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 123.375 0.422 . . . . 0.0 110.308 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -69.45 -35.65 75.87 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 122.909 0.484 . . . . 0.0 112.214 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.426 HG13 HH21 ' A' ' 33' ' ' ARG 0.25 12.7 tt -84.15 -27.95 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-N 117.707 0.23 . . . . 0.0 111.227 -174.954 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.07 -25.17 47.53 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.483 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 91' ' ' PRO . 16.6 tpp180 -68.68 -43.6 75.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.214 0.606 . . . . 0.0 110.995 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -75.84 -44.77 39.29 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 123.646 0.778 . . . . 0.0 112.352 -172.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.426 HH21 HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -77.11 -18.1 58.19 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.955 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.0 44.75 4.68 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 168.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.4 mt -117.65 15.81 14.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 176.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -94.06 -11.41 30.73 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.6 m -125.53 101.03 31.04 Favored Pre-proline 0 N--CA 1.426 -1.659 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.548 -174.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.06 165.14 85.9 Favored 'Cis proline' 0 N--CA 1.445 -1.373 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 -21.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -60.28 120.58 10.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 124.063 0.945 . . . . 0.0 110.173 -175.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -74.63 136.67 41.96 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 177.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.68 -45.63 61.33 Favored 'General case' 0 N--CA 1.433 -1.287 0 O-C-N 123.956 0.785 . . . . 0.0 110.45 -171.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.46 126.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -148.51 127.88 13.06 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.482 HG23 HG13 ' A' ' 78' ' ' VAL . 17.2 m -94.23 122.18 36.5 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.734 -178.299 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -90.52 121.33 32.37 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.7 148.82 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.9 m-70 -136.57 137.37 40.13 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 124.834 1.253 . . . . 0.0 107.95 -175.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.79 -126.94 1.62 Allowed Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 175.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -118.28 141.65 48.31 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 171.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.51 -3.07 58.96 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -76.49 -31.65 57.85 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 168.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -80.5 -32.26 37.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 118.115 -0.945 . . . . 0.0 109.982 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.52 -52.62 54.86 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.204 1.001 . . . . 0.0 110.467 171.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -53.84 -44.09 70.02 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.42 1.488 . . . . 0.0 112.05 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.02 16.02 0.61 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.25 -40.54 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 165.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 36.3 t -88.72 -30.26 19.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.454 -156.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -95.74 51.26 1.26 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -170.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 m120 49.26 50.88 17.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 129.516 3.127 . . . . 0.0 113.329 174.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -148.84 163.67 36.73 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 97.594 -4.965 . . . . 0.0 97.594 172.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.259 8.1 p-10 14.52 56.54 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 131.043 3.737 . . . . 0.0 117.799 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.91 137.24 2.29 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 106.001 -2.839 . . . . 0.0 106.001 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -106.13 157.45 34.82 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -72.06 135.55 25.41 Favored 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 123.095 2.53 . . . . 0.0 107.225 170.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -131.23 107.37 8.94 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -175.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 63.42 -108.61 0.24 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 112.989 174.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -127.39 87.01 2.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -166.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.343 1.8 p-10 64.01 27.62 14.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 128.913 2.885 . . . . 0.0 113.947 173.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 mt -110.4 163.84 13.28 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 173.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -146.78 120.58 9.26 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.08 143.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -177.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.7 p -84.43 159.92 20.69 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -174.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -122.62 -3.18 8.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 t -119.02 88.15 2.87 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 173.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.3 p -61.56 141.36 57.79 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.561 1.544 . . . . 0.0 111.862 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -114.04 161.68 17.41 Favored 'General case' 0 CA--C 1.474 -1.967 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -168.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 7.7 mt-30 -77.91 144.63 36.72 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -141.73 143.38 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.89 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.7 m -131.35 107.61 9.06 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 167.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -83.14 101.03 10.92 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.6 114.97 24.7 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -121.06 132.47 54.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -170.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.9 tp -69.28 114.24 7.35 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 125.105 1.362 . . . . 0.0 108.527 -177.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -126.76 57.26 1.45 Allowed 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -118.31 -84.2 0.95 Allowed Glycine 0 CA--C 1.482 -2.021 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.21 -15.09 4.25 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 178.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -86.91 132.34 42.28 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -81.02 -21.71 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.755 1.636 . . . . 0.0 108.93 176.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -102.24 165.05 14.55 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.13 142.12 33.71 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.222 1.948 . . . . 0.0 107.159 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.8 Cg_endo -87.63 164.39 45.6 Favored 'Cis proline' 0 N--CA 1.435 -1.923 0 CA-C-N 122.655 1.984 . . . . 0.0 108.397 12.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 37.7 m -128.07 131.95 49.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -170.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -98.15 123.04 42.0 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.59 122.42 44.57 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -93.06 127.27 38.53 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.99 133.12 35.27 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.6 m -120.04 97.24 5.51 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 171.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.6 139.01 38.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.03 -171.16 18.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 92.3 t80 -155.78 100.05 2.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 101.28 -3.6 . . . . 0.0 101.28 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -139.44 148.73 43.14 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -161.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -80.73 132.5 35.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.862 1.265 . . . . 0.0 108.442 175.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.18 142.36 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.612 -164.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.74 95.68 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.1 m -94.71 136.7 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.31 126.53 37.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 31.7 p -129.2 167.5 17.55 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -172.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.38 132.81 18.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.362 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.364 6.4 p30 75.94 -12.0 1.06 Allowed 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 170.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.02 9.08 9.09 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -141.99 127.9 10.84 Favored Pre-proline 0 N--CA 1.435 -1.196 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 8.8 Cg_exo -67.35 163.8 33.14 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.566 1.511 . . . . 0.0 114.029 -178.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.3 -19.67 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 30.8 m80 -158.68 -175.3 5.23 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -169.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 136.8 3.78 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 -179.043 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.94 134.64 37.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.966 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -100.07 40.19 1.27 Allowed 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.7 m -97.1 -31.57 12.41 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -75.3 -33.98 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.61 169.832 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -106.12 40.1 1.66 Allowed 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -172.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -87.55 -44.28 11.39 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -95.34 149.17 35.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo . . . . . 0 N--CA 1.433 -2.055 0 N-CA-C 105.946 -2.367 . . . . 0.0 105.946 175.007 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.1 t70 75.15 78.32 0.1 Allowed 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 126.64 1.976 . . . . 0.0 109.16 177.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 79.21 -2.43 2.22 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 127.686 2.394 . . . . 0.0 111.331 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -89.95 -17.12 28.52 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -69.97 -30.27 67.58 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.303 1.441 . . . . 0.0 110.624 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CE1' HD22 ' A' ' 111' ' ' LEU . 52.2 t80 -68.49 -48.3 64.79 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -76.12 -10.01 59.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -80.74 -43.68 19.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 119.352 0.978 . . . . 0.0 108.468 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -57.89 -38.23 75.43 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.791 1.637 . . . . 0.0 110.195 170.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.48 HD13 ' CE2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -78.8 -29.62 45.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.546 1.538 . . . . 0.0 113.493 -179.149 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -80.06 -32.59 39.33 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 119.773 1.17 . . . . 0.0 109.38 -174.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.36 -45.01 15.43 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 118.511 -0.757 . . . . 0.0 109.726 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -95.12 -46.82 6.63 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 119.429 1.013 . . . . 0.0 112.442 -172.08 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 9.3 t80 -70.65 118.32 13.3 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 119.766 1.166 . . . . 0.0 110.925 -174.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -139.8 99.04 3.6 Favored 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 172.153 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 -39.26 9.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -164.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -142.84 148.65 46.77 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.0 Cg_endo -72.7 153.42 54.02 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 123.515 2.81 . . . . 0.0 109.291 170.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -77.8 -57.65 3.69 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.012 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.95 179.35 17.23 Favored Glycine 0 CA--C 1.477 -2.3 0 N-CA-C 103.726 -3.749 . . . . 0.0 103.726 165.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -122.9 61.27 1.01 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -141.54 176.84 8.56 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -171.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.94 -24.46 62.44 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 124.879 1.272 . . . . 0.0 112.245 -169.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -85.4 -20.14 30.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 122.966 0.506 . . . . 0.0 110.097 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -79.18 -35.89 41.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.0 -33.92 51.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -171.203 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.18 -48.12 74.57 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 125.841 1.657 . . . . 0.0 109.687 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 m -74.97 -22.97 58.23 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 118.112 -0.946 . . . . 0.0 113.496 -175.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 14.0 tt -87.09 -24.96 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 119.241 0.928 . . . . 0.0 110.65 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.68 -29.22 62.17 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.265 -1.374 . . . . 0.0 110.259 171.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -80.19 -32.43 38.67 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -83.72 -33.12 25.18 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 118.655 0.661 . . . . 0.0 111.07 -175.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -80.45 -19.25 46.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.5 47.57 3.46 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.6 mt -122.77 14.14 10.03 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -90.63 -9.73 45.88 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -175.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m -122.54 101.37 40.34 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.788 -174.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.57 166.37 83.07 Favored 'Cis proline' 0 N--CA 1.444 -1.429 0 CA-C-N 122.83 2.047 . . . . 0.0 107.217 -21.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.68 122.09 13.27 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 124.361 1.064 . . . . 0.0 110.987 -173.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -75.07 133.64 41.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -70.22 -40.47 74.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.336 1.022 . . . . 0.0 112.01 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.37 130.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 176.055 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -145.43 128.74 16.81 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -96.66 112.32 24.11 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.11 111.05 20.54 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 174.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.1 150.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.606 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-70 -142.88 135.73 27.95 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 125.172 1.389 . . . . 0.0 107.941 -174.2 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.91 -136.52 4.61 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 173.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -96.56 145.64 25.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.99 -21.94 25.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -79.6 -24.77 41.76 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -76.02 -35.52 59.48 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.716 172.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.444 HD12 ' CE2' ' A' ' 76' ' ' PHE . 1.1 mp -52.88 -51.47 36.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.459 0 C-N-CA 124.921 1.289 . . . . 0.0 110.221 170.17 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.68 -39.74 94.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.143 0.977 . . . . 0.0 111.105 -176.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.98 10.58 4.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 72' ' ' SER . 16.3 mm -80.06 -24.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.673 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.5 m -78.65 -23.55 45.7 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.019 177.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.5 143.89 44.37 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 167.113 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -98.56 25.42 6.43 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.222 -178.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -90.55 -47.66 7.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -113.71 51.2 0.87 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -176.111 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.5 172.65 39.13 Favored Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 103.266 -3.934 . . . . 0.0 103.266 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -126.56 152.93 75.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.02 132.78 14.43 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 106.077 -2.316 . . . . 0.0 106.077 172.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -99.58 156.17 17.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 174.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -36.42 -69.88 0.1 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 129.578 3.151 . . . . 0.0 116.394 -173.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -104.24 75.36 1.25 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -171.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 65.54 15.12 9.88 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.483 3.113 . . . . 0.0 116.353 165.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.98 173.23 6.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 -169.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -139.18 107.28 5.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 tt -86.47 143.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 177.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' HD12 ' A' ' 56' ' ' ILE . 93.7 p -89.47 168.06 12.49 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.441 0.639 . . . . 0.0 111.286 -172.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -124.05 -14.99 6.96 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 t -115.27 93.69 4.4 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -51.06 133.99 26.96 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 127.24 2.216 . . . . 0.0 112.633 174.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CE2' HD12 ' A' ' 53' ' ' ILE . 88.0 m-85 -110.14 157.75 19.05 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -172.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.72 135.16 35.95 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 174.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.21 142.7 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 -173.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.2 m -130.49 102.98 6.39 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -89.16 112.67 23.72 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.8 m -91.05 118.04 30.08 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -115.04 140.07 49.35 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.47 131.88 34.71 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -169.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.58 -179.56 5.76 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.31 -86.83 0.48 Allowed Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 -178.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.74 -7.41 0.68 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -78.92 128.12 77.61 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.073 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.57 -27.69 2.07 Favored 'Trans proline' 0 N--CA 1.436 -1.896 0 N-CA-C 107.862 -1.63 . . . . 0.0 107.862 173.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -98.01 162.87 20.69 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -169.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.78 144.34 34.87 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 122.366 2.044 . . . . 0.0 107.53 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -82.57 163.25 74.7 Favored 'Cis proline' 0 N--CA 1.438 -1.739 0 CA-C-N 123.222 2.187 . . . . 0.0 109.845 8.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.3 138.28 54.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.81 -168.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -101.96 107.15 18.21 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -103.04 123.24 46.26 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.221 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -88.18 122.4 31.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.87 132.55 34.62 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.18 104.53 7.36 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.3 135.74 34.23 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.08 146.36 16.83 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -99.15 103.87 15.8 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -143.05 155.72 44.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -167.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -78.94 130.81 35.99 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.76 142.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.465 -168.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.9 t -100.39 120.46 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -113.69 160.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.23 132.44 54.17 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 171.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 99.1 m -107.93 150.89 26.52 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -169.592 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -150.24 122.17 8.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.2 p30 67.13 10.23 7.54 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.475 2.31 . . . . 0.0 116.282 173.234 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.48 -3.15 39.73 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' CE1' ' A' ' 6' ' ' TYR . 16.7 mt -117.1 135.17 23.01 Favored Pre-proline 0 CA--C 1.484 -1.592 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 15.5 Cg_exo -77.44 127.85 9.23 Favored 'Trans proline' 0 N--CA 1.421 -2.778 0 CA-C-N 122.413 1.898 . . . . 0.0 107.169 175.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.441 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -95.3 -17.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 124.16 0.913 . . . . 0.0 109.468 -175.122 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 35.7 m80 -149.54 -177.69 6.01 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -169.031 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.92 135.83 23.51 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -173.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.39 127.06 37.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.05 22.07 16.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.119 0.568 . . . . 0.0 110.192 -170.173 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -86.64 -28.81 22.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -170.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -82.82 -25.18 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.783 0 C-N-CA 124.739 1.216 . . . . 0.0 110.146 178.558 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -97.48 37.79 1.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 123.234 0.334 . . . . 0.0 110.391 -165.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 61.26 67.39 0.8 Allowed 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 127.065 2.146 . . . . 0.0 109.582 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 121.86 59.69 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.021 170.097 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.433 -2.035 0 N-CA-C 105.429 -2.566 . . . . 0.0 105.429 178.304 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 . . . . . 0 CA--C 1.488 -1.434 0 CA-C-O 120.734 0.302 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.26 55.75 0.84 Allowed 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 166.622 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -91.33 -23.77 20.0 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -91.13 0.78 57.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -75.41 -42.8 52.75 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.2 -48.18 82.73 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.801 172.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.521 0.8 OUTLIER -90.37 8.68 32.31 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 119.903 1.229 . . . . 0.0 114.21 -179.497 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -77.52 -40.0 44.21 Favored 'General case' 0 CA--C 1.494 -1.203 0 O-C-N 120.451 -1.406 . . . . 0.0 107.881 155.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.95 -28.8 70.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.303 1.041 . . . . 0.0 111.208 171.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.92 -10.57 36.04 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -68.48 -42.2 79.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 166.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 93.0 mm-40 -66.92 -68.28 0.39 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.728 171.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 88.8 m-70 -107.83 6.93 27.9 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -153.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' CD2' ' HE2' ' A' ' 50' ' ' LYS . 27.0 t80 -100.84 137.12 39.64 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-N 120.36 1.436 . . . . 0.0 107.635 165.303 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -151.49 104.25 3.05 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 162.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.94 -51.05 13.95 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -148.66 140.66 14.59 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 76.2 Cg_exo -75.06 177.16 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.5 2.134 . . . . 0.0 113.532 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.45 -67.24 0.74 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.1 -175.19 13.91 Favored Glycine 0 CA--C 1.479 -2.214 1 N-CA-C 103.092 -4.003 . . . . 0.0 103.092 166.559 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.6 mtm105 -121.88 71.21 0.98 Allowed 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -144.22 -178.45 5.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.338 -171.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.89 -32.71 74.55 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 125.744 1.617 . . . . 0.0 112.733 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 -16.47 38.53 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -177.197 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.25 -41.67 48.34 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 m -70.14 -32.7 70.82 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.37 -46.3 67.28 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -74.34 -26.17 59.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.157 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.26 16.9 tt -82.59 -33.17 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-N 118.589 0.632 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 93.5 mtp -84.89 -10.09 57.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.335 179.201 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -81.33 -40.61 23.32 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 122.005 -0.434 . . . . 0.0 110.41 169.121 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.57 -37.53 24.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 119.091 -0.481 . . . . 0.0 112.124 -172.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.4 -30.67 67.63 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 118.431 0.56 . . . . 0.0 110.005 170.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.25 48.08 3.89 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 169.062 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.3 mt -110.4 8.53 23.28 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -97.63 2.09 49.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.8 t -132.27 104.93 13.51 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.68 156.68 97.2 Favored 'Cis proline' 0 N--CA 1.444 -1.427 0 N-CA-C 106.68 -2.085 . . . . 0.0 106.68 -21.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.75 114.37 6.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 123.967 0.792 . . . . 0.0 111.895 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -75.64 132.23 40.47 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 173.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -83.02 -15.31 51.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -166.113 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 133.64 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.23 119.81 7.46 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 m -95.03 108.46 20.53 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.66 126.03 34.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mt -107.91 144.74 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -173.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.8 m-70 -131.72 127.11 36.16 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.062 -168.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.3 -130.68 2.14 Favored Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 145.99 39.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HE2' ' CD2' ' A' ' 14' ' ' TYR . 33.1 mttt -84.82 -14.55 47.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 119.29 -0.385 . . . . 0.0 110.594 -179.238 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.65 49.09 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.3 m -73.94 -42.27 60.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 117.595 -1.193 . . . . 0.0 109.14 175.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 mm -54.43 -54.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 C-N-CA 124.593 1.157 . . . . 0.0 111.953 176.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -58.17 -46.8 85.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 125.202 1.401 . . . . 0.0 111.509 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.55 12.94 1.78 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD12 ' CB ' ' A' ' 72' ' ' SER . 15.1 mm -75.55 -30.61 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 168.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.5 m -80.24 -21.19 43.07 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -82.95 163.51 21.01 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.35 -17.3 39.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.593 -175.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -87.99 128.49 35.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 165.322 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.6 t30 84.95 -8.44 0.89 Allowed 'General case' 0 C--N 1.356 0.865 0 C-N-CA 128.935 2.894 . . . . 0.0 113.441 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.8 -174.11 22.19 Favored Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 172.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -157.32 157.45 30.28 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.44 157.6 25.56 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.255 1.97 . . . . 0.0 108.244 -176.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' A' ' 69' ' ' LEU . 4.5 p80 -128.57 42.55 3.3 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 167.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.488 0.0 OUTLIER 53.82 152.27 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.285 1 C-N-CA 132.69 4.396 . . . . 0.0 119.334 -177.396 . . . . . . . . 4 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.57 50.15 3.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 110.842 -2.89 . . . . 0.0 111.917 171.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 83.89 1.45 0.96 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.045 2.938 . . . . 0.0 115.655 177.086 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 2.8 mm? -105.96 149.65 26.43 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -173.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -141.01 123.62 16.01 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -172.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tt -97.12 146.53 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.443 ' CB ' HD12 ' A' ' 56' ' ' ILE . 85.1 p -85.95 173.31 10.03 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-O 121.457 0.646 . . . . 0.0 111.395 -175.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.97 4.81 3.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.017 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.4 t -113.66 86.21 2.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -49.76 123.65 8.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.885 2.474 . . . . 0.0 113.347 -179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.49 156.29 20.29 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -83.37 143.53 30.27 Favored 'General case' 0 CA--C 1.466 -2.275 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.07 141.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -168.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -129.16 107.85 9.89 Favored 'General case' 0 CA--C 1.478 -1.811 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 166.317 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -84.01 100.66 11.21 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.4 m -84.19 106.42 15.81 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -118.8 142.23 47.9 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 -171.532 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -83.99 121.48 27.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.854 0.835 . . . . 0.0 109.014 -171.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -133.02 55.96 1.87 Allowed 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.42 -63.94 0.26 Allowed Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 105.125 -3.19 . . . . 0.0 105.125 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.08 27.32 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 173.585 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -89.99 138.87 27.41 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -83.0 -20.84 5.02 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.671 1.581 . . . . 0.0 109.242 172.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -108.03 156.86 37.53 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-O 117.615 -1.183 . . . . 0.0 108.84 -165.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -75.14 148.59 34.96 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.654 2.236 . . . . 0.0 108.719 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -81.62 166.56 72.31 Favored 'Cis proline' 0 N--CA 1.438 -1.751 0 CA-C-N 122.324 1.866 . . . . 0.0 108.654 -1.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.2 m -138.94 126.22 21.49 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -173.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -90.02 98.37 11.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -176.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -85.14 133.81 34.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -100.66 131.44 46.56 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 174.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.45 35.71 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.838 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -120.86 90.49 3.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 172.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.88 148.95 22.86 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.494 -171.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.05 -172.5 18.11 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 107.473 -2.251 . . . . 0.0 107.473 178.105 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -149.89 100.28 2.93 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -148.05 172.25 14.55 Favored 'General case' 0 CA--C 1.482 -1.64 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.418 -173.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -85.07 117.28 23.94 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -90.56 139.22 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.135 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.82 123.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.26 150.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 170.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.53 127.78 40.7 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 175.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.07 155.7 23.42 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.001 0.905 . . . . 0.0 112.0 -171.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -160.39 126.31 4.07 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.487 -2.783 . . . . 0.0 103.487 173.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 11.9 p30 66.91 14.35 9.79 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.863 2.465 . . . . 0.0 115.764 175.159 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.67 61.53 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.26 2.2 mp -107.64 138.2 19.93 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 177.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.37 112.63 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 N-CA-C 104.892 -2.772 . . . . 0.0 104.892 168.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.405 HG23 ' ND1' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -92.97 -18.6 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.814 -172.422 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.405 ' ND1' HG23 ' A' ' 113' ' ' VAL . 13.6 m80 -151.33 -179.57 7.48 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.0 141.54 51.24 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.11 124.27 30.94 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 165.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -115.65 56.71 0.75 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 t -89.25 -51.56 5.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -28.86 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -170.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -84.02 -22.25 31.37 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.985 -165.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -64.47 0.87 Allowed 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.048 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -146.07 148.07 34.07 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 174.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 N--CA 1.432 -2.093 0 N-CA-C 105.742 -2.445 . . . . 0.0 105.742 177.977 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 . . . . . 0 CA--C 1.487 -1.462 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -129.84 48.6 2.36 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -93.2 -13.64 28.11 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -90.7 -26.39 19.58 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.67 39.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.39 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.284 9.5 t80 -51.41 -64.44 0.81 Allowed 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 125.972 1.709 . . . . 0.0 109.897 164.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -80.24 1.23 29.3 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -169.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -92.02 -26.33 18.4 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 119.897 1.226 . . . . 0.0 109.083 169.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.51 -36.33 80.22 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 161.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -28.69 51.5 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.587 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.8 m -65.08 -50.9 64.36 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 119.47 1.032 . . . . 0.0 109.819 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 72.3 mt-30 -68.35 -44.58 74.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 O-C-N 123.712 0.633 . . . . 0.0 112.675 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 92.6 m-70 -103.07 -55.54 2.4 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.7 -167.128 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -76.66 117.1 17.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.013 0.911 . . . . 0.0 109.586 -167.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -134.02 96.15 3.58 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 101.045 -3.687 . . . . 0.0 101.045 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.98 -41.7 1.71 Allowed 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 128.659 2.784 . . . . 0.0 117.539 -168.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -157.57 144.8 13.52 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 65.1 Cg_exo -76.74 -176.46 3.16 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.391 2.061 . . . . 0.0 114.078 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -72.59 -73.36 0.2 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 165.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.37 -174.32 13.59 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 102.437 -4.265 . . . . 0.0 102.437 164.443 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -111.8 75.97 0.95 Allowed 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 176.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -142.65 177.13 8.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.938 -173.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -56.06 -43.1 77.61 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 127.81 2.444 . . . . 0.0 112.169 -175.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -77.57 -23.95 49.88 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.036 0.935 . . . . 0.0 110.968 -176.242 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -71.83 -47.88 50.1 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.531 ' HA ' HG22 ' A' ' 29' ' ' ILE . 5.9 t -81.41 -22.77 38.03 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.61 -169.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.9 -47.9 81.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 123.725 0.81 . . . . 0.0 109.654 170.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.9 m -68.13 -36.41 79.66 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 26' ' ' CYS . 14.2 tt -80.49 -27.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-N 118.894 0.77 . . . . 0.0 110.917 -176.209 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.428 ' HE2' ' HB3' ' A' ' 43' ' ' ASN . 3.7 mmt -71.36 -36.97 71.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 118.327 0.512 . . . . 0.0 109.934 175.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.29 -28.08 61.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -75.96 -50.57 14.57 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 118.822 0.737 . . . . 0.0 110.355 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -23.47 60.07 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.804 0.842 . . . . 0.0 112.175 -172.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 51.98 2.68 Favored Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 170.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.1 mt -113.66 9.81 17.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 p -100.9 15.57 28.09 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 124.016 0.926 . . . . 0.0 108.959 178.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -124.2 94.5 45.18 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.81 166.79 81.76 Favored 'Cis proline' 0 N--CA 1.443 -1.468 0 N-CA-C 107.021 -1.954 . . . . 0.0 107.021 -24.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.6 m -62.78 120.04 10.5 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 124.36 1.064 . . . . 0.0 112.882 -172.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -72.4 139.64 47.93 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.576 -178.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -71.83 -43.15 66.06 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.391 0.677 . . . . 0.0 111.682 -172.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.84 128.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 5.4 t30 -143.49 130.21 20.31 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -100.3 116.32 32.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.85 124.78 35.43 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mm -93.57 150.95 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.5 m-70 -142.96 127.74 18.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -177.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.04 -137.2 4.16 Favored Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 172.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -106.3 144.39 33.07 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.78 -20.95 32.41 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.471 -167.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.62 -10.2 44.16 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.327 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.0 m -76.44 -38.06 56.06 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.648 166.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.76 -52.32 62.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-N 118.907 0.776 . . . . 0.0 110.542 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.26 -45.95 89.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 125.084 1.354 . . . . 0.0 111.342 -175.271 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.13 21.97 1.03 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.45 ' HB ' HH11 ' A' ' 70' ' ' ARG . 42.8 mt -78.55 -27.11 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 165.069 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.14 -39.59 90.61 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 122.449 0.3 . . . . 0.0 111.517 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -104.97 171.26 7.41 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.408 0.623 . . . . 0.0 110.24 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.6 t30 73.33 -136.9 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.532 1.533 . . . . 0.0 114.694 153.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 61' ' ' ASN . 83.8 tttt -136.01 0.42 2.62 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 -164.356 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 60' ' ' LYS . 20.6 t30 -82.22 -20.84 36.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.58 -176.03 19.16 Favored Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 164.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.52 154.08 32.95 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.16 147.02 23.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 122.523 2.149 . . . . 0.0 107.441 -175.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -135.59 125.34 25.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? 64.66 -107.01 0.15 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.069 1.347 . . . . 0.0 111.489 171.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.96 97.21 3.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.132 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.357 2.1 p-10 64.84 24.72 12.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 129.105 2.962 . . . . 0.0 114.112 175.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 mt -111.87 168.8 9.3 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 101.196 -3.631 . . . . 0.0 101.196 172.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 ' CB ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -155.5 129.63 8.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.446 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 tt -101.01 143.43 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -175.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 56' ' ' ILE . 85.6 p -82.56 165.44 20.1 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-O 122.261 1.029 . . . . 0.0 111.417 -176.184 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -128.74 4.56 5.49 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 178.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -122.26 88.95 3.03 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 175.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -59.63 132.13 53.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.661 1.584 . . . . 0.0 112.5 -177.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -109.54 158.24 18.2 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 139.35 38.36 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 174.492 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.21 144.65 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -171.014 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -128.53 108.04 10.2 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -87.78 102.59 14.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 177.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -95.58 137.67 34.31 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -177.134 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -128.15 141.85 51.36 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.27 133.19 40.13 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 126.32 1.848 . . . . 0.0 108.031 -175.295 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -136.04 164.08 28.83 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.84 -44.58 1.44 Allowed Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 -176.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.59 17.48 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -107.35 122.52 41.02 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -79.22 -29.28 3.22 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 N-CA-C 107.612 -1.726 . . . . 0.0 107.612 173.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -101.44 156.72 34.84 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -171.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -75.05 148.2 34.78 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 122.594 2.196 . . . . 0.0 107.493 -174.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -84.11 164.08 66.2 Favored 'Cis proline' 0 CA--C 1.49 -1.675 0 CA-C-N 123.133 2.155 . . . . 0.0 109.392 10.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 m -151.86 118.88 5.85 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -167.369 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -93.99 119.74 33.29 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -98.53 123.2 42.56 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -87.12 118.01 26.23 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.83 137.63 32.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.651 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 m -120.82 112.27 18.61 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.64 148.14 28.14 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.268 0.556 . . . . 0.0 110.032 -176.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.96 32.73 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -155.32 107.49 2.67 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.17 -3.27 . . . . 0.0 102.17 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -153.51 170.35 20.97 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.797 -174.052 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.46 124.41 31.32 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -99.04 142.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -166.501 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.09 122.37 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 170.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -122.71 160.39 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 102.434 -3.173 . . . . 0.0 102.434 173.101 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.07 131.94 54.61 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 119.021 0.828 . . . . 0.0 109.146 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.9 t -97.6 148.87 22.84 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.13 1.372 . . . . 0.0 109.174 -174.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.5 123.89 12.35 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 164.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.312 13.8 p30 64.84 19.63 11.9 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 128.209 2.604 . . . . 0.0 116.679 174.002 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.3 19.69 51.71 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.331 1.3 tp -129.51 146.71 62.21 Favored Pre-proline 0 CA--C 1.481 -1.68 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 177.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.46 ' CB ' HH22 ' A' ' 70' ' ' ARG . 82.0 Cg_exo -69.46 147.04 63.91 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 121.457 1.438 . . . . 0.0 108.891 162.324 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -30.96 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 O-C-N 123.708 0.63 . . . . 0.0 109.338 175.508 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 32.5 m80 -145.33 175.73 10.08 Favored 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.965 -165.6 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.406 HD13 HG12 ' A' ' 105' ' ' VAL . 2.8 tp -125.3 139.18 53.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.82 128.06 35.64 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 167.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -108.84 52.05 0.72 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -87.42 -44.94 10.97 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -173.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.78 -28.51 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -173.462 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -84.54 -22.1 30.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.819 -165.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -80.0 -34.34 38.59 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 173.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -78.87 147.45 70.49 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -177.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 N-CA-C 105.676 -2.471 . . . . 0.0 105.676 173.457 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -143.07 95.88 2.84 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 84.88 11.2 0.31 Allowed 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.41 2.284 . . . . 0.0 107.91 -179.005 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -91.65 -29.66 16.75 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -66.23 -45.69 79.81 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.199 1.4 . . . . 0.0 109.401 179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 10' ' ' LEU . 65.8 t80 -50.54 -62.21 1.73 Allowed 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.689 1.996 . . . . 0.0 113.881 170.179 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -70.34 -13.88 62.34 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -81.33 -39.25 25.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 119.848 1.204 . . . . 0.0 110.055 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.65 -34.42 74.26 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.11 1.364 . . . . 0.0 109.646 169.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -77.25 -24.39 51.13 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 125.855 1.662 . . . . 0.0 113.341 177.313 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -66.2 -58.08 6.19 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -63.28 -52.08 63.49 Favored 'General case' 0 CA--C 1.484 -1.587 0 O-C-N 124.051 0.844 . . . . 0.0 113.046 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -101.3 -15.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -163.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 28.9 t80 -93.99 137.15 33.52 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 122.936 2.607 . . . . 0.0 109.738 177.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -151.79 100.4 2.67 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 165.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.58 -49.41 2.17 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -164.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -145.47 149.95 42.44 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 167.19 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 51.4 Cg_endo -84.07 169.71 11.37 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.42 2.08 . . . . 0.0 107.922 -175.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.87 -70.53 0.35 Allowed 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.73 15.0 Favored Glycine 0 CA--C 1.475 -2.436 1 N-CA-C 102.768 -4.133 . . . . 0.0 102.768 164.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -116.66 73.62 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 177.05 9.81 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -174.426 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.36 -18.87 62.35 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.575 1.15 . . . . 0.0 112.717 -173.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.48 -22.12 30.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 122.797 0.439 . . . . 0.0 110.183 178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -77.44 -42.02 37.56 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.1 m -67.02 -37.16 83.66 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 123.829 0.706 . . . . 0.0 112.54 -178.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.29 -42.71 87.98 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 123.679 0.792 . . . . 0.0 110.36 175.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 m -69.89 -32.32 70.59 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD11 HH21 ' A' ' 33' ' ' ARG . 6.9 tt -81.87 -33.48 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 118.915 0.78 . . . . 0.0 110.61 -176.119 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.0 mmt -73.63 -31.58 63.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.064 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -74.83 -34.68 62.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -70.94 -56.88 5.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.078 0.951 . . . . 0.0 110.596 -172.573 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.423 HH21 HD11 ' A' ' 29' ' ' ILE . 10.0 ptp180 -85.38 -18.09 34.76 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.077 -175.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.64 71.12 1.31 Allowed Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 166.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -118.41 11.89 13.15 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 173.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.8 t -96.81 3.96 51.98 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.143 0.977 . . . . 0.0 108.99 -171.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -129.52 103.09 17.92 Favored Pre-proline 0 N--CA 1.427 -1.607 0 CA-C-O 117.81 -1.091 . . . . 0.0 108.667 -177.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.71 159.19 97.1 Favored 'Cis proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.52 -2.146 . . . . 0.0 106.52 -22.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.07 119.55 16.42 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 111.994 -166.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -79.55 134.12 36.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 172.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.9 -15.3 48.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.847 -164.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.63 125.88 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -139.08 128.81 24.73 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 169.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -96.27 117.85 31.64 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -93.64 120.36 33.82 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.5 145.1 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -174.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.495 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m-70 -133.16 128.93 37.11 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -174.446 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.66 -132.39 2.9 Favored Glycine 0 CA--C 1.483 -1.955 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 176.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.19 144.48 43.12 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.133 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -84.0 -15.17 48.67 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -74.68 -35.69 62.77 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.502 1.121 . . . . 0.0 108.612 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.1 m -72.15 -37.14 69.46 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.287 176.436 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 mm -56.55 -55.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 123.912 0.885 . . . . 0.0 111.842 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -58.92 -40.01 83.26 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.422 1.089 . . . . 0.0 112.889 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -18.72 46.86 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.8 -26.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 119.718 1.145 . . . . 0.0 110.683 -176.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.4 t -77.5 -12.08 59.92 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 118.579 0.627 . . . . 0.0 111.933 -178.439 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.45 -178.94 7.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.181 0.991 . . . . 0.0 108.72 168.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.05 -28.66 61.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.88 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -74.14 154.93 38.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 172.604 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 t30 61.78 21.21 12.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.633 2.373 . . . . 0.0 116.127 171.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.87 177.47 41.5 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.1 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -143.72 157.07 59.15 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -72.39 148.18 48.28 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.382 2.055 . . . . 0.0 109.671 -176.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -134.92 127.2 30.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 62.08 -106.45 0.21 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 125.726 1.61 . . . . 0.0 112.117 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -151.95 108.76 3.5 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 2.0 p-10 66.25 24.1 10.74 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 129.727 3.211 . . . . 0.0 113.87 176.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 mt -116.15 170.86 8.19 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 171.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.464 HH12 ' HG3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -149.85 146.1 26.93 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 166.356 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.34 151.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 175.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -74.48 177.99 5.6 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.297 1.046 . . . . 0.0 112.725 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -142.04 7.13 1.8 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.4 t -130.58 94.53 3.66 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 171.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 p -57.09 130.19 45.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.065 1.746 . . . . 0.0 112.717 -177.011 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.86 156.0 17.79 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -175.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -77.24 138.58 39.5 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 175.777 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.54 142.48 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.015 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.2 m -130.62 108.51 9.97 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 167.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.6 m -81.76 101.74 10.32 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 75.9 m -88.15 110.37 20.63 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 178.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.06 145.79 49.01 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 151.38 29.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.088 0.947 . . . . 0.0 112.62 -172.608 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -125.18 44.12 2.88 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.66 -108.48 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.336 0 C-N-CA 129.454 3.407 . . . . 0.0 113.378 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.75 -51.08 4.37 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 112.436 -1.882 . . . . 0.0 111.531 -162.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 p -175.86 152.66 1.3 Allowed Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 -173.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -86.03 -13.32 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.226 1.95 . . . . 0.0 108.658 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.33 159.42 32.03 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -75.28 142.93 27.61 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 121.998 1.799 . . . . 0.0 107.507 -172.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -82.06 161.16 78.45 Favored 'Cis proline' 0 CA--C 1.487 -1.827 0 CA-C-N 123.538 2.299 . . . . 0.0 110.794 8.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 m -142.87 122.41 13.23 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -166.436 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -85.58 109.19 18.36 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -99.61 121.53 41.33 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -98.83 152.67 19.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.38 31.2 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.2 m -126.56 98.24 5.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 167.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.77 32.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.153 0.501 . . . . 0.0 109.967 -175.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.49 20.84 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 70.5 t80 -151.65 92.51 1.76 Allowed 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 101.627 -3.471 . . . . 0.0 101.627 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -136.99 154.4 50.42 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -161.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -68.14 128.88 38.18 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.9 m -93.03 120.48 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -174.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.2 t -86.84 118.39 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.585 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -122.84 157.96 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 176.394 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 128.53 40.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.8 t -107.45 136.75 46.7 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.148 0.979 . . . . 0.0 108.847 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.45 138.98 50.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 169.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 14.0 p30 65.64 17.7 10.98 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 127.17 2.188 . . . . 0.0 116.644 172.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.83 23.71 48.55 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 28.3 tp -141.14 151.05 60.82 Favored Pre-proline 0 CA--C 1.486 -1.484 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 105' ' ' VAL . 74.1 Cg_exo -66.94 162.88 35.93 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 122.552 1.947 . . . . 0.0 109.791 164.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -147.4 -27.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 O-C-N 121.616 -0.677 . . . . 0.0 111.274 176.245 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.554 ' CD2' HG23 ' A' ' 113' ' ' VAL . 88.8 m-70 -144.08 172.03 13.45 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 -173.473 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.0 134.28 54.33 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 175.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.63 121.03 27.73 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 174.232 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -103.94 45.67 0.95 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p -98.74 -30.41 12.45 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 175.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -23.5 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.635 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -101.31 -5.24 25.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.872 -172.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -68.85 -41.59 78.27 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -75.22 119.41 76.85 Favored Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 170.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.434 -1.993 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 -164.667 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 . . . . . 0 CA--C 1.486 -1.49 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -108.55 58.77 0.61 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -115.82 4.16 13.89 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.59 -18.5 26.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.164 179.001 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -68.44 -43.66 76.59 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.513 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.252 8.6 t80 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.402 -2.837 0 C-N-CA 124.768 1.227 . . . . 0.0 111.142 174.405 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -173.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -82.34 -32.36 29.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 119.479 1.036 . . . . 0.0 109.091 170.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' A' ' 10' ' ' LEU . 1.9 t80 -58.22 -38.98 77.87 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.13 164.354 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 8.4 mp -83.38 -11.51 57.53 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 119.651 1.114 . . . . 0.0 113.495 178.403 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.2 m -70.66 -45.25 65.44 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 119.564 1.075 . . . . 0.0 108.298 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.12 -41.35 67.32 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.044 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -101.56 -54.5 2.74 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.096 -169.028 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.672 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 9.6 t80 -72.45 126.41 29.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 120.45 1.477 . . . . 0.0 112.776 -165.158 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -149.17 104.37 3.41 Favored 'General case' 0 N--CA 1.424 -1.75 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 172.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.2 -32.28 10.12 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -162.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 152.38 42.9 Favored Pre-proline 0 N--CA 1.432 -1.37 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 17.2 Cg_endo -71.31 144.1 45.14 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 C-N-CA 123.265 2.643 . . . . 0.0 107.519 167.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -77.52 -51.63 10.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.6 179.68 17.35 Favored Glycine 0 CA--C 1.478 -2.259 1 N-CA-C 103.091 -4.004 . . . . 0.0 103.091 161.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.92 55.03 0.94 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.49 179.81 6.58 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -170.553 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -67.95 -23.94 65.11 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 125.352 1.461 . . . . 0.0 113.204 -172.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -25.76 37.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.51 -44.78 49.76 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.9 m -65.07 -38.07 89.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.35 -33.81 55.31 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 119.117 -0.468 . . . . 0.0 111.072 -178.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -76.57 -29.87 56.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 118.78 -0.628 . . . . 0.0 112.023 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 13.5 tt -75.92 -38.58 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.611 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.7 mtm -79.27 -23.23 43.76 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 118.136 -1.425 . . . . 0.0 113.447 -176.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -72.39 -36.81 68.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 170.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.18 -45.66 32.26 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.537 0.735 . . . . 0.0 111.479 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -76.78 -25.43 53.36 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.744 1.618 . . . . 0.0 109.344 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.12 44.48 3.8 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 163.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.8 mt -118.54 19.77 13.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -90.08 -11.33 41.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.619 1.168 . . . . 0.0 108.244 -176.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 m -121.3 105.0 39.92 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.61 161.31 94.91 Favored 'Cis proline' 0 N--CA 1.441 -1.612 0 N-CA-C 107.018 -1.955 . . . . 0.0 107.018 -22.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.95 125.54 24.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.202 1.001 . . . . 0.0 109.586 -177.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.78 142.38 38.67 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.7 -36.47 57.2 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.76 128.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -161.36 144.48 12.56 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.0 m -106.87 138.88 42.2 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 -170.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -101.87 129.77 48.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 162.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.67 150.89 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.637 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -174.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.794 ' HB2' ' HB2' ' A' ' 77' ' ' GLN 0.252 7.9 m-70 -140.25 153.12 46.42 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.741 -174.024 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.04 -124.24 3.89 Favored Glycine 0 CA--C 1.478 -2.246 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 169.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 135.58 42.93 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.968 1.366 . . . . 0.0 109.707 -177.122 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.27 -29.11 34.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.602 -1.636 . . . . 0.0 106.857 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -29.11 64.85 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.9 m -76.88 -36.79 56.47 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 116.663 -1.637 . . . . 0.0 111.485 176.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 53' ' ' ILE 0.268 6.6 tp -65.03 -46.34 91.77 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 0 CA-C-N 120.193 1.361 . . . . 0.0 110.592 -178.672 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -60.61 -43.48 97.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.428 1.091 . . . . 0.0 110.808 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.18 11.46 2.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.56 -35.99 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.097 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 167.127 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -96.74 5.29 50.91 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -112.38 18.65 18.33 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.087 0.946 . . . . 0.0 108.461 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 32.1 47.58 0.09 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 131.686 3.994 . . . . 0.0 115.744 -170.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.78 -60.7 2.21 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.55 64.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.163 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.19 146.84 8.58 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 173.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -102.49 164.06 16.42 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.92 144.01 42.19 Favored 'Trans proline' 0 N--CA 1.437 -1.797 0 C-N-CA 122.692 2.262 . . . . 0.0 106.886 166.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -136.23 33.69 2.81 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 -178.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.6 mmt-85 61.12 157.62 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 129.017 2.927 . . . . 0.0 114.73 178.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 52.84 46.77 26.09 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 128.126 2.57 . . . . 0.0 113.882 175.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.316 2.8 p-10 51.48 40.35 26.61 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.785 2.434 . . . . 0.0 114.192 -174.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.88 153.81 32.91 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 100.799 -3.778 . . . . 0.0 100.799 177.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -146.26 125.17 12.72 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -90.59 143.19 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 179.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.0 p -80.88 158.16 25.41 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.693 0.758 . . . . 0.0 112.75 -175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -108.11 -19.97 13.32 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -104.93 82.45 1.87 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 p -52.43 132.06 34.27 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 127.023 2.129 . . . . 0.0 112.413 178.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -107.26 160.42 15.61 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.794 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 7.3 mm-40 -79.76 144.3 33.72 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.77 142.14 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 m -131.54 104.56 7.03 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 169.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.0 m -86.32 105.26 16.55 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.34 111.25 20.89 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -111.36 131.52 55.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 -171.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.5 118.01 11.83 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 123.64 0.776 . . . . 0.0 108.935 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -130.93 71.38 1.47 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -175.17 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.19 -45.97 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 105.156 -3.178 . . . . 0.0 105.156 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.02 37.03 8.6 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 p -103.57 122.29 45.37 Favored Pre-proline 0 N--CA 1.434 -1.246 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -83.54 -20.21 4.88 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 CA-C-N 121.587 1.602 . . . . 0.0 108.614 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -110.9 158.44 35.74 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.318 -167.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.25 147.01 36.81 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.824 2.35 . . . . 0.0 108.382 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -82.06 165.75 72.34 Favored 'Cis proline' 0 N--CA 1.438 -1.761 0 CA-C-N 122.401 1.893 . . . . 0.0 108.489 -1.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.1 m -113.12 157.91 21.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.703 1.252 . . . . 0.0 107.637 -172.04 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -111.57 135.59 51.93 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -133.71 122.58 23.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -89.06 125.12 34.88 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.09 122.34 27.21 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -115.24 88.07 2.79 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.48 142.34 27.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.009 -172.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.11 -177.09 14.94 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 177.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -140.44 97.62 3.25 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 175.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -158.34 -179.66 8.31 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -164.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -79.91 146.84 31.92 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.053 -173.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.43 151.95 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -114.06 95.02 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 163.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.3 136.6 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.53 130.17 34.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 174.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 57.1 m -109.66 149.64 29.43 Favored 'General case' 0 CA--C 1.489 -1.376 0 O-C-N 124.136 0.897 . . . . 0.0 110.688 -173.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.21 124.97 7.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.2 p30 65.89 18.32 11.06 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.782 2.433 . . . . 0.0 116.338 171.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.3 -7.02 59.83 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -103.06 148.76 36.11 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 177.611 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -70.89 143.46 45.46 Favored 'Trans proline' 0 N--CA 1.435 -1.968 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 156.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.9 OUTLIER -121.22 -22.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.369 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 113' ' ' VAL . 31.2 m-70 -154.25 -167.35 2.61 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -167.88 136.75 2.49 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -80.5 139.66 36.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.864 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -101.88 40.77 1.28 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 172.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.3 m -96.22 -30.19 13.61 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -175.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.71 -35.41 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.941 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.241 172.411 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -103.43 43.47 1.08 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -168.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -153.34 -50.03 0.1 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 171.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -112.35 112.44 51.88 Favored Pre-proline 0 N--CA 1.431 -1.381 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.432 -2.103 0 N-CA-C 106.167 -2.282 . . . . 0.0 106.167 -176.485 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 CA--C 1.501 -0.936 0 N-CA-C 110.621 -0.141 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -90.38 -1.64 57.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.45 -45.35 59.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.55 -52.72 63.72 Favored 'General case' 0 N--CA 1.412 -2.344 0 C-N-CA 125.538 1.535 . . . . 0.0 112.366 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.449 1.8 t -87.97 9.8 21.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.99 -42.2 33.45 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 120.207 -1.558 . . . . 0.0 107.463 157.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -59.77 -36.91 77.64 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.982 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 14' ' ' TYR . 20.2 mt -83.77 -15.91 46.71 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 119.567 1.076 . . . . 0.0 113.863 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.7 m -65.8 -48.61 71.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 119.911 1.232 . . . . 0.0 108.908 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -72.91 -37.25 67.31 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -104.34 -53.64 2.68 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.251 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 14.8 t80 -76.61 115.33 16.27 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 119.232 0.924 . . . . 0.0 110.123 -168.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -134.76 98.73 4.12 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.11 -38.01 16.72 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -165.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -159.77 134.52 5.52 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -71.54 178.05 6.09 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 123.051 2.501 . . . . 0.0 114.66 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.31 -59.63 2.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -179.36 22.73 Favored Glycine 0 CA--C 1.478 -2.228 0 N-CA-C 104.403 -3.479 . . . . 0.0 104.403 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.519 HH21 ' HG3' ' A' ' 77' ' ' GLN . 11.1 mpt_? -106.84 73.46 0.94 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -156.92 173.46 16.97 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.41 -20.77 62.9 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 125.373 1.469 . . . . 0.0 113.963 -169.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -80.46 -29.61 37.47 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.32 -41.58 66.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.7 OUTLIER -80.34 -25.39 39.27 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.729 -1.188 . . . . 0.0 113.097 -170.953 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.01 -36.48 69.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 118.99 -0.528 . . . . 0.0 110.175 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.4 t -65.65 -42.96 90.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.3 tt -80.37 -28.09 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 117.83 0.286 . . . . 0.0 111.199 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 mmt -74.25 -29.99 61.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.035 -0.415 . . . . 0.0 110.325 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.457 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.3 tpp180 -66.43 -45.75 78.82 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.774 0.83 . . . . 0.0 111.869 172.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -80.22 -39.68 28.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -170.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.47 -39.65 74.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.46 68.82 1.34 Allowed Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 mt -113.94 21.83 14.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 163.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -94.6 -5.78 45.01 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 109.085 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -132.6 102.66 13.75 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.86 163.31 89.39 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.484 -1.776 . . . . 0.0 107.484 -18.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 83' ' ' LEU . 33.9 m -59.62 125.75 24.87 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 124.492 1.117 . . . . 0.0 110.693 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -76.19 138.46 40.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.83 -40.71 60.89 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 123.432 0.457 . . . . 0.0 111.256 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.91 128.0 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -148.79 131.72 16.17 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 m -96.97 124.38 40.92 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.645 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.98 120.08 30.88 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.77 149.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.636 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -143.37 138.46 29.43 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.98 -140.28 6.78 Favored Glycine 0 CA--C 1.484 -1.871 0 N-CA-C 106.651 -2.579 . . . . 0.0 106.651 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.38 146.55 25.07 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 1.2 tmtp? -83.89 -25.4 30.23 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -70.75 -34.23 71.63 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.006 1.323 . . . . 0.0 108.708 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -69.93 -41.44 74.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 117.614 -1.184 . . . . 0.0 110.459 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.74 -50.73 76.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 123.837 0.855 . . . . 0.0 111.909 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -63.87 -37.67 88.24 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.343 0.657 . . . . 0.0 111.188 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.35 4.81 8.15 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HB2' ' A' ' 72' ' ' SER . 23.0 mm -77.3 -26.85 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.7 t -82.74 -15.02 53.42 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.152 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.47 154.41 38.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -83.34 -7.49 59.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.757 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -80.41 -41.84 23.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.921 0.488 . . . . 0.0 109.769 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -123.29 31.46 5.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.67 136.95 3.37 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -90.01 154.02 47.27 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 37.2 Cg_endo -74.79 138.43 23.58 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 122.335 2.024 . . . . 0.0 106.974 169.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -130.67 104.77 7.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' CD ' ' H ' ' A' ' 67' ' ' GLU 0.398 0.0 OUTLIER 46.31 -109.59 0.23 Allowed 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 127.806 2.442 . . . . 0.0 115.661 -177.862 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 50.2 mt-10 -107.33 77.47 1.15 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.766 1.226 . . . . 0.0 108.763 -165.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.372 1.2 p-10 76.59 12.12 2.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 129.102 2.961 . . . . 0.0 114.345 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.3 mp -95.82 154.17 17.36 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 64' ' ' PRO . 13.8 mmp_? -136.57 112.64 9.7 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -95.73 132.21 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.422 ' HB2' HD12 ' A' ' 56' ' ' ILE . 96.2 p -82.45 157.05 23.79 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.652 0.739 . . . . 0.0 112.424 -168.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -108.94 -15.93 14.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.533 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -112.91 90.57 3.38 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.8 m -50.92 133.23 27.05 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 127.402 2.281 . . . . 0.0 112.419 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.4 161.3 15.43 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' HG3' HH21 ' A' ' 21' ' ' ARG . 0.3 OUTLIER -82.16 126.77 32.44 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 175.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 108.5 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.2 m -94.82 108.31 20.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.1 m -91.83 102.9 15.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.2 m -93.3 117.65 30.33 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.54 144.73 37.43 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 39' ' ' CYS . 41.2 tp -78.98 126.67 30.99 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.72 52.58 2.04 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.69 -70.54 1.18 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.71 -32.44 4.44 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.9 t -87.48 135.34 34.47 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -78.38 -22.65 9.35 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.161 1.908 . . . . 0.0 109.074 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -95.32 167.4 12.89 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -72.32 142.63 37.69 Favored 'Trans proline' 0 N--CA 1.438 -1.788 0 C-N-CA 122.028 1.819 . . . . 0.0 107.526 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.0 Cg_endo -88.15 164.56 42.96 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 CA-C-N 122.63 1.975 . . . . 0.0 108.775 15.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.7 m -130.01 122.66 28.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -94.87 117.35 30.0 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -107.28 122.6 46.88 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -96.79 121.4 38.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.67 130.33 35.02 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.9 m -118.05 95.4 4.89 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.94 34.27 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.105 -173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.94 -176.18 19.61 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.328 -3.109 . . . . 0.0 105.328 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -148.43 109.71 4.37 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.568 -3.123 . . . . 0.0 102.568 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -162.12 175.11 12.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.971 0.891 . . . . 0.0 109.018 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -77.56 142.24 39.11 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 125.244 1.418 . . . . 0.0 110.675 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.38 150.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.12 91.73 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 166.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.64 132.62 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.52 125.02 36.97 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.3 t -108.67 131.24 55.09 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -126.19 136.84 53.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 13.1 p30 65.05 18.98 11.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 127.514 2.326 . . . . 0.0 117.083 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.9 54.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 0.4 OUTLIER -134.47 132.2 20.76 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 -178.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.95 108.21 2.6 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 N-CA-C 105.78 -2.431 . . . . 0.0 105.78 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 m -94.27 -11.72 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -172.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.455 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 61.9 t60 -153.85 179.53 8.79 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -169.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.455 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -164.21 130.58 3.06 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.85 135.02 36.92 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.251 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -100.86 41.84 1.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.3 t -96.38 -32.39 12.39 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.47 -35.89 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.837 172.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 N--CA 1.422 -1.854 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -171.434 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.319 0.5 OUTLIER . . . . . 0 CA--C 1.489 -1.393 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 m -92.19 -13.82 29.98 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -43.68 67.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.268 41.4 t80 -56.82 -51.96 66.95 Favored 'General case' 0 N--CA 1.399 -3.012 0 C-N-CA 126.623 1.969 . . . . 0.0 113.422 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.482 ' HA ' ' HG ' ' A' ' 10' ' ' LEU 0.252 1.5 p -82.06 -3.24 54.22 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -85.63 -31.21 22.7 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 120.136 1.335 . . . . 0.0 108.229 167.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 115' ' ' LEU . 16.0 t80 -65.18 -36.98 85.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.407 1.083 . . . . 0.0 109.405 167.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.295 8.9 mt -69.25 -31.15 69.5 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 170.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.6 m -65.26 -44.28 88.61 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 119.509 1.049 . . . . 0.0 108.936 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 66.5 mt-30 -70.0 -55.16 10.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 123.556 0.535 . . . . 0.0 111.92 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.463 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 91.1 m-70 -96.49 -49.44 5.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.913 -162.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HB2' HD22 ' A' ' 10' ' ' LEU . 29.2 t80 -71.15 115.09 9.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 120.065 1.302 . . . . 0.0 112.635 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -138.56 98.05 3.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 100.789 -3.782 . . . . 0.0 100.789 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.82 -40.69 10.09 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.515 2.326 . . . . 0.0 117.055 -168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -157.63 144.11 13.04 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 69.0 Cg_exo -76.51 178.39 7.61 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.507 2.138 . . . . 0.0 112.916 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.64 -74.99 0.17 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.74 -176.44 14.74 Favored Glycine 0 CA--C 1.477 -2.336 1 N-CA-C 102.557 -4.217 . . . . 0.0 102.557 163.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -118.16 72.56 0.87 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -145.01 177.8 8.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.72 -22.33 63.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.704 1.202 . . . . 0.0 113.595 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.8 -29.45 40.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -41.87 69.48 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.282 0.8 OUTLIER -79.69 -26.92 40.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.227 -170.585 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.66 -35.47 70.36 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.286 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -67.73 -38.91 84.17 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 26' ' ' CYS . 4.1 tt -79.69 -30.85 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 118.535 0.607 . . . . 0.0 110.629 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -74.4 -30.09 61.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 122.392 -0.192 . . . . 0.0 111.0 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -68.43 -44.85 74.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.467 0.707 . . . . 0.0 111.873 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -71.2 -48.99 48.21 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.913 0.885 . . . . 0.0 112.277 -173.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -36.82 75.35 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.201 0.6 . . . . 0.0 110.408 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.58 68.79 1.36 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -114.91 22.48 13.41 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -91.25 -10.21 42.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 124.267 1.027 . . . . 0.0 109.132 -172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -129.99 104.54 16.82 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.65 160.01 95.66 Favored 'Cis proline' 0 N--CA 1.444 -1.404 0 N-CA-C 107.073 -1.934 . . . . 0.0 107.073 -20.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' HD13 ' A' ' 83' ' ' LEU . 59.5 m -62.92 125.26 23.37 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.059 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.01 143.17 45.67 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.03 -39.14 61.23 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.161 0.584 . . . . 0.0 111.541 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 tt -149.11 128.83 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -147.26 125.73 12.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 m -101.51 114.36 28.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.586 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -85.67 125.96 33.57 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.41 146.37 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.726 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -136.91 127.45 26.86 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 125.311 1.444 . . . . 0.0 107.949 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.65 -148.49 17.67 Favored Glycine 0 CA--C 1.483 -1.91 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -84.02 140.5 31.82 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 122.2 1.0 . . . . 0.0 108.33 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -85.27 -15.78 42.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.308 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -79.32 -31.42 43.18 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 125.317 1.447 . . . . 0.0 107.857 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.7 m -73.37 -36.47 66.11 Favored 'General case' 0 N--CA 1.424 -1.744 0 C-N-CA 124.177 0.991 . . . . 0.0 109.992 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 112' ' ' PRO . 87.7 mt -59.9 -52.25 63.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.996 0 C-N-CA 123.379 0.672 . . . . 0.0 110.992 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.05 -39.7 79.11 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.821 0.849 . . . . 0.0 112.849 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.69 10.35 3.34 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.9 mt -78.63 -30.53 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.0 t -68.08 -41.27 82.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.36 154.98 28.64 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.26 99.22 8.5 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -159.77 -49.08 0.05 Allowed 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.34 47.24 1.39 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.94 129.53 1.54 Allowed Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.76 160.63 32.66 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -72.64 138.26 28.98 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 122.914 2.409 . . . . 0.0 107.971 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -141.32 129.63 22.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 65.66 -108.72 0.16 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.052 1.341 . . . . 0.0 111.447 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -140.67 95.15 2.81 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.345 1.6 p-10 64.15 23.38 13.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 128.92 2.888 . . . . 0.0 114.327 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.9 mt -106.46 168.48 9.13 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -141.13 124.75 16.82 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.53 142.52 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.3 p -84.31 175.16 9.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.826 0.822 . . . . 0.0 110.418 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -131.45 -1.18 3.94 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -109.54 74.02 0.87 Allowed 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.4 p -51.19 123.89 10.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.137 1.775 . . . . 0.0 113.544 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -108.6 160.99 15.49 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.68 136.45 35.49 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.47 110.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -172.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.0 m -93.64 110.63 22.23 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.1 m -88.95 104.63 17.14 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.4 m -94.19 115.47 27.75 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -110.13 147.66 33.25 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB3' ' A' ' 39' ' ' CYS . 36.7 tp -79.99 112.91 17.74 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -132.81 96.54 3.82 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.85 -40.92 0.06 OUTLIER Glycine 0 CA--C 1.479 -2.197 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.6 42.48 6.46 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.8 m -114.61 107.19 51.25 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -83.76 -20.53 4.53 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 CA-C-N 122.213 1.826 . . . . 0.0 108.398 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -110.17 161.32 24.93 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -73.96 144.45 34.32 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.665 2.244 . . . . 0.0 108.31 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -81.89 163.63 76.49 Favored 'Cis proline' 0 N--CA 1.437 -1.848 0 CA-C-N 122.641 1.979 . . . . 0.0 108.731 -1.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.1 m -108.53 159.41 16.72 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.739 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.18 98.7 7.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.77 128.3 44.32 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -101.34 121.03 41.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.46 132.67 35.2 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 48.4 m -116.12 105.52 12.69 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.1 125.53 29.48 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.3 177.99 18.75 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 105.691 -2.963 . . . . 0.0 105.691 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -158.95 111.13 2.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -161.21 171.12 18.98 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.24 133.77 42.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.852 172.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.65 149.51 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.424 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.98 122.38 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.35 138.94 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.21 132.16 36.28 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.5 t -104.42 133.81 48.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 124.744 1.278 . . . . 0.0 109.903 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -132.57 141.37 48.68 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 164.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.326 11.2 p30 66.34 17.79 10.76 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.301 2.24 . . . . 0.0 116.503 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.12 50.77 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.267 3.5 tp -143.43 149.84 49.21 Favored Pre-proline 0 CA--C 1.484 -1.591 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HG2' HG22 ' A' ' 53' ' ' ILE . 50.1 Cg_exo -67.19 147.21 78.5 Favored 'Trans proline' 0 N--CA 1.436 -1.898 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 164.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.28 -19.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 42.1 t60 -155.86 178.79 9.87 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 -165.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.447 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -159.32 146.43 16.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -173.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -95.44 141.23 29.23 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -115.56 20.71 14.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.301 1.04 . . . . 0.0 110.029 -170.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.3 m -95.13 -20.75 19.01 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 118.94 0.791 . . . . 0.0 109.938 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.83 -33.0 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.42 1.088 . . . . 0.0 111.036 177.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -169.234 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.9 m -88.76 -26.52 21.7 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.13 -49.88 68.2 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.76 -57.3 11.37 Favored 'General case' 0 N--CA 1.4 -2.949 0 C-N-CA 127.209 2.204 . . . . 0.0 114.327 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.432 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 14.9 p -82.64 -2.34 53.67 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -86.12 -31.33 21.92 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -64.07 -41.18 97.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.373 166.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.335 0.7 OUTLIER -61.16 -39.81 91.51 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 172.981 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -69.65 -46.22 66.64 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 120.072 1.305 . . . . 0.0 110.463 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.92 -5.18 59.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -127.29 -62.94 1.07 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.591 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -67.43 118.3 10.57 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.957 1.253 . . . . 0.0 112.02 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -147.27 99.29 3.13 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.94 -29.58 0.85 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -163.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -153.06 157.1 33.05 Favored Pre-proline 0 N--CA 1.434 -1.234 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.5 Cg_endo -74.41 157.5 45.2 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 123.188 2.592 . . . . 0.0 108.859 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.97 -63.22 1.31 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.62 177.0 18.64 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 103.072 -4.011 . . . . 0.0 103.072 161.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' HE ' ' HB1' ' A' ' 98' ' ' ALA . 77.8 mtp180 -109.53 68.28 0.67 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.06 173.9 14.87 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -170.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.82 -14.94 61.18 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.66 1.184 . . . . 0.0 113.093 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -32.29 53.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.112 0.565 . . . . 0.0 109.621 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.95 -41.47 61.97 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.268 0.1 OUTLIER -78.45 -26.68 46.25 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 118.451 -1.299 . . . . 0.0 114.042 -170.77 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 -34.14 59.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.161 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -69.81 -32.56 71.06 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.286 14.6 tt -79.97 -35.12 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.198 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -22.31 59.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.223 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.82 -29.75 29.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 119.433 1.015 . . . . 0.0 112.959 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.6 -41.95 20.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 118.758 0.708 . . . . 0.0 110.91 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -72.42 -38.59 68.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.329 1.052 . . . . 0.0 109.54 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.73 68.01 1.41 Allowed Glycine 0 CA--C 1.48 -2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.83 17.66 16.9 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 t -90.54 -10.33 43.9 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 p -126.55 102.21 26.39 Favored Pre-proline 0 N--CA 1.428 -1.547 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.84 161.72 93.66 Favored 'Cis proline' 0 N--CA 1.445 -1.372 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -21.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.446 ' HB3' HD13 ' A' ' 83' ' ' LEU . 35.4 m -61.08 120.42 10.24 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.239 1.015 . . . . 0.0 109.673 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -79.82 145.82 32.59 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -68.78 -42.93 76.72 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.239 1.015 . . . . 0.0 113.103 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -156.4 134.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -147.91 137.01 22.15 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.4 m -99.62 122.97 43.43 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.13 122.25 35.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.4 144.45 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.552 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 20.8 m-70 -134.04 131.65 39.1 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 124.067 0.947 . . . . 0.0 108.454 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.34 -151.42 21.7 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 104.317 -3.513 . . . . 0.0 104.317 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -89.83 152.88 21.06 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.62 -8.74 51.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -36.73 49.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 p -78.62 -28.47 45.64 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.798 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 53' ' ' ILE . 4.2 tp -66.14 -44.31 91.75 Favored 'Isoleucine or valine' 0 C--N 1.368 1.399 0 CA-C-N 120.324 1.42 . . . . 0.0 110.381 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.73 -33.67 76.15 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.49 1.116 . . . . 0.0 111.437 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 8.4 5.08 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.77 -19.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.1 m -75.76 -12.77 60.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.76 156.52 32.33 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -85.94 -13.4 47.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.224 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.83 -34.0 22.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 123.06 0.544 . . . . 0.0 109.875 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -124.23 45.02 2.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.75 141.26 3.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -89.84 154.29 47.73 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.83 138.37 28.65 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.771 2.314 . . . . 0.0 106.246 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -137.94 123.08 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 60.5 -109.81 0.42 Allowed 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 125.883 1.673 . . . . 0.0 112.451 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -134.77 95.18 3.29 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.348 1.2 p-10 69.83 16.55 7.77 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 129.253 3.021 . . . . 0.0 114.531 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.2 167.32 10.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -140.56 117.41 11.05 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.54 145.82 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -91.13 152.21 20.68 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.436 0.636 . . . . 0.0 111.653 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.76 -17.55 14.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 t -108.93 85.28 2.07 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 p -50.2 135.47 21.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 127.516 2.326 . . . . 0.0 113.093 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.31 161.67 16.37 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 4.2 mt-30 -82.11 136.03 35.23 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.94 100.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m -91.56 111.47 23.0 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.0 m -94.54 102.35 14.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.9 m -96.53 122.23 39.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -118.78 144.08 46.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.1 tp -77.29 104.44 7.8 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.791 1.236 . . . . 0.0 108.852 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -87.15 155.13 20.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.28 -76.13 0.51 Allowed Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.42 38.78 2.95 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 106.758 -2.537 . . . . 0.0 106.758 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 t -94.11 117.73 67.15 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.23 -12.29 5.87 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 CA-C-N 121.897 1.713 . . . . 0.0 108.041 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -103.89 161.78 21.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -75.01 145.7 31.73 Favored 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.028 1.818 . . . . 0.0 107.424 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -83.44 165.26 67.93 Favored 'Cis proline' 0 N--CA 1.439 -1.713 0 CA-C-N 122.997 2.106 . . . . 0.0 109.623 7.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.6 m -120.66 141.26 50.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.29 100.52 10.42 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.35 108.49 21.02 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -92.68 124.05 36.41 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.63 130.08 34.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.535 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.8 m -117.7 93.34 4.12 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.418 ' HB1' ' HE ' ' A' ' 21' ' ' ARG . . . -82.19 134.79 35.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 -170.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.71 -173.25 12.94 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -159.77 108.62 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.34 178.22 5.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.974 0.893 . . . . 0.0 109.371 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -69.6 140.81 53.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.576 1.95 . . . . 0.0 111.853 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.73 152.66 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.7 t -108.3 90.47 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.36 131.36 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.08 35.65 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.8 t -106.17 133.89 50.16 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.486 1.116 . . . . 0.0 110.689 -167.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.05 125.47 33.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 13.0 p30 66.87 15.78 10.22 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 127.632 2.373 . . . . 0.0 116.748 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.58 40.86 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.9 tp -135.22 123.28 15.49 Favored Pre-proline 0 N--CA 1.435 -1.222 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.13 107.77 2.1 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 106.038 -2.331 . . . . 0.0 106.038 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.96 -18.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 123.38 0.425 . . . . 0.0 110.927 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 46.3 t60 -146.27 177.03 9.32 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.39 129.62 6.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.38 150.62 36.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.2 59.53 0.68 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -171.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.0 t -65.45 -67.06 0.47 Allowed 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.789 1.236 . . . . 0.0 111.164 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 pt -100.78 1.34 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -167.725 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.7 t30 . . . . . 0 CA--C 1.493 -1.213 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.531 1.133 . . . . 0.0 109.932 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -64.14 -54.23 37.01 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.297 1.439 . . . . 0.0 107.893 170.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.63 -41.75 95.96 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.04 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.447 0.3 OUTLIER -85.95 -3.72 58.99 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -77.47 -36.85 52.42 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 119.54 1.064 . . . . 0.0 108.911 163.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 10' ' ' LEU . 7.3 t80 -59.48 -37.23 77.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.099 0.96 . . . . 0.0 110.214 168.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -82.77 -18.69 39.78 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 119.236 0.926 . . . . 0.0 113.03 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 m -69.08 -51.83 34.72 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.482 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 12.9 pt20 -85.61 -12.35 51.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 94.7 m-70 -117.76 -51.57 2.47 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 119.08 0.855 . . . . 0.0 111.278 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -79.1 119.28 21.99 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.824 1.193 . . . . 0.0 109.58 -167.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -136.27 96.76 3.44 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 100.678 -3.823 . . . . 0.0 100.678 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.02 -45.52 2.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 128.449 2.7 . . . . 0.0 117.424 -168.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 141.94 14.17 Favored Pre-proline 0 N--CA 1.433 -1.324 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 164.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 34.4 Cg_exo -74.18 -179.07 4.36 Favored 'Trans proline' 0 N--CA 1.437 -1.827 0 C-N-CA 122.628 2.219 . . . . 0.0 114.125 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.1 -76.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.1 -174.96 13.9 Favored Glycine 0 CA--C 1.476 -2.348 1 N-CA-C 101.399 -4.68 . . . . 0.0 101.399 160.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -112.63 74.47 0.86 Allowed 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -137.81 178.13 7.35 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -72.09 -26.03 61.99 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 124.084 0.953 . . . . 0.0 111.641 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -81.52 -23.19 37.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 123.341 0.656 . . . . 0.0 109.65 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -73.64 -45.68 51.35 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 2.0 t -78.69 -23.99 45.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.768 -173.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.91 -40.4 79.13 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -68.29 -41.51 80.84 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 26' ' ' CYS . 16.3 tt -78.18 -32.06 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 117.85 0.296 . . . . 0.0 110.827 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 47.1 mtp -78.56 -27.46 45.81 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.2 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -67.34 -41.1 85.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -75.84 -46.65 29.27 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -32.67 72.8 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 123.289 0.636 . . . . 0.0 111.366 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.76 62.63 1.59 Allowed Glycine 0 CA--C 1.478 -2.258 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.4 mt -112.88 20.36 16.49 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 163.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -96.3 -8.01 33.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 p -125.05 99.84 34.02 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 167.22 81.11 Favored 'Cis proline' 0 N--CA 1.446 -1.322 0 N-CA-C 107.384 -1.814 . . . . 0.0 107.384 -22.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.47 121.91 11.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.344 1.058 . . . . 0.0 111.316 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.63 136.85 38.28 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.13 -39.46 63.29 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 123.781 0.676 . . . . 0.0 112.222 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -153.76 125.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -144.01 134.17 24.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.184 0.516 . . . . 0.0 109.886 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 78' ' ' VAL . 55.3 m -101.41 114.95 29.41 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.959 0.903 . . . . 0.0 110.339 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -90.58 119.84 31.16 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.72 150.94 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -141.88 139.52 32.63 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.6 -135.23 3.83 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.31 140.86 32.87 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -85.69 -19.6 30.65 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.31 96.46 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.546 1.938 . . . . 0.0 108.084 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -71.45 -37.55 71.38 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.97 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.3 mm -55.63 -55.75 15.77 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 119.631 1.105 . . . . 0.0 110.958 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -58.27 -42.97 87.69 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.525 1.13 . . . . 0.0 111.416 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 15.58 1.75 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mm -78.52 -23.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.14 -15.96 48.64 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.873 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.42 150.06 43.7 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -77.39 -19.61 55.91 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 124.51 1.124 . . . . 0.0 111.311 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -77.54 -40.16 43.54 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 123.159 0.584 . . . . 0.0 109.977 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -119.47 34.02 5.39 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.17 129.15 1.08 Allowed Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 106.661 -2.576 . . . . 0.0 106.661 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -99.27 159.24 30.62 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -71.85 131.17 17.9 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 122.911 2.407 . . . . 0.0 106.822 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -125.54 126.05 44.2 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 65.51 -102.49 0.08 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.26 1.424 . . . . 0.0 110.99 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.78 105.68 3.45 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 3.5 p30 75.58 1.9 3.68 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.503 3.121 . . . . 0.0 114.717 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.32 171.63 8.07 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -144.71 119.04 9.56 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -170.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 tt -98.1 138.71 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -77.34 165.39 24.52 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.615 0.721 . . . . 0.0 112.785 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.24 -27.74 11.36 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -106.1 81.12 1.59 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 p -41.1 120.11 1.3 Allowed 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.987 2.515 . . . . 0.0 113.816 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.37 158.24 16.48 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.1 mt-30 -79.92 149.49 30.86 Favored 'General case' 0 CA--C 1.472 -2.031 0 CA-C-N 113.912 -1.495 . . . . 0.0 107.384 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG21 HH22 ' A' ' 101' ' ' ARG . 0.9 OUTLIER -150.3 148.51 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -126.53 105.49 8.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 165.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -88.51 98.48 11.66 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.84 119.49 29.38 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -108.76 142.37 39.39 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.37 125.68 29.71 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.52 1.528 . . . . 0.0 107.459 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.39 47.06 2.57 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.71 -69.44 1.35 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.68 -31.06 5.69 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 p -85.55 145.4 41.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -79.57 -23.5 7.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.024 1.816 . . . . 0.0 108.773 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -99.61 165.84 13.95 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 117.979 -1.01 . . . . 0.0 108.994 -168.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -71.91 144.83 44.06 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.604 2.202 . . . . 0.0 108.141 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -86.22 165.17 52.32 Favored 'Cis proline' 0 N--CA 1.438 -1.756 0 CA-C-N 122.432 1.904 . . . . 0.0 107.914 9.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 63.9 m -132.57 126.49 32.91 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -89.8 136.75 32.85 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -124.67 122.6 37.96 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.88 115.15 27.82 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 126.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 m -117.58 103.55 10.17 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.56 130.49 35.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 120.819 0.342 . . . . 0.0 110.38 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.01 172.86 16.61 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.0 t80 -154.3 99.82 2.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.606 HH22 HG21 ' A' ' 78' ' ' VAL 0.256 0.0 OUTLIER -161.65 -179.78 7.54 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.623 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.13 133.14 47.64 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.124 0.969 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.9 142.77 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.5 t -104.66 110.09 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 165.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -106.65 152.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.03 49.19 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.2 t -109.72 131.28 55.21 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 124.745 1.278 . . . . 0.0 111.229 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -124.27 136.54 54.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 164.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.304 14.2 p30 64.15 21.56 12.6 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.9 16.87 57.41 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.29 0.9 OUTLIER -135.33 134.29 21.18 Favored Pre-proline 0 CA--C 1.487 -1.478 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.02 109.67 2.93 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 106.173 -2.28 . . . . 0.0 106.173 168.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -94.46 -12.16 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 118.11 0.413 . . . . 0.0 110.438 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -150.66 155.74 39.96 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -165.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.85 125.34 52.67 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -80.94 128.68 33.95 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -106.59 51.04 0.75 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 t -87.19 -47.23 9.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -32.12 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 . . . . . 0 N--CA 1.427 -1.605 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.304 -163.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 t -91.2 -30.63 16.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.29 -41.15 66.97 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.621 ' CE1' HD22 ' A' ' 111' ' ' LEU . 67.3 t80 -52.29 -60.65 2.96 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 127.311 2.244 . . . . 0.0 113.665 170.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.558 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 30.9 p -69.65 -20.96 63.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -78.71 -37.02 42.53 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 119.352 0.978 . . . . 0.0 110.155 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.83 -41.71 87.53 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.601 1.56 . . . . 0.0 109.625 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.397 0.3 OUTLIER -91.23 -4.46 55.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.849 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.3 m -75.9 -43.32 45.82 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 166.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.21 -40.54 86.45 Favored 'General case' 0 CA--C 1.488 -1.421 0 O-C-N 123.605 0.565 . . . . 0.0 111.201 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -106.75 -56.98 2.12 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.661 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 9.5 t80 -74.51 114.26 12.7 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.989 1.268 . . . . 0.0 110.438 -168.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.81 94.5 3.4 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.3 -33.54 0.65 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -163.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -151.34 155.99 34.77 Favored Pre-proline 0 N--CA 1.432 -1.326 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -73.3 156.87 50.51 Favored 'Trans proline' 0 N--CA 1.433 -2.073 0 C-N-CA 123.215 2.61 . . . . 0.0 110.049 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.46 -60.7 2.22 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 164.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.09 -177.01 14.66 Favored Glycine 0 CA--C 1.479 -2.19 1 N-CA-C 103.019 -4.032 . . . . 0.0 103.019 163.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -125.46 67.65 1.15 Allowed 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.64 179.12 6.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.43 -24.17 63.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -84.89 -21.28 29.78 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.75 -43.72 58.24 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.3 t -81.3 -21.66 39.13 Favored 'General case' 0 N--CA 1.412 -2.359 0 C-N-CA 117.936 -1.506 . . . . 0.0 112.543 -171.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.75 -34.34 66.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 121.879 -0.513 . . . . 0.0 110.417 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 t -70.58 -35.15 72.89 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.1 tt -86.28 -25.26 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-N 118.214 0.461 . . . . 0.0 110.943 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 mmt -77.31 -28.82 53.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 121.7 -0.625 . . . . 0.0 109.789 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.26 -38.51 71.89 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.054 0.942 . . . . 0.0 112.204 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -70.4 -51.63 28.22 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 124.531 1.132 . . . . 0.0 110.893 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -30.52 62.28 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.882 0.873 . . . . 0.0 109.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.65 60.49 2.97 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.57 16.17 22.39 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 t -100.04 0.47 40.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -129.79 104.08 17.25 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.96 156.48 99.41 Favored 'Cis proline' 0 N--CA 1.442 -1.508 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -20.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.428 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -66.81 116.38 7.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.132 0.973 . . . . 0.0 111.107 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -82.27 146.2 29.59 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -75.06 -29.75 60.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.901 1.28 . . . . 0.0 113.064 -170.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 128.25 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -141.9 137.15 31.13 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.7 m -103.78 129.95 51.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -103.97 115.24 30.09 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mm -80.3 149.81 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 C-N-CA 126.132 1.773 . . . . 0.0 107.029 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.53 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.4 m-70 -136.35 131.49 34.35 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.54 -145.84 9.9 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -105.08 148.24 27.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -84.37 -18.07 37.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -82.34 -21.82 35.81 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -72.81 -39.83 66.32 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 118.462 -0.78 . . . . 0.0 108.996 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.73 -50.98 75.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.579 1.151 . . . . 0.0 111.01 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.46 -39.36 90.58 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.783 0.833 . . . . 0.0 112.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.07 6.45 5.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.82 -30.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 m -82.73 -7.08 59.67 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -80.05 159.03 26.31 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -87.49 -4.59 58.99 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.548 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -80.69 -45.68 16.76 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -122.59 39.91 3.81 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.59 166.84 32.48 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.95 159.29 35.93 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -76.96 137.71 17.77 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.218 1.945 . . . . 0.0 107.671 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -124.83 139.09 54.16 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 66.29 -103.21 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.423 1.089 . . . . 0.0 110.227 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -163.36 113.75 1.37 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.374 0.8 OUTLIER 74.13 7.29 4.75 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 129.528 3.131 . . . . 0.0 114.376 177.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 HG12 ' A' ' 104' ' ' VAL . 2.5 mm? -107.51 164.7 11.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.31 105.49 3.35 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -166.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -85.64 138.58 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -79.88 166.17 21.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.412 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -112.92 -16.2 12.74 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -109.93 87.85 2.61 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.8 t -46.79 124.21 5.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.958 2.503 . . . . 0.0 112.238 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -104.66 155.98 18.39 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.421 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 4.6 mt-30 -80.28 152.08 29.23 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.36 151.19 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -168.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -132.47 102.61 5.79 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 165.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.1 m -86.38 102.08 13.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.02 128.17 37.76 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -113.96 147.42 38.59 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.5 tp -72.27 128.93 37.16 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -142.1 46.85 1.63 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.54 -65.57 0.9 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.28 -23.78 11.06 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -85.7 143.33 38.05 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -79.65 -22.98 7.42 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 122.049 1.833 . . . . 0.0 108.725 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -106.28 157.3 35.25 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.637 -168.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.44 150.34 36.2 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.441 2.094 . . . . 0.0 108.401 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -83.32 167.33 64.01 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 CA-C-N 122.423 1.901 . . . . 0.0 108.742 1.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.3 m -147.75 141.61 25.79 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -87.23 146.79 25.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.65 118.57 23.14 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -79.27 108.53 12.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.82 126.75 34.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -116.68 108.66 16.18 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.79 122.22 24.46 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.95 179.46 16.22 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.8 t80 -162.28 101.61 1.09 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.727 -3.434 . . . . 0.0 101.727 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 170.28 22.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.814 -171.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -75.01 130.71 39.82 Favored 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 124.225 1.01 . . . . 0.0 109.556 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.7 130.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HD12 ' A' ' 69' ' ' LEU . 59.2 t -102.89 80.45 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.3 m -95.88 142.59 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.96 39.15 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.5 m -100.04 141.81 32.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 124.298 0.999 . . . . 0.0 111.237 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.73 130.41 19.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 12.1 p30 62.59 18.25 10.34 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 128.153 2.581 . . . . 0.0 115.372 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.62 -10.67 61.04 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 6' ' ' TYR . 7.3 mt -102.76 144.04 27.81 Favored Pre-proline 0 CA--C 1.478 -1.797 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.83 114.66 4.09 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 N-CA-C 105.269 -2.627 . . . . 0.0 105.269 161.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 m -99.77 -15.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 69.1 t60 -149.03 175.41 11.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -169.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.62 129.12 2.59 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.26 135.81 39.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.926 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.18 37.44 1.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 t -95.75 -16.6 21.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 119' ' ' ILE . 1.7 pt -95.53 -21.39 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.246 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 . . . . . 0 N--CA 1.426 -1.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.72 -170.174 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -91.44 -1.8 57.45 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.826 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -74.32 -43.76 55.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 4.6 t80 -58.76 -52.67 64.72 Favored 'General case' 0 N--CA 1.41 -2.449 0 C-N-CA 124.939 1.295 . . . . 0.0 111.633 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.51 2.5 t -89.94 12.77 16.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -82.19 -40.23 22.02 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.204 -1.56 . . . . 0.0 108.1 156.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.92 -41.64 83.13 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.366 1.066 . . . . 0.0 109.525 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 19.4 mt -83.84 -13.84 52.69 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -65.55 -53.21 45.24 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 120.411 1.46 . . . . 0.0 107.811 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 4.9 pt20 -81.64 -17.14 49.13 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 84.4 m-70 -110.97 -55.03 2.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 118.965 0.802 . . . . 0.0 111.151 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 43.7 t80 -76.34 122.27 24.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.683 1.128 . . . . 0.0 109.208 -168.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -136.21 97.58 3.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.59 -38.45 4.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -166.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 140.57 9.92 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 165.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 81.1 Cg_exo -73.18 175.83 9.98 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 122.794 2.33 . . . . 0.0 113.794 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -73.21 -73.05 0.22 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.3 -176.66 14.61 Favored Glycine 0 CA--C 1.478 -2.249 1 N-CA-C 102.428 -4.269 . . . . 0.0 102.428 163.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -115.16 72.81 0.81 Allowed 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -147.83 -179.34 6.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.1 -21.66 62.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.714 1.206 . . . . 0.0 112.867 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -88.79 -15.47 34.54 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.1 -39.04 34.71 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 m -68.79 -34.32 75.34 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -66.85 -44.93 79.73 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 123.551 0.741 . . . . 0.0 109.587 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -64.75 -35.68 81.86 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.384 0.673 . . . . 0.0 112.54 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.29 13.3 tt -83.72 -28.97 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.973 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 -23.55 43.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 117.657 -1.617 . . . . 0.0 111.724 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -79.4 -32.9 43.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 118.995 0.816 . . . . 0.0 111.042 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -47.97 15.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.327 0.651 . . . . 0.0 110.064 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -76.81 -32.04 57.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.68 66.7 1.53 Allowed Glycine 0 CA--C 1.476 -2.347 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.9 31.13 6.75 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 162.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.64 2.65 44.69 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 p -124.64 94.77 43.95 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.48 167.1 81.05 Favored 'Cis proline' 0 N--CA 1.443 -1.498 0 N-CA-C 106.981 -1.969 . . . . 0.0 106.981 -24.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.2 m -63.3 116.05 5.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 124.352 1.061 . . . . 0.0 111.115 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.26 134.62 42.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -71.15 -35.4 71.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 124.373 1.045 . . . . 0.0 112.295 -168.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.43 136.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -147.58 122.11 9.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.7 m -90.89 106.33 18.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -85.88 121.37 28.42 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.0 148.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.44 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -141.15 132.87 27.27 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.36 -137.32 4.59 Favored Glycine 0 CA--C 1.483 -1.935 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -113.43 144.62 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -85.45 -17.5 36.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.906 -169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -82.26 -26.65 32.99 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.8 p -77.67 -30.11 51.83 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.658 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.93 -46.34 96.67 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 CA-C-N 119.403 1.001 . . . . 0.0 110.627 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -60.42 -38.82 85.26 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.487 1.115 . . . . 0.0 111.828 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 9.85 5.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.705 1.202 . . . . 0.0 113.889 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.48 -17.92 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.6 t -66.37 -69.94 0.27 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.452 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -141.19 118.95 11.71 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' H ' ' H ' ' A' ' 60' ' ' LYS . 54.8 t30 -159.88 -3.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 164.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' A' ' 59' ' ' ASN 0.386 62.5 pttt 57.81 26.96 13.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.859 2.064 . . . . 0.0 111.748 -156.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -105.57 -14.74 15.19 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 167.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.77 139.98 10.87 Favored Glycine 0 CA--C 1.488 -1.636 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 160.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.39 153.88 43.23 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -69.68 143.27 50.68 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.824 2.349 . . . . 0.0 108.513 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -145.56 130.84 18.55 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 66.39 -103.59 0.08 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.884 1.273 . . . . 0.0 109.549 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -156.66 102.64 2.05 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER 90.93 -12.7 0.26 Allowed 'General case' 0 C--N 1.354 0.798 0 C-N-CA 128.323 2.649 . . . . 0.0 112.526 173.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.36 158.61 16.44 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -143.67 114.97 7.98 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -92.12 141.15 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -80.8 166.35 21.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.708 0.766 . . . . 0.0 110.823 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -120.6 -14.77 8.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.4 t -109.82 86.49 2.31 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.6 p -51.75 131.6 30.51 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 127.028 2.131 . . . . 0.0 112.293 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.16 156.69 19.56 Favored 'General case' 0 CA--C 1.476 -1.896 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 -171.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.61 142.03 40.84 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.9 143.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -166.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.6 m -131.01 108.39 9.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.61 -3.107 . . . . 0.0 102.61 168.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -82.69 101.38 10.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 71.8 m -88.91 111.42 22.07 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -109.5 137.69 46.97 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -76.3 112.33 12.68 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 125.172 1.389 . . . . 0.0 108.366 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -90.81 147.76 22.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 -74.24 0.21 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 28.68 4.31 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.6 p -92.09 127.19 50.35 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -80.44 -29.76 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 N-CA-C 107.735 -1.679 . . . . 0.0 107.735 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -99.35 148.07 34.17 Favored Pre-proline 0 N--CA 1.427 -1.591 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.476 -168.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -74.91 144.37 30.51 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.643 2.229 . . . . 0.0 107.0 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -81.74 160.98 79.84 Favored 'Cis proline' 0 CA--C 1.486 -1.884 0 CA-C-N 123.705 2.359 . . . . 0.0 109.982 10.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.9 m -146.94 146.97 30.3 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -167.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -102.52 154.19 19.35 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -137.66 125.12 22.0 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -104.68 130.69 52.68 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.24 138.96 31.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 122.826 0.451 . . . . 0.0 110.737 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.2 m -133.25 95.07 3.45 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.75 153.31 17.83 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.664 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.46 -163.63 12.14 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -149.59 97.9 2.69 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.5 ttt-85 -140.65 158.89 43.31 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -165.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.55 137.32 57.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.667 1.187 . . . . 0.0 109.679 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.46 136.87 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -104.02 91.37 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.86 138.77 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.65 123.63 32.04 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.5 t -103.25 125.93 50.16 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.589 1.181 . . . . 0.0 109.493 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -109.58 126.88 54.07 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 163.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.307 0.4 OUTLIER 31.95 68.55 0.13 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 128.622 2.769 . . . . 0.0 118.359 175.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.42 4.74 90.04 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.23 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.27 0.8 OUTLIER -138.2 135.32 18.34 Favored Pre-proline 0 CA--C 1.486 -1.486 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -63.53 132.95 37.59 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.817 2.345 . . . . 0.0 106.387 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.61 -18.57 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 20.7 t60 -151.92 179.8 8.14 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 -170.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 5.6 tp -151.83 132.47 13.97 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.56 123.57 27.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.89 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -103.56 24.02 11.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.788 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.6 p -81.71 -31.58 32.06 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 121.48 -0.763 . . . . 0.0 113.056 -167.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -32.58 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 . . . . . 0 N--CA 1.427 -1.615 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.0 -165.811 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -88.78 0.25 56.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.761 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -68.14 -52.23 37.02 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -60.87 -50.72 72.27 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 117.333 -1.318 . . . . 0.0 113.164 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.527 2.3 t -90.82 11.36 22.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -81.69 -38.4 25.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 120.087 -1.633 . . . . 0.0 108.381 155.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.02 0.928 . . . . 0.0 109.686 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.66 -12.55 53.69 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.5 m -65.55 -52.22 54.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 120.68 1.582 . . . . 0.0 108.074 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.9 pt20 -79.31 -28.54 42.18 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.567 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 87.0 m-70 -100.1 -53.98 3.0 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 119.044 0.838 . . . . 0.0 110.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 48.5 t80 -73.66 134.62 43.65 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 120.296 1.407 . . . . 0.0 111.481 -166.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.62 99.92 2.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.84 -50.93 1.73 Allowed 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 128.061 2.544 . . . . 0.0 117.843 -166.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -142.69 146.59 38.82 Favored Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.7 Cg_endo -81.38 171.75 13.34 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 123.086 2.524 . . . . 0.0 108.662 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.08 -77.97 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.59 -178.88 15.59 Favored Glycine 0 CA--C 1.475 -2.427 1 N-CA-C 101.464 -4.654 . . . . 0.0 101.464 159.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.15 74.67 0.89 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -136.06 173.1 12.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -74.06 -21.27 60.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.886 0.874 . . . . 0.0 113.23 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -14.18 29.92 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.31 -41.71 63.22 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.257 0.6 OUTLIER -77.06 -25.42 52.39 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 113.054 -174.798 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.81 -39.51 73.03 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 m -70.19 -33.06 71.26 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.7 tt -85.28 -29.74 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 118.644 0.656 . . . . 0.0 110.369 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mmt -71.78 -34.76 69.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -67.04 -45.94 75.92 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.265 1.026 . . . . 0.0 113.389 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -83.37 -32.52 26.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -74.52 -38.16 62.88 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.59 68.96 1.4 Allowed Glycine 0 CA--C 1.475 -2.451 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.96 29.17 5.24 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 163.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -81.91 -13.48 57.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 111.721 -2.491 . . . . 0.0 109.963 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -119.83 106.99 40.82 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.974 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 162.89 90.92 Favored 'Cis proline' 0 N--CA 1.444 -1.399 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 -22.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB3' HD13 ' A' ' 83' ' ' LEU . 70.2 m -61.3 121.97 13.93 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.139 0.976 . . . . 0.0 110.631 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -72.79 134.65 45.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -72.44 -39.11 68.07 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 123.631 0.582 . . . . 0.0 111.555 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.95 129.08 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 172.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -144.9 120.56 10.47 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 m -96.1 116.64 29.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.5 127.27 34.85 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 53' ' ' ILE . 9.8 mm -102.35 147.4 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.464 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -170.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.509 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -138.06 133.45 33.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.18 -125.36 1.41 Allowed Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.5 147.28 46.55 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 14' ' ' TYR . 21.7 mtpt -86.26 -3.04 58.9 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -43.05 65.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.657 1.583 . . . . 0.0 107.089 172.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -80.52 -25.27 38.8 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.681 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 112' ' ' PRO . 18.0 mm -59.78 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 CA-C-N 119.079 0.854 . . . . 0.0 110.195 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -55.77 -39.35 71.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 126.02 1.728 . . . . 0.0 112.405 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.74 11.48 2.58 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.67 -31.9 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.7 m -79.0 -23.1 44.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.63 156.1 17.86 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -86.57 87.6 7.48 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.951 0.882 . . . . 0.0 109.306 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -141.06 -46.51 0.39 Allowed 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.73 58.52 1.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.43 151.88 9.54 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -107.42 157.83 34.68 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 140.0 32.18 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.766 2.31 . . . . 0.0 106.248 160.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -139.82 118.1 12.04 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -103.91 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 108.989 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -151.87 102.76 2.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 1.9 p-10 66.24 18.1 10.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 129.516 3.126 . . . . 0.0 114.582 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.0 mt -107.35 158.73 16.93 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 100.407 -3.923 . . . . 0.0 100.407 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -146.11 119.29 8.88 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.104 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.53 145.51 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 92.5 p -93.71 149.45 21.22 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -102.46 -8.31 21.2 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.7 t -106.69 85.75 2.21 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.0 m -57.35 126.43 27.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 125.566 1.546 . . . . 0.0 110.501 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.71 159.69 15.41 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.403 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 9.2 mm-40 -72.8 135.88 45.32 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 170.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.73 147.92 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -165.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.3 m -134.95 107.22 7.22 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 103.474 -2.788 . . . . 0.0 103.474 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.4 m -86.43 105.62 16.88 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.1 m -99.42 116.77 32.33 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -116.97 130.31 56.61 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 39' ' ' CYS . 22.3 tp -74.02 118.03 16.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 124.916 1.286 . . . . 0.0 108.716 -176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -90.35 115.5 27.59 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 158.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.76 94.03 1.78 Allowed Glycine 0 CA--C 1.482 -2.011 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -167.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.89 49.86 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 166.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 t -163.51 110.74 0.98 Allowed Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -80.08 -16.31 11.2 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 110.411 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.03 168.08 9.54 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.44 145.54 30.09 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.06 1.84 . . . . 0.0 108.13 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -81.76 163.81 76.62 Favored 'Cis proline' 0 N--CA 1.436 -1.872 0 CA-C-N 122.228 1.831 . . . . 0.0 107.923 -4.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -106.09 174.47 5.87 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -133.58 115.35 14.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -104.17 149.47 25.23 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -100.97 147.35 26.27 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 160.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.11 126.41 52.78 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -107.63 108.46 19.74 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.88 141.8 34.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.2 -175.46 30.17 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.4 t80 -157.69 99.68 1.73 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.905 -2.998 . . . . 0.0 102.905 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -161.61 173.78 14.27 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.81 0.814 . . . . 0.0 109.846 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -78.3 151.38 33.0 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.406 1.482 . . . . 0.0 111.148 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.96 159.18 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.12 96.26 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 165.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.79 132.35 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.51 122.58 32.14 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.42 142.29 30.22 Favored 'General case' 0 CA--C 1.488 -1.43 0 O-C-N 124.603 1.189 . . . . 0.0 110.153 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.09 129.42 18.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 167.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.337 11.2 p30 67.54 15.24 9.77 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 128.1 2.56 . . . . 0.0 115.287 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.22 62.08 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 0.9 OUTLIER -113.92 138.41 22.78 Favored Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 53' ' ' ILE . 81.8 Cg_exo -70.34 111.55 2.95 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 N-CA-C 107.048 -1.943 . . . . 0.0 107.048 166.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.46 -14.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 119.173 0.897 . . . . 0.0 110.077 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 38.6 t60 -155.06 178.52 10.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 8.9 tp -158.9 133.57 8.07 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.66 131.12 34.24 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -106.06 41.06 1.47 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -97.01 -26.26 15.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -171.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -79.22 -33.99 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.706 0 C-N-CA 123.935 0.894 . . . . 0.0 109.215 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -168.804 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 N--CA 1.429 -1.514 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.4 m -90.21 -33.13 16.3 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -69.29 -35.46 76.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.199 1.0 . . . . 0.0 111.1 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' A' ' 10' ' ' LEU . 52.7 t80 -74.29 -46.09 43.43 Favored 'General case' 0 N--CA 1.398 -3.053 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 33.7 p -73.72 -17.87 61.06 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -84.42 -35.89 22.76 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 119.514 1.052 . . . . 0.0 109.42 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -56.69 -45.79 81.58 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.531 1.532 . . . . 0.0 108.519 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -65.82 -29.91 70.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 126.854 2.062 . . . . 0.0 115.109 178.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.7 m -66.93 -52.58 41.3 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.0 pt20 -85.22 -5.05 59.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 88.8 m-70 -123.64 -55.59 1.72 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.762 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 13.6 t80 -71.29 123.86 23.24 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 120.583 1.538 . . . . 0.0 111.919 -169.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.88 97.11 3.12 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.19 -41.51 8.3 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -167.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -158.43 140.09 9.87 Favored Pre-proline 0 N--CA 1.434 -1.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 163.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -74.44 -178.86 4.28 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.651 2.234 . . . . 0.0 114.168 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -71.92 -64.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.21 -176.39 16.35 Favored Glycine 0 CA--C 1.476 -2.382 1 N-CA-C 102.343 -4.303 . . . . 0.0 102.343 164.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -109.38 75.53 0.95 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -145.5 176.42 9.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.17 -22.75 62.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 124.327 1.051 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -89.27 -17.21 29.45 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.08 -40.86 52.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.2 m -70.3 -33.28 71.35 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -68.06 -43.58 78.29 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.939 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.8 p -76.06 -23.88 55.09 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.274 12.5 tt -85.87 -28.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 119.081 0.855 . . . . 0.0 110.06 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.4 mmm -79.1 -24.05 43.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.621 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.505 HH12 ' HA ' ' A' ' 91' ' ' PRO . 14.7 tpt180 -74.53 -49.33 22.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 122.605 0.362 . . . . 0.0 111.694 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -86.44 -32.6 20.77 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.273 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -76.79 -33.84 58.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.89 71.23 1.29 Allowed Glycine 0 CA--C 1.478 -2.238 0 C-N-CA 124.987 1.279 . . . . 0.0 112.028 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.331 2.5 mm? -108.08 0.02 21.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 167.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -80.31 -3.78 50.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.005 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -129.42 108.16 17.51 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.66 153.77 98.76 Favored 'Cis proline' 0 N--CA 1.443 -1.447 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 -22.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.2 m -62.77 123.27 18.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 125.483 1.513 . . . . 0.0 112.197 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -74.12 139.62 44.69 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.8 -41.52 44.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.644 0.778 . . . . 0.0 111.899 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 tt -154.6 134.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -154.52 167.23 30.78 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.0 m -128.89 127.27 41.48 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.91 127.53 39.72 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.273 4.9 mm -94.35 146.03 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -139.8 127.77 22.19 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.06 -151.58 18.84 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.23 144.37 25.92 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.24 -22.0 45.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -70.54 -33.98 71.74 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 124.441 1.096 . . . . 0.0 110.532 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 p -76.68 -31.39 57.24 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 116.906 -1.521 . . . . 0.0 111.265 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -48.71 84.36 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-N 119.739 1.154 . . . . 0.0 110.996 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.29 -36.6 84.58 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.34 0.656 . . . . 0.0 111.657 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.78 4.91 10.56 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mm -75.94 -24.92 16.82 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.9 m -73.72 -24.59 59.94 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 122.124 -0.36 . . . . 0.0 111.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -79.68 164.8 23.46 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -93.2 0.0 56.99 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.429 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.57 -33.11 28.17 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 122.899 0.48 . . . . 0.0 110.848 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -134.73 7.31 3.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.08 -162.91 10.61 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 104.831 -3.307 . . . . 0.0 104.831 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.59 158.25 27.32 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -74.02 135.36 20.97 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.761 2.307 . . . . 0.0 107.162 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -123.07 104.61 9.32 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 69.85 -97.13 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.846 1.659 . . . . 0.0 110.528 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.45 106.51 3.13 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.358 4.5 p30 75.76 2.81 3.77 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 129.725 3.21 . . . . 0.0 114.594 169.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 mt -104.43 158.91 16.15 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -142.97 116.15 8.94 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 tt -89.32 142.14 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -81.01 161.41 24.25 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.779 0.8 . . . . 0.0 112.454 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -110.2 -17.95 13.41 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.6 t -110.06 87.87 2.62 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -52.03 129.67 27.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.671 1.989 . . . . 0.0 111.608 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -106.02 157.37 17.56 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.33 131.99 40.66 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.94 126.43 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 -165.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.7 m -119.21 110.18 16.72 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -83.13 105.17 13.89 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.81 114.63 23.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.81 136.46 53.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.44 127.67 32.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.42 1.088 . . . . 0.0 109.069 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 93.5 m-70 -119.47 171.69 8.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.61 -94.24 1.02 Allowed Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 105.939 -2.865 . . . . 0.0 105.939 -173.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.6 -6.97 1.26 Allowed Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 p -79.0 132.92 62.27 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -91.28 -9.22 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.922 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -109.76 155.58 41.24 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.95 146.19 29.12 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.369 2.046 . . . . 0.0 107.397 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.7 Cg_endo -85.99 163.4 56.19 Favored 'Cis proline' 0 N--CA 1.436 -1.899 0 CA-C-N 122.888 2.067 . . . . 0.0 108.521 12.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.8 m -150.99 126.24 9.97 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -85.81 129.23 34.89 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.93 133.24 56.17 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 81.8 mtp180 -111.72 137.51 49.52 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.74 140.55 31.17 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.157 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.7 m -123.34 110.3 15.0 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.62 155.85 23.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.549 0.69 . . . . 0.0 109.9 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.96 176.1 37.58 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 106.914 -2.474 . . . . 0.0 106.914 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -150.11 91.63 1.79 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 101.932 -3.358 . . . . 0.0 101.932 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -146.73 169.21 19.52 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -168.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.03 145.44 48.29 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.427 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.99 138.39 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.04 87.78 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.82 132.88 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.82 125.29 40.28 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 38.9 m -109.03 153.79 23.12 Favored 'General case' 0 CA--C 1.485 -1.533 0 O-C-N 124.414 1.071 . . . . 0.0 110.985 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.33 129.73 23.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 171.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 9.4 p30 68.16 12.44 8.77 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 13.15 60.1 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.64 144.89 52.69 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 67.1 Cg_exo -68.84 150.94 74.15 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 121.858 1.705 . . . . 0.0 110.694 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.57 -14.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 51.1 t60 -158.07 174.91 14.5 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -169.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -158.1 128.68 6.28 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.35 137.2 38.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.67 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -105.41 42.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -91.92 -33.77 14.76 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 -29.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.896 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.298 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.427 -1.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -169.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.3 t30 . . . . . 0 CA--C 1.489 -1.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -89.52 -7.43 54.96 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.924 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -72.75 -42.92 63.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -59.23 -48.23 82.4 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.409 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.465 2.9 t -89.86 10.75 22.53 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -78.16 -42.07 32.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.193 -1.567 . . . . 0.0 107.34 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.14 -35.18 76.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.037 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 14' ' ' TYR . 21.8 mt -86.15 -15.42 41.09 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 119.444 1.02 . . . . 0.0 113.399 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -65.8 -49.0 69.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 119.827 1.194 . . . . 0.0 108.703 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.59 -42.66 67.48 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -99.45 -51.42 3.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.695 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HD22 ' A' ' 10' ' ' LEU . 23.2 t80 -77.07 116.39 17.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 119.278 0.945 . . . . 0.0 110.7 -167.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.12 100.35 4.69 Favored 'General case' 0 N--CA 1.421 -1.921 1 N-CA-C 98.538 -4.615 . . . . 0.0 98.538 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.35 -33.5 9.09 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -165.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -154.79 144.46 15.4 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 168.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 10.7 Cg_endo -74.41 154.72 45.71 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 122.979 2.453 . . . . 0.0 109.638 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.88 -60.84 2.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.05 178.28 16.95 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 103.304 -3.919 . . . . 0.0 103.304 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -123.74 57.91 1.17 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.34 177.75 8.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -172.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.71 -18.96 62.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.591 1.156 . . . . 0.0 113.736 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -82.5 -28.03 31.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -41.31 63.32 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -81.2 -25.21 36.91 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.561 -171.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.87 -45.37 82.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -64.94 -41.13 95.78 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 26' ' ' CYS . 10.3 tt -79.51 -29.58 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.141 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -26.22 58.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.468 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -77.53 -34.18 54.01 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 117.962 0.346 . . . . 0.0 110.866 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -73.75 -52.63 12.56 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.332 0.653 . . . . 0.0 111.639 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.01 -36.38 79.88 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 123.269 0.628 . . . . 0.0 111.561 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.05 71.65 1.31 Allowed Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.321 3.4 mm? -97.99 -8.87 27.09 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 164.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -81.0 1.64 30.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.623 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 p -119.22 98.82 50.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.741 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.3 163.16 90.53 Favored 'Cis proline' 0 N--CA 1.443 -1.493 0 N-CA-C 106.595 -2.117 . . . . 0.0 106.595 -27.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.3 m -64.85 121.82 15.5 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -166.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -70.51 140.68 51.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 126.622 1.969 . . . . 0.0 107.661 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -70.87 -46.97 61.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 123.725 0.81 . . . . 0.0 113.14 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 tt -149.64 129.61 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -154.84 137.44 15.15 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.2 m -101.5 137.02 40.38 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.953 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -100.43 119.96 39.27 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 167.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.92 150.31 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.571 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -142.59 139.74 31.45 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.286 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.8 -136.34 5.12 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' SER . 1.2 m120 -95.3 140.06 30.72 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.34 -21.01 29.09 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HB3' HD22 ' A' ' 49' ' ' ASN . 65.5 ttt180 -70.2 -36.38 74.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.368 1.867 . . . . 0.0 108.874 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 49' ' ' ASN . 39.5 m -72.5 -38.41 68.12 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.776 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.7 -48.47 85.83 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 CA-C-N 118.904 0.775 . . . . 0.0 111.402 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.06 -42.1 98.83 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.147 0.579 . . . . 0.0 111.473 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.24 7.59 5.0 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 72' ' ' SER . 24.0 mm -74.74 -32.33 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.2 t -71.88 -34.28 69.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.149 0.281 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.09 160.21 33.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.451 0.643 . . . . 0.0 110.032 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -75.96 -28.91 58.09 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.823 0.849 . . . . 0.0 109.389 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -77.12 124.65 28.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 44.2 t30 73.64 36.14 0.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 128.058 2.543 . . . . 0.0 112.679 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 148.88 5.58 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -98.36 152.09 37.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.45 131.35 18.73 Favored 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 122.858 2.372 . . . . 0.0 106.272 162.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -121.56 103.05 8.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 67' ' ' GLU 0.338 14.5 ptp180 49.47 -107.33 0.24 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 128.077 2.551 . . . . 0.0 115.264 177.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 34.2 tt0 -103.74 77.53 1.48 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.516 1.126 . . . . 0.0 108.058 -167.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.317 1.6 p-10 62.25 26.65 15.98 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.45 3.1 . . . . 0.0 114.713 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.71 164.41 12.26 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -142.94 122.45 13.2 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.3 138.14 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 56' ' ' ILE . 82.8 p -82.81 153.98 24.94 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 121.818 0.818 . . . . 0.0 112.655 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 -27.23 14.95 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.955 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 p -105.77 84.02 2.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.6 p -51.17 130.84 27.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.9 1.68 . . . . 0.0 111.152 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.59 163.92 12.66 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -165.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.42 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 10.7 mt-30 -75.68 141.94 42.62 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.38 145.37 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -169.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.0 m -134.8 103.92 5.81 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.2 m -87.34 106.37 17.89 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.0 m -99.74 128.25 45.85 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -118.8 138.41 52.72 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.69 116.73 14.63 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 125.703 1.601 . . . . 0.0 110.022 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.57 110.14 18.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.26 93.17 1.81 Allowed Glycine 0 CA--C 1.484 -1.858 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.08 -11.49 49.13 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 104.888 -3.285 . . . . 0.0 104.888 161.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -165.19 132.93 2.41 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -78.15 -25.38 7.3 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.319 2.012 . . . . 0.0 109.328 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -89.58 160.27 42.12 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.26 147.13 32.59 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.282 1.988 . . . . 0.0 108.132 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -82.98 165.69 69.64 Favored 'Cis proline' 0 N--CA 1.439 -1.7 0 CA-C-N 122.879 2.064 . . . . 0.0 108.932 5.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.3 m -145.15 125.96 14.34 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -169.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.75 131.75 36.0 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.74 120.63 42.17 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -88.32 117.93 27.57 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 137.69 35.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.883 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -120.32 106.66 12.09 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 170.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.38 149.95 30.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.108 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.04 -175.14 34.62 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.7 t80 -150.86 97.87 2.53 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.241 -3.615 . . . . 0.0 101.241 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -144.25 150.81 38.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -159.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -83.24 144.98 29.39 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.752 1.221 . . . . 0.0 109.165 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.98 153.37 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.46 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 162.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.4 m -91.29 134.97 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.36 133.4 36.65 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.33 134.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.168 0.918 . . . . 0.0 111.317 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -127.44 136.59 52.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.328 5.0 p30 73.54 4.41 4.77 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.891 2.077 . . . . 0.0 116.582 168.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.78 19.69 28.56 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.254 0.7 OUTLIER -136.86 133.09 18.61 Favored Pre-proline 0 CA--C 1.49 -1.357 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.98 113.47 3.8 Favored 'Trans proline' 0 N--CA 1.435 -1.944 0 N-CA-C 106.482 -2.161 . . . . 0.0 106.482 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -96.53 -7.38 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 49.7 t60 -159.0 177.5 11.07 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 -168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -167.0 133.59 2.32 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 102.822 -3.029 . . . . 0.0 102.822 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -78.26 138.03 38.41 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.071 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -101.3 41.76 1.17 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -98.48 -32.22 11.58 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -72.27 -36.91 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.771 170.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 N--CA 1.422 -1.864 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 t -91.53 -27.52 18.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -68.4 -50.56 52.03 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.367 1.067 . . . . 0.0 111.836 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.45 ' HB2' HD23 ' A' ' 111' ' ' LEU 0.269 76.9 t80 -53.07 -53.76 45.51 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.697 169.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -69.16 -15.95 63.52 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -83.77 -36.36 23.65 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.912 1.233 . . . . 0.0 110.267 173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.732 1.213 . . . . 0.0 109.915 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -79.53 -26.94 41.36 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.83 2.052 . . . . 0.0 112.239 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -68.4 -52.48 32.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 40.3 mt-30 -68.53 -42.27 78.7 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 85.8 m-70 -105.38 -41.67 5.45 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.343 -165.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 14.6 t80 -76.02 120.16 20.96 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 120.805 1.639 . . . . 0.0 111.731 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -140.8 99.72 3.68 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 100.82 -3.77 . . . . 0.0 100.82 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -40.92 11.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.423 2.289 . . . . 0.0 117.115 -167.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.42 144.89 14.55 Favored Pre-proline 0 N--CA 1.433 -1.297 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 83.0 Cg_exo -76.65 176.84 9.58 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.654 1.569 . . . . 0.0 113.787 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -73.93 -60.2 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 165.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -151.07 -175.01 22.54 Favored Glycine 0 CA--C 1.477 -2.287 0 N-CA-C 103.322 -3.911 . . . . 0.0 103.322 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.03 74.4 0.86 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.08 170.89 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.75 -22.21 61.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -169.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -79.75 -26.57 40.68 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.124 0.42 . . . . 0.0 110.214 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.89 -43.71 62.15 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.5 OUTLIER -80.57 -25.36 38.6 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 119.02 -1.072 . . . . 0.0 113.061 -169.794 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.19 -36.79 69.31 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.307 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -69.86 -35.19 74.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 26' ' ' CYS . 15.2 tt -83.15 -29.22 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.332 0 CA-C-N 118.338 0.517 . . . . 0.0 110.096 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.4 mmt -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.328 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.527 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.4 tpp180 -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.013 0.925 . . . . 0.0 111.844 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -74.04 -49.05 25.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 123.865 0.866 . . . . 0.0 110.796 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -70.82 -37.89 73.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.199 1.0 . . . . 0.0 109.99 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.98 70.16 1.26 Allowed Glycine 0 CA--C 1.481 -2.061 0 C-N-CA 124.275 0.941 . . . . 0.0 111.266 168.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.361 2.5 mm? -104.52 -2.41 25.27 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 163.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.1 t -78.32 -8.57 58.56 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.086 -159.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -131.92 107.37 13.94 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 117.925 -1.036 . . . . 0.0 108.724 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.88 156.66 95.74 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.162 -1.899 . . . . 0.0 107.162 -19.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.1 m -57.8 122.91 14.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.616 1.567 . . . . 0.0 110.454 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 135.87 45.63 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -72.73 -38.89 67.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.632 0.773 . . . . 0.0 112.385 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -146.89 132.51 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -149.57 128.69 12.75 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.381 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 m -101.66 116.18 32.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.656 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.62 122.33 30.38 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.94 148.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.427 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -138.35 128.6 25.89 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.996 1.318 . . . . 0.0 108.42 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.01 -130.83 2.1 Favored Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.43 HD22 ' HB3' ' A' ' 51' ' ' ARG . 6.1 t30 -119.64 144.35 47.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.27 -2.75 58.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.031 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HB3' HD22 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -81.02 -30.08 34.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -75.11 -31.31 61.11 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.127 0.971 . . . . 0.0 110.342 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.12 -58.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 124.089 0.956 . . . . 0.0 110.245 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.14 -38.19 73.14 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 61' ' ' ASN . . . -57.44 -25.33 59.49 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 126.102 1.761 . . . . 0.0 113.83 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.55 -39.98 65.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 C-N-CA 125.484 1.513 . . . . 0.0 111.11 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.27 -21.06 29.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.58 53.12 0.7 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.943 0.401 . . . . 0.0 111.288 -171.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 79.44 -35.97 0.16 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.775 2.43 . . . . 0.0 115.023 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.59 154.98 38.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 55' ' ' ALA . 2.0 p-10 26.96 55.7 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 129.377 3.071 . . . . 0.0 116.038 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.57 146.5 4.93 Favored Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -128.98 164.75 36.79 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.05 137.47 19.5 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.063 1.842 . . . . 0.0 107.816 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -106.74 161.03 15.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.214 -2.514 . . . . 0.0 104.214 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -70.81 150.99 45.28 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.285 0.634 . . . . 0.0 111.693 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 69.14 55.43 0.41 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.355 2.662 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.273 3.0 p-10 51.65 45.49 28.03 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.473 2.709 . . . . 0.0 114.095 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 106' ' ' ALA . 9.2 mt -124.89 178.69 5.36 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 -171.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -151.17 112.41 4.35 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.55 150.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.4 p -99.74 161.46 13.6 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.18 18.41 5.98 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 p -117.23 100.16 7.51 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.762 -3.792 . . . . 0.0 100.762 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 120.12 11.99 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.192 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -102.76 158.4 16.28 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.06 140.86 36.32 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.34 144.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -132.8 102.3 5.6 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 170.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -84.19 103.26 13.24 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 35.1 m -94.61 116.8 29.2 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -105.11 140.61 38.03 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.91 136.57 33.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 96.4 m-70 -134.04 174.6 10.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.73 -101.39 0.72 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 106.092 -2.803 . . . . 0.0 106.092 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.15 -26.97 0.17 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.1 m -81.82 130.69 59.88 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -81.11 -25.37 4.06 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 121.968 1.779 . . . . 0.0 108.138 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -89.76 165.29 25.57 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.79 144.6 35.24 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 N-CA-C 107.584 -1.737 . . . . 0.0 107.584 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HA ' HH12 ' A' ' 31' ' ' ARG . 48.7 Cg_endo -86.8 162.47 51.43 Favored 'Cis proline' 0 N--CA 1.435 -1.928 0 CA-C-N 122.457 1.913 . . . . 0.0 109.257 19.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.523 ' H ' HH22 ' A' ' 31' ' ' ARG . 46.2 m -119.07 158.09 26.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -172.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -135.79 93.09 2.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.05 123.62 34.08 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.932 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.4 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 2.7 mpt_? -102.05 125.57 48.77 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.86 135.87 33.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.181 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.0 m -123.51 113.51 18.83 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.93 145.52 29.35 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.241 0.543 . . . . 0.0 110.024 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.7 168.46 30.5 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 105.13 -3.188 . . . . 0.0 105.13 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.02 103.04 3.7 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.84 174.88 14.32 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.051 -171.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.55 135.48 50.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 124.536 1.134 . . . . 0.0 110.233 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.91 138.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.18 110.76 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 6.5 m -107.71 151.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -96.83 140.3 31.6 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 166.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 1.5 t -119.61 146.42 45.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 124.899 1.374 . . . . 0.0 111.41 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.42 122.14 11.88 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.35 6.2 p30 72.32 3.13 4.58 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 127.917 2.487 . . . . 0.0 115.838 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.2 38.18 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 108.426 -1.869 . . . . 0.0 108.426 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 6' ' ' TYR . 1.4 mp -126.47 117.12 23.04 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 9.9 Cg_endo -77.19 120.97 5.54 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 CA-C-N 122.594 1.962 . . . . 0.0 107.9 -173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.97 -12.71 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 124.171 0.92 . . . . 0.0 111.712 -169.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 76.9 t60 -152.26 170.0 21.1 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -166.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.408 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 6.7 tp -140.44 136.14 32.73 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -84.12 134.16 34.6 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -110.59 40.23 2.03 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -99.25 -29.42 12.83 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -33.21 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.97 171.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 . . . . . 0 N--CA 1.418 -2.033 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -170.835 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 m120 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -90.5 -30.56 17.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -62.38 -51.2 68.53 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.463 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 45.5 t80 -53.9 -62.54 1.59 Allowed 'General case' 0 N--CA 1.404 -2.757 0 C-N-CA 127.103 2.161 . . . . 0.0 114.483 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.605 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 24.2 p -69.56 -16.39 63.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -81.81 -37.91 26.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 120.074 1.306 . . . . 0.0 110.02 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.85 -41.3 82.1 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.105 1.362 . . . . 0.0 109.902 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.402 0.0 OUTLIER -92.95 -6.37 48.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 118.084 0.402 . . . . 0.0 111.245 -173.25 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.7 m -73.47 -48.97 29.29 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.52 -1.363 . . . . 0.0 107.341 166.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -65.94 -41.9 90.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 126.291 1.836 . . . . 0.0 111.958 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.15 -50.28 3.2 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.562 -171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.511 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 53.9 t80 -77.88 120.98 23.52 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.585 1.538 . . . . 0.0 110.338 -168.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -139.25 94.25 2.78 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -35.5 -53.53 0.67 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 128.583 2.753 . . . . 0.0 118.338 -166.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -147.96 147.36 26.48 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 168.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -75.46 175.34 11.41 Favored 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 122.214 1.942 . . . . 0.0 113.322 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -76.05 -69.41 0.5 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.21 -176.89 14.6 Favored Glycine 0 CA--C 1.478 -2.252 1 N-CA-C 102.873 -4.091 . . . . 0.0 102.873 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -121.56 69.35 0.92 Allowed 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.63 174.65 11.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.42 -19.93 62.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.81 1.244 . . . . 0.0 113.3 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -81.31 -27.33 35.08 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.92 -34.62 51.26 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -34.03 54.93 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 123.327 0.651 . . . . 0.0 109.3 -170.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.02 -38.71 66.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.56 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -69.67 -30.82 68.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.267 14.2 tt -85.99 -27.38 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-N 118.504 0.593 . . . . 0.0 110.762 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.66 -29.41 64.58 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 118.628 -1.229 . . . . 0.0 110.066 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.64 HH22 ' H ' ' A' ' 92' ' ' CYS . 40.9 ttm-85 -81.43 -42.16 20.79 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -86.79 -28.0 23.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.44 -171.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -75.86 -36.08 59.68 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.63 72.0 1.23 Allowed Glycine 0 CA--C 1.473 -2.55 0 C-N-CA 125.164 1.364 . . . . 0.0 110.072 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.04 28.72 5.02 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 165.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -5.76 59.31 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.241 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.4 m -114.57 104.71 54.27 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.22 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 162.78 91.64 Favored 'Cis proline' 0 N--CA 1.44 -1.63 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 -24.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -70.3 114.35 8.35 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 123.677 0.791 . . . . 0.0 109.659 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -82.39 152.21 26.29 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.5 -74.38 0.1 Allowed 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.244 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -120.6 125.96 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -165.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -144.79 142.35 29.92 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.7 m -107.51 125.48 51.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.992 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.81 121.17 36.13 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.267 5.7 mm -93.63 147.64 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.81 133.07 35.53 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.97 -141.59 6.83 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 105.526 -3.029 . . . . 0.0 105.526 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -96.05 149.85 21.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.81 -18.74 27.06 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -71.31 -37.08 71.8 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -72.07 -38.33 69.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 117.375 -1.298 . . . . 0.0 111.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 53' ' ' ILE . 5.5 tp -65.54 -47.5 86.27 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 CA-C-N 119.242 0.928 . . . . 0.0 109.967 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.96 -39.37 91.9 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.661 1.584 . . . . 0.0 111.476 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.46 9.1 2.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.88 -44.04 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 165.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.3 m -99.64 42.93 1.08 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.87 24.1 3.94 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 40.38 61.98 1.45 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.5 3.12 . . . . 0.0 113.856 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' ASN . 33.6 mmtp -133.06 -35.39 1.05 Allowed 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 60' ' ' LYS . 55.0 t30 -127.92 31.45 5.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.12 149.13 12.45 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.93 147.26 64.81 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.31 132.71 15.31 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.757 2.305 . . . . 0.0 107.919 -163.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -108.68 85.07 2.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 72.12 -101.53 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.935 1.694 . . . . 0.0 111.975 172.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -116.26 81.68 1.65 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -165.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 1.5 p-10 63.83 22.54 13.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 129.196 2.998 . . . . 0.0 114.534 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.1 164.54 11.73 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.756 -3.794 . . . . 0.0 100.756 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.31 113.95 4.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 117.3 -1.76 . . . . 0.0 109.171 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 tt -85.66 139.69 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -80.66 171.38 15.1 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 0.0 111.367 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.65 -9.3 10.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -127.19 96.49 4.61 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -48.15 127.76 13.0 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 127.614 2.365 . . . . 0.0 112.939 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.31 154.14 19.33 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 3.4 mt-30 -78.28 148.17 33.98 Favored 'General case' 0 CA--C 1.469 -2.152 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.88 144.37 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -168.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.3 m -135.99 101.91 4.87 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.2 m -86.25 111.99 20.95 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 69.0 m -88.72 116.15 26.77 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -111.75 142.6 43.9 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -75.86 121.64 22.93 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -130.95 64.77 1.57 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.5 -48.88 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 105.314 -3.115 . . . . 0.0 105.314 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.29 11.94 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -106.25 124.19 36.59 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -79.98 -27.31 3.88 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 121.56 1.593 . . . . 0.0 108.078 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -105.42 147.82 35.27 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 117.386 -1.293 . . . . 0.0 107.846 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.87 144.09 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.381 2.054 . . . . 0.0 107.09 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' HH12 ' A' ' 31' ' ' ARG . 51.7 Cg_exo -82.32 161.1 77.5 Favored 'Cis proline' 0 CA--C 1.487 -1.853 0 CA-C-N 123.683 2.351 . . . . 0.0 110.697 10.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.64 ' H ' HH22 ' A' ' 31' ' ' ARG . 56.3 m -147.3 125.29 12.04 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.973 -166.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -84.55 129.34 34.86 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.23 120.05 36.52 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -97.69 127.76 43.88 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.52 127.25 33.57 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -113.25 100.09 8.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 172.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.87 130.51 35.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.93 -177.28 14.83 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 80.1 t80 -163.53 106.25 0.98 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.0 170.44 22.31 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.176 -172.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.23 131.75 44.69 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 124.195 0.998 . . . . 0.0 109.597 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.82 133.49 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.22 84.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.67 138.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.26 136.74 40.61 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.6 149.78 22.42 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 124.059 0.849 . . . . 0.0 111.458 -168.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -148.23 123.51 10.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.1 p30 64.41 18.69 11.47 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.571 2.349 . . . . 0.0 115.071 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.14 22.15 55.42 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 19.2 tp -132.24 130.21 21.9 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.37 109.23 2.28 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 123.49 2.282 . . . . 0.0 107.482 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.07 -12.42 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 O-C-N 123.731 0.644 . . . . 0.0 111.376 -171.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 59.1 t60 -143.55 176.55 9.12 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.64 131.26 2.99 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.81 125.19 28.27 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.48 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -94.04 12.65 25.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.209 1.004 . . . . 0.0 108.951 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -92.37 -6.42 50.16 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.58 0.752 . . . . 0.0 109.827 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.27 -25.05 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 N--CA 1.423 -1.788 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.68 -170.717 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 . . . . . 0 CA--C 1.502 -0.898 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t -93.36 -13.28 28.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -25.78 63.35 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.122 1.369 . . . . 0.0 110.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.13 -41.64 66.95 Favored 'General case' 0 N--CA 1.407 -2.606 0 C-N-CA 125.914 1.685 . . . . 0.0 108.94 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -81.0 -7.63 59.6 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -76.28 -47.23 24.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -57.36 -41.65 80.53 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 126.977 2.111 . . . . 0.0 110.632 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.399 0.1 OUTLIER -99.39 -5.29 29.79 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.457 -173.539 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.1 t -79.55 -38.86 33.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.727 1.603 . . . . 0.0 107.064 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.473 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.6 pt20 -82.98 -28.07 29.99 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.458 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.473 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 79.9 m-70 -103.65 -50.31 3.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 49.3 t80 -76.59 118.07 18.87 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 120.038 1.29 . . . . 0.0 110.837 -168.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -136.08 97.59 3.65 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.34 -42.09 4.37 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -166.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -160.08 134.9 5.53 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 45.6 Cg_exo -73.76 -179.8 4.91 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 122.757 2.304 . . . . 0.0 114.012 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -74.86 -71.54 0.35 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.99 -177.48 14.9 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 103.343 -3.903 . . . . 0.0 103.343 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -121.64 72.51 1.02 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.98 177.99 7.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.61 -14.44 61.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -77.54 -33.96 53.99 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.63 -39.23 62.23 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.0 t -68.52 -43.08 77.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.0 111.81 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.1 -35.46 66.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.033 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -73.21 -30.17 63.33 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.87 -28.75 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-N 118.501 0.592 . . . . 0.0 109.528 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.8 mmt -70.33 -33.29 71.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.229 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -44.47 64.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.401 0.681 . . . . 0.0 111.406 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.44 -39.56 58.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -35.59 63.75 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.18 75.54 1.05 Allowed Glycine 0 CA--C 1.479 -2.217 0 C-N-CA 124.789 1.185 . . . . 0.0 111.274 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.354 2.6 mm? -104.86 -3.69 23.14 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -78.88 -5.1 52.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.792 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 m -119.66 103.27 46.47 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.583 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.59 164.06 88.95 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 CA-C-N 122.96 2.093 . . . . 0.0 107.054 -23.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 83' ' ' LEU . 31.8 m -57.14 125.1 21.19 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.563 -171.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -76.86 141.6 40.55 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -77.18 -39.86 47.42 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.354 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.73 128.9 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -148.87 125.67 11.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -98.58 119.97 38.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.064 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.6 114.09 23.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.05 149.45 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.64 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -139.05 136.16 34.97 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 124.581 1.153 . . . . 0.0 108.063 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.09 -143.77 8.65 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.91 147.01 24.41 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -86.23 -12.81 48.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.32 -36.29 71.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.436 1.494 . . . . 0.0 109.338 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 p -81.19 -25.69 36.55 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.307 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -56.93 -50.99 73.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.297 0 CA-C-N 120.232 1.378 . . . . 0.0 110.356 166.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -62.61 -40.67 97.7 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 123.464 0.706 . . . . 0.0 112.212 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.03 29.9 0.62 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 122.958 0.503 . . . . 0.0 112.082 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 72' ' ' SER . 12.4 mm -87.64 -30.13 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 160.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.0 t -83.15 -57.16 3.39 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.399 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.89 107.44 19.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -168.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 56.25 -87.51 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.575 2.75 . . . . 0.0 116.792 163.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.27 145.13 55.47 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.222 1.409 . . . . 0.0 107.839 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.331 6.8 p-10 43.83 39.4 2.57 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 130.873 3.669 . . . . 0.0 117.473 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.58 134.8 2.27 Favored Glycine 0 CA--C 1.489 -1.542 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 168.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -122.62 162.88 36.02 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -164.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 149.13 34.24 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.653 2.236 . . . . 0.0 108.491 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -148.28 116.82 6.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -168.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 66.68 -111.44 0.17 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.211 1.404 . . . . 0.0 110.792 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -136.16 95.21 3.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.359 2.2 p-10 64.98 23.13 12.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 129.161 2.985 . . . . 0.0 114.587 172.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -106.76 163.32 13.02 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 167.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -142.41 124.73 15.56 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.09 144.75 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 56' ' ' ILE . 97.7 p -83.33 158.0 22.36 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 121.748 0.785 . . . . 0.0 110.686 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -117.18 -5.06 11.37 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -116.5 88.94 3.0 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -55.69 128.8 36.48 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.058 1.743 . . . . 0.0 110.954 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -108.32 158.71 17.25 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.416 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 5.6 mt-30 -76.89 146.31 37.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.48 146.85 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -131.8 101.95 5.67 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 164.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -79.24 103.75 9.38 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 32.2 m -90.11 112.09 23.44 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -121.5 140.21 52.48 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 39' ' ' CYS . 25.9 tp -79.3 120.32 23.59 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -135.28 56.28 1.85 Allowed 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.54 -86.56 1.81 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 106.272 -2.731 . . . . 0.0 106.272 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.66 -16.67 3.31 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 m -85.41 134.02 41.18 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -79.67 -27.56 3.97 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.848 1.698 . . . . 0.0 108.209 170.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -97.7 163.36 19.74 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.263 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.54 144.13 35.47 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 122.268 1.979 . . . . 0.0 107.431 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -83.07 163.15 72.95 Favored 'Cis proline' 0 CA--C 1.489 -1.775 0 CA-C-N 123.164 2.166 . . . . 0.0 109.936 9.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.57 122.59 36.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -88.93 113.06 24.05 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.18 126.11 51.82 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -89.89 126.28 35.66 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 131.16 35.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.0 m -119.66 90.83 3.41 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.547 -2.761 . . . . 0.0 103.547 172.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.53 130.01 36.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.51 -165.67 10.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.416 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 86.2 t80 -157.51 101.09 1.83 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.442 -3.911 . . . . 0.0 100.442 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -138.19 149.32 45.71 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -165.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -77.3 134.21 38.59 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.596 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.23 153.37 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.08 115.94 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 102.01 -3.329 . . . . 0.0 102.01 161.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.43 161.44 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -106.03 144.7 32.38 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 163.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.6 t -123.33 138.83 54.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.527 1.142 . . . . 0.0 110.068 -170.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -127.43 132.99 49.99 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.308 5.6 p30 73.74 6.32 4.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.93 20.33 21.58 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.76 144.94 18.24 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -71.12 154.63 62.18 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 122.417 1.899 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.25 -17.38 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.65 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 82.0 t60 -149.81 166.93 27.99 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -164.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -127.64 130.66 49.33 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.9 120.1 24.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 21.57 17.19 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -173.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -90.57 -16.1 29.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.697 -174.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.09 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.424 -1.77 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.609 -175.702 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.0 p -91.64 -17.05 26.11 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -76.44 -32.84 58.68 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 123.353 0.661 . . . . 0.0 110.457 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -68.01 -37.94 82.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.65 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.468 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -74.68 -19.19 60.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -72.3 -45.57 59.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.98 0.809 . . . . 0.0 108.86 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -56.69 -40.49 75.68 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.176 1.79 . . . . 0.0 111.27 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.415 0.2 OUTLIER -96.88 -2.52 43.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 118.44 0.564 . . . . 0.0 111.732 -173.328 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.6 m -76.63 -42.97 40.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -68.75 -46.49 68.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.873 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -102.68 -41.33 6.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 118.448 -0.786 . . . . 0.0 111.173 -167.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 39.4 t80 -80.84 117.09 21.18 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.558 1.527 . . . . 0.0 111.124 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.07 96.29 3.48 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 100.958 -3.719 . . . . 0.0 100.958 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.27 6.12 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 127.937 2.495 . . . . 0.0 117.573 -165.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -151.69 138.82 12.23 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 39.7 Cg_exo -74.71 179.55 5.87 Favored 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 122.824 2.35 . . . . 0.0 113.834 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.3 -70.19 0.38 Allowed 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.74 -175.35 13.96 Favored Glycine 0 CA--C 1.477 -2.332 1 N-CA-C 101.995 -4.442 . . . . 0.0 101.995 163.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -116.1 72.57 0.81 Allowed 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.32 -179.7 6.15 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.488 -170.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.55 -39.34 87.58 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 127.457 2.303 . . . . 0.0 111.836 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -83.72 -16.02 46.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 110.775 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -77.73 -40.48 41.0 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 m -69.51 -34.68 74.64 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 123.485 0.491 . . . . 0.0 111.98 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.05 -37.71 72.52 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.409 0.443 . . . . 0.0 110.04 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -70.74 -31.08 67.78 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.275 14.5 tt -86.25 -27.84 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.067 0.394 . . . . 0.0 111.713 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.76 -19.56 48.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.552 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -75.79 -42.09 51.04 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 118.781 0.719 . . . . 0.0 109.425 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -75.73 -48.42 21.96 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.865 0.866 . . . . 0.0 111.505 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.87 -27.96 44.12 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.97 65.61 1.59 Allowed Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.91 22.48 14.85 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 165.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -89.37 -12.27 40.89 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -129.83 105.95 16.88 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.4 160.17 96.25 Favored 'Cis proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 -19.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.7 m -61.1 121.67 13.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.443 1.097 . . . . 0.0 110.258 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -73.65 133.52 43.45 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -72.83 -42.31 63.93 Favored 'General case' 0 CA--C 1.491 -1.316 0 O-C-N 123.766 0.666 . . . . 0.0 112.456 -169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 tt -154.49 126.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -154.77 129.31 9.17 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -94.86 125.14 39.32 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.32 120.67 33.87 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 167.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -98.08 148.59 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -135.51 133.4 38.42 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.352 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.93 -140.59 6.39 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 104.451 -3.459 . . . . 0.0 104.451 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -105.11 148.38 26.9 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 168.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -87.43 0.48 55.44 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.186 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.36 -34.98 58.91 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 167.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -77.22 -33.26 56.22 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.458 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mm -59.26 -50.03 81.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 124.335 1.054 . . . . 0.0 110.386 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -61.33 -33.83 74.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.171 0.988 . . . . 0.0 113.275 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 7.38 8.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 mm -84.83 -21.29 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.3 t -80.16 -19.46 47.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 122.064 -0.398 . . . . 0.0 110.736 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.64 142.9 51.59 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 165.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.42 -7.43 59.58 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.742 0.817 . . . . 0.0 112.699 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -81.26 -41.77 21.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.11 15.58 16.04 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -167.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.25 112.45 0.4 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 172.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -96.01 152.15 38.75 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.44 118.46 5.61 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 122.635 2.224 . . . . 0.0 106.373 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.688 ' HE1' HG11 ' A' ' 104' ' ' VAL . 15.8 p-80 -91.13 119.97 31.69 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 61.84 -96.67 0.06 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.784 1.634 . . . . 0.0 112.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -122.28 82.02 1.91 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -171.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 0.7 OUTLIER 65.88 11.75 7.88 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 129.192 2.997 . . . . 0.0 117.826 160.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.9 OUTLIER -102.84 148.33 25.77 Favored 'General case' 0 CA--C 1.476 -1.887 1 N-CA-C 99.0 -4.445 . . . . 0.0 99.0 174.372 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -124.44 118.48 26.76 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -158.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.6 tt -95.61 137.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.5 p -80.34 164.25 23.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.626 0.727 . . . . 0.0 111.914 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.06 -11.78 8.83 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -103.69 83.33 2.12 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.8 m -47.52 124.81 7.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 127.126 2.17 . . . . 0.0 112.048 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.68 158.08 16.5 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -78.96 143.36 35.84 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.13 141.23 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -167.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.8 m -129.62 105.77 8.28 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -81.66 100.11 9.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 99.9 m -86.84 112.33 21.63 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -111.35 143.09 42.7 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.16 109.72 17.42 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -94.5 158.68 15.44 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.2 -91.13 1.48 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.71 39.65 0.46 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.3 p -92.9 120.63 67.0 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.43 -8.64 4.49 Favored 'Trans proline' 0 N--CA 1.438 -1.781 0 CA-C-N 121.618 1.614 . . . . 0.0 108.036 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -110.6 161.84 23.07 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.04 146.14 36.52 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.454 2.102 . . . . 0.0 107.684 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.79 164.25 67.63 Favored 'Cis proline' 0 N--CA 1.435 -1.925 0 CA-C-N 122.073 1.776 . . . . 0.0 107.934 3.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.54 159.78 21.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -117.02 129.12 55.81 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -124.24 124.3 42.14 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -100.65 127.85 46.9 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.48 130.98 35.92 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.027 0.442 . . . . 0.0 109.964 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -119.1 89.55 3.15 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.49 136.85 33.25 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.104 0.478 . . . . 0.0 109.907 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.19 179.26 18.82 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 88.4 t80 -143.56 101.21 3.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -160.82 175.05 12.99 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -70.56 145.88 50.5 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 124.811 1.244 . . . . 0.0 111.539 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.37 147.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.688 HG11 ' HE1' ' A' ' 65' ' ' HIS . 56.0 t -110.25 94.19 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 165.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 m -96.5 133.17 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.96 132.01 43.18 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.05 134.96 52.24 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 124.548 1.155 . . . . 0.0 111.289 -166.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.74 135.23 45.62 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 10.2 p30 68.87 12.6 8.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.395 2.278 . . . . 0.0 116.411 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.93 19.51 46.92 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.2 19.86 Favored Pre-proline 0 CA--C 1.491 -1.32 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.06 113.21 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.59 -6.98 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.7 t60 -155.04 174.83 14.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -168.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.429 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -165.98 131.58 2.45 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.94 141.58 35.9 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.529 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -103.84 44.28 1.03 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -95.2 -34.41 12.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -73.42 -33.84 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 C-N-CA 125.143 1.377 . . . . 0.0 109.498 172.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 . . . . . 0 N--CA 1.421 -1.906 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -169.1 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 CA--C 1.502 -0.874 0 CA-C-O 120.673 0.273 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -91.59 -7.06 51.23 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 124.356 1.062 . . . . 0.0 109.13 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -43.15 62.59 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -59.67 -50.84 72.28 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-O 117.523 -1.227 . . . . 0.0 112.309 173.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.433 3.4 t -87.16 9.04 21.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -76.68 -44.67 32.8 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 119.958 -1.713 . . . . 0.0 107.916 156.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.2 -31.86 70.55 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.597 1.159 . . . . 0.0 111.462 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 14' ' ' TYR . 17.3 mt -88.31 -23.77 23.35 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.691 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -71.03 -35.65 72.08 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 120.102 1.319 . . . . 0.0 109.82 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -69.29 -63.62 1.03 Allowed 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.924 168.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -88.8 -49.11 7.03 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -162.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' HD22 ' A' ' 10' ' ' LEU . 83.9 t80 -76.44 118.19 18.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.991 1.723 . . . . 0.0 110.14 -171.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -137.31 98.29 3.68 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.67 -34.71 0.4 Allowed 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 119.942 3.312 . . . . 0.0 119.942 -165.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -150.13 156.62 37.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 16.8 Cg_endo -72.18 149.76 52.37 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 123.246 2.631 . . . . 0.0 108.964 170.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -84.06 -50.91 7.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 166.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.38 -179.01 16.04 Favored Glycine 0 CA--C 1.48 -2.115 0 N-CA-C 103.621 -3.792 . . . . 0.0 103.621 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -126.6 53.03 1.69 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -141.07 -179.26 5.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.67 -38.59 72.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 128.437 2.695 . . . . 0.0 112.734 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -79.23 -23.93 43.41 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 124.129 0.971 . . . . 0.0 111.025 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -76.65 -38.94 53.75 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.3 m -69.81 -35.94 75.23 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 123.613 0.571 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.88 -35.7 64.72 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 t -70.51 -32.59 70.13 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 122.78 0.432 . . . . 0.0 111.998 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.295 10.5 tt -82.69 -30.83 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.077 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.15 -18.72 52.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.216 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -74.42 -37.15 63.41 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 119.062 0.846 . . . . 0.0 111.296 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -51.67 14.97 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.806 0.443 . . . . 0.0 110.107 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.91 -36.74 67.33 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.736 0.814 . . . . 0.0 110.646 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.98 67.02 1.57 Allowed Glycine 0 CA--C 1.479 -2.173 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.1 mt -114.46 22.88 13.27 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 164.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -99.06 2.56 46.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -146.54 103.85 3.98 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 159.05 94.83 Favored 'Cis proline' 0 N--CA 1.447 -1.246 0 CA-C-N 122.127 1.795 . . . . 0.0 107.636 -16.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.3 m -61.83 124.88 21.98 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 123.974 0.796 . . . . 0.0 110.148 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -77.95 132.28 37.8 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 171.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.17 -42.32 69.24 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.048 0.842 . . . . 0.0 112.455 -165.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.68 126.47 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -145.61 126.33 14.31 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -95.24 118.64 32.37 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.739 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.54 115.47 28.07 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.2 mm -92.13 146.13 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.582 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.3 m-70 -134.58 138.44 44.58 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.0 -153.46 24.71 Favored Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.34 138.56 34.48 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.62 -9.08 57.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -37.33 73.51 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.6 m -76.34 -30.81 57.78 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.288 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -57.28 11.83 Favored 'Isoleucine or valine' 0 C--N 1.363 1.161 0 CA-C-N 119.558 1.072 . . . . 0.0 110.377 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -68.12 -38.43 82.22 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.09 1.314 . . . . 0.0 110.958 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.66 -0.15 22.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.869 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.286 0.6 OUTLIER -79.57 -24.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.296 0 C-N-CA 116.532 -2.067 . . . . 0.0 110.113 170.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 92.8 m -98.8 34.88 1.97 Allowed 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.39 0.995 . . . . 0.0 111.074 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -118.35 21.72 12.51 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.273 13.5 p-10 26.23 46.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.551 1 C-N-CA 132.021 4.128 . . . . 0.0 116.122 -167.122 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.49 -19.37 14.42 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -127.22 28.97 5.65 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.77 161.67 31.36 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -122.56 148.41 52.92 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-O 116.092 -1.909 . . . . 0.0 106.021 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -69.92 154.82 66.69 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.767 2.311 . . . . 0.0 111.806 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -125.57 57.8 1.33 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.27 15.7 tpp180 81.56 -100.31 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.152 2.181 . . . . 0.0 113.044 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.34 78.03 1.34 Allowed 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 124.049 0.94 . . . . 0.0 109.318 -166.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.336 1.3 p-10 74.33 8.68 4.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 129.291 3.037 . . . . 0.0 113.749 169.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.17 158.78 16.07 Favored 'General case' 0 CA--C 1.466 -2.252 1 N-CA-C 98.794 -4.521 . . . . 0.0 98.794 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -152.09 138.19 18.26 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -174.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.19 136.64 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.0 p -84.38 163.2 19.69 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.39 0.614 . . . . 0.0 110.696 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -126.7 -0.97 6.74 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.0 t -101.33 92.49 4.97 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 162.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.1 m -58.33 126.58 28.13 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.28 1.432 . . . . 0.0 110.373 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -107.85 161.0 15.31 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -79.88 151.4 30.2 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.98 146.36 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -168.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.0 m -135.19 103.51 5.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 165.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.8 m -84.31 101.62 12.08 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.7 m -85.72 113.75 22.15 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -122.66 135.77 54.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.271 19.3 mt -65.4 118.28 9.15 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.106 0.479 . . . . 0.0 110.621 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -88.54 126.81 35.44 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 169.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.18 -84.86 0.38 Allowed Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 106.519 -2.633 . . . . 0.0 106.519 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.98 37.86 1.09 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.7 t -86.9 123.91 69.73 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.92 3.63 3.0 Favored 'Trans proline' 0 N--CA 1.437 -1.837 0 CA-C-N 122.192 1.818 . . . . 0.0 108.492 -171.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.35 160.71 38.53 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.19 146.17 31.67 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.73 1.62 . . . . 0.0 108.215 -171.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -82.74 161.71 75.41 Favored 'Cis proline' 0 N--CA 1.437 -1.834 0 CA-C-N 122.656 1.984 . . . . 0.0 109.482 7.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 m -119.95 111.81 18.4 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -85.76 122.4 29.79 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -121.11 111.21 17.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -85.75 129.75 34.74 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.11 127.35 32.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.7 m -114.6 92.59 4.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.14 29.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.024 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.7 -172.83 18.92 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -156.4 106.34 2.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.49 25.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.803 0.811 . . . . 0.0 109.97 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 129.38 34.49 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.053 1.341 . . . . 0.0 109.429 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.4 m -89.41 143.1 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.163 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.32 97.46 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 HH22 ' A' ' 70' ' ' ARG . 25.6 m -105.58 138.38 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.67 134.55 39.78 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.3 m -106.53 153.35 22.44 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.612 1.195 . . . . 0.0 110.135 -171.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -151.07 128.55 11.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.86 -2.645 . . . . 0.0 103.86 167.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.329 12.9 p30 66.02 17.55 10.81 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.216 2.607 . . . . 0.0 115.672 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.55 0.87 62.45 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.54 139.82 21.18 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.03 114.83 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 N-CA-C 105.224 -2.644 . . . . 0.0 105.224 164.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 m -100.32 -10.77 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 80.9 t60 -158.53 175.65 13.4 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -165.67 125.23 1.72 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.53 130.77 34.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 117' ' ' GLN . 1.0 OUTLIER -99.96 43.16 1.07 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.4 p -95.04 -18.01 21.4 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pt -97.03 -19.04 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 CA--C 1.481 -1.68 0 N-CA-C 106.014 -1.846 . . . . 0.0 106.014 178.363 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 CA--C 1.487 -1.465 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 t -93.08 -24.99 18.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 171.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -68.59 -37.94 80.24 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.167 1.387 . . . . 0.0 109.383 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 42.9 t80 -50.32 -60.65 2.77 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 127.642 2.377 . . . . 0.0 114.191 166.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -67.28 -16.58 64.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -70.84 -51.34 27.13 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.531 1.059 . . . . 0.0 109.063 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.09 -34.34 70.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 126.95 2.1 . . . . 0.0 111.555 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.0 OUTLIER -98.53 -8.91 25.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 118.698 0.681 . . . . 0.0 110.441 -171.774 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -76.52 -45.07 32.39 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 168.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -45.65 86.57 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.987 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -106.15 -49.02 3.45 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-O 118.547 -0.739 . . . . 0.0 111.782 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 60.5 t80 -76.48 121.9 23.78 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 120.136 1.335 . . . . 0.0 110.05 -167.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.72 97.17 3.2 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 102.063 -3.31 . . . . 0.0 102.063 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.29 -43.5 1.15 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 128.594 2.758 . . . . 0.0 118.291 -168.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.09 148.77 17.98 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 165.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -74.14 168.95 23.56 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 121.63 1.553 . . . . 0.0 112.443 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.96 -67.02 0.57 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.59 -178.46 15.44 Favored Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 102.159 -4.376 . . . . 0.0 102.159 163.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -113.3 72.91 0.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.14 175.76 11.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.08 -24.87 63.3 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.707 1.203 . . . . 0.0 113.176 -171.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -86.85 -18.31 31.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -41.53 62.26 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.471 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.29 0.5 OUTLIER -76.95 -26.51 54.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.167 -1.413 . . . . 0.0 113.605 -173.978 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.56 -39.33 81.08 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.293 170.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -66.88 -38.04 85.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.2 tt -80.95 -27.09 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 117.851 0.296 . . . . 0.0 110.504 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -24.58 55.73 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.186 -1.006 . . . . 0.0 112.03 174.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -75.63 -34.54 60.56 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 118.608 0.64 . . . . 0.0 111.82 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -76.99 -46.17 24.82 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 118.27 0.486 . . . . 0.0 111.769 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.28 -34.44 65.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 72.59 1.19 Allowed Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.6 mt -113.25 20.14 16.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -89.01 -7.11 56.59 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.7 m -125.65 100.86 30.87 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.553 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.52 167.48 80.19 Favored 'Cis proline' 0 N--CA 1.445 -1.359 0 N-CA-C 107.066 -1.936 . . . . 0.0 107.066 -22.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 83' ' ' LEU . 39.9 m -60.02 126.65 28.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 124.031 0.932 . . . . 0.0 111.034 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.29 139.43 46.11 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.95 -51.94 16.45 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 123.581 0.551 . . . . 0.0 110.091 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 tt -147.83 135.58 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -152.26 130.1 11.69 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.2 m -97.21 120.52 37.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.186 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -90.62 126.46 35.97 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.262 5.9 mm -89.95 148.94 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.2 m-70 -138.49 139.25 38.71 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.61 -114.32 0.6 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 106.479 -2.648 . . . . 0.0 106.479 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -134.08 134.73 42.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.04 3.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.674 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -84.79 -28.29 26.26 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.1 m -84.62 -25.29 28.67 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 53' ' ' ILE . 1.5 tp -71.19 -41.94 75.28 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -61.77 -52.36 64.56 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.949 0.899 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.6 3.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.747 1.219 . . . . 0.0 113.399 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 72' ' ' SER . 1.5 tp -76.93 -33.92 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.2 m -94.23 9.67 37.09 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -166.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -104.44 23.11 13.74 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.79 0.805 . . . . 0.0 110.737 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.4 m120 42.63 38.04 1.18 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 130.81 3.644 . . . . 0.0 114.002 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.49 -35.24 7.95 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -120.98 26.15 9.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 149.97 17.99 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 119.178 -1.486 . . . . 0.0 110.729 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -100.46 125.36 39.51 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-O 116.529 -1.7 . . . . 0.0 107.934 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.8 141.62 34.08 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.648 2.899 . . . . 0.0 108.167 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -123.76 80.39 1.8 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 65.76 -99.49 0.06 Allowed 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 126.479 1.911 . . . . 0.0 114.516 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.42 72.39 1.41 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -164.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.309 2.6 p-10 57.31 30.6 18.76 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 129.495 3.118 . . . . 0.0 114.832 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.0 161.36 20.34 Favored 'General case' 0 CA--C 1.47 -2.101 1 N-CA-C 98.677 -4.564 . . . . 0.0 98.677 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.716 HH12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -156.82 148.55 22.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -171.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.427 HG12 HG22 ' A' ' 104' ' ' VAL . 12.6 mt -114.31 126.07 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 56' ' ' ILE . 57.8 p -69.07 160.4 31.08 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -117.54 -18.75 9.67 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.143 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 t -103.44 84.02 2.25 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.2 p -52.18 136.47 30.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.179 2.192 . . . . 0.0 112.701 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.82 163.58 14.87 Favored 'General case' 0 CA--C 1.473 -2.011 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -168.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -78.33 148.26 33.85 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -145.66 146.32 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -167.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.6 m -138.5 104.84 5.25 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 m -90.17 99.8 12.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.8 m -92.49 123.57 35.89 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -115.16 146.36 41.45 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 39' ' ' CYS . 48.8 tp -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.468 1.107 . . . . 0.0 108.584 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -94.2 156.52 16.5 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.82 -79.6 0.34 Allowed Glycine 0 CA--C 1.486 -1.776 0 N-CA-C 106.036 -2.826 . . . . 0.0 106.036 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.06 27.39 6.6 Favored Glycine 0 CA--C 1.488 -1.644 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -89.38 127.28 55.55 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 171.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -80.14 -20.63 8.49 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 CA-C-N 122.686 1.995 . . . . 0.0 108.849 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -101.21 163.62 17.59 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.94 144.58 34.62 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 N-CA-C 107.516 -1.763 . . . . 0.0 107.516 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -84.08 163.19 67.82 Favored 'Cis proline' 0 CA--C 1.489 -1.746 0 CA-C-N 123.174 2.169 . . . . 0.0 110.423 13.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 m -126.24 117.31 22.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.77 83.97 1.85 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.648 1.213 . . . . 0.0 108.067 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -70.0 130.66 42.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -97.18 120.52 37.68 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.53 135.73 33.71 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -115.31 98.97 7.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.85 141.72 35.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.96 -163.01 13.91 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -162.38 108.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -146.26 151.12 37.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -167.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -75.21 135.16 41.04 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -96.31 136.79 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.725 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 119' ' ' ILE . 89.3 t -91.81 105.74 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 164.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.716 HG23 HH12 ' A' ' 70' ' ' ARG . 16.2 m -117.06 155.68 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.29 133.3 53.22 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.3 m -102.67 153.95 19.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 124.717 1.261 . . . . 0.0 111.295 -170.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -147.85 123.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 167.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.0 p30 69.63 15.76 8.11 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.307 2.243 . . . . 0.0 115.069 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.83 55.64 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 7.6 tp -128.56 133.48 25.23 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -77.33 118.56 4.68 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 CA-C-N 124.181 2.529 . . . . 0.0 106.381 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.79 -11.34 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 O-C-N 123.635 0.584 . . . . 0.0 109.802 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -145.26 152.05 39.34 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.74 127.35 55.31 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 117.53 30.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -100.75 37.93 1.63 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -166.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.2 p -87.39 -20.83 26.13 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 121.747 -0.596 . . . . 0.0 109.411 -174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.616 HD11 ' H ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -86.15 -23.5 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.105 0 C-N-CA 123.87 0.868 . . . . 0.0 109.579 173.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.404 ' CE1' HD12 ' A' ' 119' ' ' ILE . 22.6 m-30 . . . . . 0 N--CA 1.419 -2.008 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -164.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -87.92 -17.09 32.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.533 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -73.28 -41.79 63.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.53 -48.02 76.67 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.836 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -79.78 -10.41 59.78 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 120.304 1.411 . . . . 0.0 114.506 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -82.82 -30.56 28.66 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 119.093 0.86 . . . . 0.0 108.81 171.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 10' ' ' LEU . 3.3 t80 -60.25 -34.94 74.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.492 0.717 . . . . 0.0 109.986 165.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 mp -81.03 -23.3 38.7 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.9 p -75.11 -30.65 60.91 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 120.495 1.498 . . . . 0.0 110.881 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -72.74 -55.16 7.17 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -95.66 -54.04 3.5 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.708 -162.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 23.4 t80 -78.45 112.2 15.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.926 1.239 . . . . 0.0 109.977 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.43 94.07 3.58 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 101.445 -3.539 . . . . 0.0 101.445 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.9 -38.02 0.89 Allowed 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 120.141 3.386 . . . . 0.0 120.141 -162.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.7 154.38 47.92 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.9 Cg_endo -75.0 163.16 35.89 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 123.613 2.875 . . . . 0.0 109.883 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -75.16 -71.39 0.36 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 166.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.91 178.42 16.44 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.459 -3.856 . . . . 0.0 103.459 164.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -114.68 70.61 0.74 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.68 174.98 14.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.72 -16.75 62.81 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.814 1.246 . . . . 0.0 113.535 -170.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -81.75 -28.83 33.12 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -76.99 -34.3 57.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -33.57 42.07 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -169.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.58 -46.27 80.09 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 124.631 1.172 . . . . 0.0 109.34 170.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.1 t -64.33 -36.75 85.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.9 tt -83.08 -28.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 CA-C-N 118.023 0.374 . . . . 0.0 111.21 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.0 mmt -73.28 -23.88 60.35 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.117 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -82.6 -29.32 30.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 118.903 0.774 . . . . 0.0 112.58 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -80.74 -37.35 30.68 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.402 0.546 . . . . 0.0 111.122 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -22.67 55.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.671 0.388 . . . . 0.0 110.306 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.3 5.66 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.62 16.55 19.66 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -91.1 -11.71 37.79 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 m -126.42 102.9 26.0 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.74 161.48 94.12 Favored 'Cis proline' 0 N--CA 1.443 -1.494 0 N-CA-C 106.865 -2.013 . . . . 0.0 106.865 -20.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.2 m -62.12 120.62 11.23 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.96 0.904 . . . . 0.0 110.339 -175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -72.0 138.9 48.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.32 -40.98 57.87 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 123.557 0.536 . . . . 0.0 111.338 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.15 128.25 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -148.39 127.14 12.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 170.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -97.48 123.84 41.49 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.085 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -94.6 113.23 25.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.8 mm -87.37 145.34 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.53 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.565 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 8.9 m-70 -133.8 133.62 41.88 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.61 -147.12 12.43 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.313 -2.315 . . . . 0.0 107.313 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.401 HD22 ' HD3' ' A' ' 51' ' ' ARG . 4.5 m120 -94.92 149.04 21.67 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.07 -17.85 34.01 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.401 ' HD3' HD22 ' A' ' 49' ' ' ASN . 9.0 mpt_? -68.85 -40.84 79.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.439 1.896 . . . . 0.0 106.565 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.1 m -70.21 -41.95 72.97 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 116.645 -1.645 . . . . 0.0 111.665 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.1 mm -53.97 -58.18 4.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 124.368 1.067 . . . . 0.0 111.478 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.03 -42.55 90.48 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.062 1.345 . . . . 0.0 111.489 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.65 4.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mm -77.59 -31.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.2 m -94.58 7.68 44.84 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.624 0.249 . . . . 0.0 111.502 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -91.09 173.26 8.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 158.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -85.55 1.8 47.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.344 0.658 . . . . 0.0 111.555 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -77.52 -60.01 2.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.243 0.617 . . . . 0.0 111.32 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -89.34 -49.51 6.67 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.55 147.81 18.65 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -168.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.71 156.66 35.27 Favored Pre-proline 0 N--CA 1.434 -1.262 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -73.92 125.44 9.9 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 122.663 2.242 . . . . 0.0 107.629 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -117.71 123.35 45.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 66.46 -107.2 0.11 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.912 1.285 . . . . 0.0 112.124 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.75 95.61 2.88 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.333 2.2 p-10 60.31 35.55 20.71 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 128.666 2.786 . . . . 0.0 113.602 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -117.67 165.69 13.3 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 101.31 -3.589 . . . . 0.0 101.31 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.8 mtt85 -145.14 127.59 15.96 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -95.58 134.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -81.84 160.21 23.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.351 0.596 . . . . 0.0 111.054 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.97 -1.87 9.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -106.37 77.26 1.2 Allowed 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -59.69 138.06 57.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 125.898 1.679 . . . . 0.0 111.912 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -113.43 158.85 20.13 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -166.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 8.7 mt-30 -79.89 138.9 37.26 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.22 105.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -171.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.0 m -97.98 106.31 18.58 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m -87.39 112.19 21.88 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -89.38 116.29 27.47 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -121.47 142.33 50.15 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.2 tp -80.36 110.54 15.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -93.13 155.02 17.74 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.91 -89.79 1.52 Allowed Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.33 38.41 0.59 Allowed Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -80.15 126.08 80.14 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -84.88 -19.96 3.79 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 122.165 1.809 . . . . 0.0 108.314 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -110.47 160.66 27.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 117.618 -1.182 . . . . 0.0 107.962 -168.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -73.25 142.04 33.17 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 C-N-CA 122.695 2.263 . . . . 0.0 106.767 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -82.04 159.47 79.43 Favored 'Cis proline' 0 N--CA 1.435 -1.944 0 CA-C-N 123.027 2.117 . . . . 0.0 108.949 4.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.6 m -109.52 170.27 8.17 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -125.48 109.92 13.29 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -105.84 113.98 27.86 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -89.04 125.61 35.08 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.72 125.69 29.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 m -106.53 87.22 2.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.75 129.21 34.4 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.08 -167.13 14.4 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -157.32 114.26 3.01 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -155.14 156.18 35.29 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -168.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.57 139.58 42.19 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.61 172.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.22 147.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.08 94.7 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 165.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 m -91.6 136.11 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.5 m -107.03 142.62 36.38 Favored 'General case' 0 CA--C 1.485 -1.556 0 O-C-N 124.42 1.075 . . . . 0.0 110.577 -172.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -150.77 130.49 13.17 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.322 14.8 p30 64.37 20.44 12.17 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 115.553 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.77 -3.07 70.54 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER -102.73 142.42 24.53 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 176.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.72 109.85 2.93 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 N-CA-C 105.386 -2.582 . . . . 0.0 105.386 160.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 114' ' ' HIS . 2.8 m -85.98 -22.58 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.623 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.571 ' CD2' HG23 ' A' ' 113' ' ' VAL . 54.6 m-70 -156.37 -163.4 1.45 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 132.88 1.06 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.54 127.29 32.76 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -97.55 16.94 18.9 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 m -91.84 -20.85 21.03 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 118.765 0.711 . . . . 0.0 110.376 -165.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -26.71 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 C-N-CA 123.672 0.789 . . . . 0.0 109.03 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.14 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -90.05 -27.02 19.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -71.65 -41.66 68.5 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.177 0.591 . . . . 0.0 109.437 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -55.0 -56.81 15.59 Favored 'General case' 0 N--CA 1.398 -3.032 0 C-N-CA 126.158 1.783 . . . . 0.0 113.957 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 17.8 p -78.72 -6.16 55.08 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -86.28 -35.63 19.82 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 120.582 1.537 . . . . 0.0 108.496 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -41.34 87.69 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.547 1.139 . . . . 0.0 109.416 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.392 0.0 OUTLIER -97.34 0.02 47.22 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 118.267 0.485 . . . . 0.0 111.168 -174.027 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -71.22 -53.91 12.75 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 161.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.12 -40.58 94.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 124.053 0.846 . . . . 0.0 112.94 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -121.25 4.86 10.29 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.245 -162.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 30.7 t80 -110.29 130.0 55.63 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 120.173 1.351 . . . . 0.0 109.438 167.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.82 104.6 3.33 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 164.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.88 -43.38 4.05 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 118.321 2.712 . . . . 0.0 118.321 -164.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -142.24 156.49 64.4 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -71.04 147.28 54.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.584 2.856 . . . . 0.0 108.838 172.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -80.02 -53.51 6.66 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.04 -178.38 15.57 Favored Glycine 0 CA--C 1.48 -2.125 0 N-CA-C 103.331 -3.908 . . . . 0.0 103.331 164.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.11 48.01 2.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.95 179.33 6.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.896 -168.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.68 -41.52 77.47 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.707 2.403 . . . . 0.0 112.926 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -81.63 -18.93 42.96 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.865 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -74.29 -44.59 52.09 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 2.3 m -68.66 -36.93 79.2 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 124.238 0.961 . . . . 0.0 112.869 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.57 -41.87 75.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 123.371 0.42 . . . . 0.0 110.275 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.9 m -73.06 -23.17 60.53 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.827 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 9.9 tt -85.74 -36.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 119.77 1.168 . . . . 0.0 110.965 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.1 mmm -72.05 -30.77 65.49 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.19 -39.32 55.04 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.53 -48.56 26.27 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.407 -170.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -79.66 -23.77 42.29 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.152 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.37 61.95 1.52 Allowed Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 161.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.69 15.3 5.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 t -84.33 8.83 14.79 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.705 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.6 m -113.18 106.27 54.88 Favored Pre-proline 0 N--CA 1.428 -1.575 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.368 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.7 162.24 93.09 Favored 'Cis proline' 0 N--CA 1.443 -1.474 0 CA-C-N 123.401 2.25 . . . . 0.0 107.262 -22.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.28 117.48 7.9 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.58 1.152 . . . . 0.0 111.819 -168.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -73.93 137.15 43.42 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -75.09 -35.19 61.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.371 1.044 . . . . 0.0 112.629 -168.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.21 130.63 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -154.1 119.4 5.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -102.88 120.59 40.89 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.647 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.39 116.29 26.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.04 149.03 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.553 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m-70 -131.6 132.92 44.45 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.641 -172.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.85 -116.56 0.72 Allowed Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -133.5 140.69 47.38 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -88.36 -0.75 57.51 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -79.62 -31.06 41.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -78.16 -28.51 48.34 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.674 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.16 -41.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 CA-C-N 119.142 0.883 . . . . 0.0 110.609 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -58.96 -43.31 91.3 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.744 1.217 . . . . 0.0 111.122 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.94 13.6 1.35 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 72' ' ' SER . 20.1 mm -83.11 -22.88 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.6 m -84.55 -11.03 56.85 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.62 166.61 15.24 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.26 -17.06 47.28 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -81.33 -30.49 33.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -130.4 37.86 3.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.73 128.25 1.04 Allowed Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -104.89 156.05 36.61 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.04 122.17 6.57 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 122.496 2.131 . . . . 0.0 107.036 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -106.23 127.82 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 63.46 -105.2 0.15 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.415 1.486 . . . . 0.0 112.058 170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -139.75 97.77 3.33 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.341 1.9 p-10 64.37 26.72 13.62 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 129.033 2.933 . . . . 0.0 114.343 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.18 167.83 9.73 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.51 115.55 8.82 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.1 tt -96.61 139.89 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' HD12 ' A' ' 56' ' ' ILE . 93.8 p -81.32 164.86 21.88 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.591 0.71 . . . . 0.0 111.833 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -115.13 -12.68 11.88 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -116.86 90.65 3.38 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -49.9 132.92 22.71 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.543 2.337 . . . . 0.0 113.656 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.11 157.64 19.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 2.9 mt-30 -81.05 149.14 29.36 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.71 141.62 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -166.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.9 m -134.3 104.93 6.37 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.4 m -85.67 104.05 15.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 70.2 m -83.32 114.74 21.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -111.34 142.29 43.77 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -93.43 136.67 33.47 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 95.0 m-70 -140.83 172.6 12.46 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.39 -91.22 0.6 Allowed Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.62 -11.33 1.12 Allowed Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -78.46 134.86 61.53 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -80.35 -30.35 2.07 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.682 1.588 . . . . 0.0 108.093 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -97.14 154.88 37.99 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.44 -168.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.57 150.19 27.73 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 122.292 1.995 . . . . 0.0 107.429 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -81.7 165.04 74.67 Favored 'Cis proline' 0 CA--C 1.49 -1.707 0 CA-C-N 123.028 2.117 . . . . 0.0 109.462 7.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.7 m -149.84 141.49 23.55 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -167.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.73 141.33 30.63 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 36.9 m-85 -134.35 110.01 9.17 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 3.8 mpt_? -91.16 132.71 35.9 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.76 130.49 35.38 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.618 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -113.9 95.63 5.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.78 141.7 34.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.41 -173.8 23.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 84.7 t80 -160.62 107.97 1.55 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.33 164.04 39.3 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.247 -173.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.81 123.78 28.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.718 1.207 . . . . 0.0 108.745 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -96.02 139.61 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.664 -163.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.6 t -96.36 112.06 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.276 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -105.06 148.13 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 170.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.24 36.61 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.95 151.15 24.96 Favored 'General case' 0 CA--C 1.494 -1.209 0 O-C-N 124.237 0.96 . . . . 0.0 110.636 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -148.76 128.74 13.51 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.346 8.2 p30 70.77 7.85 6.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.592 2.357 . . . . 0.0 115.557 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.37 2.79 57.73 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.263 5.5 tp -113.99 154.72 45.99 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -72.0 159.35 50.45 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.054 1.836 . . . . 0.0 108.263 163.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -138.27 -20.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.493 175.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 113' ' ' VAL . 41.1 m-70 -149.86 177.71 9.57 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -126.74 136.07 51.94 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.52 118.73 28.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.08 40.26 1.36 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.0 m -96.76 -28.32 14.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 pt -91.47 -20.78 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.449 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.31 -6.63 49.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -33.46 44.39 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 0.7 OUTLIER -64.68 -50.25 67.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.055 1.342 . . . . 0.0 109.0 173.265 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.484 1.7 t -88.06 10.85 17.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -80.49 -40.78 25.51 Favored 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 119.974 -1.704 . . . . 0.0 107.836 157.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.95 -40.25 80.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.117 1.367 . . . . 0.0 109.588 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 14' ' ' TYR . 18.0 mt -83.28 -15.65 49.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.3 m -65.86 -47.71 74.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-N 120.465 1.484 . . . . 0.0 109.224 169.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 12.4 tt0 -77.83 -40.3 40.77 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 124.212 1.005 . . . . 0.0 111.187 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 80.1 m-70 -96.17 -54.92 3.13 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 118.482 0.583 . . . . 0.0 110.377 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB2' HD22 ' A' ' 10' ' ' LEU . 50.5 t80 -77.66 118.77 20.37 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.982 0.896 . . . . 0.0 110.382 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.07 98.11 3.79 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.45 -41.24 6.12 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 -165.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -156.26 139.27 10.8 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 164.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.2 Cg_endo -85.54 170.96 8.85 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.876 1.717 . . . . 0.0 108.663 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -73.25 -79.77 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -177.03 20.05 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 103.494 -3.842 . . . . 0.0 103.494 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -127.38 70.87 1.32 Allowed 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -147.46 -178.76 6.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -66.21 -26.2 67.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.824 1.249 . . . . 0.0 113.777 -171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -81.25 -27.08 35.33 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 122.599 0.36 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -72.11 -42.72 65.77 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 0.1 OUTLIER -81.25 -24.99 36.97 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 119.081 -1.048 . . . . 0.0 113.371 -170.064 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.06 -36.6 66.91 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.467 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -69.62 -34.19 73.73 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.3 tt -85.19 -24.75 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 CA-C-N 118.308 0.504 . . . . 0.0 110.579 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -31.09 63.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.588 172.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -73.75 -36.63 65.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -81.54 -41.91 20.95 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -77.63 -21.15 52.7 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.233 0.469 . . . . 0.0 111.904 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.67 50.69 1.94 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.344 4.0 mm? -108.09 -14.65 14.68 Favored 'General case' 0 CA--C 1.48 -1.749 0 C-N-CA 124.216 1.006 . . . . 0.0 108.636 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 t -74.6 -15.34 60.84 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.897 1.679 . . . . 0.0 112.735 -163.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -121.84 108.3 35.0 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.78 156.22 99.69 Favored 'Cis proline' 0 N--CA 1.441 -1.594 0 N-CA-C 106.722 -2.068 . . . . 0.0 106.722 -25.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.1 m -59.9 127.91 34.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 125.518 1.527 . . . . 0.0 112.026 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -80.3 140.27 36.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -77.06 -37.62 54.25 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.774 -168.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.56 129.7 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -152.38 130.0 11.53 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 170.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -97.64 128.72 44.55 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.893 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -94.83 118.04 31.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -87.14 148.07 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -142.86 130.09 20.93 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.719 -176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 -129.98 1.84 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 106.579 -2.609 . . . . 0.0 106.579 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -115.36 145.08 42.86 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.01 -18.83 29.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.02 0.438 . . . . 0.0 109.907 -170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -80.26 -24.64 39.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -71.07 -40.65 71.49 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 117.312 -1.328 . . . . 0.0 110.076 172.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.19 -53.87 34.31 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 C-N-CA 124.844 1.258 . . . . 0.0 111.165 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.56 -43.26 89.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.189 1.396 . . . . 0.0 111.517 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.24 8.41 9.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mm -75.37 -27.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.5 t -72.85 -29.03 62.88 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 117.564 0.165 . . . . 0.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.34 153.72 42.13 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.03 8.76 33.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.666 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.04 -50.86 7.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -110.76 -3.88 15.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.684 -166.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.31 -159.12 7.99 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 103.894 -3.682 . . . . 0.0 103.894 168.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -162.26 152.95 14.54 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -73.5 137.89 26.09 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.995 2.463 . . . . 0.0 107.503 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -129.61 122.78 29.77 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? 67.94 -100.26 0.05 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 125.181 1.393 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -162.57 108.8 1.22 Allowed 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.412 0.5 OUTLIER 86.71 -6.66 0.71 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 129.857 3.263 . . . . 0.0 114.145 173.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.8 156.82 17.27 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -141.75 115.72 9.28 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.26 141.95 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -84.47 162.71 19.81 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.63 0.729 . . . . 0.0 112.181 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.89 -27.28 9.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 m -103.03 79.78 1.79 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -47.4 133.81 12.29 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 128.336 2.654 . . . . 0.0 113.502 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -112.3 158.73 19.41 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -167.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -79.92 125.19 29.42 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.11 103.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.9 m -90.6 107.77 19.38 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -87.41 105.59 17.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.1 m -97.4 114.49 26.32 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -114.76 136.85 52.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.86 118.66 10.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.832 1.653 . . . . 0.0 107.824 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -136.39 97.5 3.6 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.32 -42.61 0.07 OUTLIER Glycine 0 CA--C 1.48 -2.136 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.72 6.18 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 m -112.13 109.92 54.17 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -85.2 -20.46 3.38 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 121.769 1.668 . . . . 0.0 108.51 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -112.1 159.46 33.62 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -169.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -75.11 145.36 30.98 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.563 2.176 . . . . 0.0 107.929 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -81.91 162.68 77.74 Favored 'Cis proline' 0 N--CA 1.436 -1.91 0 CA-C-N 122.437 1.906 . . . . 0.0 107.969 -1.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.0 m -108.45 166.03 11.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -171.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -122.27 116.75 24.64 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.76 133.02 54.98 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -99.47 117.06 33.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 165.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.39 131.68 34.66 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 m -123.31 107.83 12.09 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.45 135.01 36.55 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.898 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.72 -174.89 13.57 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 106.09 -2.804 . . . . 0.0 106.09 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.48 106.18 1.9 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -156.88 168.92 26.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -78.1 132.67 37.79 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.569 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.46 138.89 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.391 -170.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.9 t -101.22 96.13 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.24 136.65 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.58 143.54 30.07 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.8 t -136.42 137.02 40.03 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.178 0.513 . . . . 0.0 110.624 -170.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -128.23 131.73 48.8 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.306 14.1 p30 64.47 21.19 12.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 117.106 2.262 . . . . 0.0 117.106 171.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.56 53.73 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tp -144.63 118.49 5.69 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -172.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -71.51 118.29 5.58 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 CA-C-N 121.817 1.685 . . . . 0.0 111.416 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.493 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.7 OUTLIER -90.77 -26.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 118.816 0.735 . . . . 0.0 112.664 -175.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.493 ' CD2' HG23 ' A' ' 113' ' ' VAL . 25.8 m-70 -149.3 -166.2 2.49 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.1 133.56 4.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.65 141.02 34.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.509 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -105.16 42.09 1.27 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.0 m -95.87 -29.07 14.4 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -32.67 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 124.981 1.312 . . . . 0.0 109.475 170.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -171.762 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.428 -1.55 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t -93.59 -28.12 16.21 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 167.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -34.46 63.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.084 0.954 . . . . 0.0 108.803 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.481 ' HB2' HD21 ' A' ' 111' ' ' LEU . 63.3 t80 -46.46 -60.32 2.42 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 127.053 2.141 . . . . 0.0 111.796 162.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 1.6 p -72.73 -12.56 61.06 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -76.62 -41.91 44.22 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.799 1.181 . . . . 0.0 109.824 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -63.03 -36.27 83.0 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.995 1.718 . . . . 0.0 109.342 171.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -73.67 -26.7 60.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.034 1.333 . . . . 0.0 114.493 177.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 79.8 m -69.81 -51.31 34.81 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.4 pt20 -84.82 -10.25 57.36 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.613 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 83.7 m-70 -138.03 2.67 2.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 36.2 t80 -107.07 132.34 53.09 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 120.52 1.509 . . . . 0.0 108.834 171.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.33 104.36 3.09 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 167.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -37.92 16.77 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -162.14 138.13 5.8 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 86.0 Cg_exo -74.01 173.58 13.83 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.274 1.983 . . . . 0.0 114.465 -172.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.78 -73.87 0.24 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.98 -175.82 15.29 Favored Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 167.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.2 69.29 1.21 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.36 -176.96 5.68 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.45 -21.95 61.89 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.324 1.05 . . . . 0.0 113.366 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -81.95 -23.44 36.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -77.55 -37.55 50.48 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.0 m -69.46 -37.09 77.17 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -77.12 -30.71 55.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 119.456 -0.307 . . . . 0.0 110.339 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -70.33 -35.27 73.51 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.0 tt -85.96 -25.97 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 120.605 0.241 . . . . 0.0 110.89 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 mmt -76.49 -31.21 57.61 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.79 -0.569 . . . . 0.0 109.777 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -69.57 -38.64 77.48 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.159 0.984 . . . . 0.0 112.172 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -71.11 -52.04 21.59 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.465 1.106 . . . . 0.0 110.865 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.24 -26.28 39.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.145 0.578 . . . . 0.0 109.543 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.65 63.24 1.29 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 164.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.16 23.35 1.86 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.684 1.231 . . . . 0.0 108.335 174.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -84.23 -9.48 58.48 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.532 1.933 . . . . 0.0 109.696 167.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.9 t -120.22 107.77 39.0 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.82 165.45 84.87 Favored 'Cis proline' 0 N--CA 1.448 -1.184 0 CA-C-N 122.593 1.962 . . . . 0.0 107.557 -18.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 83' ' ' LEU . 49.9 m -61.38 120.51 10.59 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.798 0.839 . . . . 0.0 110.757 -175.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -79.4 144.12 34.42 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -75.19 -40.2 59.56 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 123.097 0.559 . . . . 0.0 111.762 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.26 133.76 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.8 121.09 4.85 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -102.35 115.47 30.63 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.004 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.0 120.25 26.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -101.81 146.71 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -132.49 127.92 36.26 Favored 'General case' 0 CA--C 1.485 -1.521 0 C-N-CA 124.672 1.189 . . . . 0.0 108.574 -172.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.72 -143.85 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 105.374 -3.09 . . . . 0.0 105.374 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -95.27 148.61 22.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -88.69 -17.96 28.88 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -69.55 -36.01 75.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.9 t -74.61 -36.13 62.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 117.335 -1.317 . . . . 0.0 111.006 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 53' ' ' ILE . 3.2 tp -64.85 -46.52 91.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.301 0 CA-C-N 119.542 1.065 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -61.54 -41.88 97.99 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.747 1.219 . . . . 0.0 111.243 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.62 2.39 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.5 mm -74.48 -36.32 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.8 m -85.81 -31.49 22.28 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -102.07 57.31 0.81 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 117.796 0.271 . . . . 0.0 111.242 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 34.81 65.48 0.35 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 130.174 3.389 . . . . 0.0 115.54 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.94 -58.76 0.96 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -99.51 -44.43 6.17 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 154.58 21.55 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.588 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.27 154.16 42.3 Favored Pre-proline 0 N--CA 1.434 -1.247 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.75 137.31 22.16 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.984 2.456 . . . . 0.0 107.105 -175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.5 73.49 1.19 Allowed 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 69.49 -101.28 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 126.325 1.85 . . . . 0.0 113.551 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.96 77.21 1.23 Allowed 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 123.935 0.894 . . . . 0.0 108.759 -163.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.319 6.4 p30 71.92 11.56 6.18 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 129.421 3.089 . . . . 0.0 114.222 170.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.24 157.33 16.86 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -140.11 119.33 12.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -88.76 143.35 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.3 p -83.85 169.01 15.58 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -134.63 3.79 3.3 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.4 m -105.39 79.55 1.48 Allowed 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -53.24 128.43 28.03 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 127.506 2.322 . . . . 0.0 112.18 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -108.86 158.96 17.17 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -170.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 8.5 mt-30 -77.57 145.35 36.92 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.88 142.06 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -171.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.9 m -134.5 102.51 5.34 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 102.097 -3.298 . . . . 0.0 102.097 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 106.79 14.29 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.9 m -89.24 113.04 24.22 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -124.61 136.78 54.23 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -169.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 39' ' ' CYS . 42.3 tp -78.64 123.63 27.33 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -138.06 52.65 1.84 Allowed 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.95 -88.2 2.01 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.66 -16.79 4.01 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -83.92 136.62 41.3 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -81.17 -23.4 5.28 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 121.83 1.687 . . . . 0.0 108.422 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -105.33 164.46 15.04 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -74.26 143.7 32.1 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 107.035 -1.948 . . . . 0.0 107.035 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -82.9 160.97 75.3 Favored 'Cis proline' 0 N--CA 1.435 -1.913 0 CA-C-N 123.062 2.129 . . . . 0.0 109.583 7.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.1 m -125.24 138.68 54.11 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -173.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.61 99.73 11.81 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -94.16 111.83 23.59 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -87.65 124.99 34.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.94 125.8 29.85 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.4 m -110.19 87.26 2.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.18 131.17 34.83 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -172.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.58 -162.35 9.2 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.049 -2.021 . . . . 0.0 108.049 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.413 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.9 t80 -155.21 102.32 2.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -137.91 155.62 48.73 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -158.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -74.36 127.82 33.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.54 131.55 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -92.47 113.22 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.443 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.14 141.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 173.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.24 127.69 37.81 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.7 m -108.65 151.66 25.85 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 121.836 0.827 . . . . 0.0 112.004 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.33 127.15 14.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 15.3 p30 60.01 25.38 14.6 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 128.054 2.542 . . . . 0.0 115.422 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.18 20.71 60.18 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -139.87 138.59 19.98 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.62 117.77 1.77 Allowed 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 121.535 1.584 . . . . 0.0 108.947 -170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.552 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -93.83 -23.08 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 123.572 0.545 . . . . 0.0 112.246 -176.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.552 ' CD2' HG23 ' A' ' 113' ' ' VAL . 55.9 m-70 -143.0 -177.73 5.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -170.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.4 tp -139.07 143.09 38.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 123.98 33.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -112.17 11.7 20.35 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 t -90.79 -32.43 16.11 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -25.52 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 C-N-CA 124.304 1.042 . . . . 0.0 110.749 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 . . . . . 0 N--CA 1.43 -1.432 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.086 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.7 -30.21 16.42 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 164.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -49.19 77.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 125.726 1.61 . . . . 0.0 109.549 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HB2' HD21 ' A' ' 111' ' ' LEU . 49.8 t80 -51.27 -62.85 1.37 Allowed 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 127.443 2.297 . . . . 0.0 113.542 172.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -70.86 -10.09 58.9 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -83.33 -39.5 20.68 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.597 1.09 . . . . 0.0 109.566 171.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 1.9 t80 -60.12 -37.88 81.35 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 109.617 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -74.03 -31.41 62.89 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 125.849 1.66 . . . . 0.0 113.576 178.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 p -75.26 -39.24 60.02 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 120.702 1.592 . . . . 0.0 110.646 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.36 -56.95 7.61 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 123.609 0.568 . . . . 0.0 111.253 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -89.67 -48.71 7.1 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.69 -167.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.451 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 24.5 t80 -70.68 119.46 14.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.955 1.252 . . . . 0.0 110.608 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -137.6 97.78 3.53 Favored 'General case' 0 N--CA 1.424 -1.77 1 N-CA-C 99.673 -4.195 . . . . 0.0 99.673 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.56 -41.69 10.17 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.502 2.321 . . . . 0.0 117.225 -166.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -159.57 131.09 3.98 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 168.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -70.91 180.0 3.88 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 123.146 2.564 . . . . 0.0 114.946 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.87 -77.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.76 -1.564 . . . . 0.0 106.949 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.06 -173.38 14.37 Favored Glycine 0 CA--C 1.478 -2.233 1 N-CA-C 102.284 -4.326 . . . . 0.0 102.284 162.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.29 72.29 0.86 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -143.91 179.71 7.01 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.52 -41.71 73.5 Favored 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 127.926 2.491 . . . . 0.0 112.931 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -79.21 -21.13 46.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.027 0.531 . . . . 0.0 111.904 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.4 -41.77 55.34 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.5 m -68.37 -37.21 80.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.755 0.659 . . . . 0.0 112.143 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.61 -37.92 70.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.805 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.8 m -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 13.2 tt -81.72 -29.76 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 CA-C-N 118.197 0.453 . . . . 0.0 109.87 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -25.58 51.7 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.943 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -75.92 -33.22 59.86 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.295 0.498 . . . . 0.0 111.109 173.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.17 -48.92 21.27 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.134 0.573 . . . . 0.0 110.833 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -78.41 -26.74 46.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 110.528 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.14 55.24 2.0 Favored Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 mt -116.12 13.77 15.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.56 -12.67 53.67 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.064 0.546 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 m -121.12 102.25 43.75 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.13 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 167.82 79.22 Favored 'Cis proline' 0 N--CA 1.445 -1.334 0 N-CA-C 107.049 -1.943 . . . . 0.0 107.049 -22.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.0 m -59.47 122.21 13.44 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.865 0.866 . . . . 0.0 111.331 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.44 143.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.65 -37.22 31.36 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 119.769 -0.158 . . . . 0.0 110.611 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.73 130.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -143.79 121.6 11.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.6 m -92.39 105.66 17.8 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.24 116.28 23.5 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.19 150.47 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -141.87 136.04 30.13 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 125.268 1.427 . . . . 0.0 108.151 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.49 -104.6 0.24 Allowed Glycine 0 CA--C 1.483 -1.918 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -147.84 127.12 13.01 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -86.18 -3.86 59.05 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.255 -0.278 . . . . 0.0 111.601 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -30.57 35.54 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 p -85.54 -23.31 27.74 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 117.695 -1.145 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.2 mm -59.68 -54.26 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-N 119.086 0.857 . . . . 0.0 108.715 167.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -58.38 -42.83 87.94 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.418 1.487 . . . . 0.0 112.447 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 14.94 2.33 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.54 -38.37 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.43 44.34 1.02 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.009 0.433 . . . . 0.0 110.583 -171.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -133.37 21.37 4.0 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 164.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 41.46 44.05 2.38 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.292 3.437 . . . . 0.0 114.159 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.54 -45.01 7.59 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -120.03 8.92 11.07 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.78 -169.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.02 163.73 30.22 Favored Glycine 0 CA--C 1.485 -1.791 0 C-N-CA 118.872 -1.632 . . . . 0.0 109.079 -175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -112.05 156.74 41.38 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.14 135.0 24.18 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 122.666 2.244 . . . . 0.0 106.364 166.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -129.65 133.78 47.31 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 64.59 -102.65 0.09 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.426 1.49 . . . . 0.0 111.396 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -154.88 112.56 3.42 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.342 5.8 p30 68.44 15.15 9.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 129.642 3.177 . . . . 0.0 114.55 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.86 167.93 9.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 103.306 -2.85 . . . . 0.0 103.306 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.39 109.44 4.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -172.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 tt -91.02 146.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -82.21 177.21 8.92 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.478 1.132 . . . . 0.0 111.471 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' H ' ' H ' ' A' ' 74' ' ' SER . 20.4 tptm -148.68 -0.08 0.55 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.435 ' H ' ' H ' ' A' ' 73' ' ' LYS . 36.3 t -119.76 90.14 3.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 130.01 44.76 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 125.937 1.695 . . . . 0.0 112.648 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.71 158.74 18.3 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -79.74 141.07 36.68 Favored 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.17 142.82 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -166.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -130.68 109.17 10.43 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 166.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.0 m -82.33 100.86 10.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.2 m -86.76 112.28 21.53 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.21 141.94 49.46 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 39' ' ' CYS . 28.9 tp -77.75 121.49 24.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -172.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -135.56 50.45 2.11 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.53 -63.64 0.83 Allowed Glycine 0 CA--C 1.482 -1.977 0 N-CA-C 105.401 -3.08 . . . . 0.0 105.401 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.91 -15.93 21.04 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 p -86.3 140.49 34.34 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -81.32 -22.37 5.82 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.833 1.689 . . . . 0.0 108.664 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -105.55 162.57 19.33 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.423 -168.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -74.02 146.95 37.8 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.401 2.068 . . . . 0.0 108.106 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -83.07 164.49 71.24 Favored 'Cis proline' 0 CA--C 1.49 -1.722 0 CA-C-N 122.753 2.019 . . . . 0.0 109.197 5.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 39.5 m -128.24 130.11 47.45 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -95.61 120.54 36.05 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.32 117.34 32.22 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -93.09 135.54 34.17 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.52 139.4 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.553 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 m -124.13 98.74 5.91 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 171.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 147.16 28.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.075 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.61 36.5 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -152.58 100.9 2.6 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -152.31 170.36 20.23 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.808 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -75.61 129.87 37.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 108.912 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.42 141.98 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.72 113.06 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.421 HG12 HD13 ' A' ' 115' ' ' LEU . 18.1 m -107.21 147.61 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.92 121.01 31.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 40.4 t -106.33 126.98 52.91 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 123.856 0.723 . . . . 0.0 110.741 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.61 132.82 54.46 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 5.5 p30 75.03 0.48 3.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 167.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 23.1 11.06 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 6' ' ' TYR . 19.1 tp -141.1 127.49 11.51 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 14.2 Cg_endo -78.8 102.14 1.51 Allowed 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.575 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -91.07 -23.13 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 123.694 0.798 . . . . 0.0 111.631 -166.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.575 ' CD2' HG23 ' A' ' 113' ' ' VAL . 17.3 m-70 -138.37 -177.6 4.92 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 5.2 tp -124.65 135.91 53.48 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.91 138.2 31.74 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.56 51.24 0.77 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.3 t -81.41 -49.54 10.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.327 0.651 . . . . 0.0 109.953 -171.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.87 -28.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -173.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 N--CA 1.428 -1.569 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.3 -163.897 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 t30 . . . . . 0 CA--C 1.498 -1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -88.24 -20.8 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -75.49 -21.02 58.39 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.259 1.023 . . . . 0.0 110.407 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -76.29 -39.05 55.24 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.777 1.231 . . . . 0.0 108.232 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.478 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -80.31 -10.6 59.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.22 0.918 . . . . 0.0 113.464 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -75.04 -46.35 35.5 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.94 -34.45 71.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.249 2.22 . . . . 0.0 111.631 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.332 0.0 OUTLIER -106.97 -4.66 18.82 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.753 0.821 . . . . 0.0 111.726 -173.254 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 t -83.64 -28.74 28.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 169.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -67.82 -70.33 0.26 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 163.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -105.48 12.95 30.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -155.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 36.7 t80 -112.33 128.05 56.17 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.187 1.358 . . . . 0.0 109.33 169.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -145.34 100.9 3.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 166.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.16 -39.57 6.26 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 -166.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -154.81 137.3 10.02 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 171.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 40.9 Cg_endo -86.25 174.53 6.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 121.731 1.621 . . . . 0.0 108.72 -171.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -74.33 -50.54 18.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 172.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.23 -174.07 28.48 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -114.6 66.43 0.68 Allowed 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -150.58 173.48 14.07 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -172.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.11 -23.39 63.03 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.82 1.248 . . . . 0.0 113.185 -171.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.09 30.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -74.12 -43.85 56.0 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.3 m -67.34 -36.02 80.58 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.79 -34.37 62.41 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.39 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.5 t -69.21 -36.62 77.45 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 tt -82.4 -28.08 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 117.873 0.306 . . . . 0.0 111.017 -175.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mmt -78.33 -24.75 46.42 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.832 176.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -42.4 63.81 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 172.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -45.1 30.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.527 0.331 . . . . 0.0 111.761 -169.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.17 -22.03 53.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.13 56.22 1.62 Allowed Glycine 0 C--N 1.352 1.454 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.326 4.0 mm? -108.73 -16.71 14.12 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 124.532 1.133 . . . . 0.0 108.855 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -76.19 -11.47 59.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.577 1.551 . . . . 0.0 112.883 -164.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t -124.79 108.52 28.38 Favored Pre-proline 0 N--CA 1.438 -1.025 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.838 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.72 157.66 98.41 Favored 'Cis proline' 0 N--CA 1.447 -1.227 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 -23.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.7 m -54.89 129.98 39.54 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 125.43 1.492 . . . . 0.0 113.258 -173.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -77.27 132.91 38.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 171.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.64 -38.55 58.79 Favored 'General case' 0 CA--C 1.487 -1.477 0 O-C-N 123.495 0.497 . . . . 0.0 110.871 -169.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.48 135.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 174.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.09 120.03 7.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.2 m -96.73 107.62 20.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.09 117.22 25.68 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.0 mt -98.44 147.68 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -175.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.51 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -137.62 129.93 29.36 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 125.392 1.477 . . . . 0.0 108.797 -169.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.57 -134.98 3.59 Favored Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 106.006 -2.838 . . . . 0.0 106.006 173.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.94 142.38 29.74 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 173.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.88 -21.22 29.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -74.08 -30.36 62.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.094 1.358 . . . . 0.0 109.437 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.2 m -77.2 -33.22 56.33 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 117.414 -1.279 . . . . 0.0 110.871 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -56.01 -56.14 14.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 119.037 0.835 . . . . 0.0 110.11 172.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -56.59 -41.24 76.64 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.92 15.39 1.1 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.8 mt -81.16 -34.21 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 168.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.44 -44.67 62.05 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.782 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.49 156.46 22.84 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.91 87.12 7.25 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.057 0.456 . . . . 0.0 109.933 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.73 -47.52 1.04 Allowed 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.99 58.55 1.35 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 177.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.49 151.42 10.91 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 174.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -115.71 157.95 43.19 Favored Pre-proline 0 N--CA 1.432 -1.362 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -74.3 143.24 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.898 2.399 . . . . 0.0 106.506 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -142.03 127.38 18.77 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? 65.2 -107.39 0.14 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.026 1.33 . . . . 0.0 110.375 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.89 101.02 3.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.364 2.3 p-10 63.82 25.84 14.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 129.08 2.952 . . . . 0.0 114.505 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.09 157.4 17.87 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 168.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -138.14 120.97 16.46 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 tt -88.61 145.59 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.6 p -88.15 165.45 15.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.649 0.738 . . . . 0.0 109.914 -175.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.96 11.77 5.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -123.06 96.17 4.9 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.6 m -62.26 131.63 50.02 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 124.368 1.067 . . . . 0.0 110.645 175.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -112.58 155.87 23.64 Favored 'General case' 0 CA--C 1.473 -1.999 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 138.53 39.22 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 140.84 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -167.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.0 m -129.3 105.67 8.29 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 167.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 m -85.55 99.98 11.62 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.1 m -85.65 112.1 20.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -117.74 145.99 44.09 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.268 17.1 mt -65.82 135.71 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.029 0.442 . . . . 0.0 110.365 175.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.35 45.44 2.76 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 156.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.01 -83.35 1.42 Allowed Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.08 -25.8 5.7 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -85.35 131.47 48.0 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -84.01 -14.77 7.18 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.097 1.865 . . . . 0.0 108.561 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -100.35 168.05 9.98 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.64 143.77 34.52 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.61 163.98 51.46 Favored 'Cis proline' 0 N--CA 1.436 -1.883 0 CA-C-N 122.35 1.875 . . . . 0.0 108.008 10.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.9 m -128.75 125.99 39.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -172.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -95.38 128.0 41.88 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -120.07 126.06 49.83 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -90.96 129.78 36.95 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.09 129.58 34.86 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -120.44 90.26 3.29 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.86 150.89 23.24 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.354 0.597 . . . . 0.0 110.742 -172.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.53 -170.38 20.28 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -144.08 90.19 2.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -124.39 145.99 49.14 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -159.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -80.89 128.79 34.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.29 138.91 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.604 -164.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -95.24 113.55 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.63 141.51 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 172.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.64 128.16 36.53 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.0 m -108.11 154.01 22.33 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.139 0.899 . . . . 0.0 110.893 -175.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -147.13 127.41 13.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.321 8.6 p30 69.75 11.97 7.93 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.784 2.034 . . . . 0.0 114.679 177.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.86 55.45 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tp -141.46 142.26 25.78 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -70.75 152.53 64.24 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 CA-C-N 121.946 1.731 . . . . 0.0 111.564 -173.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.555 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -134.72 -25.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.407 -178.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.555 ' CD2' HG23 ' A' ' 113' ' ' VAL . 36.8 m-70 -143.18 178.02 8.0 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -173.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.65 139.9 36.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -173.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.26 121.58 29.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -107.6 10.28 29.18 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -93.18 -20.39 20.52 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -76.0 -36.71 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.797 0 C-N-CA 123.623 0.769 . . . . 0.0 110.933 173.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 . . . . . 0 N--CA 1.427 -1.597 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -170.31 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -90.88 -14.24 32.11 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.017 177.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.44 HH21 ' CE1' ' A' ' 114' ' ' HIS . 29.1 tpt180 -74.1 -45.32 49.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.61 -55.31 35.61 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-O 116.551 -1.69 . . . . 0.0 111.493 168.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -81.78 -1.22 46.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 122.011 2.187 . . . . 0.0 115.659 -170.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -85.61 -30.69 23.09 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.63 -28.98 70.28 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.307 0.643 . . . . 0.0 111.205 164.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.535 HD12 ' HE3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -84.98 -23.47 28.7 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.327 0.967 . . . . 0.0 112.252 177.792 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -72.77 -38.19 67.4 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 120.323 1.42 . . . . 0.0 109.106 174.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' HG3' HD21 ' A' ' 43' ' ' ASN . 2.0 tp-100 -65.37 -58.2 6.46 Favored 'General case' 0 N--CA 1.413 -2.282 0 C-N-CA 124.724 1.209 . . . . 0.0 112.498 172.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -125.62 27.99 6.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -160.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -133.66 136.42 44.74 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 166.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -152.85 108.61 3.31 Favored 'General case' 0 N--CA 1.423 -1.811 1 N-CA-C 100.172 -4.011 . . . . 0.0 100.172 169.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -36.02 5.21 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 118.702 2.852 . . . . 0.0 118.702 -164.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -145.65 154.91 52.75 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 19.7 Cg_endo -70.92 143.08 44.34 Favored 'Trans proline' 0 N--CA 1.431 -2.203 0 C-N-CA 123.423 2.749 . . . . 0.0 107.6 165.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -80.35 -50.83 9.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 168.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.07 179.45 17.34 Favored Glycine 0 CA--C 1.478 -2.233 0 N-CA-C 103.994 -3.643 . . . . 0.0 103.994 163.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -123.36 53.59 1.32 Allowed 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -140.03 -179.08 5.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -170.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.25 -23.1 63.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.841 1.256 . . . . 0.0 113.084 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -86.53 -20.03 28.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 122.962 0.505 . . . . 0.0 110.178 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.55 -41.53 46.25 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -69.15 -35.62 76.55 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 123.797 0.685 . . . . 0.0 112.768 -177.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.7 -39.11 67.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -75.43 -24.3 57.06 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.261 12.7 tt -82.86 -33.04 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.612 0 CA-C-N 118.852 0.751 . . . . 0.0 109.563 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mmt -77.91 -20.84 52.16 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.624 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -72.1 -44.81 62.64 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.239 0.472 . . . . 0.0 111.858 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.69 -39.8 50.89 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.924 0.489 . . . . 0.0 111.964 -173.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -75.78 -29.98 58.95 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 123.316 0.646 . . . . 0.0 110.222 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 52.41 2.49 Favored Glycine 0 CA--C 1.491 -1.43 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 170.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.6 mt -121.85 18.28 11.01 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -91.85 -10.76 38.56 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.4 1.08 . . . . 0.0 108.802 -173.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -129.57 105.22 17.33 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.1 159.36 95.67 Favored 'Cis proline' 0 N--CA 1.444 -1.425 0 N-CA-C 107.133 -1.91 . . . . 0.0 107.133 -19.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.406 ' HB3' HD13 ' A' ' 83' ' ' LEU . 44.4 m -63.05 123.09 17.69 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.968 0.907 . . . . 0.0 109.522 -177.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -71.42 140.78 50.22 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.02 -46.73 50.37 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.965 0.506 . . . . 0.0 111.049 -172.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 132.52 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.479 HD21 ' HG3' ' A' ' 12' ' ' GLN . 7.3 t-20 -151.16 119.15 6.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -96.22 112.84 24.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -177.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -87.6 118.48 27.11 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 171.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.17 152.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -177.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.583 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 7.3 m-70 -136.26 133.18 36.72 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 124.648 1.179 . . . . 0.0 108.195 -171.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.83 -119.66 0.88 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -132.6 138.72 47.5 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HE3' HD12 ' A' ' 10' ' ' LEU . 30.8 mtpt -86.74 -7.14 58.54 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.451 -172.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -80.27 -32.52 38.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -36.93 73.6 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 123.996 0.919 . . . . 0.0 110.543 174.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.41 -53.1 51.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 C-N-CA 124.906 1.282 . . . . 0.0 111.38 174.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.75 -39.24 76.92 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.285 1.034 . . . . 0.0 113.038 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.41 9.4 11.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.602 0.761 . . . . 0.0 112.978 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 72' ' ' SER . 22.3 mm -78.56 -28.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 168.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.02 -21.01 51.41 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -80.51 170.8 15.87 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -88.1 5.89 38.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.834 0.854 . . . . 0.0 110.685 -178.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -75.02 -63.24 1.31 Allowed 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 123.842 0.857 . . . . 0.0 110.169 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -89.0 -50.58 6.09 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -176.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.1 149.21 19.12 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -163.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -102.98 154.57 37.45 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -178.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.03 141.58 33.16 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 123.102 2.535 . . . . 0.0 106.828 175.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -134.99 34.68 3.1 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -169.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 62.21 156.56 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 129.072 2.949 . . . . 0.0 114.05 -176.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 42.89 54.58 4.68 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 129.209 3.004 . . . . 0.0 115.831 176.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.311 2.7 p-10 52.58 34.46 15.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.622 2.769 . . . . 0.0 114.764 -176.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.92 151.54 25.65 Favored 'General case' 0 CA--C 1.478 -1.813 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -140.62 118.26 11.61 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -175.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -85.69 146.15 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 176.32 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.414 ' HB2' HD12 ' A' ' 56' ' ' ILE . 83.6 p -92.69 169.0 10.83 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -131.23 -6.17 3.83 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -106.28 78.86 1.33 Allowed 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.6 t -46.74 127.76 10.03 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 128.324 2.65 . . . . 0.0 113.218 -177.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.73 157.69 18.32 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -170.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 139.58 41.45 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.5 140.98 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -170.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -132.45 110.56 10.61 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 164.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -88.7 101.19 13.75 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.35 114.36 22.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -121.72 129.1 52.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -168.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 39' ' ' CYS . 34.5 tp -72.98 114.9 11.64 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.989 1.316 . . . . 0.0 108.09 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -138.68 95.9 3.05 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 -176.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.12 -41.41 0.05 OUTLIER Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 -177.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.42 41.23 6.58 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -177.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -117.81 106.6 45.64 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -82.76 -21.66 4.83 Favored 'Trans proline' 0 N--CA 1.439 -1.708 0 CA-C-N 121.535 1.584 . . . . 0.0 108.935 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -107.24 161.69 22.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.98 142.52 31.43 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.498 2.132 . . . . 0.0 107.486 -176.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -82.77 161.58 75.36 Favored 'Cis proline' 0 CA--C 1.486 -1.876 0 CA-C-N 123.06 2.128 . . . . 0.0 108.798 4.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.1 m -109.41 159.22 17.2 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -173.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -116.58 90.28 3.3 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.02 117.45 30.69 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -102.53 132.25 48.71 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 131.08 35.28 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -117.39 86.34 2.5 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.02 148.48 21.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.999 -172.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -152.69 -163.37 11.6 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -146.72 98.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 101.033 -3.691 . . . . 0.0 101.033 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -133.16 144.49 49.9 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -162.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.475 HD22 HD12 ' A' ' 71' ' ' ILE . 2.3 p-10 -74.85 124.58 27.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.95 140.66 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.313 -165.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.07 114.91 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 165.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.6 141.84 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -101.52 113.44 26.56 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.6 p -113.99 163.64 14.86 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 122.319 1.057 . . . . 0.0 113.085 -173.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -153.64 136.46 15.34 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.354 7.9 p30 71.72 2.95 4.49 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.716 2.406 . . . . 0.0 116.092 174.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.6 -2.41 34.32 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.41 128.7 25.8 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -73.58 119.65 6.05 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.682 -2.084 . . . . 0.0 106.682 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.665 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -105.62 -17.01 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 123.952 0.783 . . . . 0.0 110.021 -167.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.665 ' CD2' HG23 ' A' ' 113' ' ' VAL . 70.5 m-70 -153.34 177.17 11.17 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.29 142.03 35.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -174.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.74 126.68 37.94 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 167.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -108.88 10.9 26.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -173.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -87.72 -25.68 23.32 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.17 0.51 . . . . 0.0 109.789 -166.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -21.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 C-N-CA 124.161 0.984 . . . . 0.0 109.889 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -169.388 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 m -94.02 0.46 56.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.801 1.24 . . . . 0.0 109.934 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.467 ' HE ' ' CE1' ' A' ' 114' ' ' HIS . 30.7 tpt180 -75.86 -39.52 56.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -46.63 69.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 124.15 0.98 . . . . 0.0 109.868 176.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.408 0.2 OUTLIER -83.89 -2.23 56.05 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -179.085 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -83.88 -30.09 26.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.538 1.063 . . . . 0.0 109.291 165.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD2' HD23 ' A' ' 10' ' ' LEU . 2.3 t80 -61.45 -35.37 77.42 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.153 0.981 . . . . 0.0 109.034 164.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.45 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -83.43 -18.68 37.87 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.079 177.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -69.07 -52.26 30.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-N 119.79 1.177 . . . . 0.0 108.481 176.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 15.7 tt0 -77.28 -38.02 51.66 Favored 'General case' 0 N--CA 1.404 -2.742 0 C-N-CA 124.286 1.034 . . . . 0.0 110.437 -173.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 70.0 m-70 -98.31 -54.96 2.9 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.48 -175.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -77.63 119.98 21.94 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 119.98 1.264 . . . . 0.0 108.738 -167.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -137.14 98.37 3.72 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 100.682 -3.821 . . . . 0.0 100.682 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.64 -42.55 0.8 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -165.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -144.11 151.94 53.35 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 165.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 11.9 Cg_endo -71.81 155.43 58.2 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 123.859 3.039 . . . . 0.0 109.916 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -78.64 -53.45 7.16 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 170.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.74 -179.88 17.76 Favored Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 166.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -121.4 61.72 0.92 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -178.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.3 -179.42 7.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.57 -10.47 59.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -78.36 -33.23 49.14 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -75.63 -39.16 58.23 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.02 -42.95 79.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.3 -31.85 62.65 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 122.799 0.44 . . . . 0.0 110.597 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -67.46 -38.72 84.89 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.478 176.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 14.6 tt -80.31 -25.34 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 CA-C-N 118.042 0.383 . . . . 0.0 111.385 -176.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -29.89 61.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.774 -1.57 . . . . 0.0 111.536 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -75.66 -29.91 59.25 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.199 0.454 . . . . 0.0 112.22 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -78.97 -44.83 21.6 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.77 0.828 . . . . 0.0 110.746 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -81.05 -26.21 36.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.639 0.376 . . . . 0.0 110.438 -172.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.37 49.04 3.34 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 171.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.61 14.86 15.52 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 t -86.49 -13.31 46.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.08 0.952 . . . . 0.0 108.727 -176.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 m -122.38 103.63 38.3 Favored Pre-proline 0 N--CA 1.424 -1.73 0 CA-C-O 117.867 -1.064 . . . . 0.0 108.495 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.34 161.05 95.31 Favored 'Cis proline' 0 N--CA 1.441 -1.6 0 N-CA-C 106.888 -2.005 . . . . 0.0 106.888 -23.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -60.39 124.49 20.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.813 1.245 . . . . 0.0 111.118 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -73.02 135.48 44.92 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -75.0 -39.64 61.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.312 -170.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.6 tt -148.69 133.91 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -151.53 121.34 7.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.5 112.1 24.24 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.27 116.26 23.51 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.55 151.37 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.605 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.9 m-70 -144.15 140.68 29.52 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.61 1.62 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 107.115 -2.394 . . . . 0.0 107.115 175.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -119.79 137.0 54.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -85.58 -20.67 29.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 120.959 0.409 . . . . 0.0 110.636 -166.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -79.82 -22.47 42.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.5 m -76.09 -34.36 59.53 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.967 171.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.18 -51.23 73.52 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 119.829 1.195 . . . . 0.0 110.073 171.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.93 -40.42 93.18 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.673 0.789 . . . . 0.0 111.16 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.72 21.06 1.96 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.94 -28.7 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 t -78.15 -41.5 34.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.895 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -79.22 149.87 31.78 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 170.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -78.77 104.22 9.24 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -160.14 -57.74 0.06 Allowed 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -177.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -136.88 22.31 3.07 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.67 -178.82 21.47 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 105.288 -3.125 . . . . 0.0 105.288 166.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -137.2 161.28 61.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -171.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -74.49 147.3 36.11 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.884 2.389 . . . . 0.0 107.323 162.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -139.44 101.48 4.24 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 65.54 -102.26 0.08 Allowed 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 111.144 -177.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.24 102.38 3.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -174.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 2.8 p-10 65.34 22.26 12.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 129.896 3.278 . . . . 0.0 114.625 173.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.13 158.35 17.49 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 100.63 -3.841 . . . . 0.0 100.63 163.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -141.9 111.46 6.58 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -171.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 tt -94.25 140.37 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -87.68 167.47 13.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 121.387 0.613 . . . . 0.0 110.329 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 -1.49 4.37 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -113.43 86.6 2.42 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 173.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.0 m -53.44 137.95 34.61 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.058 2.143 . . . . 0.0 113.16 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -111.16 155.64 22.59 Favored 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.42 141.69 43.16 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 175.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.53 145.96 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -168.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -130.99 107.16 8.89 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 167.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -85.51 100.35 11.85 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.8 m -84.16 113.95 21.44 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -121.03 129.95 53.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 -176.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 tp -69.01 116.76 9.83 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.825 1.25 . . . . 0.0 109.257 -174.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -135.87 99.0 4.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -175.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.69 -42.12 0.18 Allowed Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 -178.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.38 43.59 7.35 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 t -112.72 108.82 53.54 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -86.1 -17.67 3.75 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 CA-C-N 122.193 1.819 . . . . 0.0 109.064 -176.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.75 160.65 28.85 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-O 117.43 -1.271 . . . . 0.0 107.954 -168.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.66 145.9 33.48 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.674 2.25 . . . . 0.0 108.425 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -81.17 164.31 77.62 Favored 'Cis proline' 0 N--CA 1.437 -1.841 0 CA-C-N 122.299 1.857 . . . . 0.0 108.176 -4.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.8 m -107.46 156.13 19.3 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.458 -170.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -110.54 118.39 36.11 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.71 148.3 41.2 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.69 119.87 40.13 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 166.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.26 115.84 26.04 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -110.69 87.97 2.66 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.64 143.57 26.7 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.265 0.555 . . . . 0.0 110.769 -171.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -149.41 -163.72 11.19 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 178.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -146.67 101.21 3.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -138.22 147.63 43.95 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -164.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -74.22 128.7 36.22 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.504 1.121 . . . . 0.0 108.515 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.16 137.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.16 -167.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.53 110.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 165.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.23 152.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.0 136.12 33.24 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 168.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.9 t -126.52 138.64 53.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 123.527 0.517 . . . . 0.0 109.701 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.74 133.56 44.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 170.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.301 14.2 p30 63.22 23.79 14.02 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 117.068 2.248 . . . . 0.0 117.068 171.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.52 19.15 57.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.45 116.12 5.43 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -170.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -72.02 111.49 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 CA-C-N 122.091 1.782 . . . . 0.0 111.39 -170.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.516 HG23 ' CD2' ' A' ' 114' ' ' HIS . 1.0 OUTLIER -89.9 -24.32 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.376 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 113' ' ' VAL . 28.5 m-70 -151.88 -168.65 3.13 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.66 149.56 40.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -175.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.22 127.76 43.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 171.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -110.78 13.77 22.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -86.01 -32.34 21.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -172.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -23.34 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 C-N-CA 125.513 1.525 . . . . 0.0 111.817 177.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 106.49 -1.671 . . . . 0.0 106.49 -167.403 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -92.37 -29.93 16.06 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.413 ' HE ' ' HE1' ' A' ' 114' ' ' HIS . 29.1 mmm180 -70.47 -40.77 73.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.312 0.645 . . . . 0.0 109.427 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 111' ' ' LEU . 61.4 t80 -46.56 -65.66 0.52 Allowed 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 126.602 1.961 . . . . 0.0 111.168 166.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.715 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.297 5.4 p -70.43 -11.84 61.18 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -83.71 -36.61 23.56 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.126 0.876 . . . . 0.0 109.521 173.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.24 -35.53 81.11 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.701 1.6 . . . . 0.0 110.515 170.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.715 ' HB2' ' HA ' ' A' ' 7' ' ' THR 0.271 0.2 OUTLIER -67.06 -38.04 85.1 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 128.709 2.803 . . . . 0.0 112.452 174.667 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -66.64 -51.87 51.35 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.86 -29.09 50.23 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 124.114 0.966 . . . . 0.0 112.439 -170.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -105.78 -58.25 1.93 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.001 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -72.6 111.93 8.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.73 0.776 . . . . 0.0 110.689 -163.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -134.96 98.28 3.97 Favored 'General case' 0 N--CA 1.421 -1.878 1 N-CA-C 98.553 -4.61 . . . . 0.0 98.553 176.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -33.65 3.8 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -163.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.91 154.18 46.8 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.9 Cg_endo -69.53 145.08 57.39 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 123.642 2.895 . . . . 0.0 109.164 171.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -86.04 -46.85 10.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 169.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.24 -177.21 14.82 Favored Glycine 0 CA--C 1.48 -2.133 0 N-CA-C 103.364 -3.894 . . . . 0.0 103.364 164.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -133.98 35.22 3.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -121.45 -179.22 4.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -35.88 79.77 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 125.973 1.709 . . . . 0.0 112.812 -171.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -81.82 -22.17 37.21 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.084 0.554 . . . . 0.0 110.033 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.85 -42.22 61.12 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -83.54 -19.97 34.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.729 -0.789 . . . . 0.0 113.045 -170.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.02 -39.42 66.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.3 t -67.15 -38.28 85.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.282 15.2 tt -86.74 -25.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 CA-C-N 118.358 0.527 . . . . 0.0 112.024 -175.464 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 mmt -77.49 -25.64 50.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.707 173.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -72.16 -38.3 69.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.131 0.572 . . . . 0.0 111.821 173.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -79.99 -40.1 28.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 122.607 0.363 . . . . 0.0 110.698 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -23.08 40.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.036 0.534 . . . . 0.0 110.571 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.8 47.57 4.18 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.36 6.76 12.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 t -94.61 -0.6 54.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 m -122.09 102.14 40.85 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 117.768 -1.11 . . . . 0.0 108.668 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.74 158.06 98.84 Favored 'Cis proline' 0 N--CA 1.441 -1.58 0 N-CA-C 106.842 -2.022 . . . . 0.0 106.842 -23.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.0 m -63.21 118.97 8.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 124.707 1.203 . . . . 0.0 111.914 -170.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.39 134.11 45.25 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -72.68 -36.35 67.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 124.567 1.167 . . . . 0.0 112.89 -166.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -154.77 123.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -153.3 151.63 30.22 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.515 177.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.8 m -112.21 136.61 51.42 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.503 -168.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -99.33 116.74 32.19 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 162.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.2 mt -89.89 150.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.483 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 -178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.581 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.6 m-70 -139.95 139.77 36.2 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 125.143 1.377 . . . . 0.0 108.863 -175.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.07 5.79 Favored Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 105.734 -2.946 . . . . 0.0 105.734 173.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -102.68 147.93 26.21 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 170.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -85.45 -16.28 40.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.99 -33.17 59.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.693 1.597 . . . . 0.0 107.071 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.9 m -75.73 -34.56 60.33 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.005 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 mm -54.95 -55.37 16.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 CA-C-N 119.349 0.977 . . . . 0.0 110.155 172.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.39 -35.01 77.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 123.875 0.87 . . . . 0.0 113.23 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.48 -0.25 19.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' ARG . 13.6 mm -73.66 -27.51 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.74 9.01 38.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.125 0.488 . . . . 0.0 111.599 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -88.56 162.09 16.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 160.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.511 HD22 HH12 ' A' ' 70' ' ' ARG . 9.6 t-20 -88.18 -9.8 51.93 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -68.4 -50.48 52.6 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.252 1.421 . . . . 0.0 110.178 178.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -123.76 37.5 4.4 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -168.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.5 152.67 10.9 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 171.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -105.77 156.44 36.57 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -176.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -74.75 140.44 26.21 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 123.003 2.469 . . . . 0.0 106.821 172.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -136.67 133.7 36.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -176.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 62.11 -103.26 0.13 Allowed 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.899 1.68 . . . . 0.0 112.219 169.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.79 103.8 2.64 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.362 2.5 p-10 62.0 30.78 18.06 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 129.139 2.975 . . . . 0.0 113.883 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.2 mt -115.13 170.19 8.55 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 171.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.511 HH12 HD22 ' A' ' 59' ' ' ASN . 21.9 mmt180 -147.17 116.4 6.95 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -174.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -93.87 136.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.5 p -83.56 160.91 21.35 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.45 -25.53 11.83 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.698 174.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -104.87 89.17 3.08 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 p -49.62 129.71 19.74 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 127.229 2.212 . . . . 0.0 111.916 171.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -105.19 156.44 18.11 Favored 'General case' 0 CA--C 1.478 -1.815 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -170.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.434 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.4 mt-30 -78.9 148.16 32.83 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 174.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.76 146.97 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -166.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.5 m -134.38 99.68 4.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 167.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -89.64 104.24 16.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -177.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.73 122.41 36.17 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -106.87 132.83 52.38 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.63 117.12 18.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.476 1.51 . . . . 0.0 109.007 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -112.1 152.41 28.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.34 -97.97 0.22 Allowed Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 106.014 -2.835 . . . . 0.0 106.014 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.03 1.5 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 -178.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.5 t -84.68 130.01 54.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -83.19 -20.9 4.83 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.989 1.793 . . . . 0.0 108.279 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -96.47 159.9 30.81 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -76.18 148.12 30.47 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.309 2.006 . . . . 0.0 107.221 -176.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -85.54 165.09 56.38 Favored 'Cis proline' 0 N--CA 1.438 -1.74 0 CA-C-N 123.035 2.12 . . . . 0.0 108.133 13.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.1 m -154.87 130.3 9.78 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -165.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.79 103.01 15.4 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -85.83 120.81 27.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -92.47 112.57 24.57 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.45 130.65 35.29 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.028 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -118.72 108.61 15.1 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.268 -2.494 . . . . 0.0 104.268 175.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.68 129.31 35.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.74 169.5 23.17 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 106.002 -2.839 . . . . 0.0 106.002 178.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 85.0 t80 -149.22 105.86 3.55 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -152.44 158.69 42.98 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 121.884 0.85 . . . . 0.0 110.32 -168.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.0 129.55 34.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.319 175.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.8 148.17 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.737 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.5 t -106.5 92.45 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -93.3 139.16 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.16 126.29 31.88 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 46.9 t -108.48 135.99 48.84 Favored 'General case' 0 CA--C 1.49 -1.34 0 O-C-N 123.875 0.734 . . . . 0.0 110.497 -175.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.22 137.5 39.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.299 16.5 p30 60.15 26.45 15.85 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 127.05 2.14 . . . . 0.0 116.101 175.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.56 22.76 59.58 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 177.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -149.91 135.07 9.72 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.038 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 98.0 Cg_exo -77.72 111.58 3.15 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 CA-C-N 122.354 1.876 . . . . 0.0 110.972 -177.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.549 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -86.78 -26.84 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 123.838 0.711 . . . . 0.0 111.693 -174.664 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.549 ' CD2' HG23 ' A' ' 113' ' ' VAL . 53.0 m-70 -146.52 -171.72 3.8 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -171.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 132.01 4.11 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 177.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -74.41 135.81 42.38 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.322 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -96.8 36.89 1.34 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.9 p -95.66 -19.71 19.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -92.64 -23.23 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 178.641 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 CA--C 1.478 -1.79 0 C-N-CA 125.332 1.453 . . . . 0.0 108.448 -178.503 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -93.39 -9.04 40.09 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -20.92 58.23 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.704 1.602 . . . . 0.0 109.678 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.79 -41.25 62.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 C-N-CA 125.188 1.395 . . . . 0.0 108.039 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -79.36 -12.81 59.91 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 177.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.4 m170 -73.67 -47.32 40.62 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.74 -46.35 74.27 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 126.401 1.88 . . . . 0.0 110.221 173.114 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.1 OUTLIER -93.25 -4.54 51.69 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.759 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -78.65 -43.81 25.28 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 120.655 1.57 . . . . 0.0 107.782 166.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.81 -46.27 79.26 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -97.16 -48.55 5.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.882 -172.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 45.8 t80 -78.68 117.15 19.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 119.963 1.256 . . . . 0.0 110.397 -168.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -134.61 96.4 3.56 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 174.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.37 -43.66 3.64 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 128.278 2.631 . . . . 0.0 117.724 -166.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -155.25 144.25 14.98 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 67.5 Cg_exo -74.74 174.79 12.07 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.863 1.708 . . . . 0.0 113.736 -177.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -70.73 -67.84 0.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 168.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.61 -175.16 13.69 Favored Glycine 0 CA--C 1.475 -2.451 1 N-CA-C 101.618 -4.593 . . . . 0.0 101.618 163.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -115.87 73.64 0.85 Allowed 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.34 176.7 9.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.38 -21.59 61.99 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.476 1.111 . . . . 0.0 112.884 -171.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -75.8 -30.27 58.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.238 177.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.95 -40.62 53.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 m -69.65 -35.32 75.07 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.17 -36.8 69.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 123.375 0.422 . . . . 0.0 110.308 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -69.45 -35.65 75.87 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 122.909 0.484 . . . . 0.0 112.214 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.426 HG13 HH21 ' A' ' 33' ' ' ARG 0.25 12.7 tt -84.15 -27.95 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-N 117.707 0.23 . . . . 0.0 111.227 -174.954 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.07 -25.17 47.53 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.483 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 91' ' ' PRO . 16.6 tpp180 -68.68 -43.6 75.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.214 0.606 . . . . 0.0 110.995 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -75.84 -44.77 39.29 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 123.646 0.778 . . . . 0.0 112.352 -172.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.426 HH21 HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -77.11 -18.1 58.19 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.0 44.75 4.68 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 168.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.4 mt -117.65 15.81 14.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 176.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -94.06 -11.41 30.73 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.6 m -125.53 101.03 31.04 Favored Pre-proline 0 N--CA 1.426 -1.659 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.548 -174.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.06 165.14 85.9 Favored 'Cis proline' 0 N--CA 1.445 -1.373 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 -21.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -60.28 120.58 10.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 124.063 0.945 . . . . 0.0 110.173 -175.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -74.63 136.67 41.96 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 177.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.68 -45.63 61.33 Favored 'General case' 0 N--CA 1.433 -1.287 0 O-C-N 123.956 0.785 . . . . 0.0 110.45 -171.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.46 126.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -148.51 127.88 13.06 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.482 HG23 HG13 ' A' ' 78' ' ' VAL . 17.2 m -94.23 122.18 36.5 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.734 -178.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -90.52 121.33 32.37 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.7 148.82 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.9 m-70 -136.57 137.37 40.13 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 124.834 1.253 . . . . 0.0 107.95 -175.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.79 -126.94 1.62 Allowed Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 175.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -118.28 141.65 48.31 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 171.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.51 -3.07 58.96 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -76.49 -31.65 57.85 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 168.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -80.5 -32.26 37.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 118.115 -0.945 . . . . 0.0 109.982 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.52 -52.62 54.86 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.204 1.001 . . . . 0.0 110.467 171.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -53.84 -44.09 70.02 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.42 1.488 . . . . 0.0 112.05 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.02 16.02 0.61 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.25 -40.54 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 165.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 36.3 t -88.72 -30.26 19.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.454 -156.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -95.74 51.26 1.26 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -170.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 m120 49.26 50.88 17.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 129.516 3.127 . . . . 0.0 113.329 174.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -148.84 163.67 36.73 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 97.594 -4.965 . . . . 0.0 97.594 172.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.259 8.1 p-10 14.52 56.54 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 131.043 3.737 . . . . 0.0 117.799 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.91 137.24 2.29 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 106.001 -2.839 . . . . 0.0 106.001 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -106.13 157.45 34.82 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -72.06 135.55 25.41 Favored 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 123.095 2.53 . . . . 0.0 107.225 170.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -131.23 107.37 8.94 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -175.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 63.42 -108.61 0.24 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 112.989 174.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -127.39 87.01 2.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -166.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.343 1.8 p-10 64.01 27.62 14.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 128.913 2.885 . . . . 0.0 113.947 173.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 mt -110.4 163.84 13.28 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 173.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -146.78 120.58 9.26 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.08 143.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -177.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.7 p -84.43 159.92 20.69 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -174.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -122.62 -3.18 8.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 t -119.02 88.15 2.87 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 173.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.3 p -61.56 141.36 57.79 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.561 1.544 . . . . 0.0 111.862 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -114.04 161.68 17.41 Favored 'General case' 0 CA--C 1.474 -1.967 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -168.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 7.7 mt-30 -77.91 144.63 36.72 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -141.73 143.38 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.7 m -131.35 107.61 9.06 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 167.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -83.14 101.03 10.92 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.6 114.97 24.7 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -121.06 132.47 54.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -170.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.9 tp -69.28 114.24 7.35 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 125.105 1.362 . . . . 0.0 108.527 -177.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -126.76 57.26 1.45 Allowed 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -118.31 -84.2 0.95 Allowed Glycine 0 CA--C 1.482 -2.021 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.21 -15.09 4.25 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 178.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -86.91 132.34 42.28 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -81.02 -21.71 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.755 1.636 . . . . 0.0 108.93 176.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -102.24 165.05 14.55 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.13 142.12 33.71 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.222 1.948 . . . . 0.0 107.159 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.8 Cg_endo -87.63 164.39 45.6 Favored 'Cis proline' 0 N--CA 1.435 -1.923 0 CA-C-N 122.655 1.984 . . . . 0.0 108.397 12.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 37.7 m -128.07 131.95 49.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -170.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -98.15 123.04 42.0 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.59 122.42 44.57 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -93.06 127.27 38.53 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.99 133.12 35.27 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.6 m -120.04 97.24 5.51 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 171.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.6 139.01 38.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.03 -171.16 18.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 92.3 t80 -155.78 100.05 2.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 101.28 -3.6 . . . . 0.0 101.28 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -139.44 148.73 43.14 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -161.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -80.73 132.5 35.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.862 1.265 . . . . 0.0 108.442 175.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.18 142.36 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.612 -164.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.74 95.68 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.1 m -94.71 136.7 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.31 126.53 37.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 31.7 p -129.2 167.5 17.55 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -172.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.38 132.81 18.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.364 6.4 p30 75.94 -12.0 1.06 Allowed 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 170.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.02 9.08 9.09 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -141.99 127.9 10.84 Favored Pre-proline 0 N--CA 1.435 -1.196 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 8.8 Cg_exo -67.35 163.8 33.14 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.566 1.511 . . . . 0.0 114.029 -178.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -132.3 -19.67 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.507 ' CD2' HG23 ' A' ' 113' ' ' VAL . 74.9 m-70 -158.68 -175.3 5.23 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -169.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 136.8 3.78 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 -179.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.94 134.64 37.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.966 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -100.07 40.19 1.27 Allowed 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.7 m -97.1 -31.57 12.41 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -75.3 -33.98 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.61 169.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -172.196 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 111.331 0.123 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -89.95 -17.12 28.52 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -69.97 -30.27 67.58 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.303 1.441 . . . . 0.0 110.624 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CE1' HD22 ' A' ' 111' ' ' LEU . 52.2 t80 -68.49 -48.3 64.79 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -76.12 -10.01 59.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -80.74 -43.68 19.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 119.352 0.978 . . . . 0.0 108.468 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -57.89 -38.23 75.43 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.791 1.637 . . . . 0.0 110.195 170.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.48 HD13 ' CE2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -78.8 -29.62 45.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.546 1.538 . . . . 0.0 113.493 -179.149 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -80.06 -32.59 39.33 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 119.773 1.17 . . . . 0.0 109.38 -174.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.36 -45.01 15.43 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 118.511 -0.757 . . . . 0.0 109.726 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -95.12 -46.82 6.63 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 119.429 1.013 . . . . 0.0 112.442 -172.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 9.3 t80 -70.65 118.32 13.3 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 119.766 1.166 . . . . 0.0 110.925 -174.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -139.8 99.04 3.6 Favored 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 172.153 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 -39.26 9.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -164.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -142.84 148.65 46.77 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.0 Cg_endo -72.7 153.42 54.02 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 123.515 2.81 . . . . 0.0 109.291 170.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -77.8 -57.65 3.69 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.95 179.35 17.23 Favored Glycine 0 CA--C 1.477 -2.3 0 N-CA-C 103.726 -3.749 . . . . 0.0 103.726 165.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -122.9 61.27 1.01 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -141.54 176.84 8.56 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -171.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.94 -24.46 62.44 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 124.879 1.272 . . . . 0.0 112.245 -169.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -85.4 -20.14 30.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 122.966 0.506 . . . . 0.0 110.097 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -79.18 -35.89 41.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.0 -33.92 51.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -171.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.18 -48.12 74.57 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 125.841 1.657 . . . . 0.0 109.687 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 m -74.97 -22.97 58.23 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 118.112 -0.946 . . . . 0.0 113.496 -175.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 14.0 tt -87.09 -24.96 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 119.241 0.928 . . . . 0.0 110.65 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.68 -29.22 62.17 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.265 -1.374 . . . . 0.0 110.259 171.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -80.19 -32.43 38.67 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -83.72 -33.12 25.18 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 118.655 0.661 . . . . 0.0 111.07 -175.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -80.45 -19.25 46.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.5 47.57 3.46 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.6 mt -122.77 14.14 10.03 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -90.63 -9.73 45.88 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -175.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m -122.54 101.37 40.34 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.788 -174.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.57 166.37 83.07 Favored 'Cis proline' 0 N--CA 1.444 -1.429 0 CA-C-N 122.83 2.047 . . . . 0.0 107.217 -21.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.68 122.09 13.27 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 124.361 1.064 . . . . 0.0 110.987 -173.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -75.07 133.64 41.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -70.22 -40.47 74.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.336 1.022 . . . . 0.0 112.01 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.37 130.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 176.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -145.43 128.74 16.81 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -96.66 112.32 24.11 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.11 111.05 20.54 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 174.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.1 150.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.606 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-70 -142.88 135.73 27.95 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 125.172 1.389 . . . . 0.0 107.941 -174.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.91 -136.52 4.61 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 173.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -96.56 145.64 25.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.99 -21.94 25.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -79.6 -24.77 41.76 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -76.02 -35.52 59.48 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.716 172.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.444 HD12 ' CE2' ' A' ' 76' ' ' PHE . 1.1 mp -52.88 -51.47 36.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.459 0 C-N-CA 124.921 1.289 . . . . 0.0 110.221 170.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.68 -39.74 94.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.143 0.977 . . . . 0.0 111.105 -176.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.98 10.58 4.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 72' ' ' SER . 16.3 mm -80.06 -24.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.5 m -78.65 -23.55 45.7 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.019 177.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.5 143.89 44.37 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 167.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -98.56 25.42 6.43 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.222 -178.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -90.55 -47.66 7.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -113.71 51.2 0.87 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -176.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.5 172.65 39.13 Favored Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 103.266 -3.934 . . . . 0.0 103.266 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -126.56 152.93 75.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.02 132.78 14.43 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 106.077 -2.316 . . . . 0.0 106.077 172.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -99.58 156.17 17.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 174.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -36.42 -69.88 0.1 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 129.578 3.151 . . . . 0.0 116.394 -173.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -104.24 75.36 1.25 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -171.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 65.54 15.12 9.88 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.483 3.113 . . . . 0.0 116.353 165.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.98 173.23 6.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 -169.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -139.18 107.28 5.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 tt -86.47 143.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 177.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' HD12 ' A' ' 56' ' ' ILE . 93.7 p -89.47 168.06 12.49 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.441 0.639 . . . . 0.0 111.286 -172.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -124.05 -14.99 6.96 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 t -115.27 93.69 4.4 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -51.06 133.99 26.96 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 127.24 2.216 . . . . 0.0 112.633 174.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CE2' HD12 ' A' ' 53' ' ' ILE . 88.0 m-85 -110.14 157.75 19.05 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -172.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.72 135.16 35.95 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 174.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.21 142.7 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 -173.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.2 m -130.49 102.98 6.39 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -89.16 112.67 23.72 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.8 m -91.05 118.04 30.08 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -115.04 140.07 49.35 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.47 131.88 34.71 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -169.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.58 -179.56 5.76 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.31 -86.83 0.48 Allowed Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 -178.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.74 -7.41 0.68 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -78.92 128.12 77.61 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.073 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.57 -27.69 2.07 Favored 'Trans proline' 0 N--CA 1.436 -1.896 0 N-CA-C 107.862 -1.63 . . . . 0.0 107.862 173.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -98.01 162.87 20.69 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -169.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.78 144.34 34.87 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 122.366 2.044 . . . . 0.0 107.53 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -82.57 163.25 74.7 Favored 'Cis proline' 0 N--CA 1.438 -1.739 0 CA-C-N 123.222 2.187 . . . . 0.0 109.845 8.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.3 138.28 54.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.81 -168.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -101.96 107.15 18.21 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -103.04 123.24 46.26 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -88.18 122.4 31.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.87 132.55 34.62 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.18 104.53 7.36 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.3 135.74 34.23 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.08 146.36 16.83 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -99.15 103.87 15.8 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -143.05 155.72 44.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -167.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -78.94 130.81 35.99 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.76 142.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.465 -168.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.9 t -100.39 120.46 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -113.69 160.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.23 132.44 54.17 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 171.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 99.1 m -107.93 150.89 26.52 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -169.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -150.24 122.17 8.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.2 p30 67.13 10.23 7.54 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.475 2.31 . . . . 0.0 116.282 173.234 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.48 -3.15 39.73 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' CE1' ' A' ' 6' ' ' TYR . 16.7 mt -117.1 135.17 23.01 Favored Pre-proline 0 CA--C 1.484 -1.592 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 15.5 Cg_exo -77.44 127.85 9.23 Favored 'Trans proline' 0 N--CA 1.421 -2.778 0 CA-C-N 122.413 1.898 . . . . 0.0 107.169 175.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.641 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -95.3 -17.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 124.16 0.913 . . . . 0.0 109.468 -175.122 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.641 ' CD2' HG23 ' A' ' 113' ' ' VAL . 84.2 m-70 -149.54 -177.69 6.01 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -169.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.92 135.83 23.51 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -173.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.39 127.06 37.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.05 22.07 16.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.119 0.568 . . . . 0.0 110.192 -170.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -86.64 -28.81 22.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -170.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -82.82 -25.18 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.783 0 C-N-CA 124.739 1.216 . . . . 0.0 110.146 178.558 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 . . . . . 0 N--CA 1.43 -1.426 0 O-C-N 123.234 0.334 . . . . 0.0 110.391 -165.948 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -91.13 0.78 57.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -75.41 -42.8 52.75 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.2 -48.18 82.73 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.801 172.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.521 0.8 OUTLIER -90.37 8.68 32.31 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 119.903 1.229 . . . . 0.0 114.21 -179.497 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -77.52 -40.0 44.21 Favored 'General case' 0 CA--C 1.494 -1.203 0 O-C-N 120.451 -1.406 . . . . 0.0 107.881 155.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.95 -28.8 70.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.303 1.041 . . . . 0.0 111.208 171.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.92 -10.57 36.04 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -68.48 -42.2 79.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 166.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 93.0 mm-40 -66.92 -68.28 0.39 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.728 171.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 88.8 m-70 -107.83 6.93 27.9 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -153.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.415 ' CD2' ' HE2' ' A' ' 50' ' ' LYS . 27.0 t80 -100.84 137.12 39.64 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-N 120.36 1.436 . . . . 0.0 107.635 165.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -151.49 104.25 3.05 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 162.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.94 -51.05 13.95 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -148.66 140.66 14.59 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 76.2 Cg_exo -75.06 177.16 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.5 2.134 . . . . 0.0 113.532 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.45 -67.24 0.74 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.1 -175.19 13.91 Favored Glycine 0 CA--C 1.479 -2.214 1 N-CA-C 103.092 -4.003 . . . . 0.0 103.092 166.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.6 mtm105 -121.88 71.21 0.98 Allowed 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -144.22 -178.45 5.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.338 -171.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.89 -32.71 74.55 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 125.744 1.617 . . . . 0.0 112.733 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 -16.47 38.53 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -177.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.25 -41.67 48.34 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 m -70.14 -32.7 70.82 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.37 -46.3 67.28 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -74.34 -26.17 59.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.26 16.9 tt -82.59 -33.17 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-N 118.589 0.632 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 93.5 mtp -84.89 -10.09 57.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.335 179.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -81.33 -40.61 23.32 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 122.005 -0.434 . . . . 0.0 110.41 169.121 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.57 -37.53 24.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 119.091 -0.481 . . . . 0.0 112.124 -172.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.4 -30.67 67.63 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 118.431 0.56 . . . . 0.0 110.005 170.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.25 48.08 3.89 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 169.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.3 mt -110.4 8.53 23.28 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -97.63 2.09 49.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.8 t -132.27 104.93 13.51 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.68 156.68 97.2 Favored 'Cis proline' 0 N--CA 1.444 -1.427 0 N-CA-C 106.68 -2.085 . . . . 0.0 106.68 -21.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.75 114.37 6.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 123.967 0.792 . . . . 0.0 111.895 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -75.64 132.23 40.47 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 173.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -83.02 -15.31 51.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -166.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 133.64 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.23 119.81 7.46 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 m -95.03 108.46 20.53 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.66 126.03 34.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mt -107.91 144.74 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -173.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.8 m-70 -131.72 127.11 36.16 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.062 -168.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.3 -130.68 2.14 Favored Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 145.99 39.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HE2' ' CD2' ' A' ' 14' ' ' TYR . 33.1 mttt -84.82 -14.55 47.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 119.29 -0.385 . . . . 0.0 110.594 -179.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.65 49.09 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.3 m -73.94 -42.27 60.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 117.595 -1.193 . . . . 0.0 109.14 175.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 mm -54.43 -54.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 C-N-CA 124.593 1.157 . . . . 0.0 111.953 176.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -58.17 -46.8 85.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 125.202 1.401 . . . . 0.0 111.509 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.55 12.94 1.78 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.443 HD12 ' CB ' ' A' ' 72' ' ' SER . 15.1 mm -75.55 -30.61 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 168.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.5 m -80.24 -21.19 43.07 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -82.95 163.51 21.01 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.35 -17.3 39.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.593 -175.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -87.99 128.49 35.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 165.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.6 t30 84.95 -8.44 0.89 Allowed 'General case' 0 C--N 1.356 0.865 0 C-N-CA 128.935 2.894 . . . . 0.0 113.441 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.8 -174.11 22.19 Favored Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 172.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -157.32 157.45 30.28 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.44 157.6 25.56 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.255 1.97 . . . . 0.0 108.244 -176.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.662 ' HE1' HG11 ' A' ' 104' ' ' VAL . 13.8 p-80 -128.57 42.55 3.3 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 167.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.488 0.0 OUTLIER 53.82 152.27 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.285 1 C-N-CA 132.69 4.396 . . . . 0.0 119.334 -177.396 . . . . . . . . 4 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.57 50.15 3.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 110.842 -2.89 . . . . 0.0 111.917 171.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 83.89 1.45 0.96 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.045 2.938 . . . . 0.0 115.655 177.086 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 2.8 mm? -105.96 149.65 26.43 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -173.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -141.01 123.62 16.01 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -172.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tt -97.12 146.53 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.443 ' CB ' HD12 ' A' ' 56' ' ' ILE . 85.1 p -85.95 173.31 10.03 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-O 121.457 0.646 . . . . 0.0 111.395 -175.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.97 4.81 3.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.4 t -113.66 86.21 2.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -49.76 123.65 8.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.885 2.474 . . . . 0.0 113.347 -179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.49 156.29 20.29 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -83.37 143.53 30.27 Favored 'General case' 0 CA--C 1.466 -2.275 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.07 141.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -168.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -129.16 107.85 9.89 Favored 'General case' 0 CA--C 1.478 -1.811 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 166.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -84.01 100.66 11.21 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.4 m -84.19 106.42 15.81 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -118.8 142.23 47.9 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 -171.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -83.99 121.48 27.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.854 0.835 . . . . 0.0 109.014 -171.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.02 55.96 1.87 Allowed 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.42 -63.94 0.26 Allowed Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 105.125 -3.19 . . . . 0.0 105.125 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.08 27.32 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 173.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -89.99 138.87 27.41 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -83.0 -20.84 5.02 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.671 1.581 . . . . 0.0 109.242 172.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -108.03 156.86 37.53 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-O 117.615 -1.183 . . . . 0.0 108.84 -165.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -75.14 148.59 34.96 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.654 2.236 . . . . 0.0 108.719 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -81.62 166.56 72.31 Favored 'Cis proline' 0 N--CA 1.438 -1.751 0 CA-C-N 122.324 1.866 . . . . 0.0 108.654 -1.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.2 m -138.94 126.22 21.49 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -173.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -90.02 98.37 11.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -176.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -85.14 133.81 34.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -100.66 131.44 46.56 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 174.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.45 35.71 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.838 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -120.86 90.49 3.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 172.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.88 148.95 22.86 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.494 -171.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.05 -172.5 18.11 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 107.473 -2.251 . . . . 0.0 107.473 178.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -149.89 100.28 2.93 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -148.05 172.25 14.55 Favored 'General case' 0 CA--C 1.482 -1.64 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.418 -173.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -85.07 117.28 23.94 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -90.56 139.22 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.662 HG11 ' HE1' ' A' ' 65' ' ' HIS . 59.9 t -94.82 123.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.26 150.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 170.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.53 127.78 40.7 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 175.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.07 155.7 23.42 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.001 0.905 . . . . 0.0 112.0 -171.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -160.39 126.31 4.07 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.487 -2.783 . . . . 0.0 103.487 173.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 11.9 p30 66.91 14.35 9.79 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.863 2.465 . . . . 0.0 115.764 175.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.67 61.53 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.26 2.2 mp -107.64 138.2 19.93 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 177.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.37 112.63 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 N-CA-C 104.892 -2.772 . . . . 0.0 104.892 168.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -92.97 -18.6 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.814 -172.422 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.605 ' CD2' HG23 ' A' ' 113' ' ' VAL . 21.2 m-70 -151.33 -179.57 7.48 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.0 141.54 51.24 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.11 124.27 30.94 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 165.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 117' ' ' GLN . 1.4 mm-40 -115.65 56.71 0.75 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -179.046 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 t -89.25 -51.56 5.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -28.86 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -170.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.424 -1.771 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.985 -165.448 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.431 -1.403 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -90.7 -26.39 19.58 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.67 39.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.284 9.5 t80 -51.41 -64.44 0.81 Allowed 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 125.972 1.709 . . . . 0.0 109.897 164.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -80.24 1.23 29.3 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -169.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -92.02 -26.33 18.4 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 119.897 1.226 . . . . 0.0 109.083 169.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.51 -36.33 80.22 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 161.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -28.69 51.5 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.587 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.8 m -65.08 -50.9 64.36 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 119.47 1.032 . . . . 0.0 109.819 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 72.3 mt-30 -68.35 -44.58 74.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 O-C-N 123.712 0.633 . . . . 0.0 112.675 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 92.6 m-70 -103.07 -55.54 2.4 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.7 -167.128 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -76.66 117.1 17.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.013 0.911 . . . . 0.0 109.586 -167.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -134.02 96.15 3.58 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 101.045 -3.687 . . . . 0.0 101.045 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.98 -41.7 1.71 Allowed 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 128.659 2.784 . . . . 0.0 117.539 -168.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -157.57 144.8 13.52 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 65.1 Cg_exo -76.74 -176.46 3.16 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.391 2.061 . . . . 0.0 114.078 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -72.59 -73.36 0.2 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 165.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.37 -174.32 13.59 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 102.437 -4.265 . . . . 0.0 102.437 164.443 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -111.8 75.97 0.95 Allowed 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 176.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -142.65 177.13 8.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.938 -173.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -56.06 -43.1 77.61 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 127.81 2.444 . . . . 0.0 112.169 -175.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -77.57 -23.95 49.88 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.036 0.935 . . . . 0.0 110.968 -176.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -71.83 -47.88 50.1 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.531 ' HA ' HG22 ' A' ' 29' ' ' ILE . 5.9 t -81.41 -22.77 38.03 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.61 -169.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.9 -47.9 81.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 123.725 0.81 . . . . 0.0 109.654 170.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.9 m -68.13 -36.41 79.66 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 26' ' ' CYS . 14.2 tt -80.49 -27.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-N 118.894 0.77 . . . . 0.0 110.917 -176.209 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.428 ' HE2' ' HB3' ' A' ' 43' ' ' ASN . 3.7 mmt -71.36 -36.97 71.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 118.327 0.512 . . . . 0.0 109.934 175.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.29 -28.08 61.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -75.96 -50.57 14.57 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 118.822 0.737 . . . . 0.0 110.355 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -23.47 60.07 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.804 0.842 . . . . 0.0 112.175 -172.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 51.98 2.68 Favored Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 170.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.1 mt -113.66 9.81 17.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 p -100.9 15.57 28.09 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 124.016 0.926 . . . . 0.0 108.959 178.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -124.2 94.5 45.18 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.81 166.79 81.76 Favored 'Cis proline' 0 N--CA 1.443 -1.468 0 N-CA-C 107.021 -1.954 . . . . 0.0 107.021 -24.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.6 m -62.78 120.04 10.5 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 124.36 1.064 . . . . 0.0 112.882 -172.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -72.4 139.64 47.93 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.576 -178.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -71.83 -43.15 66.06 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.391 0.677 . . . . 0.0 111.682 -172.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.84 128.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 7.2 t-20 -143.49 130.21 20.31 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -100.3 116.32 32.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.85 124.78 35.43 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mm -93.57 150.95 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.5 m-70 -142.96 127.74 18.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -177.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.04 -137.2 4.16 Favored Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 172.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -106.3 144.39 33.07 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.78 -20.95 32.41 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.471 -167.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.62 -10.2 44.16 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.0 m -76.44 -38.06 56.06 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.648 166.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.76 -52.32 62.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-N 118.907 0.776 . . . . 0.0 110.542 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.26 -45.95 89.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 125.084 1.354 . . . . 0.0 111.342 -175.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.13 21.97 1.03 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.45 ' HB ' HH11 ' A' ' 70' ' ' ARG . 42.8 mt -78.55 -27.11 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 165.069 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.14 -39.59 90.61 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 122.449 0.3 . . . . 0.0 111.517 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -104.97 171.26 7.41 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.408 0.623 . . . . 0.0 110.24 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.6 t30 73.33 -136.9 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.532 1.533 . . . . 0.0 114.694 153.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 61' ' ' ASN . 83.8 tttt -136.01 0.42 2.62 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 -164.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 60' ' ' LYS . 20.6 t30 -82.22 -20.84 36.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.58 -176.03 19.16 Favored Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 164.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.52 154.08 32.95 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.16 147.02 23.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 122.523 2.149 . . . . 0.0 107.441 -175.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -135.59 125.34 25.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? 64.66 -107.01 0.15 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.069 1.347 . . . . 0.0 111.489 171.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.96 97.21 3.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.357 2.1 p-10 64.84 24.72 12.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 129.105 2.962 . . . . 0.0 114.112 175.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 mt -111.87 168.8 9.3 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 101.196 -3.631 . . . . 0.0 101.196 172.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 ' CB ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -155.5 129.63 8.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.446 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 tt -101.01 143.43 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -175.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 56' ' ' ILE . 85.6 p -82.56 165.44 20.1 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-O 122.261 1.029 . . . . 0.0 111.417 -176.184 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -128.74 4.56 5.49 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 178.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -122.26 88.95 3.03 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 175.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -59.63 132.13 53.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.661 1.584 . . . . 0.0 112.5 -177.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -109.54 158.24 18.2 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 139.35 38.36 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 174.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.21 144.65 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -171.014 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -128.53 108.04 10.2 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -87.78 102.59 14.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 177.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -95.58 137.67 34.31 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -177.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -128.15 141.85 51.36 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.27 133.19 40.13 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 126.32 1.848 . . . . 0.0 108.031 -175.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -136.04 164.08 28.83 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.84 -44.58 1.44 Allowed Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 -176.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.59 17.48 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -107.35 122.52 41.02 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -79.22 -29.28 3.22 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 N-CA-C 107.612 -1.726 . . . . 0.0 107.612 173.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -101.44 156.72 34.84 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -171.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -75.05 148.2 34.78 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 122.594 2.196 . . . . 0.0 107.493 -174.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -84.11 164.08 66.2 Favored 'Cis proline' 0 CA--C 1.49 -1.675 0 CA-C-N 123.133 2.155 . . . . 0.0 109.392 10.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 m -151.86 118.88 5.85 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -167.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -93.99 119.74 33.29 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -98.53 123.2 42.56 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -87.12 118.01 26.23 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.83 137.63 32.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.651 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 m -120.82 112.27 18.61 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.64 148.14 28.14 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.268 0.556 . . . . 0.0 110.032 -176.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.96 32.73 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -155.32 107.49 2.67 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.17 -3.27 . . . . 0.0 102.17 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -153.51 170.35 20.97 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.797 -174.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.46 124.41 31.32 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -99.04 142.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -166.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.09 122.37 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 170.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -122.71 160.39 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 102.434 -3.173 . . . . 0.0 102.434 173.101 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.07 131.94 54.61 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 119.021 0.828 . . . . 0.0 109.146 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.9 t -97.6 148.87 22.84 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.13 1.372 . . . . 0.0 109.174 -174.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.5 123.89 12.35 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 164.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.312 13.8 p30 64.84 19.63 11.9 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 128.209 2.604 . . . . 0.0 116.679 174.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.3 19.69 51.71 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.331 1.3 tp -129.51 146.71 62.21 Favored Pre-proline 0 CA--C 1.481 -1.68 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 177.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.46 ' CB ' HH22 ' A' ' 70' ' ' ARG . 82.0 Cg_exo -69.46 147.04 63.91 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 121.457 1.438 . . . . 0.0 108.891 162.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.473 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -129.09 -30.96 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 O-C-N 123.708 0.63 . . . . 0.0 109.338 175.508 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.473 ' CD2' HG23 ' A' ' 113' ' ' VAL . 88.2 m-70 -145.33 175.73 10.08 Favored 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.965 -165.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.406 HD13 HG12 ' A' ' 105' ' ' VAL . 2.8 tp -125.3 139.18 53.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.82 128.06 35.64 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 167.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -108.84 52.05 0.72 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -87.42 -44.94 10.97 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -173.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.78 -28.51 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -173.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.426 -1.629 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.819 -165.808 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 CA--C 1.504 -0.826 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -91.65 -29.66 16.75 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -66.23 -45.69 79.81 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.199 1.4 . . . . 0.0 109.401 179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 10' ' ' LEU . 65.8 t80 -50.54 -62.21 1.73 Allowed 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.689 1.996 . . . . 0.0 113.881 170.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -70.34 -13.88 62.34 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -81.33 -39.25 25.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 119.848 1.204 . . . . 0.0 110.055 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.65 -34.42 74.26 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.11 1.364 . . . . 0.0 109.646 169.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -77.25 -24.39 51.13 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 125.855 1.662 . . . . 0.0 113.341 177.313 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -66.2 -58.08 6.19 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.28 -52.08 63.49 Favored 'General case' 0 CA--C 1.484 -1.587 0 O-C-N 124.051 0.844 . . . . 0.0 113.046 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -101.3 -15.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -163.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 28.9 t80 -93.99 137.15 33.52 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 122.936 2.607 . . . . 0.0 109.738 177.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -151.79 100.4 2.67 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 165.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.58 -49.41 2.17 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -164.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -145.47 149.95 42.44 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 167.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 51.4 Cg_endo -84.07 169.71 11.37 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.42 2.08 . . . . 0.0 107.922 -175.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.87 -70.53 0.35 Allowed 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.73 15.0 Favored Glycine 0 CA--C 1.475 -2.436 1 N-CA-C 102.768 -4.133 . . . . 0.0 102.768 164.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -116.66 73.62 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 177.05 9.81 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -174.426 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.36 -18.87 62.35 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.575 1.15 . . . . 0.0 112.717 -173.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.48 -22.12 30.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 122.797 0.439 . . . . 0.0 110.183 178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -77.44 -42.02 37.56 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.1 m -67.02 -37.16 83.66 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 123.829 0.706 . . . . 0.0 112.54 -178.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.29 -42.71 87.98 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 123.679 0.792 . . . . 0.0 110.36 175.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 m -69.89 -32.32 70.59 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD11 HH21 ' A' ' 33' ' ' ARG . 6.9 tt -81.87 -33.48 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 118.915 0.78 . . . . 0.0 110.61 -176.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.0 mmt -73.63 -31.58 63.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.064 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -74.83 -34.68 62.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -70.94 -56.88 5.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.078 0.951 . . . . 0.0 110.596 -172.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.423 HH21 HD11 ' A' ' 29' ' ' ILE . 10.0 ptp180 -85.38 -18.09 34.76 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.077 -175.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.64 71.12 1.31 Allowed Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 166.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -118.41 11.89 13.15 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 173.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.8 t -96.81 3.96 51.98 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.143 0.977 . . . . 0.0 108.99 -171.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -129.52 103.09 17.92 Favored Pre-proline 0 N--CA 1.427 -1.607 0 CA-C-O 117.81 -1.091 . . . . 0.0 108.667 -177.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.71 159.19 97.1 Favored 'Cis proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.52 -2.146 . . . . 0.0 106.52 -22.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.07 119.55 16.42 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 111.994 -166.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -79.55 134.12 36.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 172.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.9 -15.3 48.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.847 -164.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.63 125.88 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -139.08 128.81 24.73 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 169.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -96.27 117.85 31.64 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -93.64 120.36 33.82 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.5 145.1 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -174.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.495 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m-70 -133.16 128.93 37.11 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -174.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.66 -132.39 2.9 Favored Glycine 0 CA--C 1.483 -1.955 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 176.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.19 144.48 43.12 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -84.0 -15.17 48.67 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -74.68 -35.69 62.77 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.502 1.121 . . . . 0.0 108.612 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.1 m -72.15 -37.14 69.46 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.287 176.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 mm -56.55 -55.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 123.912 0.885 . . . . 0.0 111.842 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -58.92 -40.01 83.26 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.422 1.089 . . . . 0.0 112.889 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -18.72 46.86 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.8 -26.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 119.718 1.145 . . . . 0.0 110.683 -176.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.4 t -77.5 -12.08 59.92 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 118.579 0.627 . . . . 0.0 111.933 -178.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.45 -178.94 7.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.181 0.991 . . . . 0.0 108.72 168.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.05 -28.66 61.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.88 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -74.14 154.93 38.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 172.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 t30 61.78 21.21 12.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.633 2.373 . . . . 0.0 116.127 171.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.87 177.47 41.5 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -143.72 157.07 59.15 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -72.39 148.18 48.28 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.382 2.055 . . . . 0.0 109.671 -176.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -134.92 127.2 30.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 62.08 -106.45 0.21 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 125.726 1.61 . . . . 0.0 112.117 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -151.95 108.76 3.5 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 2.0 p-10 66.25 24.1 10.74 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 129.727 3.211 . . . . 0.0 113.87 176.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 mt -116.15 170.86 8.19 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 171.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.464 HH12 ' HG3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -149.85 146.1 26.93 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 166.356 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.34 151.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 175.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -74.48 177.99 5.6 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.297 1.046 . . . . 0.0 112.725 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -142.04 7.13 1.8 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.4 t -130.58 94.53 3.66 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 171.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 p -57.09 130.19 45.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.065 1.746 . . . . 0.0 112.717 -177.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.86 156.0 17.79 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -175.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -77.24 138.58 39.5 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 175.777 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.54 142.48 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.015 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.2 m -130.62 108.51 9.97 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 167.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.6 m -81.76 101.74 10.32 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 75.9 m -88.15 110.37 20.63 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 178.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.06 145.79 49.01 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 151.38 29.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.088 0.947 . . . . 0.0 112.62 -172.608 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -125.18 44.12 2.88 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.66 -108.48 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.336 0 C-N-CA 129.454 3.407 . . . . 0.0 113.378 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.75 -51.08 4.37 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 112.436 -1.882 . . . . 0.0 111.531 -162.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 p -175.86 152.66 1.3 Allowed Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 -173.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -86.03 -13.32 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.226 1.95 . . . . 0.0 108.658 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.33 159.42 32.03 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -75.28 142.93 27.61 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 121.998 1.799 . . . . 0.0 107.507 -172.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -82.06 161.16 78.45 Favored 'Cis proline' 0 CA--C 1.487 -1.827 0 CA-C-N 123.538 2.299 . . . . 0.0 110.794 8.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 m -142.87 122.41 13.23 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -166.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -85.58 109.19 18.36 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -99.61 121.53 41.33 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -98.83 152.67 19.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.38 31.2 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.2 m -126.56 98.24 5.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 167.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.77 32.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.153 0.501 . . . . 0.0 109.967 -175.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.49 20.84 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 70.5 t80 -151.65 92.51 1.76 Allowed 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 101.627 -3.471 . . . . 0.0 101.627 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -136.99 154.4 50.42 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -161.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -68.14 128.88 38.18 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.9 m -93.03 120.48 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -174.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.2 t -86.84 118.39 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -122.84 157.96 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 176.394 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 128.53 40.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.8 t -107.45 136.75 46.7 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.148 0.979 . . . . 0.0 108.847 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.45 138.98 50.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 169.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 14.0 p30 65.64 17.7 10.98 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 127.17 2.188 . . . . 0.0 116.644 172.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.83 23.71 48.55 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 28.3 tp -141.14 151.05 60.82 Favored Pre-proline 0 CA--C 1.486 -1.484 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 105' ' ' VAL . 74.1 Cg_exo -66.94 162.88 35.93 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 122.552 1.947 . . . . 0.0 109.791 164.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -147.4 -27.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 O-C-N 121.616 -0.677 . . . . 0.0 111.274 176.245 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.554 ' CD2' HG23 ' A' ' 113' ' ' VAL . 88.8 m-70 -144.08 172.03 13.45 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 -173.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.0 134.28 54.33 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 175.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.63 121.03 27.73 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 174.232 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -103.94 45.67 0.95 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p -98.74 -30.41 12.45 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 175.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -23.5 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 N--CA 1.429 -1.495 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.872 -172.837 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.59 -18.5 26.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.164 179.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -68.44 -43.66 76.59 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.513 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.252 8.6 t80 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.402 -2.837 0 C-N-CA 124.768 1.227 . . . . 0.0 111.142 174.405 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -173.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -82.34 -32.36 29.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 119.479 1.036 . . . . 0.0 109.091 170.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' A' ' 10' ' ' LEU . 1.9 t80 -58.22 -38.98 77.87 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.13 164.354 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 8.4 mp -83.38 -11.51 57.53 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 119.651 1.114 . . . . 0.0 113.495 178.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.2 m -70.66 -45.25 65.44 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 119.564 1.075 . . . . 0.0 108.298 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.12 -41.35 67.32 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.044 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CE1' HD12 ' A' ' 115' ' ' LEU . 93.5 m-70 -101.56 -54.5 2.74 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.096 -169.028 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.672 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 9.6 t80 -72.45 126.41 29.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 120.45 1.477 . . . . 0.0 112.776 -165.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -149.17 104.37 3.41 Favored 'General case' 0 N--CA 1.424 -1.75 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 172.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.2 -32.28 10.12 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -162.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 152.38 42.9 Favored Pre-proline 0 N--CA 1.432 -1.37 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 17.2 Cg_endo -71.31 144.1 45.14 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 C-N-CA 123.265 2.643 . . . . 0.0 107.519 167.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -77.52 -51.63 10.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.6 179.68 17.35 Favored Glycine 0 CA--C 1.478 -2.259 1 N-CA-C 103.091 -4.004 . . . . 0.0 103.091 161.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.92 55.03 0.94 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.49 179.81 6.58 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -170.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -67.95 -23.94 65.11 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 125.352 1.461 . . . . 0.0 113.204 -172.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -25.76 37.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.51 -44.78 49.76 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.9 m -65.07 -38.07 89.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.35 -33.81 55.31 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 119.117 -0.468 . . . . 0.0 111.072 -178.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -76.57 -29.87 56.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 118.78 -0.628 . . . . 0.0 112.023 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 13.5 tt -75.92 -38.58 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.611 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.7 mtm -79.27 -23.23 43.76 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 118.136 -1.425 . . . . 0.0 113.447 -176.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -72.39 -36.81 68.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 170.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.18 -45.66 32.26 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.537 0.735 . . . . 0.0 111.479 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -76.78 -25.43 53.36 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.744 1.618 . . . . 0.0 109.344 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.12 44.48 3.8 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 163.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.8 mt -118.54 19.77 13.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -90.08 -11.33 41.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.619 1.168 . . . . 0.0 108.244 -176.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 m -121.3 105.0 39.92 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.61 161.31 94.91 Favored 'Cis proline' 0 N--CA 1.441 -1.612 0 N-CA-C 107.018 -1.955 . . . . 0.0 107.018 -22.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.95 125.54 24.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.202 1.001 . . . . 0.0 109.586 -177.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.78 142.38 38.67 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.7 -36.47 57.2 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.76 128.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -161.36 144.48 12.56 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.0 m -106.87 138.88 42.2 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 -170.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -101.87 129.77 48.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 162.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.67 150.89 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.637 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -174.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.794 ' HB2' ' HB2' ' A' ' 77' ' ' GLN 0.252 7.9 m-70 -140.25 153.12 46.42 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.741 -174.024 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.04 -124.24 3.89 Favored Glycine 0 CA--C 1.478 -2.246 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 169.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 135.58 42.93 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.968 1.366 . . . . 0.0 109.707 -177.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.27 -29.11 34.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.602 -1.636 . . . . 0.0 106.857 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -29.11 64.85 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.9 m -76.88 -36.79 56.47 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 116.663 -1.637 . . . . 0.0 111.485 176.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 53' ' ' ILE 0.268 6.6 tp -65.03 -46.34 91.77 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 0 CA-C-N 120.193 1.361 . . . . 0.0 110.592 -178.672 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -60.61 -43.48 97.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.428 1.091 . . . . 0.0 110.808 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.18 11.46 2.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.56 -35.99 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.097 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 167.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -96.74 5.29 50.91 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -112.38 18.65 18.33 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.087 0.946 . . . . 0.0 108.461 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 32.1 47.58 0.09 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 131.686 3.994 . . . . 0.0 115.744 -170.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.78 -60.7 2.21 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.55 64.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.163 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.19 146.84 8.58 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 173.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -102.49 164.06 16.42 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.92 144.01 42.19 Favored 'Trans proline' 0 N--CA 1.437 -1.797 0 C-N-CA 122.692 2.262 . . . . 0.0 106.886 166.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -136.23 33.69 2.81 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 -178.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.6 mmt-85 61.12 157.62 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 129.017 2.927 . . . . 0.0 114.73 178.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 52.84 46.77 26.09 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 128.126 2.57 . . . . 0.0 113.882 175.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.316 2.8 p-10 51.48 40.35 26.61 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.785 2.434 . . . . 0.0 114.192 -174.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.88 153.81 32.91 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 100.799 -3.778 . . . . 0.0 100.799 177.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -146.26 125.17 12.72 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -90.59 143.19 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 179.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.0 p -80.88 158.16 25.41 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.693 0.758 . . . . 0.0 112.75 -175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -108.11 -19.97 13.32 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -104.93 82.45 1.87 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 p -52.43 132.06 34.27 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 127.023 2.129 . . . . 0.0 112.413 178.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -107.26 160.42 15.61 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.794 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 7.3 mm-40 -79.76 144.3 33.72 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.77 142.14 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 m -131.54 104.56 7.03 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 169.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.0 m -86.32 105.26 16.55 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.34 111.25 20.89 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -111.36 131.52 55.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 -171.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.5 118.01 11.83 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 123.64 0.776 . . . . 0.0 108.935 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -130.93 71.38 1.47 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -175.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.19 -45.97 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 105.156 -3.178 . . . . 0.0 105.156 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.02 37.03 8.6 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 p -103.57 122.29 45.37 Favored Pre-proline 0 N--CA 1.434 -1.246 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -83.54 -20.21 4.88 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 CA-C-N 121.587 1.602 . . . . 0.0 108.614 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -110.9 158.44 35.74 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.318 -167.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.25 147.01 36.81 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.824 2.35 . . . . 0.0 108.382 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -82.06 165.75 72.34 Favored 'Cis proline' 0 N--CA 1.438 -1.761 0 CA-C-N 122.401 1.893 . . . . 0.0 108.489 -1.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.1 m -113.12 157.91 21.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.703 1.252 . . . . 0.0 107.637 -172.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -111.57 135.59 51.93 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -133.71 122.58 23.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -89.06 125.12 34.88 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.09 122.34 27.21 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -115.24 88.07 2.79 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.48 142.34 27.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.009 -172.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.11 -177.09 14.94 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 177.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -140.44 97.62 3.25 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 175.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -158.34 -179.66 8.31 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -164.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -79.91 146.84 31.92 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.053 -173.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.43 151.95 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -114.06 95.02 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 163.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.3 136.6 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.53 130.17 34.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 174.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 57.1 m -109.66 149.64 29.43 Favored 'General case' 0 CA--C 1.489 -1.376 0 O-C-N 124.136 0.897 . . . . 0.0 110.688 -173.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.21 124.97 7.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.2 p30 65.89 18.32 11.06 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.782 2.433 . . . . 0.0 116.338 171.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.3 -7.02 59.83 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -103.06 148.76 36.11 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 177.611 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -70.89 143.46 45.46 Favored 'Trans proline' 0 N--CA 1.435 -1.968 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 156.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.9 OUTLIER -121.22 -22.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.369 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 113' ' ' VAL . 31.2 m-70 -154.25 -167.35 2.61 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -167.88 136.75 2.49 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 -179.656 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -80.5 139.66 36.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.864 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -101.88 40.77 1.28 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 172.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.3 m -96.22 -30.19 13.61 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -175.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.71 -35.41 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.941 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.241 172.411 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 N--CA 1.422 -1.84 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -168.37 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 . . . . . 0 CA--C 1.487 -1.45 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 59.34 71.83 0.56 Allowed 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 126.397 1.879 . . . . 0.0 111.577 172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 93.15 -28.84 0.03 OUTLIER 'General case' 0 C--N 1.358 0.937 0 C-N-CA 127.613 2.365 . . . . 0.0 110.621 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -90.38 -1.64 57.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.45 -45.35 59.99 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -56.55 -52.72 63.72 Favored 'General case' 0 N--CA 1.412 -2.344 0 C-N-CA 125.538 1.535 . . . . 0.0 112.366 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.449 1.8 t -87.97 9.8 21.03 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -77.99 -42.2 33.45 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 120.207 -1.558 . . . . 0.0 107.463 157.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -59.77 -36.91 77.64 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.982 170.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.43 HD22 ' HB2' ' A' ' 14' ' ' TYR . 20.2 mt -83.77 -15.91 46.71 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 119.567 1.076 . . . . 0.0 113.863 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.7 m -65.8 -48.61 71.18 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 119.911 1.232 . . . . 0.0 108.908 167.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -72.91 -37.25 67.31 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -104.34 -53.64 2.68 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 118.761 -0.637 . . . . 0.0 110.251 -169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' A' ' 50' ' ' LYS . 14.8 t80 -76.61 115.33 16.27 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 119.232 0.924 . . . . 0.0 110.123 -168.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -134.76 98.73 4.12 Favored 'General case' 0 N--CA 1.419 -1.994 1 N-CA-C 99.385 -4.302 . . . . 0.0 99.385 175.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.11 -38.01 16.72 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -165.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -159.77 134.52 5.52 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -71.54 178.05 6.09 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 123.051 2.501 . . . . 0.0 114.66 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -71.31 -59.63 2.66 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -179.36 22.73 Favored Glycine 0 CA--C 1.478 -2.228 0 N-CA-C 104.403 -3.479 . . . . 0.0 104.403 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.519 HH21 ' HG3' ' A' ' 77' ' ' GLN . 11.1 mpt_? -106.84 73.46 0.94 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -156.92 173.46 16.97 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -70.41 -20.77 62.9 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 125.373 1.469 . . . . 0.0 113.963 -169.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -80.46 -29.61 37.47 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -72.32 -41.58 66.38 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.448 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.7 OUTLIER -80.34 -25.39 39.27 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.729 -1.188 . . . . 0.0 113.097 -170.953 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -72.01 -36.48 69.72 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 118.99 -0.528 . . . . 0.0 110.175 171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.4 t -65.65 -42.96 90.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.3 tt -80.37 -28.09 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 117.83 0.286 . . . . 0.0 111.199 -174.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.3 mmt -74.25 -29.99 61.94 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.035 -0.415 . . . . 0.0 110.325 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.457 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.3 tpp180 -66.43 -45.75 78.82 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 123.774 0.83 . . . . 0.0 111.869 172.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -80.22 -39.68 28.6 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -170.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -70.47 -39.65 74.13 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.46 68.82 1.34 Allowed Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.7 mt -113.94 21.83 14.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 163.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.4 t -94.6 -5.78 45.01 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 123.958 0.903 . . . . 0.0 109.085 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -132.6 102.66 13.75 Favored Pre-proline 0 N--CA 1.438 -1.062 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.86 163.31 89.39 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.484 -1.776 . . . . 0.0 107.484 -18.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.461 ' HB3' HD13 ' A' ' 83' ' ' LEU . 33.9 m -59.62 125.75 24.87 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 124.492 1.117 . . . . 0.0 110.693 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -76.19 138.46 40.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.83 -40.71 60.89 Favored 'General case' 0 CA--C 1.49 -1.338 0 O-C-N 123.432 0.457 . . . . 0.0 111.256 -171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 tt -151.91 128.0 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -148.79 131.72 16.17 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.8 m -96.97 124.38 40.92 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.645 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -89.98 120.08 30.88 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 168.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.77 149.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.636 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -143.37 138.46 29.43 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.98 -140.28 6.78 Favored Glycine 0 CA--C 1.484 -1.871 0 N-CA-C 106.651 -2.579 . . . . 0.0 106.651 176.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -97.38 146.55 25.07 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.477 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 1.2 tmtp? -83.89 -25.4 30.23 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -70.75 -34.23 71.63 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.006 1.323 . . . . 0.0 108.708 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -69.93 -41.44 74.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 117.614 -1.184 . . . . 0.0 110.459 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -57.74 -50.73 76.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 123.837 0.855 . . . . 0.0 111.909 177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -63.87 -37.67 88.24 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.343 0.657 . . . . 0.0 111.188 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.35 4.81 8.15 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' HB2' ' A' ' 72' ' ' SER . 23.0 mm -77.3 -26.85 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 171.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.7 t -82.74 -15.02 53.42 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.152 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.47 154.41 38.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 165.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -83.34 -7.49 59.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.757 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -80.41 -41.84 23.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.921 0.488 . . . . 0.0 109.769 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -123.29 31.46 5.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -170.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.67 136.95 3.37 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 171.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -90.01 154.02 47.27 Favored Pre-proline 0 N--CA 1.433 -1.318 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 37.2 Cg_endo -74.79 138.43 23.58 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 122.335 2.024 . . . . 0.0 106.974 169.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -130.67 104.77 7.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' CD ' ' H ' ' A' ' 67' ' ' GLU 0.398 0.0 OUTLIER 46.31 -109.59 0.23 Allowed 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 127.806 2.442 . . . . 0.0 115.661 -177.862 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 50.2 mt-10 -107.33 77.47 1.15 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.766 1.226 . . . . 0.0 108.763 -165.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.372 1.2 p-10 76.59 12.12 2.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 129.102 2.961 . . . . 0.0 114.345 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.3 mp -95.82 154.17 17.36 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 64' ' ' PRO . 13.8 mmp_? -136.57 112.64 9.7 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.2 tt -95.73 132.21 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.422 ' HB2' HD12 ' A' ' 56' ' ' ILE . 96.2 p -82.45 157.05 23.79 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.652 0.739 . . . . 0.0 112.424 -168.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -108.94 -15.93 14.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.533 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.1 t -112.91 90.57 3.38 Favored 'General case' 0 CA--C 1.481 -1.689 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.8 m -50.92 133.23 27.05 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 127.402 2.281 . . . . 0.0 112.419 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.4 161.3 15.43 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.519 ' HG3' HH21 ' A' ' 21' ' ' ARG . 0.3 OUTLIER -82.16 126.77 32.44 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 175.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.29 108.5 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -167.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.2 m -94.82 108.31 20.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.1 m -91.83 102.9 15.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 15.2 m -93.3 117.65 30.33 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.54 144.73 37.43 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 39' ' ' CYS . 41.2 tp -78.98 126.67 30.99 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.72 52.58 2.04 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.69 -70.54 1.18 Allowed Glycine 0 CA--C 1.482 -2.023 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.71 -32.44 4.44 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 106.952 -2.459 . . . . 0.0 106.952 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.9 t -87.48 135.34 34.47 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -78.38 -22.65 9.35 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 122.161 1.908 . . . . 0.0 109.074 174.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -95.32 167.4 12.89 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -72.32 142.63 37.69 Favored 'Trans proline' 0 N--CA 1.438 -1.788 0 C-N-CA 122.028 1.819 . . . . 0.0 107.526 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.457 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.0 Cg_endo -88.15 164.56 42.96 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 CA-C-N 122.63 1.975 . . . . 0.0 108.775 15.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 54.7 m -130.01 122.66 28.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -94.87 117.35 30.0 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -107.28 122.6 46.88 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -96.79 121.4 38.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.67 130.33 35.02 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.9 m -118.05 95.4 4.89 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.94 34.27 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.105 -173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.94 -176.18 19.61 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.328 -3.109 . . . . 0.0 105.328 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -148.43 109.71 4.37 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 102.568 -3.123 . . . . 0.0 102.568 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -162.12 175.11 12.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.971 0.891 . . . . 0.0 109.018 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -77.56 142.24 39.11 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 125.244 1.418 . . . . 0.0 110.675 -176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.38 150.58 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.12 91.73 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 166.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -90.64 132.62 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -92.52 125.02 36.97 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.3 t -108.67 131.24 55.09 Favored 'General case' 0 CA--C 1.489 -1.403 0 O-C-N 124.149 0.905 . . . . 0.0 111.236 -168.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -126.19 136.84 53.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 13.1 p30 65.05 18.98 11.71 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 127.514 2.326 . . . . 0.0 117.083 171.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.9 54.98 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 0.4 OUTLIER -134.47 132.2 20.76 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 -178.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.95 108.21 2.6 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 N-CA-C 105.78 -2.431 . . . . 0.0 105.78 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 m -94.27 -11.72 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 -172.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.455 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 61.9 t60 -153.85 179.53 8.79 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -169.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.455 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -164.21 130.58 3.06 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.85 135.02 36.92 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.251 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -100.86 41.84 1.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.3 t -96.38 -32.39 12.39 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.47 -35.89 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.837 172.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.06 43.4 1.11 Allowed 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -171.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -94.35 -42.15 9.05 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.7 tpp85 -133.99 101.85 12.45 Favored Pre-proline 0 N--CA 1.43 -1.464 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.432 -2.117 0 N-CA-C 105.927 -2.374 . . . . 0.0 105.927 -174.444 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.563 HE22 ' CE1' ' A' ' 8' ' ' HIS . 83.2 mt-30 . . . . . 0 CA--C 1.487 -1.449 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -149.84 100.07 2.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.319 0.5 OUTLIER 109.36 -26.04 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 129.613 3.165 . . . . 0.0 107.893 176.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.5 m -92.19 -13.82 29.98 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -43.68 67.07 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.268 41.4 t80 -56.82 -51.96 66.95 Favored 'General case' 0 N--CA 1.399 -3.012 0 C-N-CA 126.623 1.969 . . . . 0.0 113.422 171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.482 ' HA ' ' HG ' ' A' ' 10' ' ' LEU 0.252 1.5 p -82.06 -3.24 54.22 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 -178.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.563 ' CE1' HE22 ' A' ' 1' ' ' GLN . 22.2 m170 -85.63 -31.21 22.7 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 120.136 1.335 . . . . 0.0 108.229 167.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.428 ' CE1' ' HB3' ' A' ' 115' ' ' LEU . 16.0 t80 -65.18 -36.98 85.89 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 124.407 1.083 . . . . 0.0 109.405 167.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.295 8.9 mt -69.25 -31.15 69.5 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 170.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.6 m -65.26 -44.28 88.61 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 119.509 1.049 . . . . 0.0 108.936 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 66.5 mt-30 -70.0 -55.16 10.3 Favored 'General case' 0 CA--C 1.489 -1.385 0 O-C-N 123.556 0.535 . . . . 0.0 111.92 173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.463 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 91.1 m-70 -96.49 -49.44 5.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-O 118.513 -0.756 . . . . 0.0 112.913 -162.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' HB2' HD22 ' A' ' 10' ' ' LEU . 29.2 t80 -71.15 115.09 9.89 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 120.065 1.302 . . . . 0.0 112.635 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -138.56 98.05 3.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 100.789 -3.782 . . . . 0.0 100.789 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.82 -40.69 10.09 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 127.515 2.326 . . . . 0.0 117.055 -168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -157.63 144.11 13.04 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 164.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 69.0 Cg_exo -76.51 178.39 7.61 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.507 2.138 . . . . 0.0 112.916 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.64 -74.99 0.17 Allowed 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.74 -176.44 14.74 Favored Glycine 0 CA--C 1.477 -2.336 1 N-CA-C 102.557 -4.217 . . . . 0.0 102.557 163.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -118.16 72.56 0.87 Allowed 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -145.01 177.8 8.5 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -69.72 -22.33 63.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 124.704 1.202 . . . . 0.0 113.595 -168.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.8 -29.45 40.31 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.27 -41.87 69.48 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.282 0.8 OUTLIER -79.69 -26.92 40.79 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 118.807 -1.157 . . . . 0.0 113.227 -170.585 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.66 -35.47 70.36 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 118.902 -0.571 . . . . 0.0 110.286 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -67.73 -38.91 84.17 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 26' ' ' CYS . 4.1 tt -79.69 -30.85 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 CA-C-N 118.535 0.607 . . . . 0.0 110.629 -175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -74.4 -30.09 61.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 122.392 -0.192 . . . . 0.0 111.0 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -68.43 -44.85 74.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.467 0.707 . . . . 0.0 111.873 172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -71.2 -48.99 48.21 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.913 0.885 . . . . 0.0 112.277 -173.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.03 -36.82 75.35 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.201 0.6 . . . . 0.0 110.408 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.58 68.79 1.36 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.9 mt -114.91 22.48 13.41 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 103.195 -2.891 . . . . 0.0 103.195 162.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.0 t -91.25 -10.21 42.38 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 124.267 1.027 . . . . 0.0 109.132 -172.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -129.99 104.54 16.82 Favored Pre-proline 0 N--CA 1.439 -1.002 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.65 160.01 95.66 Favored 'Cis proline' 0 N--CA 1.444 -1.404 0 N-CA-C 107.073 -1.934 . . . . 0.0 107.073 -20.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.407 ' HB3' HD13 ' A' ' 83' ' ' LEU . 59.5 m -62.92 125.26 23.37 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 124.029 0.932 . . . . 0.0 110.059 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.01 143.17 45.67 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -75.03 -39.14 61.23 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.161 0.584 . . . . 0.0 111.541 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.7 tt -149.11 128.83 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -147.26 125.73 12.42 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.0 m -101.51 114.36 28.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.586 -175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -85.67 125.96 33.57 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.41 146.37 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.726 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -136.91 127.45 26.86 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 125.311 1.444 . . . . 0.0 107.949 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.65 -148.49 17.67 Favored Glycine 0 CA--C 1.483 -1.91 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -84.02 140.5 31.82 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-O 122.2 1.0 . . . . 0.0 108.33 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -85.27 -15.78 42.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.308 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -79.32 -31.42 43.18 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 125.317 1.447 . . . . 0.0 107.857 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 39.7 m -73.37 -36.47 66.11 Favored 'General case' 0 N--CA 1.424 -1.744 0 C-N-CA 124.177 0.991 . . . . 0.0 109.992 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.417 HG22 ' HG2' ' A' ' 112' ' ' PRO . 87.7 mt -59.9 -52.25 63.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.996 0 C-N-CA 123.379 0.672 . . . . 0.0 110.992 174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.05 -39.7 79.11 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.821 0.849 . . . . 0.0 112.849 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.69 10.35 3.34 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.9 mt -78.63 -30.53 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 170.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 24.0 t -68.08 -41.27 82.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -79.36 154.98 28.64 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.26 99.22 8.5 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -159.77 -49.08 0.05 Allowed 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -144.34 47.24 1.39 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.94 129.53 1.54 Allowed Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -114.76 160.63 32.66 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -72.64 138.26 28.98 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 122.914 2.409 . . . . 0.0 107.971 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 44.4 t60 -141.32 129.63 22.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -171.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 65.66 -108.72 0.16 Allowed 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 125.052 1.341 . . . . 0.0 111.447 170.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -140.67 95.15 2.81 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.924 -2.251 . . . . 0.0 104.924 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.345 1.6 p-10 64.15 23.38 13.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 128.92 2.888 . . . . 0.0 114.327 175.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.9 mt -106.46 168.48 9.13 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -141.13 124.75 16.82 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.53 142.52 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.3 p -84.31 175.16 9.58 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.826 0.822 . . . . 0.0 110.418 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -131.45 -1.18 3.94 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.9 p -109.54 74.02 0.87 Allowed 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.4 p -51.19 123.89 10.46 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 126.137 1.775 . . . . 0.0 113.544 -174.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -108.6 160.99 15.49 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -81.68 136.45 35.49 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.47 110.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -172.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 99.0 m -93.64 110.63 22.23 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.1 m -88.95 104.63 17.14 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 13.4 m -94.19 115.47 27.75 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -110.13 147.66 33.25 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB3' ' A' ' 39' ' ' CYS . 36.7 tp -79.99 112.91 17.74 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -132.81 96.54 3.82 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.85 -40.92 0.06 OUTLIER Glycine 0 CA--C 1.479 -2.197 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.6 42.48 6.46 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.8 m -114.61 107.19 51.25 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -83.76 -20.53 4.53 Favored 'Trans proline' 0 N--CA 1.439 -1.688 0 CA-C-N 122.213 1.826 . . . . 0.0 108.398 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -110.17 161.32 24.93 Favored Pre-proline 0 N--CA 1.429 -1.489 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -73.96 144.45 34.32 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.665 2.244 . . . . 0.0 108.31 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -81.89 163.63 76.49 Favored 'Cis proline' 0 N--CA 1.437 -1.848 0 CA-C-N 122.641 1.979 . . . . 0.0 108.731 -1.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.1 m -108.53 159.41 16.72 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.739 -172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -114.18 98.7 7.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.77 128.3 44.32 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -101.34 121.03 41.17 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.46 132.67 35.2 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 48.4 m -116.12 105.52 12.69 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.1 125.53 29.48 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.3 177.99 18.75 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 105.691 -2.963 . . . . 0.0 105.691 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -158.95 111.13 2.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.8 -3.037 . . . . 0.0 102.8 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -161.21 171.12 18.98 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.24 133.77 42.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.852 172.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.5 m -102.65 149.51 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.424 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.98 122.38 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 172.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.9 m -120.35 138.94 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.21 132.16 36.28 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.5 t -104.42 133.81 48.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 O-C-N 124.744 1.278 . . . . 0.0 109.903 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -132.57 141.37 48.68 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 164.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.326 11.2 p30 66.34 17.79 10.76 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.301 2.24 . . . . 0.0 116.503 173.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.91 23.12 50.77 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.267 3.5 tp -143.43 149.84 49.21 Favored Pre-proline 0 CA--C 1.484 -1.591 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 -176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HG2' HG22 ' A' ' 53' ' ' ILE . 50.1 Cg_exo -67.19 147.21 78.5 Favored 'Trans proline' 0 N--CA 1.436 -1.898 0 N-CA-C 107.525 -1.76 . . . . 0.0 107.525 164.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.28 -19.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 42.1 t60 -155.86 178.79 9.87 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 -165.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.447 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -159.32 146.43 16.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -173.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -95.44 141.23 29.23 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -115.56 20.71 14.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.301 1.04 . . . . 0.0 110.029 -170.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.3 m -95.13 -20.75 19.01 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 118.94 0.791 . . . . 0.0 109.938 -170.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -75.83 -33.0 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.42 1.088 . . . . 0.0 111.036 177.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -93.71 -9.09 38.89 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -77.31 -66.41 0.83 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.47 128.98 30.07 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 N--CA 1.434 -2.026 0 N-CA-C 105.723 -2.453 . . . . 0.0 105.723 -179.471 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 . . . . . 0 CA--C 1.486 -1.488 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -102.74 68.01 1.01 Allowed 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -109.31 -0.03 19.31 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.9 m -88.76 -26.52 21.7 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 170.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -65.13 -49.88 68.2 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -53.76 -57.3 11.37 Favored 'General case' 0 N--CA 1.4 -2.949 0 C-N-CA 127.209 2.204 . . . . 0.0 114.327 174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.432 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 14.9 p -82.64 -2.34 53.67 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -86.12 -31.33 21.92 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 168.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -64.07 -41.18 97.44 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.373 166.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.335 0.7 OUTLIER -61.16 -39.81 91.51 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 172.981 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -69.65 -46.22 66.64 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 120.072 1.305 . . . . 0.0 110.463 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -86.92 -5.18 59.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -127.29 -62.94 1.07 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.591 175.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -67.43 118.3 10.57 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 119.957 1.253 . . . . 0.0 112.02 -166.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -147.27 99.29 3.13 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.94 -29.58 0.85 Allowed 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 119.074 2.99 . . . . 0.0 119.074 -163.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -153.06 157.1 33.05 Favored Pre-proline 0 N--CA 1.434 -1.234 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.5 Cg_endo -74.41 157.5 45.2 Favored 'Trans proline' 0 N--CA 1.435 -1.962 0 C-N-CA 123.188 2.592 . . . . 0.0 108.859 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -74.97 -63.22 1.31 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 168.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.62 177.0 18.64 Favored Glycine 0 CA--C 1.476 -2.39 1 N-CA-C 103.072 -4.011 . . . . 0.0 103.072 161.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' HE ' ' HB1' ' A' ' 98' ' ' ALA . 77.8 mtp180 -109.53 68.28 0.67 Allowed 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.06 173.9 14.87 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -170.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -73.82 -14.94 61.18 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.66 1.184 . . . . 0.0 113.093 -172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -32.29 53.68 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 123.112 0.565 . . . . 0.0 109.621 175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.95 -41.47 61.97 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.268 0.1 OUTLIER -78.45 -26.68 46.25 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 118.451 -1.299 . . . . 0.0 114.042 -170.77 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 -34.14 59.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.161 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.2 m -69.81 -32.56 71.06 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.286 14.6 tt -79.97 -35.12 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 118.55 -0.738 . . . . 0.0 110.198 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -74.47 -22.31 59.16 Favored 'General case' 0 N--CA 1.439 -1.019 0 C-N-CA 118.207 -1.397 . . . . 0.0 112.223 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.82 -29.75 29.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 119.433 1.015 . . . . 0.0 112.959 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.6 -41.95 20.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 118.758 0.708 . . . . 0.0 110.91 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -72.42 -38.59 68.33 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.329 1.052 . . . . 0.0 109.54 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.73 68.01 1.41 Allowed Glycine 0 CA--C 1.48 -2.123 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 47.0 mt -114.83 17.66 16.9 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 t -90.54 -10.33 43.9 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 p -126.55 102.21 26.39 Favored Pre-proline 0 N--CA 1.428 -1.547 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.84 161.72 93.66 Favored 'Cis proline' 0 N--CA 1.445 -1.372 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -21.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.446 ' HB3' HD13 ' A' ' 83' ' ' LEU . 35.4 m -61.08 120.42 10.24 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.239 1.015 . . . . 0.0 109.673 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -79.82 145.82 32.59 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -68.78 -42.93 76.72 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.239 1.015 . . . . 0.0 113.103 -169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.1 tt -156.4 134.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -147.91 137.01 22.15 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.4 m -99.62 122.97 43.43 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -93.13 122.25 35.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.3 mm -90.4 144.45 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.552 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 20.8 m-70 -134.04 131.65 39.1 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 124.067 0.947 . . . . 0.0 108.454 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.34 -151.42 21.7 Favored Glycine 0 CA--C 1.48 -2.138 0 N-CA-C 104.317 -3.513 . . . . 0.0 104.317 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -89.83 152.88 21.06 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.62 -8.74 51.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.9 -36.73 49.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.7 p -78.62 -28.47 45.64 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.798 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 53' ' ' ILE . 4.2 tp -66.14 -44.31 91.75 Favored 'Isoleucine or valine' 0 C--N 1.368 1.399 0 CA-C-N 120.324 1.42 . . . . 0.0 110.381 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.73 -33.67 76.15 Favored 'General case' 0 CA--C 1.501 -0.916 0 C-N-CA 124.49 1.116 . . . . 0.0 111.437 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 8.4 5.08 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.9 mm -79.77 -19.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 79.1 m -75.76 -12.77 60.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -76.76 156.52 32.33 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -85.94 -13.4 47.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.224 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -84.83 -34.0 22.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 123.06 0.544 . . . . 0.0 109.875 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -124.23 45.02 2.59 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.75 141.26 3.15 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 107.314 -2.314 . . . . 0.0 107.314 171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -89.84 154.29 47.73 Favored Pre-proline 0 N--CA 1.435 -1.207 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -72.83 138.37 28.65 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.771 2.314 . . . . 0.0 106.246 166.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -137.94 123.08 19.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 60.5 -109.81 0.42 Allowed 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 125.883 1.673 . . . . 0.0 112.451 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -134.77 95.18 3.29 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.348 1.2 p-10 69.83 16.55 7.77 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 129.253 3.021 . . . . 0.0 114.531 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.2 167.32 10.52 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -140.56 117.41 11.05 Favored 'General case' 0 CA--C 1.481 -1.705 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.54 145.82 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.501 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.0 p -91.13 152.21 20.68 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.436 0.636 . . . . 0.0 111.653 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -104.76 -17.55 14.57 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 173.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.5 t -108.93 85.28 2.07 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 p -50.2 135.47 21.15 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 127.516 2.326 . . . . 0.0 113.093 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -112.31 161.67 16.37 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -170.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 4.2 mt-30 -82.11 136.03 35.23 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.94 100.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.0 m -91.56 111.47 23.0 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.0 m -94.54 102.35 14.28 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 27.9 m -96.53 122.23 39.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -118.78 144.08 46.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.1 tp -77.29 104.44 7.8 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.791 1.236 . . . . 0.0 108.852 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -87.15 155.13 20.24 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.28 -76.13 0.51 Allowed Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.42 38.78 2.95 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 106.758 -2.537 . . . . 0.0 106.758 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.5 t -94.11 117.73 67.15 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.23 -12.29 5.87 Favored 'Trans proline' 0 N--CA 1.436 -1.888 0 CA-C-N 121.897 1.713 . . . . 0.0 108.041 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -103.89 161.78 21.93 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -75.01 145.7 31.73 Favored 'Trans proline' 0 N--CA 1.437 -1.798 0 C-N-CA 122.028 1.818 . . . . 0.0 107.424 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -83.44 165.26 67.93 Favored 'Cis proline' 0 N--CA 1.439 -1.713 0 CA-C-N 122.997 2.106 . . . . 0.0 109.623 7.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.6 m -120.66 141.26 50.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -103.29 100.52 10.42 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.35 108.49 21.02 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -92.68 124.05 36.41 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.63 130.08 34.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.535 -173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.8 m -117.7 93.34 4.12 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.418 ' HB1' ' HE ' ' A' ' 21' ' ' ARG . . . -82.19 134.79 35.32 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.339 -170.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -135.71 -173.25 12.94 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 107.282 -2.327 . . . . 0.0 107.282 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -159.77 108.62 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.677 -2.712 . . . . 0.0 103.677 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.34 178.22 5.0 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 121.974 0.893 . . . . 0.0 109.371 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -69.6 140.81 53.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.576 1.95 . . . . 0.0 111.853 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.73 152.66 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 77.7 t -108.3 90.47 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.439 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 167.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.36 131.36 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.9 125.08 35.65 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.8 t -106.17 133.89 50.16 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 124.486 1.116 . . . . 0.0 110.689 -167.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.05 125.47 33.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 170.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 13.0 p30 66.87 15.78 10.22 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 127.632 2.373 . . . . 0.0 116.748 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.18 22.58 40.86 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.9 tp -135.22 123.28 15.49 Favored Pre-proline 0 N--CA 1.435 -1.222 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.13 107.77 2.1 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 N-CA-C 106.038 -2.331 . . . . 0.0 106.038 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.1 m -92.96 -18.3 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 O-C-N 123.38 0.425 . . . . 0.0 110.927 -169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 46.3 t60 -146.27 177.03 9.32 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -158.39 129.62 6.47 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.38 150.62 36.78 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.2 59.53 0.68 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -171.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.0 t -65.45 -67.06 0.47 Allowed 'General case' 0 CA--C 1.496 -1.123 0 C-N-CA 124.789 1.236 . . . . 0.0 111.164 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.5 pt -100.78 1.34 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -99.78 4.69 45.46 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -167.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.9 tpp85 -104.42 -23.96 13.11 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 146.86 59.74 Favored Pre-proline 0 N--CA 1.436 -1.126 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 172.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 N--CA 1.435 -1.967 0 N-CA-C 106.437 -2.178 . . . . 0.0 106.437 178.433 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 . . . . . 0 CA--C 1.486 -1.497 0 CA-C-O 120.667 0.27 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -157.02 105.45 2.15 Favored 'General case' 0 CA--C 1.486 -1.519 0 N-CA-C 103.139 -2.912 . . . . 0.0 103.139 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.7 t30 111.67 -35.32 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 129.188 2.995 . . . . 0.0 105.57 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.6 t -88.61 -1.07 57.87 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 124.531 1.133 . . . . 0.0 109.932 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HA ' ' HE ' ' A' ' 5' ' ' ARG . 0.1 OUTLIER -64.14 -54.23 37.01 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.297 1.439 . . . . 0.0 107.893 170.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.63 -41.75 95.96 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-O 117.233 -1.365 . . . . 0.0 113.04 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.447 0.3 OUTLIER -85.95 -3.72 58.99 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -77.47 -36.85 52.42 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 119.54 1.064 . . . . 0.0 108.911 163.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 10' ' ' LEU . 7.3 t80 -59.48 -37.23 77.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.099 0.96 . . . . 0.0 110.214 168.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -82.77 -18.69 39.78 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-N 119.236 0.926 . . . . 0.0 113.03 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 m -69.08 -51.83 34.72 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.482 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 12.9 pt20 -85.61 -12.35 51.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.482 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 94.7 m-70 -117.76 -51.57 2.47 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 119.08 0.855 . . . . 0.0 111.278 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -79.1 119.28 21.99 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.824 1.193 . . . . 0.0 109.58 -167.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -136.27 96.76 3.44 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 100.678 -3.823 . . . . 0.0 100.678 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.02 -45.52 2.64 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 128.449 2.7 . . . . 0.0 117.424 -168.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 141.94 14.17 Favored Pre-proline 0 N--CA 1.433 -1.324 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 164.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 34.4 Cg_exo -74.18 -179.07 4.36 Favored 'Trans proline' 0 N--CA 1.437 -1.827 0 C-N-CA 122.628 2.219 . . . . 0.0 114.125 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -70.1 -76.65 0.1 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.1 -174.96 13.9 Favored Glycine 0 CA--C 1.476 -2.348 1 N-CA-C 101.399 -4.68 . . . . 0.0 101.399 160.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -112.63 74.47 0.86 Allowed 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -137.81 178.13 7.35 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -72.09 -26.03 61.99 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 124.084 0.953 . . . . 0.0 111.641 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -81.52 -23.19 37.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 123.341 0.656 . . . . 0.0 109.65 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -73.64 -45.68 51.35 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 2.0 t -78.69 -23.99 45.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.768 -173.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -68.91 -40.4 79.13 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 172.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -68.29 -41.51 80.84 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 26' ' ' CYS . 16.3 tt -78.18 -32.06 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 CA-C-N 117.85 0.296 . . . . 0.0 110.827 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 47.1 mtp -78.56 -27.46 45.81 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.2 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -67.34 -41.1 85.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -75.84 -46.65 29.27 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -32.67 72.8 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 123.289 0.636 . . . . 0.0 111.366 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.76 62.63 1.59 Allowed Glycine 0 CA--C 1.478 -2.258 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 172.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.4 mt -112.88 20.36 16.49 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 103.468 -2.79 . . . . 0.0 103.468 163.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -96.3 -8.01 33.85 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 p -125.05 99.84 34.02 Favored Pre-proline 0 N--CA 1.429 -1.499 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.99 167.22 81.11 Favored 'Cis proline' 0 N--CA 1.446 -1.322 0 N-CA-C 107.384 -1.814 . . . . 0.0 107.384 -22.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.47 121.91 11.38 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.344 1.058 . . . . 0.0 111.316 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -77.63 136.85 38.28 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.13 -39.46 63.29 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 123.781 0.676 . . . . 0.0 112.222 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.4 tt -153.76 125.07 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -144.01 134.17 24.3 Favored 'General case' 0 CA--C 1.492 -1.259 0 CA-C-O 121.184 0.516 . . . . 0.0 109.886 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 78' ' ' VAL . 55.3 m -101.41 114.95 29.41 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.959 0.903 . . . . 0.0 110.339 -175.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -90.58 119.84 31.16 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -92.72 150.94 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -141.88 139.52 32.63 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.6 -135.23 3.83 Favored Glycine 0 CA--C 1.486 -1.759 0 N-CA-C 107.61 -2.196 . . . . 0.0 107.61 174.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.31 140.86 32.87 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -85.69 -19.6 30.65 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.31 96.46 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 126.546 1.938 . . . . 0.0 108.084 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -71.45 -37.55 71.38 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 116.572 -1.68 . . . . 0.0 111.97 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.3 mm -55.63 -55.75 15.77 Favored 'Isoleucine or valine' 0 C--N 1.365 1.272 0 CA-C-N 119.631 1.105 . . . . 0.0 110.958 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -58.27 -42.97 87.69 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.525 1.13 . . . . 0.0 111.416 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 15.58 1.75 Allowed 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mm -78.52 -23.91 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.14 -15.96 48.64 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.873 176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.42 150.06 43.7 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -77.39 -19.61 55.91 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 124.51 1.124 . . . . 0.0 111.311 -172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -77.54 -40.16 43.54 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 123.159 0.584 . . . . 0.0 109.977 -173.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -119.47 34.02 5.39 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.17 129.15 1.08 Allowed Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 106.661 -2.576 . . . . 0.0 106.661 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -99.27 159.24 30.62 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -71.85 131.17 17.9 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 122.911 2.407 . . . . 0.0 106.822 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -125.54 126.05 44.2 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 65.51 -102.49 0.08 Allowed 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 125.26 1.424 . . . . 0.0 110.99 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.78 105.68 3.45 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 103.692 -2.707 . . . . 0.0 103.692 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 3.5 p30 75.58 1.9 3.68 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 129.503 3.121 . . . . 0.0 114.717 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.32 171.63 8.07 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -144.71 119.04 9.56 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -170.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.2 tt -98.1 138.71 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -77.34 165.39 24.52 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 121.615 0.721 . . . . 0.0 112.785 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -105.24 -27.74 11.36 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -106.1 81.12 1.59 Allowed 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.0 p -41.1 120.11 1.3 Allowed 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.987 2.515 . . . . 0.0 113.816 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.37 158.24 16.48 Favored 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.1 mt-30 -79.92 149.49 30.86 Favored 'General case' 0 CA--C 1.472 -2.031 0 CA-C-N 113.912 -1.495 . . . . 0.0 107.384 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG21 HH22 ' A' ' 101' ' ' ARG . 0.9 OUTLIER -150.3 148.51 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.1 m -126.53 105.49 8.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 165.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -88.51 98.48 11.66 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.84 119.49 29.38 Favored 'General case' 0 CA--C 1.477 -1.832 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -108.76 142.37 39.39 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -78.37 125.68 29.71 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.52 1.528 . . . . 0.0 107.459 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.39 47.06 2.57 Favored 'General case' 0 CA--C 1.489 -1.383 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -85.71 -69.44 1.35 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.68 -31.06 5.69 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 107.14 -2.384 . . . . 0.0 107.14 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 26.6 p -85.55 145.4 41.94 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -79.57 -23.5 7.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.024 1.816 . . . . 0.0 108.773 170.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -99.61 165.84 13.95 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 117.979 -1.01 . . . . 0.0 108.994 -168.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -71.91 144.83 44.06 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 122.604 2.202 . . . . 0.0 108.141 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -86.22 165.17 52.32 Favored 'Cis proline' 0 N--CA 1.438 -1.756 0 CA-C-N 122.432 1.904 . . . . 0.0 107.914 9.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 63.9 m -132.57 126.49 32.91 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -89.8 136.75 32.85 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -124.67 122.6 37.96 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.88 115.15 27.82 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.57 126.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.9 m -117.58 103.55 10.17 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.56 130.49 35.16 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 120.819 0.342 . . . . 0.0 110.38 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.01 172.86 16.61 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 106.867 -2.493 . . . . 0.0 106.867 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.0 t80 -154.3 99.82 2.24 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 103.159 -2.904 . . . . 0.0 103.159 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.606 HH22 HG21 ' A' ' 78' ' ' VAL 0.256 0.0 OUTLIER -161.65 -179.78 7.54 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -174.623 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -69.13 133.14 47.64 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 124.124 0.969 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 m -87.9 142.77 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.198 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.5 t -104.66 110.09 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 165.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -106.65 152.38 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.03 49.19 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.2 t -109.72 131.28 55.21 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 124.745 1.278 . . . . 0.0 111.229 -174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -124.27 136.54 54.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 164.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.304 14.2 p30 64.15 21.56 12.6 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 169.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.9 16.87 57.41 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.29 0.9 OUTLIER -135.33 134.29 21.18 Favored Pre-proline 0 CA--C 1.487 -1.478 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -176.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.02 109.67 2.93 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 106.173 -2.28 . . . . 0.0 106.173 168.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.3 m -94.46 -12.16 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 118.11 0.413 . . . . 0.0 110.438 -173.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -150.66 155.74 39.96 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -165.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.85 125.34 52.67 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -80.94 128.68 33.95 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -106.59 51.04 0.75 Allowed 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.2 t -87.19 -47.23 9.04 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -32.12 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.334 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -87.57 -10.23 52.14 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.304 -163.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.08 -33.83 61.71 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.382 0.427 . . . . 0.0 110.221 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.39 128.52 84.15 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 173.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 N-CA-C 106.669 -2.089 . . . . 0.0 106.669 -174.325 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 . . . . . 0 CA--C 1.489 -1.383 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -148.27 90.19 1.79 Allowed 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 81.71 5.78 1.21 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 127.396 2.278 . . . . 0.0 108.002 -170.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.0 t -91.2 -30.63 16.55 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 171.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -72.29 -41.15 66.97 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.621 ' CE1' HD22 ' A' ' 111' ' ' LEU . 67.3 t80 -52.29 -60.65 2.96 Favored 'General case' 0 N--CA 1.406 -2.626 0 C-N-CA 127.311 2.244 . . . . 0.0 113.665 170.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.558 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 30.9 p -69.65 -20.96 63.57 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -175.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -78.71 -37.02 42.53 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 119.352 0.978 . . . . 0.0 110.155 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.83 -41.71 87.53 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.601 1.56 . . . . 0.0 109.625 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.397 0.3 OUTLIER -91.23 -4.46 55.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -176.849 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.3 m -75.9 -43.32 45.82 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 166.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -67.21 -40.54 86.45 Favored 'General case' 0 CA--C 1.488 -1.421 0 O-C-N 123.605 0.565 . . . . 0.0 111.201 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -106.75 -56.98 2.12 Favored 'General case' 0 N--CA 1.414 -2.268 0 CA-C-O 118.621 -0.704 . . . . 0.0 111.661 -166.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 9.5 t80 -74.51 114.26 12.7 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 119.989 1.268 . . . . 0.0 110.438 -168.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.81 94.5 3.4 Favored 'General case' 0 CA--C 1.481 -1.692 0 N-CA-C 101.295 -3.594 . . . . 0.0 101.295 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.3 -33.54 0.65 Allowed 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 119.717 3.229 . . . . 0.0 119.717 -163.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -151.34 155.99 34.77 Favored Pre-proline 0 N--CA 1.432 -1.326 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 166.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -73.3 156.87 50.51 Favored 'Trans proline' 0 N--CA 1.433 -2.073 0 C-N-CA 123.215 2.61 . . . . 0.0 110.049 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.46 -60.7 2.22 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 104.438 -2.43 . . . . 0.0 104.438 164.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.09 -177.01 14.66 Favored Glycine 0 CA--C 1.479 -2.19 1 N-CA-C 103.019 -4.032 . . . . 0.0 103.019 163.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.0 mtm180 -125.46 67.65 1.15 Allowed 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -137.64 179.12 6.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -69.43 -24.17 63.78 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.824 0.85 . . . . 0.0 112.861 -171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -84.89 -21.28 29.78 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.237 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.75 -43.72 58.24 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 174.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HA ' HG22 ' A' ' 29' ' ' ILE . 4.3 t -81.3 -21.66 39.13 Favored 'General case' 0 N--CA 1.412 -2.359 0 C-N-CA 117.936 -1.506 . . . . 0.0 112.543 -171.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.75 -34.34 66.97 Favored 'General case' 0 N--CA 1.437 -1.104 0 O-C-N 121.879 -0.513 . . . . 0.0 110.417 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 t -70.58 -35.15 72.89 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.1 tt -86.28 -25.26 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 CA-C-N 118.214 0.461 . . . . 0.0 110.943 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.2 mmt -77.31 -28.82 53.36 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 121.7 -0.625 . . . . 0.0 109.789 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.26 -38.51 71.89 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.054 0.942 . . . . 0.0 112.204 170.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -70.4 -51.63 28.22 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 124.531 1.132 . . . . 0.0 110.893 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.17 -30.52 62.28 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.882 0.873 . . . . 0.0 109.11 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.65 60.49 2.97 Favored Glycine 0 CA--C 1.472 -2.645 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.57 16.17 22.39 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 170.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 t -100.04 0.47 40.95 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.4 t -129.79 104.08 17.25 Favored Pre-proline 0 N--CA 1.435 -1.201 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.96 156.48 99.41 Favored 'Cis proline' 0 N--CA 1.442 -1.508 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -20.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.428 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -66.81 116.38 7.63 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.132 0.973 . . . . 0.0 111.107 -174.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -82.27 146.2 29.59 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -75.06 -29.75 60.81 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 124.901 1.28 . . . . 0.0 113.064 -170.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 128.25 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -141.9 137.15 31.13 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.7 m -103.78 129.95 51.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -103.97 115.24 30.09 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 169.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mm -80.3 149.81 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 C-N-CA 126.132 1.773 . . . . 0.0 107.029 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.53 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.4 m-70 -136.35 131.49 34.35 Favored 'General case' 0 CA--C 1.488 -1.415 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.54 -145.84 9.9 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 106.353 -2.699 . . . . 0.0 106.353 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -105.08 148.24 27.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -84.37 -18.07 37.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.9 mtt85 -82.34 -21.82 35.81 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.2 t -72.81 -39.83 66.32 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 118.462 -0.78 . . . . 0.0 108.996 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.73 -50.98 75.76 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.579 1.151 . . . . 0.0 111.01 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -61.46 -39.36 90.58 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 123.783 0.833 . . . . 0.0 112.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.07 6.45 5.28 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.5 mm -73.82 -30.61 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.6 m -82.73 -7.08 59.67 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -80.05 159.03 26.31 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -87.49 -4.59 58.99 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.548 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -80.69 -45.68 16.76 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -122.59 39.91 3.81 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -169.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.59 166.84 32.48 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 104.974 -3.25 . . . . 0.0 104.974 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.95 159.29 35.93 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -172.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -76.96 137.71 17.77 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.218 1.945 . . . . 0.0 107.671 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -124.83 139.09 54.16 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 66.29 -103.21 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.423 1.089 . . . . 0.0 110.227 172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -163.36 113.75 1.37 Allowed 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.374 0.8 OUTLIER 74.13 7.29 4.75 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 129.528 3.131 . . . . 0.0 114.376 177.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 HG12 ' A' ' 104' ' ' VAL . 2.5 mm? -107.51 164.7 11.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.525 -3.509 . . . . 0.0 101.525 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -150.31 105.49 3.35 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -166.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -85.64 138.58 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -79.88 166.17 21.93 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.412 -178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -112.92 -16.2 12.74 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.5 t -109.93 87.85 2.61 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.8 t -46.79 124.21 5.92 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 127.958 2.503 . . . . 0.0 112.238 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -104.66 155.98 18.39 Favored 'General case' 0 CA--C 1.478 -1.82 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.421 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 4.6 mt-30 -80.28 152.08 29.23 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.36 151.19 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -168.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.0 m -132.47 102.61 5.79 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 165.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.1 m -86.38 102.08 13.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.5 m -92.02 128.17 37.76 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -113.96 147.42 38.59 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 102.47 -3.159 . . . . 0.0 102.47 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.5 tp -72.27 128.93 37.16 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -142.1 46.85 1.63 Allowed 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 104.251 -2.5 . . . . 0.0 104.251 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -97.54 -65.57 0.9 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 105.498 -3.041 . . . . 0.0 105.498 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.28 -23.78 11.06 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.8 m -85.7 143.33 38.05 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -79.65 -22.98 7.42 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 C-N-CA 122.049 1.833 . . . . 0.0 108.725 168.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -106.28 157.3 35.25 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.637 -168.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.44 150.34 36.2 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.441 2.094 . . . . 0.0 108.401 -173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -83.32 167.33 64.01 Favored 'Cis proline' 0 N--CA 1.44 -1.657 0 CA-C-N 122.423 1.901 . . . . 0.0 108.742 1.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.3 m -147.75 141.61 25.79 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -87.23 146.79 25.84 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -128.65 118.57 23.14 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -79.27 108.53 12.85 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 173.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.82 126.75 34.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.8 m -116.68 108.66 16.18 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.79 122.22 24.46 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.95 179.46 16.22 Favored Glycine 0 N--CA 1.433 -1.504 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.8 t80 -162.28 101.61 1.09 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.727 -3.434 . . . . 0.0 101.727 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 170.28 22.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.814 -171.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -75.01 130.71 39.82 Favored 'General case' 0 CA--C 1.489 -1.393 0 C-N-CA 124.225 1.01 . . . . 0.0 109.556 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.0 m -87.7 130.5 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HD12 ' A' ' 69' ' ' LEU . 59.2 t -102.89 80.45 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.3 m -95.88 142.59 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.96 39.15 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.5 m -100.04 141.81 32.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 124.298 0.999 . . . . 0.0 111.237 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.73 130.41 19.05 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 12.1 p30 62.59 18.25 10.34 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 128.153 2.581 . . . . 0.0 115.372 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.62 -10.67 61.04 Favored Glycine 0 C--N 1.353 1.483 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.621 HD22 ' CE1' ' A' ' 6' ' ' TYR . 7.3 mt -102.76 144.04 27.81 Favored Pre-proline 0 CA--C 1.478 -1.797 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.83 114.66 4.09 Favored 'Trans proline' 0 N--CA 1.428 -2.359 0 N-CA-C 105.269 -2.627 . . . . 0.0 105.269 161.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 m -99.77 -15.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 69.1 t60 -149.03 175.41 11.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -169.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.62 129.12 2.59 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.26 135.81 39.66 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.926 174.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.18 37.44 1.25 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 t -95.75 -16.6 21.83 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 119' ' ' ILE . 1.7 pt -95.53 -21.39 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.246 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -106.28 -23.94 12.42 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.72 -170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -134.16 73.06 1.48 Allowed 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -69.83 129.35 91.17 Favored Pre-proline 0 N--CA 1.432 -1.349 0 CA-C-N 113.042 -1.89 . . . . 0.0 107.983 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.433 -2.037 0 N-CA-C 106.279 -2.239 . . . . 0.0 106.279 -176.612 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 CA--C 1.487 -1.458 0 CA-C-O 120.683 0.278 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.5 59.99 0.74 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -91.98 -24.1 19.34 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -91.44 -1.8 57.45 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.826 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -74.32 -43.76 55.33 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 4.6 t80 -58.76 -52.67 64.72 Favored 'General case' 0 N--CA 1.41 -2.449 0 C-N-CA 124.939 1.295 . . . . 0.0 111.633 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.51 2.5 t -89.94 12.77 16.5 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -177.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -82.19 -40.23 22.02 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 120.204 -1.56 . . . . 0.0 108.1 156.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.92 -41.64 83.13 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.366 1.066 . . . . 0.0 109.525 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 14' ' ' TYR . 19.4 mt -83.84 -13.84 52.69 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.1 m -65.55 -53.21 45.24 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 120.411 1.46 . . . . 0.0 107.811 167.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 4.9 pt20 -81.64 -17.14 49.13 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 84.4 m-70 -110.97 -55.03 2.54 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 118.965 0.802 . . . . 0.0 111.151 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 43.7 t80 -76.34 122.27 24.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.683 1.128 . . . . 0.0 109.208 -168.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -136.21 97.58 3.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 100.633 -3.84 . . . . 0.0 100.633 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.59 -38.45 4.25 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -166.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 140.57 9.92 Favored Pre-proline 0 N--CA 1.435 -1.21 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 165.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 81.1 Cg_exo -73.18 175.83 9.98 Favored 'Trans proline' 0 N--CA 1.436 -1.884 0 C-N-CA 122.794 2.33 . . . . 0.0 113.794 -176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -73.21 -73.05 0.22 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.3 -176.66 14.61 Favored Glycine 0 CA--C 1.478 -2.249 1 N-CA-C 102.428 -4.269 . . . . 0.0 102.428 163.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -115.16 72.81 0.81 Allowed 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -147.83 -179.34 6.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -71.1 -21.66 62.19 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.714 1.206 . . . . 0.0 112.867 -172.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -88.79 -15.47 34.54 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -79.1 -39.04 34.71 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 m -68.79 -34.32 75.34 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -66.85 -44.93 79.73 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 123.551 0.741 . . . . 0.0 109.587 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.5 t -64.75 -35.68 81.86 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 123.384 0.673 . . . . 0.0 112.54 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.29 13.3 tt -83.72 -28.97 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.973 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.17 -23.55 43.84 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 117.657 -1.617 . . . . 0.0 111.724 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -79.4 -32.9 43.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 118.995 0.816 . . . . 0.0 111.042 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.21 -47.97 15.03 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 123.327 0.651 . . . . 0.0 110.064 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -76.81 -32.04 57.36 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.68 66.7 1.53 Allowed Glycine 0 CA--C 1.476 -2.347 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.9 31.13 6.75 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 162.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.64 2.65 44.69 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.1 p -124.64 94.77 43.95 Favored Pre-proline 0 N--CA 1.427 -1.578 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.48 167.1 81.05 Favored 'Cis proline' 0 N--CA 1.443 -1.498 0 N-CA-C 106.981 -1.969 . . . . 0.0 106.981 -24.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.2 m -63.3 116.05 5.12 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 124.352 1.061 . . . . 0.0 111.115 -174.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -74.26 134.62 42.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -71.15 -35.4 71.68 Favored 'General case' 0 N--CA 1.433 -1.279 0 O-C-N 124.373 1.045 . . . . 0.0 112.295 -168.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.43 136.34 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -147.58 122.11 9.77 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.7 m -90.89 106.33 18.44 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -85.88 121.37 28.42 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.0 mm -93.0 148.91 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.44 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -141.15 132.87 27.27 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.36 -137.32 4.59 Favored Glycine 0 CA--C 1.483 -1.935 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -113.43 144.62 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -85.45 -17.5 36.36 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.906 -169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -82.26 -26.65 32.99 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.8 p -77.67 -30.11 51.83 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-O 117.259 -1.353 . . . . 0.0 110.658 173.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.93 -46.34 96.67 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 CA-C-N 119.403 1.001 . . . . 0.0 110.627 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -60.42 -38.82 85.26 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.487 1.115 . . . . 0.0 111.828 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 9.85 5.85 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.705 1.202 . . . . 0.0 113.889 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.48 -17.92 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 170.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.6 t -66.37 -69.94 0.27 Allowed 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.452 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -141.19 118.95 11.71 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' H ' ' H ' ' A' ' 60' ' ' LYS . 54.8 t30 -159.88 -3.46 0.07 Allowed 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 164.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' H ' ' H ' ' A' ' 59' ' ' ASN 0.386 62.5 pttt 57.81 26.96 13.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.859 2.064 . . . . 0.0 111.748 -156.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -105.57 -14.74 15.19 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 102.869 -3.012 . . . . 0.0 102.869 167.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -137.77 139.98 10.87 Favored Glycine 0 CA--C 1.488 -1.636 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 160.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.39 153.88 43.23 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -69.68 143.27 50.68 Favored 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 122.824 2.349 . . . . 0.0 108.513 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -145.56 130.84 18.55 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 -171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 66.39 -103.59 0.08 Allowed 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.884 1.273 . . . . 0.0 109.549 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -156.66 102.64 2.05 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.335 0.0 OUTLIER 90.93 -12.7 0.26 Allowed 'General case' 0 C--N 1.354 0.798 0 C-N-CA 128.323 2.649 . . . . 0.0 112.526 173.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.36 158.61 16.44 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -143.67 114.97 7.98 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.0 tt -92.12 141.15 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 96.7 p -80.8 166.35 21.04 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.708 0.766 . . . . 0.0 110.823 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -120.6 -14.77 8.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.4 t -109.82 86.49 2.31 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.6 p -51.75 131.6 30.51 Favored 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 127.028 2.131 . . . . 0.0 112.293 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -109.16 156.69 19.56 Favored 'General case' 0 CA--C 1.476 -1.896 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 -171.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.61 142.03 40.84 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.9 143.04 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.825 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -166.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.6 m -131.01 108.39 9.76 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 102.61 -3.107 . . . . 0.0 102.61 168.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.6 m -82.69 101.38 10.81 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 71.8 m -88.91 111.42 22.07 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -109.5 137.69 46.97 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -76.3 112.33 12.68 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 125.172 1.389 . . . . 0.0 108.366 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -90.81 147.76 22.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.75 -74.24 0.21 Allowed Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 109.11 28.68 4.31 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.6 p -92.09 127.19 50.35 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -80.44 -29.76 2.27 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 N-CA-C 107.735 -1.679 . . . . 0.0 107.735 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -99.35 148.07 34.17 Favored Pre-proline 0 N--CA 1.427 -1.591 0 CA-C-O 117.738 -1.125 . . . . 0.0 108.476 -168.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -74.91 144.37 30.51 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.643 2.229 . . . . 0.0 107.0 -175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -81.74 160.98 79.84 Favored 'Cis proline' 0 CA--C 1.486 -1.884 0 CA-C-N 123.705 2.359 . . . . 0.0 109.982 10.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.9 m -146.94 146.97 30.3 Favored 'General case' 0 CA--C 1.482 -1.657 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -167.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -102.52 154.19 19.35 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -137.66 125.12 22.0 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -104.68 130.69 52.68 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.24 138.96 31.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 122.826 0.451 . . . . 0.0 110.737 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.2 m -133.25 95.07 3.45 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -94.75 153.31 17.83 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.121 0.486 . . . . 0.0 111.664 -170.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.46 -163.63 12.14 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -149.59 97.9 2.69 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 30.5 ttt-85 -140.65 158.89 43.31 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -165.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -64.55 137.32 57.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.667 1.187 . . . . 0.0 109.679 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.46 136.87 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -104.02 91.37 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.86 138.77 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -86.65 123.63 32.04 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.5 t -103.25 125.93 50.16 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.589 1.181 . . . . 0.0 109.493 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -109.58 126.88 54.07 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 163.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.307 0.4 OUTLIER 31.95 68.55 0.13 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 128.622 2.769 . . . . 0.0 118.359 175.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.42 4.74 90.04 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.453 -0.637 . . . . 0.0 113.23 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.27 0.8 OUTLIER -138.2 135.32 18.34 Favored Pre-proline 0 CA--C 1.486 -1.486 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -176.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -63.53 132.95 37.59 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.817 2.345 . . . . 0.0 106.387 161.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.61 -18.57 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 20.7 t60 -151.92 179.8 8.14 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 -170.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 5.6 tp -151.83 132.47 13.97 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.56 123.57 27.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.89 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -103.56 24.02 11.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.788 -167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.6 p -81.71 -31.58 32.06 Favored 'General case' 0 CA--C 1.497 -1.063 0 O-C-N 121.48 -0.763 . . . . 0.0 113.056 -167.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -32.58 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -175.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -84.21 -21.77 31.1 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.0 -165.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -81.54 -60.22 2.34 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -124.2 107.82 30.05 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo . . . . . 0 N--CA 1.435 -1.967 0 N-CA-C 105.949 -2.366 . . . . 0.0 105.949 172.195 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 . . . . . 0 CA--C 1.487 -1.443 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.31 60.69 0.61 Allowed 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -92.62 -23.36 19.03 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -88.78 0.25 56.68 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.761 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -68.14 -52.23 37.02 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -60.87 -50.72 72.27 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 117.333 -1.318 . . . . 0.0 113.164 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.527 2.3 t -90.82 11.36 22.73 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -81.69 -38.4 25.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 120.087 -1.633 . . . . 0.0 108.381 155.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.02 0.928 . . . . 0.0 109.686 168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.66 -12.55 53.69 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.5 m -65.55 -52.22 54.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 120.68 1.582 . . . . 0.0 108.074 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.9 pt20 -79.31 -28.54 42.18 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -174.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.567 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 87.0 m-70 -100.1 -53.98 3.0 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 119.044 0.838 . . . . 0.0 110.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 48.5 t80 -73.66 134.62 43.65 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 120.296 1.407 . . . . 0.0 111.481 -166.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.62 99.92 2.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 102.92 -2.992 . . . . 0.0 102.92 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.84 -50.93 1.73 Allowed 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 128.061 2.544 . . . . 0.0 117.843 -166.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -142.69 146.59 38.82 Favored Pre-proline 0 N--CA 1.436 -1.13 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.7 Cg_endo -81.38 171.75 13.34 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 123.086 2.524 . . . . 0.0 108.662 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -70.08 -77.97 0.08 Allowed 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.59 -178.88 15.59 Favored Glycine 0 CA--C 1.475 -2.427 1 N-CA-C 101.464 -4.654 . . . . 0.0 101.464 159.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -110.15 74.67 0.89 Allowed 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -136.06 173.1 12.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -74.06 -21.27 60.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.886 0.874 . . . . 0.0 113.23 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -14.18 29.92 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.31 -41.71 63.22 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 169.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.257 0.6 OUTLIER -77.06 -25.42 52.39 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.296 -0.962 . . . . 0.0 113.054 -174.798 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.81 -39.51 73.03 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 m -70.19 -33.06 71.26 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.467 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.7 tt -85.28 -29.74 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-N 118.644 0.656 . . . . 0.0 110.369 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mmt -71.78 -34.76 69.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -67.04 -45.94 75.92 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.265 1.026 . . . . 0.0 113.389 173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -83.37 -32.52 26.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -169.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -74.52 -38.16 62.88 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.59 68.96 1.4 Allowed Glycine 0 CA--C 1.475 -2.451 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.96 29.17 5.24 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.287 -3.227 . . . . 0.0 102.287 163.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 t -81.91 -13.48 57.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 111.721 -2.491 . . . . 0.0 109.963 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.0 t -119.83 106.99 40.82 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.974 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.36 162.89 90.92 Favored 'Cis proline' 0 N--CA 1.444 -1.399 0 N-CA-C 106.977 -1.97 . . . . 0.0 106.977 -22.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB3' HD13 ' A' ' 83' ' ' LEU . 70.2 m -61.3 121.97 13.93 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.139 0.976 . . . . 0.0 110.631 -174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -72.79 134.65 45.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -72.44 -39.11 68.07 Favored 'General case' 0 CA--C 1.492 -1.251 0 O-C-N 123.631 0.582 . . . . 0.0 111.555 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.95 129.08 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 172.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -144.9 120.56 10.47 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.0 m -96.1 116.64 29.29 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.5 127.27 34.85 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 HG21 HD11 ' A' ' 53' ' ' ILE . 9.8 mm -102.35 147.4 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.464 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -170.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.509 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -138.06 133.45 33.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.18 -125.36 1.41 Allowed Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 106.985 -2.446 . . . . 0.0 106.985 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.5 147.28 46.55 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 14' ' ' TYR . 21.7 mtpt -86.26 -3.04 58.9 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -43.05 65.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.657 1.583 . . . . 0.0 107.089 172.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.1 p -80.52 -25.27 38.8 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.681 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 112' ' ' PRO . 18.0 mm -59.78 -59.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 CA-C-N 119.079 0.854 . . . . 0.0 110.195 168.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -55.77 -39.35 71.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 126.02 1.728 . . . . 0.0 112.405 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.74 11.48 2.58 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.67 -31.9 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.245 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 169.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.7 m -79.0 -23.1 44.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.63 156.1 17.86 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -86.57 87.6 7.48 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 121.951 0.882 . . . . 0.0 109.306 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -141.06 -46.51 0.39 Allowed 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.73 58.52 1.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.43 151.88 9.54 Favored Glycine 0 N--CA 1.427 -1.944 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 170.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -107.42 157.83 34.68 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 140.0 32.18 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 122.766 2.31 . . . . 0.0 106.248 160.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -139.82 118.1 12.04 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.81 -103.91 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 124.467 1.107 . . . . 0.0 108.989 176.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -151.87 102.76 2.86 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 1.9 p-10 66.24 18.1 10.86 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 129.516 3.126 . . . . 0.0 114.582 175.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.0 mt -107.35 158.73 16.93 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 100.407 -3.923 . . . . 0.0 100.407 170.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -146.11 119.29 8.88 Favored 'General case' 0 CA--C 1.485 -1.541 0 C-N-CA 118.949 -1.1 . . . . 0.0 108.104 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.53 145.51 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 92.5 p -93.71 149.45 21.22 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -102.46 -8.31 21.2 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.7 t -106.69 85.75 2.21 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.0 m -57.35 126.43 27.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 125.566 1.546 . . . . 0.0 110.501 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -103.71 159.69 15.41 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.403 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 9.2 mm-40 -72.8 135.88 45.32 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 170.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -144.73 147.92 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -165.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.3 m -134.95 107.22 7.22 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 103.474 -2.788 . . . . 0.0 103.474 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.4 m -86.43 105.62 16.88 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.1 m -99.42 116.77 32.33 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -116.97 130.31 56.61 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 39' ' ' CYS . 22.3 tp -74.02 118.03 16.5 Favored 'General case' 0 CA--C 1.496 -1.103 0 C-N-CA 124.916 1.286 . . . . 0.0 108.716 -176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 84' ' ' HIS . 0.3 OUTLIER -90.35 115.5 27.59 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 158.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.76 94.03 1.78 Allowed Glycine 0 CA--C 1.482 -2.011 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -167.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.09 -8.89 49.86 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 166.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.9 t -163.51 110.74 0.98 Allowed Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -80.08 -16.31 11.2 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 122.18 1.92 . . . . 0.0 110.411 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.03 168.08 9.54 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.44 145.54 30.09 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.06 1.84 . . . . 0.0 108.13 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -81.76 163.81 76.62 Favored 'Cis proline' 0 N--CA 1.436 -1.872 0 CA-C-N 122.228 1.831 . . . . 0.0 107.923 -4.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -106.09 174.47 5.87 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -133.58 115.35 14.59 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 167.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -104.17 149.47 25.23 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -100.97 147.35 26.27 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 160.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -117.11 126.41 52.78 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -107.63 108.46 19.74 Favored 'General case' 0 CA--C 1.489 -1.367 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 173.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.88 141.8 34.23 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.2 -175.46 30.17 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.4 t80 -157.69 99.68 1.73 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.905 -2.998 . . . . 0.0 102.905 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -161.61 173.78 14.27 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.81 0.814 . . . . 0.0 109.846 -173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -78.3 151.38 33.0 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 125.406 1.482 . . . . 0.0 111.148 -174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.96 159.18 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.12 96.26 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.302 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 165.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -93.79 132.35 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -88.51 122.58 32.14 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.6 m -98.42 142.29 30.22 Favored 'General case' 0 CA--C 1.488 -1.43 0 O-C-N 124.603 1.189 . . . . 0.0 110.153 -174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -144.09 129.42 18.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 167.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.337 11.2 p30 67.54 15.24 9.77 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 128.1 2.56 . . . . 0.0 115.287 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.22 62.08 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 0.9 OUTLIER -113.92 138.41 22.78 Favored Pre-proline 0 CA--C 1.487 -1.448 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.435 ' HG2' HG22 ' A' ' 53' ' ' ILE . 81.8 Cg_exo -70.34 111.55 2.95 Favored 'Trans proline' 0 N--CA 1.436 -1.894 0 N-CA-C 107.048 -1.943 . . . . 0.0 107.048 166.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.7 m -95.46 -14.32 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 119.173 0.897 . . . . 0.0 110.077 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.451 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 38.6 t60 -155.06 178.52 10.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 8.9 tp -158.9 133.57 8.07 Favored 'General case' 0 CA--C 1.483 -1.632 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -86.66 131.12 34.24 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -106.06 41.06 1.47 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.8 m -97.01 -26.26 15.08 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -171.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.425 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -79.22 -33.99 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.706 0 C-N-CA 123.935 0.894 . . . . 0.0 109.215 176.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.39 19.17 21.03 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -168.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -40.05 68.28 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 124.9 1.28 . . . . 0.0 108.593 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -72.06 137.53 81.96 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo . . . . . 0 N--CA 1.431 -2.177 0 N-CA-C 104.698 -2.847 . . . . 0.0 104.698 172.336 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 . . . . . 0 CA--C 1.486 -1.51 0 CA-C-O 120.696 0.284 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -123.19 49.15 1.71 Allowed 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -107.69 -5.3 17.5 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.4 m -90.21 -33.13 16.3 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -69.29 -35.46 76.04 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.199 1.0 . . . . 0.0 111.1 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' A' ' 10' ' ' LEU . 52.7 t80 -74.29 -46.09 43.43 Favored 'General case' 0 N--CA 1.398 -3.053 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 33.7 p -73.72 -17.87 61.06 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.1 m170 -84.42 -35.89 22.76 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 119.514 1.052 . . . . 0.0 109.42 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -56.69 -45.79 81.58 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.531 1.532 . . . . 0.0 108.519 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -65.82 -29.91 70.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 126.854 2.062 . . . . 0.0 115.109 178.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.7 m -66.93 -52.58 41.3 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.0 pt20 -85.22 -5.05 59.35 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -172.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 88.8 m-70 -123.64 -55.59 1.72 Allowed 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 118.431 -0.795 . . . . 0.0 111.762 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 13.6 t80 -71.29 123.86 23.24 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-N 120.583 1.538 . . . . 0.0 111.919 -169.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -140.88 97.11 3.12 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.19 -41.51 8.3 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -167.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -158.43 140.09 9.87 Favored Pre-proline 0 N--CA 1.434 -1.263 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 163.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -74.44 -178.86 4.28 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.651 2.234 . . . . 0.0 114.168 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -71.92 -64.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.21 -176.39 16.35 Favored Glycine 0 CA--C 1.476 -2.382 1 N-CA-C 102.343 -4.303 . . . . 0.0 102.343 164.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -109.38 75.53 0.95 Allowed 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -145.5 176.42 9.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.17 -22.75 62.93 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 124.327 1.051 . . . . 0.0 113.402 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -89.27 -17.21 29.45 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -76.08 -40.86 52.12 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 172.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.2 m -70.3 -33.28 71.35 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -68.06 -43.58 78.29 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.939 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 83.8 p -76.06 -23.88 55.09 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.274 12.5 tt -85.87 -28.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 CA-C-N 119.081 0.855 . . . . 0.0 110.06 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.4 mmm -79.1 -24.05 43.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 118.502 -1.279 . . . . 0.0 109.621 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.505 HH12 ' HA ' ' A' ' 91' ' ' PRO . 14.7 tpt180 -74.53 -49.33 22.4 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 122.605 0.362 . . . . 0.0 111.694 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -86.44 -32.6 20.77 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.273 -168.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -76.79 -33.84 58.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.89 71.23 1.29 Allowed Glycine 0 CA--C 1.478 -2.238 0 C-N-CA 124.987 1.279 . . . . 0.0 112.028 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.331 2.5 mm? -108.08 0.02 21.44 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 167.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -80.31 -3.78 50.77 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.005 -167.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.1 t -129.42 108.16 17.51 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.66 153.77 98.76 Favored 'Cis proline' 0 N--CA 1.443 -1.447 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 -22.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.2 m -62.77 123.27 18.02 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 125.483 1.513 . . . . 0.0 112.197 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -74.12 139.62 44.69 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -76.8 -41.52 44.13 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.644 0.778 . . . . 0.0 111.899 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 tt -154.6 134.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -154.52 167.23 30.78 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.0 m -128.89 127.27 41.48 Favored 'General case' 0 CA--C 1.486 -1.493 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.91 127.53 39.72 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.273 4.9 mm -94.35 146.03 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -139.8 127.77 22.19 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.06 -151.58 18.84 Favored Glycine 0 CA--C 1.484 -1.892 0 N-CA-C 105.375 -3.09 . . . . 0.0 105.375 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.23 144.37 25.92 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -79.24 -22.0 45.4 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -70.54 -33.98 71.74 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 124.441 1.096 . . . . 0.0 110.532 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 p -76.68 -31.39 57.24 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 116.906 -1.521 . . . . 0.0 111.265 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -48.71 84.36 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-N 119.739 1.154 . . . . 0.0 110.996 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.29 -36.6 84.58 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.34 0.656 . . . . 0.0 111.657 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.78 4.91 10.56 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mm -75.94 -24.92 16.82 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.9 m -73.72 -24.59 59.94 Favored 'General case' 0 N--CA 1.438 -1.061 0 O-C-N 122.124 -0.36 . . . . 0.0 111.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -79.68 164.8 23.46 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -93.2 0.0 56.99 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.429 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.57 -33.11 28.17 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 122.899 0.48 . . . . 0.0 110.848 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -134.73 7.31 3.5 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -149.08 -162.91 10.61 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 104.831 -3.307 . . . . 0.0 104.831 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.59 158.25 27.32 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -74.02 135.36 20.97 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 122.761 2.307 . . . . 0.0 107.162 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -123.07 104.61 9.32 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 69.85 -97.13 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 125.846 1.659 . . . . 0.0 110.528 -177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.45 106.51 3.13 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 -173.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.358 4.5 p30 75.76 2.81 3.77 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 129.725 3.21 . . . . 0.0 114.594 169.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 mt -104.43 158.91 16.15 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -142.97 116.15 8.94 Favored 'General case' 0 CA--C 1.482 -1.67 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 tt -89.32 142.14 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.7 p -81.01 161.41 24.25 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.779 0.8 . . . . 0.0 112.454 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -110.2 -17.95 13.41 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 174.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.6 t -110.06 87.87 2.62 Favored 'General case' 0 CA--C 1.481 -1.691 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 p -52.03 129.67 27.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.671 1.989 . . . . 0.0 111.608 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -106.02 157.37 17.56 Favored 'General case' 0 CA--C 1.476 -1.891 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -75.33 131.99 40.66 Favored 'General case' 0 CA--C 1.471 -2.085 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.94 126.43 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 102.581 -3.118 . . . . 0.0 102.581 -165.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.7 m -119.21 110.18 16.72 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 41.2 m -83.13 105.17 13.89 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 72.4 m -86.81 114.63 23.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.81 136.46 53.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 tp -79.44 127.67 32.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.42 1.088 . . . . 0.0 109.069 -174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 93.5 m-70 -119.47 171.69 8.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.61 -94.24 1.02 Allowed Glycine 0 CA--C 1.487 -1.695 0 N-CA-C 105.939 -2.865 . . . . 0.0 105.939 -173.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.6 -6.97 1.26 Allowed Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 p -79.0 132.92 62.27 Favored Pre-proline 0 N--CA 1.436 -1.136 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -91.28 -9.22 3.04 Favored 'Trans proline' 0 N--CA 1.435 -1.922 0 N-CA-C 107.877 -1.624 . . . . 0.0 107.877 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -109.76 155.58 41.24 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.95 146.19 29.12 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.369 2.046 . . . . 0.0 107.397 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.505 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.7 Cg_endo -85.99 163.4 56.19 Favored 'Cis proline' 0 N--CA 1.436 -1.899 0 CA-C-N 122.888 2.067 . . . . 0.0 108.521 12.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.8 m -150.99 126.24 9.97 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -85.81 129.23 34.89 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -114.93 133.24 56.17 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 81.8 mtp180 -111.72 137.51 49.52 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.74 140.55 31.17 Favored 'General case' 0 CA--C 1.487 -1.452 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.157 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.7 m -123.34 110.3 15.0 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 164.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.62 155.85 23.01 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.549 0.69 . . . . 0.0 109.9 -175.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.96 176.1 37.58 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 106.914 -2.474 . . . . 0.0 106.914 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -150.11 91.63 1.79 Allowed 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 101.932 -3.358 . . . . 0.0 101.932 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -146.73 169.21 19.52 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -168.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -72.03 145.44 48.29 Favored 'General case' 0 CA--C 1.486 -1.517 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.427 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.8 m -101.99 138.39 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -103.04 87.78 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.235 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 172.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.82 132.88 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.171 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -95.82 125.29 40.28 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 38.9 m -109.03 153.79 23.12 Favored 'General case' 0 CA--C 1.485 -1.533 0 O-C-N 124.414 1.071 . . . . 0.0 110.985 -171.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -140.33 129.73 23.97 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 171.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 9.4 p30 68.16 12.44 8.77 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 126.984 2.114 . . . . 0.0 114.84 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 13.15 60.1 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.64 144.89 52.69 Favored Pre-proline 0 CA--C 1.496 -1.118 0 N-CA-C 103.498 -2.778 . . . . 0.0 103.498 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 67.1 Cg_exo -68.84 150.94 74.15 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 121.858 1.705 . . . . 0.0 110.694 -175.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.57 -14.08 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 51.1 t60 -158.07 174.91 14.5 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -169.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.459 HD12 ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -158.1 128.68 6.28 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -77.35 137.2 38.61 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.67 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -105.41 42.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.6 m -91.92 -33.77 14.76 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.2 -29.41 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.896 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.298 172.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -109.64 32.72 4.82 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -169.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -86.08 -44.76 12.01 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.12 144.94 40.71 Favored Pre-proline 0 N--CA 1.427 -1.579 0 N-CA-C 101.861 -3.385 . . . . 0.0 101.861 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.433 -2.076 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 -177.924 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.488 -1.437 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.34 62.96 0.61 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -100.17 -22.78 15.04 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 t -89.52 -7.43 54.96 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.924 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -72.75 -42.92 63.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -59.23 -48.23 82.4 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 117.62 -1.181 . . . . 0.0 112.409 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.465 2.9 t -89.86 10.75 22.53 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -78.16 -42.07 32.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 O-C-N 120.193 -1.567 . . . . 0.0 107.34 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.14 -35.18 76.39 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.037 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 14' ' ' TYR . 21.8 mt -86.15 -15.42 41.09 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 119.444 1.02 . . . . 0.0 113.399 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 m -65.8 -49.0 69.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 119.827 1.194 . . . . 0.0 108.703 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -71.59 -42.66 67.48 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -99.45 -51.42 3.79 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.695 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.481 ' HB2' HD22 ' A' ' 10' ' ' LEU . 23.2 t80 -77.07 116.39 17.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 119.278 0.945 . . . . 0.0 110.7 -167.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.12 100.35 4.69 Favored 'General case' 0 N--CA 1.421 -1.921 1 N-CA-C 98.538 -4.615 . . . . 0.0 98.538 174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.35 -33.5 9.09 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -165.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -154.79 144.46 15.4 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 168.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.571 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 10.7 Cg_endo -74.41 154.72 45.71 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 C-N-CA 122.979 2.453 . . . . 0.0 109.638 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -77.88 -60.84 2.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.05 178.28 16.95 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 103.304 -3.919 . . . . 0.0 103.304 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -123.74 57.91 1.17 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.34 177.75 8.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -172.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -71.71 -18.96 62.12 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.591 1.156 . . . . 0.0 113.736 -169.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -82.5 -28.03 31.38 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.47 -41.31 63.32 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -81.2 -25.21 36.91 Favored 'General case' 0 N--CA 1.425 -1.699 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.561 -171.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.87 -45.37 82.37 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -64.94 -41.13 95.78 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 26' ' ' CYS . 10.3 tt -79.51 -29.58 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.25 0 CA-C-O 119.482 -0.294 . . . . 0.0 111.141 -175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -26.22 58.16 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.468 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -77.53 -34.18 54.01 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 117.962 0.346 . . . . 0.0 110.866 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -73.75 -52.63 12.56 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.332 0.653 . . . . 0.0 111.639 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.01 -36.38 79.88 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 123.269 0.628 . . . . 0.0 111.561 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.05 71.65 1.31 Allowed Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.321 3.4 mm? -97.99 -8.87 27.09 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 164.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 p -81.0 1.64 30.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 113.386 -1.734 . . . . 0.0 113.623 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 p -119.22 98.82 50.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.741 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.3 163.16 90.53 Favored 'Cis proline' 0 N--CA 1.443 -1.493 0 N-CA-C 106.595 -2.117 . . . . 0.0 106.595 -27.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.3 m -64.85 121.82 15.5 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -166.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -70.51 140.68 51.91 Favored 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 126.622 1.969 . . . . 0.0 107.661 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -70.87 -46.97 61.67 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 123.725 0.81 . . . . 0.0 113.14 -171.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 tt -149.64 129.61 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -154.84 137.44 15.15 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 86.2 m -101.5 137.02 40.38 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.953 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -100.43 119.96 39.27 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 167.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -89.92 150.31 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.618 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.571 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -142.59 139.74 31.45 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.286 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.8 -136.34 5.12 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 107.103 -2.399 . . . . 0.0 107.103 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' SER . 1.2 m120 -95.3 140.06 30.72 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -85.34 -21.01 29.09 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HB3' HD22 ' A' ' 49' ' ' ASN . 65.5 ttt180 -70.2 -36.38 74.56 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 126.368 1.867 . . . . 0.0 108.874 174.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 49' ' ' ASN . 39.5 m -72.5 -38.41 68.12 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 117.364 -1.303 . . . . 0.0 110.776 176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.7 -48.47 85.83 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 CA-C-N 118.904 0.775 . . . . 0.0 111.402 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -62.06 -42.1 98.83 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 123.147 0.579 . . . . 0.0 111.473 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.24 7.59 5.0 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.422 HD12 ' CB ' ' A' ' 72' ' ' SER . 24.0 mm -74.74 -32.33 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.09 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 169.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 47.2 t -71.88 -34.28 69.04 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 123.149 0.281 . . . . 0.0 110.751 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.09 160.21 33.3 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.451 0.643 . . . . 0.0 110.032 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -75.96 -28.91 58.09 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.823 0.849 . . . . 0.0 109.389 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -77.12 124.65 28.11 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 44.2 t30 73.64 36.14 0.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 128.058 2.543 . . . . 0.0 112.679 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.14 148.88 5.58 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -98.36 152.09 37.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -172.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.45 131.35 18.73 Favored 'Trans proline' 0 N--CA 1.437 -1.848 0 C-N-CA 122.858 2.372 . . . . 0.0 106.272 162.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -121.56 103.05 8.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.486 ' HG3' ' H ' ' A' ' 67' ' ' GLU 0.338 14.5 ptp180 49.47 -107.33 0.24 Allowed 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 128.077 2.551 . . . . 0.0 115.264 177.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' H ' ' HG3' ' A' ' 66' ' ' ARG . 34.2 tt0 -103.74 77.53 1.48 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.516 1.126 . . . . 0.0 108.058 -167.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.317 1.6 p-10 62.25 26.65 15.98 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 129.45 3.1 . . . . 0.0 114.713 169.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 mt -107.71 164.41 12.26 Favored 'General case' 0 CA--C 1.477 -1.853 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 174.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -142.94 122.45 13.2 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.3 138.14 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 56' ' ' ILE . 82.8 p -82.81 153.98 24.94 Favored 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 121.818 0.818 . . . . 0.0 112.655 -172.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 -27.23 14.95 Favored 'General case' 0 CA--C 1.491 -1.299 0 CA-C-N 114.392 -1.276 . . . . 0.0 107.955 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.4 p -105.77 84.02 2.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.6 p -51.17 130.84 27.15 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.9 1.68 . . . . 0.0 111.152 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -107.59 163.92 12.66 Favored 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -165.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.42 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 10.7 mt-30 -75.68 141.94 42.62 Favored 'General case' 0 CA--C 1.475 -1.924 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.38 145.37 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -169.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.0 m -134.8 103.92 5.81 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 170.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.2 m -87.34 106.37 17.89 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.0 m -99.74 128.25 45.85 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -118.8 138.41 52.72 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 -176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -73.69 116.73 14.63 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 125.703 1.601 . . . . 0.0 110.022 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -84.57 110.14 18.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.26 93.17 1.81 Allowed Glycine 0 CA--C 1.484 -1.858 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.08 -11.49 49.13 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 104.888 -3.285 . . . . 0.0 104.888 161.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.5 t -165.19 132.93 2.41 Favored Pre-proline 0 N--CA 1.431 -1.379 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -78.15 -25.38 7.3 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 122.319 2.012 . . . . 0.0 109.328 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -89.58 160.27 42.12 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.26 147.13 32.59 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.282 1.988 . . . . 0.0 108.132 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -82.98 165.69 69.64 Favored 'Cis proline' 0 N--CA 1.439 -1.7 0 CA-C-N 122.879 2.064 . . . . 0.0 108.932 5.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 31.3 m -145.15 125.96 14.34 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -169.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -79.75 131.75 36.0 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 172.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -112.74 120.63 42.17 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -88.32 117.93 27.57 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 137.69 35.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.883 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.9 m -120.32 106.66 12.09 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 170.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.38 149.95 30.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.108 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.04 -175.14 34.62 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 89.7 t80 -150.86 97.87 2.53 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 101.241 -3.615 . . . . 0.0 101.241 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -144.25 150.81 38.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -159.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -83.24 144.98 29.39 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.752 1.221 . . . . 0.0 109.165 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.3 m -98.98 153.37 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -173.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.46 94.4 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 162.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.4 m -91.29 134.97 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 104.646 -2.353 . . . . 0.0 104.646 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -93.36 133.4 36.65 Favored 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.33 134.27 55.3 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.168 0.918 . . . . 0.0 111.317 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -127.44 136.59 52.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 167.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.328 5.0 p30 73.54 4.41 4.77 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.891 2.077 . . . . 0.0 116.582 168.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.78 19.69 28.56 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.254 0.7 OUTLIER -136.86 133.09 18.61 Favored Pre-proline 0 CA--C 1.49 -1.357 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 -178.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.98 113.47 3.8 Favored 'Trans proline' 0 N--CA 1.435 -1.944 0 N-CA-C 106.482 -2.161 . . . . 0.0 106.482 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -96.53 -7.38 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.465 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 49.7 t60 -159.0 177.5 11.07 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 -168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -167.0 133.59 2.32 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 102.822 -3.029 . . . . 0.0 102.822 -178.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -78.26 138.03 38.41 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.071 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -101.3 41.76 1.17 Allowed 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -98.48 -32.22 11.58 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -72.27 -36.91 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.781 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.771 170.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -105.39 34.1 3.4 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -170.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -97.18 -27.64 14.46 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 133.26 79.74 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 170.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo . . . . . 0 N--CA 1.434 -1.98 0 N-CA-C 105.287 -2.62 . . . . 0.0 105.287 177.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 . . . . . 0 CA--C 1.484 -1.57 0 CA-C-O 120.594 0.235 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -120.4 47.62 1.74 Allowed 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -109.61 -3.64 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 t -91.53 -27.52 18.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -68.4 -50.56 52.03 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 124.367 1.067 . . . . 0.0 111.836 -172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.45 ' HB2' HD23 ' A' ' 111' ' ' LEU 0.269 76.9 t80 -53.07 -53.76 45.51 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.697 169.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -69.16 -15.95 63.52 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -83.77 -36.36 23.65 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-N 119.912 1.233 . . . . 0.0 110.267 173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.732 1.213 . . . . 0.0 109.915 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.479 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -79.53 -26.94 41.36 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.83 2.052 . . . . 0.0 112.239 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.9 m -68.4 -52.48 32.47 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 40.3 mt-30 -68.53 -42.27 78.7 Favored 'General case' 0 CA--C 1.484 -1.563 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 85.8 m-70 -105.38 -41.67 5.45 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.343 -165.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 14.6 t80 -76.02 120.16 20.96 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-N 120.805 1.639 . . . . 0.0 111.731 -173.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -140.8 99.72 3.68 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 100.82 -3.77 . . . . 0.0 100.82 170.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -40.92 11.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.423 2.289 . . . . 0.0 117.115 -167.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -156.42 144.89 14.55 Favored Pre-proline 0 N--CA 1.433 -1.297 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 83.0 Cg_exo -76.65 176.84 9.58 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.654 1.569 . . . . 0.0 113.787 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -73.93 -60.2 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 165.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -151.07 -175.01 22.54 Favored Glycine 0 CA--C 1.477 -2.287 0 N-CA-C 103.322 -3.911 . . . . 0.0 103.322 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.03 74.4 0.86 Allowed 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -148.08 170.89 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.75 -22.21 61.64 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -169.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -79.75 -26.57 40.68 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.124 0.42 . . . . 0.0 110.214 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.89 -43.71 62.15 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.27 0.5 OUTLIER -80.57 -25.36 38.6 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 119.02 -1.072 . . . . 0.0 113.061 -169.794 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.19 -36.79 69.31 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.307 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -69.86 -35.19 74.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 26' ' ' CYS . 15.2 tt -83.15 -29.22 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.332 0 CA-C-N 118.338 0.517 . . . . 0.0 110.096 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.4 mmt -73.53 -34.27 65.14 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.328 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 HH12 ' HA ' ' A' ' 91' ' ' PRO . 17.4 tpp180 -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.013 0.925 . . . . 0.0 111.844 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -74.04 -49.05 25.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 123.865 0.866 . . . . 0.0 110.796 -171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -70.82 -37.89 73.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.199 1.0 . . . . 0.0 109.99 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.98 70.16 1.26 Allowed Glycine 0 CA--C 1.481 -2.061 0 C-N-CA 124.275 0.941 . . . . 0.0 111.266 168.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.361 2.5 mm? -104.52 -2.41 25.27 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 163.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.1 t -78.32 -8.57 58.56 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.086 -159.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.4 t -131.92 107.37 13.94 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-O 117.925 -1.036 . . . . 0.0 108.724 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.88 156.66 95.74 Favored 'Cis proline' 0 N--CA 1.445 -1.356 0 N-CA-C 107.162 -1.899 . . . . 0.0 107.162 -19.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.1 m -57.8 122.91 14.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.616 1.567 . . . . 0.0 110.454 -176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 135.87 45.63 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -72.73 -38.89 67.29 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.632 0.773 . . . . 0.0 112.385 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tt -146.89 132.51 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -149.57 128.69 12.75 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 118.822 -1.151 . . . . 0.0 108.381 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 m -101.66 116.18 32.17 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.656 -172.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -86.62 122.33 30.38 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.94 148.65 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.566 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.427 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.3 m-70 -138.35 128.6 25.89 Favored 'General case' 0 CA--C 1.489 -1.4 0 C-N-CA 124.996 1.318 . . . . 0.0 108.42 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.01 -130.83 2.1 Favored Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.43 HD22 ' HB3' ' A' ' 51' ' ' ARG . 6.1 t30 -119.64 144.35 47.2 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 173.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -87.27 -2.75 58.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.031 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HB3' HD22 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -81.02 -30.08 34.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 169.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -75.11 -31.31 61.11 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 124.127 0.971 . . . . 0.0 110.342 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.12 -58.54 6.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 124.089 0.956 . . . . 0.0 110.245 170.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.14 -38.19 73.14 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HB3' HD21 ' A' ' 61' ' ' ASN . . . -57.44 -25.33 59.49 Favored 'General case' 0 CA--C 1.488 -1.412 0 C-N-CA 126.102 1.761 . . . . 0.0 113.83 -178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.8 mt -56.55 -39.98 65.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.268 0 C-N-CA 125.484 1.513 . . . . 0.0 111.11 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 35.2 m -85.27 -21.06 29.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -106.58 53.12 0.7 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.943 0.401 . . . . 0.0 111.288 -171.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 79.44 -35.97 0.16 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 127.775 2.43 . . . . 0.0 115.023 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -74.59 154.98 38.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 55' ' ' ALA . 2.0 p-10 26.96 55.7 0.06 Allowed 'General case' 0 C--N 1.358 0.938 0 C-N-CA 129.377 3.071 . . . . 0.0 116.038 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.57 146.5 4.93 Favored Glycine 0 N--CA 1.427 -1.956 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -128.98 164.75 36.79 Favored Pre-proline 0 N--CA 1.436 -1.173 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -76.05 137.47 19.5 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.063 1.842 . . . . 0.0 107.816 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -106.74 161.03 15.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.214 -2.514 . . . . 0.0 104.214 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -70.81 150.99 45.28 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.285 0.634 . . . . 0.0 111.693 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 69.14 55.43 0.41 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 128.355 2.662 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.273 3.0 p-10 51.65 45.49 28.03 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.473 2.709 . . . . 0.0 114.095 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 106' ' ' ALA . 9.2 mt -124.89 178.69 5.36 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 -171.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -151.17 112.41 4.35 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 -171.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.55 150.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.4 p -99.74 161.46 13.6 Favored 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -129.18 18.41 5.98 Favored 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 p -117.23 100.16 7.51 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 100.762 -3.792 . . . . 0.0 100.762 172.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 120.12 11.99 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.192 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -102.76 158.4 16.28 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.06 140.86 36.32 Favored 'General case' 0 CA--C 1.475 -1.934 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.34 144.33 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -168.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 92.0 m -132.8 102.3 5.6 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 170.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.7 m -84.19 103.26 13.24 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 35.1 m -94.61 116.8 29.2 Favored 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -105.11 140.61 38.03 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -84.91 136.57 33.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.4 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 96.4 m-70 -134.04 174.6 10.31 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 122.73 -101.39 0.72 Allowed Glycine 0 CA--C 1.487 -1.704 0 N-CA-C 106.092 -2.803 . . . . 0.0 106.092 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.15 -26.97 0.17 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.1 m -81.82 130.69 59.88 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -81.11 -25.37 4.06 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 121.968 1.779 . . . . 0.0 108.138 174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -89.76 165.29 25.57 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.79 144.6 35.24 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 N-CA-C 107.584 -1.737 . . . . 0.0 107.584 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HA ' HH12 ' A' ' 31' ' ' ARG . 48.7 Cg_endo -86.8 162.47 51.43 Favored 'Cis proline' 0 N--CA 1.435 -1.928 0 CA-C-N 122.457 1.913 . . . . 0.0 109.257 19.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.523 ' H ' HH22 ' A' ' 31' ' ' ARG . 46.2 m -119.07 158.09 26.53 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -172.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -135.79 93.09 2.89 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.05 123.62 34.08 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.932 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 2.7 mpt_? -102.05 125.57 48.77 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 171.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.86 135.87 33.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.181 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.0 m -123.51 113.51 18.83 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.93 145.52 29.35 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 121.241 0.543 . . . . 0.0 110.024 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.7 168.46 30.5 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 105.13 -3.188 . . . . 0.0 105.13 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.02 103.04 3.7 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -158.84 174.88 14.32 Favored 'General case' 0 CA--C 1.49 -1.363 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.051 -171.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -69.55 135.48 50.11 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 124.536 1.134 . . . . 0.0 110.233 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.5 m -91.91 138.91 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.9 t -102.18 110.76 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.655 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 6.5 m -107.71 151.04 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -96.83 140.3 31.6 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 166.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 1.5 t -119.61 146.42 45.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 O-C-N 124.899 1.374 . . . . 0.0 111.41 -170.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -144.42 122.14 11.88 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.35 6.2 p30 72.32 3.13 4.58 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 127.917 2.487 . . . . 0.0 115.838 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.71 14.2 38.18 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 108.426 -1.869 . . . . 0.0 108.426 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 6' ' ' TYR . 1.4 mp -126.47 117.12 23.04 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 103.934 -2.617 . . . . 0.0 103.934 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 9.9 Cg_endo -77.19 120.97 5.54 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 CA-C-N 122.594 1.962 . . . . 0.0 107.9 -173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.97 -12.71 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 124.171 0.92 . . . . 0.0 111.712 -169.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 76.9 t60 -152.26 170.0 21.1 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -166.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.408 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 6.7 tp -140.44 136.14 32.73 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -84.12 134.16 34.6 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 168.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -110.59 40.23 2.03 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 60.0 p -99.25 -29.42 12.83 Favored 'General case' 0 CA--C 1.49 -1.34 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.43 -33.21 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.97 171.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -105.29 47.88 0.86 Allowed 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -170.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -128.37 -53.37 1.27 Allowed 'General case' 0 CA--C 1.485 -1.532 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -127.38 115.17 21.4 Favored Pre-proline 0 N--CA 1.428 -1.551 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo . . . . . 0 N--CA 1.434 -2.019 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 -174.268 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 CA--C 1.486 -1.484 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -115.01 53.17 0.82 Allowed 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -113.39 2.56 15.5 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -90.5 -30.56 17.21 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -62.38 -51.2 68.53 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.463 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 45.5 t80 -53.9 -62.54 1.59 Allowed 'General case' 0 N--CA 1.404 -2.757 0 C-N-CA 127.103 2.161 . . . . 0.0 114.483 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.605 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 24.2 p -69.56 -16.39 63.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -81.81 -37.91 26.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 120.074 1.306 . . . . 0.0 110.02 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -57.85 -41.3 82.1 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 125.105 1.362 . . . . 0.0 109.902 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.605 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.402 0.0 OUTLIER -92.95 -6.37 48.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 118.084 0.402 . . . . 0.0 111.245 -173.25 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.7 m -73.47 -48.97 29.29 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 120.52 -1.363 . . . . 0.0 107.341 166.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -65.94 -41.9 90.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 C-N-CA 126.291 1.836 . . . . 0.0 111.958 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -106.15 -50.28 3.2 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 118.572 -0.728 . . . . 0.0 111.562 -171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.511 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 53.9 t80 -77.88 120.98 23.52 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.585 1.538 . . . . 0.0 110.338 -168.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -139.25 94.25 2.78 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 103.036 -2.95 . . . . 0.0 103.036 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -35.5 -53.53 0.67 Allowed 'General case' 0 CA--C 1.49 -1.339 0 C-N-CA 128.583 2.753 . . . . 0.0 118.338 -166.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -147.96 147.36 26.48 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 168.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -75.46 175.34 11.41 Favored 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 122.214 1.942 . . . . 0.0 113.322 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -76.05 -69.41 0.5 Allowed 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 168.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.21 -176.89 14.6 Favored Glycine 0 CA--C 1.478 -2.252 1 N-CA-C 102.873 -4.091 . . . . 0.0 102.873 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -121.56 69.35 0.92 Allowed 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.63 174.65 11.0 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -173.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.42 -19.93 62.96 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 124.81 1.244 . . . . 0.0 113.3 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -81.31 -27.33 35.08 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -77.92 -34.62 51.26 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -34.03 54.93 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 123.327 0.651 . . . . 0.0 109.3 -170.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.02 -38.71 66.46 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.56 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -69.67 -30.82 68.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.267 14.2 tt -85.99 -27.38 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-N 118.504 0.593 . . . . 0.0 110.762 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.5 mmt -71.66 -29.41 64.58 Favored 'General case' 0 N--CA 1.438 -1.075 0 C-N-CA 118.628 -1.229 . . . . 0.0 110.066 172.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.64 HH22 ' H ' ' A' ' 92' ' ' CYS . 40.9 ttm-85 -81.43 -42.16 20.79 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -86.79 -28.0 23.24 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.44 -171.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -75.86 -36.08 59.68 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.63 72.0 1.23 Allowed Glycine 0 CA--C 1.473 -2.55 0 C-N-CA 125.164 1.364 . . . . 0.0 110.072 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.04 28.72 5.02 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 101.747 -3.427 . . . . 0.0 101.747 165.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -5.76 59.31 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 112.533 -2.121 . . . . 0.0 111.241 167.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.4 m -114.57 104.71 54.27 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.22 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 162.78 91.64 Favored 'Cis proline' 0 N--CA 1.44 -1.63 0 N-CA-C 106.707 -2.074 . . . . 0.0 106.707 -24.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -70.3 114.35 8.35 Favored 'General case' 0 N--CA 1.421 -1.893 0 C-N-CA 123.677 0.791 . . . . 0.0 109.659 -174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -82.39 152.21 26.29 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -63.5 -74.38 0.1 Allowed 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 124.478 1.111 . . . . 0.0 109.244 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -120.6 125.96 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -165.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -144.79 142.35 29.92 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 63.7 m -107.51 125.48 51.33 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.992 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.81 121.17 36.13 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.267 5.7 mm -93.63 147.64 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -136.81 133.07 35.53 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.97 -141.59 6.83 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 105.526 -3.029 . . . . 0.0 105.526 172.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -96.05 149.85 21.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.81 -18.74 27.06 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -71.31 -37.08 71.8 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -72.07 -38.33 69.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 117.375 -1.298 . . . . 0.0 111.036 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 53' ' ' ILE . 5.5 tp -65.54 -47.5 86.27 Favored 'Isoleucine or valine' 0 C--N 1.366 1.3 0 CA-C-N 119.242 0.928 . . . . 0.0 109.967 -177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.96 -39.37 91.9 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.661 1.584 . . . . 0.0 111.476 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.46 9.1 2.34 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.88 -44.04 92.81 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 165.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.3 m -99.64 42.93 1.08 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -169.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.87 24.1 3.94 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 40.38 61.98 1.45 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.5 3.12 . . . . 0.0 113.856 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' H ' ' H ' ' A' ' 61' ' ' ASN . 33.6 mmtp -133.06 -35.39 1.05 Allowed 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 60' ' ' LYS . 55.0 t30 -127.92 31.45 5.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.12 149.13 12.45 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.93 147.26 64.81 Favored Pre-proline 0 N--CA 1.434 -1.237 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -75.31 132.71 15.31 Favored 'Trans proline' 0 N--CA 1.44 -1.631 0 C-N-CA 122.757 2.305 . . . . 0.0 107.919 -163.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -108.68 85.07 2.04 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 72.12 -101.53 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.935 1.694 . . . . 0.0 111.975 172.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -116.26 81.68 1.65 Allowed 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -165.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 1.5 p-10 63.83 22.54 13.08 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 129.196 2.998 . . . . 0.0 114.534 170.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.6 mt -105.1 164.54 11.73 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.756 -3.794 . . . . 0.0 100.756 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.31 113.95 4.99 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 117.3 -1.76 . . . . 0.0 109.171 -173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 tt -85.66 139.69 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.6 p -80.66 171.38 15.1 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.257 0.551 . . . . 0.0 111.367 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.65 -9.3 10.78 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -127.19 96.49 4.61 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -48.15 127.76 13.0 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 127.614 2.365 . . . . 0.0 112.939 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -102.31 154.14 19.33 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 3.4 mt-30 -78.28 148.17 33.98 Favored 'General case' 0 CA--C 1.469 -2.152 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.88 144.37 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -168.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.3 m -135.99 101.91 4.87 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 102.219 -3.252 . . . . 0.0 102.219 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.2 m -86.25 111.99 20.95 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 69.0 m -88.72 116.15 26.77 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -111.75 142.6 43.9 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 tp -75.86 121.64 22.93 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -130.95 64.77 1.57 Allowed 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.5 -48.88 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 105.314 -3.115 . . . . 0.0 105.314 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.5 32.29 11.94 Favored Glycine 0 CA--C 1.49 -1.523 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -106.25 124.19 36.59 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -79.98 -27.31 3.88 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 CA-C-N 121.56 1.593 . . . . 0.0 108.078 173.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -105.42 147.82 35.27 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 117.386 -1.293 . . . . 0.0 107.846 -170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -75.87 144.09 27.11 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.381 2.054 . . . . 0.0 107.09 -173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' HH12 ' A' ' 31' ' ' ARG . 51.7 Cg_exo -82.32 161.1 77.5 Favored 'Cis proline' 0 CA--C 1.487 -1.853 0 CA-C-N 123.683 2.351 . . . . 0.0 110.697 10.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.64 ' H ' HH22 ' A' ' 31' ' ' ARG . 56.3 m -147.3 125.29 12.04 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.973 -166.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -84.55 129.34 34.86 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -118.23 120.05 36.52 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -97.69 127.76 43.88 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.52 127.25 33.57 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -176.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -113.25 100.09 8.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 172.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.87 130.51 35.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.93 -177.28 14.83 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 106.936 -2.466 . . . . 0.0 106.936 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 80.1 t80 -163.53 106.25 0.98 Allowed 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 -178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.0 170.44 22.31 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.176 -172.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.23 131.75 44.69 Favored 'General case' 0 CA--C 1.489 -1.388 0 C-N-CA 124.195 0.998 . . . . 0.0 109.597 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.3 m -91.82 133.49 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.22 84.32 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.67 138.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.26 136.74 40.61 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.6 149.78 22.42 Favored 'General case' 0 CA--C 1.49 -1.335 0 O-C-N 124.059 0.849 . . . . 0.0 111.458 -168.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -148.23 123.51 10.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 169.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.1 p30 64.41 18.69 11.47 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.571 2.349 . . . . 0.0 115.071 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.14 22.15 55.42 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 19.2 tp -132.24 130.21 21.9 Favored Pre-proline 0 N--CA 1.433 -1.308 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -80.37 109.23 2.28 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 CA-C-N 123.49 2.282 . . . . 0.0 107.482 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.07 -12.42 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 O-C-N 123.731 0.644 . . . . 0.0 111.376 -171.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.44 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 59.1 t60 -143.55 176.55 9.12 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.1 OUTLIER -164.64 131.26 2.99 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.81 125.19 28.27 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.923 -1.489 . . . . 0.0 108.48 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -94.04 12.65 25.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.209 1.004 . . . . 0.0 108.951 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 88.9 p -92.37 -6.42 50.16 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 123.58 0.752 . . . . 0.0 109.827 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 pt -88.27 -25.05 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -100.29 -19.65 16.25 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.68 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -75.93 -44.06 41.94 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -78.87 143.19 61.65 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo . . . . . 0 N--CA 1.432 -2.12 0 N-CA-C 105.566 -2.513 . . . . 0.0 105.566 173.82 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.33 64.72 0.16 Allowed 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 126.658 1.983 . . . . 0.0 108.531 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 77.15 -3.81 2.43 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 127.624 2.369 . . . . 0.0 112.427 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.5 t -93.36 -13.28 28.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 171.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -25.78 63.35 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.122 1.369 . . . . 0.0 110.578 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.13 -41.64 66.95 Favored 'General case' 0 N--CA 1.407 -2.606 0 C-N-CA 125.914 1.685 . . . . 0.0 108.94 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.467 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.7 OUTLIER -81.0 -7.63 59.6 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 177.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.7 m170 -76.28 -47.23 24.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 168.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -57.36 -41.65 80.53 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 126.977 2.111 . . . . 0.0 110.632 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.399 0.1 OUTLIER -99.39 -5.29 29.79 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.457 -173.539 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.1 t -79.55 -38.86 33.18 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.727 1.603 . . . . 0.0 107.064 169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 14.6 pt20 -82.98 -28.07 29.99 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.458 -176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.473 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 79.9 m-70 -103.65 -50.31 3.46 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.685 -0.674 . . . . 0.0 110.855 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 49.3 t80 -76.59 118.07 18.87 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 120.038 1.29 . . . . 0.0 110.837 -168.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -136.08 97.59 3.65 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 100.658 -3.83 . . . . 0.0 100.658 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.34 -42.09 4.37 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 118.02 2.6 . . . . 0.0 118.02 -166.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -160.08 134.9 5.53 Favored Pre-proline 0 N--CA 1.433 -1.303 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 45.6 Cg_exo -73.76 -179.8 4.91 Favored 'Trans proline' 0 N--CA 1.437 -1.812 0 C-N-CA 122.757 2.304 . . . . 0.0 114.012 -176.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -74.86 -71.54 0.35 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.99 -177.48 14.9 Favored Glycine 0 CA--C 1.477 -2.304 0 N-CA-C 103.343 -3.903 . . . . 0.0 103.343 166.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtm180 -121.64 72.51 1.02 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.98 177.99 7.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.61 -14.44 61.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -170.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -77.54 -33.96 53.99 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.63 -39.23 62.23 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.0 t -68.52 -43.08 77.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.0 111.81 -173.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.1 -35.46 66.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.033 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -73.21 -30.17 63.33 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.8 tt -82.87 -28.75 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.384 0 CA-C-N 118.501 0.592 . . . . 0.0 109.528 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.8 mmt -70.33 -33.29 71.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.229 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -44.47 64.22 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.401 0.681 . . . . 0.0 111.406 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -75.44 -39.56 58.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -171.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.28 -35.59 63.75 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.18 75.54 1.05 Allowed Glycine 0 CA--C 1.479 -2.217 0 C-N-CA 124.789 1.185 . . . . 0.0 111.274 169.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.354 2.6 mm? -104.86 -3.69 23.14 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.0 p -78.88 -5.1 52.72 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 113.448 -1.705 . . . . 0.0 113.792 -165.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.6 m -119.66 103.27 46.47 Favored Pre-proline 0 N--CA 1.426 -1.669 0 CA-C-O 117.575 -1.203 . . . . 0.0 108.583 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.59 164.06 88.95 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 CA-C-N 122.96 2.093 . . . . 0.0 107.054 -23.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' HB3' HD13 ' A' ' 83' ' ' LEU . 31.8 m -57.14 125.1 21.19 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.113 1.365 . . . . 0.0 112.563 -171.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -76.86 141.6 40.55 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -77.18 -39.86 47.42 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.354 -172.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.73 128.9 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -148.87 125.67 11.18 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -98.58 119.97 38.21 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.509 -0.768 . . . . 0.0 109.064 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.6 114.09 23.03 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.9 mt -94.05 149.45 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.64 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.419 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.8 m-70 -139.05 136.16 34.97 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 124.581 1.153 . . . . 0.0 108.063 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.09 -143.77 8.65 Favored Glycine 0 CA--C 1.483 -1.931 0 N-CA-C 105.978 -2.849 . . . . 0.0 105.978 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -96.91 147.01 24.41 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -86.23 -12.81 48.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -71.32 -36.29 71.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 125.436 1.494 . . . . 0.0 109.338 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.4 p -81.19 -25.69 36.55 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.307 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -56.93 -50.99 73.98 Favored 'Isoleucine or valine' 0 C--N 1.366 1.297 0 CA-C-N 120.232 1.378 . . . . 0.0 110.356 166.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -62.61 -40.67 97.7 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 123.464 0.706 . . . . 0.0 112.212 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.03 29.9 0.62 Allowed 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 122.958 0.503 . . . . 0.0 112.082 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CB ' ' A' ' 72' ' ' SER . 12.4 mm -87.64 -30.13 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.495 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 160.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 37.0 t -83.15 -57.16 3.39 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.399 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.89 107.44 19.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -168.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 56.25 -87.51 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.575 2.75 . . . . 0.0 116.792 163.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -67.27 145.13 55.47 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.222 1.409 . . . . 0.0 107.839 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.331 6.8 p-10 43.83 39.4 2.57 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 130.873 3.669 . . . . 0.0 117.473 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.58 134.8 2.27 Favored Glycine 0 CA--C 1.489 -1.542 0 N-CA-C 106.198 -2.761 . . . . 0.0 106.198 168.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -122.62 162.88 36.02 Favored Pre-proline 0 N--CA 1.435 -1.178 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -164.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 149.13 34.24 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.653 2.236 . . . . 0.0 108.491 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -148.28 116.82 6.59 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -168.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 66.68 -111.44 0.17 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 125.211 1.404 . . . . 0.0 110.792 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -136.16 95.21 3.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.359 2.2 p-10 64.98 23.13 12.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 129.161 2.985 . . . . 0.0 114.587 172.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.8 mt -106.76 163.32 13.02 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 167.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -142.41 124.73 15.56 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.1 tt -97.09 144.75 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -174.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 56' ' ' ILE . 97.7 p -83.33 158.0 22.36 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-O 121.748 0.785 . . . . 0.0 110.686 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -117.18 -5.06 11.37 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.3 p -116.5 88.94 3.0 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 47.5 t -55.69 128.8 36.48 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 126.058 1.743 . . . . 0.0 110.954 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -108.32 158.71 17.25 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -169.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.416 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 5.6 mt-30 -76.89 146.31 37.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.48 146.85 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.9 m -131.8 101.95 5.67 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 164.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 m -79.24 103.75 9.38 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 32.2 m -90.11 112.09 23.44 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -121.5 140.21 52.48 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -172.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 39' ' ' CYS . 25.9 tp -79.3 120.32 23.59 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -170.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -135.28 56.28 1.85 Allowed 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -108.54 -86.56 1.81 Allowed Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 106.272 -2.731 . . . . 0.0 106.272 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 138.66 -16.67 3.31 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 106.527 -2.629 . . . . 0.0 106.527 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 m -85.41 134.02 41.18 Favored Pre-proline 0 N--CA 1.432 -1.351 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -79.67 -27.56 3.97 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 C-N-CA 121.848 1.698 . . . . 0.0 108.209 170.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -97.7 163.36 19.74 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.263 -170.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.54 144.13 35.47 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 122.268 1.979 . . . . 0.0 107.431 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -83.07 163.15 72.95 Favored 'Cis proline' 0 CA--C 1.489 -1.775 0 CA-C-N 123.164 2.166 . . . . 0.0 109.936 9.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.57 122.59 36.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 -171.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.0 tp-100 -88.93 113.06 24.05 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.18 126.11 51.82 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -89.89 126.28 35.66 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.96 131.16 35.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 37.0 m -119.66 90.83 3.41 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 103.547 -2.761 . . . . 0.0 103.547 172.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.53 130.01 36.41 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.51 -165.67 10.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.416 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 86.2 t80 -157.51 101.09 1.83 Allowed 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.442 -3.911 . . . . 0.0 100.442 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -138.19 149.32 45.71 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -165.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -77.3 134.21 38.59 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.326 -1.306 . . . . 0.0 107.596 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.23 153.37 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 55.3 t -113.08 115.94 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 102.01 -3.329 . . . . 0.0 102.01 161.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.7 m -104.43 161.44 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 114' ' ' HIS . . . -106.03 144.7 32.38 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 163.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.6 t -123.33 138.83 54.52 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 124.527 1.142 . . . . 0.0 110.068 -170.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -127.43 132.99 49.99 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 167.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.308 5.6 p30 73.74 6.32 4.93 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 167.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.93 20.33 21.58 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 tp -149.76 144.94 18.24 Favored Pre-proline 0 CA--C 1.5 -0.974 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -71.12 154.63 62.18 Favored 'Trans proline' 0 N--CA 1.441 -1.583 0 CA-C-N 122.417 1.899 . . . . 0.0 110.508 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.25 -17.38 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.65 ' HB3' ' HB3' ' A' ' 106' ' ' ALA . 82.0 t60 -149.81 166.93 27.99 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -164.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -127.64 130.66 49.33 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.9 120.1 24.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 21.57 17.19 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -173.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -90.57 -16.1 29.39 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 119.469 -0.3 . . . . 0.0 110.697 -174.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.09 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -94.26 -11.0 31.08 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.609 -175.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -78.42 -35.11 47.46 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -78.4 139.47 59.71 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 N--CA 1.432 -2.104 0 N-CA-C 106.047 -2.328 . . . . 0.0 106.047 -179.202 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 CA--C 1.485 -1.527 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -123.11 42.21 3.26 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 169.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.28 -8.65 19.15 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 168.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.0 p -91.64 -17.05 26.11 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.1 tpt180 -76.44 -32.84 58.68 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 123.353 0.661 . . . . 0.0 110.457 -170.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -68.01 -37.94 82.02 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 118.076 -0.964 . . . . 0.0 111.65 171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -74.68 -19.19 60.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -72.3 -45.57 59.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-N 118.98 0.809 . . . . 0.0 108.86 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -56.69 -40.49 75.68 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 126.176 1.79 . . . . 0.0 111.27 173.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.415 0.2 OUTLIER -96.88 -2.52 43.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 118.44 0.564 . . . . 0.0 111.732 -173.328 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.6 m -76.63 -42.97 40.24 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 164.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -68.75 -46.49 68.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.873 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -102.68 -41.33 6.26 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 118.448 -0.786 . . . . 0.0 111.173 -167.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 39.4 t80 -80.84 117.09 21.18 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 120.558 1.527 . . . . 0.0 111.124 -170.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -135.07 96.29 3.48 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 100.958 -3.719 . . . . 0.0 100.958 172.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.27 6.12 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 127.937 2.495 . . . . 0.0 117.573 -165.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -151.69 138.82 12.23 Favored Pre-proline 0 N--CA 1.439 -1.01 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 39.7 Cg_exo -74.71 179.55 5.87 Favored 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 122.824 2.35 . . . . 0.0 113.834 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.3 -70.19 0.38 Allowed 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.74 -175.35 13.96 Favored Glycine 0 CA--C 1.477 -2.332 1 N-CA-C 101.995 -4.442 . . . . 0.0 101.995 163.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -116.1 72.57 0.81 Allowed 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -140.32 -179.7 6.15 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.488 -170.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.55 -39.34 87.58 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 127.457 2.303 . . . . 0.0 111.836 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -83.72 -16.02 46.46 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 123.555 0.742 . . . . 0.0 110.775 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -77.73 -40.48 41.0 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 m -69.51 -34.68 74.64 Favored 'General case' 0 CA--C 1.493 -1.243 0 O-C-N 123.485 0.491 . . . . 0.0 111.98 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -71.05 -37.71 72.52 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.409 0.443 . . . . 0.0 110.04 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -70.74 -31.08 67.78 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.275 14.5 tt -86.25 -27.84 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 118.067 0.394 . . . . 0.0 111.713 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.76 -19.56 48.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 118.896 -1.122 . . . . 0.0 110.552 171.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -75.79 -42.09 51.04 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 118.781 0.719 . . . . 0.0 109.425 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -75.73 -48.42 21.96 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 123.865 0.866 . . . . 0.0 111.505 -169.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -78.87 -27.96 44.12 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.97 65.61 1.59 Allowed Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.4 mt -111.91 22.48 14.85 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 165.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -89.37 -12.27 40.89 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.3 t -129.83 105.95 16.88 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.4 160.17 96.25 Favored 'Cis proline' 0 N--CA 1.444 -1.392 0 N-CA-C 107.32 -1.839 . . . . 0.0 107.32 -19.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 51.7 m -61.1 121.67 13.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.443 1.097 . . . . 0.0 110.258 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -73.65 133.52 43.45 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -72.83 -42.31 63.93 Favored 'General case' 0 CA--C 1.491 -1.316 0 O-C-N 123.766 0.666 . . . . 0.0 112.456 -169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.0 tt -154.49 126.7 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -154.77 129.31 9.17 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.7 m -94.86 125.14 39.32 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.32 120.67 33.87 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 167.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.4 mt -98.08 148.59 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.626 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' GLN . 1.8 m-70 -135.51 133.4 38.42 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 114.658 -1.156 . . . . 0.0 108.352 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.93 -140.59 6.39 Favored Glycine 0 CA--C 1.485 -1.784 0 N-CA-C 104.451 -3.459 . . . . 0.0 104.451 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -105.11 148.38 26.9 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 168.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -87.43 0.48 55.44 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.186 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -76.36 -34.98 58.91 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 167.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.2 m -77.22 -33.26 56.22 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 124.359 1.064 . . . . 0.0 110.458 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.3 mm -59.26 -50.03 81.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 124.335 1.054 . . . . 0.0 110.386 172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -61.33 -33.83 74.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 124.171 0.988 . . . . 0.0 113.275 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.63 7.38 8.49 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 mm -84.83 -21.29 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.3 t -80.16 -19.46 47.1 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 122.064 -0.398 . . . . 0.0 110.736 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -70.64 142.9 51.59 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 165.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.42 -7.43 59.58 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.742 0.817 . . . . 0.0 112.699 -172.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -81.26 -41.77 21.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -116.11 15.58 16.04 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -167.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.25 112.45 0.4 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 172.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -96.01 152.15 38.75 Favored Pre-proline 0 N--CA 1.433 -1.285 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -72.44 118.46 5.61 Favored 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 122.635 2.224 . . . . 0.0 106.373 174.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.688 ' HE1' HG11 ' A' ' 104' ' ' VAL . 15.8 p-80 -91.13 119.97 31.69 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 103.918 -2.623 . . . . 0.0 103.918 176.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 61.84 -96.67 0.06 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.784 1.634 . . . . 0.0 112.31 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -122.28 82.02 1.91 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -171.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.332 0.7 OUTLIER 65.88 11.75 7.88 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 129.192 2.997 . . . . 0.0 117.826 160.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.9 OUTLIER -102.84 148.33 25.77 Favored 'General case' 0 CA--C 1.476 -1.887 1 N-CA-C 99.0 -4.445 . . . . 0.0 99.0 174.372 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -124.44 118.48 26.76 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -158.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.6 tt -95.61 137.33 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.5 p -80.34 164.25 23.28 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.626 0.727 . . . . 0.0 111.914 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -121.06 -11.78 8.83 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -103.69 83.33 2.12 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 105.269 -2.122 . . . . 0.0 105.269 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.8 m -47.52 124.81 7.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 127.126 2.17 . . . . 0.0 112.048 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -102.68 158.08 16.5 Favored 'General case' 0 CA--C 1.474 -1.972 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 10.6 mt-30 -78.96 143.36 35.84 Favored 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.13 141.23 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -167.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 93.8 m -129.62 105.77 8.28 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.7 m -81.66 100.11 9.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 99.9 m -86.84 112.33 21.63 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 -177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -111.35 143.09 42.7 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -83.16 109.72 17.42 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -173.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -94.5 158.68 15.44 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.2 -91.13 1.48 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.71 39.65 0.46 Allowed Glycine 0 CA--C 1.486 -1.751 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.3 p -92.9 120.63 67.0 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -89.43 -8.64 4.49 Favored 'Trans proline' 0 N--CA 1.438 -1.781 0 CA-C-N 121.618 1.614 . . . . 0.0 108.036 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -110.6 161.84 23.07 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.04 146.14 36.52 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 122.454 2.102 . . . . 0.0 107.684 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.79 164.25 67.63 Favored 'Cis proline' 0 N--CA 1.435 -1.925 0 CA-C-N 122.073 1.776 . . . . 0.0 107.934 3.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.54 159.78 21.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -172.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -117.02 129.12 55.81 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 103.192 -2.892 . . . . 0.0 103.192 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -124.24 124.3 42.14 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -100.65 127.85 46.9 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.48 130.98 35.92 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 121.027 0.442 . . . . 0.0 109.964 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 41.2 m -119.1 89.55 3.15 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.49 136.85 33.25 Favored 'General case' 0 CA--C 1.491 -1.3 0 CA-C-O 121.104 0.478 . . . . 0.0 109.907 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -139.19 179.26 18.82 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 106.443 -2.663 . . . . 0.0 106.443 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 88.4 t80 -143.56 101.21 3.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.4 ptt-85 -160.82 175.05 12.99 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -70.56 145.88 50.5 Favored 'General case' 0 CA--C 1.489 -1.397 0 C-N-CA 124.811 1.244 . . . . 0.0 111.539 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.9 m -98.37 147.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.688 HG11 ' HE1' ' A' ' 65' ' ' HIS . 56.0 t -110.25 94.19 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 N-CA-C 102.922 -2.992 . . . . 0.0 102.922 165.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.3 m -96.5 133.17 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.96 132.01 43.18 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.05 134.96 52.24 Favored 'General case' 0 CA--C 1.493 -1.219 0 O-C-N 124.548 1.155 . . . . 0.0 111.289 -166.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -132.74 135.23 45.62 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.327 10.2 p30 68.87 12.6 8.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.395 2.278 . . . . 0.0 116.411 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.93 19.51 46.92 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.2 19.86 Favored Pre-proline 0 CA--C 1.491 -1.32 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -74.06 113.21 3.73 Favored 'Trans proline' 0 N--CA 1.435 -1.958 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 172.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.59 -6.98 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 76.7 t60 -155.04 174.83 14.62 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -168.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.429 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -165.98 131.58 2.45 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 104.463 -2.421 . . . . 0.0 104.463 -177.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.94 141.58 35.9 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.529 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -103.84 44.28 1.03 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.4 t -95.2 -34.41 12.24 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.462 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -73.42 -33.84 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.793 0 C-N-CA 125.143 1.377 . . . . 0.0 109.498 172.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -106.92 30.63 5.98 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -85.91 -63.58 1.3 Allowed 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.74 151.71 54.1 Favored Pre-proline 0 N--CA 1.429 -1.503 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 170.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo . . . . . 0 N--CA 1.433 -2.076 0 N-CA-C 105.065 -2.706 . . . . 0.0 105.065 175.76 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.487 -1.474 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -127.46 84.03 2.22 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 m120 80.83 2.61 1.72 Allowed 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 127.833 2.453 . . . . 0.0 111.133 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -91.59 -7.06 51.23 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 124.356 1.062 . . . . 0.0 109.13 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -43.15 62.59 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -59.67 -50.84 72.28 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-O 117.523 -1.227 . . . . 0.0 112.309 173.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.433 3.4 t -87.16 9.04 21.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -76.68 -44.67 32.8 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 119.958 -1.713 . . . . 0.0 107.916 156.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.2 -31.86 70.55 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.597 1.159 . . . . 0.0 111.462 172.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD22 ' HB2' ' A' ' 14' ' ' TYR . 17.3 mt -88.31 -23.77 23.35 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.691 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.2 p -71.03 -35.65 72.08 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 120.102 1.319 . . . . 0.0 109.82 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -69.29 -63.62 1.03 Allowed 'General case' 0 CA--C 1.491 -1.305 0 C-N-CA 120.699 -0.401 . . . . 0.0 110.924 168.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -88.8 -49.11 7.03 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -162.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' HD22 ' A' ' 10' ' ' LEU . 83.9 t80 -76.44 118.19 18.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 120.991 1.723 . . . . 0.0 110.14 -171.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -137.31 98.29 3.68 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.67 -34.71 0.4 Allowed 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 119.942 3.312 . . . . 0.0 119.942 -165.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -150.13 156.62 37.68 Favored Pre-proline 0 N--CA 1.435 -1.182 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 168.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 16.8 Cg_endo -72.18 149.76 52.37 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 123.246 2.631 . . . . 0.0 108.964 170.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -84.06 -50.91 7.53 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 166.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.38 -179.01 16.04 Favored Glycine 0 CA--C 1.48 -2.115 0 N-CA-C 103.621 -3.792 . . . . 0.0 103.621 165.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -126.6 53.03 1.69 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -141.07 -179.26 5.99 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.67 -38.59 72.41 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 128.437 2.695 . . . . 0.0 112.734 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.0 ttm-85 -79.23 -23.93 43.41 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 124.129 0.971 . . . . 0.0 111.025 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -76.65 -38.94 53.75 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.3 m -69.81 -35.94 75.23 Favored 'General case' 0 CA--C 1.49 -1.336 0 O-C-N 123.613 0.571 . . . . 0.0 112.54 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.88 -35.7 64.72 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 t -70.51 -32.59 70.13 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 122.78 0.432 . . . . 0.0 111.998 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.295 10.5 tt -82.69 -30.83 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-O 119.308 -0.377 . . . . 0.0 111.077 -176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.15 -18.72 52.59 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 118.727 -1.189 . . . . 0.0 111.216 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -74.42 -37.15 63.41 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 119.062 0.846 . . . . 0.0 111.296 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -51.67 14.97 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 122.806 0.443 . . . . 0.0 110.107 -174.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.91 -36.74 67.33 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 123.736 0.814 . . . . 0.0 110.646 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.98 67.02 1.57 Allowed Glycine 0 CA--C 1.479 -2.173 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.1 mt -114.46 22.88 13.27 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 164.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 15.2 t -99.06 2.56 46.27 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -174.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 43.9 t -146.54 103.85 3.98 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 177.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.36 159.05 94.83 Favored 'Cis proline' 0 N--CA 1.447 -1.246 0 CA-C-N 122.127 1.795 . . . . 0.0 107.636 -16.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.3 m -61.83 124.88 21.98 Favored 'General case' 0 N--CA 1.426 -1.647 0 O-C-N 123.974 0.796 . . . . 0.0 110.148 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -77.95 132.28 37.8 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 171.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.17 -42.32 69.24 Favored 'General case' 0 CA--C 1.485 -1.545 0 O-C-N 124.048 0.842 . . . . 0.0 112.455 -165.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.68 126.47 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -145.61 126.33 14.31 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -95.24 118.64 32.37 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.739 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -91.54 115.47 28.07 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.2 mm -92.13 146.13 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.582 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 9.3 m-70 -134.58 138.44 44.58 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -177.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 157.0 -153.46 24.71 Favored Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -82.34 138.56 34.48 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.62 -9.08 57.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -37.33 73.51 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.6 m -76.34 -30.81 57.78 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 117.43 -1.271 . . . . 0.0 111.288 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.73 -57.28 11.83 Favored 'Isoleucine or valine' 0 C--N 1.363 1.161 0 CA-C-N 119.558 1.072 . . . . 0.0 110.377 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -68.12 -38.43 82.22 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 120.09 1.314 . . . . 0.0 110.958 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.66 -0.15 22.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 117.039 -1.458 . . . . 0.0 114.869 -177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.286 0.6 OUTLIER -79.57 -24.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.296 0 C-N-CA 116.532 -2.067 . . . . 0.0 110.113 170.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 92.8 m -98.8 34.88 1.97 Allowed 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.39 0.995 . . . . 0.0 111.074 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -118.35 21.72 12.51 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 163.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . 0.273 13.5 p-10 26.23 46.35 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.551 1 C-N-CA 132.021 4.128 . . . . 0.0 116.122 -167.122 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.49 -19.37 14.42 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -127.22 28.97 5.65 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 -171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.77 161.67 31.36 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -122.56 148.41 52.92 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-O 116.092 -1.909 . . . . 0.0 106.021 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -69.92 154.82 66.69 Favored 'Trans proline' 0 CA--C 1.499 -1.24 0 C-N-CA 122.767 2.311 . . . . 0.0 111.806 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -125.57 57.8 1.33 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.27 15.7 tpp180 81.56 -100.31 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 127.152 2.181 . . . . 0.0 113.044 172.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.34 78.03 1.34 Allowed 'General case' 0 CA--C 1.488 -1.409 0 C-N-CA 124.049 0.94 . . . . 0.0 109.318 -166.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.336 1.3 p-10 74.33 8.68 4.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 129.291 3.037 . . . . 0.0 113.749 169.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.17 158.78 16.07 Favored 'General case' 0 CA--C 1.466 -2.252 1 N-CA-C 98.794 -4.521 . . . . 0.0 98.794 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 HG22 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -152.09 138.19 18.26 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 -174.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.19 136.64 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -174.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 88.0 p -84.38 163.2 19.69 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 121.39 0.614 . . . . 0.0 110.696 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -126.7 -0.97 6.74 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.0 t -101.33 92.49 4.97 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 103.059 -2.941 . . . . 0.0 103.059 162.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.1 m -58.33 126.58 28.13 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.28 1.432 . . . . 0.0 110.373 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -107.85 161.0 15.31 Favored 'General case' 0 CA--C 1.475 -1.939 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -79.88 151.4 30.2 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.98 146.36 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -168.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.0 m -135.19 103.51 5.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 165.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.8 m -84.31 101.62 12.08 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.7 m -85.72 113.75 22.15 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -122.66 135.77 54.69 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 -167.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.271 19.3 mt -65.4 118.28 9.15 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 121.106 0.479 . . . . 0.0 110.621 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -88.54 126.81 35.44 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 169.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.18 -84.86 0.38 Allowed Glycine 0 CA--C 1.485 -1.794 0 N-CA-C 106.519 -2.633 . . . . 0.0 106.519 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 114.98 37.86 1.09 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 42.7 t -86.9 123.91 69.73 Favored Pre-proline 0 N--CA 1.438 -1.049 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.92 3.63 3.0 Favored 'Trans proline' 0 N--CA 1.437 -1.837 0 CA-C-N 122.192 1.818 . . . . 0.0 108.492 -171.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.35 160.71 38.53 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -75.19 146.17 31.67 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.73 1.62 . . . . 0.0 108.215 -171.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -82.74 161.71 75.41 Favored 'Cis proline' 0 N--CA 1.437 -1.834 0 CA-C-N 122.656 1.984 . . . . 0.0 109.482 7.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 m -119.95 111.81 18.4 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -85.76 122.4 29.79 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -121.11 111.21 17.15 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -85.75 129.75 34.74 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.11 127.35 32.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 51.7 m -114.6 92.59 4.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.14 29.77 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.024 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.7 -172.83 18.92 Favored Glycine 0 N--CA 1.432 -1.568 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -156.4 106.34 2.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.87 168.49 25.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.803 0.811 . . . . 0.0 109.97 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 129.38 34.49 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.053 1.341 . . . . 0.0 109.429 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.4 m -89.41 143.1 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.163 -171.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.5 t -96.32 97.46 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 HH22 ' A' ' 70' ' ' ARG . 25.6 m -105.58 138.38 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -96.67 134.55 39.78 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 11.3 m -106.53 153.35 22.44 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.612 1.195 . . . . 0.0 110.135 -171.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -151.07 128.55 11.4 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.86 -2.645 . . . . 0.0 103.86 167.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.329 12.9 p30 66.02 17.55 10.81 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.216 2.607 . . . . 0.0 115.672 175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.55 0.87 62.45 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.54 139.82 21.18 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 177.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.03 114.83 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 N-CA-C 105.224 -2.644 . . . . 0.0 105.224 164.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 m -100.32 -10.77 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 80.9 t60 -158.53 175.65 13.4 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -165.67 125.23 1.72 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 -178.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.53 130.77 34.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' A' ' 117' ' ' GLN . 1.0 OUTLIER -99.96 43.16 1.07 Allowed 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -174.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 56.4 p -95.04 -18.01 21.4 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.2 pt -97.03 -19.04 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.368 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.94 48.47 0.89 Allowed 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 106.014 -1.846 . . . . 0.0 106.014 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -116.33 -3.56 11.93 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.87 138.0 69.63 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.434 -1.974 0 C-N-CA 122.613 2.209 . . . . 0.0 106.542 -164.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 CA--C 1.487 -1.461 0 CA-C-O 120.652 0.263 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -114.61 53.68 0.8 Allowed 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 169.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -111.66 0.01 16.2 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 t -93.08 -24.99 18.11 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 171.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -68.59 -37.94 80.24 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.167 1.387 . . . . 0.0 109.383 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CD1' ' HG ' ' A' ' 111' ' ' LEU . 42.9 t80 -50.32 -60.65 2.77 Favored 'General case' 0 N--CA 1.402 -2.84 0 C-N-CA 127.642 2.377 . . . . 0.0 114.191 166.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.6 OUTLIER -67.28 -16.58 64.36 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -70.84 -51.34 27.13 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 119.531 1.059 . . . . 0.0 109.063 170.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -58.09 -34.34 70.07 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 126.95 2.1 . . . . 0.0 111.555 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.0 OUTLIER -98.53 -8.91 25.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 118.698 0.681 . . . . 0.0 110.441 -171.774 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 m -76.52 -45.07 32.39 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 168.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -45.65 86.57 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 126.585 1.954 . . . . 0.0 111.987 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -106.15 -49.02 3.45 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-O 118.547 -0.739 . . . . 0.0 111.782 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 60.5 t80 -76.48 121.9 23.78 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 120.136 1.335 . . . . 0.0 110.05 -167.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -139.72 97.17 3.2 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 102.063 -3.31 . . . . 0.0 102.063 175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.29 -43.5 1.15 Allowed 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 128.594 2.758 . . . . 0.0 118.291 -168.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -156.09 148.77 17.98 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 165.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -74.14 168.95 23.56 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 121.63 1.553 . . . . 0.0 112.443 -176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -71.96 -67.02 0.57 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.59 -178.46 15.44 Favored Glycine 0 CA--C 1.476 -2.393 1 N-CA-C 102.159 -4.376 . . . . 0.0 102.159 163.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -113.3 72.91 0.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -151.14 175.76 11.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.08 -24.87 63.3 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.707 1.203 . . . . 0.0 113.176 -171.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -86.85 -18.31 31.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -41.53 62.26 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.29 0.5 OUTLIER -76.95 -26.51 54.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 118.167 -1.413 . . . . 0.0 113.605 -173.978 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -68.56 -39.33 81.08 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.293 170.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -66.88 -38.04 85.54 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 26' ' ' CYS . 20.2 tt -80.95 -27.09 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 CA-C-N 117.851 0.296 . . . . 0.0 110.504 -177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -24.58 55.73 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.186 -1.006 . . . . 0.0 112.03 174.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -75.63 -34.54 60.56 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 118.608 0.64 . . . . 0.0 111.82 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -76.99 -46.17 24.82 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 118.27 0.486 . . . . 0.0 111.769 -176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -73.28 -34.44 65.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.68 72.59 1.19 Allowed Glycine 0 CA--C 1.478 -2.256 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.6 mt -113.25 20.14 16.45 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.1 p -89.01 -7.11 56.59 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.392 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.7 m -125.65 100.86 30.87 Favored Pre-proline 0 N--CA 1.426 -1.661 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.553 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.52 167.48 80.19 Favored 'Cis proline' 0 N--CA 1.445 -1.359 0 N-CA-C 107.066 -1.936 . . . . 0.0 107.066 -22.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' HD13 ' A' ' 83' ' ' LEU . 39.9 m -60.02 126.65 28.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 124.031 0.932 . . . . 0.0 111.034 -177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -73.29 139.43 46.11 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -72.95 -51.94 16.45 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 123.581 0.551 . . . . 0.0 110.091 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.8 tt -147.83 135.58 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -152.26 130.1 11.69 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.2 m -97.21 120.52 37.73 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.186 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -90.62 126.46 35.97 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . 0.262 5.9 mm -89.95 148.94 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.326 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.409 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.2 m-70 -138.49 139.25 38.71 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.61 -114.32 0.6 Allowed Glycine 0 CA--C 1.481 -2.088 0 N-CA-C 106.479 -2.648 . . . . 0.0 106.479 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -134.08 134.73 42.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -89.04 3.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.674 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -84.79 -28.29 26.26 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 168.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.1 m -84.62 -25.29 28.67 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.639 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 53' ' ' ILE . 1.5 tp -71.19 -41.94 75.28 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -61.77 -52.36 64.56 Favored 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 123.949 0.899 . . . . 0.0 110.315 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.6 3.97 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 124.747 1.219 . . . . 0.0 113.399 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 72' ' ' SER . 1.5 tp -76.93 -33.92 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 6.2 m -94.23 9.67 37.09 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -166.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -104.44 23.11 13.74 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 121.79 0.805 . . . . 0.0 110.737 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.4 m120 42.63 38.04 1.18 Allowed 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 130.81 3.644 . . . . 0.0 114.002 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -104.49 -35.24 7.95 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -120.98 26.15 9.23 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.63 149.97 17.99 Favored Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 119.178 -1.486 . . . . 0.0 110.729 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -100.46 125.36 39.51 Favored Pre-proline 0 N--CA 1.436 -1.162 0 CA-C-O 116.529 -1.7 . . . . 0.0 107.934 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -72.8 141.62 34.08 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 123.648 2.899 . . . . 0.0 108.167 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -123.76 80.39 1.8 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 65.76 -99.49 0.06 Allowed 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 126.479 1.911 . . . . 0.0 114.516 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -101.42 72.39 1.41 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -164.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.309 2.6 p-10 57.31 30.6 18.76 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 129.495 3.118 . . . . 0.0 114.832 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.0 161.36 20.34 Favored 'General case' 0 CA--C 1.47 -2.101 1 N-CA-C 98.677 -4.564 . . . . 0.0 98.677 173.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.716 HH12 HG23 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -156.82 148.55 22.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -171.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.427 HG12 HG22 ' A' ' 104' ' ' VAL . 12.6 mt -114.31 126.07 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -173.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 56' ' ' ILE . 57.8 p -69.07 160.4 31.08 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -117.54 -18.75 9.67 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.143 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 45.1 t -103.44 84.02 2.25 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.2 p -52.18 136.47 30.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 127.179 2.192 . . . . 0.0 112.701 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -113.82 163.58 14.87 Favored 'General case' 0 CA--C 1.473 -2.011 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 -168.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -78.33 148.26 33.85 Favored 'General case' 0 CA--C 1.477 -1.86 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -145.66 146.32 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 -167.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.6 m -138.5 104.84 5.25 Favored 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 171.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.7 m -90.17 99.8 12.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.8 m -92.49 123.57 35.89 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -115.16 146.36 41.45 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 39' ' ' CYS . 48.8 tp -71.92 111.24 7.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 124.468 1.107 . . . . 0.0 108.584 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -94.2 156.52 16.5 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 103.39 -2.819 . . . . 0.0 103.39 170.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.82 -79.6 0.34 Allowed Glycine 0 CA--C 1.486 -1.776 0 N-CA-C 106.036 -2.826 . . . . 0.0 106.036 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.06 27.39 6.6 Favored Glycine 0 CA--C 1.488 -1.644 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.0 t -89.38 127.28 55.55 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 171.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -80.14 -20.63 8.49 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 CA-C-N 122.686 1.995 . . . . 0.0 108.849 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -101.21 163.62 17.59 Favored Pre-proline 0 N--CA 1.427 -1.589 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -73.94 144.58 34.62 Favored 'Trans proline' 0 N--CA 1.437 -1.824 0 N-CA-C 107.516 -1.763 . . . . 0.0 107.516 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -84.08 163.19 67.82 Favored 'Cis proline' 0 CA--C 1.489 -1.746 0 CA-C-N 123.174 2.169 . . . . 0.0 110.423 13.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 26.8 m -126.24 117.31 22.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.77 83.97 1.85 Allowed 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.648 1.213 . . . . 0.0 108.067 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -70.0 130.66 42.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -97.18 120.52 37.68 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.53 135.73 33.71 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.3 m -115.31 98.97 7.06 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 173.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.85 141.72 35.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.96 -163.01 13.91 Favored Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -162.38 108.95 1.27 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 102.384 -3.191 . . . . 0.0 102.384 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -146.26 151.12 37.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -167.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -75.21 135.16 41.04 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.6 m -96.31 136.79 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.725 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.616 ' H ' HD11 ' A' ' 119' ' ' ILE . 89.3 t -91.81 105.74 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.372 0 N-CA-C 101.768 -3.419 . . . . 0.0 101.768 164.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.716 HG23 HH12 ' A' ' 70' ' ' ARG . 16.2 m -117.06 155.68 18.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -109.29 133.3 53.22 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.3 m -102.67 153.95 19.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 124.717 1.261 . . . . 0.0 111.295 -170.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -147.85 123.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 167.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.0 p30 69.63 15.76 8.11 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 127.307 2.243 . . . . 0.0 115.069 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.83 55.64 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 6' ' ' TYR . 7.6 tp -128.56 133.48 25.23 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -77.33 118.56 4.68 Favored 'Trans proline' 0 N--CA 1.44 -1.657 0 CA-C-N 124.181 2.529 . . . . 0.0 106.381 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 m -109.79 -11.34 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 O-C-N 123.635 0.584 . . . . 0.0 109.802 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -145.26 152.05 39.34 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.74 127.35 55.31 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.51 117.53 30.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 170.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -100.75 37.93 1.63 Allowed 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -166.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.2 p -87.39 -20.83 26.13 Favored 'General case' 0 CA--C 1.494 -1.198 0 O-C-N 121.747 -0.596 . . . . 0.0 109.411 -174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.616 HD11 ' H ' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -86.15 -23.5 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.105 0 C-N-CA 123.87 0.868 . . . . 0.0 109.579 173.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.404 ' CE1' HD12 ' A' ' 119' ' ' ILE . 22.6 m-30 -106.97 54.26 0.68 Allowed 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -164.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 62.57 77.69 0.32 Allowed 'General case' 0 CA--C 1.485 -1.52 0 C-N-CA 129.057 2.943 . . . . 0.0 109.523 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -57.71 125.72 73.71 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.515 171.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo . . . . . 0 N--CA 1.433 -2.069 0 N-CA-C 105.633 -2.487 . . . . 0.0 105.633 177.517 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 . . . . . 0 CA--C 1.486 -1.514 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -110.77 62.6 0.61 Allowed 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -94.8 -15.99 23.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -87.92 -17.09 32.14 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.533 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -73.28 -41.79 63.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -64.53 -48.02 76.67 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.836 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -79.78 -10.41 59.78 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 120.304 1.411 . . . . 0.0 114.506 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -82.82 -30.56 28.66 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 119.093 0.86 . . . . 0.0 108.81 171.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.472 ' CD2' HD12 ' A' ' 10' ' ' LEU . 3.3 t80 -60.25 -34.94 74.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.492 0.717 . . . . 0.0 109.986 165.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 10.8 mp -81.03 -23.3 38.7 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.9 p -75.11 -30.65 60.91 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 120.495 1.498 . . . . 0.0 110.881 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -72.74 -55.16 7.17 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 170.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -95.66 -54.04 3.5 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.708 -162.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 23.4 t80 -78.45 112.2 15.26 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 119.926 1.239 . . . . 0.0 109.977 -168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -130.43 94.07 3.58 Favored 'General case' 0 CA--C 1.48 -1.729 0 N-CA-C 101.445 -3.539 . . . . 0.0 101.445 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.9 -38.02 0.89 Allowed 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 120.141 3.386 . . . . 0.0 120.141 -162.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -146.7 154.38 47.92 Favored Pre-proline 0 CA--C 1.502 -0.897 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 166.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 31.9 Cg_endo -75.0 163.16 35.89 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 123.613 2.875 . . . . 0.0 109.883 174.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -75.16 -71.39 0.36 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 166.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.91 178.42 16.44 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.459 -3.856 . . . . 0.0 103.459 164.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -114.68 70.61 0.74 Allowed 'General case' 0 CA--C 1.488 -1.43 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -154.68 174.98 14.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -172.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.72 -16.75 62.81 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.814 1.246 . . . . 0.0 113.535 -170.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -81.75 -28.83 33.12 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -76.99 -34.3 57.53 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.49 -33.57 42.07 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -169.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -65.58 -46.27 80.09 Favored 'General case' 0 CA--C 1.492 -1.282 0 C-N-CA 124.631 1.172 . . . . 0.0 109.34 170.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.1 t -64.33 -36.75 85.15 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.9 tt -83.08 -28.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.287 0 CA-C-N 118.023 0.374 . . . . 0.0 111.21 -176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.0 mmt -73.28 -23.88 60.35 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.117 173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -82.6 -29.32 30.27 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 118.903 0.774 . . . . 0.0 112.58 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -80.74 -37.35 30.68 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 118.402 0.546 . . . . 0.0 111.122 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -22.67 55.96 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.671 0.388 . . . . 0.0 110.306 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.3 5.66 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 168.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.62 16.55 19.66 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 t -91.1 -11.71 37.79 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 m -126.42 102.9 26.0 Favored Pre-proline 0 N--CA 1.425 -1.717 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.74 161.48 94.12 Favored 'Cis proline' 0 N--CA 1.443 -1.494 0 N-CA-C 106.865 -2.013 . . . . 0.0 106.865 -20.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.462 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.2 m -62.12 120.62 11.23 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.96 0.904 . . . . 0.0 110.339 -175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -72.0 138.9 48.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -75.32 -40.98 57.87 Favored 'General case' 0 CA--C 1.491 -1.297 0 O-C-N 123.557 0.536 . . . . 0.0 111.338 -171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.15 128.25 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -148.39 127.14 12.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 170.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -97.48 123.84 41.49 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.085 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -94.6 113.23 25.01 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.8 mm -87.37 145.34 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.53 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 -175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.565 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 8.9 m-70 -133.8 133.62 41.88 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.61 -147.12 12.43 Favored Glycine 0 CA--C 1.486 -1.752 0 N-CA-C 107.313 -2.315 . . . . 0.0 107.313 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.401 HD22 ' HD3' ' A' ' 51' ' ' ARG . 4.5 m120 -94.92 149.04 21.67 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.07 -17.85 34.01 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.401 ' HD3' HD22 ' A' ' 49' ' ' ASN . 9.0 mpt_? -68.85 -40.84 79.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.439 1.896 . . . . 0.0 106.565 175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.1 m -70.21 -41.95 72.97 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-O 116.645 -1.645 . . . . 0.0 111.665 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.1 mm -53.97 -58.18 4.08 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 124.368 1.067 . . . . 0.0 111.478 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.03 -42.55 90.48 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.062 1.345 . . . . 0.0 111.489 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.48 10.65 4.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mm -77.59 -31.89 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.222 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 167.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 80.2 m -94.58 7.68 44.84 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 120.624 0.249 . . . . 0.0 111.502 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -91.09 173.26 8.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 158.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -85.55 1.8 47.53 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 123.344 0.658 . . . . 0.0 111.555 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -77.52 -60.01 2.54 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 123.243 0.617 . . . . 0.0 111.32 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -89.34 -49.51 6.67 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.55 147.81 18.65 Favored Glycine 0 CA--C 1.487 -1.684 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -168.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -103.71 156.66 35.27 Favored Pre-proline 0 N--CA 1.434 -1.262 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -73.92 125.44 9.9 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 122.663 2.242 . . . . 0.0 107.629 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -117.71 123.35 45.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 66.46 -107.2 0.11 Allowed 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.912 1.285 . . . . 0.0 112.124 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.75 95.61 2.88 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.333 2.2 p-10 60.31 35.55 20.71 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 128.666 2.786 . . . . 0.0 113.602 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.1 mt -117.67 165.69 13.3 Favored 'General case' 0 CA--C 1.479 -1.764 0 N-CA-C 101.31 -3.589 . . . . 0.0 101.31 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.8 mtt85 -145.14 127.59 15.96 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 173.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -95.58 134.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.1 p -81.84 160.21 23.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-O 121.351 0.596 . . . . 0.0 111.054 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -120.97 -1.87 9.81 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.4 m -106.37 77.26 1.2 Allowed 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -59.69 138.06 57.86 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 125.898 1.679 . . . . 0.0 111.912 -174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -113.43 158.85 20.13 Favored 'General case' 0 CA--C 1.473 -2.012 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -166.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 47' ' ' HIS . 8.7 mt-30 -79.89 138.9 37.26 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.22 105.97 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -171.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.0 m -97.98 106.31 18.58 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m -87.39 112.19 21.88 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 66.4 m -89.38 116.29 27.47 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -121.47 142.33 50.15 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 103.449 -2.797 . . . . 0.0 103.449 -175.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 39' ' ' CYS . 47.2 tp -80.36 110.54 15.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -93.13 155.02 17.74 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 175.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.91 -89.79 1.52 Allowed Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 107.491 -2.244 . . . . 0.0 107.491 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.33 38.41 0.59 Allowed Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -80.15 126.08 80.14 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 169.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -84.88 -19.96 3.79 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 122.165 1.809 . . . . 0.0 108.314 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -110.47 160.66 27.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 117.618 -1.182 . . . . 0.0 107.962 -168.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -73.25 142.04 33.17 Favored 'Trans proline' 0 N--CA 1.437 -1.846 0 C-N-CA 122.695 2.263 . . . . 0.0 106.767 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -82.04 159.47 79.43 Favored 'Cis proline' 0 N--CA 1.435 -1.944 0 CA-C-N 123.027 2.117 . . . . 0.0 108.949 4.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.6 m -109.52 170.27 8.17 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -125.48 109.92 13.29 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 167.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -105.84 113.98 27.86 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -89.04 125.61 35.08 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 172.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.72 125.69 29.98 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.0 m -106.53 87.22 2.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.983 -2.969 . . . . 0.0 102.983 168.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.75 129.21 34.4 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.08 -167.13 14.4 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -157.32 114.26 3.01 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.8 ttt-85 -155.14 156.18 35.29 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -168.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -75.57 139.58 42.19 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.61 172.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.22 147.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.08 94.7 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 165.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 m -91.6 136.11 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -80.91 126.08 30.92 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.5 m -107.03 142.62 36.38 Favored 'General case' 0 CA--C 1.485 -1.556 0 O-C-N 124.42 1.075 . . . . 0.0 110.577 -172.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -150.77 130.49 13.17 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 166.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.322 14.8 p30 64.37 20.44 12.17 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 128.202 2.601 . . . . 0.0 115.553 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.77 -3.07 70.54 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 110.586 -1.005 . . . . 0.0 110.586 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.261 0.3 OUTLIER -102.73 142.42 24.53 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 176.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.72 109.85 2.93 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 N-CA-C 105.386 -2.582 . . . . 0.0 105.386 160.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 114' ' ' HIS . 2.8 m -85.98 -22.58 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.623 -177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.571 ' CD2' HG23 ' A' ' 113' ' ' VAL . 54.6 m-70 -156.37 -163.4 1.45 Allowed 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -171.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 132.88 1.06 Allowed 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 -175.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.54 127.29 32.76 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -97.55 16.94 18.9 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.7 m -91.84 -20.85 21.03 Favored 'General case' 0 CA--C 1.49 -1.339 0 CA-C-N 118.765 0.711 . . . . 0.0 110.376 -165.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -26.71 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 C-N-CA 123.672 0.789 . . . . 0.0 109.03 175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -98.55 -4.01 35.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -169.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 45.2 ttm180 -91.42 -66.91 0.89 Allowed 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -113.1 112.65 49.72 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.433 -2.054 0 N-CA-C 105.338 -2.601 . . . . 0.0 105.338 177.362 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -120.07 43.06 2.78 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -110.32 -4.12 15.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 173.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -90.05 -27.02 19.98 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -71.65 -41.66 68.5 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.177 0.591 . . . . 0.0 109.437 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -55.0 -56.81 15.59 Favored 'General case' 0 N--CA 1.398 -3.032 0 C-N-CA 126.158 1.783 . . . . 0.0 113.957 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.532 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 17.8 p -78.72 -6.16 55.08 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -86.28 -35.63 19.82 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 120.582 1.537 . . . . 0.0 108.496 172.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.06 -41.34 87.69 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.547 1.139 . . . . 0.0 109.416 167.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.392 0.0 OUTLIER -97.34 0.02 47.22 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 118.267 0.485 . . . . 0.0 111.168 -174.027 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 m -71.22 -53.91 12.75 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 161.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.12 -40.58 94.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 124.053 0.846 . . . . 0.0 112.94 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -121.25 4.86 10.29 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 118.181 -0.914 . . . . 0.0 113.245 -162.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.628 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 30.7 t80 -110.29 130.0 55.63 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 120.173 1.351 . . . . 0.0 109.438 167.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -149.82 104.6 3.33 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 164.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.88 -43.38 4.05 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 118.321 2.712 . . . . 0.0 118.321 -164.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -142.24 156.49 64.4 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 18.4 Cg_endo -71.04 147.28 54.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.584 2.856 . . . . 0.0 108.838 172.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -80.02 -53.51 6.66 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.04 -178.38 15.57 Favored Glycine 0 CA--C 1.48 -2.125 0 N-CA-C 103.331 -3.908 . . . . 0.0 103.331 164.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -128.11 48.01 2.34 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -133.95 179.33 6.31 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.896 -168.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -56.68 -41.52 77.47 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 127.707 2.403 . . . . 0.0 112.926 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -81.63 -18.93 42.96 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.865 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -74.29 -44.59 52.09 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 2.3 m -68.66 -36.93 79.2 Favored 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 124.238 0.961 . . . . 0.0 112.869 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -69.57 -41.87 75.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 123.371 0.42 . . . . 0.0 110.275 177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.9 m -73.06 -23.17 60.53 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.827 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 9.9 tt -85.74 -36.84 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 119.77 1.168 . . . . 0.0 110.965 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.1 mmm -72.05 -30.77 65.49 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -76.19 -39.32 55.04 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -74.53 -48.56 26.27 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-O 118.494 -0.765 . . . . 0.0 111.407 -170.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -79.66 -23.77 42.29 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.305 -1.358 . . . . 0.0 111.152 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.37 61.95 1.52 Allowed Glycine 0 CA--C 1.49 -1.483 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 161.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.69 15.3 5.92 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 t -84.33 8.83 14.79 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.705 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.6 m -113.18 106.27 54.88 Favored Pre-proline 0 N--CA 1.428 -1.575 0 CA-C-O 117.423 -1.275 . . . . 0.0 108.368 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.7 162.24 93.09 Favored 'Cis proline' 0 N--CA 1.443 -1.474 0 CA-C-N 123.401 2.25 . . . . 0.0 107.262 -22.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.28 117.48 7.9 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.58 1.152 . . . . 0.0 111.819 -168.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -73.93 137.15 43.42 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -75.09 -35.19 61.81 Favored 'General case' 0 CA--C 1.489 -1.386 0 O-C-N 124.371 1.044 . . . . 0.0 112.629 -168.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tt -150.21 130.63 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -154.1 119.4 5.11 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.6 m -102.88 120.59 40.89 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.647 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -88.39 116.29 26.51 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 168.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.7 mt -92.04 149.03 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.553 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m-70 -131.6 132.92 44.45 Favored 'General case' 0 CA--C 1.488 -1.412 0 CA-C-N 113.43 -1.714 . . . . 0.0 108.641 -172.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.85 -116.56 0.72 Allowed Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 105.952 -2.859 . . . . 0.0 105.952 173.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -133.5 140.69 47.38 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -88.36 -0.75 57.51 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -79.62 -31.06 41.59 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.3 m -78.16 -28.51 48.34 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-O 117.86 -1.066 . . . . 0.0 110.674 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 tp -68.16 -41.02 83.79 Favored 'Isoleucine or valine' 0 C--N 1.363 1.19 0 CA-C-N 119.142 0.883 . . . . 0.0 110.609 175.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -58.96 -43.31 91.3 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.744 1.217 . . . . 0.0 111.122 173.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.94 13.6 1.35 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.418 HD12 ' CB ' ' A' ' 72' ' ' SER . 20.1 mm -83.11 -22.88 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 169.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.6 m -84.55 -11.03 56.85 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.62 166.61 15.24 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -82.26 -17.06 47.28 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -81.33 -30.49 33.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -130.4 37.86 3.81 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 172.73 128.25 1.04 Allowed Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 105.959 -2.856 . . . . 0.0 105.959 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -104.89 156.05 36.61 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -171.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -76.04 122.17 6.57 Favored 'Trans proline' 0 N--CA 1.437 -1.847 0 C-N-CA 122.496 2.131 . . . . 0.0 107.036 -174.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -106.23 127.82 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 63.46 -105.2 0.15 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.415 1.486 . . . . 0.0 112.058 170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -139.75 97.77 3.33 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.341 1.9 p-10 64.37 26.72 13.62 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 129.033 2.933 . . . . 0.0 114.343 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.18 167.83 9.73 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -142.51 115.55 8.82 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.1 tt -96.61 139.89 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 N-CA-C 105.007 -2.219 . . . . 0.0 105.007 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.418 ' CB ' HD12 ' A' ' 56' ' ' ILE . 93.8 p -81.32 164.86 21.88 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.591 0.71 . . . . 0.0 111.833 -173.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -115.13 -12.68 11.88 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.1 t -116.86 90.65 3.38 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 104.84 -2.281 . . . . 0.0 104.84 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 m -49.9 132.92 22.71 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 127.543 2.337 . . . . 0.0 113.656 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -110.11 157.64 19.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 2.9 mt-30 -81.05 149.14 29.36 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.71 141.62 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -166.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 64.9 m -134.3 104.93 6.37 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 165.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.4 m -85.67 104.05 15.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 70.2 m -83.32 114.74 21.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -111.34 142.29 43.77 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -93.43 136.67 33.47 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 95' ' ' ARG . 95.0 m-70 -140.83 172.6 12.46 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -175.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.39 -91.22 0.6 Allowed Glycine 0 CA--C 1.484 -1.895 0 N-CA-C 106.167 -2.773 . . . . 0.0 106.167 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 148.62 -11.33 1.12 Allowed Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.7 p -78.46 134.86 61.53 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -80.35 -30.35 2.07 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.682 1.588 . . . . 0.0 108.093 173.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -97.14 154.88 37.99 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 117.948 -1.025 . . . . 0.0 108.44 -168.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -77.57 150.19 27.73 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 C-N-CA 122.292 1.995 . . . . 0.0 107.429 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -81.7 165.04 74.67 Favored 'Cis proline' 0 CA--C 1.49 -1.707 0 CA-C-N 123.028 2.117 . . . . 0.0 109.462 7.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.7 m -149.84 141.49 23.55 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -167.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.73 141.33 30.63 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 36.9 m-85 -134.35 110.01 9.17 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 84' ' ' HIS . 3.8 mpt_? -91.16 132.71 35.9 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.76 130.49 35.38 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.618 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.1 m -113.9 95.63 5.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.78 141.7 34.5 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.41 -173.8 23.75 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 84.7 t80 -160.62 107.97 1.55 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 -178.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.33 164.04 39.3 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.247 -173.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.81 123.78 28.03 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 124.718 1.207 . . . . 0.0 108.745 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.0 m -96.02 139.61 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.664 -163.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.6 t -96.36 112.06 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.276 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 172.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 m -105.06 148.13 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 170.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.25 127.24 36.61 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.95 151.15 24.96 Favored 'General case' 0 CA--C 1.494 -1.209 0 O-C-N 124.237 0.96 . . . . 0.0 110.636 -176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -148.76 128.74 13.51 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 103.807 -2.664 . . . . 0.0 103.807 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.346 8.2 p30 70.77 7.85 6.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.592 2.357 . . . . 0.0 115.557 173.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.37 2.79 57.73 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.263 5.5 tp -113.99 154.72 45.99 Favored Pre-proline 0 N--CA 1.431 -1.4 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -72.0 159.35 50.45 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 122.054 1.836 . . . . 0.0 108.263 163.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.6 OUTLIER -138.27 -20.22 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.493 175.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 113' ' ' VAL . 41.1 m-70 -149.86 177.71 9.57 Favored 'General case' 0 CA--C 1.481 -1.686 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -126.74 136.07 51.94 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.52 118.73 28.37 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.08 40.26 1.36 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -173.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.0 m -96.76 -28.32 14.33 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 pt -91.47 -20.78 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.339 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -97.83 -9.67 26.04 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -71.76 -37.03 70.58 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 171.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -73.24 129.72 85.6 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo . . . . . 0 N--CA 1.434 -1.986 0 N-CA-C 106.158 -2.285 . . . . 0.0 106.158 -171.163 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 . . . . . 0 CA--C 1.488 -1.44 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.02 61.86 0.66 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -88.61 -28.27 20.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.3 t -92.31 -6.63 49.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.511 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -33.46 44.39 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 10' ' ' LEU . 0.7 OUTLIER -64.68 -50.25 67.75 Favored 'General case' 0 N--CA 1.42 -1.949 0 C-N-CA 125.055 1.342 . . . . 0.0 109.0 173.265 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.484 1.7 t -88.06 10.85 17.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -80.49 -40.78 25.51 Favored 'General case' 0 CA--C 1.497 -1.089 0 O-C-N 119.974 -1.704 . . . . 0.0 107.836 157.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -57.95 -40.25 80.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.117 1.367 . . . . 0.0 109.588 169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 14' ' ' TYR . 18.0 mt -83.28 -15.65 49.36 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.3 m -65.86 -47.71 74.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-N 120.465 1.484 . . . . 0.0 109.224 169.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 12.4 tt0 -77.83 -40.3 40.77 Favored 'General case' 0 N--CA 1.408 -2.554 0 C-N-CA 124.212 1.005 . . . . 0.0 111.187 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 80.1 m-70 -96.17 -54.92 3.13 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 118.482 0.583 . . . . 0.0 110.377 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' HB2' HD22 ' A' ' 10' ' ' LEU . 50.5 t80 -77.66 118.77 20.37 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.982 0.896 . . . . 0.0 110.382 -165.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.07 98.11 3.79 Favored 'General case' 0 N--CA 1.422 -1.855 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.45 -41.24 6.12 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 117.821 2.526 . . . . 0.0 117.821 -165.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -156.26 139.27 10.8 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 164.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 37.2 Cg_endo -85.54 170.96 8.85 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.876 1.717 . . . . 0.0 108.663 -169.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -73.25 -79.77 0.08 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -177.03 20.05 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 103.494 -3.842 . . . . 0.0 103.494 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -127.38 70.87 1.32 Allowed 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -147.46 -178.76 6.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -66.21 -26.2 67.27 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 124.824 1.249 . . . . 0.0 113.777 -171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -81.25 -27.08 35.33 Favored 'General case' 0 N--CA 1.433 -1.299 0 C-N-CA 122.599 0.36 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -72.11 -42.72 65.77 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 29' ' ' ILE 0.259 0.1 OUTLIER -81.25 -24.99 36.97 Favored 'General case' 0 N--CA 1.423 -1.784 0 C-N-CA 119.081 -1.048 . . . . 0.0 113.371 -170.064 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.06 -36.6 66.91 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 119.084 -0.484 . . . . 0.0 110.467 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -69.62 -34.19 73.73 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.465 HG22 ' HA ' ' A' ' 26' ' ' CYS . 19.3 tt -85.19 -24.75 6.93 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.11 0 CA-C-N 118.308 0.504 . . . . 0.0 110.579 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -31.09 63.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.588 172.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -73.75 -36.63 65.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -81.54 -41.91 20.95 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -77.63 -21.15 52.7 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.233 0.469 . . . . 0.0 111.904 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.67 50.69 1.94 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.344 4.0 mm? -108.09 -14.65 14.68 Favored 'General case' 0 CA--C 1.48 -1.749 0 C-N-CA 124.216 1.006 . . . . 0.0 108.636 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 t -74.6 -15.34 60.84 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 125.897 1.679 . . . . 0.0 112.735 -163.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 p -121.84 108.3 35.0 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.78 156.22 99.69 Favored 'Cis proline' 0 N--CA 1.441 -1.594 0 N-CA-C 106.722 -2.068 . . . . 0.0 106.722 -25.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.1 m -59.9 127.91 34.26 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 125.518 1.527 . . . . 0.0 112.026 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -80.3 140.27 36.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -77.06 -37.62 54.25 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.774 -168.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.56 129.7 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -152.38 130.0 11.53 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 170.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.9 m -97.64 128.72 44.55 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 114.666 -1.152 . . . . 0.0 107.893 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -94.83 118.04 31.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.6 mt -87.14 148.07 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.663 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.4 m-70 -142.86 130.09 20.93 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.719 -176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.16 -129.98 1.84 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 106.579 -2.609 . . . . 0.0 106.579 175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -115.36 145.08 42.86 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 104.52 -2.4 . . . . 0.0 104.52 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -87.01 -18.83 29.72 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.02 0.438 . . . . 0.0 109.907 -170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -80.26 -24.64 39.95 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.9 t -71.07 -40.65 71.49 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 117.312 -1.328 . . . . 0.0 110.076 172.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 mm -56.19 -53.87 34.31 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 C-N-CA 124.844 1.258 . . . . 0.0 111.165 175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -58.56 -43.26 89.28 Favored 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.189 1.396 . . . . 0.0 111.517 -178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.24 8.41 9.04 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.6 mm -75.37 -27.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.5 t -72.85 -29.03 62.88 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 117.564 0.165 . . . . 0.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.34 153.72 42.13 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.03 8.76 33.79 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.666 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.04 -50.86 7.09 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -110.76 -3.88 15.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.684 -166.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.31 -159.12 7.99 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 103.894 -3.682 . . . . 0.0 103.894 168.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -162.26 152.95 14.54 Favored Pre-proline 0 N--CA 1.437 -1.111 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -73.5 137.89 26.09 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 122.995 2.463 . . . . 0.0 107.503 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -129.61 122.78 29.77 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? 67.94 -100.26 0.05 Allowed 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 125.181 1.393 . . . . 0.0 109.689 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -162.57 108.8 1.22 Allowed 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.412 0.5 OUTLIER 86.71 -6.66 0.71 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 129.857 3.263 . . . . 0.0 114.145 173.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -101.8 156.82 17.27 Favored 'General case' 0 CA--C 1.481 -1.695 0 N-CA-C 102.907 -2.997 . . . . 0.0 102.907 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -141.75 115.72 9.28 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 tt -90.26 141.95 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 82.8 p -84.47 162.71 19.81 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 121.63 0.729 . . . . 0.0 112.181 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.89 -27.28 9.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.6 m -103.03 79.78 1.79 Allowed 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.5 p -47.4 133.81 12.29 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 128.336 2.654 . . . . 0.0 113.502 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -112.3 158.73 19.41 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -167.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -79.92 125.19 29.42 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.11 103.43 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.9 m -90.6 107.77 19.38 Favored 'General case' 0 CA--C 1.489 -1.404 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -87.41 105.59 17.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 57.1 m -97.4 114.49 26.32 Favored 'General case' 0 CA--C 1.477 -1.852 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -114.76 136.85 52.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.944 -2.613 . . . . 0.0 103.944 -175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.86 118.66 10.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 125.832 1.653 . . . . 0.0 107.824 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -136.39 97.5 3.6 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.32 -42.61 0.07 OUTLIER Glycine 0 CA--C 1.48 -2.136 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.72 6.18 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 m -112.13 109.92 54.17 Favored Pre-proline 0 N--CA 1.437 -1.077 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -85.2 -20.46 3.38 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 CA-C-N 121.769 1.668 . . . . 0.0 108.51 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -112.1 159.46 33.62 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -169.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -75.11 145.36 30.98 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 122.563 2.176 . . . . 0.0 107.929 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -81.91 162.68 77.74 Favored 'Cis proline' 0 N--CA 1.436 -1.91 0 CA-C-N 122.437 1.906 . . . . 0.0 107.969 -1.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 21.0 m -108.45 166.03 11.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -171.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -122.27 116.75 24.64 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -112.76 133.02 54.98 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -99.47 117.06 33.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 165.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -84.39 131.68 34.66 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.0 m -123.31 107.83 12.09 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.45 135.01 36.55 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.898 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -137.72 -174.89 13.57 Favored Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 106.09 -2.804 . . . . 0.0 106.09 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -158.48 106.18 1.9 Allowed 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 177.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -156.88 168.92 26.01 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -78.1 132.67 37.79 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.569 -175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.6 m -94.46 138.89 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.391 -170.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.9 t -101.22 96.13 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -92.24 136.65 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.58 143.54 30.07 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 44.8 t -136.42 137.02 40.03 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.178 0.513 . . . . 0.0 110.624 -170.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -128.23 131.73 48.8 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.306 14.1 p30 64.47 21.19 12.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 117.106 2.262 . . . . 0.0 117.106 171.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.56 53.73 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 tp -144.63 118.49 5.69 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -172.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -71.51 118.29 5.58 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 CA-C-N 121.817 1.685 . . . . 0.0 111.416 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.493 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.7 OUTLIER -90.77 -26.24 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 118.816 0.735 . . . . 0.0 112.664 -175.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.493 ' CD2' HG23 ' A' ' 113' ' ' VAL . 25.8 m-70 -149.3 -166.2 2.49 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.1 133.56 4.55 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.65 141.02 34.04 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.509 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -105.16 42.09 1.27 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.0 m -95.87 -29.07 14.4 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.84 -32.67 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.929 0 C-N-CA 124.981 1.312 . . . . 0.0 109.475 170.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -105.61 41.45 1.38 Allowed 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.36 -37.23 20.12 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -82.94 150.35 61.53 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.432 -2.128 0 N-CA-C 104.202 -3.038 . . . . 0.0 104.202 162.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 . . . . . 0 CA--C 1.486 -1.511 0 CA-C-O 120.902 0.382 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -125.56 48.18 2.09 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -109.59 -2.46 17.52 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t -93.59 -28.12 16.21 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 167.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -34.46 63.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.084 0.954 . . . . 0.0 108.803 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' HB2' HD21 ' A' ' 111' ' ' LEU . 63.3 t80 -46.46 -60.32 2.42 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 127.053 2.141 . . . . 0.0 111.796 162.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 1.6 p -72.73 -12.56 61.06 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 116.295 1.961 . . . . 0.0 116.295 -176.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -76.62 -41.91 44.22 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.799 1.181 . . . . 0.0 109.824 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -63.03 -36.27 83.0 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.995 1.718 . . . . 0.0 109.342 171.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.482 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -73.67 -26.7 60.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.034 1.333 . . . . 0.0 114.493 177.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 79.8 m -69.81 -51.31 34.81 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HG3' ' CD2' ' A' ' 13' ' ' HIS . 13.4 pt20 -84.82 -10.25 57.36 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -171.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.613 ' CD2' ' HG3' ' A' ' 12' ' ' GLN . 83.7 m-70 -138.03 2.67 2.37 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 36.2 t80 -107.07 132.34 53.09 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 120.52 1.509 . . . . 0.0 108.834 171.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -151.33 104.36 3.09 Favored 'General case' 0 CA--C 1.48 -1.732 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 167.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -37.92 16.77 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 117.069 2.248 . . . . 0.0 117.069 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -162.14 138.13 5.8 Favored Pre-proline 0 N--CA 1.435 -1.183 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 86.0 Cg_exo -74.01 173.58 13.83 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 122.274 1.983 . . . . 0.0 114.465 -172.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.78 -73.87 0.24 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 169.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.98 -175.82 15.29 Favored Glycine 0 CA--C 1.48 -2.124 0 N-CA-C 103.538 -3.825 . . . . 0.0 103.538 167.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -126.2 69.29 1.21 Allowed 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -150.36 -176.96 5.68 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.45 -21.95 61.89 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.324 1.05 . . . . 0.0 113.366 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -81.95 -23.44 36.13 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -77.55 -37.55 50.48 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.0 m -69.46 -37.09 77.17 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -77.12 -30.71 55.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 119.456 -0.307 . . . . 0.0 110.339 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -70.33 -35.27 73.51 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.0 tt -85.96 -25.97 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 120.605 0.241 . . . . 0.0 110.89 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 mmt -76.49 -31.21 57.61 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 121.79 -0.569 . . . . 0.0 109.777 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -69.57 -38.64 77.48 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.159 0.984 . . . . 0.0 112.172 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -71.11 -52.04 21.59 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.465 1.106 . . . . 0.0 110.865 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -80.24 -26.28 39.15 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.145 0.578 . . . . 0.0 109.543 -175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.65 63.24 1.29 Allowed Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 164.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.16 23.35 1.86 Allowed 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.684 1.231 . . . . 0.0 108.335 174.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -84.23 -9.48 58.48 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 126.532 1.933 . . . . 0.0 109.696 167.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.9 t -120.22 107.77 39.0 Favored Pre-proline 0 N--CA 1.438 -1.046 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -73.82 165.45 84.87 Favored 'Cis proline' 0 N--CA 1.448 -1.184 0 CA-C-N 122.593 1.962 . . . . 0.0 107.557 -18.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' HD13 ' A' ' 83' ' ' LEU . 49.9 m -61.38 120.51 10.59 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.798 0.839 . . . . 0.0 110.757 -175.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -79.4 144.12 34.42 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -75.19 -40.2 59.56 Favored 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 123.097 0.559 . . . . 0.0 111.762 -171.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.26 133.76 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.8 121.09 4.85 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 173.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -102.35 115.47 30.63 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.004 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.0 120.25 26.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 172.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.6 mt -101.81 146.71 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.1 m-70 -132.49 127.92 36.26 Favored 'General case' 0 CA--C 1.485 -1.521 0 C-N-CA 124.672 1.189 . . . . 0.0 108.574 -172.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.72 -143.85 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 105.374 -3.09 . . . . 0.0 105.374 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -95.27 148.61 22.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -88.69 -17.96 28.88 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -69.55 -36.01 75.95 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.9 t -74.61 -36.13 62.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 117.335 -1.317 . . . . 0.0 111.006 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 53' ' ' ILE . 3.2 tp -64.85 -46.52 91.67 Favored 'Isoleucine or valine' 0 C--N 1.366 1.301 0 CA-C-N 119.542 1.065 . . . . 0.0 111.047 -179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -61.54 -41.88 97.99 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.747 1.219 . . . . 0.0 111.243 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.62 2.39 9.95 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.5 mm -74.48 -36.32 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 170.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.8 m -85.81 -31.49 22.28 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -102.07 57.31 0.81 Allowed 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 117.796 0.271 . . . . 0.0 111.242 -170.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 34.81 65.48 0.35 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 130.174 3.389 . . . . 0.0 115.54 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.94 -58.76 0.96 Allowed 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -99.51 -44.43 6.17 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.17 154.58 21.55 Favored Glycine 0 N--CA 1.432 -1.632 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.588 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.27 154.16 42.3 Favored Pre-proline 0 N--CA 1.434 -1.247 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -74.75 137.31 22.16 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.984 2.456 . . . . 0.0 107.105 -175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -123.5 73.49 1.19 Allowed 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 69.49 -101.28 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 126.325 1.85 . . . . 0.0 113.551 174.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -105.96 77.21 1.23 Allowed 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 123.935 0.894 . . . . 0.0 108.759 -163.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.319 6.4 p30 71.92 11.56 6.18 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 129.421 3.089 . . . . 0.0 114.222 170.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.2 mt -101.24 157.33 16.86 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 103.09 -2.93 . . . . 0.0 103.09 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -140.11 119.33 12.85 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 tt -88.76 143.35 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 95.3 p -83.85 169.01 15.58 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-O 121.102 0.477 . . . . 0.0 110.631 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -134.63 3.79 3.3 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.4 m -105.39 79.55 1.48 Allowed 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 170.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -53.24 128.43 28.03 Favored 'General case' 0 CA--C 1.495 -1.162 0 C-N-CA 127.506 2.322 . . . . 0.0 112.18 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -108.86 158.96 17.17 Favored 'General case' 0 CA--C 1.469 -2.169 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 -170.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 8.5 mt-30 -77.57 145.35 36.92 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.88 142.06 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -171.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.9 m -134.5 102.51 5.34 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 102.097 -3.298 . . . . 0.0 102.097 169.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -82.11 106.79 14.29 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.9 m -89.24 113.04 24.22 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -124.61 136.78 54.23 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -169.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 39' ' ' CYS . 42.3 tp -78.64 123.63 27.33 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -170.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -138.06 52.65 1.84 Allowed 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 173.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -100.95 -88.2 2.01 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.66 -16.79 4.01 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 -177.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.7 m -83.92 136.62 41.3 Favored Pre-proline 0 N--CA 1.432 -1.349 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -81.17 -23.4 5.28 Favored 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 121.83 1.687 . . . . 0.0 108.422 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -105.33 164.46 15.04 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -74.26 143.7 32.1 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 N-CA-C 107.035 -1.948 . . . . 0.0 107.035 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -82.9 160.97 75.3 Favored 'Cis proline' 0 N--CA 1.435 -1.913 0 CA-C-N 123.062 2.129 . . . . 0.0 109.583 7.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 57.1 m -125.24 138.68 54.11 Favored 'General case' 0 CA--C 1.485 -1.556 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -173.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -94.61 99.73 11.81 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -94.16 111.83 23.59 Favored 'General case' 0 CA--C 1.484 -1.575 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -87.65 124.99 34.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.94 125.8 29.85 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 31.4 m -110.19 87.26 2.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 171.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -88.18 131.17 34.83 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -172.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -142.58 -162.35 9.2 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.049 -2.021 . . . . 0.0 108.049 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.413 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 91.9 t80 -155.21 102.32 2.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 -137.91 155.62 48.73 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -158.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -74.36 127.82 33.97 Favored 'General case' 0 CA--C 1.486 -1.512 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.54 131.55 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -176.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 95.4 t -92.47 113.22 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.443 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.9 m -105.14 141.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.127 -2.546 . . . . 0.0 104.127 173.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.24 127.69 37.81 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.7 m -108.65 151.66 25.85 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 121.836 0.827 . . . . 0.0 112.004 -168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -146.33 127.15 14.41 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.315 15.3 p30 60.01 25.38 14.6 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 128.054 2.542 . . . . 0.0 115.422 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.18 20.71 60.18 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 177.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -139.87 138.59 19.98 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 177.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -85.62 117.77 1.77 Allowed 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 121.535 1.584 . . . . 0.0 108.947 -170.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.552 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -93.83 -23.08 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 123.572 0.545 . . . . 0.0 112.246 -176.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.552 ' CD2' HG23 ' A' ' 113' ' ' VAL . 55.9 m-70 -143.0 -177.73 5.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -170.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.4 tp -139.07 143.09 38.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.75 123.98 33.7 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -112.17 11.7 20.35 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.6 t -90.79 -32.43 16.11 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.62 -25.52 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 C-N-CA 124.304 1.042 . . . . 0.0 110.749 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -100.44 25.16 7.97 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -84.3 -73.61 0.42 Allowed 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -93.33 122.36 63.22 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 174.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.437 -1.851 0 C-N-CA 122.431 2.087 . . . . 0.0 107.443 -168.281 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 . . . . . 0 CA--C 1.489 -1.393 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -145.96 89.73 1.91 Allowed 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 82.65 6.25 0.92 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 127.452 2.301 . . . . 0.0 108.018 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -91.7 -30.21 16.42 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 164.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -49.19 77.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 125.726 1.61 . . . . 0.0 109.549 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' HB2' HD21 ' A' ' 111' ' ' LEU . 49.8 t80 -51.27 -62.85 1.37 Allowed 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 127.443 2.297 . . . . 0.0 113.542 172.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -70.86 -10.09 58.9 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -83.33 -39.5 20.68 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.597 1.09 . . . . 0.0 109.566 171.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 1.9 t80 -60.12 -37.88 81.35 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 109.617 168.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HG ' ' CB ' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -74.03 -31.41 62.89 Favored 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 125.849 1.66 . . . . 0.0 113.576 178.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 p -75.26 -39.24 60.02 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 120.702 1.592 . . . . 0.0 110.646 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -67.36 -56.95 7.61 Favored 'General case' 0 CA--C 1.486 -1.507 0 O-C-N 123.609 0.568 . . . . 0.0 111.253 174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -89.67 -48.71 7.1 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.69 -167.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.451 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 24.5 t80 -70.68 119.46 14.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.955 1.252 . . . . 0.0 110.608 -175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -137.6 97.78 3.53 Favored 'General case' 0 N--CA 1.424 -1.77 1 N-CA-C 99.673 -4.195 . . . . 0.0 99.673 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.56 -41.69 10.17 Favored 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.502 2.321 . . . . 0.0 117.225 -166.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -159.57 131.09 3.98 Favored Pre-proline 0 N--CA 1.434 -1.248 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 168.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -70.91 180.0 3.88 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 123.146 2.564 . . . . 0.0 114.946 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.87 -77.65 0.09 Allowed 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 113.76 -1.564 . . . . 0.0 106.949 170.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.06 -173.38 14.37 Favored Glycine 0 CA--C 1.478 -2.233 1 N-CA-C 102.284 -4.326 . . . . 0.0 102.284 162.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.29 72.29 0.86 Allowed 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -143.91 179.71 7.01 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -170.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.52 -41.71 73.5 Favored 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 127.926 2.491 . . . . 0.0 112.931 -176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -79.21 -21.13 46.73 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.027 0.531 . . . . 0.0 111.904 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.4 -41.77 55.34 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.5 m -68.37 -37.21 80.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 123.755 0.659 . . . . 0.0 112.143 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -71.61 -37.92 70.88 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.805 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.8 m -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 13.2 tt -81.72 -29.76 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 CA-C-N 118.197 0.453 . . . . 0.0 109.87 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -25.58 51.7 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.943 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -75.92 -33.22 59.86 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.295 0.498 . . . . 0.0 111.109 173.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.17 -48.92 21.27 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 123.134 0.573 . . . . 0.0 110.833 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -78.41 -26.74 46.48 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 123.548 0.739 . . . . 0.0 110.528 -175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.14 55.24 2.0 Favored Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 169.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 mt -116.12 13.77 15.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 174.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.56 -12.67 53.67 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 123.064 0.546 . . . . 0.0 109.854 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 m -121.12 102.25 43.75 Favored Pre-proline 0 N--CA 1.426 -1.638 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.13 -173.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.36 167.82 79.22 Favored 'Cis proline' 0 N--CA 1.445 -1.334 0 N-CA-C 107.049 -1.943 . . . . 0.0 107.049 -22.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 83' ' ' LEU . 45.0 m -59.47 122.21 13.44 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.865 0.866 . . . . 0.0 111.331 -175.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -72.44 143.05 48.61 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -80.65 -37.22 31.36 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 119.769 -0.158 . . . . 0.0 110.611 -174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.73 130.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -143.79 121.6 11.95 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.6 m -92.39 105.66 17.8 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -85.24 116.28 23.5 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.19 150.47 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -141.87 136.04 30.13 Favored 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 125.268 1.427 . . . . 0.0 108.151 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.49 -104.6 0.24 Allowed Glycine 0 CA--C 1.483 -1.918 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 173.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -147.84 127.12 13.01 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 -174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -86.18 -3.86 59.05 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 122.255 -0.278 . . . . 0.0 111.601 -172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.87 -30.57 35.54 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 p -85.54 -23.31 27.74 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 117.695 -1.145 . . . . 0.0 111.384 175.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.2 mm -59.68 -54.26 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 CA-C-N 119.086 0.857 . . . . 0.0 108.715 167.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -58.38 -42.83 87.94 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.418 1.487 . . . . 0.0 112.447 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.64 14.94 2.33 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.54 -38.37 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 164.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.5 t -103.43 44.34 1.02 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.009 0.433 . . . . 0.0 110.583 -171.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -133.37 21.37 4.0 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 164.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 41.46 44.05 2.38 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.292 3.437 . . . . 0.0 114.159 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.54 -45.01 7.59 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -120.03 8.92 11.07 Favored 'General case' 0 CA--C 1.485 -1.522 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.78 -169.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.02 163.73 30.22 Favored Glycine 0 CA--C 1.485 -1.791 0 C-N-CA 118.872 -1.632 . . . . 0.0 109.079 -175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -112.05 156.74 41.38 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -72.14 135.0 24.18 Favored 'Trans proline' 0 N--CA 1.435 -1.95 0 C-N-CA 122.666 2.244 . . . . 0.0 106.364 166.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -129.65 133.78 47.31 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 64.59 -102.65 0.09 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.426 1.49 . . . . 0.0 111.396 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -154.88 112.56 3.42 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.342 5.8 p30 68.44 15.15 9.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 129.642 3.177 . . . . 0.0 114.55 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.6 mt -108.86 167.93 9.72 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 103.306 -2.85 . . . . 0.0 103.306 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.39 109.44 4.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -172.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.7 tt -91.02 146.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 m -82.21 177.21 8.92 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.478 1.132 . . . . 0.0 111.471 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' H ' ' H ' ' A' ' 74' ' ' SER . 20.4 tptm -148.68 -0.08 0.55 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 103.508 -2.775 . . . . 0.0 103.508 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.435 ' H ' ' H ' ' A' ' 73' ' ' LYS . 36.3 t -119.76 90.14 3.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 130.01 44.76 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 125.937 1.695 . . . . 0.0 112.648 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.71 158.74 18.3 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -79.74 141.07 36.68 Favored 'General case' 0 CA--C 1.471 -2.094 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.17 142.82 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 -166.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.4 m -130.68 109.17 10.43 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 166.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.0 m -82.33 100.86 10.2 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.2 m -86.76 112.28 21.53 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -120.21 141.94 49.46 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 39' ' ' CYS . 28.9 tp -77.75 121.49 24.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -172.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -135.56 50.45 2.11 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 173.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -99.53 -63.64 0.83 Allowed Glycine 0 CA--C 1.482 -1.977 0 N-CA-C 105.401 -3.08 . . . . 0.0 105.401 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.91 -15.93 21.04 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.8 p -86.3 140.49 34.34 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -81.32 -22.37 5.82 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.833 1.689 . . . . 0.0 108.664 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -105.55 162.57 19.33 Favored Pre-proline 0 N--CA 1.432 -1.343 0 CA-C-O 117.936 -1.03 . . . . 0.0 108.423 -168.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -74.02 146.95 37.8 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.401 2.068 . . . . 0.0 108.106 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -83.07 164.49 71.24 Favored 'Cis proline' 0 CA--C 1.49 -1.722 0 CA-C-N 122.753 2.019 . . . . 0.0 109.197 5.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 39.5 m -128.24 130.11 47.45 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -95.61 120.54 36.05 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.32 117.34 32.22 Favored 'General case' 0 CA--C 1.481 -1.706 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -93.09 135.54 34.17 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.52 139.4 30.9 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.553 -175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 m -124.13 98.74 5.91 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 171.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.01 147.16 28.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.075 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.61 36.5 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 108.226 -1.95 . . . . 0.0 108.226 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -152.58 100.9 2.6 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -152.31 170.36 20.23 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.808 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -75.61 129.87 37.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.945 1.698 . . . . 0.0 108.912 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 32.9 m -102.42 141.98 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -168.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.6 t -93.72 113.06 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 171.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.421 HG12 HD13 ' A' ' 115' ' ' LEU . 18.1 m -107.21 147.61 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -89.92 121.01 31.63 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 40.4 t -106.33 126.98 52.91 Favored 'General case' 0 CA--C 1.486 -1.482 0 O-C-N 123.856 0.723 . . . . 0.0 110.741 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.61 132.82 54.46 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.32 5.5 p30 75.03 0.48 3.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 167.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 23.1 11.06 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 6' ' ' TYR . 19.1 tp -141.1 127.49 11.51 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 14.2 Cg_endo -78.8 102.14 1.51 Allowed 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.575 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -91.07 -23.13 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 123.694 0.798 . . . . 0.0 111.631 -166.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.575 ' CD2' HG23 ' A' ' 113' ' ' VAL . 17.3 m-70 -138.37 -177.6 4.92 Favored 'General case' 0 CA--C 1.481 -1.711 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 5.2 tp -124.65 135.91 53.48 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 177.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.91 138.2 31.74 Favored 'General case' 0 CA--C 1.482 -1.648 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.56 51.24 0.77 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 177.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.3 t -81.41 -49.54 10.53 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.327 0.651 . . . . 0.0 109.953 -171.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.87 -28.02 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -173.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -81.19 -21.96 39.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.3 -163.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -84.84 -30.8 24.21 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 123.144 0.278 . . . . 0.0 111.202 175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.5 146.47 69.85 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.433 -2.061 0 N-CA-C 106.081 -2.315 . . . . 0.0 106.081 176.14 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 CA--C 1.489 -1.386 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.49 ' H ' ' HB2' ' A' ' 5' ' ' ARG . 2.8 m-20 66.64 83.1 0.17 Allowed 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 127.198 2.199 . . . . 0.0 109.197 -178.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.4 t30 101.14 -32.83 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 128.935 2.894 . . . . 0.0 107.908 -175.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -88.24 -20.8 25.01 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.49 ' HB2' ' H ' ' A' ' 2' ' ' ASP . 1.1 tmt_? -75.49 -21.02 58.39 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.259 1.023 . . . . 0.0 110.407 -178.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -76.29 -39.05 55.24 Favored 'General case' 0 N--CA 1.413 -2.31 0 C-N-CA 124.777 1.231 . . . . 0.0 108.232 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.478 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 1.1 p -80.31 -10.6 59.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.22 0.918 . . . . 0.0 113.464 176.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -75.04 -46.35 35.5 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 167.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -58.94 -34.45 71.77 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.249 2.22 . . . . 0.0 111.631 176.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 14' ' ' TYR 0.332 0.0 OUTLIER -106.97 -4.66 18.82 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.753 0.821 . . . . 0.0 111.726 -173.254 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.6 t -83.64 -28.74 28.2 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 169.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -67.82 -70.33 0.26 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 163.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -105.48 12.95 30.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -155.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.613 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 36.7 t80 -112.33 128.05 56.17 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-N 120.187 1.358 . . . . 0.0 109.33 169.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -145.34 100.9 3.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 102.228 -3.249 . . . . 0.0 102.228 166.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.16 -39.57 6.26 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 118.266 2.691 . . . . 0.0 118.266 -166.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -154.81 137.3 10.02 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 171.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 40.9 Cg_endo -86.25 174.53 6.08 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 121.731 1.621 . . . . 0.0 108.72 -171.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -74.33 -50.54 18.35 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 172.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.23 -174.07 28.48 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 174.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -114.6 66.43 0.68 Allowed 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 -177.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -150.58 173.48 14.07 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -172.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -70.11 -23.39 63.03 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.82 1.248 . . . . 0.0 113.185 -171.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -21.09 30.14 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -74.12 -43.85 56.0 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.3 m -67.34 -36.02 80.58 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -74.79 -34.37 62.41 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.39 179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.5 t -69.21 -36.62 77.45 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.8 tt -82.4 -28.08 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-N 117.873 0.306 . . . . 0.0 111.017 -175.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.4 mmt -78.33 -24.75 46.42 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.832 176.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -42.4 63.81 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 172.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -45.1 30.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 122.527 0.331 . . . . 0.0 111.761 -169.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.17 -22.03 53.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.13 56.22 1.62 Allowed Glycine 0 C--N 1.352 1.454 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 167.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . 0.326 4.0 mm? -108.73 -16.71 14.12 Favored 'General case' 0 CA--C 1.479 -1.786 0 C-N-CA 124.532 1.133 . . . . 0.0 108.855 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.6 t -76.19 -11.47 59.93 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.577 1.551 . . . . 0.0 112.883 -164.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.0 t -124.79 108.52 28.38 Favored Pre-proline 0 N--CA 1.438 -1.025 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.838 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.72 157.66 98.41 Favored 'Cis proline' 0 N--CA 1.447 -1.227 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 -23.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 21.7 m -54.89 129.98 39.54 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 125.43 1.492 . . . . 0.0 113.258 -173.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -77.27 132.91 38.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 171.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.64 -38.55 58.79 Favored 'General case' 0 CA--C 1.487 -1.477 0 O-C-N 123.495 0.497 . . . . 0.0 110.871 -169.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 tt -147.48 135.91 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 174.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.09 120.03 7.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.2 m -96.73 107.62 20.11 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -174.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -87.09 117.22 25.68 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.0 mt -98.44 147.68 6.63 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -175.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.51 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 2.2 m-70 -137.62 129.93 29.36 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 125.392 1.477 . . . . 0.0 108.797 -169.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 163.57 -134.98 3.59 Favored Glycine 0 CA--C 1.481 -2.06 0 N-CA-C 106.006 -2.838 . . . . 0.0 106.006 173.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -97.94 142.38 29.74 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 173.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -84.88 -21.22 29.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -74.08 -30.36 62.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.094 1.358 . . . . 0.0 109.437 174.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.2 m -77.2 -33.22 56.33 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 117.414 -1.279 . . . . 0.0 110.871 175.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -56.01 -56.14 14.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 CA-C-N 119.037 0.835 . . . . 0.0 110.11 172.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -56.59 -41.24 76.64 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.175 0.99 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.92 15.39 1.1 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 95.8 mt -81.16 -34.21 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 168.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.44 -44.67 62.05 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.782 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.49 156.46 22.84 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -87.91 87.12 7.25 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.057 0.456 . . . . 0.0 109.933 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.73 -47.52 1.04 Allowed 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.99 58.55 1.35 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 177.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.49 151.42 10.91 Favored Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 106.874 -2.49 . . . . 0.0 106.874 174.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -115.71 157.95 43.19 Favored Pre-proline 0 N--CA 1.432 -1.362 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 -177.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -74.3 143.24 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 122.898 2.399 . . . . 0.0 106.506 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -142.03 127.38 18.77 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -175.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? 65.2 -107.39 0.14 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.026 1.33 . . . . 0.0 110.375 171.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.89 101.02 3.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.364 2.3 p-10 63.82 25.84 14.18 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 129.08 2.952 . . . . 0.0 114.505 175.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.5 mt -107.09 157.4 17.87 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 101.943 -3.354 . . . . 0.0 101.943 168.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -138.14 120.97 16.46 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 tt -88.61 145.59 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 177.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.6 p -88.15 165.45 15.09 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.649 0.738 . . . . 0.0 109.914 -175.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -130.96 11.77 5.13 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 177.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.1 t -123.06 96.17 4.9 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 102.351 -3.203 . . . . 0.0 102.351 170.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.6 m -62.26 131.63 50.02 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 124.368 1.067 . . . . 0.0 110.645 175.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -112.58 155.87 23.64 Favored 'General case' 0 CA--C 1.473 -1.999 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -173.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.55 138.53 39.22 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.65 140.84 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -167.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 86.0 m -129.3 105.67 8.29 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 167.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 m -85.55 99.98 11.62 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 176.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 74.1 m -85.65 112.1 20.69 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -117.74 145.99 44.09 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . 0.268 17.1 mt -65.82 135.71 55.22 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.029 0.442 . . . . 0.0 110.365 175.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.35 45.44 2.76 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 156.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -91.01 -83.35 1.42 Allowed Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.08 -25.8 5.7 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.1 t -85.35 131.47 48.0 Favored Pre-proline 0 N--CA 1.431 -1.376 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 177.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -84.01 -14.77 7.18 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 122.097 1.865 . . . . 0.0 108.561 177.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -100.35 168.05 9.98 Favored Pre-proline 0 N--CA 1.431 -1.404 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -73.64 143.77 34.52 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 107.106 -1.921 . . . . 0.0 107.106 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -86.61 163.98 51.46 Favored 'Cis proline' 0 N--CA 1.436 -1.883 0 CA-C-N 122.35 1.875 . . . . 0.0 108.008 10.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 38.9 m -128.75 125.99 39.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -172.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -95.38 128.0 41.88 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 176.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -120.07 126.06 49.83 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -176.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -90.96 129.78 36.95 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.09 129.58 34.86 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 174.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.8 m -120.44 90.26 3.29 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -87.86 150.89 23.24 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.354 0.597 . . . . 0.0 110.742 -172.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -154.53 -170.38 20.28 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -144.08 90.19 2.1 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 101.804 -3.406 . . . . 0.0 101.804 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -124.39 145.99 49.14 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -159.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -80.89 128.79 34.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.7 m -105.29 138.91 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.604 -164.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.6 t -95.24 113.55 29.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 170.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.7 m -111.63 141.51 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 172.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.64 128.16 36.53 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.0 m -108.11 154.01 22.33 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.139 0.899 . . . . 0.0 110.893 -175.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -147.13 127.41 13.9 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.321 8.6 p30 69.75 11.97 7.93 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.784 2.034 . . . . 0.0 114.679 177.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.95 15.86 55.45 Favored Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.9 tp -141.46 142.26 25.78 Favored Pre-proline 0 N--CA 1.439 -1.016 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -70.75 152.53 64.24 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 CA-C-N 121.946 1.731 . . . . 0.0 111.564 -173.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.555 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -134.72 -25.61 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.407 -178.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.555 ' CD2' HG23 ' A' ' 113' ' ' VAL . 36.8 m-70 -143.18 178.02 8.0 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -173.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.65 139.9 36.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -173.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.26 121.58 29.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 168.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -107.6 10.28 29.18 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.1 t -93.18 -20.39 20.52 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -76.0 -36.71 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.797 0 C-N-CA 123.623 0.769 . . . . 0.0 110.933 173.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -92.22 -6.79 49.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -170.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -127.07 62.45 1.34 Allowed 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 104.448 -2.426 . . . . 0.0 104.448 176.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -76.29 147.61 79.65 Favored Pre-proline 0 N--CA 1.432 -1.349 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.875 -178.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 N--CA 1.433 -2.075 0 N-CA-C 106.008 -2.343 . . . . 0.0 106.008 173.661 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 . . . . . 0 CA--C 1.485 -1.554 0 CA-C-O 120.578 0.228 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -120.74 50.9 1.28 Allowed 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 170.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -101.85 -10.52 19.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 169.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -90.88 -14.24 32.11 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.017 177.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.44 HH21 ' CE1' ' A' ' 114' ' ' HIS . 29.1 tpt180 -74.1 -45.32 49.8 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -178.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -56.61 -55.31 35.61 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-O 116.551 -1.69 . . . . 0.0 111.493 168.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 p -81.78 -1.22 46.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 122.011 2.187 . . . . 0.0 115.659 -170.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -85.61 -30.69 23.09 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 167.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -63.63 -28.98 70.28 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 123.307 0.643 . . . . 0.0 111.205 164.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.535 HD12 ' HE3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -84.98 -23.47 28.7 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 119.327 0.967 . . . . 0.0 112.252 177.792 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -72.77 -38.19 67.4 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 120.323 1.42 . . . . 0.0 109.106 174.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' HG3' HD21 ' A' ' 43' ' ' ASN . 2.0 tp-100 -65.37 -58.2 6.46 Favored 'General case' 0 N--CA 1.413 -2.282 0 C-N-CA 124.724 1.209 . . . . 0.0 112.498 172.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -125.62 27.99 6.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -160.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -133.66 136.42 44.74 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 166.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -152.85 108.61 3.31 Favored 'General case' 0 N--CA 1.423 -1.811 1 N-CA-C 100.172 -4.011 . . . . 0.0 100.172 169.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.98 -36.02 5.21 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 118.702 2.852 . . . . 0.0 118.702 -164.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -145.65 154.91 52.75 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 171.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 19.7 Cg_endo -70.92 143.08 44.34 Favored 'Trans proline' 0 N--CA 1.431 -2.203 0 C-N-CA 123.423 2.749 . . . . 0.0 107.6 165.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -80.35 -50.83 9.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 168.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.07 179.45 17.34 Favored Glycine 0 CA--C 1.478 -2.233 0 N-CA-C 103.994 -3.643 . . . . 0.0 103.994 163.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -123.36 53.59 1.32 Allowed 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -140.03 -179.08 5.76 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -170.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.25 -23.1 63.81 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.841 1.256 . . . . 0.0 113.084 -171.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -86.53 -20.03 28.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 122.962 0.505 . . . . 0.0 110.178 -179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.55 -41.53 46.25 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -69.15 -35.62 76.55 Favored 'General case' 0 N--CA 1.433 -1.298 0 O-C-N 123.797 0.685 . . . . 0.0 112.768 -177.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.7 -39.11 67.26 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 119.326 -0.369 . . . . 0.0 110.029 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -75.43 -24.3 57.06 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.261 12.7 tt -82.86 -33.04 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.612 0 CA-C-N 118.852 0.751 . . . . 0.0 109.563 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 mmt -77.91 -20.84 52.16 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.624 178.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -72.1 -44.81 62.64 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.239 0.472 . . . . 0.0 111.858 170.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.69 -39.8 50.89 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 122.924 0.489 . . . . 0.0 111.964 -173.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -75.78 -29.98 58.95 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 123.316 0.646 . . . . 0.0 110.222 -179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 52.41 2.49 Favored Glycine 0 CA--C 1.491 -1.43 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 170.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 50.6 mt -121.85 18.28 11.01 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 177.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -91.85 -10.76 38.56 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.4 1.08 . . . . 0.0 108.802 -173.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.1 t -129.57 105.22 17.33 Favored Pre-proline 0 N--CA 1.439 -1.017 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.1 159.36 95.67 Favored 'Cis proline' 0 N--CA 1.444 -1.425 0 N-CA-C 107.133 -1.91 . . . . 0.0 107.133 -19.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.406 ' HB3' HD13 ' A' ' 83' ' ' LEU . 44.4 m -63.05 123.09 17.69 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 123.968 0.907 . . . . 0.0 109.522 -177.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -71.42 140.78 50.22 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.02 -46.73 50.37 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 122.965 0.506 . . . . 0.0 111.049 -172.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 132.52 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.479 HD21 ' HG3' ' A' ' 12' ' ' GLN . 7.3 t-20 -151.16 119.15 6.23 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.3 m -96.22 112.84 24.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -177.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -87.6 118.48 27.11 Favored 'General case' 0 CA--C 1.495 -1.158 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 171.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.17 152.2 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -177.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.583 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 7.3 m-70 -136.26 133.18 36.72 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 124.648 1.179 . . . . 0.0 108.195 -171.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 165.83 -119.66 0.88 Allowed Glycine 0 CA--C 1.483 -1.911 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 174.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -132.6 138.72 47.5 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.512 -2.773 . . . . 0.0 103.512 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.535 ' HE3' HD12 ' A' ' 10' ' ' LEU . 30.8 mtpt -86.74 -7.14 58.54 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.451 -172.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -80.27 -32.52 38.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -70.67 -36.93 73.6 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 123.996 0.919 . . . . 0.0 110.543 174.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.41 -53.1 51.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 C-N-CA 124.906 1.282 . . . . 0.0 111.38 174.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -57.75 -39.24 76.92 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.285 1.034 . . . . 0.0 113.038 176.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.41 9.4 11.16 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 123.602 0.761 . . . . 0.0 112.978 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 72' ' ' SER . 22.3 mm -78.56 -28.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 168.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.02 -21.01 51.41 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 -179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -80.51 170.8 15.87 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -88.1 5.89 38.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.834 0.854 . . . . 0.0 110.685 -178.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -75.02 -63.24 1.31 Allowed 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 123.842 0.857 . . . . 0.0 110.169 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -89.0 -50.58 6.09 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -176.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.1 149.21 19.12 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -163.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -102.98 154.57 37.45 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -178.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.03 141.58 33.16 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 123.102 2.535 . . . . 0.0 106.828 175.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -134.99 34.68 3.1 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 -169.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 62.21 156.56 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 129.072 2.949 . . . . 0.0 114.05 -176.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 42.89 54.58 4.68 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 129.209 3.004 . . . . 0.0 115.831 176.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.311 2.7 p-10 52.58 34.46 15.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.622 2.769 . . . . 0.0 114.764 -176.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.8 mt -107.92 151.54 25.65 Favored 'General case' 0 CA--C 1.478 -1.813 0 N-CA-C 101.682 -3.451 . . . . 0.0 101.682 177.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -140.62 118.26 11.61 Favored 'General case' 0 CA--C 1.48 -1.747 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -175.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 102' ' ' ASN . 0.3 OUTLIER -85.69 146.15 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 176.32 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.414 ' HB2' HD12 ' A' ' 56' ' ' ILE . 83.6 p -92.69 169.0 10.83 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -131.23 -6.17 3.83 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -106.28 78.86 1.33 Allowed 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.6 t -46.74 127.76 10.03 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 128.324 2.65 . . . . 0.0 113.218 -177.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -108.73 157.69 18.32 Favored 'General case' 0 CA--C 1.479 -1.757 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -170.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.08 139.58 41.45 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 174.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.5 140.98 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -170.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.4 m -132.45 110.56 10.61 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 164.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.3 m -88.7 101.19 13.75 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 89.0 m -85.35 114.36 22.36 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -121.72 129.1 52.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -168.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 39' ' ' CYS . 34.5 tp -72.98 114.9 11.64 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.989 1.316 . . . . 0.0 108.09 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.9 t60 -138.68 95.9 3.05 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 -176.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.12 -41.41 0.05 OUTLIER Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 -177.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.42 41.23 6.58 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 -177.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.5 p -117.81 106.6 45.64 Favored Pre-proline 0 N--CA 1.436 -1.158 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -82.76 -21.66 4.83 Favored 'Trans proline' 0 N--CA 1.439 -1.708 0 CA-C-N 121.535 1.584 . . . . 0.0 108.935 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -107.24 161.69 22.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.98 142.52 31.43 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 122.498 2.132 . . . . 0.0 107.486 -176.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -82.77 161.58 75.36 Favored 'Cis proline' 0 CA--C 1.486 -1.876 0 CA-C-N 123.06 2.128 . . . . 0.0 108.798 4.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 34.1 m -109.41 159.22 17.2 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -173.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -116.58 90.28 3.3 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -96.02 117.45 30.69 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -102.53 132.25 48.71 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 174.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.08 131.08 35.28 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.429 -176.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 27.1 m -117.39 86.34 2.5 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 170.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.02 148.48 21.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.999 -172.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -152.69 -163.37 11.6 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 179.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -146.72 98.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 101.033 -3.691 . . . . 0.0 101.033 179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.2 ttt-85 -133.16 144.49 49.9 Favored 'General case' 0 CA--C 1.488 -1.424 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -162.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.475 HD22 HD12 ' A' ' 71' ' ' ILE . 2.3 p-10 -74.85 124.58 27.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 169.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.95 140.66 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.313 -165.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 84.1 t -92.07 114.91 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 103.841 -2.652 . . . . 0.0 103.841 165.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.6 141.84 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 169.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -101.52 113.44 26.56 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 18.6 p -113.99 163.64 14.86 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-O 122.319 1.057 . . . . 0.0 113.085 -173.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -153.64 136.46 15.34 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 174.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.354 7.9 p30 71.72 2.95 4.49 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.716 2.406 . . . . 0.0 116.092 174.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.6 -2.41 34.32 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.41 128.7 25.8 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -73.58 119.65 6.05 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 N-CA-C 106.682 -2.084 . . . . 0.0 106.682 172.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.665 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.5 OUTLIER -105.62 -17.01 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 123.952 0.783 . . . . 0.0 110.021 -167.533 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.665 ' CD2' HG23 ' A' ' 113' ' ' VAL . 70.5 m-70 -153.34 177.17 11.17 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -169.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.29 142.03 35.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -174.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.74 126.68 37.94 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 167.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -108.88 10.9 26.39 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -173.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.0 m -87.72 -25.68 23.32 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.17 0.51 . . . . 0.0 109.789 -166.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -21.0 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 C-N-CA 124.161 0.984 . . . . 0.0 109.889 177.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -103.0 52.98 0.78 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.352 16.4 ptm180 57.9 61.94 2.23 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 129.184 2.994 . . . . 0.0 113.301 176.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -138.28 102.54 8.12 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 164.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo . . . . . 0 N--CA 1.435 -1.955 0 N-CA-C 105.823 -2.414 . . . . 0.0 105.823 174.402 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -125.26 34.98 4.84 Favored 'General case' 0 CA--C 1.475 -1.932 0 CA-C-O 123.426 1.584 . . . . 0.0 107.388 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -95.97 -23.73 16.71 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 111.528 -2.578 . . . . 0.0 104.651 160.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.6 m -94.02 0.46 56.0 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.801 1.24 . . . . 0.0 109.934 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.467 ' HE ' ' CE1' ' A' ' 114' ' ' HIS . 30.7 tpt180 -75.86 -39.52 56.41 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.47 -46.63 69.22 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 124.15 0.98 . . . . 0.0 109.868 176.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.408 0.2 OUTLIER -83.89 -2.23 56.05 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -179.085 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -83.88 -30.09 26.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.538 1.063 . . . . 0.0 109.291 165.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CD2' HD23 ' A' ' 10' ' ' LEU . 2.3 t80 -61.45 -35.37 77.42 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.153 0.981 . . . . 0.0 109.034 164.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.45 HD23 ' CD2' ' A' ' 9' ' ' PHE . 3.7 mt -83.43 -18.68 37.87 Favored 'General case' 0 CA--C 1.496 -1.115 0 CA-C-O 117.942 -1.028 . . . . 0.0 113.079 177.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.0 m -69.07 -52.26 30.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-N 119.79 1.177 . . . . 0.0 108.481 176.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG2' ' CD2' ' A' ' 13' ' ' HIS . 15.7 tt0 -77.28 -38.02 51.66 Favored 'General case' 0 N--CA 1.404 -2.742 0 C-N-CA 124.286 1.034 . . . . 0.0 110.437 -173.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' CD2' ' HG2' ' A' ' 12' ' ' GLN . 70.0 m-70 -98.31 -54.96 2.9 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 118.616 -0.707 . . . . 0.0 111.48 -175.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -77.63 119.98 21.94 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 119.98 1.264 . . . . 0.0 108.738 -167.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -137.14 98.37 3.72 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 100.682 -3.821 . . . . 0.0 100.682 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.64 -42.55 0.8 Allowed 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 118.987 2.958 . . . . 0.0 118.987 -165.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -144.11 151.94 53.35 Favored Pre-proline 0 N--CA 1.442 -0.856 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 165.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 11.9 Cg_endo -71.81 155.43 58.2 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 123.859 3.039 . . . . 0.0 109.916 173.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -78.64 -53.45 7.16 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 170.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.74 -179.88 17.76 Favored Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 166.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -121.4 61.72 0.92 Allowed 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 -178.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -150.3 -179.42 7.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -176.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.57 -10.47 59.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -170.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -78.36 -33.23 49.14 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -75.63 -39.16 58.23 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.02 -42.95 79.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.3 -31.85 62.65 Favored 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 122.799 0.44 . . . . 0.0 110.597 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.9 t -67.46 -38.72 84.89 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 118.921 -0.562 . . . . 0.0 111.478 176.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 14.6 tt -80.31 -25.34 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 CA-C-N 118.042 0.383 . . . . 0.0 111.385 -176.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -29.89 61.19 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 117.774 -1.57 . . . . 0.0 111.536 172.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -75.66 -29.91 59.25 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 118.199 0.454 . . . . 0.0 112.22 177.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -78.97 -44.83 21.6 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.77 0.828 . . . . 0.0 110.746 -178.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -81.05 -26.21 36.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 122.639 0.376 . . . . 0.0 110.438 -172.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.37 49.04 3.34 Favored Glycine 0 CA--C 1.488 -1.597 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 171.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 17.7 mt -116.61 14.86 15.52 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 173.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 t -86.49 -13.31 46.43 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 124.08 0.952 . . . . 0.0 108.727 -176.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.9 m -122.38 103.63 38.3 Favored Pre-proline 0 N--CA 1.424 -1.73 0 CA-C-O 117.867 -1.064 . . . . 0.0 108.495 -175.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.34 161.05 95.31 Favored 'Cis proline' 0 N--CA 1.441 -1.6 0 N-CA-C 106.888 -2.005 . . . . 0.0 106.888 -23.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -60.39 124.49 20.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.813 1.245 . . . . 0.0 111.118 -175.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -73.02 135.48 44.92 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -75.0 -39.64 61.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.312 -170.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.6 tt -148.69 133.91 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -151.53 121.34 7.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.5 112.1 24.24 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -176.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -85.27 116.26 23.51 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.7 mm -87.55 151.37 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -176.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.605 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 3.9 m-70 -144.15 140.68 29.52 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.61 1.62 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 107.115 -2.394 . . . . 0.0 107.115 175.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -119.79 137.0 54.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -85.58 -20.67 29.2 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 120.959 0.409 . . . . 0.0 110.636 -166.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -79.82 -22.47 42.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.5 m -76.09 -34.36 59.53 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 116.831 -1.557 . . . . 0.0 110.967 171.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.18 -51.23 73.52 Favored 'Isoleucine or valine' 0 C--N 1.368 1.4 0 CA-C-N 119.829 1.195 . . . . 0.0 110.073 171.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.93 -40.42 93.18 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 123.673 0.789 . . . . 0.0 111.16 -178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.72 21.06 1.96 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.94 -28.7 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.174 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 t -78.15 -41.5 34.67 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.895 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -79.22 149.87 31.78 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 170.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -78.77 104.22 9.24 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -160.14 -57.74 0.06 Allowed 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 -177.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -136.88 22.31 3.07 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.67 -178.82 21.47 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 105.288 -3.125 . . . . 0.0 105.288 166.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -137.2 161.28 61.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -171.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -74.49 147.3 36.11 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 122.884 2.389 . . . . 0.0 107.323 162.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -139.44 101.48 4.24 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? 65.54 -102.26 0.08 Allowed 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 111.144 -177.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.24 102.38 3.72 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -174.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.368 2.8 p-10 65.34 22.26 12.02 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 129.896 3.278 . . . . 0.0 114.625 173.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.0 mt -108.13 158.35 17.49 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 100.63 -3.841 . . . . 0.0 100.63 163.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -141.9 111.46 6.58 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 -171.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.0 tt -94.25 140.37 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.286 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 83.1 p -87.68 167.47 13.84 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-O 121.387 0.613 . . . . 0.0 110.329 -177.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 -1.49 4.37 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -113.43 86.6 2.42 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 173.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.0 m -53.44 137.95 34.61 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.058 2.143 . . . . 0.0 113.16 -178.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -111.16 155.64 22.59 Favored 'General case' 0 CA--C 1.48 -1.728 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.42 141.69 43.16 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 175.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.53 145.96 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -168.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.6 m -130.99 107.16 8.89 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 167.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.1 m -85.51 100.35 11.85 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 55.8 m -84.16 113.95 21.44 Favored 'General case' 0 CA--C 1.48 -1.748 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 178.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -121.03 129.95 53.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.658 -2.719 . . . . 0.0 103.658 -176.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.9 tp -69.01 116.76 9.83 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 124.825 1.25 . . . . 0.0 109.257 -174.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -135.87 99.0 4.04 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -175.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.69 -42.12 0.18 Allowed Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 -178.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.38 43.59 7.35 Favored Glycine 0 CA--C 1.487 -1.663 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.4 t -112.72 108.82 53.54 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -86.1 -17.67 3.75 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 CA-C-N 122.193 1.819 . . . . 0.0 109.064 -176.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -111.75 160.65 28.85 Favored Pre-proline 0 N--CA 1.431 -1.396 0 CA-C-O 117.43 -1.271 . . . . 0.0 107.954 -168.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -74.66 145.9 33.48 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 122.674 2.25 . . . . 0.0 108.425 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -81.17 164.31 77.62 Favored 'Cis proline' 0 N--CA 1.437 -1.841 0 CA-C-N 122.299 1.857 . . . . 0.0 108.176 -4.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.8 m -107.46 156.13 19.3 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.458 -170.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -110.54 118.39 36.11 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.71 148.3 41.2 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.69 119.87 40.13 Favored 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 166.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.26 115.84 26.04 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.8 m -110.69 87.97 2.66 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.64 143.57 26.7 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-O 121.265 0.555 . . . . 0.0 110.769 -171.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -149.41 -163.72 11.19 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 178.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -146.67 101.21 3.43 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.8 ttt85 -138.22 147.63 43.95 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -164.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -74.22 128.7 36.22 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.504 1.121 . . . . 0.0 108.515 173.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.3 m -95.16 137.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.16 -167.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.5 t -98.53 110.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 165.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.4 m -98.23 152.06 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 172.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.0 136.12 33.24 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 168.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.9 t -126.52 138.64 53.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 O-C-N 123.527 0.517 . . . . 0.0 109.701 -175.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -131.74 133.56 44.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 170.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.301 14.2 p30 63.22 23.79 14.02 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 117.068 2.248 . . . . 0.0 117.068 171.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.52 19.15 57.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -144.45 116.12 5.43 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -170.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -72.02 111.49 3.18 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 CA-C-N 122.091 1.782 . . . . 0.0 111.39 -170.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.516 HG23 ' CD2' ' A' ' 114' ' ' HIS . 1.0 OUTLIER -89.9 -24.32 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -170.376 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.516 ' CD2' HG23 ' A' ' 113' ' ' VAL . 28.5 m-70 -151.88 -168.65 3.13 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -141.66 149.56 40.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -175.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.22 127.76 43.48 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 171.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -110.78 13.77 22.3 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.4 m -86.01 -32.34 21.53 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -172.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.5 -23.34 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 C-N-CA 125.513 1.525 . . . . 0.0 111.817 177.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -105.97 56.8 0.67 Allowed 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.49 -1.671 . . . . 0.0 106.49 -167.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . 0.282 14.9 ptm180 52.61 61.88 2.97 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 129.363 3.065 . . . . 0.0 113.211 172.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -68.41 128.84 93.02 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo . . . . . 0 N--CA 1.433 -2.073 0 N-CA-C 105.816 -2.417 . . . . 0.0 105.816 177.628 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 . . . . . 0 CA--C 1.485 -1.547 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -118.36 51.53 1.08 Allowed 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 176.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -113.72 1.85 15.01 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 104.335 -2.468 . . . . 0.0 104.335 173.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.9 m -92.37 -29.93 16.06 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' HE ' ' HE1' ' A' ' 114' ' ' HIS . 29.1 mmm180 -70.47 -40.77 73.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 123.312 0.645 . . . . 0.0 109.427 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HB2' HD21 ' A' ' 111' ' ' LEU . 61.4 t80 -46.56 -65.66 0.52 Allowed 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 126.602 1.961 . . . . 0.0 111.168 166.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.715 ' HA ' ' HB2' ' A' ' 10' ' ' LEU 0.297 5.4 p -70.43 -11.84 61.18 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -172.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -83.71 -36.61 23.56 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 119.126 0.876 . . . . 0.0 109.521 173.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.24 -35.53 81.11 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.701 1.6 . . . . 0.0 110.515 170.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.715 ' HB2' ' HA ' ' A' ' 7' ' ' THR 0.271 0.2 OUTLIER -67.06 -38.04 85.1 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 128.709 2.803 . . . . 0.0 112.452 174.667 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 76.7 m -66.64 -51.87 51.35 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.86 -29.09 50.23 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 124.114 0.966 . . . . 0.0 112.439 -170.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -105.78 -58.25 1.93 Allowed 'General case' 0 CA--C 1.485 -1.52 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.001 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -72.6 111.93 8.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.73 0.776 . . . . 0.0 110.689 -163.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -134.96 98.28 3.97 Favored 'General case' 0 N--CA 1.421 -1.878 1 N-CA-C 98.553 -4.61 . . . . 0.0 98.553 176.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -33.65 3.8 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -163.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.91 154.18 46.8 Favored Pre-proline 0 N--CA 1.432 -1.359 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.9 Cg_endo -69.53 145.08 57.39 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 123.642 2.895 . . . . 0.0 109.164 171.367 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -86.04 -46.85 10.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 169.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.24 -177.21 14.82 Favored Glycine 0 CA--C 1.48 -2.133 0 N-CA-C 103.364 -3.894 . . . . 0.0 103.364 164.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -133.98 35.22 3.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -121.45 -179.22 4.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -35.88 79.77 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 125.973 1.709 . . . . 0.0 112.812 -171.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -81.82 -22.17 37.21 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 123.084 0.554 . . . . 0.0 110.033 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -73.85 -42.22 61.12 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 176.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -83.54 -19.97 34.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 119.729 -0.789 . . . . 0.0 113.045 -170.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.02 -39.42 66.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 169.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.3 t -67.15 -38.28 85.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 26' ' ' CYS 0.282 15.2 tt -86.74 -25.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.023 0 CA-C-N 118.358 0.527 . . . . 0.0 112.024 -175.464 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.8 mmt -77.49 -25.64 50.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 118.669 -1.212 . . . . 0.0 108.707 173.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -72.16 -38.3 69.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 123.131 0.572 . . . . 0.0 111.821 173.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -79.99 -40.1 28.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 122.607 0.363 . . . . 0.0 110.698 -170.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -80.49 -23.08 40.38 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 123.036 0.534 . . . . 0.0 110.571 -177.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.8 47.57 4.18 Favored Glycine 0 CA--C 1.489 -1.56 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 169.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -117.36 6.76 12.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 t -94.61 -0.6 54.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 m -122.09 102.14 40.85 Favored Pre-proline 0 N--CA 1.425 -1.714 0 CA-C-O 117.768 -1.11 . . . . 0.0 108.668 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.74 158.06 98.84 Favored 'Cis proline' 0 N--CA 1.441 -1.58 0 N-CA-C 106.842 -2.022 . . . . 0.0 106.842 -23.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 35.0 m -63.21 118.97 8.7 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 124.707 1.203 . . . . 0.0 111.914 -170.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -72.39 134.11 45.25 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -72.68 -36.35 67.86 Favored 'General case' 0 CA--C 1.491 -1.315 0 O-C-N 124.567 1.167 . . . . 0.0 112.89 -166.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.1 tt -154.77 123.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 172.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -153.3 151.63 30.22 Favored 'General case' 0 CA--C 1.484 -1.574 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.515 177.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.8 m -112.21 136.61 51.42 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.503 -168.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -99.33 116.74 32.19 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 162.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.2 mt -89.89 150.79 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.483 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 -178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.581 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.6 m-70 -139.95 139.77 36.2 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 125.143 1.377 . . . . 0.0 108.863 -175.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.07 5.79 Favored Glycine 0 CA--C 1.482 -1.989 0 N-CA-C 105.734 -2.946 . . . . 0.0 105.734 173.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -102.68 147.93 26.21 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 170.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -85.45 -16.28 40.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -75.99 -33.17 59.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.693 1.597 . . . . 0.0 107.071 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.9 m -75.73 -34.56 60.33 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 116.578 -1.677 . . . . 0.0 111.005 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.1 mm -54.95 -55.37 16.34 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 CA-C-N 119.349 0.977 . . . . 0.0 110.155 172.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.39 -35.01 77.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 123.875 0.87 . . . . 0.0 113.23 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.48 -0.25 19.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 70' ' ' ARG . 13.6 mm -73.66 -27.51 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 172.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.3 t -93.74 9.01 38.83 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.125 0.488 . . . . 0.0 111.599 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -88.56 162.09 16.59 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 160.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.511 HD22 HH12 ' A' ' 70' ' ' ARG . 9.6 t-20 -88.18 -9.8 51.93 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -68.4 -50.48 52.6 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.252 1.421 . . . . 0.0 110.178 178.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -123.76 37.5 4.4 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -168.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.5 152.67 10.9 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 171.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -105.77 156.44 36.57 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 -176.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -74.75 140.44 26.21 Favored 'Trans proline' 0 N--CA 1.437 -1.842 0 C-N-CA 123.003 2.469 . . . . 0.0 106.821 172.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -136.67 133.7 36.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -176.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 62.11 -103.26 0.13 Allowed 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.899 1.68 . . . . 0.0 112.219 169.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.79 103.8 2.64 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.362 2.5 p-10 62.0 30.78 18.06 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 129.139 2.975 . . . . 0.0 113.883 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.2 mt -115.13 170.19 8.55 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 103.792 -2.67 . . . . 0.0 103.792 171.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.511 HH12 HD22 ' A' ' 59' ' ' ASN . 21.9 mmt180 -147.17 116.4 6.95 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 -174.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 tt -93.87 136.76 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 93.5 p -83.56 160.91 21.35 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -173.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.45 -25.53 11.83 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.698 174.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.6 m -104.87 89.17 3.08 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 p -49.62 129.71 19.74 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 127.229 2.212 . . . . 0.0 111.916 171.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -105.19 156.44 18.11 Favored 'General case' 0 CA--C 1.478 -1.815 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -170.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.434 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 6.4 mt-30 -78.9 148.16 32.83 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 174.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.76 146.97 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 -166.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.5 m -134.38 99.68 4.45 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 102.774 -3.047 . . . . 0.0 102.774 167.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.0 m -89.64 104.24 16.82 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -177.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.73 122.41 36.17 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -176.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -106.87 132.83 52.38 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -77.63 117.12 18.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.476 1.51 . . . . 0.0 109.007 -173.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -112.1 152.41 28.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 141.34 -97.97 0.22 Allowed Glycine 0 CA--C 1.483 -1.96 0 N-CA-C 106.014 -2.835 . . . . 0.0 106.014 178.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.48 -19.03 1.5 Allowed Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 -178.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.5 t -84.68 130.01 54.79 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -83.19 -20.9 4.83 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 121.989 1.793 . . . . 0.0 108.279 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -96.47 159.9 30.81 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -175.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -76.18 148.12 30.47 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 122.309 2.006 . . . . 0.0 107.221 -176.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -85.54 165.09 56.38 Favored 'Cis proline' 0 N--CA 1.438 -1.74 0 CA-C-N 123.035 2.12 . . . . 0.0 108.133 13.078 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.1 m -154.87 130.3 9.78 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -165.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.79 103.01 15.4 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -85.83 120.81 27.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -92.47 112.57 24.57 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 173.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.45 130.65 35.29 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.028 -177.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -118.72 108.61 15.1 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 104.268 -2.494 . . . . 0.0 104.268 175.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.68 129.31 35.38 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.74 169.5 23.17 Favored Glycine 0 CA--C 1.488 -1.634 0 N-CA-C 106.002 -2.839 . . . . 0.0 106.002 178.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 85.0 t80 -149.22 105.86 3.55 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.475 -3.528 . . . . 0.0 101.475 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -152.44 158.69 42.98 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 121.884 0.85 . . . . 0.0 110.32 -168.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.0 129.55 34.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.319 175.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.8 148.17 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.737 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.5 t -106.5 92.45 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -93.3 139.16 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 -178.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.16 126.29 31.88 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 46.9 t -108.48 135.99 48.84 Favored 'General case' 0 CA--C 1.49 -1.34 0 O-C-N 123.875 0.734 . . . . 0.0 110.497 -175.541 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.22 137.5 39.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.32 -2.845 . . . . 0.0 103.32 170.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.299 16.5 p30 60.15 26.45 15.85 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 127.05 2.14 . . . . 0.0 116.101 175.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.56 22.76 59.58 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 177.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -149.91 135.07 9.72 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.038 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 98.0 Cg_exo -77.72 111.58 3.15 Favored 'Trans proline' 0 N--CA 1.439 -1.677 0 CA-C-N 122.354 1.876 . . . . 0.0 110.972 -177.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.549 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -86.78 -26.84 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 123.838 0.711 . . . . 0.0 111.693 -174.664 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.549 ' CD2' HG23 ' A' ' 113' ' ' VAL . 53.0 m-70 -146.52 -171.72 3.8 Favored 'General case' 0 CA--C 1.483 -1.602 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 -171.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 132.01 4.11 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 104.016 -2.586 . . . . 0.0 104.016 177.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -74.41 135.81 42.38 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.322 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -96.8 36.89 1.34 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 71.9 p -95.66 -19.71 19.51 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 0.8 OUTLIER -92.64 -23.23 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.332 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 178.641 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -108.99 38.67 2.22 Favored 'General case' 0 CA--C 1.478 -1.79 0 C-N-CA 125.332 1.453 . . . . 0.0 108.448 -178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -98.14 -27.01 14.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 168.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 -83.12 142.08 43.86 Favored Pre-proline 0 N--CA 1.428 -1.545 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 N-CA-C 106.056 -2.325 . . . . 0.0 106.056 -178.258 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 CA--C 1.486 -1.5 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 61.36 65.79 0.93 Allowed 'General case' 0 CA--C 1.492 -1.281 0 C-N-CA 126.804 2.041 . . . . 0.0 110.521 175.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 81.36 -6.71 1.53 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 127.612 2.365 . . . . 0.0 112.441 -179.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -93.39 -9.04 40.09 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -20.92 58.23 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.704 1.602 . . . . 0.0 109.678 -179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -73.79 -41.25 62.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 C-N-CA 125.188 1.395 . . . . 0.0 108.039 173.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 0.8 OUTLIER -79.36 -12.81 59.91 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 177.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.4 m170 -73.67 -47.32 40.62 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 169.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.74 -46.35 74.27 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 126.401 1.88 . . . . 0.0 110.221 173.114 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 7' ' ' THR 0.43 0.1 OUTLIER -93.25 -4.54 51.69 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -171.759 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -78.65 -43.81 25.28 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 120.655 1.57 . . . . 0.0 107.782 166.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.81 -46.27 79.26 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -97.16 -48.55 5.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.882 -172.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 45.8 t80 -78.68 117.15 19.56 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 119.963 1.256 . . . . 0.0 110.397 -168.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -134.61 96.4 3.56 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 100.65 -3.833 . . . . 0.0 100.65 174.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.37 -43.66 3.64 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 128.278 2.631 . . . . 0.0 117.724 -166.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -155.25 144.25 14.98 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 67.5 Cg_exo -74.74 174.79 12.07 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.863 1.708 . . . . 0.0 113.736 -177.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -70.73 -67.84 0.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 168.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.61 -175.16 13.69 Favored Glycine 0 CA--C 1.475 -2.451 1 N-CA-C 101.618 -4.593 . . . . 0.0 101.618 163.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -115.87 73.64 0.85 Allowed 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.34 176.7 9.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -173.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -71.38 -21.59 61.99 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.476 1.111 . . . . 0.0 112.884 -171.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -75.8 -30.27 58.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.238 177.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.95 -40.62 53.65 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 m -69.65 -35.32 75.07 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -72.17 -36.8 69.38 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 123.375 0.422 . . . . 0.0 110.308 177.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -69.45 -35.65 75.87 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 122.909 0.484 . . . . 0.0 112.214 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.426 HG13 HH21 ' A' ' 33' ' ' ARG 0.25 12.7 tt -84.15 -27.95 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-N 117.707 0.23 . . . . 0.0 111.227 -174.954 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.0 mmt -78.07 -25.17 47.53 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.483 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 91' ' ' PRO . 16.6 tpp180 -68.68 -43.6 75.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 123.214 0.606 . . . . 0.0 110.995 173.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -75.84 -44.77 39.29 Favored 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 123.646 0.778 . . . . 0.0 112.352 -172.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.426 HH21 HG13 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -77.11 -18.1 58.19 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.955 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.0 44.75 4.68 Favored Glycine 0 CA--C 1.486 -1.724 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 168.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.4 mt -117.65 15.81 14.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 176.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -94.06 -11.41 30.73 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.6 m -125.53 101.03 31.04 Favored Pre-proline 0 N--CA 1.426 -1.659 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.548 -174.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.06 165.14 85.9 Favored 'Cis proline' 0 N--CA 1.445 -1.373 0 N-CA-C 107.017 -1.955 . . . . 0.0 107.017 -21.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' HD13 ' A' ' 83' ' ' LEU . 36.9 m -60.28 120.58 10.1 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 124.063 0.945 . . . . 0.0 110.173 -175.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -74.63 136.67 41.96 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 177.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.68 -45.63 61.33 Favored 'General case' 0 N--CA 1.433 -1.287 0 O-C-N 123.956 0.785 . . . . 0.0 110.45 -171.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.46 126.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -148.51 127.88 13.06 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.482 HG23 HG13 ' A' ' 78' ' ' VAL . 17.2 m -94.23 122.18 36.5 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.734 -178.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -90.52 121.33 32.37 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -95.7 148.82 4.93 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.434 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 1.9 m-70 -136.57 137.37 40.13 Favored 'General case' 0 CA--C 1.49 -1.365 0 C-N-CA 124.834 1.253 . . . . 0.0 107.95 -175.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.79 -126.94 1.62 Allowed Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 175.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -118.28 141.65 48.31 Favored 'General case' 0 CA--C 1.484 -1.559 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 171.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -86.51 -3.07 58.96 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 173.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -76.49 -31.65 57.85 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 168.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.7 t -80.5 -32.26 37.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 118.115 -0.945 . . . . 0.0 109.982 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.5 mm -57.52 -52.62 54.86 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.204 1.001 . . . . 0.0 110.467 171.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -53.84 -44.09 70.02 Favored 'General case' 0 CA--C 1.497 -1.067 0 C-N-CA 125.42 1.488 . . . . 0.0 112.05 174.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.02 16.02 0.61 Allowed 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -177.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.25 -40.54 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 165.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 36.3 t -88.72 -30.26 19.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.454 -156.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -95.74 51.26 1.26 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -170.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 m120 49.26 50.88 17.3 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 129.516 3.127 . . . . 0.0 113.329 174.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -148.84 163.67 36.73 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 97.594 -4.965 . . . . 0.0 97.594 172.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . 0.259 8.1 p-10 14.52 56.54 0.01 OUTLIER 'General case' 0 C--N 1.361 1.085 0 C-N-CA 131.043 3.737 . . . . 0.0 117.799 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.91 137.24 2.29 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 106.001 -2.839 . . . . 0.0 106.001 -179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -106.13 157.45 34.82 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -72.06 135.55 25.41 Favored 'Trans proline' 0 N--CA 1.438 -1.757 0 C-N-CA 123.095 2.53 . . . . 0.0 107.225 170.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -131.23 107.37 8.94 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -175.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 63.42 -108.61 0.24 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.528 1.531 . . . . 0.0 112.989 174.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -127.39 87.01 2.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -166.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.343 1.8 p-10 64.01 27.62 14.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 128.913 2.885 . . . . 0.0 113.947 173.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 mt -110.4 163.84 13.28 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 173.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -146.78 120.58 9.26 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.08 143.17 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -177.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.7 p -84.43 159.92 20.69 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -174.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -122.62 -3.18 8.8 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 179.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 t -119.02 88.15 2.87 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 173.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 25.3 p -61.56 141.36 57.79 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.561 1.544 . . . . 0.0 111.862 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -114.04 161.68 17.41 Favored 'General case' 0 CA--C 1.474 -1.967 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -168.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 7.7 mt-30 -77.91 144.63 36.72 Favored 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG13 HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -141.73 143.38 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.7 m -131.35 107.61 9.06 Favored 'General case' 0 CA--C 1.478 -1.819 0 N-CA-C 102.693 -3.077 . . . . 0.0 102.693 167.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.6 m -83.14 101.03 10.92 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 77.1 m -87.6 114.97 24.7 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -179.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -121.06 132.47 54.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -170.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 39' ' ' CYS . 39.9 tp -69.28 114.24 7.35 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 125.105 1.362 . . . . 0.0 108.527 -177.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -126.76 57.26 1.45 Allowed 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -118.31 -84.2 0.95 Allowed Glycine 0 CA--C 1.482 -2.021 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.21 -15.09 4.25 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 178.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.7 t -86.91 132.34 42.28 Favored Pre-proline 0 N--CA 1.435 -1.198 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -81.02 -21.71 6.56 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.755 1.636 . . . . 0.0 108.93 176.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -102.24 165.05 14.55 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -171.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -73.13 142.12 33.71 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.222 1.948 . . . . 0.0 107.159 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HA ' HH12 ' A' ' 31' ' ' ARG . 57.8 Cg_endo -87.63 164.39 45.6 Favored 'Cis proline' 0 N--CA 1.435 -1.923 0 CA-C-N 122.655 1.984 . . . . 0.0 108.397 12.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 37.7 m -128.07 131.95 49.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -170.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -98.15 123.04 42.0 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 173.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -116.59 122.42 44.57 Favored 'General case' 0 CA--C 1.483 -1.614 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -93.06 127.27 38.53 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.99 133.12 35.27 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 36.6 m -120.04 97.24 5.51 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 171.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.6 139.01 38.62 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -176.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.03 -171.16 18.86 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.412 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 92.3 t80 -155.78 100.05 2.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 101.28 -3.6 . . . . 0.0 101.28 -178.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.9 ttt85 -139.44 148.73 43.14 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -161.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -80.73 132.5 35.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 124.862 1.265 . . . . 0.0 108.442 175.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.18 142.36 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.612 -164.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.74 95.68 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 177.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.1 m -94.71 136.7 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 178.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -92.31 126.53 37.43 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 173.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 31.7 p -129.2 167.5 17.55 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-O 121.929 0.871 . . . . 0.0 112.591 -172.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -147.38 132.81 18.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.364 6.4 p30 75.94 -12.0 1.06 Allowed 'General case' 0 C--N 1.353 0.729 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 170.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 119.02 9.08 9.09 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -175.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -141.99 127.9 10.84 Favored Pre-proline 0 N--CA 1.435 -1.196 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 8.8 Cg_exo -67.35 163.8 33.14 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.566 1.511 . . . . 0.0 114.029 -178.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.2 OUTLIER -132.3 -19.67 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.507 ' CD2' HG23 ' A' ' 113' ' ' VAL . 74.9 m-70 -158.68 -175.3 5.23 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -169.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 136.8 3.78 Favored 'General case' 0 CA--C 1.485 -1.543 0 N-CA-C 103.911 -2.625 . . . . 0.0 103.911 -179.043 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.94 134.64 37.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.966 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -100.07 40.19 1.27 Allowed 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 171.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.7 m -97.1 -31.57 12.41 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG12 ' H ' ' A' ' 119' ' ' ILE . 0.4 OUTLIER -75.3 -33.98 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.852 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.61 169.832 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -106.12 40.1 1.66 Allowed 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -172.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -87.55 -44.28 11.39 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -95.34 149.17 35.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo . . . . . 0 N--CA 1.433 -2.055 0 N-CA-C 105.946 -2.367 . . . . 0.0 105.946 175.007 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 . . . . . 0 CA--C 1.489 -1.387 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.1 t70 75.15 78.32 0.1 Allowed 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 126.64 1.976 . . . . 0.0 109.16 177.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 79.21 -2.43 2.22 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 127.686 2.394 . . . . 0.0 111.331 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 m -89.95 -17.12 28.52 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -69.97 -30.27 67.58 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.303 1.441 . . . . 0.0 110.624 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CE1' HD22 ' A' ' 111' ' ' LEU . 52.2 t80 -68.49 -48.3 64.79 Favored 'General case' 0 N--CA 1.399 -2.986 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -76.12 -10.01 59.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -80.74 -43.68 19.85 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 119.352 0.978 . . . . 0.0 108.468 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -57.89 -38.23 75.43 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 125.791 1.637 . . . . 0.0 110.195 170.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.48 HD13 ' CE2' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -78.8 -29.62 45.01 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 125.546 1.538 . . . . 0.0 113.493 -179.149 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -80.06 -32.59 39.33 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 119.773 1.17 . . . . 0.0 109.38 -174.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -82.36 -45.01 15.43 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-O 118.511 -0.757 . . . . 0.0 109.726 179.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -95.12 -46.82 6.63 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 119.429 1.013 . . . . 0.0 112.442 -172.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 9.3 t80 -70.65 118.32 13.3 Favored 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 119.766 1.166 . . . . 0.0 110.925 -174.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -139.8 99.04 3.6 Favored 'General case' 0 N--CA 1.424 -1.745 1 N-CA-C 99.926 -4.102 . . . . 0.0 99.926 172.153 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.06 -39.26 9.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -164.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -142.84 148.65 46.77 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 13.0 Cg_endo -72.7 153.42 54.02 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 123.515 2.81 . . . . 0.0 109.291 170.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.4 mm100 -77.8 -57.65 3.69 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 171.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.95 179.35 17.23 Favored Glycine 0 CA--C 1.477 -2.3 0 N-CA-C 103.726 -3.749 . . . . 0.0 103.726 165.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -122.9 61.27 1.01 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -141.54 176.84 8.56 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -171.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.94 -24.46 62.44 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 124.879 1.272 . . . . 0.0 112.245 -169.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -85.4 -20.14 30.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 122.966 0.506 . . . . 0.0 110.097 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -79.18 -35.89 41.17 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 175.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.0 -33.92 51.05 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -171.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.18 -48.12 74.57 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 125.841 1.657 . . . . 0.0 109.687 173.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 m -74.97 -22.97 58.23 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-O 118.112 -0.946 . . . . 0.0 113.496 -175.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 14.0 tt -87.09 -24.96 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 119.241 0.928 . . . . 0.0 110.65 178.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.68 -29.22 62.17 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.265 -1.374 . . . . 0.0 110.259 171.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -80.19 -32.43 38.67 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 177.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -83.72 -33.12 25.18 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 118.655 0.661 . . . . 0.0 111.07 -175.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -80.45 -19.25 46.48 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.5 47.57 3.46 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 166.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.6 mt -122.77 14.14 10.03 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -90.63 -9.73 45.88 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -175.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 m -122.54 101.37 40.34 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-O 117.691 -1.147 . . . . 0.0 108.788 -174.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.57 166.37 83.07 Favored 'Cis proline' 0 N--CA 1.444 -1.429 0 CA-C-N 122.83 2.047 . . . . 0.0 107.217 -21.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 29.9 m -59.68 122.09 13.27 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 124.361 1.064 . . . . 0.0 110.987 -173.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -75.07 133.64 41.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -70.22 -40.47 74.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 O-C-N 124.336 1.022 . . . . 0.0 112.01 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.37 130.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 176.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -145.43 128.74 16.81 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -96.66 112.32 24.11 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -87.11 111.05 20.54 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 174.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.1 150.36 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -177.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.606 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 4.1 m-70 -142.88 135.73 27.95 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 125.172 1.389 . . . . 0.0 107.941 -174.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.91 -136.52 4.61 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 106.455 -2.658 . . . . 0.0 106.455 173.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -96.56 145.64 25.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 173.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -86.99 -21.94 25.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -79.6 -24.77 41.76 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.1 t -76.02 -35.52 59.48 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 117.273 -1.346 . . . . 0.0 109.716 172.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.444 HD12 ' CE2' ' A' ' 76' ' ' PHE . 1.1 mp -52.88 -51.47 36.85 Favored 'Isoleucine or valine' 0 C--N 1.37 1.459 0 C-N-CA 124.921 1.289 . . . . 0.0 110.221 170.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -64.68 -39.74 94.19 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 124.143 0.977 . . . . 0.0 111.105 -176.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.98 10.58 4.12 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 72' ' ' SER . 16.3 mm -80.06 -24.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 34.5 m -78.65 -23.55 45.7 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.019 177.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -74.5 143.89 44.37 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 167.113 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -98.56 25.42 6.43 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.222 -178.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -90.55 -47.66 7.56 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -113.71 51.2 0.87 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -176.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.5 172.65 39.13 Favored Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 103.266 -3.934 . . . . 0.0 103.266 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -126.56 152.93 75.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 178.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -76.02 132.78 14.43 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 106.077 -2.316 . . . . 0.0 106.077 172.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -99.58 156.17 17.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 103.63 -2.73 . . . . 0.0 103.63 174.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -36.42 -69.88 0.1 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 129.578 3.151 . . . . 0.0 116.394 -173.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -104.24 75.36 1.25 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -171.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 65.54 15.12 9.88 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 129.483 3.113 . . . . 0.0 116.353 165.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -110.98 173.23 6.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 -169.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -139.18 107.28 5.73 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -172.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.8 tt -86.47 143.82 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 177.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.453 ' HB2' HD12 ' A' ' 56' ' ' ILE . 93.7 p -89.47 168.06 12.49 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.441 0.639 . . . . 0.0 111.286 -172.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -124.05 -14.99 6.96 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -175.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 t -115.27 93.69 4.4 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.8 m -51.06 133.99 26.96 Favored 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 127.24 2.216 . . . . 0.0 112.633 174.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CE2' HD12 ' A' ' 53' ' ' ILE . 88.0 m-85 -110.14 157.75 19.05 Favored 'General case' 0 CA--C 1.478 -1.816 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -172.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.72 135.16 35.95 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 103.507 -2.775 . . . . 0.0 103.507 174.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -135.21 142.7 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 -173.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 74.2 m -130.49 102.98 6.39 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 103.482 -2.785 . . . . 0.0 103.482 169.337 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -89.16 112.67 23.72 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 36.8 m -91.05 118.04 30.08 Favored 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -115.04 140.07 49.35 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 177.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.47 131.88 34.71 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -169.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -136.58 -179.56 5.76 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.31 -86.83 0.48 Allowed Glycine 0 CA--C 1.484 -1.863 0 N-CA-C 106.46 -2.656 . . . . 0.0 106.46 -178.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 150.74 -7.41 0.68 Allowed Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.8 m -78.92 128.12 77.61 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.073 -178.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -82.57 -27.69 2.07 Favored 'Trans proline' 0 N--CA 1.436 -1.896 0 N-CA-C 107.862 -1.63 . . . . 0.0 107.862 173.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -98.01 162.87 20.69 Favored Pre-proline 0 N--CA 1.429 -1.514 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -169.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.78 144.34 34.87 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 122.366 2.044 . . . . 0.0 107.53 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -82.57 163.25 74.7 Favored 'Cis proline' 0 N--CA 1.438 -1.739 0 CA-C-N 123.222 2.187 . . . . 0.0 109.845 8.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.3 138.28 54.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.81 -168.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -101.96 107.15 18.21 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -103.04 123.24 46.26 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -88.18 122.4 31.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -88.87 132.55 34.62 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 91.8 m -130.18 104.53 7.36 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 168.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.3 135.74 34.23 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.08 146.36 16.83 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -99.15 103.87 15.8 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 103.282 -2.859 . . . . 0.0 103.282 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -143.05 155.72 44.68 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -167.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -78.94 130.81 35.99 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.8 m -99.76 142.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.465 -168.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.9 t -100.39 120.46 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.392 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.067 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.0 m -113.69 160.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 174.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.23 132.44 54.17 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 171.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 112' ' ' PRO . 99.1 m -107.93 150.89 26.52 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -169.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -150.24 122.17 8.19 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 171.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 9.2 p30 67.13 10.23 7.54 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 127.475 2.31 . . . . 0.0 116.282 173.234 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.48 -3.15 39.73 Favored Glycine 0 C--N 1.353 1.519 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.512 HD22 ' CE1' ' A' ' 6' ' ' TYR . 16.7 mt -117.1 135.17 23.01 Favored Pre-proline 0 CA--C 1.484 -1.592 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 176.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 107' ' ' CYS . 15.5 Cg_exo -77.44 127.85 9.23 Favored 'Trans proline' 0 N--CA 1.421 -2.778 0 CA-C-N 122.413 1.898 . . . . 0.0 107.169 175.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.641 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -95.3 -17.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 124.16 0.913 . . . . 0.0 109.468 -175.122 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.641 ' CD2' HG23 ' A' ' 113' ' ' VAL . 84.2 m-70 -149.54 -177.69 6.01 Favored 'General case' 0 CA--C 1.482 -1.636 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -169.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.4 tp -145.92 135.83 23.51 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -173.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -92.39 127.06 37.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.05 22.07 16.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 123.119 0.568 . . . . 0.0 110.192 -170.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.3 m -86.64 -28.81 22.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -170.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -82.82 -25.18 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.783 0 C-N-CA 124.739 1.216 . . . . 0.0 110.146 178.558 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -97.48 37.79 1.33 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 123.234 0.334 . . . . 0.0 110.391 -165.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 61.26 67.39 0.8 Allowed 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 127.065 2.146 . . . . 0.0 109.582 178.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 121.86 59.69 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.021 170.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo . . . . . 0 N--CA 1.433 -2.035 0 N-CA-C 105.429 -2.566 . . . . 0.0 105.429 178.304 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 . . . . . 0 CA--C 1.488 -1.434 0 CA-C-O 120.734 0.302 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.26 55.75 0.84 Allowed 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 166.622 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -91.33 -23.77 20.0 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.3 t -91.13 0.78 57.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.335 -179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -75.41 -42.8 52.75 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.464 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -61.2 -48.18 82.73 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 117.743 -1.122 . . . . 0.0 112.801 172.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.521 0.8 OUTLIER -90.37 8.68 32.31 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 119.903 1.229 . . . . 0.0 114.21 -179.497 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -77.52 -40.0 44.21 Favored 'General case' 0 CA--C 1.494 -1.203 0 O-C-N 120.451 -1.406 . . . . 0.0 107.881 155.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.95 -28.8 70.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.303 1.041 . . . . 0.0 111.208 171.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.92 -10.57 36.04 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 174.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.3 m -68.48 -42.2 79.04 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 166.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 93.0 mm-40 -66.92 -68.28 0.39 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.728 171.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.446 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 88.8 m-70 -107.83 6.93 27.9 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -153.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.415 ' CD2' ' HE2' ' A' ' 50' ' ' LYS . 27.0 t80 -100.84 137.12 39.64 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-N 120.36 1.436 . . . . 0.0 107.635 165.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -151.49 104.25 3.05 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 101.715 -3.439 . . . . 0.0 101.715 162.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.94 -51.05 13.95 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -165.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -148.66 140.66 14.59 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 76.2 Cg_exo -75.06 177.16 8.97 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.5 2.134 . . . . 0.0 113.532 -178.294 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.45 -67.24 0.74 Allowed 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 169.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.1 -175.19 13.91 Favored Glycine 0 CA--C 1.479 -2.214 1 N-CA-C 103.092 -4.003 . . . . 0.0 103.092 166.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.6 mtm105 -121.88 71.21 0.98 Allowed 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 178.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -144.22 -178.45 5.96 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.338 -171.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.89 -32.71 74.55 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 125.744 1.617 . . . . 0.0 112.733 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.85 -16.47 38.53 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 123.085 0.554 . . . . 0.0 110.231 -177.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.25 -41.67 48.34 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 173.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 m -70.14 -32.7 70.82 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.37 -46.3 67.28 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -74.34 -26.17 59.98 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.26 16.9 tt -82.59 -33.17 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-N 118.589 0.632 . . . . 0.0 109.928 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 93.5 mtp -84.89 -10.09 57.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.729 -0.789 . . . . 0.0 110.335 179.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.8 ttt85 -81.33 -40.61 23.32 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 122.005 -0.434 . . . . 0.0 110.41 169.121 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.57 -37.53 24.99 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 119.091 -0.481 . . . . 0.0 112.124 -172.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -70.4 -30.67 67.63 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 118.431 0.56 . . . . 0.0 110.005 170.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.25 48.08 3.89 Favored Glycine 0 CA--C 1.486 -1.732 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 169.062 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.3 mt -110.4 8.53 23.28 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -178.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.6 t -97.63 2.09 49.47 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.8 t -132.27 104.93 13.51 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.68 156.68 97.2 Favored 'Cis proline' 0 N--CA 1.444 -1.427 0 N-CA-C 106.68 -2.085 . . . . 0.0 106.68 -21.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.75 114.37 6.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 123.967 0.792 . . . . 0.0 111.895 -170.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -75.64 132.23 40.47 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 173.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -83.02 -15.31 51.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -166.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.86 133.64 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.318 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -149.23 119.81 7.46 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 171.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.8 m -95.03 108.46 20.53 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -87.66 126.03 34.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 174.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mt -107.91 144.74 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -173.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 2.8 m-70 -131.72 127.11 36.16 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.062 -168.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.3 -130.68 2.14 Favored Glycine 0 CA--C 1.488 -1.65 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 177.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 145.99 39.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HE2' ' CD2' ' A' ' 14' ' ' TYR . 33.1 mttt -84.82 -14.55 47.68 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 119.29 -0.385 . . . . 0.0 110.594 -179.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.65 49.09 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 74.3 m -73.94 -42.27 60.79 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-O 117.595 -1.193 . . . . 0.0 109.14 175.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.8 mm -54.43 -54.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.362 1.115 0 C-N-CA 124.593 1.157 . . . . 0.0 111.953 176.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -58.17 -46.8 85.09 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 125.202 1.401 . . . . 0.0 111.509 179.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.55 12.94 1.78 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -178.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.443 HD12 ' CB ' ' A' ' 72' ' ' SER . 15.1 mm -75.55 -30.61 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 168.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.5 m -80.24 -21.19 43.07 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -82.95 163.51 21.01 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 172.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -84.35 -17.3 39.91 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.593 -175.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -87.99 128.49 35.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 165.322 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.6 t30 84.95 -8.44 0.89 Allowed 'General case' 0 C--N 1.356 0.865 0 C-N-CA 128.935 2.894 . . . . 0.0 113.441 175.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.8 -174.11 22.19 Favored Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 172.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -157.32 157.45 30.28 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 -176.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -79.44 157.6 25.56 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.255 1.97 . . . . 0.0 108.244 -176.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.662 ' HE1' HG11 ' A' ' 104' ' ' VAL . 13.8 p-80 -128.57 42.55 3.3 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 103.062 -2.94 . . . . 0.0 103.062 167.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.488 0.0 OUTLIER 53.82 152.27 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.285 1 C-N-CA 132.69 4.396 . . . . 0.0 119.334 -177.396 . . . . . . . . 4 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.57 50.15 3.67 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 110.842 -2.89 . . . . 0.0 111.917 171.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 83.89 1.45 0.96 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 129.045 2.938 . . . . 0.0 115.655 177.086 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' HB3' ' CE1' ' A' ' 65' ' ' HIS . 2.8 mm? -105.96 149.65 26.43 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -173.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -141.01 123.62 16.01 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -172.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.6 tt -97.12 146.53 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.443 ' CB ' HD12 ' A' ' 56' ' ' ILE . 85.1 p -85.95 173.31 10.03 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-O 121.457 0.646 . . . . 0.0 111.395 -175.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -135.97 4.81 3.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.4 t -113.66 86.21 2.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.1 t -49.76 123.65 8.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 127.885 2.474 . . . . 0.0 113.347 -179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -109.49 156.29 20.29 Favored 'General case' 0 CA--C 1.475 -1.933 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -174.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -83.37 143.53 30.27 Favored 'General case' 0 CA--C 1.466 -2.275 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.07 141.55 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 -168.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 96.7 m -129.16 107.85 9.89 Favored 'General case' 0 CA--C 1.478 -1.811 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 166.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.1 m -84.01 100.66 11.21 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 175.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 73.4 m -84.19 106.42 15.81 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 176.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -118.8 142.23 47.9 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 -171.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -83.99 121.48 27.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.854 0.835 . . . . 0.0 109.014 -171.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -133.02 55.96 1.87 Allowed 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.42 -63.94 0.26 Allowed Glycine 0 CA--C 1.482 -1.971 0 N-CA-C 105.125 -3.19 . . . . 0.0 105.125 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.08 27.32 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 173.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.4 p -89.99 138.87 27.41 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -83.0 -20.84 5.02 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 121.671 1.581 . . . . 0.0 109.242 172.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -108.03 156.86 37.53 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-O 117.615 -1.183 . . . . 0.0 108.84 -165.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -75.14 148.59 34.96 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 122.654 2.236 . . . . 0.0 108.719 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -81.62 166.56 72.31 Favored 'Cis proline' 0 N--CA 1.438 -1.751 0 CA-C-N 122.324 1.866 . . . . 0.0 108.654 -1.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.2 m -138.94 126.22 21.49 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -173.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -90.02 98.37 11.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -176.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -85.14 133.81 34.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -100.66 131.44 46.56 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 174.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.82 130.45 35.71 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.838 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 40.2 m -120.86 90.49 3.33 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 172.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -89.88 148.95 22.86 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.209 0.528 . . . . 0.0 110.494 -171.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.05 -172.5 18.11 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 107.473 -2.251 . . . . 0.0 107.473 178.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -149.89 100.28 2.93 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 102.237 -3.246 . . . . 0.0 102.237 176.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -148.05 172.25 14.55 Favored 'General case' 0 CA--C 1.482 -1.64 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.418 -173.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -85.07 117.28 23.94 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -90.56 139.22 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -166.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.662 HG11 ' HE1' ' A' ' 65' ' ' HIS . 59.9 t -94.82 123.39 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.26 150.21 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 170.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.53 127.78 40.7 Favored 'General case' 0 CA--C 1.488 -1.437 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 175.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.07 155.7 23.42 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.001 0.905 . . . . 0.0 112.0 -171.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -160.39 126.31 4.07 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.487 -2.783 . . . . 0.0 103.487 173.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.332 11.9 p30 66.91 14.35 9.79 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.863 2.465 . . . . 0.0 115.764 175.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.67 61.53 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.26 2.2 mp -107.64 138.2 19.93 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 177.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.37 112.63 3.23 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 N-CA-C 104.892 -2.772 . . . . 0.0 104.892 168.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -92.97 -18.6 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.814 -172.422 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.605 ' CD2' HG23 ' A' ' 113' ' ' VAL . 21.2 m-70 -151.33 -179.57 7.48 Favored 'General case' 0 CA--C 1.478 -1.8 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.0 141.54 51.24 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.11 124.27 30.94 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 165.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 117' ' ' GLN . 1.4 mm-40 -115.65 56.71 0.75 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 -179.046 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 42.7 t -89.25 -51.56 5.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.36 -28.86 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.557 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -170.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -84.02 -22.25 31.37 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.524 -1.217 . . . . 0.0 109.985 -165.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -64.47 0.87 Allowed 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.048 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -146.07 148.07 34.07 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 174.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 N--CA 1.432 -2.093 0 N-CA-C 105.742 -2.445 . . . . 0.0 105.742 177.977 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 . . . . . 0 CA--C 1.487 -1.462 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -129.84 48.6 2.36 Favored 'General case' 0 CA--C 1.484 -1.592 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -93.2 -13.64 28.11 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -90.7 -26.39 19.58 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.67 39.39 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -176.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.284 9.5 t80 -51.41 -64.44 0.81 Allowed 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 125.972 1.709 . . . . 0.0 109.897 164.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.6 p -80.24 1.23 29.3 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -169.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -92.02 -26.33 18.4 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 119.897 1.226 . . . . 0.0 109.083 169.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.51 -36.33 80.22 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 161.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -28.69 51.5 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.587 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.8 m -65.08 -50.9 64.36 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 119.47 1.032 . . . . 0.0 109.819 179.189 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HB2' ' CD2' ' A' ' 13' ' ' HIS . 72.3 mt-30 -68.35 -44.58 74.96 Favored 'General case' 0 CA--C 1.482 -1.638 0 O-C-N 123.712 0.633 . . . . 0.0 112.675 -179.109 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 92.6 m-70 -103.07 -55.54 2.4 Favored 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.7 -167.128 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -76.66 117.1 17.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 122.013 0.911 . . . . 0.0 109.586 -167.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -134.02 96.15 3.58 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 101.045 -3.687 . . . . 0.0 101.045 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.98 -41.7 1.71 Allowed 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 128.659 2.784 . . . . 0.0 117.539 -168.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -157.57 144.8 13.52 Favored Pre-proline 0 N--CA 1.435 -1.205 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 161.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 47' ' ' HIS . 65.1 Cg_exo -76.74 -176.46 3.16 Favored 'Trans proline' 0 N--CA 1.438 -1.741 0 C-N-CA 122.391 2.061 . . . . 0.0 114.078 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -72.59 -73.36 0.2 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 165.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.37 -174.32 13.59 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 102.437 -4.265 . . . . 0.0 102.437 164.443 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -111.8 75.97 0.95 Allowed 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 176.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -142.65 177.13 8.52 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.938 -173.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -56.06 -43.1 77.61 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 127.81 2.444 . . . . 0.0 112.169 -175.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 55.2 ttm-85 -77.57 -23.95 49.88 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.036 0.935 . . . . 0.0 110.968 -176.242 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -71.83 -47.88 50.1 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.531 ' HA ' HG22 ' A' ' 29' ' ' ILE . 5.9 t -81.41 -22.77 38.03 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 118.24 -1.384 . . . . 0.0 111.61 -169.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -62.9 -47.9 81.3 Favored 'General case' 0 N--CA 1.433 -1.325 0 C-N-CA 123.725 0.81 . . . . 0.0 109.654 170.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.9 m -68.13 -36.41 79.66 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -177.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 26' ' ' CYS . 14.2 tt -80.49 -27.19 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 CA-C-N 118.894 0.77 . . . . 0.0 110.917 -176.209 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.428 ' HE2' ' HB3' ' A' ' 43' ' ' ASN . 3.7 mmt -71.36 -36.97 71.68 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 118.327 0.512 . . . . 0.0 109.934 175.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.29 -28.08 61.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -75.96 -50.57 14.57 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-N 118.822 0.737 . . . . 0.0 110.355 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -23.47 60.07 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.804 0.842 . . . . 0.0 112.175 -172.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.06 51.98 2.68 Favored Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 170.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.1 mt -113.66 9.81 17.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 176.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.7 p -100.9 15.57 28.09 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 124.016 0.926 . . . . 0.0 108.959 178.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -124.2 94.5 45.18 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.81 166.79 81.76 Favored 'Cis proline' 0 N--CA 1.443 -1.468 0 N-CA-C 107.021 -1.954 . . . . 0.0 107.021 -24.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.6 m -62.78 120.04 10.5 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 124.36 1.064 . . . . 0.0 112.882 -172.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -72.4 139.64 47.93 Favored 'General case' 0 CA--C 1.491 -1.312 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.576 -178.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -71.83 -43.15 66.06 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 123.391 0.677 . . . . 0.0 111.682 -172.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.84 128.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 7.2 t-20 -143.49 130.21 20.31 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 m -100.3 116.32 32.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -176.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -90.85 124.78 35.43 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mm -93.57 150.95 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -177.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 18' ' ' PRO . 3.5 m-70 -142.96 127.74 18.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -177.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.04 -137.2 4.16 Favored Glycine 0 CA--C 1.484 -1.872 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 172.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -106.3 144.39 33.07 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -83.78 -20.95 32.41 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.471 -167.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -90.62 -10.2 44.16 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.0 m -76.44 -38.06 56.06 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.648 166.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.76 -52.32 62.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-N 118.907 0.776 . . . . 0.0 110.542 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -59.26 -45.95 89.82 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 125.084 1.354 . . . . 0.0 111.342 -175.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.13 21.97 1.03 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -175.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.45 ' HB ' HH11 ' A' ' 70' ' ' ARG . 42.8 mt -78.55 -27.11 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 165.069 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 95.8 m -61.14 -39.59 90.61 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 122.449 0.3 . . . . 0.0 111.517 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -104.97 171.26 7.41 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.408 0.623 . . . . 0.0 110.24 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.6 t30 73.33 -136.9 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.532 1.533 . . . . 0.0 114.694 153.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.401 ' H ' ' H ' ' A' ' 61' ' ' ASN . 83.8 tttt -136.01 0.42 2.62 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 -164.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' A' ' 60' ' ' LYS . 20.6 t30 -82.22 -20.84 36.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -145.58 -176.03 19.16 Favored Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 106.94 -2.464 . . . . 0.0 106.94 164.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.52 154.08 32.95 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.16 147.02 23.11 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 C-N-CA 122.523 2.149 . . . . 0.0 107.441 -175.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -135.59 125.34 25.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? 64.66 -107.01 0.15 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.069 1.347 . . . . 0.0 111.489 171.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -143.96 97.21 3.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 -172.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.357 2.1 p-10 64.84 24.72 12.81 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 129.105 2.962 . . . . 0.0 114.112 175.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 mt -111.87 168.8 9.3 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 101.196 -3.631 . . . . 0.0 101.196 172.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 ' CB ' ' A' ' 112' ' ' PRO . 0.1 OUTLIER -155.5 129.63 8.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.446 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 tt -101.01 143.43 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 -175.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.407 ' HA ' HG23 ' A' ' 56' ' ' ILE . 85.6 p -82.56 165.44 20.1 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-O 122.261 1.029 . . . . 0.0 111.417 -176.184 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -128.74 4.56 5.49 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 178.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.9 t -122.26 88.95 3.03 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 103.608 -2.738 . . . . 0.0 103.608 175.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -59.63 132.13 53.04 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 125.661 1.584 . . . . 0.0 112.5 -177.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -109.54 158.24 18.2 Favored 'General case' 0 CA--C 1.479 -1.787 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -174.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 139.35 38.36 Favored 'General case' 0 CA--C 1.481 -1.683 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 174.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.21 144.65 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 -171.014 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.0 m -128.53 108.04 10.2 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 170.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -87.78 102.59 14.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 177.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -95.58 137.67 34.31 Favored 'General case' 0 CA--C 1.472 -2.02 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 -177.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -128.15 141.85 51.36 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 178.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -76.27 133.19 40.13 Favored 'General case' 0 CA--C 1.489 -1.368 0 C-N-CA 126.32 1.848 . . . . 0.0 108.031 -175.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -136.04 164.08 28.83 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.84 -44.58 1.44 Allowed Glycine 0 CA--C 1.489 -1.566 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 -176.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.59 17.48 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.3 m -107.35 122.52 41.02 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 105.249 -2.13 . . . . 0.0 105.249 176.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -79.22 -29.28 3.22 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 N-CA-C 107.612 -1.726 . . . . 0.0 107.612 173.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -101.44 156.72 34.84 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -171.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -75.05 148.2 34.78 Favored 'Trans proline' 0 N--CA 1.439 -1.684 0 C-N-CA 122.594 2.196 . . . . 0.0 107.493 -174.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -84.11 164.08 66.2 Favored 'Cis proline' 0 CA--C 1.49 -1.675 0 CA-C-N 123.133 2.155 . . . . 0.0 109.392 10.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.3 m -151.86 118.88 5.85 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -167.369 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -93.99 119.74 33.29 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -98.53 123.2 42.56 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -87.12 118.01 26.23 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 175.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.83 137.63 32.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.651 -177.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 33.4 m -120.82 112.27 18.61 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 172.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.64 148.14 28.14 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.268 0.556 . . . . 0.0 110.032 -176.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.53 178.96 32.73 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -155.32 107.49 2.67 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 102.17 -3.27 . . . . 0.0 102.17 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -153.51 170.35 20.97 Favored 'General case' 0 CA--C 1.488 -1.427 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.797 -174.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -84.46 124.41 31.32 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -99.04 142.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.221 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -166.501 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.09 122.37 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 170.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG12 HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -122.71 160.39 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 N-CA-C 102.434 -3.173 . . . . 0.0 102.434 173.101 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 114' ' ' HIS . . . -110.07 131.94 54.61 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 119.021 0.828 . . . . 0.0 109.146 176.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.9 t -97.6 148.87 22.84 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 125.13 1.372 . . . . 0.0 109.174 -174.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.5 123.89 12.35 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 164.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.312 13.8 p30 64.84 19.63 11.9 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 128.209 2.604 . . . . 0.0 116.679 174.002 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.3 19.69 51.71 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.331 1.3 tp -129.51 146.71 62.21 Favored Pre-proline 0 CA--C 1.481 -1.68 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 177.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.46 ' CB ' HH22 ' A' ' 70' ' ' ARG . 82.0 Cg_exo -69.46 147.04 63.91 Favored 'Trans proline' 0 N--CA 1.427 -2.411 0 C-N-CA 121.457 1.438 . . . . 0.0 108.891 162.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.473 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.0 OUTLIER -129.09 -30.96 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 O-C-N 123.708 0.63 . . . . 0.0 109.338 175.508 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.473 ' CD2' HG23 ' A' ' 113' ' ' VAL . 88.2 m-70 -145.33 175.73 10.08 Favored 'General case' 0 CA--C 1.473 -1.997 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.965 -165.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.406 HD13 HG12 ' A' ' 105' ' ' VAL . 2.8 tp -125.3 139.18 53.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.82 128.06 35.64 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 167.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -108.84 52.05 0.72 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -87.42 -44.94 10.97 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 -173.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.78 -28.51 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.459 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -173.462 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -84.54 -22.1 30.25 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.819 -165.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -80.0 -34.34 38.59 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 110.278 -0.268 . . . . 0.0 110.278 173.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -78.87 147.45 70.49 Favored Pre-proline 0 N--CA 1.435 -1.212 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -177.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.433 -2.077 0 N-CA-C 105.676 -2.471 . . . . 0.0 105.676 173.457 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -143.07 95.88 2.84 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 84.88 11.2 0.31 Allowed 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.41 2.284 . . . . 0.0 107.91 -179.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -91.65 -29.66 16.75 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 170.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -66.23 -45.69 79.81 Favored 'General case' 0 CA--C 1.492 -1.265 0 C-N-CA 125.199 1.4 . . . . 0.0 109.401 179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CE2' HD13 ' A' ' 10' ' ' LEU . 65.8 t80 -50.54 -62.21 1.73 Allowed 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.689 1.996 . . . . 0.0 113.881 170.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -70.34 -13.88 62.34 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -174.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -81.33 -39.25 25.43 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 119.848 1.204 . . . . 0.0 110.055 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.65 -34.42 74.26 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.11 1.364 . . . . 0.0 109.646 169.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -77.25 -24.39 51.13 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 125.855 1.662 . . . . 0.0 113.341 177.313 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.4 m -66.2 -58.08 6.19 Favored 'General case' 0 CA--C 1.481 -1.694 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -63.28 -52.08 63.49 Favored 'General case' 0 CA--C 1.484 -1.587 0 O-C-N 124.051 0.844 . . . . 0.0 113.046 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -101.3 -15.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -163.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.503 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 28.9 t80 -93.99 137.15 33.52 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 122.936 2.607 . . . . 0.0 109.738 177.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -151.79 100.4 2.67 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 103.785 -2.672 . . . . 0.0 103.785 165.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.58 -49.41 2.17 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 118.492 2.775 . . . . 0.0 118.492 -164.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -145.47 149.95 42.44 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 167.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 51.4 Cg_endo -84.07 169.71 11.37 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.42 2.08 . . . . 0.0 107.922 -175.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.87 -70.53 0.35 Allowed 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.23 -177.73 15.0 Favored Glycine 0 CA--C 1.475 -2.436 1 N-CA-C 102.768 -4.133 . . . . 0.0 102.768 164.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -116.66 73.62 0.87 Allowed 'General case' 0 CA--C 1.485 -1.522 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 177.05 9.81 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -174.426 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.36 -18.87 62.35 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.575 1.15 . . . . 0.0 112.717 -173.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -84.48 -22.12 30.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 122.797 0.439 . . . . 0.0 110.183 178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -77.44 -42.02 37.56 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 175.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.1 m -67.02 -37.16 83.66 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 123.829 0.706 . . . . 0.0 112.54 -178.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.29 -42.71 87.98 Favored 'General case' 0 CA--C 1.492 -1.253 0 C-N-CA 123.679 0.792 . . . . 0.0 110.36 175.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 m -69.89 -32.32 70.59 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -177.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD11 HH21 ' A' ' 33' ' ' ARG . 6.9 tt -81.87 -33.48 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 118.915 0.78 . . . . 0.0 110.61 -176.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.0 mmt -73.63 -31.58 63.6 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 121.249 -0.18 . . . . 0.0 111.064 179.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -74.83 -34.68 62.37 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 174.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -70.94 -56.88 5.26 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.078 0.951 . . . . 0.0 110.596 -172.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.423 HH21 HD11 ' A' ' 29' ' ' ILE . 10.0 ptp180 -85.38 -18.09 34.76 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.077 -175.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.64 71.12 1.31 Allowed Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.661 -0.975 . . . . 0.0 110.661 166.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.8 mt -118.41 11.89 13.15 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 173.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.8 t -96.81 3.96 51.98 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.143 0.977 . . . . 0.0 108.99 -171.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.2 m -129.52 103.09 17.92 Favored Pre-proline 0 N--CA 1.427 -1.607 0 CA-C-O 117.81 -1.091 . . . . 0.0 108.667 -177.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.71 159.19 97.1 Favored 'Cis proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.52 -2.146 . . . . 0.0 106.52 -22.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.07 119.55 16.42 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-O 121.378 0.609 . . . . 0.0 111.994 -166.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -79.55 134.12 36.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 172.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.9 -15.3 48.55 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.847 -164.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.63 125.88 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 176.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -139.08 128.81 24.73 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 169.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -96.27 117.85 31.64 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -93.64 120.36 33.82 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -94.5 145.1 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -174.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.495 ' CG ' ' HD3' ' A' ' 18' ' ' PRO . 5.9 m-70 -133.16 128.93 37.11 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -174.446 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 160.66 -132.39 2.9 Favored Glycine 0 CA--C 1.483 -1.955 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 176.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.19 144.48 43.12 Favored 'General case' 0 CA--C 1.485 -1.545 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -84.0 -15.17 48.67 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -74.68 -35.69 62.77 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 124.502 1.121 . . . . 0.0 108.612 176.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.1 m -72.15 -37.14 69.46 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.287 176.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 mm -56.55 -55.89 16.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 123.912 0.885 . . . . 0.0 111.842 174.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -58.92 -40.01 83.26 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.422 1.089 . . . . 0.0 112.889 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.89 -18.72 46.86 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -70.8 -26.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 CA-C-N 119.718 1.145 . . . . 0.0 110.683 -176.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.4 t -77.5 -12.08 59.92 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 118.579 0.627 . . . . 0.0 111.933 -178.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -81.45 -178.94 7.16 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.181 0.991 . . . . 0.0 108.72 168.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.05 -28.66 61.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.88 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -74.14 154.93 38.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 172.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 t30 61.78 21.21 12.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.633 2.373 . . . . 0.0 116.127 171.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 171.87 177.47 41.5 Favored Glycine 0 CA--C 1.485 -1.838 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -143.72 157.07 59.15 Favored Pre-proline 0 N--CA 1.432 -1.338 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -72.39 148.18 48.28 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.382 2.055 . . . . 0.0 109.671 -176.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -134.92 127.2 30.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 62.08 -106.45 0.21 Allowed 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 125.726 1.61 . . . . 0.0 112.117 177.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -151.95 108.76 3.5 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.36 2.0 p-10 66.25 24.1 10.74 Favored 'General case' 0 CA--C 1.505 -0.788 0 C-N-CA 129.727 3.211 . . . . 0.0 113.87 176.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 mt -116.15 170.86 8.19 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 171.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.464 HH12 ' HG3' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -149.85 146.1 26.93 Favored 'General case' 0 CA--C 1.474 -1.955 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 166.356 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.34 151.8 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 N-CA-C 103.809 -2.663 . . . . 0.0 103.809 175.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -74.48 177.99 5.6 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 122.297 1.046 . . . . 0.0 112.725 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -142.04 7.13 1.8 Allowed 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 173.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.4 t -130.58 94.53 3.66 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 171.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.7 p -57.09 130.19 45.03 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 126.065 1.746 . . . . 0.0 112.717 -177.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.86 156.0 17.79 Favored 'General case' 0 CA--C 1.48 -1.718 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -175.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.408 ' HA ' ' HD1' ' A' ' 100' ' ' PHE . 0.4 OUTLIER -77.24 138.58 39.5 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 175.777 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.54 142.48 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.015 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.2 m -130.62 108.51 9.97 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 167.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.6 m -81.76 101.74 10.32 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 177.213 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 75.9 m -88.15 110.37 20.63 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 178.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -124.06 145.79 49.01 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -170.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.26 151.38 29.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 122.088 0.947 . . . . 0.0 112.62 -172.608 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -125.18 44.12 2.88 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.66 -108.48 0.09 OUTLIER Glycine 0 CA--C 1.477 -2.336 0 C-N-CA 129.454 3.407 . . . . 0.0 113.378 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.75 -51.08 4.37 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 112.436 -1.882 . . . . 0.0 111.531 -162.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.3 p -175.86 152.66 1.3 Allowed Pre-proline 0 N--CA 1.434 -1.251 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 -173.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -86.03 -13.32 5.59 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.226 1.95 . . . . 0.0 108.658 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -96.33 159.42 32.03 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -75.28 142.93 27.61 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 C-N-CA 121.998 1.799 . . . . 0.0 107.507 -172.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -82.06 161.16 78.45 Favored 'Cis proline' 0 CA--C 1.487 -1.827 0 CA-C-N 123.538 2.299 . . . . 0.0 110.794 8.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 5.5 m -142.87 122.41 13.23 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -166.436 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -85.58 109.19 18.36 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -174.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -99.61 121.53 41.33 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -98.83 152.67 19.47 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.38 31.2 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.2 m -126.56 98.24 5.33 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 167.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.19 142.77 32.89 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 121.153 0.501 . . . . 0.0 109.967 -175.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -146.13 -177.49 20.84 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 77' ' ' GLN . 70.5 t80 -151.65 92.51 1.76 Allowed 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 101.627 -3.471 . . . . 0.0 101.627 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -136.99 154.4 50.42 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -161.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -68.14 128.88 38.18 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 168.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.9 m -93.03 120.48 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -174.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 75.2 t -86.84 118.39 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.585 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 112' ' ' PRO . 0.6 OUTLIER -122.84 157.96 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 N-CA-C 103.506 -2.775 . . . . 0.0 103.506 176.394 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -94.11 128.53 40.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.8 t -107.45 136.75 46.7 Favored 'General case' 0 CA--C 1.491 -1.295 0 C-N-CA 124.148 0.979 . . . . 0.0 108.847 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.45 138.98 50.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.788 -2.671 . . . . 0.0 103.788 169.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.31 14.0 p30 65.64 17.7 10.98 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 127.17 2.188 . . . . 0.0 116.644 172.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.83 23.71 48.55 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.251 28.3 tp -141.14 151.05 60.82 Favored Pre-proline 0 CA--C 1.486 -1.484 0 N-CA-C 101.351 -3.574 . . . . 0.0 101.351 -179.076 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 105' ' ' VAL . 74.1 Cg_exo -66.94 162.88 35.93 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 122.552 1.947 . . . . 0.0 109.791 164.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.4 OUTLIER -147.4 -27.14 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 O-C-N 121.616 -0.677 . . . . 0.0 111.274 176.245 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.554 ' CD2' HG23 ' A' ' 113' ' ' VAL . 88.8 m-70 -144.08 172.03 13.45 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 -173.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.0 134.28 54.33 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 175.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.63 121.03 27.73 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 174.232 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -103.94 45.67 0.95 Allowed 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -176.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 29.8 p -98.74 -30.41 12.45 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 175.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.66 -23.5 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.217 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -172.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -101.31 -5.24 25.71 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.872 -172.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -68.85 -41.59 78.27 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -75.22 119.41 76.85 Favored Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 170.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.434 -1.993 0 N-CA-C 106.453 -2.172 . . . . 0.0 106.453 -164.667 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 . . . . . 0 CA--C 1.486 -1.49 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -108.55 58.77 0.61 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 176.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -115.82 4.16 13.89 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 169.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.59 -18.5 26.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.164 179.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -68.44 -43.66 76.59 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.513 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.252 8.6 t80 -59.84 -55.91 28.33 Favored 'General case' 0 N--CA 1.402 -2.837 0 C-N-CA 124.768 1.227 . . . . 0.0 111.142 174.405 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -77.18 -7.82 56.49 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -173.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -82.34 -32.36 29.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-N 119.479 1.036 . . . . 0.0 109.091 170.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.446 ' CD2' HD12 ' A' ' 10' ' ' LEU . 1.9 t80 -58.22 -38.98 77.87 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.13 164.354 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' A' ' 14' ' ' TYR . 8.4 mp -83.38 -11.51 57.53 Favored 'General case' 0 C--N 1.354 0.78 0 CA-C-N 119.651 1.114 . . . . 0.0 113.495 178.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.2 m -70.66 -45.25 65.44 Favored 'General case' 0 CA--C 1.492 -1.257 0 CA-C-N 119.564 1.075 . . . . 0.0 108.298 169.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.12 -41.35 67.32 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.044 179.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CE1' HD12 ' A' ' 115' ' ' LEU . 93.5 m-70 -101.56 -54.5 2.74 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.096 -169.028 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.672 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 9.6 t80 -72.45 126.41 29.77 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 120.45 1.477 . . . . 0.0 112.776 -165.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -149.17 104.37 3.41 Favored 'General case' 0 N--CA 1.424 -1.75 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 172.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.2 -32.28 10.12 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 118.452 2.76 . . . . 0.0 118.452 -162.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.2 152.38 42.9 Favored Pre-proline 0 N--CA 1.432 -1.37 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 173.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' HD3' ' CG ' ' A' ' 47' ' ' HIS . 17.2 Cg_endo -71.31 144.1 45.14 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 C-N-CA 123.265 2.643 . . . . 0.0 107.519 167.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -77.52 -51.63 10.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 170.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.6 179.68 17.35 Favored Glycine 0 CA--C 1.478 -2.259 1 N-CA-C 103.091 -4.004 . . . . 0.0 103.091 161.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -118.92 55.03 0.94 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.49 179.81 6.58 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -170.553 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -67.95 -23.94 65.11 Favored 'General case' 0 N--CA 1.437 -1.123 0 C-N-CA 125.352 1.461 . . . . 0.0 113.204 -172.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -80.88 -25.76 37.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.51 -44.78 49.76 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 21.9 m -65.07 -38.07 89.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.35 -33.81 55.31 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 119.117 -0.468 . . . . 0.0 111.072 -178.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -76.57 -29.87 56.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 118.78 -0.628 . . . . 0.0 112.023 179.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.288 13.5 tt -75.92 -38.58 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 118.796 -0.621 . . . . 0.0 109.611 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.7 mtm -79.27 -23.23 43.76 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 118.136 -1.425 . . . . 0.0 113.447 -176.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -72.39 -36.81 68.78 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 170.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -76.18 -45.66 32.26 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 123.537 0.735 . . . . 0.0 111.479 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -76.78 -25.43 53.36 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.744 1.618 . . . . 0.0 109.344 -173.228 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.12 44.48 3.8 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 163.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.8 mt -118.54 19.77 13.19 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -90.08 -11.33 41.67 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.619 1.168 . . . . 0.0 108.244 -176.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.2 m -121.3 105.0 39.92 Favored Pre-proline 0 N--CA 1.424 -1.738 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.61 161.31 94.91 Favored 'Cis proline' 0 N--CA 1.441 -1.612 0 N-CA-C 107.018 -1.955 . . . . 0.0 107.018 -22.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.3 m -63.95 125.54 24.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.202 1.001 . . . . 0.0 109.586 -177.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -77.78 142.38 38.67 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -76.7 -36.47 57.2 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -171.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.76 128.65 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -161.36 144.48 12.56 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.0 m -106.87 138.88 42.2 Favored 'General case' 0 CA--C 1.487 -1.456 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.964 -170.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -101.87 129.77 48.19 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 162.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.2 mt -99.67 150.89 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.637 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -174.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.794 ' HB2' ' HB2' ' A' ' 77' ' ' GLN 0.252 7.9 m-70 -140.25 153.12 46.42 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.741 -174.024 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.04 -124.24 3.89 Favored Glycine 0 CA--C 1.478 -2.246 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 169.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.65 135.58 42.93 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 122.968 1.366 . . . . 0.0 109.707 -177.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.27 -29.11 34.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.602 -1.636 . . . . 0.0 106.857 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -29.11 64.85 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.9 m -76.88 -36.79 56.47 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-O 116.663 -1.637 . . . . 0.0 111.485 176.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 53' ' ' ILE 0.268 6.6 tp -65.03 -46.34 91.77 Favored 'Isoleucine or valine' 0 C--N 1.369 1.435 0 CA-C-N 120.193 1.361 . . . . 0.0 110.592 -178.672 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -60.61 -43.48 97.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.428 1.091 . . . . 0.0 110.808 176.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.18 11.46 2.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.8 mm -76.56 -35.99 27.03 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.097 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 167.127 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.6 m -96.74 5.29 50.91 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -112.38 18.65 18.33 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.087 0.946 . . . . 0.0 108.461 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 9.7 p30 32.1 47.58 0.09 Allowed 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 131.686 3.994 . . . . 0.0 115.744 -170.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.78 -60.7 2.21 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.55 64.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.163 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.19 146.84 8.58 Favored Glycine 0 N--CA 1.432 -1.606 0 N-CA-C 107.599 -2.2 . . . . 0.0 107.599 173.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -102.49 164.06 16.42 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -174.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.92 144.01 42.19 Favored 'Trans proline' 0 N--CA 1.437 -1.797 0 C-N-CA 122.692 2.262 . . . . 0.0 106.886 166.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -136.23 33.69 2.81 Favored 'General case' 0 CA--C 1.482 -1.669 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 -178.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.6 mmt-85 61.12 157.62 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 129.017 2.927 . . . . 0.0 114.73 178.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 52.84 46.77 26.09 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 128.126 2.57 . . . . 0.0 113.882 175.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.316 2.8 p-10 51.48 40.35 26.61 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.785 2.434 . . . . 0.0 114.192 -174.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.7 mt -117.88 153.81 32.91 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 100.799 -3.778 . . . . 0.0 100.799 177.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -146.26 125.17 12.72 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -178.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.6 tt -90.59 143.19 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 179.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.0 p -80.88 158.16 25.41 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.693 0.758 . . . . 0.0 112.75 -175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -108.11 -19.97 13.32 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 t -104.93 82.45 1.87 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 -177.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.2 p -52.43 132.06 34.27 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 127.023 2.129 . . . . 0.0 112.413 178.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -107.26 160.42 15.61 Favored 'General case' 0 CA--C 1.474 -1.969 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.794 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . 7.3 mm-40 -79.76 144.3 33.72 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 169.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.77 142.14 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 55.2 m -131.54 104.56 7.03 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 169.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.0 m -86.32 105.26 16.55 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 58.1 m -87.34 111.25 20.89 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -111.36 131.52 55.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 -171.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.5 118.01 11.83 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 123.64 0.776 . . . . 0.0 108.935 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -130.93 71.38 1.47 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 -175.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.19 -45.97 0.02 OUTLIER Glycine 0 CA--C 1.483 -1.939 0 N-CA-C 105.156 -3.178 . . . . 0.0 105.156 179.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.02 37.03 8.6 Favored Glycine 0 N--CA 1.433 -1.5 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 178.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 p -103.57 122.29 45.37 Favored Pre-proline 0 N--CA 1.434 -1.246 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 175.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -83.54 -20.21 4.88 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 CA-C-N 121.587 1.602 . . . . 0.0 108.614 176.077 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -110.9 158.44 35.74 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.318 -167.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.25 147.01 36.81 Favored 'Trans proline' 0 N--CA 1.438 -1.763 0 C-N-CA 122.824 2.35 . . . . 0.0 108.382 -173.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -82.06 165.75 72.34 Favored 'Cis proline' 0 N--CA 1.438 -1.761 0 CA-C-N 122.401 1.893 . . . . 0.0 108.489 -1.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.1 m -113.12 157.91 21.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.703 1.252 . . . . 0.0 107.637 -172.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -111.57 135.59 51.93 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 167.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -133.71 122.58 23.58 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.2 ttt85 -89.06 125.12 34.88 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.09 122.34 27.21 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.4 m -115.24 88.07 2.79 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.48 142.34 27.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.009 -172.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -138.11 -177.09 14.94 Favored Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 177.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -140.44 97.62 3.25 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 101.933 -3.358 . . . . 0.0 101.933 175.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -158.34 -179.66 8.31 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -164.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -79.91 146.84 31.92 Favored 'General case' 0 CA--C 1.49 -1.352 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.053 -173.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.3 m -99.43 151.95 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.6 t -114.06 95.02 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 163.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.7 m -88.3 136.6 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 -179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.53 130.17 34.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 174.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 57.1 m -109.66 149.64 29.43 Favored 'General case' 0 CA--C 1.489 -1.376 0 O-C-N 124.136 0.897 . . . . 0.0 110.688 -173.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.21 124.97 7.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . 0.324 13.2 p30 65.89 18.32 11.06 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.782 2.433 . . . . 0.0 116.338 171.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.3 -7.02 59.83 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 178.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -103.06 148.76 36.11 Favored Pre-proline 0 N--CA 1.426 -1.646 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 177.611 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -70.89 143.46 45.46 Favored 'Trans proline' 0 N--CA 1.435 -1.968 0 N-CA-C 106.261 -2.246 . . . . 0.0 106.261 156.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 114' ' ' HIS . 0.9 OUTLIER -121.22 -22.34 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.278 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.369 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 113' ' ' VAL . 31.2 m-70 -154.25 -167.35 2.61 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -167.88 136.75 2.49 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 -179.656 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -80.5 139.66 36.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.627 -1.169 . . . . 0.0 109.864 176.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -101.88 40.77 1.28 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 172.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.3 m -96.22 -30.19 13.61 Favored 'General case' 0 CA--C 1.484 -1.585 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -175.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 119' ' ' ILE . 0.0 OUTLIER -76.71 -35.41 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.941 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.241 172.411 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -103.43 43.47 1.08 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -168.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -153.34 -50.03 0.1 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 171.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -112.35 112.44 51.88 Favored Pre-proline 0 N--CA 1.431 -1.381 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 178.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.432 -2.103 0 N-CA-C 106.167 -2.282 . . . . 0.0 106.167 -176.485 . . . . . . . . 0 0 . 1 stop_ save_